data_2l28_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l28 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.16 154.6 23.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.532 ' CD1' HG22 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -121.53 114.56 21.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.226 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.492 ' CD1' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -114.73 122.9 47.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.47 0.652 . . . . 0.0 112.466 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.493 ' CH2' HG13 ' A' ' 115' ' ' VAL . 6.7 p90 -164.12 165.15 22.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.189 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.39 136.06 53.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.361 . . . . 0.0 111.737 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -125.89 144.26 50.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.518 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.472 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.9 p30 -98.41 -169.29 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -49.27 46.1 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.175 0.512 . . . . 0.0 110.59 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -29.24 63.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.288 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.02 31.09 6.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.415 ' HB3' ' OD2' ' A' ' 8' ' ' ASP . 7.5 tt -83.43 167.9 17.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.592 0.235 . . . . 0.0 110.618 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.406 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.348 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.404 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 68.0 mt -77.82 89.29 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.854 0.359 . . . . 0.0 111.813 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.6 ttp -99.4 120.81 40.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.454 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 40.3 t -79.82 158.36 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 111.646 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.458 HG11 ' CE2' ' A' ' 49' ' ' PHE . 34.5 m -161.67 149.93 4.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.89 149.35 44.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.846 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -48.22 -52.4 21.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.116 0.458 . . . . 0.0 110.119 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.463 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -56.34 -34.64 66.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.251 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -70.36 -54.8 11.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.131 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 73' ' ' ALA . 35.7 t80 -50.39 -28.06 7.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.457 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -66.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -57.5 -30.41 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.591 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CE2' HG11 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -36.42 133.69 0.61 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.705 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -38.99 -29.12 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.394 2.729 . . . . 0.0 113.766 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -162.19 152.31 16.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 111.197 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.52 108.9 10.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 88.1 Cg_endo -82.22 -179.09 22.9 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.364 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 51.0 mt -82.23 145.82 53.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.774 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.65 109.66 2.54 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.419 2.079 . . . . 0.0 112.236 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 77.55 14.68 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.8 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -132.89 112.63 12.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.638 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 46.6 m -70.51 113.03 7.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.083 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.38 156.66 17.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.305 0.574 . . . . 0.0 112.079 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.29 141.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.152 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.05 123.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.916 0.388 . . . . 0.0 111.351 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -105.62 120.12 40.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.421 HG23 ' CG ' ' A' ' 68' ' ' TYR . 1.8 t -153.6 155.77 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.5 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.861 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.2 tt0 -74.12 134.05 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.97 1.83 53.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.672 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -127.79 3.6 6.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.61 0.243 . . . . 0.0 111.503 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.503 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.0 t80 -57.1 137.82 55.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 111.419 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -130.39 173.39 10.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.218 1.008 . . . . 0.0 112.613 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.52 143.3 19.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.576 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.4 101.16 7.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.791 0.329 . . . . 0.0 110.336 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.46 -40.92 2.9 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.749 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 46' ' ' TYR . . . -70.16 166.89 18.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.551 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.13 140.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 15.0 t -109.3 117.66 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 26.9 m -126.96 167.36 21.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.426 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -116.82 -22.33 8.6 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.685 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.64 -173.62 4.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.622 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.469 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 19.3 t -69.72 -9.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.728 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.64 -34.72 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.443 . . . . 0.0 110.107 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.24 -30.81 62.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 ' CG2' ' A' ' 76' ' ' VAL . 23.1 t -73.52 -49.39 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 109.998 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.409 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 5.7 m-85 -57.08 -28.02 62.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.909 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.29 -42.22 88.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.039 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.89 -56.23 12.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.16 -22.8 30.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.976 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.72 -41.73 71.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -83.82 -10.02 58.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.546 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -123.71 64.73 32.27 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.59 -0.8 6.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.044 2.496 . . . . 0.0 112.756 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.54 26.95 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.4 163.57 12.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.454 . . . . 0.0 111.457 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.98 159.76 14.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.571 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.4 tp -113.52 113.58 25.33 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.837 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -134.54 121.59 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.679 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 17.6 mm -81.0 132.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.06 0.457 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -96.9 -50.55 4.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.067 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.09 -169.35 42.46 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.75 -160.78 36.47 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 117.635 0.717 . . . . 0.0 112.493 -0.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.57 -48.76 19.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.765 0.317 . . . . 0.0 111.301 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.8 -32.46 52.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.122 0.487 . . . . 0.0 110.403 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.416 HD11 ' HB3' ' A' ' 62' ' ' LEU . 45.8 mm -85.23 -27.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.205 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -60.67 -57.46 12.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.751 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 107' ' ' LYS . 1.6 t -66.81 -9.97 42.84 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.93 -0.481 . . . . 0.0 112.263 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.34 -39.87 62.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.05 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 1.9 m-85 -101.36 -3.18 29.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.767 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 104' ' ' THR . 1.8 pttt -49.16 -32.52 10.33 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -0.73 57.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -120.48 -26.9 5.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.342 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 3' ' ' PHE . 62.7 t -50.11 126.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.59 -12.65 19.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.04 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 95.9 m -148.28 141.79 25.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.523 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 12.9 mt -123.62 146.78 47.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.262 0.554 . . . . 0.0 111.743 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -135.55 116.97 14.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' A' ' 156' ' ' GLU . 1.0 OUTLIER -131.71 141.95 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.427 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.41 99.25 7.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.608 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -75.53 100.06 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.384 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mt -84.66 126.54 33.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.325 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.11 -43.51 82.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.208 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.85 167.55 48.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.514 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.2 p -101.2 150.79 22.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 111.0 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -130.37 149.32 52.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 167.38 15.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.421 . . . . 0.0 111.318 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.69 164.67 11.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.89 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -1.29 12.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.503 0.192 . . . . 0.0 111.316 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 m -109.22 128.65 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -105.24 164.07 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.54 147.4 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.592 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -71.14 164.39 57.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.27 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.592 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.0 Cg_endo -74.92 102.9 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.357 2.038 . . . . 0.0 112.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.407 HD13 ' CH2' ' A' ' 5' ' ' TRP . 2.9 mt -88.1 144.35 26.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.54 70.49 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.302 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -55.04 -24.98 27.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.292 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -30.3 65.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 0.0 110.474 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -80.32 -25.65 39.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 85.5 m-85 -100.26 176.58 5.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.772 0.32 . . . . 0.0 110.43 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -137.09 140.71 42.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.508 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.2 ttpm? -79.93 114.81 19.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 17.1 m -97.64 -19.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -164.11 140.76 6.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.5 p -163.75 112.65 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.036 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -148.1 125.34 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 3.5 m -79.24 145.72 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 152' ' ' THR . 5.0 t -119.2 103.5 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -84.49 99.81 10.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 -179.92 7.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.4 p -53.41 -46.98 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 110.581 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.482 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -79.11 124.27 84.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.368 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.96 -29.44 89.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 112.599 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.37 -18.75 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.2 mt -83.94 7.06 19.5 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.579 0.228 . . . . 0.0 111.466 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 144' ' ' VAL . 91.1 m -71.07 164.91 24.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -171.05 157.63 5.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.603 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 45.1 m -123.2 126.56 47.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.588 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.22 105.44 17.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HB2' HG21 ' A' ' 115' ' ' VAL . 75.3 mt-10 -106.37 124.61 49.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.196 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 21.8 t -116.55 113.68 43.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.259 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.508 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 20.2 m95 -108.62 150.23 27.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.937 0.399 . . . . 0.0 111.481 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -127.51 119.0 25.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -57.08 130.8 47.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -104.37 -176.06 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.137 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 52.2 m . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.68 151.11 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.4 m-30 -118.03 107.8 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.212 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.59 HD11 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -106.36 124.78 50.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.332 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.456 ' CH2' HG11 ' A' ' 115' ' ' VAL . 6.0 p90 -168.38 174.24 7.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.4 137.79 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.5 pt20 -119.26 156.57 29.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 111.332 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -102.58 169.06 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.23 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.11 -30.04 6.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.929 0.395 . . . . 0.0 110.568 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -89.02 -27.51 20.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.0 22.15 6.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.714 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.2 tt -77.27 166.46 23.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.633 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.466 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mttp . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 54.2 mt -86.88 88.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 O-C-N 122.012 -0.43 . . . . 0.0 110.768 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 5.6 ttp -100.13 119.12 37.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.58 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 2.7 t -87.53 128.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.43 154.94 40.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.378 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 162.13 53.79 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.843 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.462 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -58.5 -50.01 75.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.984 0.392 . . . . 0.0 110.654 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.462 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 tpt180 -61.03 -35.96 78.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 110.297 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 -50.41 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.387 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.3 t80 -52.59 -25.09 9.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -69.63 -65.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -28.07 61.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.33 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CZ ' ' HE3' ' A' ' 39' ' ' MET . 0.5 OUTLIER -37.69 136.86 0.72 Allowed Pre-proline 0 N--CA 1.467 0.404 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.779 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.17 -30.47 25.64 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.802 2.335 . . . . 0.0 113.074 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -159.34 151.96 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -140.98 110.93 6.61 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HG3' ' O ' ' A' ' 71' ' ' GLN . 10.9 Cg_exo -81.35 178.54 31.02 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.585 -1.423 . . . . 0.0 111.996 -0.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 31.8 mt -83.16 156.0 66.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.15 107.42 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.404 2.069 . . . . 0.0 112.875 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 70.74 4.75 5.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.508 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -108.51 122.92 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.938 0.399 . . . . 0.0 111.411 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.4 m -75.13 117.02 16.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.158 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -105.58 156.04 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.445 . . . . 0.0 112.015 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 24.6 t -136.97 137.42 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.337 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 76' ' ' VAL . 57.6 t -107.76 126.59 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 0.0 111.323 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -107.65 117.2 33.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.969 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.415 HG22 ' CG ' ' A' ' 68' ' ' TYR . 1.3 t -148.43 161.36 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.959 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -79.08 -11.42 59.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.452 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tp60 -82.35 134.03 35.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.535 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -84.01 -29.63 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.636 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.85 2.24 54.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.159 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.2 t80 -58.83 139.5 56.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 1.3 mt-30 -128.7 174.37 9.49 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.219 1.009 . . . . 0.0 112.447 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.13 144.32 21.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.847 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 13.6 mt-30 -73.52 96.85 2.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.362 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.36 -37.01 3.15 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.645 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.12 171.51 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 112.024 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 85' ' ' TYR . 13.8 t -97.78 140.35 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.467 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 38.9 t -106.95 104.77 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.24 0.543 . . . . 0.0 112.281 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 23.6 m -117.44 166.93 11.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.366 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -121.91 -19.89 6.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.307 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.42 ' HA ' HD23 ' A' ' 62' ' ' LEU . 1.8 t70 -155.65 -178.87 7.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.209 0.528 . . . . 0.0 111.602 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.44 HG23 ' CG ' ' A' ' 106' ' ' PHE . 15.8 t -66.29 -8.97 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.767 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.73 -35.02 16.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.487 . . . . 0.0 109.869 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.91 -32.93 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.903 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.471 HG22 ' CG2' ' A' ' 76' ' ' VAL . 39.9 t -70.73 -49.99 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.545 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.2 m-85 -55.79 -26.24 45.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.897 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.76 88.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.026 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CE1' HG22 ' A' ' 74' ' ' VAL . 58.3 t80 -66.07 -57.14 8.39 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.96 14.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.467 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.03 -36.72 80.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 -2.59 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.222 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -128.56 68.28 77.77 Favored Pre-proline 0 N--CA 1.456 -0.161 0 CA-C-O 121.082 0.467 . . . . 0.0 110.298 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.97 0.55 3.04 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.41 2.74 . . . . 0.0 113.087 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.92 -19.69 17.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.229 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 5.0 mm100 -109.83 154.99 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -98.16 174.92 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.365 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 1' ' ' THR . 0.0 OUTLIER -111.49 109.07 18.84 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.574 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' MET . 39.2 t -124.24 108.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.298 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.462 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 18.5 mm -85.55 142.36 13.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.384 0.612 . . . . 0.0 111.961 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -111.45 -44.66 3.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.371 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.91 -165.75 38.56 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.622 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.43 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -82.53 -161.19 29.28 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.401 0.6 . . . . 0.0 112.651 -0.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.71 -48.07 69.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.855 0.359 . . . . 0.0 111.078 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -58.09 -29.19 65.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.608 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 62' ' ' LEU . 20.7 mm -79.95 -29.28 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.358 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.428 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 3.5 m-85 -58.44 -55.91 28.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.733 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.519 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.4 t -65.17 -9.83 26.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.47 -43.41 27.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.843 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CG ' HG23 ' A' ' 79' ' ' VAL . 5.6 m-85 -93.56 -6.79 45.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.338 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.519 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 10.9 pttp -49.8 -32.98 15.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.399 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -78.87 -6.04 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.764 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.09 -24.7 4.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 3' ' ' PHE . 76.6 t -44.43 124.58 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.94 0.4 . . . . 0.0 111.447 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.452 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 6.3 t70 -103.07 -1.22 29.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.687 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 86.3 m -161.46 142.51 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.585 0.231 . . . . 0.0 111.065 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 7.0 mt -123.58 144.95 49.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.213 0.53 . . . . 0.0 111.415 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.9 mt -135.33 118.94 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.761 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.456 HG11 ' CH2' ' A' ' 5' ' ' TRP . 2.9 m -134.78 144.8 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.424 . . . . 0.0 111.688 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.84 119.31 35.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 7.1 mtm180 -102.05 104.7 15.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.418 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -87.8 136.46 32.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.44 -48.23 68.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.27 -138.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.7 p -144.23 168.2 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 0.0 111.335 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 80.0 m-85 -131.2 137.74 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.743 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 166.53 10.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.734 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.24 -159.12 29.18 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.13 22.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.5 m -146.08 137.82 24.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.863 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -109.34 165.82 11.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -177.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pt -104.06 156.73 35.3 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.88 99.9 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.671 2.247 . . . . 0.0 112.194 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.73 148.08 23.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.955 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.37 70.6 6.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.424 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 94.4 m95 -53.41 -27.64 25.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.094 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.09 -29.11 67.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.421 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.57 -20.67 42.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 43.5 m-85 -100.02 175.86 5.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.5 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 2.5 m -134.32 139.95 46.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.422 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.639 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 7.7 ttpt -83.94 111.56 19.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.4 m -98.8 -17.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.487 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -163.89 140.21 6.62 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.443 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.639 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 81.0 p -168.04 105.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.464 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -142.79 121.25 12.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.649 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.2 m -71.16 145.59 49.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.21 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 152' ' ' THR . 4.4 t -117.77 103.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.579 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -86.61 100.27 12.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.358 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -83.24 -176.9 6.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -56.68 -54.15 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.942 0.401 . . . . 0.0 110.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.51 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.6 t30 -73.63 127.84 87.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.847 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.63 -31.6 92.34 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.037 1.825 . . . . 0.0 112.563 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.62 -21.48 28.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.8 mt -82.08 8.79 9.84 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 144' ' ' VAL . 95.5 m -75.28 164.1 26.79 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.9 p80 -175.58 162.19 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.994 0.426 . . . . 0.0 111.581 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 7.7 m -122.12 144.85 48.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.911 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -111.65 110.06 20.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.71 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 115' ' ' VAL . 7.0 mm-40 -98.68 151.26 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.7 t -141.77 106.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.009 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 25.1 m95 -108.5 146.18 33.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.106 0.479 . . . . 0.0 111.949 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -124.81 112.74 17.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.233 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.2 tttt -51.17 131.74 27.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.227 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -92.39 168.59 11.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.295 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.159 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 11.8 m . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.28 152.47 27.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.498 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.3 m-30 -118.11 112.03 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.21 126.34 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.673 0.749 . . . . 0.0 112.881 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.484 ' CH2' HG12 ' A' ' 115' ' ' VAL . 9.0 p90 -164.6 164.73 21.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.055 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.04 134.93 54.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 111.472 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 2.7 pt20 -115.61 140.34 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -97.82 -167.42 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -51.36 -34.66 35.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.784 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.63 -28.42 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 94.83 45.86 3.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.466 ' CD1' ' HA3' ' A' ' 124' ' ' GLY . 1.4 mt -91.11 174.31 7.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.415 HG23 ' CD1' ' A' ' 5' ' ' TRP . 1.1 pp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.653 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 mttm . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.566 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 74.3 mt -74.55 94.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 112.016 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.6 ttp -103.48 126.81 50.85 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.014 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.459 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 21.1 t -78.9 158.22 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 27.3 m -165.04 142.98 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.99 158.5 51.2 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.81 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -52.84 -48.51 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.058 0.429 . . . . 0.0 110.77 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -62.66 -27.01 68.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 0.0 110.467 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.2 m -75.73 -44.62 40.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.589 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -61.33 -31.59 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -66.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.71 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 49' ' ' PHE . 3.9 t -54.7 -33.05 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -26.38 114.31 0.23 Allowed Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.883 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.88 -37.0 21.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.043 2.495 . . . . 0.0 113.307 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' CE ' HD23 ' A' ' 54' ' ' LEU . 2.6 tmmm? -147.13 118.93 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.777 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.86 140.16 21.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.18 -167.1 5.06 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.23 -1.571 . . . . 0.0 112.004 -0.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.561 ' HB3' ' CD ' ' A' ' 57' ' ' ARG . 81.9 mt -111.61 137.47 21.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.06 -66.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.65 2.233 . . . . 0.0 113.302 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.82 19.8 1.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.488 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.561 ' CD ' ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -142.27 121.43 12.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.119 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.566 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 39.9 m -80.59 128.11 33.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.289 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -115.02 147.36 40.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 111.843 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG12 ' CG2' ' A' ' 76' ' ' VAL . 3.3 t -131.12 132.65 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.464 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -97.73 128.89 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.289 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -107.07 115.38 30.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -147.4 156.75 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -74.15 -12.4 60.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.888 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tt0 -80.39 133.5 35.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -84.67 -11.13 56.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.962 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.37 4.41 20.66 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.4 t80 -58.26 140.45 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.54 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.634 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -126.48 173.85 9.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 179.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.49 143.68 20.09 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.648 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.73 96.75 5.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.742 0.306 . . . . 0.0 110.696 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.11 2.65 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.959 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.16 167.75 17.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.071 0.462 . . . . 0.0 111.718 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.438 HG13 ' CD1' ' A' ' 85' ' ' TYR . 32.3 t -97.07 140.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.421 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.3 t -104.23 117.66 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.368 0.604 . . . . 0.0 112.477 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 28.1 m -127.31 167.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.962 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.426 ' O ' HD21 ' A' ' 62' ' ' LEU . 4.7 m80 -119.13 -22.18 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.539 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -159.33 -175.02 4.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.667 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 106' ' ' PHE . 11.8 t -66.64 -11.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.786 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.69 -36.82 17.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 0.0 109.752 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.65 -31.74 65.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.478 HG23 HG22 ' A' ' 76' ' ' VAL . 31.6 t -69.68 -53.82 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.986 0.422 . . . . 0.0 109.938 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.497 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 5.6 m-85 -53.61 -27.6 27.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.971 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.49 88.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.895 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CD1' HG13 ' A' ' 74' ' ' VAL . 68.5 t80 -64.43 -54.49 31.87 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.78 -24.2 34.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -71.39 -33.63 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -83.16 -8.72 59.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.376 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -124.82 66.01 47.32 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.019 0.437 . . . . 0.0 110.277 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.3 -0.46 2.89 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.099 2.533 . . . . 0.0 112.831 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.09 -30.28 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.009 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.93 161.81 14.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -98.76 174.77 6.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 1' ' ' THR . 8.5 tp -122.27 118.8 29.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.383 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.5 t -132.87 121.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.432 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 8.7 mm -83.25 133.39 29.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.11 0.481 . . . . 0.0 111.832 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.402 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -101.22 -50.04 3.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.21 -171.13 43.94 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.717 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.45 -160.98 36.79 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.674 0.737 . . . . 0.0 112.69 -0.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.02 10.18 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.733 0.301 . . . . 0.0 111.508 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -52.62 -30.52 31.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.553 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.89 -21.62 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . 2.7 m-85 -66.29 -51.75 54.25 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.506 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -70.75 -9.59 57.65 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 111.916 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.47 -37.87 35.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.482 ' HA ' HG23 ' A' ' 79' ' ' VAL . 6.3 m-85 -95.87 -11.12 27.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.682 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 9.4 pttp -51.4 -29.14 14.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.97 -12.45 60.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.411 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.89 -20.73 5.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.498 HG22 ' CD1' ' A' ' 3' ' ' PHE . 81.0 t -44.53 128.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.063 0.458 . . . . 0.0 111.317 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 6.2 t0 -110.47 -3.87 15.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.582 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.778 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.9 m -155.7 134.47 11.92 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.598 0.237 . . . . 0.0 111.08 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 136' ' ' PHE . 11.7 mt -117.01 144.08 44.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mt -135.91 115.51 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.502 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.484 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -131.4 141.34 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.39 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.44 112.78 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -96.26 100.44 12.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.366 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.0 OUTLIER -86.66 131.21 34.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.47 89.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.103 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.67 -173.3 0.08 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 p -124.54 136.58 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -138.15 157.49 46.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.91 170.37 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 12' ' ' LEU . . . -161.26 125.87 1.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.701 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.56 14.05 24.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.509 0.195 . . . . 0.0 111.42 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -162.85 137.27 6.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.939 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.33 160.78 14.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.202 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.411 ' HG3' ' N ' ' A' ' 129' ' ' ILE . 15.9 tpt -81.51 159.34 24.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.452 HD11 ' CA ' ' A' ' 104' ' ' THR . 1.1 pp -91.81 165.07 21.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.415 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.63 128.37 23.23 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.628 2.218 . . . . 0.0 112.043 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.408 HD13 ' CH2' ' A' ' 5' ' ' TRP . 2.5 mt -112.36 139.67 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.19 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 63.05 7.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -53.9 -24.37 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -31.14 65.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.03 -16.39 47.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.397 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 160' ' ' LYS . 77.9 m-85 -103.45 168.28 9.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 110.69 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.656 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -132.59 140.93 48.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.978 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 5.6 ttpt -79.93 119.41 22.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.41 -19.37 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.0 m -167.07 140.45 3.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.49 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 5.2 p -169.27 108.68 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -147.84 125.39 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.779 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.1 m -71.2 146.11 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.728 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 152' ' ' THR . 10.5 t -118.78 103.47 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.592 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -88.29 102.02 14.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.576 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.76 -174.4 4.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.654 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.9 p -58.0 -51.21 70.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.523 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.9 t30 -76.5 134.02 70.25 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.871 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.56 -35.29 60.48 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.985 1.79 . . . . 0.0 112.393 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.5 mt -78.45 8.91 4.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 144' ' ' VAL . 93.6 m -78.71 161.11 27.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.45 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -172.11 157.81 4.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.008 0.432 . . . . 0.0 111.594 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 7.5 m -119.06 131.48 55.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.574 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -99.79 105.21 16.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.755 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HB2' HG21 ' A' ' 115' ' ' VAL . 4.3 mt-10 -102.81 122.11 43.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.477 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.8 t -116.79 114.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 138' ' ' LYS . 30.5 m95 -112.15 150.56 30.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 111.556 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -126.8 115.02 18.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.829 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.497 ' HB2' ' CE1' ' A' ' 136' ' ' PHE . 3.0 ttpt -51.73 138.22 23.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.287 0.565 . . . . 0.0 112.434 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.656 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -125.87 -164.03 1.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.339 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.063 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.452 ' O ' HG11 ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.707 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.93 146.35 39.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.542 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.5 m-85 -110.2 115.79 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.531 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 tp -113.73 120.96 42.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.496 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 4.1 p90 -166.17 164.65 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.274 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.32 55.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 111.48 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 pt20 -123.29 153.05 40.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.157 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -103.18 -174.07 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.717 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -24.92 19.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -91.99 -31.17 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.744 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.98 22.74 7.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.669 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -87.22 153.09 21.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.45 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.9 mmtt . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 71.8 mt -86.6 85.27 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.051 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ttp -102.12 123.07 45.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.39 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 43.3 t -76.01 156.51 5.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.522 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 34.9 m -164.18 137.46 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.74 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.21 161.37 34.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.933 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -56.99 -47.2 81.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.861 0.33 . . . . 0.0 110.767 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.416 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.8 tpp180 -66.36 -30.48 70.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.388 . . . . 0.0 110.336 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 m -68.2 -43.73 77.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.204 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -59.05 -31.14 68.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.43 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.42 -66.1 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.1 t -50.07 -41.61 48.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.9 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.424 ' CE2' HG11 ' A' ' 41' ' ' VAL . 6.9 m-85 -42.44 152.92 0.32 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-O 120.781 0.324 . . . . 0.0 111.448 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -41.73 -72.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.063 2.509 . . . . 0.0 113.542 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.66 177.15 8.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.45 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 2.4 ptp180 -122.1 105.76 36.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 86.9 Cg_endo -87.89 -179.96 17.07 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.457 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.422 ' CD1' ' HD2' ' A' ' 57' ' ' ARG . 34.2 mt -61.18 158.53 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 12.9 Cg_endo -56.72 87.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.412 2.075 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 42.8 mt-10 69.62 47.55 0.64 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.351 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.422 ' HD2' ' CD1' ' A' ' 54' ' ' LEU . 17.0 mtt180 -140.79 126.05 18.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.671 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 92.0 m -76.5 105.84 7.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -104.6 145.86 29.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.224 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 12.1 t -117.63 141.78 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.097 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.8 t -108.32 124.42 64.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.116 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.28 121.05 44.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.484 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.511 HG23 ' CD2' ' A' ' 68' ' ' TYR . 2.5 t -157.17 160.13 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -75.52 -5.51 45.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.19 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.4 tp60 -78.71 129.85 35.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.63 -28.06 31.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.139 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.56 7.55 46.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 7.7 t80 -60.57 142.49 55.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.348 0.594 . . . . 0.0 111.897 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 14.9 mm100 -134.77 175.72 9.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.39 1.09 . . . . 0.0 112.888 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 142.64 19.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -78.11 100.94 6.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.35 -43.0 2.8 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.807 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.08 170.18 11.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.446 . . . . 0.0 111.709 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.414 HG11 ' CD1' ' A' ' 85' ' ' TYR . 18.5 t -99.48 140.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.42 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 21.5 t -111.36 119.97 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.357 0.599 . . . . 0.0 112.121 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.445 HG23 HG21 ' A' ' 82' ' ' VAL . 34.1 m -126.61 168.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.409 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -119.14 -25.46 6.17 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.794 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.07 -176.13 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.641 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.413 HG12 ' CD2' ' A' ' 106' ' ' PHE . 21.7 t -69.63 -10.73 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.688 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.72 -30.99 18.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 110.364 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.26 -26.59 52.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.445 HG21 HG23 ' A' ' 76' ' ' VAL . 16.7 t -78.41 -50.81 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 109.806 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.2 m-85 -57.33 -28.78 63.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.913 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.77 -38.29 79.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.7 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.414 ' CD1' HG11 ' A' ' 74' ' ' VAL . 67.4 t80 -68.12 -59.23 3.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.51 -22.84 14.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.202 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.89 -37.38 75.99 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.035 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.478 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 7.5 mt-30 -83.81 -4.49 58.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.233 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -124.76 65.04 43.77 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.563 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.8 -0.99 6.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.925 2.417 . . . . 0.0 112.829 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.7 -31.67 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 20.6 mt-30 -102.28 157.44 16.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -99.14 158.99 15.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.51 115.89 29.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.28 110.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.33 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.481 HD13 ' CG2' ' A' ' 40' ' ' VAL . 4.9 mm -77.2 129.03 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 0.0 111.079 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.19 -37.14 6.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.59 -169.11 42.17 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.785 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.34 -161.01 30.6 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 122.266 -0.549 . . . . 0.0 112.545 -0.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -55.12 -51.18 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.054 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -55.53 -27.64 50.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.591 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.439 ' CD1' ' HB3' ' A' ' 62' ' ' LEU . 49.0 mm -79.34 -32.94 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.0 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.455 ' HA ' ' CE2' ' A' ' 3' ' ' PHE . 6.2 m-85 -54.08 -58.16 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.65 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.568 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.1 t -65.78 -9.92 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.74 -41.56 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 110' ' ' VAL . 3.0 m-85 -101.56 -2.57 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.462 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 39.0 pttt -49.8 -34.36 19.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.731 0.3 . . . . 0.0 111.767 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 4.07 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.64 -25.0 3.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.542 HG22 ' CD1' ' A' ' 3' ' ' PHE . 62.9 t -44.04 129.35 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 120.97 0.414 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.411 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 24.5 t70 -103.41 2.77 34.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.124 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 97.8 m -166.97 138.63 3.32 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.538 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 21.2 mt -120.17 144.81 47.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.9 mt -135.31 115.23 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.2 m -132.16 143.05 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.848 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.35 105.67 13.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.235 179.31 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -81.98 101.67 10.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -84.91 125.73 32.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.974 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 -56.93 12.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.312 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.16 168.26 15.85 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.87 163.19 12.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CZ ' HD11 ' A' ' 118' ' ' LEU . 4.5 m-85 -136.39 147.99 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -98.75 132.67 43.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.692 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.14 -179.7 47.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.527 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.26 -0.18 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.7 m -118.13 122.45 43.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.032 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.74 175.98 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.4 tpt -76.61 153.3 35.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.855 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.443 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.8 pp -81.23 164.14 51.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.249 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.27 101.6 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.839 2.359 . . . . 0.0 112.686 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.415 ' CD1' ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -91.25 145.42 24.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.67 75.7 4.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.247 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -55.29 -21.25 13.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.304 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -28.36 61.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.3 t0 -80.74 -17.27 51.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.177 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.476 ' HZ ' ' HB ' ' A' ' 110' ' ' VAL . 91.5 m-85 -109.1 166.35 10.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.94 0.4 . . . . 0.0 111.559 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.731 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -125.24 140.31 52.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.739 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpm? -81.19 121.35 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.615 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 34.1 m -110.21 -15.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.612 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.33 139.87 3.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.81 0.338 . . . . 0.0 110.928 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.2 p -163.09 109.79 1.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -143.65 119.27 10.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.332 . . . . 0.0 111.283 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 5.0 m -74.09 144.61 44.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.244 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 t -116.53 106.22 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.126 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.69 105.49 17.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.588 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.86 -177.18 6.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.559 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 p -59.64 -42.01 91.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.465 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.4 t30 -81.78 126.35 75.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.23 -29.18 88.44 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.295 1.997 . . . . 0.0 112.274 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.54 -24.08 23.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.037 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.7 mt -81.32 6.28 14.78 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 52.1 m -71.38 164.5 25.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.071 0.463 . . . . 0.0 110.124 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.58 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.1 p80 -174.37 160.95 3.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.13 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 26.9 m -122.69 150.16 43.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.629 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -111.05 105.21 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.54 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.502 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.1 mt-10 -105.05 121.63 44.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 111.631 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 4.1 t -112.93 111.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.696 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.2 m95 -110.89 150.33 29.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 111.487 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -128.39 120.91 27.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.496 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.5 tmmt? -45.5 125.93 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.643 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.731 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -109.79 -176.27 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.105 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.51 144.92 42.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.8 m-30 -107.66 112.9 25.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.457 ' CD1' ' H ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.33 124.92 53.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.36 0.6 . . . . 0.0 112.43 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.481 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 4.9 p90 -170.91 174.05 4.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.617 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.76 139.77 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.183 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -120.48 154.76 34.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 111.422 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 12' ' ' LEU . 1.1 p30 -108.62 -177.7 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.441 ' HG2' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -47.88 -49.63 29.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.32 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.23 -19.55 64.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.55 25.89 21.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.347 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -90.4 161.98 15.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.857 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 5' ' ' TRP . 11.4 pt . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.202 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 58.6 mt -82.18 88.42 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.6 ttp -97.91 116.89 31.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.801 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.414 HG21 ' CD1' ' A' ' 96' ' ' ILE . 5.8 t -86.3 125.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.09 0.471 . . . . 0.0 111.688 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.444 HG12 ' CE2' ' A' ' 49' ' ' PHE . 24.5 m -132.13 155.13 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.502 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.13 147.0 32.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.756 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -45.09 -49.29 11.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.72 0.26 . . . . 0.0 111.459 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 3.8 ttt180 -62.14 -36.88 83.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 0.0 110.146 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -63.34 -49.38 74.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.475 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.545 ' O ' ' HB2' ' A' ' 49' ' ' PHE . 2.9 t80 -50.3 -43.76 53.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.875 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -52.38 -63.98 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.766 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -35.08 67.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.37 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -34.98 138.52 0.35 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-O 120.905 0.384 . . . . 0.0 111.973 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.19 -29.99 18.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.253 2.635 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 149.33 31.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.387 . . . . 0.0 111.501 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -138.65 106.37 7.63 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -86.0 -166.91 4.37 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.273 -0.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.483 ' HB3' ' CD ' ' A' ' 57' ' ' ARG . 75.4 mt -100.58 142.05 23.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.92 121.17 6.77 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 112.798 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 69.98 3.09 4.18 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.771 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.483 ' CD ' ' HB3' ' A' ' 54' ' ' LEU . 3.4 mtt-85 -114.42 108.8 17.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.0 m -68.24 113.19 5.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -104.73 150.37 24.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.397 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 t -134.83 133.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.2 t -103.01 124.04 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.753 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -105.72 111.23 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.907 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.434 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -142.83 170.81 15.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 111.285 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -86.91 -14.19 42.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.683 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.6 tt0 -79.17 133.58 36.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 23.4 mt-10 -80.89 -25.61 37.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.79 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.89 6.78 48.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.492 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.2 t80 -60.08 136.24 57.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.216 0.532 . . . . 0.0 111.6 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.452 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -132.04 173.71 10.93 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.254 1.026 . . . . 0.0 112.703 179.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.07 141.41 18.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.096 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.26 101.56 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.807 0.337 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -41.39 2.92 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.638 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.44 167.74 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.52 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.78 140.77 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 19.2 t -110.03 119.87 59.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.228 0.537 . . . . 0.0 112.066 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 HG22 ' A' ' 82' ' ' VAL . 27.6 m -130.19 167.11 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.664 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.439 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 17.3 m80 -118.28 -22.51 7.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.65 -176.72 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.206 0.527 . . . . 0.0 111.507 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 106' ' ' PHE . 35.6 t -71.89 -9.36 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.661 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.13 -33.78 19.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.487 . . . . 0.0 109.785 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.85 -32.3 63.59 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.124 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.497 HG22 HG23 ' A' ' 76' ' ' VAL . 43.4 t -72.19 -52.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.412 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.3 m-85 -54.13 -28.09 37.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.27 -40.19 93.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.471 ' CE2' ' CD2' ' A' ' 89' ' ' HIS . 65.1 t80 -66.99 -57.42 6.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.33 -23.3 8.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.097 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 3.5 mmtp -69.4 -40.11 77.56 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -85.06 -4.95 59.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.529 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 93.4 m-70 -127.38 60.59 44.26 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.02 -0.03 5.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.236 2.624 . . . . 0.0 112.916 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.75 -35.7 19.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.03 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -99.5 163.92 12.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.473 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.3 160.69 14.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.926 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.3 117.06 29.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.53 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.94 117.83 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.174 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 5.4 mm -81.92 133.13 29.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.262 0.553 . . . . 0.0 111.484 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.53 -48.66 4.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.056 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.43 -164.13 36.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.165 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.15 -161.02 34.83 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.674 0.737 . . . . 0.0 112.704 -0.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.77 -48.97 59.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.323 . . . . 0.0 111.41 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -58.5 -29.85 66.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.877 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.2 mm -79.43 -29.93 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.268 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.9 m-85 -57.16 -54.14 50.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.862 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.644 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -70.12 -8.49 50.0 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.024 -0.423 . . . . 0.0 111.839 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.34 -38.98 40.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' HA ' HG23 ' A' ' 79' ' ' VAL . 29.3 m-85 -99.63 -10.03 22.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.308 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.644 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 18.5 pttp -52.17 -31.73 32.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.758 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.74 -5.1 52.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.656 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.2 -21.66 3.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 3' ' ' PHE . 76.9 t -44.81 123.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 111.302 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 3.9 t70 -103.13 7.69 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.267 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.2 m -168.39 135.84 2.09 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.821 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 17.0 mt -117.92 143.7 46.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.491 . . . . 0.0 111.531 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mt -135.28 115.08 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.664 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.481 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -134.69 144.69 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.024 0.44 . . . . 0.0 111.744 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.79 105.56 13.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.577 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 6.5 mmt85 -80.7 100.33 8.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mp -82.21 127.94 33.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.431 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.11 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.884 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -50.43 144.49 11.09 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.443 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.441 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 35.3 p -91.5 132.61 36.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.981 0.42 . . . . 0.0 111.374 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -134.23 163.57 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -116.56 150.86 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.112 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.8 -173.72 23.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.788 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -33.98 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.954 0.407 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 60.7 m -108.71 139.44 43.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.98 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -115.89 172.39 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 111.681 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -70.22 143.6 52.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.1 pt -68.45 154.33 94.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.96 97.73 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.512 2.142 . . . . 0.0 111.975 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.62 146.69 26.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 72.45 4.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.325 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -55.7 -22.37 23.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.423 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -28.81 62.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -80.64 -23.46 39.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 71.8 m-85 -102.09 174.08 6.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.479 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -137.79 142.85 40.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.474 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.6 ttpt -79.96 120.54 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.787 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.01 -21.75 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.433 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.4 m -162.74 140.69 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 16.1 p -160.62 109.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -139.43 115.2 10.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.27 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 8.4 m -74.42 144.14 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 153' ' ' HIS . 2.5 p -121.77 105.26 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.997 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -88.7 107.14 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.787 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.27 -175.77 5.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.486 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.7 p -57.45 -50.45 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.749 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.464 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -74.41 124.66 90.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.102 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.97 -27.21 84.44 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.154 1.903 . . . . 0.0 112.301 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -19.89 22.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.674 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.3 mt -84.85 7.77 19.72 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 153' ' ' HIS . 74.5 m -72.88 168.22 19.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -175.46 162.48 2.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.257 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 24.5 m -125.23 137.91 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.797 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 141' ' ' SER . 94.4 m-85 -98.4 106.3 18.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -108.69 126.61 53.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.857 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.72 115.9 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.251 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.3 m95 -111.97 151.16 29.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 0.0 111.377 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -127.02 117.13 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.828 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.518 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.1 OUTLIER -55.46 131.47 46.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.93 0.395 . . . . 0.0 111.613 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.479 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 1.8 ptmt 177.5 156.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.991 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 110' ' ' VAL . 85.2 m . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.83 148.93 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.511 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 2.6 m-30 -114.18 112.28 22.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.491 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.82 121.52 44.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 0.0 111.807 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.496 ' CZ2' HG11 ' A' ' 115' ' ' VAL . 5.0 p90 -166.85 172.73 10.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.448 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.88 134.37 50.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -119.98 155.81 32.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.952 0.406 . . . . 0.0 111.182 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.7 -172.83 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.687 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.13 63.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.06 -23.12 52.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.71 22.61 17.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.358 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.37 159.75 20.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.22 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.415 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.6 mt -78.62 86.75 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.4 ttp -99.99 120.31 39.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.934 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 80.3 t -77.57 156.76 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.974 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 33.6 m -162.49 141.22 2.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.43 153.45 52.92 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.506 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.493 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -51.33 -51.05 57.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.223 0.512 . . . . 0.0 110.815 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.493 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.9 tpt85 -57.88 -34.48 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.061 0.458 . . . . 0.0 110.19 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 49' ' ' PHE . 2.8 m -69.75 -55.9 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.398 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -46.63 -28.69 1.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -65.44 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.237 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -50.18 -35.4 26.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.654 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CE2' HG13 ' A' ' 41' ' ' VAL . 5.4 m-85 -40.93 157.95 0.18 Allowed Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -52.23 -71.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.611 2.207 . . . . 0.0 113.257 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -124.15 173.6 8.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.7 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.9 mtp180 -133.99 104.43 11.63 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.913 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 89.9 Cg_endo -85.19 -167.06 4.76 Favored 'Cis proline' 0 C--N 1.349 0.588 0 C-N-CA 123.912 -1.287 . . . . 0.0 112.144 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.569 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 95.4 mt -93.87 151.36 39.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.629 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.35 110.15 2.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.666 2.244 . . . . 0.0 112.972 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.18 4.27 5.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.002 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.569 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 5.7 mtt180 -112.59 101.07 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.038 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 24.0 m -66.05 107.81 2.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -103.38 156.1 17.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.243 0.544 . . . . 0.0 112.14 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.431 HG12 ' CG2' ' A' ' 76' ' ' VAL . 8.3 t -132.43 136.91 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.883 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.4 t -105.93 127.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.586 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -109.92 116.12 31.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.202 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 1.6 t -147.19 167.14 24.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.903 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -85.14 -12.01 53.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.611 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -72.93 134.83 44.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -85.2 -7.9 58.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.883 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -118.7 7.46 11.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.606 0.241 . . . . 0.0 111.522 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.9 t80 -58.14 139.57 54.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.193 0.52 . . . . 0.0 111.817 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.27 173.84 8.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.043 0.925 . . . . 0.0 111.99 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.27 142.97 19.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.495 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -77.93 97.99 5.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.745 0.307 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.41 2.99 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.234 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.89 171.72 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.443 HG22 ' CE1' ' A' ' 85' ' ' TYR . 12.4 t -97.46 139.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.476 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 68' ' ' TYR . 41.9 t -103.69 107.95 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.281 0.562 . . . . 0.0 112.193 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 28.7 m -118.23 167.79 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.973 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 63' ' ' THR . 13.1 m170 -120.38 -21.21 6.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -160.59 -173.32 3.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 106' ' ' PHE . 12.8 t -66.94 -10.18 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.765 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.0 -38.33 16.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 110.019 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.32 -30.73 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.871 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.429 HG23 HG21 ' A' ' 76' ' ' VAL . 21.5 t -71.01 -53.59 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.969 0.414 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.408 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.7 m-85 -54.09 -27.08 30.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.934 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.36 -44.99 85.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.443 ' CE1' HG22 ' A' ' 74' ' ' VAL . 85.0 t80 -64.95 -55.33 19.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.16 -22.61 17.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.875 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.4 mmpt? -70.09 -38.04 75.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.05 -6.2 59.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.622 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -126.48 67.4 65.52 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.998 0.427 . . . . 0.0 110.558 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.8 -0.23 4.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.162 2.575 . . . . 0.0 113.079 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.33 -30.3 22.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 111.039 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -112.27 156.83 21.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 111.529 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.66 174.96 6.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 1' ' ' THR . 7.8 tp -104.68 110.73 23.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 4' ' ' LEU . 80.8 t -119.52 102.46 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.694 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.427 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 11.1 mm -78.36 128.45 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 111.634 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -95.77 -47.64 6.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.0 -168.29 41.36 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.41 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.31 -160.82 34.64 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 117.824 0.812 . . . . 0.0 112.557 -0.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.14 -51.57 13.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -55.84 -33.09 64.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.536 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 39.3 mm -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.2 m-85 -60.51 -57.5 12.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.694 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.554 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 3.9 t -67.13 -9.98 45.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -74.76 -46.04 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.462 ' HA ' HG22 ' A' ' 79' ' ' VAL . 2.3 m-85 -94.53 -6.44 43.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 14.7 pttp -52.26 -30.2 26.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.912 0.386 . . . . 0.0 111.056 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.83 -7.21 58.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.269 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.43 -20.06 6.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.511 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 74.0 t -44.75 127.34 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.358 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.406 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 12.7 t70 -105.04 2.78 29.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 52.1 m -167.47 139.29 3.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 136' ' ' PHE . 11.6 mt -119.72 146.62 45.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.33 0.586 . . . . 0.0 112.164 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 4' ' ' LEU . 27.1 mt -135.6 112.39 10.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.198 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.496 HG11 ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -130.59 141.79 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 111.596 -179.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -117.43 102.8 9.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.665 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.4 ttp85 -80.42 102.77 9.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.736 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.93 123.46 28.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.26 82.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.372 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 150' ' ' ALA . . . -57.71 -163.25 0.05 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.609 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.3 p -143.41 137.83 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.057 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -128.81 162.04 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -111.87 143.08 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.8 -166.67 23.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.597 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.46 -23.48 3.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -109.1 134.01 52.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.802 0.334 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 -174.0 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -164.8 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.623 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -118.31 166.27 14.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.224 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.2 Cg_endo -75.7 103.52 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.43 2.087 . . . . 0.0 112.221 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.83 145.93 26.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.6 74.6 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.236 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -57.5 -20.53 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.48 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.93 -30.87 64.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.76 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.04 -21.96 39.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 78.5 m-85 -103.44 176.6 5.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 111.326 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -138.93 141.9 38.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.441 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 3.0 ttpt -78.15 124.33 27.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 33.8 m -109.18 -18.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.511 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.3 m -168.05 140.28 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.867 0.365 . . . . 0.0 111.368 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 6.4 p -155.48 111.13 3.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -144.08 115.42 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.8 m -76.97 143.1 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.124 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 152' ' ' THR . 3.0 t -114.8 105.73 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.212 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -86.13 97.2 10.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.652 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -78.98 178.18 8.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.1 p -57.41 -52.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.699 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.476 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.32 125.68 91.3 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.806 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -28.83 87.77 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.085 1.857 . . . . 0.0 112.633 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HA ' ' CA ' ' A' ' 120' ' ' GLY . . . -90.02 -20.86 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.664 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.7 mt -83.24 7.19 17.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.597 0.237 . . . . 0.0 111.477 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 144' ' ' VAL . 62.6 m -72.43 167.0 21.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.5 p80 -175.37 162.14 2.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.641 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 19.4 m -125.79 139.11 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.588 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.9 105.17 17.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.37 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.481 ' HB2' HG21 ' A' ' 115' ' ' VAL . 2.2 mm-40 -103.56 121.55 43.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.284 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 13.7 t -115.13 114.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.709 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.432 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.6 m95 -112.35 150.63 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.462 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -127.5 117.62 22.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -54.91 132.8 47.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.299 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -114.67 -168.32 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.403 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.089 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.514 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 m . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.33 150.14 29.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.484 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 2.3 m-30 -117.95 115.83 25.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.89 124.49 51.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.469 0.652 . . . . 0.0 112.602 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.484 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 4.3 p90 -171.85 173.22 4.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.41 140.45 52.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.387 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -128.58 157.87 40.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.6 179.76 4.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.688 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.515 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.0 OUTLIER -50.94 -36.09 36.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.119 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -30.95 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.752 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.54 46.9 2.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.312 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' HG ' ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -107.34 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.559 ' N ' ' HG ' ' A' ' 12' ' ' LEU . 4.6 pt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.596 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 38' ' ' ILE . 80.8 mt -82.05 86.7 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.08 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.2 ttp -99.34 117.59 34.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.686 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.416 HG21 HG12 ' A' ' 82' ' ' VAL . 3.6 t -85.08 127.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.8 m -134.58 149.66 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.32 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.71 51.78 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.116 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -58.59 -52.56 65.16 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.854 0.327 . . . . 0.0 110.321 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.505 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 1.1 tpp180 -58.89 -37.27 76.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 m -69.96 -42.1 73.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.226 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -64.1 -41.65 97.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.18 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -57.8 -66.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.785 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' PHE . 88.6 p -61.23 -30.63 70.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -30.41 133.32 0.22 Allowed Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.775 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_exo -38.39 -35.08 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.129 2.553 . . . . 0.0 113.252 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.35 139.76 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -140.3 108.12 6.75 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.55 -170.51 8.46 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.519 -1.45 . . . . 0.0 112.195 -0.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.569 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 28.0 mt -99.21 155.95 35.98 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 104.63 1.45 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.576 2.184 . . . . 0.0 112.704 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 69.8 6.89 5.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.569 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 1.8 mtt180 -109.3 113.0 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.885 0.374 . . . . 0.0 111.552 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.7 m -67.33 107.98 2.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.996 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.23 141.83 39.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.929 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.1 t -117.15 143.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.095 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 43' ' ' ARG . 94.2 t -110.87 124.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 0.0 111.589 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -103.58 121.08 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 7.0 t -158.58 162.52 37.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.816 0.341 . . . . 0.0 111.208 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -86.08 -3.65 58.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.335 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tp60 -77.96 131.56 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.857 0.36 . . . . 0.0 110.38 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.49 -30.27 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.275 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -98.99 10.85 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 5.9 t80 -61.84 141.98 57.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.22 0.533 . . . . 0.0 111.917 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.432 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 12.5 mm-40 -134.31 177.58 7.65 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.388 1.09 . . . . 0.0 112.899 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.54 144.69 19.62 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 112.996 -1.911 . . . . 0.0 110.641 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.03 96.92 2.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 0.0 110.46 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.53 -34.66 3.28 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.41 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.33 169.46 13.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 112.021 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 85' ' ' TYR . 21.2 t -97.93 140.4 18.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.572 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 43.3 t -106.08 109.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.401 0.62 . . . . 0.0 112.461 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 34.6 m -117.81 163.89 14.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.891 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -116.69 -24.46 7.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.727 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.93 -174.03 4.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.143 0.497 . . . . 0.0 111.495 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.431 HG21 ' CD1' ' A' ' 106' ' ' PHE . 45.5 t -70.25 -10.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.476 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.94 -31.43 18.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.023 0.44 . . . . 0.0 110.304 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.24 -28.79 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 76' ' ' VAL . 22.6 t -76.5 -52.9 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -54.55 -28.06 43.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.65 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -68.15 -39.63 82.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 88.9 t80 -66.12 -56.81 9.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.02 -22.23 14.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.923 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -67.72 -41.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -82.69 -4.88 58.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.564 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 98.1 m-70 -125.95 64.42 51.77 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 110.301 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.6 0.13 3.86 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.371 2.714 . . . . 0.0 113.011 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -30.13 21.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.725 0.298 . . . . 0.0 110.808 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.427 . . . . 0.0 111.592 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -98.45 169.41 9.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.273 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.34 115.82 30.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.306 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -123.86 106.35 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.433 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.1 mm -78.42 139.49 18.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.981 0.419 . . . . 0.0 111.265 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.463 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.2 -39.48 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.194 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.49 -168.04 41.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -81.73 -161.29 27.68 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 117.347 0.574 . . . . 0.0 112.549 -0.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.65 -42.13 74.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.978 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.72 -28.12 69.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.633 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.7 mm -80.39 -35.45 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.16 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.9 m-85 -51.76 -55.98 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.526 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.545 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.1 t -66.18 -9.66 33.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.02 -41.58 28.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.695 0.283 . . . . 0.0 111.226 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CD1' HG21 ' A' ' 79' ' ' VAL . 4.0 m-85 -95.33 -7.46 38.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.23 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.5 OUTLIER -50.85 -32.46 20.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.36 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -4.64 47.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.71 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.0 -20.6 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.514 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 90.7 t -44.74 140.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.154 0.502 . . . . 0.0 111.692 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -126.94 7.35 6.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.604 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.7 m -168.41 138.33 2.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.873 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 11.6 mt -122.8 142.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.313 0.577 . . . . 0.0 112.049 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.8 mt -130.52 114.35 15.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.2 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 156' ' ' GLU . 1.5 m -138.37 148.53 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.29 112.71 24.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 9.0 mmt180 -89.22 104.7 17.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 14.6 mt -85.96 114.6 22.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.03 -26.89 28.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.652 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 150' ' ' ALA . . . -92.22 -173.44 41.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.848 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.515 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 32.3 t -116.82 165.74 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 10.2 m-85 -152.03 168.26 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.04 170.3 16.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 12' ' ' LEU . . . 148.97 153.99 6.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.819 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -120.07 5.11 10.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.628 0.251 . . . . 0.0 111.459 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.5 m -131.25 138.71 49.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -114.32 163.09 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.417 ' HG3' ' NE1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.93 -179.12 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.022 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 pt -101.27 159.72 28.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.21 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.59 105.14 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.794 2.329 . . . . 0.0 112.421 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mt -96.09 150.77 20.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.038 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.31 72.8 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.456 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 81.0 m95 -56.9 -23.09 42.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.32 -30.26 66.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 0.0 110.457 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.63 -19.42 45.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.99 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.477 ' CD1' HD12 ' A' ' 113' ' ' LEU . 52.0 m-85 -107.87 167.76 9.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.576 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -129.98 141.24 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -79.92 109.11 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 159' ' ' GLN . 27.2 m -90.54 -22.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.7 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.2 m -159.58 140.72 12.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -157.11 113.03 2.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.211 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -136.28 130.11 32.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 3.8 m -89.84 132.03 35.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.15 0.5 . . . . 0.0 112.194 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 t -105.15 113.0 41.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.626 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.473 ' HA ' ' CG2' ' A' ' 152' ' ' THR . 17.1 mt-10 -96.88 97.47 9.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.36 -176.04 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.267 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.4 p -63.49 -24.03 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.041 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.495 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -90.69 120.66 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.91 -18.79 59.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.529 2.153 . . . . 0.0 112.36 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.421 ' HA ' ' HA3' ' A' ' 120' ' ' GLY . . . -95.81 -25.87 15.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.816 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.2 mt -85.1 2.45 43.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.741 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 145' ' ' GLU . 16.6 m -83.47 82.46 8.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 111.083 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -98.04 -171.74 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 21.6 m -134.11 137.84 44.84 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 141' ' ' SER . 10.9 m-85 -86.06 106.76 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 115' ' ' VAL . 11.3 mt-10 -105.46 121.47 44.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 21.5 t -114.61 111.8 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.895 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 16.3 m95 -107.93 151.34 25.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.114 0.483 . . . . 0.0 112.022 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.417 ' HB2' ' CG1' ' A' ' 139' ' ' VAL . 3.3 mt-30 -132.39 131.61 41.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.364 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -49.44 123.74 8.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 111.465 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.429 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -110.1 -175.55 2.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.959 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.191 179.694 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.5 154.62 24.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.587 . . . . 0.0 112.557 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.458 ' CD1' HG23 ' A' ' 110' ' ' VAL . 1.3 m-85 -121.22 117.47 27.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.778 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 tp -115.41 124.56 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.465 ' CH2' HG13 ' A' ' 115' ' ' VAL . 4.3 p90 -168.52 163.3 12.42 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.51 136.29 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -118.21 153.17 34.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -102.89 -178.17 3.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.235 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.479 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -48.82 -49.08 40.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.28 0.562 . . . . 0.0 109.843 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -69.79 -25.65 63.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.815 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.58 32.64 5.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.5 pp -100.93 166.04 11.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mttm . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.506 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 54.0 mt -72.28 89.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.15 126.95 51.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 21.4 t -79.77 158.73 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.108 0.48 . . . . 0.0 112.189 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 31.1 m -160.24 150.86 5.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.852 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.7 155.87 43.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.907 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.42 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -54.87 -49.09 72.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.922 0.361 . . . . 0.0 110.776 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.42 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 15.2 tpt85 -62.88 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -69.88 -43.27 72.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.664 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -63.9 -29.26 70.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.023 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -66.15 -66.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.901 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 17.0 t -53.27 -30.73 40.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -31.13 123.37 0.34 Allowed Pre-proline 0 N--CA 1.468 0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.606 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.61 -27.46 5.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.789 2.326 . . . . 0.0 113.251 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -171.31 117.57 0.44 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.298 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -122.05 141.2 33.72 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.96 -174.41 12.2 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.261 -1.558 . . . . 0.0 111.702 -0.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.499 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 17.0 mt -95.1 154.91 39.48 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 54' ' ' LEU . 19.1 Cg_endo -57.52 -83.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.702 2.268 . . . . 0.0 113.137 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -96.42 33.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 4.0 mtt180 -132.09 100.96 5.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.326 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.506 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 51.6 m -68.23 121.85 17.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.785 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -105.83 151.09 24.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.252 0.548 . . . . 0.0 112.191 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.0 140.93 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.174 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.1 t -111.31 118.33 57.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 111.604 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.439 HD13 ' N ' ' A' ' 78' ' ' ASP . 3.4 tp -104.21 112.16 25.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 t -149.99 162.24 40.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -76.9 -6.39 52.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.594 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.759 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.6 tp60 -74.01 125.29 27.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.706 0.288 . . . . 0.0 110.441 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.1 -8.13 59.7 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.52 11.8 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.759 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.3 t80 -58.37 148.26 28.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.119 0.485 . . . . 0.0 111.45 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 25.9 mm100 -132.32 174.46 10.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.437 1.113 . . . . 0.0 112.728 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 141.96 16.78 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.375 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -82.15 96.65 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 110.147 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.33 -45.77 1.36 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.544 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.72 163.36 28.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.986 0.422 . . . . 0.0 111.759 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 85' ' ' TYR . 11.3 t -96.17 140.62 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 18.7 t -102.55 119.23 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.699 . . . . 0.0 112.26 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 HG21 HG22 ' A' ' 82' ' ' VAL . 30.0 m -128.32 167.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.729 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -115.43 -23.59 8.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.713 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' N ' HD13 ' A' ' 62' ' ' LEU . 1.4 t70 -153.02 179.84 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.134 0.493 . . . . 0.0 111.581 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 11.6 t -65.53 -10.15 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.751 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.5 -33.0 19.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.59 -27.23 58.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.807 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.441 HG22 HG21 ' A' ' 76' ' ' VAL . 16.5 t -74.01 -55.22 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.649 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 13.0 m-85 -55.57 -28.23 53.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.801 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.37 90.81 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.46 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 73.8 t80 -63.4 -54.05 42.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.394 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -23.81 44.18 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.328 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -71.75 -33.41 68.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.417 ' HG2' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -89.02 -9.36 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.246 179.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 94.5 m-70 -125.0 66.23 49.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.61 0.24 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.393 2.729 . . . . 0.0 113.014 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -37.17 27.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -107.75 161.79 14.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.34 174.67 6.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.253 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.2 tp -116.1 114.84 25.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.504 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.58 112.65 28.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 ' CG2' ' A' ' 40' ' ' VAL . 3.4 mm -81.4 131.38 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.844 0.354 . . . . 0.0 111.416 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.78 -41.88 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.876 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.57 -168.49 41.56 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.806 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.76 -160.74 33.93 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 122.027 -0.69 . . . . 0.0 112.588 -0.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -50.52 -58.35 5.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.81 -28.13 5.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.67 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 37.2 mm -81.23 -28.66 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.386 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.438 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.3 m-85 -59.39 -58.67 7.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.007 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.502 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 13.6 t -66.79 -9.9 41.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.25 -41.62 57.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.459 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 2.2 m-85 -98.21 -3.97 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.644 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 38.7 pttt -51.61 -33.99 35.53 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.88 0.372 . . . . 0.0 111.114 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.17 -3.85 47.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.586 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.34 -21.93 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 3' ' ' PHE . 94.7 t -45.87 134.88 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.036 0.446 . . . . 0.0 111.505 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -116.66 6.01 13.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.598 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 46.2 m -168.03 141.66 3.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.311 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 13.8 mt -123.54 146.0 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.22 0.533 . . . . 0.0 111.814 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.2 mt -135.57 117.44 15.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.884 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.465 HG13 ' CH2' ' A' ' 5' ' ' TRP . 1.4 m -135.13 144.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.408 . . . . 0.0 111.49 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -112.92 113.19 25.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.802 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.37 100.7 12.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.464 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 2.2 mp -91.54 131.61 36.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.416 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.48 -52.63 64.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.047 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.24 -172.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.564 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -123.27 164.03 19.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 111.038 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.29 165.15 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 166.57 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.54 153.12 6.5 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.762 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.98 6.1 12.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.653 0.264 . . . . 0.0 111.107 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.8 m -133.94 145.23 49.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.368 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.2 pttp -122.21 173.77 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.5 tpt -69.32 153.15 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.438 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.7 pp -78.9 163.36 60.84 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.56 101.42 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.336 . . . . 0.0 112.653 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.41 149.03 21.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.636 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.49 77.31 3.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.455 ' CZ3' HD12 ' A' ' 113' ' ' LEU . 86.4 m95 -61.16 -17.83 54.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.352 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.26 -34.45 63.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 110.464 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.11 -17.79 56.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.474 ' CD1' HD11 ' A' ' 113' ' ' LEU . 59.8 m-85 -105.39 169.23 8.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 110.826 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.704 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -129.31 141.33 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 0.7 OUTLIER -82.88 119.06 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.312 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 10.0 m -101.45 -21.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.896 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.2 m -160.74 143.36 12.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.264 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.87 111.7 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.2 ttp-105 -146.66 120.41 9.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.416 . . . . 0.0 111.398 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.3 m -74.57 145.97 42.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.214 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 152' ' ' THR . 14.4 t -116.45 102.57 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.426 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -85.31 99.66 11.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.63 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.47 -176.51 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.507 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.0 p -54.36 -56.53 17.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 34.2 t-20 -74.54 124.16 89.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.796 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.8 -27.52 84.13 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.262 1.975 . . . . 0.0 112.887 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.16 -19.44 26.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.5 mt -84.32 8.0 17.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.639 0.257 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 144' ' ' VAL . 97.0 m -73.33 165.17 25.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p-80 -172.73 159.33 4.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.223 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 19.1 m -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.548 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -118.69 105.76 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.661 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' HB2' HG21 ' A' ' 115' ' ' VAL . 12.8 mt-10 -106.63 124.88 50.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.856 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 10.5 t -116.3 112.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 22.0 m95 -106.75 149.83 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.435 . . . . 0.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -132.29 129.7 39.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -46.52 123.55 5.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.523 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.704 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -105.42 178.49 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.066 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 4.7 m . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.43 154.47 22.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -122.76 116.35 23.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.505 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 tp -114.95 122.5 46.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.509 ' CZ2' HG12 ' A' ' 115' ' ' VAL . 3.0 p90 -167.22 168.33 13.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.615 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.85 141.26 49.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 111.29 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.39 153.77 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.89 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.77 -177.06 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -36.2 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.15 -21.32 29.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.46 25.04 29.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -101.58 148.87 24.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.318 . . . . 0.0 111.003 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 126' ' ' THR . 1.1 pt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.63 87.72 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.644 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.1 ttp -99.0 124.21 43.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.603 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 20.9 t -77.54 157.39 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.989 0.423 . . . . 0.0 111.838 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 32.6 m -161.18 147.8 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.956 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.39 155.55 53.06 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.062 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.55 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.31 -52.19 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.972 0.386 . . . . 0.0 110.126 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -57.77 -30.68 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.46 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.5 m -71.29 -49.26 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.798 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -55.03 -35.7 64.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.487 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -66.83 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.938 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 49' ' ' PHE . 99.7 p -52.8 -37.19 59.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.815 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CE1' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.49 127.35 0.25 Allowed Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.908 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.5 -27.68 19.57 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.071 2.514 . . . . 0.0 113.814 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 2.7 ttmm -151.75 147.95 27.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.966 0.412 . . . . 0.0 111.525 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.09 109.69 10.67 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.612 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 4.0 Cg_exo -86.53 168.04 46.0 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.792 -1.337 . . . . 0.0 112.048 -0.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 7.7 mt -59.45 164.86 4.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.645 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 10.9 Cg_endo -54.23 91.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 113.05 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 64.82 23.36 12.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.262 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 23.1 mtt180 -109.57 132.19 54.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.917 0.389 . . . . 0.0 111.444 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.8 m -84.05 108.14 16.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.772 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.51 158.17 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 112.089 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 HG12 ' CG2' ' A' ' 76' ' ' VAL . 10.7 t -130.8 143.33 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.042 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 43' ' ' ARG . 99.5 t -108.84 122.08 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -104.25 122.94 46.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.272 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.453 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -156.29 165.71 35.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.217 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -84.36 -9.0 58.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.3 tt0 -76.0 133.55 40.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -88.1 6.81 34.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.938 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.98 3.15 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.4 t80 -57.27 139.19 53.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.456 . . . . 0.0 111.299 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.4 ' O ' ' CE1' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -126.67 176.37 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.92 0.866 . . . . 0.0 112.253 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.65 146.19 23.16 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.118 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -94.34 96.23 9.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.508 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.59 13.38 53.82 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.057 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.55 172.87 12.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.925 0.393 . . . . 0.0 111.627 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.429 HG23 ' CZ ' ' A' ' 85' ' ' TYR . 14.0 t -100.24 140.17 19.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.41 116.0 49.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.09 0.472 . . . . 0.0 111.992 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 27.4 m -124.83 162.2 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.656 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' THR . 3.5 m170 -111.19 -23.19 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.365 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.71 -171.39 3.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.222 0.534 . . . . 0.0 111.64 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 106' ' ' PHE . 6.0 t -69.87 -9.22 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.07 16.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.149 0.499 . . . . 0.0 109.948 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.43 -28.14 56.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.694 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.74 -51.08 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.3 m-85 -57.23 -25.51 59.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.667 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.93 -42.28 81.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.176 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.429 ' CZ ' HG23 ' A' ' 74' ' ' VAL . 68.2 t80 -65.06 -56.07 15.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.72 -22.55 36.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.954 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.9 -31.88 68.66 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 15.3 mt-30 -87.1 -7.42 58.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.443 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.19 67.92 56.2 Favored Pre-proline 0 N--CA 1.456 -0.132 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.65 -0.32 2.99 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.133 2.555 . . . . 0.0 112.928 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.94 -24.54 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.304 . . . . 0.0 111.17 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.75 155.17 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.14 167.59 10.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.994 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 tp -120.04 113.02 19.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.081 0.467 . . . . 0.0 111.499 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.49 109.72 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.188 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.479 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 3.7 mm -77.59 130.68 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -105.5 -42.89 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.492 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.7 -169.02 41.34 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.896 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.403 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -87.06 -160.92 35.75 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 122.118 -0.637 . . . . 0.0 112.7 -0.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.76 -53.5 39.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 111.404 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -27.62 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.1 mm -81.42 -22.7 10.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.1 m-85 -64.65 -55.24 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.726 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 10.6 t -66.54 -9.75 38.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.73 41.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.624 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 3.6 m-85 -95.66 -5.37 42.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.57 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 2.0 pttt -51.52 -33.57 32.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.79 0.328 . . . . 0.0 111.336 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -84.73 -0.29 53.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.739 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -124.42 -24.58 4.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' A' ' 3' ' ' PHE . 58.5 t -48.21 122.14 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.634 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.95 3.47 44.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 93.9 m -165.43 142.21 5.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.284 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 136' ' ' PHE . 8.1 mt -125.76 146.09 49.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.902 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.4 mt -134.75 119.31 18.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.697 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.509 HG12 ' CZ2' ' A' ' 5' ' ' TRP . 2.1 m -135.29 145.26 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 106.47 15.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.309 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -93.1 104.58 16.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.835 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.2 mp -91.48 128.13 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.52 -49.09 37.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.217 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.46 172.6 3.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.298 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.2 t -112.71 147.96 35.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.5 m-85 -122.02 153.0 39.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -111.13 141.0 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -169.62 -167.77 30.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.55 -16.68 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.606 0.241 . . . . 0.0 111.537 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 13' ' ' ILE . 40.7 m -109.14 131.96 54.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.697 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.57 173.44 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.755 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.429 ' HE2' ' CE2' ' A' ' 5' ' ' TRP . 17.1 tpt -78.35 147.14 34.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.632 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -64.08 166.96 8.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.632 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.1 Cg_endo -77.13 98.04 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.265 1.977 . . . . 0.0 112.674 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.71 145.08 25.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 78.58 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.448 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 91.1 m95 -60.16 -20.11 56.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.51 -32.88 66.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -24.13 51.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.013 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.47 ' CD1' HD12 ' A' ' 113' ' ' LEU . 77.3 m-85 -97.49 173.6 7.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.867 0.365 . . . . 0.0 110.76 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.13 143.36 44.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.504 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.8 ttpm? -84.0 108.64 17.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.816 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -91.37 -26.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.318 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.0 m -154.86 140.7 18.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 35.4 p -164.6 111.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.07 122.57 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.68 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 4.0 m -78.43 144.28 35.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.18 0.514 . . . . 0.0 111.54 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.423 ' O ' HG21 ' A' ' 152' ' ' THR . 3.3 t -116.27 105.12 17.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -86.12 98.97 11.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.847 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -81.33 -175.3 5.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.0 p -57.72 -57.66 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.453 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -68.56 120.17 73.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.91 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.5 -25.96 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.964 1.776 . . . . 0.0 112.324 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.47 -18.4 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.431 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.1 mt -87.15 8.86 21.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.599 0.237 . . . . 0.0 111.359 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 144' ' ' VAL . 79.7 m -71.48 169.29 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 11.0 p80 -174.34 160.79 3.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 10.4 m -127.69 133.95 49.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.627 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -94.33 106.45 18.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.483 ' HB2' HG21 ' A' ' 115' ' ' VAL . 13.9 mt-10 -103.3 121.75 43.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.415 . . . . 0.0 111.971 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.43 111.26 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.094 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.504 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.5 m95 -107.61 148.34 29.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.979 0.418 . . . . 0.0 111.721 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -126.92 117.28 22.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.448 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.8 tmtt? -49.77 132.45 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -99.96 171.91 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.626 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.02 148.87 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.527 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -111.81 114.45 27.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.244 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.27 121.26 43.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.495 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 3.1 p90 -167.58 176.21 6.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.499 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.6 150.33 46.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 111.823 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.98 147.6 37.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.617 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -103.69 -167.91 1.43 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -48.59 66.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.842 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.68 -26.49 60.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.65 20.89 12.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.636 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.58 149.37 40.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.766 0.317 . . . . 0.0 110.645 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.499 -179.649 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 93' ' ' GLU . 79.0 mt -80.19 87.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.54 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.8 ttp -100.73 122.45 43.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.412 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 3.1 t -91.12 129.18 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.423 HG13 ' CZ ' ' A' ' 49' ' ' PHE . 33.7 m -129.92 147.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.115 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.79 151.76 52.44 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.932 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -48.07 -55.91 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.906 0.384 . . . . 0.0 110.385 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.35 68.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.57 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -73.68 -31.37 63.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.44 ' CD2' HG23 ' A' ' 61' ' ' VAL . 51.8 t80 -75.82 -33.04 60.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.815 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.21 -67.23 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.575 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -58.73 -30.04 67.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.738 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CZ ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -34.31 149.44 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.905 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.55 -32.73 5.93 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.187 2.591 . . . . 0.0 113.932 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.38 152.9 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 9.1 mtp180 -124.72 101.72 32.93 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.2 Cg_endo -86.25 -168.11 5.08 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.965 -1.265 . . . . 0.0 112.213 0.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.626 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 88.0 mt -95.76 159.8 31.65 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 18.9 Cg_endo -60.26 95.85 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.728 2.285 . . . . 0.0 113.638 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 66.35 18.49 10.89 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.441 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.626 ' HG3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -109.77 107.57 17.61 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.946 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 m -62.13 106.67 0.76 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.982 0.42 . . . . 0.0 110.164 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -105.54 156.88 17.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.201 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG12 ' CG2' ' A' ' 76' ' ' VAL . 5.2 t -130.2 144.08 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.84 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' CD2' ' A' ' 46' ' ' TYR . 89.6 t -116.09 106.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -89.0 118.14 28.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.015 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -148.95 169.84 19.67 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.926 0.393 . . . . 0.0 111.352 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -88.24 -9.25 53.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.5 tp60 -78.1 128.76 34.31 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.438 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 7.5 mt-10 -79.76 -16.15 56.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.787 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.29 9.12 25.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.5 t80 -58.77 140.37 55.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.007 0.432 . . . . 0.0 111.612 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -124.96 178.34 5.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.107 0.956 . . . . 0.0 112.004 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.97 145.33 20.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.784 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.45 95.88 4.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.368 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.93 -39.35 2.96 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.051 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.29 172.33 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.688 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 9.4 t -97.38 140.21 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.98 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.55 118.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.391 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 30.5 m -127.72 165.09 27.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.845 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 5.1 m170 -116.18 -23.19 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 110.813 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.19 -167.57 2.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 111.305 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 106' ' ' PHE . 4.0 t -74.42 -8.83 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.7 -32.9 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.092 0.472 . . . . 0.0 109.922 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.89 -27.54 57.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.496 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 76' ' ' VAL . 68.7 t -73.09 -54.05 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.462 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.9 m-85 -55.98 -24.82 40.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.941 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.74 86.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.831 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -66.69 -57.26 7.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.15 11.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.028 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.91 -38.06 76.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -83.89 -4.78 58.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.563 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -127.26 66.42 68.37 Favored Pre-proline 0 N--CA 1.455 -0.182 0 CA-C-O 121.015 0.436 . . . . 0.0 110.248 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.61 -0.01 5.41 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.231 2.621 . . . . 0.0 113.058 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -27.88 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.707 0.289 . . . . 0.0 111.087 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -105.08 159.23 16.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.658 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 42.1 mt-10 -98.09 159.23 15.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.135 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.1 tp -108.54 116.39 31.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.525 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 39' ' ' MET . 38.5 t -130.43 114.61 29.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.36 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.0 mm -82.51 131.1 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.632 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.86 -45.34 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.636 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.407 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.3 -166.3 39.05 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.406 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.407 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -92.74 -160.7 35.9 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 117.821 0.81 . . . . 0.0 112.741 -0.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.98 -48.56 16.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.466 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -60.19 -30.94 69.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.67 -26.61 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.501 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.2 m-85 -60.39 -56.38 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.465 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 14.9 t -65.93 -10.1 35.79 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.54 -43.28 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 110' ' ' VAL . 5.1 m-85 -95.4 -3.61 46.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.555 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 16.5 pttp -48.91 -33.07 10.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.783 0.325 . . . . 0.0 111.397 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.05 3.85 50.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.53 -27.9 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 0.0 111.517 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 3' ' ' PHE . 92.7 t -52.04 123.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.196 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.65 8.01 43.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.426 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 76.3 m -167.56 142.97 3.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.815 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 16.2 mt -123.49 145.35 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.321 0.581 . . . . 0.0 111.723 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 mt -135.64 120.0 17.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.46 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.495 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.9 m -136.35 145.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.043 0.449 . . . . 0.0 111.864 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -111.81 108.5 17.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.038 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.9 ttm180 -80.57 99.24 8.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.98 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.59 125.93 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.21 74.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.71 163.75 6.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.497 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 59.5 p -105.87 159.47 15.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.802 0.334 . . . . 0.0 111.034 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -147.4 145.43 29.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.779 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -100.72 147.11 26.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.764 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.43 174.19 46.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.733 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.9 42.83 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.204 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 m -162.38 124.81 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -112.67 172.74 6.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.964 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.414 ' HE2' ' CE2' ' A' ' 5' ' ' TRP . 17.1 tpt -72.62 157.59 37.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -79.2 163.76 58.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.289 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.58 93.76 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.749 2.3 . . . . 0.0 111.961 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -83.49 142.67 30.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.809 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.87 70.48 8.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.42 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 96.3 m95 -56.57 -21.75 28.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -73.31 -33.27 65.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.509 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 -10.49 58.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.102 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.462 ' CG ' HD11 ' A' ' 113' ' ' LEU . 45.1 m-85 -108.73 169.43 8.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.403 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -132.44 141.2 48.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.585 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 3.3 ttpp -85.11 128.99 34.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 5.7 m -115.92 -17.86 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.1 m -164.51 143.32 7.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.493 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.72 111.76 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.161 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -139.73 118.34 12.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.4 m -81.48 145.06 30.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.392 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 152' ' ' THR . 5.4 t -121.12 103.36 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.34 102.22 12.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.33 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.44 -176.46 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.3 p -53.86 -55.84 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.481 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.46 121.77 85.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.946 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.06 -27.02 83.86 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.134 1.889 . . . . 0.0 112.413 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.65 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.669 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.6 mt -86.96 9.26 20.0 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.592 0.234 . . . . 0.0 111.551 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 144' ' ' VAL . 95.9 m -70.72 165.92 21.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 11.8 p-80 -170.61 156.51 5.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.133 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 16.3 m -120.05 153.58 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.589 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.405 ' N ' HG21 ' A' ' 154' ' ' THR . 96.1 m-85 -116.3 105.04 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.414 ' HB2' HG21 ' A' ' 115' ' ' VAL . 2.8 mt-10 -101.26 153.96 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 26.7 t -142.31 107.09 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 28.8 m95 -107.54 145.5 33.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.977 0.417 . . . . 0.0 111.897 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -125.83 114.75 18.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.504 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.429 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 1.9 ttmt -46.44 134.0 9.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.08 0.467 . . . . 0.0 112.06 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.403 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -124.19 -166.08 1.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.399 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.076 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.79 154.41 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.29 0.567 . . . . 0.0 112.446 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.504 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -119.07 112.59 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.603 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.4 tp -113.52 121.78 45.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.532 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 2.8 p90 -167.31 164.5 15.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.927 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.76 135.34 54.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.699 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.06 155.48 44.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -96.62 -172.49 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -38.56 59.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.023 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -32.65 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.84 37.01 2.64 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mt -98.35 151.32 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.739 0.304 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.285 -179.741 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.66 87.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ttp -102.04 125.76 48.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 112.155 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 20.8 t -82.19 158.81 3.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.646 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.5 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 34.5 m -165.1 141.06 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.455 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.01 154.13 53.03 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.477 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -53.16 -51.92 60.47 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.336 0.568 . . . . 0.0 110.687 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.9 tpt180 -57.64 -32.78 67.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.013 0.435 . . . . 0.0 110.112 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -70.74 -46.79 62.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.986 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.5 t80 -55.16 -40.7 70.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.112 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -66.15 0.55 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.941 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -52.26 -40.03 61.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.552 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -33.52 127.95 0.41 Allowed Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.674 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -43.88 -26.52 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.144 2.562 . . . . 0.0 113.771 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -151.59 138.02 18.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.59 107.95 6.03 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.48 166.51 81.57 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.593 -1.42 . . . . 0.0 112.244 -0.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 75.8 mt -76.23 158.95 81.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.47 112.04 3.46 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.492 2.128 . . . . 0.0 112.802 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 69.15 8.48 6.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.022 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.498 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -114.06 110.71 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.427 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.0 m -68.73 107.19 2.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -101.11 154.58 18.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.983 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 8.8 t -125.72 141.37 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.633 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.415 HG11 ' CE1' ' A' ' 68' ' ' TYR . 98.8 t -110.72 124.67 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 111.72 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' A' ' 76' ' ' VAL . 2.1 mt -105.33 118.69 37.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.102 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 1.3 t -155.51 158.67 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.284 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -75.15 -4.32 38.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.62 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -85.83 126.03 33.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.398 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 6.2 mt-10 -78.31 -29.57 47.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.547 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -92.31 6.51 46.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.418 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.467 ' CD2' ' CG2' ' A' ' 63' ' ' THR . 3.1 t80 -59.81 139.31 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -137.16 169.89 17.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.758 1.266 . . . . 0.0 113.752 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.75 134.09 11.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.267 -2.242 . . . . 0.0 109.566 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -78.97 106.51 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.108 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 -56.51 0.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.1 169.31 15.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 12.8 t -94.11 140.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.335 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 17.2 t -112.01 123.16 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 111.419 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.711 HG21 HG22 ' A' ' 82' ' ' VAL . 27.1 m -130.32 175.88 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 m80 -123.16 -25.32 4.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.012 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.47 -171.33 3.9 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.467 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 18.7 t -71.38 -10.81 14.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.732 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.86 -32.72 18.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 110.15 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.09 -27.62 59.96 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.903 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HG21 ' A' ' 76' ' ' VAL . 57.4 t -74.5 -52.48 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 9.6 m-85 -54.74 -27.93 44.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.933 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.445 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -64.13 -45.82 86.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.14 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 74' ' ' VAL . 56.1 t80 -62.64 -54.42 39.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.05 -23.28 7.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.336 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 83' ' ' PHE . 12.3 mttt -68.61 -44.11 74.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.54 -2.32 41.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.7 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -129.01 61.63 57.92 Favored Pre-proline 0 N--CA 1.456 -0.136 0 CA-C-O 120.951 0.405 . . . . 0.0 110.491 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.01 -0.75 8.97 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.011 2.474 . . . . 0.0 112.954 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.22 -38.69 26.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.92 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -107.73 168.83 8.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.23 164.67 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.321 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.78 122.91 49.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.796 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.47 118.82 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.27 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.463 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 8.0 mm -83.52 130.73 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.907 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.412 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -98.38 -48.73 4.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.82 -168.01 39.21 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.572 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -93.84 -160.86 35.1 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 117.717 0.758 . . . . 0.0 112.622 -0.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.48 -56.38 7.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.838 0.351 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -52.53 -29.81 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.5 mm -83.43 -28.52 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.982 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -59.62 -55.44 34.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.507 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 12.4 t -67.76 -10.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.961 -0.462 . . . . 0.0 112.065 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.51 -39.07 58.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.949 0.404 . . . . 0.0 110.707 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.467 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 3.3 m-85 -100.0 -5.34 28.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 11.9 pttt -51.23 -31.33 20.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 111.617 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.64 2.77 52.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -126.83 -24.86 3.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.587 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.504 HG21 ' CD1' ' A' ' 3' ' ' PHE . 77.8 t -49.07 125.75 3.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.937 0.399 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -102.96 4.38 37.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.92 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.696 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 92.1 m -166.76 139.59 3.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.518 HD12 ' CG ' ' A' ' 136' ' ' PHE . 16.2 mt -118.25 144.98 45.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.213 0.53 . . . . 0.0 111.933 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -135.34 113.82 11.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.598 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.532 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -133.98 143.88 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.782 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.32 107.49 15.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -92.21 103.9 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.3 mp -86.33 129.07 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.74 75.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.161 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.43 177.65 2.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 p -111.85 156.87 21.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 0.0 110.966 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -148.9 154.25 39.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.77 134.41 35.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 138.21 6.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.457 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.26 6.88 19.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.622 0.249 . . . . 0.0 111.339 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.4 m -128.0 124.18 36.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -94.88 136.46 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.42 ' HE1' ' CZ2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -61.26 174.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.557 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.0 OUTLIER -89.84 163.26 33.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.159 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 65.2 Cg_endo -74.85 101.04 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.41 2.073 . . . . 0.0 112.198 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.72 147.22 25.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.57 84.21 2.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -64.86 -16.35 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.083 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.85 -32.65 63.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.905 0.384 . . . . 0.0 110.73 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -79.56 -28.01 41.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.927 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.518 ' CG ' HD12 ' A' ' 113' ' ' LEU . 72.3 m-85 -97.6 169.71 9.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.666 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -134.66 143.74 47.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.501 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.3 ttpm? -81.13 119.97 24.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.6 m -103.12 -21.36 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.235 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.0 m -162.56 140.33 8.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.461 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 18.2 p -165.19 113.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -147.96 130.95 16.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.002 0.429 . . . . 0.0 111.236 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 5.1 m -84.8 146.12 27.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.073 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 152' ' ' THR . 5.0 t -117.16 102.69 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.899 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.04 97.82 7.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.096 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.96 -178.19 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.299 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -60.97 2.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 110.574 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.47 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.37 117.06 40.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.666 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.75 -26.73 58.12 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.979 1.786 . . . . 0.0 112.402 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.53 -17.16 26.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 12.7 mt -88.34 11.25 17.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.622 0.248 . . . . 0.0 111.387 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.479 HG21 ' O ' ' A' ' 144' ' ' VAL . 87.7 m -71.59 168.43 17.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -171.45 157.65 4.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.544 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 17.6 m -126.71 147.59 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.441 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' HG23 ' A' ' 115' ' ' VAL . 2.4 mt-10 -104.37 124.57 49.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.808 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.3 t -118.42 115.72 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.272 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 18.5 m95 -112.61 151.21 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.508 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -125.95 110.95 14.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.863 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 4.5 tttt -49.09 138.85 11.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.666 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 39.5 mtmt -115.59 -175.11 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.409 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.103 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.25 147.12 38.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -110.28 115.59 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.574 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tp -116.06 123.93 49.17 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.52 ' CH2' HG13 ' A' ' 115' ' ' VAL . 3.8 p90 -167.99 162.77 13.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.77 131.57 56.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.114 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.44 154.33 37.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.717 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.465 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 2.2 p-10 -102.97 -176.8 3.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -47.92 -42.15 26.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.34 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 -25.99 54.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.455 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.63 25.47 9.22 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.59 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 126' ' ' THR . 0.4 OUTLIER -95.65 162.48 13.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.665 0.269 . . . . 0.0 110.736 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 pt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.343 -179.767 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 mttt . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.406 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 60.4 mt -84.74 88.41 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 18.2 ttp -95.31 118.24 31.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.223 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG23 ' CG1' ' A' ' 82' ' ' VAL . 3.5 t -88.11 126.61 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.01 148.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.323 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.59 157.6 52.74 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.61 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.482 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -50.94 -53.13 35.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.097 0.449 . . . . 0.0 110.606 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.482 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 14.9 tpt180 -59.95 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.592 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -64.6 -38.33 90.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.508 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.56 -39.82 89.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.634 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -66.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.2 t -54.24 -34.92 61.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.576 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -35.12 124.54 0.58 Allowed Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.839 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -43.43 -29.67 2.13 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.154 2.57 . . . . 0.0 113.652 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -142.11 132.81 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.171 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -141.21 107.96 6.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.804 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 71' ' ' GLN . 55.3 Cg_endo -90.14 176.8 18.7 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.162 0.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.5 ' CD1' ' HD2' ' A' ' 57' ' ' ARG . 55.0 mt -87.38 140.03 32.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.52 -84.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.962 2.442 . . . . 0.0 113.917 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -85.19 11.66 9.46 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.5 ' HD2' ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -112.27 113.42 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.959 0.409 . . . . 0.0 111.412 -178.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 81.4 m -70.15 114.05 7.92 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.512 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 57' ' ' ARG . 2.4 m-80 -104.69 154.68 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.72 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG1' HG21 ' A' ' 76' ' ' VAL . 10.8 t -135.8 132.35 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.788 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t -105.03 125.32 60.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.827 0.346 . . . . 0.0 111.648 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -107.27 115.26 29.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 3.6 t -149.02 166.37 28.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 111.194 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -82.69 -10.19 59.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.351 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.8 tp60 -79.65 132.06 36.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.307 . . . . 0.0 110.484 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 2.4 mt-10 -82.95 -31.07 27.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.809 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.91 6.25 45.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.263 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.0 t80 -60.43 136.76 58.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 111.67 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.76 171.88 12.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.408 1.099 . . . . 0.0 112.78 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.6 139.99 16.75 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.108 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 3.4 mt-30 -71.73 100.67 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.3 -36.96 3.33 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.694 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.91 170.17 14.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.82 140.24 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.466 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.15 106.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 29.1 m -117.73 167.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.439 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 6.6 m170 -119.61 -20.66 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.73 -175.2 5.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 111.77 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.481 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 7.5 t -68.33 -9.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.004 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.17 -34.1 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.3 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.1 -29.38 60.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.718 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.489 ' CG1' HG23 ' A' ' 40' ' ' VAL . 95.8 t -73.02 -55.84 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.46 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 8.1 m-85 -53.43 -26.12 18.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.987 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.76 87.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -67.67 -58.21 5.06 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.62 -23.02 15.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.211 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.95 -36.3 72.54 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.37 -7.18 59.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.663 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -124.96 66.63 50.71 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.031 0.443 . . . . 0.0 110.578 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.21 -0.41 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.234 2.623 . . . . 0.0 113.04 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.91 -31.74 15.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 160.1 14.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 111.411 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -98.59 166.22 11.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.082 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.88 117.91 27.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.44 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.76 112.06 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.314 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 11.9 mm -77.76 118.99 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.61 11.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.083 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.8 -166.36 39.29 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.501 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.4 -160.97 36.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 117.708 0.754 . . . . 0.0 112.524 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.27 -49.38 53.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.92 -30.37 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.304 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.422 ' CD1' HD22 ' A' ' 62' ' ' LEU . 42.2 mm -81.67 -26.75 9.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 6.0 m-85 -61.35 -58.61 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 4.6 t -67.14 -9.99 45.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.07 -38.84 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.487 ' O ' HG22 ' A' ' 110' ' ' VAL . 2.1 m-85 -100.21 -3.85 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.404 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.464 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 4.2 pttp -47.71 -33.56 7.12 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 4.35 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.678 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -125.0 -28.82 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 3' ' ' PHE . 92.1 t -45.16 131.13 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.273 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -104.3 1.83 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 40.3 m -167.5 143.34 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.365 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 33.7 mt -119.93 145.01 47.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.443 0.639 . . . . 0.0 111.925 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 mt -135.47 115.05 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.333 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.52 HG13 ' CH2' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -135.16 145.36 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.68 105.4 12.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.626 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -75.01 100.14 4.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.14 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.32 120.76 26.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.89 -52.81 47.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.023 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.24 162.61 36.05 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.009 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 3.6 t -102.72 156.89 17.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.9 m-85 -136.03 138.65 42.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -112.29 144.13 42.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.81 -125.39 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.318 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.13 31.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 2.9 m -156.78 123.01 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.727 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.2 167.5 10.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.3 tpt -79.79 155.89 27.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.736 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.5 pp -81.28 162.72 57.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.81 103.59 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.052 2.502 . . . . 0.0 112.744 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.403 ' CD1' ' CZ2' ' A' ' 5' ' ' TRP . 2.0 mt -91.68 145.07 24.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.94 78.76 2.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.971 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.47 ' CZ3' HD12 ' A' ' 113' ' ' LEU . 80.2 m95 -60.44 -19.94 58.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.8 -29.47 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.554 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.6 -28.17 45.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.832 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.554 ' CD1' HD11 ' A' ' 113' ' ' LEU . 92.5 m-85 -97.58 177.13 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.693 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 1.9 m -134.89 141.03 46.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 9.0 ttpt -84.0 117.84 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.494 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 27.2 m -105.68 -16.1 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.976 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 m -164.53 140.77 6.07 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.621 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.6 p -163.46 113.54 1.33 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -148.17 120.27 8.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.5 m -73.65 144.71 45.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.309 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 t -122.34 108.93 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.378 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.23 101.0 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.45 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -80.8 -176.14 5.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.411 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.8 t30 -77.08 130.89 74.0 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.138 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.73 -30.3 78.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.218 1.945 . . . . 0.0 112.656 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -89.89 -23.94 21.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.775 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.411 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 18.8 mt -80.06 4.06 18.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.491 0.186 . . . . 0.0 111.452 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 98.9 m -69.19 163.41 24.97 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.3 p80 -176.35 163.59 2.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.182 0.515 . . . . 0.0 112.265 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 116' ' ' THR . 87.8 m -120.8 147.17 45.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.024 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.81 105.4 14.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.732 0.301 . . . . 0.0 110.905 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.418 ' HB2' HG21 ' A' ' 115' ' ' VAL . 30.4 mt-10 -108.78 125.7 52.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 15.5 t -116.5 114.79 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.597 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.5 m95 -110.5 150.57 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.646 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -126.85 116.21 20.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.881 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.526 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 8.6 ttpt -51.8 130.1 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.384 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -96.08 172.9 7.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.342 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.097 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.405 ' O ' HG11 ' A' ' 110' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -104.99 154.65 19.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 112.308 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.487 ' CD1' ' HB ' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -123.9 114.01 19.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.2 tp -112.86 121.57 45.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.499 ' CZ2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -165.18 163.89 20.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.525 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.86 135.97 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.966 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.29 149.71 48.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.377 . . . . 0.0 110.969 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.5 p-10 -110.78 -168.24 1.28 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.021 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -35.41 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.088 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 -28.95 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.012 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.12 12.81 22.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.879 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.93 144.96 47.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.768 0.284 . . . . 0.0 110.586 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.539 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 51.6 mt -74.64 91.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.765 0.317 . . . . 0.0 111.522 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.1 ttp -101.92 120.45 40.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 15.3 t -80.3 159.19 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.869 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 28.7 m -161.72 157.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.34 155.51 43.89 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.906 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.466 ' HA ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.8 -52.68 64.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.982 0.391 . . . . 0.0 110.389 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -59.06 -32.64 69.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -71.59 -38.14 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.539 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 6.7 t80 -66.5 -25.94 66.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -72.65 -66.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 111.109 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.4 t -57.08 -31.44 65.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.43 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -26.24 135.16 0.1 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.88 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.64 -33.91 88.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.701 2.267 . . . . 0.0 112.929 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -160.08 122.41 3.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.25 135.62 15.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.252 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.77 160.41 71.42 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.14 -1.608 . . . . 0.0 111.838 -0.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.768 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 51.1 mt -75.15 156.36 85.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.05 -82.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.953 2.435 . . . . 0.0 113.653 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB2' ' NH1' ' A' ' 57' ' ' ARG . 5.3 mt-10 -93.18 27.6 2.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.411 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.768 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -125.2 111.68 15.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.403 . . . . 0.0 111.637 -178.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 53.4 m -72.35 119.53 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -102.73 151.44 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 112.083 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 17.1 t -132.07 142.76 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.392 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 43' ' ' ARG . 50.0 t -115.45 121.03 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.727 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.1 tp -104.78 117.14 33.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 0.7 OUTLIER -150.25 167.44 26.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.822 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -89.13 -10.05 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tt0 -73.79 137.06 43.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -88.46 5.96 39.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.118 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.55 5.85 4.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.607 0.241 . . . . 0.0 111.618 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.5 t80 -60.17 141.71 55.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.333 0.587 . . . . 0.0 112.014 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -131.93 173.8 10.82 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.249 1.024 . . . . 0.0 112.641 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.3 143.4 20.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.699 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.96 98.85 2.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.636 0.255 . . . . 0.0 110.799 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.57 -36.13 3.14 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.662 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.75 170.49 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 111.892 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 HG22 ' CE1' ' A' ' 85' ' ' TYR . 7.6 t -96.33 139.75 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.172 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 20.1 t -104.59 107.85 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 111.835 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 30.3 m -117.96 168.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.754 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.3 m170 -119.01 -22.37 7.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.552 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.44 -169.48 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 111.523 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 106' ' ' PHE . 4.8 t -73.44 -10.36 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.62 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.1 -34.82 19.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.231 0.539 . . . . 0.0 109.836 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.46 -30.38 61.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.419 HG21 HG23 ' A' ' 76' ' ' VAL . 17.5 t -72.16 -53.06 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.006 0.431 . . . . 0.0 109.876 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.674 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 4.3 m-85 -54.54 -28.34 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.823 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.6 96.43 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.72 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.437 ' CE1' HG22 ' A' ' 74' ' ' VAL . 65.0 t80 -65.57 -55.93 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.9 13.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.333 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 14.4 mmmt -69.35 -39.71 77.96 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -81.3 -4.61 56.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -126.86 65.58 63.21 Favored Pre-proline 0 N--CA 1.456 -0.151 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.7 -0.5 6.95 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.19 2.593 . . . . 0.0 112.775 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -91.71 -32.25 15.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -104.18 161.53 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.127 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -99.03 162.76 12.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.3 tp -109.29 115.84 30.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 39' ' ' MET . 44.7 t -131.05 115.5 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.487 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 7.0 mm -82.36 141.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.403 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.08 -44.66 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 176.01 -168.63 40.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.691 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.416 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.76 36.67 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 121.94 -0.741 . . . . 0.0 112.479 -0.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.47 -52.95 15.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.288 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -56.07 -29.27 60.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.535 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 62' ' ' LEU . 40.2 mm -81.47 -28.51 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.48 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.0 m-85 -60.2 -58.36 8.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.873 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.475 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 11.7 t -65.63 -10.12 33.08 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 121.73 -0.606 . . . . 0.0 112.228 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.58 -43.77 54.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.842 0.354 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HA ' HG23 ' A' ' 79' ' ' VAL . 3.9 m-85 -96.19 -1.37 48.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.559 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.475 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 6.9 pttt -50.91 -34.59 29.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.915 0.388 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.66 2.66 40.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.69 -27.62 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.619 0.247 . . . . 0.0 111.572 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.459 HG22 ' CD1' ' A' ' 3' ' ' PHE . 68.0 t -45.46 123.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.912 0.387 . . . . 0.0 111.284 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 13.8 t70 -107.02 7.54 29.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.24 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.5 m -168.39 140.0 2.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.365 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 ' CG ' ' A' ' 136' ' ' PHE . 7.1 mt -125.51 147.34 49.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.323 0.583 . . . . 0.0 112.079 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt -135.4 117.03 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.317 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.499 HG12 ' CZ2' ' A' ' 5' ' ' TRP . 2.1 m -131.76 141.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.94 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.25 109.6 18.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.198 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 14.0 mtt180 -84.07 99.59 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.385 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.63 120.62 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.305 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.99 -47.55 44.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.83 152.1 49.97 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.378 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 173.04 8.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.817 0.341 . . . . 0.0 111.093 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 3.2 m-85 -145.52 178.37 8.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.777 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.85 170.05 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 148.96 176.88 22.65 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.771 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.12 17.56 9.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.163 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -133.65 131.74 39.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.637 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -113.14 170.41 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 tpt -74.13 145.83 43.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.666 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 2.0 pp -66.42 166.66 16.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.187 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.666 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.1 Cg_endo -75.1 106.71 2.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.243 1.962 . . . . 0.0 112.319 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.92 147.51 23.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.86 69.51 5.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.433 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 88.7 m95 -53.39 -24.92 13.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.36 -29.8 64.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.328 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.6 -18.57 51.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.033 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.459 ' CG ' HD13 ' A' ' 113' ' ' LEU . 85.0 m-85 -106.83 168.49 9.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.418 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -131.22 141.61 50.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.0 ttpt -81.88 109.43 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.547 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.4 m -92.27 -26.42 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.384 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.1 m -154.93 140.3 17.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.588 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 51.9 p -169.58 115.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.969 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -147.91 119.02 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.076 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.5 m -71.08 145.91 49.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.032 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 t -119.67 104.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.657 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -85.07 100.2 11.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.22 173.78 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.1 p -53.54 -44.25 69.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.631 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.463 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 9.9 t30 -82.68 132.17 52.61 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.34 -33.29 89.43 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.395 2.063 . . . . 0.0 112.613 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.55 -28.52 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.0 mt -76.74 5.05 8.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.9 m -71.56 158.4 36.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -174.12 160.59 3.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.951 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 22.2 m -122.58 138.6 54.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.946 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 141' ' ' SER . 88.6 m-85 -102.6 106.35 17.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 32.7 mt-10 -108.16 125.72 51.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.1 t -116.6 112.35 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.75 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.494 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 17.4 m95 -107.22 151.16 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 112.003 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -130.35 127.18 38.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.831 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 10.9 tttp -54.13 130.54 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 111.359 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.418 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -116.79 -168.56 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.836 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.15 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.408 ' O ' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.746 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.32 146.67 40.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.479 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.6 m-30 -110.2 111.07 22.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.551 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -108.63 118.99 38.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.479 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 4.6 p90 -167.96 172.99 8.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.32 135.67 46.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -117.58 161.51 19.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.047 0.451 . . . . 0.0 111.444 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.6 -167.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -39.5 71.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.759 0.314 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.56 -27.49 37.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.25 22.98 10.85 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.683 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.33 152.91 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.614 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.443 HG22 ' CD1' ' A' ' 5' ' ' TRP . 1.5 pp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.679 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 58' ' ' THR . 17.7 mttm . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 93' ' ' GLU . 75.4 mt -88.93 88.55 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.302 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.2 OUTLIER -102.06 126.29 48.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.368 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 2.0 t -90.79 129.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.447 HG13 ' CE2' ' A' ' 49' ' ' PHE . 21.7 m -133.54 138.03 51.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.242 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.43 153.74 39.31 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.005 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.5 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -50.74 -53.53 30.84 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.936 0.398 . . . . 0.0 110.075 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -54.5 -42.41 70.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -65.06 -40.76 95.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 28.8 t80 -60.48 -29.57 69.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.913 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.51 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.6 t -58.49 -31.08 67.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.305 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -29.8 135.79 0.18 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.996 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 75.9 Cg_exo -48.83 -35.11 30.06 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.276 . . . . 0.0 112.85 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.07 142.78 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.35 112.04 6.55 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -81.72 178.81 29.52 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.984 -0.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.432 HD11 ' HD2' ' A' ' 57' ' ' ARG . 64.1 mt -84.21 140.69 39.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.603 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.62 110.98 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.495 2.13 . . . . 0.0 112.835 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 74.37 -0.17 3.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.35 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HD2' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -109.57 116.23 31.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.66 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 33.3 m -70.08 111.5 5.79 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.456 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -107.14 154.86 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.947 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 18.8 t -128.02 143.42 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.389 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 76' ' ' VAL . 90.0 t -111.69 126.98 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.889 0.376 . . . . 0.0 111.069 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -105.64 123.39 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.361 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 1.2 t -157.2 158.33 36.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -79.67 -6.57 57.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.3 tt0 -78.78 131.29 36.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.817 0.341 . . . . 0.0 110.974 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 4.21 29.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.91 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.4 7.29 4.92 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.424 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.0 t80 -59.23 144.98 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.051 0.453 . . . . 0.0 111.2 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -133.94 174.27 10.65 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.368 1.08 . . . . 0.0 113.014 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.91 144.47 21.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.709 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -81.0 96.66 7.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.89 0.376 . . . . 0.0 110.643 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -44.7 2.06 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.78 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.06 168.04 17.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 111.74 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.445 HG11 ' CD1' ' A' ' 85' ' ' TYR . 28.3 t -96.26 141.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.408 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 28.4 t -108.1 120.83 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.333 0.587 . . . . 0.0 111.912 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.439 ' CG2' HG21 ' A' ' 82' ' ' VAL . 27.7 m -127.59 169.55 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.633 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' THR . 7.9 m170 -117.52 -25.58 6.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.835 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.5 -174.62 5.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.015 0.436 . . . . 0.0 111.16 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' A' ' 106' ' ' PHE . 11.2 t -67.92 -11.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.533 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -34.21 19.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.441 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.86 -26.15 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.023 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 76' ' ' VAL . 43.1 t -75.98 -54.71 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.557 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 14.5 m-85 -53.34 -27.89 25.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.885 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.53 87.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.969 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' CD1' HG11 ' A' ' 74' ' ' VAL . 86.1 t80 -65.3 -56.32 13.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.95 -24.86 59.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.034 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -68.8 -43.5 75.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -79.1 -10.7 59.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.286 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -122.88 65.6 26.92 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.15 -0.4 4.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.159 2.572 . . . . 0.0 113.166 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.92 -37.85 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.1 164.1 11.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.433 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 5.7 mm-40 -99.13 171.26 8.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 tp -115.91 116.67 28.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 39' ' ' MET . 49.1 t -128.58 114.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.527 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.411 HD11 ' CE2' ' A' ' 106' ' ' PHE . 7.6 mm -83.34 140.2 16.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.077 0.465 . . . . 0.0 111.234 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.84 -36.34 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.57 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -170.93 43.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.555 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.45 -161.23 32.81 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 117.376 0.588 . . . . 0.0 112.512 -0.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.04 -53.53 54.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -55.34 -27.3 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.5 mm -83.16 -27.47 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.854 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.431 ' HB3' HG12 ' A' ' 129' ' ' ILE . 1.9 m-85 -60.61 -56.52 20.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.38 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.426 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 1.8 t -67.71 -10.07 49.25 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.24 -47.21 20.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.343 . . . . 0.0 110.732 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 79' ' ' VAL . 9.3 m-85 -86.18 -9.38 56.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.321 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 3.2 pttp -52.42 -29.76 25.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -75.88 -7.43 54.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 22.5 m-20 -129.58 -19.89 3.32 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 53.5 t -43.81 127.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.112 0.482 . . . . 0.0 110.935 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 10.5 t0 -108.55 6.58 26.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.48 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.746 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 18.7 m -169.68 137.92 1.8 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.72 0.295 . . . . 0.0 110.6 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 6.1 mt -122.7 145.67 48.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.168 0.509 . . . . 0.0 111.605 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mt -134.84 117.41 15.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.578 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.453 HG13 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -133.96 144.0 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.009 0.433 . . . . 0.0 111.837 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.36 104.71 11.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.4 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 2.9 ttt-85 -75.8 100.75 4.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.452 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.4 108.29 19.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.087 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.45 -39.73 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.408 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.6 -167.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.701 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.81 146.8 41.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 111.007 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.3 m-85 -134.47 162.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -99.73 134.05 43.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.002 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.01 -174.36 33.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.793 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.86 21.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.251 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -139.11 127.69 23.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -173.6 1.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.201 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.3 pp -112.11 160.15 31.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.88 102.48 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.831 2.354 . . . . 0.0 112.746 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.34 146.44 27.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.29 76.35 5.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -60.04 -19.12 51.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.365 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.13 -33.22 65.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -81.77 -17.19 48.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.428 ' CD2' HD12 ' A' ' 113' ' ' LEU . 79.6 m-85 -106.68 167.75 9.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.906 0.384 . . . . 0.0 111.163 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.518 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -127.68 141.02 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.516 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.638 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 12.1 ttpp -81.81 115.99 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.416 HG23 ' HB ' ' A' ' 157' ' ' VAL . 27.1 m -101.04 -18.76 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.783 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.4 m -164.25 140.54 6.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.535 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.638 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 93.0 p -164.95 113.33 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.48 126.02 13.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.9 m -80.5 145.04 32.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.294 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.79 109.05 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.91 104.5 16.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -177.2 5.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.3 p -58.02 -42.34 85.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.46 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 3.4 t30 -80.99 134.5 52.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.342 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.96 -32.31 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.202 1.934 . . . . 0.0 112.429 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.11 -25.61 22.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.5 mt -76.18 5.11 7.33 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 153' ' ' HIS . 72.0 m -72.89 162.27 29.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.565 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -175.97 162.67 2.61 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 0.0 112.033 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 38.5 m -122.5 129.82 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.33 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -93.66 107.89 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.28 152.29 20.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' A' ' 139' ' ' VAL . 19.0 t -142.41 110.22 2.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.759 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.459 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 29.8 m95 -109.8 145.74 36.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.397 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.15 129.51 39.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.373 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -49.08 122.19 5.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 111.447 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.518 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.9 OUTLIER -97.8 176.14 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.063 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 110' ' ' VAL . 87.6 m . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.747 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -107.95 154.79 21.11 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.8 m-30 -120.68 107.92 13.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.831 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.44 115.38 30.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.475 0.655 . . . . 0.0 112.231 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.473 ' CZ2' HG11 ' A' ' 115' ' ' VAL . 5.7 p90 -158.37 166.19 32.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.856 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.36 133.28 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.1 pt20 -131.63 157.03 44.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.435 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -108.18 -162.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.361 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.443 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.28 -49.96 74.41 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -33.37 72.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.23 33.15 3.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.776 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.4 mm? -73.84 127.14 32.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.423 HG23 ' CD1' ' A' ' 5' ' ' TRP . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.423 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.0 mtmm . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 80.7 mt -84.52 87.46 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.759 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.431 ' HE2' ' O ' ' A' ' 39' ' ' MET . 0.4 OUTLIER -100.31 122.63 43.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.922 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 21.6 t -82.84 158.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.612 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 35.1 m -164.32 144.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.36 152.9 52.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.753 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.443 ' HA ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.27 -52.26 53.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.861 0.33 . . . . 0.0 110.81 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.81 -32.18 70.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.086 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 m -70.15 -37.38 75.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.443 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -66.96 -26.28 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.034 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.73 -66.42 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -47.27 -37.97 11.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.476 ' CE2' HG13 ' A' ' 41' ' ' VAL . 2.8 m-30 -36.21 148.26 0.17 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -43.77 -69.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 0.0 112.713 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -139.09 167.57 21.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.53 117.38 29.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.65 -171.0 8.34 Favored 'Cis proline' 0 C--N 1.349 0.594 0 C-N-CA 123.716 -1.369 . . . . 0.0 112.348 -0.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mt -79.98 162.87 60.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 24.4 Cg_endo -61.56 92.47 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.744 2.296 . . . . 0.0 113.101 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 60.29 33.8 20.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.624 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.634 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 10.7 mtp180 -124.02 114.3 19.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.203 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 41.4 m -65.14 107.21 1.48 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.124 0.488 . . . . 0.0 110.192 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.418 HD22 HD13 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.3 154.45 18.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.424 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 11.8 t -130.91 132.61 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.731 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 43' ' ' ARG . 96.0 t -104.22 127.59 58.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 111.717 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD1' HG22 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -109.32 113.3 26.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.995 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.419 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.2 t -148.6 167.37 25.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 111.279 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -84.11 -7.31 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.282 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.1 tp60 -80.46 128.8 34.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.467 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -28.01 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.8 9.62 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.65 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.2 t80 -59.86 141.08 56.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.064 0.459 . . . . 0.0 111.489 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -129.93 174.0 10.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.255 1.026 . . . . 0.0 112.54 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.47 143.72 20.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.58 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -74.31 96.24 2.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.445 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.94 -35.52 3.65 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.172 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.96 166.32 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.95 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.412 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 15.3 t -96.67 140.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.412 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 t -106.8 120.56 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.313 0.578 . . . . 0.0 112.18 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.456 ' CG2' HG23 ' A' ' 82' ' ' VAL . 24.9 m -132.77 172.04 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.965 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -122.21 -20.2 6.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.06 -175.68 5.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.101 0.476 . . . . 0.0 111.74 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.428 HG22 ' CG ' ' A' ' 106' ' ' PHE . 14.4 t -69.19 -10.24 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.614 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.48 -36.22 17.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.138 0.494 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.417 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -72.62 -33.71 66.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG23 ' CG2' ' A' ' 76' ' ' VAL . 27.2 t -70.29 -49.98 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.642 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 2.9 m-85 -54.34 -28.7 44.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.178 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.33 -39.79 85.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 50.8 t80 -66.37 -57.62 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.98 -23.06 43.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.893 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.642 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -72.08 -32.0 66.62 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 109.958 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.441 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 10.0 mt-30 -84.64 -9.02 58.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -121.21 65.17 14.54 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.027 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.36 -1.53 3.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.808 2.339 . . . . 0.0 112.647 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.03 -29.06 15.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.32 159.81 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.68 170.01 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.201 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -112.95 113.15 25.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.2 t -124.09 107.18 18.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.721 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.439 ' CD1' HG22 ' A' ' 40' ' ' VAL . 9.2 mm -76.46 134.69 28.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.137 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.434 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.96 -38.52 5.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.14 -167.35 40.31 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.09 -161.08 23.07 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 122.063 -0.669 . . . . 0.0 112.571 -0.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . -54.5 -51.63 64.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.826 0.346 . . . . 0.0 111.26 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -31.71 68.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.591 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 33.4 mm -72.67 -27.66 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 2.4 m-85 -60.85 -54.35 46.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.572 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 7.7 t -69.26 -10.38 57.54 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.872 -0.517 . . . . 0.0 111.989 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.12 -39.91 54.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.434 ' O ' HG21 ' A' ' 110' ' ' VAL . 3.4 m-85 -96.17 -8.24 33.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.552 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.84 -28.83 17.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.16 -1.46 49.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.469 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -132.01 -20.1 2.51 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.492 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 71.0 t -44.04 128.76 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.887 0.375 . . . . 0.0 111.222 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.9 t70 -106.16 1.59 26.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.301 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.747 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 72.7 m -166.99 135.09 2.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.674 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.437 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 9.6 mt -118.99 144.38 46.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 111.672 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mt -134.95 115.97 14.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.044 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.473 HG11 ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -132.77 142.74 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 111.672 -179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.8 114.4 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.5 102.29 14.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.673 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -83.47 133.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.36 -57.43 10.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.339 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.14 168.2 38.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.747 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -99.33 172.51 7.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.804 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -148.97 178.49 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.11 0.481 . . . . 0.0 111.442 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.55 171.48 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.434 ' HA3' ' CD1' ' A' ' 12' ' ' LEU . . . 161.41 -179.69 36.66 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.61 5.75 4.02 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.4 ' O ' HD11 ' A' ' 12' ' ' LEU . 5.3 m -134.24 137.22 44.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 111.108 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 165.4 11.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -173.72 0.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 111.086 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.434 HG12 ' CB ' ' A' ' 103' ' ' PHE . 2.2 pp -118.47 164.03 22.48 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.083 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.11 136.65 57.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.636 2.224 . . . . 0.0 112.006 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -128.3 148.27 50.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.07 77.47 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.437 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.3 m95 -60.32 -19.0 53.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.324 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -29.31 62.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.57 -26.73 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.455 ' HZ ' ' HB ' ' A' ' 110' ' ' VAL . 95.4 m-85 -97.71 173.95 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.18 140.5 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.483 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -79.72 111.67 16.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.833 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -93.88 -25.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.3 m -160.28 140.46 11.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 111.158 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.46 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 17.2 p -162.99 111.53 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -147.76 122.41 9.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 111.434 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 4.8 m -76.38 144.93 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.35 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 t -115.62 105.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -93.61 104.94 17.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.406 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -86.69 -177.09 6.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -54.42 -51.49 64.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.502 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -76.58 127.0 85.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.044 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.21 -31.5 93.15 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.137 1.891 . . . . 0.0 112.413 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.26 -22.41 33.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.869 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.9 mt -81.75 10.46 6.16 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.0 m -79.55 164.97 23.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 110.32 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.673 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 7.9 p80 -174.08 160.9 3.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.152 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 18.2 m -125.45 135.43 52.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -100.83 109.25 21.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' HG21 ' A' ' 115' ' ' VAL . 2.3 mt-10 -107.16 126.81 52.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.944 0.402 . . . . 0.0 111.378 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.4 t -118.82 116.36 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.26 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.483 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.9 m95 -112.53 150.18 31.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.058 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -128.58 118.31 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.303 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 2.6 ttpp -53.55 133.91 41.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.578 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.51 10.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.511 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.087 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 111' ' ' ASP . 91.4 m . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.52 0.2 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.79 152.64 28.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -115.45 116.26 27.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.458 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.1 tp -115.25 122.03 44.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 2.8 p90 -168.35 165.2 12.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.88 141.65 51.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 4.9 pt20 -127.35 156.55 41.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.838 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.54 -170.52 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.54 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -50.01 -46.34 52.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.42 -21.42 59.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 90.2 47.94 3.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.16 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.439 ' CD2' ' HA3' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -87.27 174.72 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.378 -179.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.69 87.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.68 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.4 ttp -99.94 111.94 24.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.581 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG23 HG11 ' A' ' 82' ' ' VAL . 2.8 t -86.2 129.82 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.77 153.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.648 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.95 157.05 53.49 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.213 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -53.18 -52.78 57.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.397 . . . . 0.0 110.345 179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.7 tpt180 -56.82 -44.81 82.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.325 0.583 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 m -61.16 -36.65 80.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 49' ' ' PHE . 9.5 t80 -66.02 -24.71 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -65.83 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.396 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.4 t -48.19 -31.65 6.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.222 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 46' ' ' TYR . 3.5 m-30 -46.44 166.46 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.99 -70.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.795 2.33 . . . . 0.0 112.932 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -145.72 -167.11 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.97 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -132.3 113.81 14.61 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 6.4 Cg_exo -87.83 -160.9 1.72 Allowed 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.057 -0.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.703 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 12.2 mt -86.9 168.27 18.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 37.8 Cg_endo -66.87 93.9 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.443 2.095 . . . . 0.0 113.043 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 64.99 14.05 9.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.33 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.703 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 6.0 mtp180 -109.11 116.95 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.388 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.4 m -67.11 110.93 3.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.866 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.424 ' ND2' HD11 ' A' ' 54' ' ' LEU . 2.4 m120 -106.0 157.48 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.437 0.637 . . . . 0.0 112.641 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' CG1' HG21 ' A' ' 76' ' ' VAL . 8.2 t -136.14 135.76 49.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.33 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 43' ' ' ARG . 85.9 t -109.46 128.11 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.925 0.393 . . . . 0.0 111.636 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -107.61 119.74 40.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.434 HG22 ' CB ' ' A' ' 68' ' ' TYR . 1.9 t -150.47 170.95 17.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -95.06 -10.13 31.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.718 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.0 tt0 -68.87 132.27 46.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.8 0.334 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.22 56.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.71 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.01 14.64 18.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.628 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.1 t80 -60.95 142.1 56.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.444 0.64 . . . . 0.0 111.978 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -135.79 172.99 12.21 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.316 1.055 . . . . 0.0 112.873 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.97 140.61 17.99 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.094 -1.867 . . . . 0.0 110.106 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.8 mp0 -73.77 100.2 3.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.78 0.324 . . . . 0.0 110.85 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 87.15 -38.17 3.16 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.395 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.62 171.34 10.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.674 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.46 140.37 18.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.507 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -107.95 116.84 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 0.0 112.032 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 33.1 m -126.29 171.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -121.14 -22.54 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.736 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -155.2 -173.95 4.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.7 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.448 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 14.8 t -68.22 -10.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.14 -33.92 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.088 0.47 . . . . 0.0 110.075 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.424 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -77.19 -27.22 53.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.886 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.445 HG11 HG23 ' A' ' 40' ' ' VAL . 72.4 t -73.47 -53.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.518 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.6 m-85 -55.01 -26.74 39.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.709 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.84 97.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.411 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 38.9 t80 -67.19 -57.68 6.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.04 -25.66 5.17 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.232 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -66.58 -44.37 82.43 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -79.74 -0.3 33.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.546 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.411 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 62.9 m-70 -127.57 60.26 43.11 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.981 0.42 . . . . 0.0 110.269 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.3 -0.25 7.08 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.146 2.564 . . . . 0.0 112.812 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.5 -38.29 30.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.067 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.17 167.68 10.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 111.243 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.54 166.31 11.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.501 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.401 HD23 ' CG1' ' A' ' 82' ' ' VAL . 13.6 tp -97.43 116.64 30.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.988 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' MET . 12.3 t -122.82 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.529 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 12.7 mm -80.59 140.53 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.418 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.73 -37.99 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.405 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.75 -168.42 41.52 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.681 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.408 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.54 -160.97 34.0 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 117.561 0.681 . . . . 0.0 112.528 -0.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.54 63.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -29.06 60.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.599 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 96' ' ' ILE . 27.7 mm -84.08 -26.31 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.547 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.2 m-85 -60.45 -58.46 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 3.8 t -66.51 -9.08 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.34 -39.35 39.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.71 0.29 . . . . 0.0 111.283 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 2.3 m-85 -103.23 -5.76 22.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 7.0 pttt -42.47 -31.14 0.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -90.35 -26.76 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.1 -31.68 17.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.483 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 70.8 t -48.99 129.32 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 1' ' ' THR . 6.3 t70 -105.86 9.24 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.616 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.2 m -166.85 140.91 3.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.549 HD13 ' CG ' ' A' ' 136' ' ' PHE . 13.8 mt -121.62 144.24 48.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.305 0.574 . . . . 0.0 111.743 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mt -135.38 117.53 15.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.139 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 1.2 m -136.33 146.51 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.479 . . . . 0.0 112.108 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.97 108.47 16.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.301 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 8.3 tpt180 -79.51 101.16 8.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.317 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.49 124.89 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.258 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.3 6.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.29 175.31 3.27 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.664 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.6 p -105.72 159.37 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 110.947 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -147.31 155.17 41.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.84 170.1 10.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.652 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.439 ' HA3' ' CD2' ' A' ' 12' ' ' LEU . . . 157.57 163.85 13.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.262 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.45 -27.1 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.6 0.238 . . . . 0.0 111.348 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.4 m -109.17 146.67 33.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.742 0.306 . . . . 0.0 111.008 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 177.56 4.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.417 ' HE1' ' CE2' ' A' ' 5' ' ' TRP . 17.0 tpt -76.94 156.68 31.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.3 pp -82.84 157.79 66.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.26 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.22 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.72 2.28 . . . . 0.0 112.507 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.45 146.63 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.38 75.78 2.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.012 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -56.39 -23.45 38.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -27.81 63.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.554 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.7 -24.82 44.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.737 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.549 ' CG ' HD13 ' A' ' 113' ' ' LEU . 78.5 m-85 -104.05 173.58 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.637 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -128.72 139.79 52.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.471 ' HD2' ' CB ' ' A' ' 141' ' ' SER . 1.2 ttpp -83.7 108.0 16.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.574 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.79 -18.11 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.722 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 m -162.62 140.46 8.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.722 0.296 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.471 ' CB ' ' HD2' ' A' ' 138' ' ' LYS . 2.2 p -169.85 108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -142.66 118.12 10.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.3 m -67.11 145.28 55.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.04 103.74 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.284 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.86 102.15 14.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.32 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 174.23 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.6 p -52.53 -44.16 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 151' ' ' LEU . 3.2 t30 -80.51 128.49 72.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.352 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.43 -30.35 86.85 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.393 2.062 . . . . 0.0 112.592 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.7 -22.98 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 148' ' ' ASN . 19.4 mt -81.01 6.3 13.85 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 99.6 m -70.2 162.38 28.5 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.163 0.506 . . . . 0.0 110.396 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -172.38 159.09 4.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.836 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 116' ' ' THR . 6.8 m -119.0 150.25 40.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -113.84 105.04 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 115' ' ' VAL . 28.5 mt-10 -109.78 125.29 52.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.037 0.446 . . . . 0.0 112.183 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.84 114.22 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.211 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.462 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.1 m95 -108.31 150.59 27.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.064 0.459 . . . . 0.0 111.985 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.33 125.33 36.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.32 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.07 123.28 6.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.661 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.637 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -107.67 -177.59 3.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.133 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.738 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.77 149.2 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.48 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 3.4 m-30 -113.64 108.35 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.48 117.15 33.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.605 0.717 . . . . 0.0 112.45 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.477 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.1 p90 -161.52 166.84 26.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.261 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.86 132.55 54.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.607 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.7 pt20 -118.5 143.87 46.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -91.93 -167.82 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.42 52.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.01 -27.68 48.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.73 29.53 4.64 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.259 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' CD2' ' HA3' ' A' ' 124' ' ' GLY . 1.9 tt -84.27 157.87 21.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.962 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.448 ' N ' HD21 ' A' ' 12' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.459 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 93' ' ' GLU . 6.7 mmtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.559 0.695 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.501 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 20.4 mt -64.41 110.7 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.692 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.8 ttp -100.79 115.26 29.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.584 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.509 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 2.7 t -88.99 124.3 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.167 0.508 . . . . 0.0 112.201 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.0 144.33 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.379 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.09 156.97 51.79 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.172 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.48 -51.01 68.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 110.514 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.432 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -58.43 -34.87 71.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -68.24 -47.49 67.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -54.13 -31.91 53.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -66.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.652 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 49' ' ' PHE . 2.4 m -57.6 -30.75 65.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.42 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -32.92 122.7 0.42 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.9 -179.23 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.28 -38.2 88.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.963 2.442 . . . . 0.0 113.311 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.57 116.28 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.429 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.51 135.09 14.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.709 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.42 -171.86 8.41 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.354 -1.519 . . . . 0.0 112.161 -0.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 57' ' ' ARG . 95.7 mt -97.84 147.2 32.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.571 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.67 -86.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.091 2.527 . . . . 0.0 113.451 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.84 25.65 8.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.624 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.429 ' HB2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.142 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 80.3 m -74.7 122.0 22.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 111.873 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -102.81 152.79 20.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.9 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.509 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 2.2 t -137.38 131.71 44.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.5 t -103.47 126.19 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.272 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.416 HD13 ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -109.87 108.29 18.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.944 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.446 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 2.9 t -144.19 164.11 31.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 111.396 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -81.1 -9.83 59.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.289 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.668 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.9 tp60 -71.74 127.18 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.332 . . . . 0.0 110.392 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -27.91 55.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -105.13 16.93 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.641 0.258 . . . . 0.0 111.493 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.668 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.6 t80 -62.25 137.24 58.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.485 0.659 . . . . 0.0 112.454 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.41 171.99 11.06 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.251 1.024 . . . . 0.0 112.357 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.07 140.14 16.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -76.07 96.81 3.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.813 0.339 . . . . 0.0 110.941 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.95 -42.26 2.31 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.556 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 167.92 19.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.133 0.492 . . . . 0.0 112.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.81 140.89 15.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.127 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 t -107.01 121.61 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.386 0.612 . . . . 0.0 111.955 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.551 HG21 HG21 ' A' ' 82' ' ' VAL . 18.0 m -132.74 178.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.131 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -127.79 -21.11 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.8 -177.11 6.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.457 . . . . 0.0 111.591 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' A' ' 106' ' ' PHE . 24.2 t -70.08 -11.17 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.433 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.11 -37.24 17.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.107 0.48 . . . . 0.0 110.064 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.83 -30.63 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.665 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.551 HG21 HG21 ' A' ' 76' ' ' VAL . 23.3 t -72.35 -55.81 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.484 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 8.5 m-85 -52.49 -31.21 34.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.6 -43.81 97.87 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 87.5 t80 -61.04 -52.6 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.3 -22.33 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.35 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mtmt -70.99 -37.14 72.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.126 0.489 . . . . 0.0 109.874 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -8.7 59.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 92' ' ' GLN . 95.1 m-70 -120.01 62.45 8.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.93 -6.04 8.69 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.655 2.237 . . . . 0.0 112.226 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -99.55 -25.75 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.982 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 89' ' ' HIS . 10.3 mt-30 -94.11 151.6 19.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 29.2 mt-10 -99.09 174.76 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.58 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 1' ' ' THR . 17.2 tp -131.23 111.17 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 111.308 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 39' ' ' MET . 83.9 t -129.23 116.14 38.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.458 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 6.3 mm -82.02 138.13 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.88 0.371 . . . . 0.0 111.082 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.76 -33.14 5.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.94 -171.89 44.41 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.462 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.62 -160.97 36.17 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 117.588 0.694 . . . . 0.0 112.632 -0.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.01 -55.75 15.9 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.8 0.333 . . . . 0.0 111.294 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -56.47 -31.92 64.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.025 0.441 . . . . 0.0 110.464 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.4 mm -77.11 -30.54 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.053 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.0 m-85 -58.02 -52.98 63.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.366 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.527 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 12.0 t -69.53 -10.22 57.19 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.36 -39.71 64.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 0.0 110.671 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 3.8 m-85 -102.35 -3.55 26.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.584 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.527 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 5.9 pttt -51.65 -31.23 24.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.7 -5.69 58.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.555 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.82 -20.65 8.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.657 0.265 . . . . 0.0 111.475 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.543 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 73.4 t -45.58 134.15 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.12 0.486 . . . . 0.0 111.427 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 18.1 t70 -111.26 -0.32 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.738 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.6 m -166.74 137.44 3.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.565 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 6.1 mt -118.13 145.64 44.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.24 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 4' ' ' LEU . 9.4 mt -134.96 112.74 10.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.062 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.1 m -127.94 137.39 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.055 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.92 119.93 36.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.182 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 100.6 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 0.9 OUTLIER -81.13 135.31 35.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.94 -53.84 52.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 122' ' ' PHE . . . -58.04 156.32 19.52 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.234 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 p -97.04 154.13 17.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -142.68 156.48 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.824 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 156.92 16.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.252 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.483 ' HA3' ' CD2' ' A' ' 12' ' ' LEU . . . 178.56 175.41 45.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.911 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.22 22.08 4.45 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.3 m -133.0 126.96 33.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.75 0.31 . . . . 0.0 110.838 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -108.65 162.31 14.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.3 tpt -72.93 158.44 35.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.491 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.2 pp -88.75 164.97 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.178 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.22 96.79 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 112.655 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.1 149.49 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.997 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.02 71.35 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.479 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.476 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 95.6 m95 -58.96 -20.11 49.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.86 -32.06 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.756 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -79.39 -24.52 42.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.57 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 95.5 m-85 -101.46 171.62 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 111.076 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -134.93 141.76 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.592 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.2 ttpm? -84.76 105.81 15.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 34.9 m -89.9 -17.96 7.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.985 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -161.85 141.47 10.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 111.17 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.592 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 99.2 p -172.01 108.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -147.87 130.52 15.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.26 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 1.4 m -74.27 146.3 43.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.148 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 152' ' ' THR . 11.3 t -118.3 104.62 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.383 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -93.33 104.89 17.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.72 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.7 -174.51 4.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.498 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -54.58 -54.89 35.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.864 0.364 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.515 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.8 t30 -75.93 141.08 71.07 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.769 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.77 -36.57 18.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.819 1.679 . . . . 0.0 112.369 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.91 -23.4 44.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.878 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -77.69 9.61 3.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.566 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 153' ' ' HIS . 50.3 m -83.95 158.64 21.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.434 ' N ' HG23 ' A' ' 152' ' ' THR . 0.6 OUTLIER -170.68 155.83 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 116' ' ' THR . 39.6 m -117.69 129.44 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.404 ' OH ' ' CE1' ' A' ' 153' ' ' HIS . 57.2 m-85 -100.77 105.64 16.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.409 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.495 ' HB2' HG22 ' A' ' 115' ' ' VAL . 17.0 mt-10 -104.61 126.68 51.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.307 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 6.2 t -118.07 112.56 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.539 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 30.2 m95 -104.63 148.27 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.067 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -128.33 119.22 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.747 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.4 tttt -51.54 135.13 28.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.26 -165.86 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.575 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 9.6 m . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.698 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.93 148.64 33.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.9 m-85 -113.87 112.24 23.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.278 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.84 127.83 55.34 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.474 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 5.5 p90 -168.63 163.8 12.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.216 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.22 131.73 53.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.862 0.363 . . . . 0.0 111.732 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.541 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 7.5 pt20 -130.61 161.54 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.415 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.11 -169.03 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HD3' ' HB3' ' A' ' 121' ' ' SER . 0.0 OUTLIER -55.34 -27.73 49.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.67 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 9.2 t70 -90.63 -33.98 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 105.17 57.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.859 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 67.1 mt -110.22 152.23 26.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.343 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.446 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 40.8 mt -76.82 88.96 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 111.579 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.5 ttp -103.11 126.74 50.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.641 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 39.3 t -79.87 156.51 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.759 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 31.2 m -163.7 140.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.984 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.76 147.75 48.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.32 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.578 ' HG2' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -49.93 -46.39 52.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.445 0.622 . . . . 0.0 110.613 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -58.97 -39.55 82.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 109.963 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -65.98 -48.67 70.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.984 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -57.31 -27.22 61.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.79 -66.23 0.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.658 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.12 -23.88 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.437 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -35.71 133.12 0.53 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.901 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 99.6 Cg_exo -46.8 -35.96 18.74 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.144 2.563 . . . . 0.0 113.534 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.84 148.55 31.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.197 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.95 111.84 6.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.252 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -81.76 179.09 28.53 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 123.408 -1.497 . . . . 0.0 111.787 -0.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.518 ' HB3' ' CD ' ' A' ' 57' ' ' ARG . 77.8 mt -78.87 143.42 62.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.766 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.81 109.2 2.06 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.514 2.143 . . . . 0.0 112.609 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 73.19 0.12 3.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.968 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' CD ' ' HB3' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -109.89 106.88 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 -179.343 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 87.9 m -64.99 120.31 12.36 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.11 157.32 19.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.203 0.525 . . . . 0.0 112.362 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 17.7 t -134.15 143.58 37.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.765 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 43' ' ' ARG . 57.8 t -113.58 111.04 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.179 0.514 . . . . 0.0 111.891 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -91.58 118.35 30.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.304 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -155.37 148.17 24.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.936 179.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -69.02 -6.32 27.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.258 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.7 tt0 -73.29 131.6 42.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.329 . . . . 0.0 110.747 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -85.42 5.47 30.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.838 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -134.6 7.72 3.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.4 t80 -59.91 137.51 58.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.289 0.566 . . . . 0.0 111.594 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 1.3 mt-30 -133.15 171.94 13.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.454 1.121 . . . . 0.0 113.14 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.5 140.29 17.13 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.138 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.97 102.56 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.07 -41.05 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.274 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.49 170.51 14.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.017 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 21.6 t -98.53 141.33 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 14.8 t -114.37 122.37 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 0.0 112.187 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' CG2' HG21 ' A' ' 82' ' ' VAL . 27.3 m -129.91 173.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.111 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' THR . 6.0 m170 -118.44 -24.22 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.1 -171.82 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 111.165 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.6 t -68.91 -11.29 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.54 -36.84 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 110.094 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.81 -29.67 63.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.89 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 76' ' ' VAL . 21.5 t -72.3 -55.19 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 120.904 0.383 . . . . 0.0 110.039 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.519 ' O ' ' HG3' ' A' ' 87' ' ' LYS . 9.4 m-85 -53.61 -27.59 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.817 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.08 -48.64 79.28 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.846 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.424 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 83.1 t80 -58.98 -51.24 70.91 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.99 -22.84 16.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.095 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 6.6 mtmp? -67.78 -44.5 77.29 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -79.63 -2.83 44.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.596 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.424 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 61.7 m-70 -128.68 64.43 69.04 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-O 120.995 0.426 . . . . 0.0 110.388 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.19 -0.01 6.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.184 2.589 . . . . 0.0 112.935 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.89 -31.83 18.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.169 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.74 162.94 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.364 . . . . 0.0 111.34 -179.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -104.17 174.71 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.223 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 1' ' ' THR . 6.2 tp -110.5 117.08 32.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 t -121.53 107.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.093 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.406 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 16.4 mm -76.76 132.08 33.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 111.593 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.405 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.13 -37.15 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.027 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.34 -172.66 45.0 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.827 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.9 -161.11 31.7 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 122.216 -0.579 . . . . 0.0 112.535 -0.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.3 -55.36 32.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.737 0.303 . . . . 0.0 111.045 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -55.14 -26.49 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.571 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.9 mm -80.62 -26.41 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.436 ' HB3' HG12 ' A' ' 129' ' ' ILE . 3.4 m-85 -62.71 -55.84 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.472 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.529 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 4.6 t -66.72 -10.11 43.53 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.38 -41.3 48.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.118 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' O ' HG22 ' A' ' 110' ' ' VAL . 2.5 m-85 -96.69 -8.28 31.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.478 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.91 -29.24 19.23 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.856 0.36 . . . . 0.0 111.161 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.52 -3.74 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.551 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -128.8 -19.09 3.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 77.7 t -44.45 131.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.44 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 9.9 t70 -109.22 4.36 22.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.285 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 21.7 m -167.74 135.72 2.38 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.6 0.238 . . . . 0.0 110.821 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 13.8 mt -116.52 142.44 46.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mt -135.53 115.69 13.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.474 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -138.1 147.39 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.92 105.91 13.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.022 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 18.3 ttt180 -86.39 104.71 16.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.79 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.421 HD22 ' CE1' ' A' ' 122' ' ' PHE . 6.8 mp -85.14 128.3 34.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.931 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.55 -54.0 48.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.056 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.13 168.52 19.85 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.46 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.409 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 95.3 p -105.28 141.97 35.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.683 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -137.11 175.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 162.55 29.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 164.08 133.15 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -106.05 -24.8 12.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.64 0.257 . . . . 0.0 111.237 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.36 144.73 37.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 111.198 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.56 -174.63 2.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.0 tpt -86.24 160.01 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.189 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.6 pp -86.87 166.24 27.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.193 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.406 ' CD ' ' HB ' ' A' ' 129' ' ' ILE . 20.3 Cg_exo -66.29 94.25 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.874 2.383 . . . . 0.0 112.908 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.42 149.01 23.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.068 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.7 77.74 3.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.419 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 92.6 m95 -59.32 -18.2 35.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.532 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.57 -30.93 61.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 111.032 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.78 -25.79 49.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.274 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 95.8 m-85 -97.18 174.23 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.004 0.43 . . . . 0.0 111.541 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.409 ' CB ' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -136.88 142.74 42.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.0 OUTLIER -78.26 119.3 21.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.978 179.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.16 -23.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.219 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.7 m -163.23 140.77 7.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.607 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 80.9 p -160.7 110.12 1.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.978 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -141.64 114.54 8.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.015 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 7.4 m -73.07 143.99 47.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.481 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.48 105.3 18.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.951 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -90.73 102.15 14.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.714 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.79 -177.73 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.595 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 36.3 p -59.51 -49.52 77.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.495 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 4.3 t30 -74.41 125.44 89.83 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.774 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.5 -28.21 86.91 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.089 1.859 . . . . 0.0 112.338 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -89.3 -20.07 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.027 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.8 mt -84.91 8.75 16.44 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 80.4 m -73.25 166.27 23.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.912 0.387 . . . . 0.0 110.004 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 3.6 p80 -173.74 160.33 3.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 8.0 m -126.84 140.13 52.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.264 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -100.03 105.72 17.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.468 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -104.24 121.81 44.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.928 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.6 t -114.51 112.96 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.8 m95 -112.63 150.8 30.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.274 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -128.51 118.89 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.36 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.3 tttt -57.35 133.08 54.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.865 0.364 . . . . 0.0 111.153 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.409 ' HE2' ' CB ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 177.16 157.67 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.099 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.141 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.537 0.208 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.23 143.08 37.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.296 0.57 . . . . 0.0 112.366 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.477 ' CD1' HG23 ' A' ' 110' ' ' VAL . 1.3 m-30 -112.36 112.98 24.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.543 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -113.15 123.16 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 111.648 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.495 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 5.6 p90 -166.29 173.88 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.518 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.68 137.65 51.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 111.612 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -130.25 157.0 43.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.592 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 20.7 p-10 -108.33 -171.67 1.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -36.47 64.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.38 -28.03 34.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.702 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.6 -4.22 66.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.893 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 2.5 pp -80.59 157.46 26.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.927 0.363 . . . . 0.0 111.021 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.43 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.3 mt -81.34 88.67 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.118 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.1 ttp -99.07 123.13 43.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 4.4 t -89.22 128.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.4 ' CG1' ' HE3' ' A' ' 39' ' ' MET . 33.5 m -131.49 148.12 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.538 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.87 151.22 51.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.385 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -49.83 -51.12 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.415 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.8 tpt180 -62.18 -36.76 82.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.303 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -66.86 -36.25 81.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.942 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.53 -22.34 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.592 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -65.22 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.2 t -48.37 -36.58 14.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -43.18 157.27 0.25 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.012 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.12 -67.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.673 2.249 . . . . 0.0 112.768 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.25 164.06 36.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 16.9 mtm180 -117.12 115.08 38.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 67.6 Cg_endo -88.74 -164.99 2.78 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.005 -1.248 . . . . 0.0 112.329 0.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 55.4 mt -107.51 144.63 29.63 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.437 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 37.3 Cg_endo -65.97 118.11 5.22 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.555 2.17 . . . . 0.0 112.638 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 7.1 mt-10 68.02 7.49 5.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.944 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.511 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 1.3 mtt180 -119.24 100.31 7.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.887 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 34.9 m -67.72 109.92 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -104.39 139.51 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.305 0.574 . . . . 0.0 112.265 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 4.5 t -113.0 143.16 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.121 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.41 HG13 ' HA ' ' A' ' 43' ' ' ARG . 84.9 t -114.77 125.06 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 111.9 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.9 tp -104.66 120.36 41.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -153.62 171.18 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -91.91 -8.03 47.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.6 tt0 -77.9 130.72 36.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.339 . . . . 0.0 110.786 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -80.79 0.05 36.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.004 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -126.79 10.03 7.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.578 0.228 . . . . 0.0 111.407 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.49 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.4 t80 -59.34 141.62 54.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -132.52 174.54 10.17 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 122.343 1.068 . . . . 0.0 112.902 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.84 143.62 20.77 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.398 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -73.17 98.56 2.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.771 0.319 . . . . 0.0 110.835 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.18 -36.7 2.89 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.535 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.69 172.38 8.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 0.0 111.489 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.99 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.76 122.72 67.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.134 0.492 . . . . 0.0 111.365 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.442 ' CG2' HG23 ' A' ' 82' ' ' VAL . 30.8 m -133.61 168.61 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.334 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 65' ' ' GLN . 9.0 m80 -117.1 -22.52 8.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.358 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.06 -177.36 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 111.578 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.465 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 21.5 t -70.79 -8.57 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.99 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.76 -31.24 17.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 110.053 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.429 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -77.03 -27.26 54.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.681 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.442 HG23 ' CG2' ' A' ' 76' ' ' VAL . 95.2 t -75.67 -52.59 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 8.2 m-85 -57.39 -25.02 58.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.689 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -66.3 -57.55 7.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.4 43.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.04 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.652 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.14 -33.01 72.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 9.7 mt-30 -88.75 -4.13 58.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.26 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -126.02 63.97 50.69 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.33 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.06 -0.14 5.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.169 2.579 . . . . 0.0 112.94 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.79 -37.23 30.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -112.14 163.84 13.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -98.64 164.25 12.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -108.16 124.96 51.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.313 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 39' ' ' MET . 69.3 t -131.87 118.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.345 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 3.0 mm -82.48 138.69 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 111.408 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -102.63 -52.98 2.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.775 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.11 -166.15 38.95 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.48 -161.01 36.77 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 117.813 0.806 . . . . 0.0 112.639 -0.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.78 -44.13 38.65 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.81 0.338 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.82 -34.33 74.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.717 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.4 mm -80.97 -23.11 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -63.21 -52.06 63.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.55 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.52 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 14.5 t -68.48 -9.58 49.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.35 -39.99 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 110.68 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.465 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 4.2 m-85 -100.69 -4.8 27.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.368 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.3 pttt -48.18 -32.65 7.32 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.94 -2.16 58.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.789 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 m-20 -119.18 -26.89 5.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.585 0.231 . . . . 0.0 111.554 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 3' ' ' PHE . 82.5 t -45.91 122.48 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 111.576 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -105.85 8.35 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.022 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.7 m -168.25 138.29 2.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.969 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.432 HD11 ' CZ3' ' A' ' 133' ' ' TRP . 5.8 mt -121.46 146.2 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.319 0.581 . . . . 0.0 112.101 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.3 mt -135.15 114.67 12.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.241 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.495 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -136.89 147.33 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.128 0.489 . . . . 0.0 112.133 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -107.93 119.01 38.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.915 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -79.46 99.01 7.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.383 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mt -85.94 108.96 18.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.177 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.33 78.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.034 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.5 171.49 54.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.554 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t -110.14 162.65 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 111.018 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 6.6 m-85 -138.42 170.05 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.253 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.42 169.95 8.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.89 -170.73 24.76 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.689 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.26 29.22 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.018 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -141.62 129.83 22.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 16.5 tttm -111.55 150.24 30.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.806 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.17 179.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.54 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.6 pt -97.27 162.67 21.91 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.188 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.2 Cg_endo -73.86 99.3 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.45 2.1 . . . . 0.0 112.102 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.427 ' CD1' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt -88.46 147.84 24.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 74.19 2.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.024 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.432 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 92.7 m95 -54.52 -24.17 19.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.94 -26.29 62.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.3 t0 -83.23 -19.51 36.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.737 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 89.9 m-85 -107.93 165.9 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.626 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.544 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -126.61 139.79 52.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 110.509 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 11.2 ttpt -79.6 117.25 20.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.464 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 24.5 m -101.94 -21.84 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.927 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -163.09 140.61 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 8.6 p -155.94 111.02 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.501 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -141.42 117.1 10.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.789 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.2 m -72.62 133.48 44.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.161 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.64 109.77 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.583 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.495 ' HA ' ' CG2' ' A' ' 152' ' ' THR . 11.2 mt-10 -96.99 97.51 9.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -81.51 -161.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.191 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.2 p -74.38 -48.65 26.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.9 t30 -69.18 119.85 72.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.075 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.31 -20.57 56.29 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.083 1.856 . . . . 0.0 111.989 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -23.65 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.573 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.6 mt -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 145' ' ' GLU . 1.7 m -85.86 82.21 8.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 5.3 p80 -97.12 -171.3 2.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.565 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 55.9 m -125.55 165.26 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.079 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' SER . 1.6 m-85 -118.79 105.85 11.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.96 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.4 mt-10 -109.69 125.27 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.778 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.0 t -116.12 115.04 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.278 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.452 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 23.8 m95 -111.97 150.47 30.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.22 0.534 . . . . 0.0 111.655 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -127.28 121.12 30.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.784 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 2.3 tmmt? -54.94 130.42 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 0.0 111.62 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.544 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.59 -170.52 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.553 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.126 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 110' ' ' VAL . 21.7 m . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.72 145.36 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.515 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.8 m-85 -112.17 111.53 22.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.314 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -111.16 119.07 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.544 0.688 . . . . 0.0 112.569 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.496 ' CZ2' HG11 ' A' ' 115' ' ' VAL . 6.7 p90 -160.32 166.89 28.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.411 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.99 140.18 48.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.957 0.408 . . . . 0.0 111.769 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -138.99 141.34 38.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.675 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -100.35 -163.38 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.436 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -51.63 -48.9 63.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.345 0.593 . . . . 0.0 109.978 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.55 -32.69 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.037 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.11 43.47 3.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.4 OUTLIER -82.51 165.15 20.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.753 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.452 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.483 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 62.8 mt -74.43 89.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.12 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 ttp -99.61 125.0 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.651 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 21.4 t -79.14 157.36 4.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.423 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.483 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 31.2 m -162.91 153.19 3.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.13 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 154.36 47.76 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.813 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.931 0.366 . . . . 0.0 110.813 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.4 tpm_? -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.575 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -71.4 -47.5 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -58.21 -23.47 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.18 -65.82 0.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -56.45 -26.8 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.381 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -39.84 130.27 1.51 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.551 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.3 -27.96 5.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.383 . . . . 0.0 113.329 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -157.12 133.05 9.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.286 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -126.84 108.2 22.41 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 69.3 Cg_endo -80.49 -171.96 10.41 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.582 -1.424 . . . . 0.0 111.831 0.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 64.4 mt -91.55 158.19 40.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.44 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.78 -43.6 56.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.91 2.406 . . . . 0.0 113.533 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 4.6 mt-10 -140.58 46.05 1.8 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.835 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -146.53 111.37 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.339 . . . . 0.0 111.811 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.1 m -71.29 115.5 10.52 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -101.07 159.42 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.475 0.655 . . . . 0.0 112.59 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.442 ' CG1' HG21 ' A' ' 76' ' ' VAL . 5.7 t -137.17 133.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.366 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.7 126.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HG ' ' CG2' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -105.24 118.8 37.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.052 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.97 161.85 42.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.15 -10.64 59.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.723 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -81.44 134.25 35.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -82.88 -24.98 32.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -95.65 4.46 53.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.666 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.557 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.0 t80 -59.3 140.68 55.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 111.403 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.479 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 1.1 mt-30 -132.79 172.92 11.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.314 1.054 . . . . 0.0 112.846 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.38 143.83 20.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.728 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -88.2 98.05 11.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.52 62.01 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.036 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.66 166.08 17.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.88 0.372 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 HG21 ' CE1' ' A' ' 85' ' ' TYR . 16.2 t -96.17 138.17 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.986 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 38.6 t -104.4 104.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.322 0.582 . . . . 0.0 112.541 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 82' ' ' VAL . 26.5 m -117.41 166.29 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.398 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -116.35 -19.05 10.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.584 0.23 . . . . 0.0 111.062 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -157.99 -176.3 5.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.611 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 106' ' ' PHE . 18.4 t -68.41 -8.36 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.952 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -35.93 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.219 0.533 . . . . 0.0 109.794 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -73.37 -32.57 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.701 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 76' ' ' VAL . 97.6 t -70.7 -50.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -57.03 -25.54 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.202 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.39 82.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.045 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' ' NE2' ' A' ' 89' ' ' HIS . 92.5 t80 -65.49 -56.65 11.24 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.78 -21.71 11.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.96 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -69.13 -39.97 78.56 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.53 -5.6 58.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.387 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.452 ' NE2' ' CE1' ' A' ' 85' ' ' TYR . 98.1 m-70 -126.28 65.89 59.41 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.547 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.58 -0.42 5.94 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.104 2.536 . . . . 0.0 112.923 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.19 -30.91 16.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.69 158.34 16.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -98.86 164.49 12.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.8 tp -114.01 114.64 26.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.97 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.24 116.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.211 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.9 mm -77.98 134.9 27.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.087 0.47 . . . . 0.0 111.412 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.42 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -106.84 -46.92 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.87 -170.83 43.95 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.894 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.3 -160.81 36.89 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 122.002 -0.705 . . . . 0.0 112.647 -0.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.47 11.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -52.52 -28.68 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 62' ' ' LEU . 48.5 mm -85.16 -27.36 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.3 m-85 -60.28 -52.97 63.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.551 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.538 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 12.6 t -67.66 -9.76 46.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.09 -41.71 58.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.799 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.501 ' HA ' HG23 ' A' ' 79' ' ' VAL . 3.3 m-85 -101.55 -3.62 28.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.7 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 20.9 pttp -48.07 -32.21 6.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.751 0.31 . . . . 0.0 111.669 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -87.35 -19.19 28.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.552 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.8 -22.79 15.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.486 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.515 HG22 ' CD1' ' A' ' 3' ' ' PHE . 98.2 t -44.76 126.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.968 0.413 . . . . 0.0 111.61 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -101.82 -7.96 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.674 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 35.2 m -160.1 141.95 12.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.308 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 15.5 mt -120.38 145.81 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 111.649 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.98 114.89 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 156' ' ' GLU . 1.2 m -135.41 145.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.991 0.424 . . . . 0.0 111.956 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -109.94 99.12 8.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.692 179.209 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 99.82 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.796 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.6 mp -86.04 127.47 34.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.404 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.8 -47.52 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.665 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -82.24 160.44 40.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 13.7 t -91.39 166.28 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -138.55 167.55 21.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.31 167.66 13.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 161.83 166.26 20.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.7 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.29 -28.17 7.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.666 0.269 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.0 m -109.27 148.8 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.28 174.96 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.77 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.5 tpt -73.58 158.53 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.626 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -84.39 165.53 37.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.066 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.4 Cg_endo -74.97 96.11 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.323 2.015 . . . . 0.0 112.307 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.73 149.47 24.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.85 72.59 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.008 0.432 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.468 ' CZ3' HD12 ' A' ' 113' ' ' LEU . 91.1 m95 -58.49 -21.04 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -32.31 65.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.93 0.395 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -80.43 -15.67 56.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 113' ' ' LEU . 68.9 m-85 -107.43 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.095 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.44 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -127.9 142.26 51.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.634 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.513 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.8 OUTLIER -83.62 109.88 17.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 33.1 m -93.65 -22.44 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.448 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.0 m -159.45 140.62 12.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.181 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.6 p -165.4 116.08 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 -147.3 122.78 10.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 1.8 m -78.41 145.01 35.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.22 0.533 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 152' ' ' THR . 8.1 t -120.35 103.41 13.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.138 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.42 103.76 15.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.717 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.71 -172.66 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.107 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.6 p -54.72 -58.86 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 110.465 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.476 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -69.84 118.76 66.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.896 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.88 -22.35 62.12 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.112 1.875 . . . . 0.0 112.361 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -95.27 -16.03 22.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.367 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.7 mt -88.4 9.05 24.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.785 0.326 . . . . 0.0 111.164 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 144' ' ' VAL . 61.2 m -68.94 167.91 14.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.936 0.398 . . . . 0.0 109.993 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -167.99 153.9 7.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 18.4 m -122.69 128.96 51.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.826 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -90.69 104.77 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.408 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.497 ' HB2' HG22 ' A' ' 115' ' ' VAL . 33.8 mt-10 -107.41 125.54 51.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 30.6 t -116.66 114.02 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.093 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.513 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 22.7 m95 -108.77 148.91 29.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -129.14 121.0 26.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.33 130.07 6.44 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.44 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -127.2 -163.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.195 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.044 179.787 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.559 0.219 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.16 145.66 39.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.489 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.7 m-30 -109.83 114.05 27.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.551 HD11 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.15 120.75 42.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.475 -179.243 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.483 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 4.5 p90 -166.48 166.42 16.36 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.379 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.78 136.0 54.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.242 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -124.85 154.06 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.04 -179.48 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.497 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.07 -45.04 15.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 110.471 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -23.19 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.526 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 27.07 9.1 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.219 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.14 150.91 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.778 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 126' ' ' THR . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.3 mttt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.499 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 61.3 mt -72.51 89.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 111.285 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 ttp -97.78 117.27 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.339 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.505 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 24.5 t -76.93 157.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.234 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 32.8 m -163.89 150.05 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.79 156.26 51.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.9 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.445 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.32 -50.18 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.962 0.381 . . . . 0.0 110.402 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.441 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.9 tpm_? -62.06 -29.64 70.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.323 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -74.1 -48.63 28.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.626 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -57.93 -28.32 64.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.708 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.91 -65.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.427 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.5 m -58.93 -26.59 64.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.395 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -35.74 137.83 0.44 Allowed Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HD2' ' CD2' ' A' ' 49' ' ' PHE . 58.5 Cg_exo -53.21 -32.34 59.72 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.928 2.419 . . . . 0.0 113.357 -179.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.18 137.99 18.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.383 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 5.8 ptm180 -141.43 114.84 6.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -89.25 168.2 34.51 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.657 -1.393 . . . . 0.0 111.919 -0.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 73.7 mt -78.07 149.92 77.13 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.6 -78.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.786 2.324 . . . . 0.0 113.098 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 37.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.294 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.553 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -148.33 133.19 18.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.128 0.49 . . . . 0.0 111.967 -179.246 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.1 m -92.11 119.63 31.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.153 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.09 157.43 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.608 . . . . 0.0 112.439 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 76' ' ' VAL . 3.5 t -137.37 138.34 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.333 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.9 t -114.57 120.32 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.795 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -102.16 118.97 38.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.475 ' CG2' ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.93 171.21 17.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.101 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -95.59 -12.47 25.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -62.94 133.03 54.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.885 0.374 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.28 1.69 20.86 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.45 16.63 2.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.536 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.0 t80 -58.5 139.32 55.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.193 0.52 . . . . 0.0 111.955 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.36 173.56 10.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.23 1.014 . . . . 0.0 112.367 178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.11 144.18 20.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -81.52 99.32 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.03 -46.79 2.45 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.2 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 172.84 6.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 0.0 111.657 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.454 HG22 ' CE1' ' A' ' 85' ' ' TYR . 10.4 t -97.98 139.73 19.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.96 115.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.116 0.484 . . . . 0.0 111.865 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.473 ' CG2' HG21 ' A' ' 82' ' ' VAL . 25.5 m -125.33 170.16 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.973 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.9 m170 -120.9 -21.91 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.344 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -153.54 -175.31 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.102 0.477 . . . . 0.0 111.54 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.432 HG13 ' CD2' ' A' ' 106' ' ' PHE . 33.7 t -69.61 -9.48 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.621 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.61 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 109.926 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.435 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -75.88 -29.96 58.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 179.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' CG2' ' A' ' 76' ' ' VAL . 60.8 t -72.06 -52.45 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.2 m-85 -55.95 -26.79 49.6 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.986 178.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.92 -45.44 89.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.019 178.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' CE1' HG22 ' A' ' 74' ' ' VAL . 82.1 t80 -64.08 -54.49 33.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.77 -23.14 16.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.315 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 4.1 mmtp -67.28 -46.59 73.17 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -79.21 -2.83 42.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.448 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.444 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 54.7 m-70 -125.48 62.64 41.3 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.385 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.28 -0.53 5.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.064 2.51 . . . . 0.0 112.904 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -31.22 17.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.965 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -105.8 156.57 18.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -99.87 164.55 11.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.018 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tp -104.72 111.81 24.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.945 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.87 103.43 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.437 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 13.1 mm -73.71 132.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.027 0.441 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -104.01 -45.18 4.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.685 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.1 -166.81 39.71 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.695 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.39 -160.99 26.34 Favored Glycine 0 C--N 1.34 0.801 0 O-C-N 122.196 -0.59 . . . . 0.0 112.552 -0.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.05 66.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.73 0.3 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -53.91 -27.45 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.583 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 102' ' ' ILE . 32.1 mm -80.79 -29.0 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 3' ' ' PHE . 5.8 m-85 -59.64 -56.24 24.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.458 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.498 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 11.2 t -66.32 -10.16 40.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.28 51.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.653 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.432 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.7 m-85 -99.59 -5.48 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.35 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.9 pttp -49.5 -31.67 10.6 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.756 0.313 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.25 0.48 53.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.288 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.05 -26.31 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.548 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.489 HG22 ' CD1' ' A' ' 3' ' ' PHE . 92.7 t -43.95 127.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.845 0.355 . . . . 0.0 111.55 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.429 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 11.3 t70 -105.27 3.72 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.322 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 m -167.6 137.84 2.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.599 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 9.2 mt -118.78 145.24 45.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.3 0.571 . . . . 0.0 111.819 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.26 113.05 10.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.483 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.6 m -132.58 143.09 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.6 107.05 14.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.433 179.436 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.7 OUTLIER -79.62 100.18 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.19 126.57 30.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.19 -53.14 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.004 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.46 170.68 9.31 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.353 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.2 p -106.78 147.04 30.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.7 m-85 -141.63 139.76 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -110.72 149.04 31.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.009 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.14 -143.4 3.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.554 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.33 21.94 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.424 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.6 m -159.99 134.08 7.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -107.37 158.43 17.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.963 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.8 177.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.491 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.4 pp -103.36 154.58 37.66 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.0 102.39 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.74 2.293 . . . . 0.0 112.687 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.9 147.85 22.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.008 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.74 76.25 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.451 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.415 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 86.9 m95 -57.79 -20.97 39.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.304 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.81 -29.32 63.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.844 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -78.58 -26.93 45.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.1 m-85 -99.16 176.55 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.77 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 m -137.3 141.93 41.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.246 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.479 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -80.67 119.02 22.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 -179.652 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -103.52 -11.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.7 m -171.51 140.35 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.74 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.0 p -167.93 110.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -148.11 120.64 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.0 m -69.01 145.38 53.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.236 0.541 . . . . 0.0 111.594 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.63 105.21 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.261 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -87.61 101.97 14.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.814 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.04 -171.41 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.493 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.7 p -60.19 -57.19 13.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.0 110.685 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.492 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -71.86 124.5 90.98 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.002 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.2 -28.46 86.96 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.961 1.774 . . . . 0.0 112.362 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.9 -21.1 25.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.395 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.5 mt -85.32 7.23 23.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.504 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 51.5 m -70.86 166.0 22.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.2 p80 -172.95 159.72 4.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.73 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 116' ' ' THR . 28.8 m -119.93 147.05 45.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.347 179.24 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -110.29 104.68 13.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.653 0.264 . . . . 0.0 110.827 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.46 ' HB2' HG23 ' A' ' 115' ' ' VAL . 30.9 mt-10 -106.83 124.29 49.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 111.755 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.74 114.12 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.159 179.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.479 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.5 m95 -110.03 150.7 28.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.51 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.74 115.2 19.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -56.84 131.52 49.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.673 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.57 156.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 178.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.176 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 18.0 m . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.798 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.08 154.9 25.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.493 ' CD1' HG21 ' A' ' 110' ' ' VAL . 1.5 m-30 -119.08 113.46 20.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.552 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.94 117.37 33.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 5.3 p90 -162.25 165.41 26.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.827 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 8.9 pt20 -129.99 156.25 44.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -103.66 -171.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.407 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.3 -27.66 37.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.082 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -32.89 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.032 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 101.72 46.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.528 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.91 163.99 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.827 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 58' ' ' THR . 12.0 mmtt . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 94' ' ' LEU . 62.0 mt -86.48 88.21 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.955 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.1 ttp -97.59 118.2 33.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.691 -179.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 3.3 t -89.93 125.11 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.89 145.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.309 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.63 156.0 49.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.041 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -52.94 -52.89 56.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.479 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -59.56 -35.7 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.105 0.479 . . . . 0.0 110.291 179.154 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -64.72 -50.43 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.162 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' OH ' ' HB3' ' A' ' 53' ' ' PRO . 9.0 t80 -49.15 -34.34 14.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.702 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -63.06 -66.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.677 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -49.22 -46.26 45.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.457 ' C ' ' O ' ' A' ' 48' ' ' SER . 1.9 m-85 -26.13 138.02 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 O-C-N 123.474 0.484 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -35.64 -71.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.947 2.431 . . . . 0.0 112.806 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.37 134.53 46.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 0.0 110.619 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.77 125.2 30.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HB3' ' OH ' ' A' ' 46' ' ' TYR . 90.4 Cg_endo -83.49 -170.29 7.75 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.627 -1.406 . . . . 0.0 112.026 -0.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 35.9 mt -89.98 151.21 44.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.592 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.04 110.68 3.08 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.596 2.197 . . . . 0.0 113.08 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 68.21 8.25 6.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.484 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 6.0 mtt180 -109.45 113.88 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.795 0.331 . . . . 0.0 111.545 -178.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 63.5 m -64.11 109.32 1.79 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -101.85 152.57 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 14.1 t -133.79 130.62 56.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.305 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.6 130.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.418 . . . . 0.0 111.559 -178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.425 ' HB3' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.63 119.95 40.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.451 HG22 ' CG ' ' A' ' 68' ' ' TYR . 1.1 t -150.55 158.38 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.897 0.379 . . . . 0.0 111.36 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -75.41 -11.78 60.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.4 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -88.03 132.74 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.786 0.327 . . . . 0.0 110.774 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 4.3 mp0 -82.8 -21.78 34.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.519 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -91.31 -0.59 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.582 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.451 ' CG ' HG22 ' A' ' 63' ' ' THR . 7.2 t80 -59.28 140.83 55.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.108 0.48 . . . . 0.0 111.453 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.447 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -134.31 171.98 13.52 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.442 1.115 . . . . 0.0 113.213 179.563 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.41 139.54 16.5 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.877 -1.965 . . . . 0.0 110.049 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.06 102.01 6.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.9 0.381 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.18 -44.97 1.96 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.826 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 166.7 20.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 85' ' ' TYR . 22.6 t -97.15 140.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.267 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 22.8 t -106.76 118.44 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 112.185 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 82' ' ' VAL . 30.8 m -127.54 168.14 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.69 178.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.41 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 1.6 m80 -119.86 -23.08 6.55 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.563 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.79 -177.33 6.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 111.467 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.424 HG22 ' CG ' ' A' ' 106' ' ' PHE . 11.7 t -65.45 -11.4 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.615 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.83 -37.24 16.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.236 0.541 . . . . 0.0 109.751 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.17 -34.41 70.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.694 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 76' ' ' VAL . 29.2 t -68.38 -54.27 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.981 0.42 . . . . 0.0 109.988 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 5.8 m-85 -51.84 -27.83 13.87 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.933 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.519 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -63.05 -45.33 92.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.713 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.471 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 76.1 t80 -62.76 -53.83 48.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.141 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.81 -22.88 5.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 179.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 8.3 mttt -70.23 -41.54 73.43 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.072 0.463 . . . . 0.0 109.754 178.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -4.54 56.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.625 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 90.1 m-70 -129.63 62.76 65.13 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.63 -0.35 5.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.174 2.582 . . . . 0.0 112.845 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.75 -30.16 17.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.773 0.32 . . . . 0.0 110.834 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -103.08 162.09 13.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.094 0.473 . . . . 0.0 111.624 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -97.69 174.44 6.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.906 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.445 HD12 HG21 ' A' ' 38' ' ' ILE . 1.1 tp -119.66 113.87 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 111.409 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 39' ' ' MET . 40.1 t -127.59 111.87 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.289 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 8.7 mm -82.62 141.51 14.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.67 -39.88 4.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.84 -165.48 38.29 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.556 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.04 -161.23 23.25 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 117.358 0.579 . . . . 0.0 112.48 -0.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.73 -50.88 69.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -57.03 -25.25 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.709 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 62' ' ' LEU . 42.2 mm -79.29 -36.89 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.771 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.3 m-85 -50.81 -56.76 10.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.446 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -67.22 -9.65 42.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.759 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.93 -42.25 24.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 110.977 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 5.4 m-85 -93.54 -11.53 31.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.244 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.6 OUTLIER -50.34 -28.71 8.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.235 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.12 -8.38 59.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.601 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.53 -23.58 4.39 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.493 HG21 ' CD1' ' A' ' 3' ' ' PHE . 90.7 t -44.11 128.99 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 18.0 t70 -102.51 -12.73 17.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.341 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.798 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 77.9 m -151.61 140.07 20.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.016 -179.149 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD13 ' CG ' ' A' ' 136' ' ' PHE . 13.7 mt -119.18 146.05 45.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.279 0.562 . . . . 0.0 111.56 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.6 mt -135.13 112.66 10.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.549 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.491 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -134.52 144.99 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 111.76 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -109.9 114.42 27.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.361 179.044 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -86.31 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.2 121.67 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.201 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.67 -61.72 2.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.224 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.65 -172.19 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.6 p -121.98 157.93 30.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.99 166.39 30.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.78 169.82 3.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.89 135.95 4.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.953 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -38.46 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -117.57 137.31 52.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.3 163.34 12.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.014 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -173.16 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.438 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.6 pp -108.39 163.89 15.96 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.29 99.57 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.953 2.435 . . . . 0.0 112.736 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.4 146.02 25.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.074 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.48 80.77 2.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -60.82 -20.08 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.123 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.53 -30.34 65.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.913 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.46 -27.39 41.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.512 ' CG ' HD13 ' A' ' 113' ' ' LEU . 77.2 m-85 -97.83 176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.823 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 m -136.13 141.98 44.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.623 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 8.6 ttpt -83.56 116.79 22.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 21.1 m -102.34 -18.95 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 157' ' ' VAL . 48.7 m -163.6 141.06 7.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.699 0.285 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.623 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 86.1 p -169.48 106.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -140.77 118.96 12.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.827 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 1.4 m -68.71 145.18 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.166 0.508 . . . . 0.0 111.527 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 152' ' ' THR . 9.0 t -119.61 103.94 14.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.185 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -86.83 103.68 15.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.503 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.2 -174.13 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.448 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.3 p -55.37 -56.62 18.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.722 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.49 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -72.73 121.75 85.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.57 -25.54 79.18 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.035 1.823 . . . . 0.0 112.292 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.14 -19.62 22.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -86.35 8.16 22.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.66 0.267 . . . . 0.0 111.367 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 144' ' ' VAL . 66.0 m -68.79 165.63 19.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.0 p80 -168.99 155.1 6.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 21.8 m -118.26 132.21 56.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -94.94 104.42 16.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.843 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -100.8 151.37 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.23 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 12.3 t -141.99 107.68 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.825 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 26.8 m95 -108.81 146.07 34.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -126.43 114.41 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.676 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -52.64 131.09 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.883 -179.436 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -97.45 176.31 5.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.741 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.132 179.985 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.18 145.5 40.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.494 ' CZ ' ' CG2' ' A' ' 110' ' ' VAL . 2.0 m-30 -109.3 112.3 24.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.425 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.8 123.96 51.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.757 -179.504 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.8 p90 -165.52 164.95 19.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.319 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' ILE . . . -120.77 138.2 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.669 0.271 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -122.41 149.81 43.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 0.0 111.253 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -103.39 -162.96 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -42.04 72.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.53 -27.86 31.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.96 26.28 5.84 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.578 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -79.61 147.59 32.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 110.621 -179.929 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.478 HD12 HG23 ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.1 mttp . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 121.941 0.877 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' CG2' ' CG2' ' A' ' 60' ' ' VAL . 6.8 mt -62.76 110.23 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.583 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.665 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.0 ttp -99.17 114.27 26.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.495 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.617 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 11.3 t -87.53 125.55 41.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.3 m -132.2 149.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.158 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.14 158.02 53.61 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.086 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.83 -45.39 78.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.404 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 17.2 tpt180 -63.55 -32.4 73.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 110.477 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 m -72.2 -42.47 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 11.2 t80 -65.86 -24.41 66.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -66.8 -19.92 65.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.65 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -34.4 134.44 0.39 Allowed Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.658 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.14 -41.29 58.21 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.936 2.424 . . . . 0.0 113.252 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -151.15 131.29 13.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.341 . . . . 0.0 111.029 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -132.22 125.29 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.028 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 83.6 Cg_endo -90.12 -179.32 12.93 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.137 -0.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 65.5 mt -75.88 152.8 84.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.62 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.82 101.7 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.552 2.168 . . . . 0.0 112.959 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 68.46 21.04 8.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.149 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 3.8 mmt180 -116.63 139.84 50.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.7 m -86.8 115.47 24.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.0 0.429 . . . . 0.0 111.435 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -101.11 156.83 17.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 12.7 t -137.13 131.74 46.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.5 t -105.99 121.93 58.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.085 -179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.29 107.18 17.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.112 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.423 HG23 ' CD2' ' A' ' 68' ' ' TYR . 6.3 t -143.7 164.81 29.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.162 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -79.74 -8.45 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.312 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.5 tp60 -79.81 124.69 28.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.354 . . . . 0.0 110.489 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.27 -30.38 54.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.93 14.5 28.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.359 . . . . 0.0 111.181 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.752 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 5.7 t80 -63.18 147.23 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.142 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.43 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.8 mm100 -124.89 174.76 7.74 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.475 1.131 . . . . 0.0 112.868 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.54 143.07 18.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.89 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -66.35 94.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.29 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.59 -20.17 2.31 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.775 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.76 170.85 15.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.12 0.485 . . . . 0.0 112.071 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 85' ' ' TYR . 19.8 t -92.95 140.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.456 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 68' ' ' TYR . 24.5 t -103.47 106.98 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.457 . . . . 0.0 111.771 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 HG21 HG22 ' A' ' 82' ' ' VAL . 30.7 m -119.67 176.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.051 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -128.94 -21.12 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.82 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.69 -174.81 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.199 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG12 ' CD2' ' A' ' 106' ' ' PHE . 25.2 t -70.02 -11.06 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.67 -38.59 16.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.091 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.19 -34.45 76.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.672 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.477 HG22 HG21 ' A' ' 76' ' ' VAL . 20.8 t -69.29 -53.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.599 179.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -53.37 -31.03 42.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.062 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.55 -47.03 87.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 69.0 t80 -60.69 -52.75 63.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.81 -26.26 57.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.609 178.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -66.44 -39.55 88.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.002 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -84.84 -1.13 56.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.148 178.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 42.5 m-70 -124.83 60.34 26.28 Favored Pre-proline 0 N--CA 1.456 -0.142 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.098 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.14 -3.25 5.8 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.866 2.377 . . . . 0.0 112.508 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -100.66 -25.6 14.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.026 179.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -98.83 160.13 14.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.328 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -105.9 174.89 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.412 HD13 ' CG1' ' A' ' 82' ' ' VAL . 10.0 tp -122.33 110.45 15.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 39' ' ' MET . 17.2 t -124.28 109.69 23.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 3.7 mm -82.6 131.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.398 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.473 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.26 -47.31 5.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.718 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.76 -168.1 41.19 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.392 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.27 -160.78 36.85 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 117.8 0.8 . . . . 0.0 112.814 0.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.64 -57.99 3.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 111.69 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.98 -31.98 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 102' ' ' ILE . 37.7 mm -80.97 -26.43 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.292 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -61.69 -51.93 66.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.631 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.572 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 13.9 t -68.81 -10.01 54.32 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.17 -47.07 46.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD2' HG12 ' A' ' 79' ' ' VAL . 8.0 m-85 -95.11 -2.61 49.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.726 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.572 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 37.4 pttt -54.38 -32.2 56.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -79.63 -8.46 59.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.793 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.05 -18.07 7.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.516 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 48.7 t -48.0 134.69 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.32 6.02 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.199 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 3.7 m -170.58 142.79 2.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.429 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.454 HD11 ' CZ3' ' A' ' 133' ' ' TRP . 8.3 mt -122.55 144.69 48.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.084 0.468 . . . . 0.0 111.578 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.1 mt -135.22 118.35 16.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.155 179.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 156' ' ' GLU . 1.2 m -131.54 140.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.819 0.342 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.22 121.99 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.26 101.4 10.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.661 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.8 mp -83.82 134.98 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.59 -51.99 61.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.63 170.95 9.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.0 p -105.76 170.72 7.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.1 m-85 -148.0 168.75 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.015 0.436 . . . . 0.0 111.279 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -114.1 146.89 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.315 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 168.85 176.9 39.34 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.674 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.67 62.3 1.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.5 m -164.14 124.46 2.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.7 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.19 164.98 13.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -177.69 4.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -103.53 165.1 14.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.301 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.9 102.66 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.665 2.244 . . . . 0.0 112.071 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.8 mt -90.26 148.24 23.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.73 78.96 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.454 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 86.5 m95 -61.23 -19.53 61.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.161 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.71 -32.92 66.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.652 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.72 -18.49 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.427 ' CG ' HD12 ' A' ' 113' ' ' LEU . 62.7 m-85 -106.32 167.14 10.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.483 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.492 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -131.05 141.19 50.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.9 ttpm? -82.73 113.9 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.662 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 35.3 m -97.41 -25.79 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.563 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -156.06 140.55 16.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.882 0.373 . . . . 0.0 111.184 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.557 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 53.4 p -166.15 105.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.753 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -146.07 129.83 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 111.675 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.3 m -77.54 146.72 36.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.767 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 152' ' ' THR . 6.1 t -117.32 104.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.363 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.77 104.7 16.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.57 -172.96 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.442 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 60.9 p -55.69 -58.48 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.589 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.627 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 10.2 t30 -76.6 136.01 67.99 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.841 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.21 -34.38 68.43 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.986 1.79 . . . . 0.0 112.686 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.74 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.487 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.627 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.3 mt -77.65 10.31 2.78 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 153' ' ' HIS . 57.4 m -85.44 159.91 19.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.08 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.56 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -173.46 160.55 3.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 17.2 m -122.3 144.69 48.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.71 179.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.88 105.22 13.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 115' ' ' VAL . 1.9 mt-10 -99.2 121.33 40.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.902 0.382 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 18.1 t -116.2 111.62 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.484 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 32.1 m95 -106.13 148.62 27.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.959 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -129.68 123.86 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.225 179.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.45 128.82 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.542 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.492 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.16 -173.82 2.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.758 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.125 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.542 0.21 . . . . 0.0 110.491 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.61 149.3 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.348 0.594 . . . . 0.0 112.438 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.5 m-30 -116.68 113.0 22.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.58 118.57 36.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 112.014 -179.486 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.472 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 4.4 p90 -164.09 174.51 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.12 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.42 135.17 49.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 111.673 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.6 pt20 -132.82 154.64 50.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 15.5 p-10 -107.55 -167.62 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -40.95 68.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -28.97 47.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.05 19.51 11.66 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.754 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 3.8 mt -70.97 175.73 4.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.168 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mttm . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.82 90.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ttp -102.69 121.59 42.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.932 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 96' ' ' ILE . 9.7 t -89.55 131.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.28 142.06 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.184 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.94 156.83 43.5 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.095 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.489 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.3 -52.61 58.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.858 0.329 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -60.21 -34.25 73.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.075 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -67.65 -45.5 75.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -59.46 -27.27 65.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.5 -66.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.725 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -52.44 -30.37 29.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CE1' ' CD1' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -37.05 122.34 0.83 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.935 -179.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 64.3 Cg_exo -42.91 -27.24 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.233 2.622 . . . . 0.0 113.729 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.62 148.92 28.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 111.236 -179.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -141.15 107.76 6.23 Favored Pre-proline 0 CA--C 1.533 0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.5 Cg_endo -88.43 178.78 18.39 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.158 -0.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.517 ' CB ' ' HB2' ' A' ' 57' ' ' ARG . 10.6 mt -76.64 155.33 83.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.36 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HD2' ' CD2' ' A' ' 54' ' ' LEU . 9.7 Cg_endo -52.98 -74.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.703 2.268 . . . . 0.0 112.385 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -113.38 50.64 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.104 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.517 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -142.47 101.49 3.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.987 -179.618 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.3 m -62.16 113.52 2.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -107.74 148.34 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.431 0.634 . . . . 0.0 112.348 -178.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.86 139.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.389 178.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 43' ' ' ARG . 92.7 t -108.34 124.02 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.845 -178.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.41 117.98 36.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.419 HG23 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.48 162.15 41.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.727 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -83.0 -8.57 59.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 8.8 tt0 -85.13 131.19 34.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 111.057 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -25.21 42.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.59 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -94.74 5.17 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.753 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 5.9 t80 -58.98 148.05 32.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.023 0.439 . . . . 0.0 111.088 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.406 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -136.15 174.85 10.16 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.201 1.001 . . . . 0.0 112.848 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.87 145.0 21.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.793 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -74.65 95.91 2.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.311 . . . . 0.0 110.314 179.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.2 -34.95 3.18 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.305 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.76 169.64 14.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 111.916 -179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.442 HG23 ' CZ ' ' A' ' 85' ' ' TYR . 5.1 t -96.69 140.65 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.331 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 68' ' ' TYR . 20.1 t -107.63 118.54 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.186 0.517 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.44 171.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.839 178.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -122.38 -22.43 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.55 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -158.15 -175.65 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.051 0.453 . . . . 0.0 111.08 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.466 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 9.4 t -65.66 -11.34 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.72 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.49 16.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.15 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.68 -29.36 63.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.613 179.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG1' HG21 ' A' ' 40' ' ' VAL . 25.1 t -70.99 -52.63 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.436 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.6 m-85 -54.18 -26.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.586 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.34 -44.07 88.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.956 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.442 ' CZ ' HG23 ' A' ' 74' ' ' VAL . 88.3 t80 -66.7 -56.6 9.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.57 -23.65 17.69 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.561 178.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.05 -39.75 78.98 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.723 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -83.73 -5.45 59.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.403 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -129.54 64.92 73.31 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.22 1.08 3.78 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.424 2.749 . . . . 0.0 113.001 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 -33.4 25.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.969 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.5 160.72 15.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 111.621 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -98.43 156.48 16.73 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 tp -96.29 115.08 26.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.349 -179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.55 114.55 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.422 ' CD1' HG22 ' A' ' 40' ' ' VAL . 9.2 mm -81.77 139.43 17.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.068 0.461 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.479 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -108.55 -46.1 3.74 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.51 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.87 -170.4 43.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.317 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.33 -160.93 36.82 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 117.409 0.605 . . . . 0.0 112.605 0.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.38 -45.93 36.39 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -58.74 -34.34 71.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 102' ' ' ILE . 28.7 mm -82.28 -29.51 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.1 m-85 -57.67 -57.13 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.661 -179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.503 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.2 t -67.47 -9.61 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.47 -44.45 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.0 111.302 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.466 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 16.2 m-85 -91.82 -7.95 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -52.21 -31.18 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 110.918 179.869 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.452 ' N ' ' HG2' ' A' ' 107' ' ' LYS . 1.5 t0 -75.35 -10.99 59.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.554 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -122.41 -19.77 6.31 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.469 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 75.8 t -45.18 120.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.44 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 19.4 t70 -100.3 -3.9 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.269 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 49.7 m -160.07 141.91 12.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.088 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.413 HD23 ' CG1' ' A' ' 110' ' ' VAL . 7.3 mt -123.29 147.62 46.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.248 0.547 . . . . 0.0 111.859 -179.161 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.76 113.58 11.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.387 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.472 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.3 m -129.65 140.94 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -110.57 106.76 16.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.507 179.502 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 35.8 mtp180 -80.06 98.64 7.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.86 122.67 28.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.29 -66.81 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.51 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.65 162.9 5.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.604 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 p -95.1 168.16 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.899 0.381 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 3.4 m-85 -138.76 160.42 39.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.48 139.76 53.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.131 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.44 -146.41 5.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.634 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.86 -29.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.508 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -108.9 137.98 45.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -178.71 3.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -73.75 159.17 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.16 156.23 48.96 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.269 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.36 100.83 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.725 2.283 . . . . 0.0 112.459 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.8 149.14 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 69.11 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.03 0.443 . . . . 0.0 110.709 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -55.22 -22.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -31.57 66.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 110.662 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -80.81 -20.06 43.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.937 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 94.1 m-85 -104.26 168.71 8.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.075 0.464 . . . . 0.0 111.29 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.651 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -130.54 142.56 50.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.929 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.631 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 6.1 ttpt -81.97 115.03 20.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.59 -17.43 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.603 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.3 m -165.93 140.64 4.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 110.969 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.631 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.2 p -165.71 112.87 0.93 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -147.85 121.03 8.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.84 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.6 m -73.54 144.45 46.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.176 0.512 . . . . 0.0 111.916 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.5 t -117.3 105.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.968 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -90.48 103.36 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.949 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -169.7 2.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.352 179.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.6 p -60.23 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.931 0.396 . . . . 0.0 110.467 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.473 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -67.43 118.61 58.43 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.83 -25.48 61.65 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.887 1.725 . . . . 0.0 112.377 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.42 -20.27 25.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.147 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 mt -86.41 8.88 19.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.71 0.29 . . . . 0.0 111.106 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 153' ' ' HIS . 55.1 m -72.4 168.4 18.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.947 0.403 . . . . 0.0 110.001 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.433 ' N ' ' CG2' ' A' ' 152' ' ' THR . 1.5 p80 -173.52 160.18 3.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.038 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.71 ' O ' ' HA ' ' A' ' 116' ' ' THR . 18.6 m -122.04 145.41 48.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.772 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -106.41 104.64 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.767 0.318 . . . . 0.0 110.441 179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.462 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.4 mt-10 -109.08 127.54 54.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.974 0.416 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.35 114.02 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.557 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.46 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.3 m95 -108.4 148.14 30.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.123 -179.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -125.49 112.21 15.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.519 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -49.32 133.33 19.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.214 0.531 . . . . 0.0 112.259 -179.405 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.651 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 32.6 mtmt -108.48 -178.47 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.786 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.995 -179.875 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 25.4 m . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.3 151.14 30.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -116.1 111.8 20.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.346 178.933 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.541 HD11 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.31 122.81 48.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.42 0.628 . . . . 0.0 112.351 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.494 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 4.8 p90 -168.61 168.8 10.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.674 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.55 133.28 52.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -129.07 164.27 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.137 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -110.18 -171.62 1.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -30.42 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.4 -32.22 19.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.25 36.01 3.23 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.651 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.39 145.92 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.772 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.409 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HD3' ' HB3' ' A' ' 92' ' ' GLN . 7.0 mmtp . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 52.9 mt -79.06 88.29 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.237 0.471 . . . . 0.0 111.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.1 ttp -96.13 120.13 35.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.403 -179.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.444 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 21.4 t -81.23 153.42 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 49' ' ' PHE . 28.2 m -161.87 146.42 4.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.58 155.47 51.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.841 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.6 -51.33 56.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.938 0.369 . . . . 0.0 110.889 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.405 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 5.4 tpp180 -60.14 -31.91 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -73.5 -43.4 60.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.612 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 52' ' ' ARG . 24.5 t80 -61.94 -29.24 70.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.8 -66.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.2 p -48.21 -37.08 15.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.357 -179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.493 ' CE2' HG12 ' A' ' 41' ' ' VAL . 2.7 m-30 -37.68 149.42 0.19 Allowed Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.492 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.52 -73.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.503 2.135 . . . . 0.0 112.305 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.16 167.42 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.0 111.003 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HG2' ' CE2' ' A' ' 46' ' ' TYR . 45.4 mtp180 -129.13 111.28 18.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.959 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 66.9 Cg_endo -89.5 -171.33 5.88 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.173 -0.09 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 74.7 mt -80.53 158.96 70.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.236 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 58.2 Cg_endo -72.2 107.16 2.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.531 2.154 . . . . 0.0 113.445 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 74.12 4.4 4.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.27 178.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.548 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 15.6 mtt180 -112.6 116.41 30.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 0.0 111.542 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 43.1 m -73.11 111.4 8.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 3.3 m-80 -98.92 156.94 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.247 0.546 . . . . 0.0 112.195 -178.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 7.1 t -137.05 132.17 46.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.16 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 43' ' ' ARG . 88.6 t -104.61 128.39 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.717 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -107.65 125.33 51.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.504 -179.896 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.414 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -165.68 150.46 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 179.618 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 21.5 t-80 -74.43 -2.68 26.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.702 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.837 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 8.6 tp60 -70.95 133.61 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -88.57 -3.23 58.85 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -128.25 5.98 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.569 0.223 . . . . 0.0 111.5 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.837 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.0 t80 -59.93 141.8 54.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.236 0.541 . . . . 0.0 111.968 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.434 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 13.7 mm100 -127.11 178.45 6.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.08 0.943 . . . . 0.0 112.104 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.46 144.53 19.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.607 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -76.96 96.36 4.35 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.338 179.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.88 -40.15 3.09 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.961 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . . . -68.61 168.46 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.732 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 t -96.88 140.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.344 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 40.2 t -100.09 107.32 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 0.0 112.314 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 27.1 m -117.68 161.59 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.026 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 77' ' ' HIS . 1.3 m170 -111.67 -22.45 11.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.231 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -161.38 -168.86 2.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.174 0.512 . . . . 0.0 111.594 -179.153 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 106' ' ' PHE . 3.1 t -70.3 -10.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.539 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.87 -37.35 16.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.212 0.53 . . . . 0.0 109.768 178.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.93 -32.95 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.757 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 76' ' ' VAL . 24.3 t -70.0 -51.71 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.4 m-85 -56.33 -27.42 55.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.334 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -64.54 -44.83 89.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 179.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.27 -54.07 43.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.07 -22.84 52.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.899 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.21 -30.11 63.28 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.22 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 5.9 mt-30 -92.95 -13.0 29.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.33 178.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -125.16 65.03 47.42 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.433 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.8 0.17 5.3 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.258 2.638 . . . . 0.0 113.018 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.02 -41.42 35.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -100.51 165.89 11.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.092 0.472 . . . . 0.0 111.669 -179.436 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -98.4 170.38 8.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.034 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.58 114.21 22.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.445 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.46 113.29 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.308 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 5.7 mm -79.11 135.1 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.01 0.433 . . . . 0.0 111.183 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -110.27 -41.3 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.209 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.55 -169.7 41.88 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.738 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.3 -160.74 36.32 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 122.103 -0.645 . . . . 0.0 112.558 -0.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.49 60.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.669 0.271 . . . . 0.0 111.203 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 -60.19 -30.49 69.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.8 mm -76.88 -26.27 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.936 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 3.5 m-85 -62.58 -58.01 9.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.704 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.491 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 8.9 t -67.63 -10.27 50.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.688 -0.633 . . . . 0.0 111.751 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.56 -37.7 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.597 ' HA ' HG21 ' A' ' 79' ' ' VAL . 2.8 m-85 -101.36 -3.17 29.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.503 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 20.2 pttp -49.84 -32.5 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.73 0.3 . . . . 0.0 111.486 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -92.5 1.59 57.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.651 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.0 -26.87 4.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.705 0.288 . . . . 0.0 111.31 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 3' ' ' PHE . 58.6 t -48.96 128.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 5.5 t70 -100.99 -7.38 23.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.3 m -156.21 140.29 16.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 11.5 mt -120.29 144.71 47.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.184 0.516 . . . . 0.0 111.674 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 mt -135.61 117.02 14.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.805 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.494 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -134.94 144.83 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 111.663 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.57 109.85 18.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.435 179.319 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -93.45 103.64 15.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.548 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.32 130.97 37.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -49.96 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.4 156.16 39.04 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.313 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 86.2 p -101.26 142.97 31.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -123.03 156.55 34.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -113.27 134.83 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.996 0.427 . . . . 0.0 111.409 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.34 -162.44 11.83 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.392 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 8.36 3.02 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.5 m -120.3 109.93 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.798 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -92.38 142.48 27.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -178.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.445 HG12 ' CB ' ' A' ' 103' ' ' PHE . 2.3 pp -111.75 158.68 35.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.14 135.46 66.2 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.709 2.273 . . . . 0.0 112.281 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.413 HD13 ' CH2' ' A' ' 5' ' ' TRP . 3.8 mt -120.53 143.4 48.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.129 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 79.56 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.421 ' CZ3' HD12 ' A' ' 113' ' ' LEU . 85.8 m95 -63.53 -15.03 56.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -33.46 62.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.996 0.426 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.18 -16.09 47.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.334 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 110' ' ' VAL . 66.3 m-85 -106.9 164.47 12.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.813 0.34 . . . . 0.0 111.027 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.405 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -125.6 140.87 52.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -85.06 114.56 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.677 179.654 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 159' ' ' GLN . 16.0 m -101.74 -18.96 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.52 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.69 139.98 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.398 . . . . 0.0 111.248 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -168.75 106.87 0.45 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.331 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -142.55 122.11 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.367 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.1 m -72.82 145.8 46.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.316 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 152' ' ' THR . 4.7 t -114.99 103.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 178.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 99.23 11.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.471 -179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.84 -177.66 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.7 p -54.33 -54.51 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.505 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -73.45 124.28 90.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.947 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 -29.53 89.33 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.124 1.882 . . . . 0.0 112.268 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.99 -18.52 28.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.801 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.5 mt -86.03 10.45 14.19 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 144' ' ' VAL . 55.1 m -74.69 166.15 24.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.516 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -172.15 158.94 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.218 179.7 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 33.4 m -123.06 133.76 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -98.77 107.86 20.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -97.17 149.69 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.081 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 16.7 t -141.28 106.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.003 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 24.2 m95 -110.15 146.24 35.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.0 111.779 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.461 ' HB2' HG11 ' A' ' 139' ' ' VAL . 13.7 mt-30 -128.11 119.79 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.159 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 7.7 tttm -46.44 129.0 10.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.735 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.405 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 1.6 ptpt -109.28 -176.85 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.816 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.145 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.16 154.6 23.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.532 ' CD1' HG22 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -121.53 114.56 21.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.226 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.492 ' CD1' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -114.73 122.9 47.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.47 0.652 . . . . 0.0 112.466 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' CH2' HG13 ' A' ' 115' ' ' VAL . 6.7 p90 -164.12 165.15 22.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.189 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.39 136.06 53.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.361 . . . . 0.0 111.737 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -125.89 144.26 50.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.518 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.9 p30 -98.41 -169.29 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -49.27 46.1 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.175 0.512 . . . . 0.0 110.59 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -29.24 63.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.288 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.02 31.09 6.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.415 ' HB3' ' OD2' ' A' ' 8' ' ' ASP . 7.5 tt -83.43 167.9 17.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.592 0.235 . . . . 0.0 110.618 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.406 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -128.22 -64.59 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.348 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' N ' HD23 ' A' ' 12' ' ' LEU . . . -157.4 -163.59 12.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.642 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 168.64 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 0.0 110.917 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.93 -36.79 6.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.99 62.58 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.662 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.34 -43.14 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 110.659 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.446 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 62.92 51.19 1.45 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.55 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 42.8 Cg_endo -76.51 -67.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.103 1.869 . . . . 0.0 111.979 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.552 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 0.0 OUTLIER 175.82 164.43 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.395 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -123.15 145.61 48.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.843 0.354 . . . . 0.0 111.022 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.14 150.21 60.57 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.29 -39.89 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.574 2.183 . . . . 0.0 112.676 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -75.09 -43.14 54.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.294 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.89 -18.03 60.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.475 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 tp -84.62 -36.24 22.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.161 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -59.03 -39.59 82.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.243 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 33' ' ' GLN . 28.5 t80 -73.62 -41.4 62.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.198 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 4' ' ' LEU . 33.0 t80 -51.41 -39.31 57.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.238 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.54 -57.48 2.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.683 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -46.17 -24.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 29' ' ' TYR . 5.8 mm-40 -52.63 -56.33 16.15 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -121.81 3.62 10.02 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 32' ' ' ALA . 9.4 m -47.34 162.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.7 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 77.85 9.88 86.61 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.963 -0.91 . . . . 0.0 115.09 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -152.12 -164.62 2.01 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.654 1.727 . . . . 0.0 109.081 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.404 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 68.0 mt -77.82 89.29 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.854 0.359 . . . . 0.0 111.813 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.406 ' HG3' ' CG2' ' A' ' 34' ' ' THR . 9.6 ttp -99.4 120.81 40.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.454 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 40.3 t -79.82 158.36 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 111.646 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.458 HG11 ' CE2' ' A' ' 49' ' ' PHE . 34.5 m -161.67 149.93 4.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.89 149.35 44.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.846 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -48.22 -52.4 21.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.116 0.458 . . . . 0.0 110.119 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.463 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -56.34 -34.64 66.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.251 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -70.36 -54.8 11.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.131 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 73' ' ' ALA . 35.7 t80 -50.39 -28.06 7.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.457 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -66.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -57.5 -30.41 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.591 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CE2' HG11 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -36.42 133.69 0.61 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.705 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -38.99 -29.12 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.394 2.729 . . . . 0.0 113.766 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -162.19 152.31 16.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 111.197 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.52 108.9 10.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 88.1 Cg_endo -82.22 -179.09 22.9 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.364 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 51.0 mt -82.23 145.82 53.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.774 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.65 109.66 2.54 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.419 2.079 . . . . 0.0 112.236 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 2.9 mt-10 77.55 14.68 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.8 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -132.89 112.63 12.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.638 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 46.6 m -70.51 113.03 7.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.083 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.38 156.66 17.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.305 0.574 . . . . 0.0 112.079 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.29 141.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.152 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.05 123.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.916 0.388 . . . . 0.0 111.351 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -105.62 120.12 40.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.421 HG23 ' CG ' ' A' ' 68' ' ' TYR . 1.8 t -153.6 155.77 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.5 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.861 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.2 tt0 -74.12 134.05 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.97 1.83 53.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.672 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -127.79 3.6 6.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.61 0.243 . . . . 0.0 111.503 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.503 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.0 t80 -57.1 137.82 55.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 111.419 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -130.39 173.39 10.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.218 1.008 . . . . 0.0 112.613 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.52 143.3 19.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.576 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.4 101.16 7.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.791 0.329 . . . . 0.0 110.336 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.46 -40.92 2.9 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.749 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 46' ' ' TYR . . . -70.16 166.89 18.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.551 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.13 140.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 15.0 t -109.3 117.66 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 26.9 m -126.96 167.36 21.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.426 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -116.82 -22.33 8.6 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.685 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.64 -173.62 4.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.622 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.469 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 19.3 t -69.72 -9.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.728 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.64 -34.72 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.443 . . . . 0.0 110.107 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.24 -30.81 62.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 ' CG2' ' A' ' 76' ' ' VAL . 23.1 t -73.52 -49.39 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 109.998 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.409 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 5.7 m-85 -57.08 -28.02 62.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.909 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.29 -42.22 88.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.039 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.89 -56.23 12.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.16 -22.8 30.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.976 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.72 -41.73 71.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -83.82 -10.02 58.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.546 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -123.71 64.73 32.27 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.59 -0.8 6.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.044 2.496 . . . . 0.0 112.756 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.54 26.95 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.4 163.57 12.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.454 . . . . 0.0 111.457 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.98 159.76 14.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.571 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.4 tp -113.52 113.58 25.33 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.837 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.49 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 30.3 t -134.54 121.59 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.679 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 17.6 mm -81.0 132.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.06 0.457 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -96.9 -50.55 4.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.067 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.09 -169.35 42.46 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.75 -160.78 36.47 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 117.635 0.717 . . . . 0.0 112.493 -0.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.57 -48.76 19.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.765 0.317 . . . . 0.0 111.301 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.8 -32.46 52.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.122 0.487 . . . . 0.0 110.403 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.416 HD11 ' HB3' ' A' ' 62' ' ' LEU . 45.8 mm -85.23 -27.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.205 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -60.67 -57.46 12.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.751 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 107' ' ' LYS . 1.6 t -66.81 -9.97 42.84 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.93 -0.481 . . . . 0.0 112.263 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.34 -39.87 62.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.05 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 1.9 m-85 -101.36 -3.18 29.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.767 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 104' ' ' THR . 1.8 pttt -49.16 -32.52 10.33 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -0.73 57.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -120.48 -26.9 5.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.342 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 3' ' ' PHE . 62.7 t -50.11 126.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.59 -12.65 19.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.04 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 95.9 m -148.28 141.79 25.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.523 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 12.9 mt -123.62 146.78 47.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.262 0.554 . . . . 0.0 111.743 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -135.55 116.97 14.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' A' ' 156' ' ' GLU . 1.0 OUTLIER -131.71 141.95 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.427 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.41 99.25 7.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.608 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -75.53 100.06 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.384 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mt -84.66 126.54 33.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.325 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.11 -43.51 82.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.208 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.85 167.55 48.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.514 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.2 p -101.2 150.79 22.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 111.0 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -130.37 149.32 52.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 167.38 15.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.421 . . . . 0.0 111.318 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.69 164.67 11.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.89 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -1.29 12.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.503 0.192 . . . . 0.0 111.316 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 m -109.22 128.65 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -105.24 164.07 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.54 147.4 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.592 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -71.14 164.39 57.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.27 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.592 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.0 Cg_endo -74.92 102.9 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.357 2.038 . . . . 0.0 112.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.407 HD13 ' CH2' ' A' ' 5' ' ' TRP . 2.9 mt -88.1 144.35 26.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.54 70.49 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.302 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -55.04 -24.98 27.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.292 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -30.3 65.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 0.0 110.474 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -80.32 -25.65 39.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 85.5 m-85 -100.26 176.58 5.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.772 0.32 . . . . 0.0 110.43 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -137.09 140.71 42.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.508 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.2 ttpm? -79.93 114.81 19.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 17.1 m -97.64 -19.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -164.11 140.76 6.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.5 p -163.75 112.65 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.036 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -148.1 125.34 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 3.5 m -79.24 145.72 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 152' ' ' THR . 5.0 t -119.2 103.5 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -84.49 99.81 10.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 -179.92 7.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.4 p -53.41 -46.98 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 110.581 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.482 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -79.11 124.27 84.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.368 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.96 -29.44 89.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 112.599 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.37 -18.75 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.2 mt -83.94 7.06 19.5 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.579 0.228 . . . . 0.0 111.466 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 144' ' ' VAL . 91.1 m -71.07 164.91 24.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -171.05 157.63 5.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.603 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 45.1 m -123.2 126.56 47.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.588 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.22 105.44 17.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HB2' HG21 ' A' ' 115' ' ' VAL . 75.3 mt-10 -106.37 124.61 49.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.196 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 21.8 t -116.55 113.68 43.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.259 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.508 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 20.2 m95 -108.62 150.23 27.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.937 0.399 . . . . 0.0 111.481 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -127.51 119.0 25.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -57.08 130.8 47.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -104.37 -176.06 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.137 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 52.2 m . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.68 151.11 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.4 m-30 -118.03 107.8 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.212 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.59 HD11 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -106.36 124.78 50.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.332 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.456 ' CH2' HG11 ' A' ' 115' ' ' VAL . 6.0 p90 -168.38 174.24 7.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.4 137.79 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.5 pt20 -119.26 156.57 29.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 111.332 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -102.58 169.06 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.23 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.11 -30.04 6.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.929 0.395 . . . . 0.0 110.568 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -89.02 -27.51 20.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.0 22.15 6.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.714 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.2 tt -77.27 166.46 23.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.633 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.59 -51.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.466 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.48 -167.13 39.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.585 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -92.9 -172.78 3.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 110.795 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.98 20.07 7.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.33 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.78 96.61 2.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.581 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -149.28 -36.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.651 0.262 . . . . 0.0 111.316 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 mt 65.72 69.34 0.62 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.44 -167.97 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.555 2.17 . . . . 0.0 112.277 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -66.18 93.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.6 144.75 26.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.011 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mt -105.05 158.11 32.78 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.782 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.52 1.52 8.35 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.664 2.243 . . . . 0.0 113.019 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -85.57 -37.54 19.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.698 0.285 . . . . 0.0 111.268 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.17 -57.43 2.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.277 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -40.49 -35.19 0.42 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.195 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.94 -32.31 72.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.366 . . . . 0.0 111.438 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -81.3 -40.77 23.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -68.64 -40.88 80.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.902 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -63.39 -61.88 2.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.749 0.309 . . . . 0.0 111.772 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.58 -23.12 5.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -91.01 -6.46 53.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.425 HG21 ' HG ' ' A' ' 4' ' ' LEU . 37.4 p -146.0 24.99 1.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.508 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 20.6 m -108.3 150.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.73 29.01 57.73 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 116.827 1.491 . . . . 0.0 116.827 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 5.5 mttp -145.74 -166.47 2.46 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.419 2.109 . . . . 0.0 108.732 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 54.2 mt -86.88 88.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 O-C-N 122.012 -0.43 . . . . 0.0 110.768 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 5.6 ttp -100.13 119.12 37.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.58 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 2.7 t -87.53 128.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.43 154.94 40.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.378 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 162.13 53.79 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.843 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.462 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -58.5 -50.01 75.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.984 0.392 . . . . 0.0 110.654 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.462 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 tpt180 -61.03 -35.96 78.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 110.297 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 -50.41 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.387 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.3 t80 -52.59 -25.09 9.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -69.63 -65.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -28.07 61.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.33 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CZ ' ' HE3' ' A' ' 39' ' ' MET . 0.5 OUTLIER -37.69 136.86 0.72 Allowed Pre-proline 0 N--CA 1.467 0.404 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.779 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.17 -30.47 25.64 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.802 2.335 . . . . 0.0 113.074 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -159.34 151.96 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -140.98 110.93 6.61 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HG3' ' O ' ' A' ' 71' ' ' GLN . 10.9 Cg_exo -81.35 178.54 31.02 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.585 -1.423 . . . . 0.0 111.996 -0.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 31.8 mt -83.16 156.0 66.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.15 107.42 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.404 2.069 . . . . 0.0 112.875 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.585 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.6 mm-40 70.74 4.75 5.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.508 ' HD2' ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -108.51 122.92 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.938 0.399 . . . . 0.0 111.411 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.4 m -75.13 117.02 16.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.158 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -105.58 156.04 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.445 . . . . 0.0 112.015 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 24.6 t -136.97 137.42 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.337 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 76' ' ' VAL . 57.6 t -107.76 126.59 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 0.0 111.323 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -107.65 117.2 33.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.969 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.415 HG22 ' CG ' ' A' ' 68' ' ' TYR . 1.3 t -148.43 161.36 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.959 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -79.08 -11.42 59.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.452 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tp60 -82.35 134.03 35.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.535 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -84.01 -29.63 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.636 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.85 2.24 54.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.159 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.2 t80 -58.83 139.5 56.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 1.3 mt-30 -128.7 174.37 9.49 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.219 1.009 . . . . 0.0 112.447 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.13 144.32 21.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.847 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 13.6 mt-30 -73.52 96.85 2.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.362 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.36 -37.01 3.15 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.645 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.12 171.51 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 112.024 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.431 HG22 ' CE1' ' A' ' 85' ' ' TYR . 13.8 t -97.78 140.35 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.467 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 38.9 t -106.95 104.77 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.24 0.543 . . . . 0.0 112.281 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 23.6 m -117.44 166.93 11.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.366 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -121.91 -19.89 6.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.307 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' HA ' HD23 ' A' ' 62' ' ' LEU . 1.8 t70 -155.65 -178.87 7.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.209 0.528 . . . . 0.0 111.602 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.44 HG23 ' CG ' ' A' ' 106' ' ' PHE . 15.8 t -66.29 -8.97 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.767 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.73 -35.02 16.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.487 . . . . 0.0 109.869 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.91 -32.93 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.903 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.471 HG22 ' CG2' ' A' ' 76' ' ' VAL . 39.9 t -70.73 -49.99 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.545 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.2 m-85 -55.79 -26.24 45.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.897 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.76 88.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.026 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CE1' HG22 ' A' ' 74' ' ' VAL . 58.3 t80 -66.07 -57.14 8.39 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.96 14.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.467 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.03 -36.72 80.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 -2.59 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.222 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -128.56 68.28 77.77 Favored Pre-proline 0 N--CA 1.456 -0.161 0 CA-C-O 121.082 0.467 . . . . 0.0 110.298 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.97 0.55 3.04 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.41 2.74 . . . . 0.0 113.087 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.92 -19.69 17.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.229 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 5.0 mm100 -109.83 154.99 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -98.16 174.92 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.365 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 1' ' ' THR . 0.0 OUTLIER -111.49 109.07 18.84 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.574 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' MET . 39.2 t -124.24 108.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.298 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.462 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 18.5 mm -85.55 142.36 13.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.384 0.612 . . . . 0.0 111.961 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -111.45 -44.66 3.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.371 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.91 -165.75 38.56 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.622 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.43 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -82.53 -161.19 29.28 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.401 0.6 . . . . 0.0 112.651 -0.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.71 -48.07 69.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.855 0.359 . . . . 0.0 111.078 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -58.09 -29.19 65.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.608 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 62' ' ' LEU . 20.7 mm -79.95 -29.28 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.358 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.428 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 3.5 m-85 -58.44 -55.91 28.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.733 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.519 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.4 t -65.17 -9.83 26.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.47 -43.41 27.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.843 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CG ' HG23 ' A' ' 79' ' ' VAL . 5.6 m-85 -93.56 -6.79 45.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.338 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.519 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 10.9 pttp -49.8 -32.98 15.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.399 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -78.87 -6.04 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.764 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.09 -24.7 4.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 3' ' ' PHE . 76.6 t -44.43 124.58 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.94 0.4 . . . . 0.0 111.447 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.452 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 6.3 t70 -103.07 -1.22 29.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.687 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 86.3 m -161.46 142.51 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.585 0.231 . . . . 0.0 111.065 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 7.0 mt -123.58 144.95 49.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.213 0.53 . . . . 0.0 111.415 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.9 mt -135.33 118.94 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.761 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.456 HG11 ' CH2' ' A' ' 5' ' ' TRP . 2.9 m -134.78 144.8 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.424 . . . . 0.0 111.688 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.84 119.31 35.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 7.1 mtm180 -102.05 104.7 15.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.418 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.4 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -87.8 136.46 32.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.44 -48.23 68.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.27 -138.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.7 p -144.23 168.2 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 0.0 111.335 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 80.0 m-85 -131.2 137.74 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.743 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 166.53 10.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.734 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.24 -159.12 29.18 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.13 22.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.5 m -146.08 137.82 24.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.863 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -109.34 165.82 11.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -177.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pt -104.06 156.73 35.3 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.88 99.9 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.671 2.247 . . . . 0.0 112.194 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.73 148.08 23.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.955 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.37 70.6 6.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.424 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 94.4 m95 -53.41 -27.64 25.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.094 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.09 -29.11 67.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.421 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.57 -20.67 42.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 43.5 m-85 -100.02 175.86 5.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.5 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 2.5 m -134.32 139.95 46.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.422 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.639 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 7.7 ttpt -83.94 111.56 19.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.4 m -98.8 -17.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.487 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -163.89 140.21 6.62 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.443 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.639 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 81.0 p -168.04 105.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.464 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -142.79 121.25 12.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.649 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.2 m -71.16 145.59 49.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.21 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 152' ' ' THR . 4.4 t -117.77 103.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.579 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -86.61 100.27 12.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.358 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -83.24 -176.9 6.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -56.68 -54.15 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.942 0.401 . . . . 0.0 110.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.51 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.6 t30 -73.63 127.84 87.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.847 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.63 -31.6 92.34 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.037 1.825 . . . . 0.0 112.563 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.62 -21.48 28.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.8 mt -82.08 8.79 9.84 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 144' ' ' VAL . 95.5 m -75.28 164.1 26.79 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.9 p80 -175.58 162.19 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.994 0.426 . . . . 0.0 111.581 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 7.7 m -122.12 144.85 48.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.911 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -111.65 110.06 20.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.71 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 115' ' ' VAL . 7.0 mm-40 -98.68 151.26 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.7 t -141.77 106.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.009 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 25.1 m95 -108.5 146.18 33.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.106 0.479 . . . . 0.0 111.949 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -124.81 112.74 17.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.233 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.2 tttt -51.17 131.74 27.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.227 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -92.39 168.59 11.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.295 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.159 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 11.8 m . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.778 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.28 152.47 27.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.498 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.3 m-30 -118.11 112.03 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.21 126.34 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.673 0.749 . . . . 0.0 112.881 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.484 ' CH2' HG12 ' A' ' 115' ' ' VAL . 9.0 p90 -164.6 164.73 21.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.055 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.04 134.93 54.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 111.472 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 2.7 pt20 -115.61 140.34 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -97.82 -167.42 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -51.36 -34.66 35.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.784 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.63 -28.42 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 94.83 45.86 3.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.466 ' CD1' ' HA3' ' A' ' 124' ' ' GLY . 1.4 mt -91.11 174.31 7.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.415 HG23 ' CD1' ' A' ' 5' ' ' TRP . 1.1 pp -139.72 -58.07 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.653 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.94 152.32 34.78 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.425 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.99 149.46 6.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 111.115 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.67 107.02 15.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.821 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.61 137.39 2.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.591 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 10.2 t60 -106.48 111.35 23.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.619 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.56 109.24 27.79 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.937 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 18' ' ' HIS . 69.7 Cg_endo -92.5 58.28 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.948 2.432 . . . . 0.0 112.511 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -90.82 178.48 6.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.157 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.9 -7.43 14.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.67 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.4 mt -94.4 112.48 57.79 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.592 0.234 . . . . 0.0 110.916 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -81.31 54.13 5.03 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.735 2.29 . . . . 0.0 112.416 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.75 -68.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.15 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -95.29 -21.85 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.536 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.87 -25.05 66.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.739 0.304 . . . . 0.0 111.338 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.5 OUTLIER -84.53 -68.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.241 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.514 ' CE2' ' CE1' ' A' ' 155' ' ' TYR . 12.4 t80 -42.98 -26.27 0.13 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.082 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -69.09 0.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.687 0.28 . . . . 0.0 110.994 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm105 -92.59 -40.62 10.68 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -59.59 -13.03 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' NE2' ' CE1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -81.16 -50.53 9.49 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.538 ' HB ' ' HG ' ' A' ' 4' ' ' LEU . 5.4 t -83.18 -24.43 32.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.585 ' HB ' ' HG2' ' A' ' 57' ' ' ARG . 35.5 m -60.89 142.97 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 0.0 110.977 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.526 ' H ' ' CG ' ' A' ' 57' ' ' ARG . . . 119.82 -10.18 11.28 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.82 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -151.65 -164.51 2.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.503 1.151 . . . . 0.0 109.555 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.566 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 74.3 mt -74.55 94.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 112.016 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.445 ' HG3' ' OG1' ' A' ' 34' ' ' THR . 8.6 ttp -103.48 126.81 50.85 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.014 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.459 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 21.1 t -78.9 158.22 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 27.3 m -165.04 142.98 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.99 158.5 51.2 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.81 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -52.84 -48.51 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.058 0.429 . . . . 0.0 110.77 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -62.66 -27.01 68.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 0.0 110.467 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.2 m -75.73 -44.62 40.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.589 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -61.33 -31.59 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -66.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.71 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 49' ' ' PHE . 3.9 t -54.7 -33.05 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -26.38 114.31 0.23 Allowed Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.883 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.88 -37.0 21.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.043 2.495 . . . . 0.0 113.307 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' CE ' HD23 ' A' ' 54' ' ' LEU . 2.6 tmmm? -147.13 118.93 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.777 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.86 140.16 21.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.18 -167.1 5.06 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.23 -1.571 . . . . 0.0 112.004 -0.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.561 ' HB3' ' CD ' ' A' ' 57' ' ' ARG . 81.9 mt -111.61 137.47 21.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.06 -66.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.65 2.233 . . . . 0.0 113.302 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.82 19.8 1.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.488 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.585 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -142.27 121.43 12.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.119 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.566 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 39.9 m -80.59 128.11 33.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.289 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -115.02 147.36 40.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 111.843 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG12 ' CG2' ' A' ' 76' ' ' VAL . 3.3 t -131.12 132.65 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.464 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -97.73 128.89 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.289 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -107.07 115.38 30.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -147.4 156.75 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -74.15 -12.4 60.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.888 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tt0 -80.39 133.5 35.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -84.67 -11.13 56.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.962 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.37 4.41 20.66 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.4 t80 -58.26 140.45 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.54 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.634 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -126.48 173.85 9.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 179.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.49 143.68 20.09 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.648 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.73 96.75 5.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.742 0.306 . . . . 0.0 110.696 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.11 2.65 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.959 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.16 167.75 17.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.071 0.462 . . . . 0.0 111.718 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.438 HG13 ' CD1' ' A' ' 85' ' ' TYR . 32.3 t -97.07 140.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.421 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.3 t -104.23 117.66 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.368 0.604 . . . . 0.0 112.477 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 28.1 m -127.31 167.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.962 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.426 ' O ' HD21 ' A' ' 62' ' ' LEU . 4.7 m80 -119.13 -22.18 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.539 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -159.33 -175.02 4.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.667 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 106' ' ' PHE . 11.8 t -66.64 -11.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.786 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.69 -36.82 17.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 0.0 109.752 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.65 -31.74 65.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.478 HG23 HG22 ' A' ' 76' ' ' VAL . 31.6 t -69.68 -53.82 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.986 0.422 . . . . 0.0 109.938 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.497 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 5.6 m-85 -53.61 -27.6 27.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.971 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.49 88.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.895 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CD1' HG13 ' A' ' 74' ' ' VAL . 68.5 t80 -64.43 -54.49 31.87 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.78 -24.2 34.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -71.39 -33.63 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -83.16 -8.72 59.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.376 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -124.82 66.01 47.32 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.019 0.437 . . . . 0.0 110.277 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.3 -0.46 2.89 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.099 2.533 . . . . 0.0 112.831 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.09 -30.28 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.009 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.93 161.81 14.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -98.76 174.77 6.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 1' ' ' THR . 8.5 tp -122.27 118.8 29.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.383 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.5 t -132.87 121.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.432 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 8.7 mm -83.25 133.39 29.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.11 0.481 . . . . 0.0 111.832 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.402 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -101.22 -50.04 3.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.21 -171.13 43.94 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.717 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.45 -160.98 36.79 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.674 0.737 . . . . 0.0 112.69 -0.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.02 10.18 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.733 0.301 . . . . 0.0 111.508 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -52.62 -30.52 31.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.553 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.89 -21.62 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . 2.7 m-85 -66.29 -51.75 54.25 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.506 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -70.75 -9.59 57.65 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 111.916 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.47 -37.87 35.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.482 ' HA ' HG23 ' A' ' 79' ' ' VAL . 6.3 m-85 -95.87 -11.12 27.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.682 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 9.4 pttp -51.4 -29.14 14.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.97 -12.45 60.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.411 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.89 -20.73 5.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.498 HG22 ' CD1' ' A' ' 3' ' ' PHE . 81.0 t -44.53 128.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.063 0.458 . . . . 0.0 111.317 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 6.2 t0 -110.47 -3.87 15.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.582 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.778 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.9 m -155.7 134.47 11.92 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.598 0.237 . . . . 0.0 111.08 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 136' ' ' PHE . 11.7 mt -117.01 144.08 44.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mt -135.91 115.51 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.502 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.484 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -131.4 141.34 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.39 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.484 HG21 ' CD1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -113.44 112.78 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -96.26 100.44 12.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.366 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.0 OUTLIER -86.66 131.21 34.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.47 89.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.103 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.67 -173.3 0.08 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 p -124.54 136.58 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -138.15 157.49 46.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.91 170.37 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 12' ' ' LEU . . . -161.26 125.87 1.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.701 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.56 14.05 24.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.509 0.195 . . . . 0.0 111.42 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -162.85 137.27 6.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.939 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.33 160.78 14.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.202 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.411 ' HG3' ' N ' ' A' ' 129' ' ' ILE . 15.9 tpt -81.51 159.34 24.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.452 HD11 ' CA ' ' A' ' 104' ' ' THR . 1.1 pp -91.81 165.07 21.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.415 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.63 128.37 23.23 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.628 2.218 . . . . 0.0 112.043 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.408 HD13 ' CH2' ' A' ' 5' ' ' TRP . 2.5 mt -112.36 139.67 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.19 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 63.05 7.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -53.9 -24.37 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -31.14 65.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.03 -16.39 47.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.397 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 160' ' ' LYS . 77.9 m-85 -103.45 168.28 9.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 110.69 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.656 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -132.59 140.93 48.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.978 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 5.6 ttpt -79.93 119.41 22.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.41 -19.37 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.0 m -167.07 140.45 3.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.49 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 5.2 p -169.27 108.68 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -147.84 125.39 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.779 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.1 m -71.2 146.11 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.728 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 152' ' ' THR . 10.5 t -118.78 103.47 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.592 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -88.29 102.02 14.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.576 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.76 -174.4 4.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.654 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.9 p -58.0 -51.21 70.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.523 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.9 t30 -76.5 134.02 70.25 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.871 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.56 -35.29 60.48 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.985 1.79 . . . . 0.0 112.393 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.5 mt -78.45 8.91 4.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 144' ' ' VAL . 93.6 m -78.71 161.11 27.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.45 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -172.11 157.81 4.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.008 0.432 . . . . 0.0 111.594 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 7.5 m -119.06 131.48 55.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.574 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.514 ' CE1' ' CE2' ' A' ' 29' ' ' TYR . 45.1 m-85 -99.79 105.21 16.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.755 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HB2' HG21 ' A' ' 115' ' ' VAL . 4.3 mt-10 -102.81 122.11 43.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.477 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.8 t -116.79 114.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 138' ' ' LYS . 30.5 m95 -112.15 150.56 30.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 111.556 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -126.8 115.02 18.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.829 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.497 ' HB2' ' CE1' ' A' ' 136' ' ' PHE . 3.0 ttpt -51.73 138.22 23.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.287 0.565 . . . . 0.0 112.434 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.656 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -125.87 -164.03 1.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.339 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.063 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.452 ' O ' HG11 ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.707 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.93 146.35 39.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.542 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.5 m-85 -110.2 115.79 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.531 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 tp -113.73 120.96 42.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.496 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 4.1 p90 -166.17 164.65 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.274 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.32 55.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 111.48 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 pt20 -123.29 153.05 40.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.157 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -103.18 -174.07 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.717 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -24.92 19.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -91.99 -31.17 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.744 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.98 22.74 7.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.669 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -87.22 153.09 21.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.02 -75.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.85 -154.55 6.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -163.58 102.81 0.93 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.68 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -87.93 58.16 4.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.42 -101.62 0.26 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.442 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -139.25 85.98 2.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.83 156.74 40.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.963 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.8 -41.9 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.578 2.186 . . . . 0.0 112.642 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.11 176.69 9.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -130.9 -167.58 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.787 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -136.42 129.44 17.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.834 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.06 -24.75 9.42 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.504 2.136 . . . . 0.0 112.638 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.27 -28.66 59.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.219 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.23 -44.9 92.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 0.0 110.979 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.95 -69.21 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.537 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -17.58 64.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.89 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -62.21 -74.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.742 0.306 . . . . 0.0 111.424 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -91.91 30.38 1.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.826 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.49 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 28.0 ttp85 -73.29 -61.35 1.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.832 0.349 . . . . 0.0 110.958 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -85.29 -11.41 54.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.818 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -84.26 -8.04 59.16 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.7 p -145.19 11.25 1.33 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 31' ' ' ARG . 6.9 m -94.32 150.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.628 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 54.15 35.33 54.52 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 116.136 1.215 . . . . 0.0 116.136 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.45 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.9 mmtt -149.46 -176.2 5.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 120.262 2.031 . . . . 0.0 107.721 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 71.8 mt -86.6 85.27 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.051 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ttp -102.12 123.07 45.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.39 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.495 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 43.3 t -76.01 156.51 5.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.522 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 34.9 m -164.18 137.46 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.74 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.21 161.37 34.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.933 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -56.99 -47.2 81.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.861 0.33 . . . . 0.0 110.767 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.416 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.8 tpp180 -66.36 -30.48 70.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.388 . . . . 0.0 110.336 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 m -68.2 -43.73 77.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.204 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -59.05 -31.14 68.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.43 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.42 -66.1 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.1 t -50.07 -41.61 48.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.9 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.424 ' CE2' HG11 ' A' ' 41' ' ' VAL . 6.9 m-85 -42.44 152.92 0.32 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-O 120.781 0.324 . . . . 0.0 111.448 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -41.73 -72.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.063 2.509 . . . . 0.0 113.542 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.66 177.15 8.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.45 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 2.4 ptp180 -122.1 105.76 36.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 86.9 Cg_endo -87.89 -179.96 17.07 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.457 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.422 ' CD1' ' HD2' ' A' ' 57' ' ' ARG . 34.2 mt -61.18 158.53 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 12.9 Cg_endo -56.72 87.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.412 2.075 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 42.8 mt-10 69.62 47.55 0.64 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.351 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 17.0 mtt180 -140.79 126.05 18.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.671 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 92.0 m -76.5 105.84 7.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -104.6 145.86 29.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.224 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 12.1 t -117.63 141.78 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.097 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.8 t -108.32 124.42 64.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.116 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.28 121.05 44.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.484 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.511 HG23 ' CD2' ' A' ' 68' ' ' TYR . 2.5 t -157.17 160.13 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -75.52 -5.51 45.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.19 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.4 tp60 -78.71 129.85 35.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.63 -28.06 31.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.139 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.56 7.55 46.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 7.7 t80 -60.57 142.49 55.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.348 0.594 . . . . 0.0 111.897 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 14.9 mm100 -134.77 175.72 9.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.39 1.09 . . . . 0.0 112.888 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 142.64 19.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -78.11 100.94 6.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.35 -43.0 2.8 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.807 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.08 170.18 11.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.446 . . . . 0.0 111.709 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.414 HG11 ' CD1' ' A' ' 85' ' ' TYR . 18.5 t -99.48 140.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.42 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 21.5 t -111.36 119.97 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.357 0.599 . . . . 0.0 112.121 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.445 HG23 HG21 ' A' ' 82' ' ' VAL . 34.1 m -126.61 168.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.409 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -119.14 -25.46 6.17 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.794 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.07 -176.13 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.641 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.413 HG12 ' CD2' ' A' ' 106' ' ' PHE . 21.7 t -69.63 -10.73 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.688 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.72 -30.99 18.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 110.364 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.26 -26.59 52.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.445 HG21 HG23 ' A' ' 76' ' ' VAL . 16.7 t -78.41 -50.81 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 109.806 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.2 m-85 -57.33 -28.78 63.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.913 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.77 -38.29 79.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.7 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' CD1' HG11 ' A' ' 74' ' ' VAL . 67.4 t80 -68.12 -59.23 3.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.51 -22.84 14.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.202 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.89 -37.38 75.99 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.035 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.478 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 7.5 mt-30 -83.81 -4.49 58.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.233 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -124.76 65.04 43.77 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.563 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.8 -0.99 6.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.925 2.417 . . . . 0.0 112.829 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.7 -31.67 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 20.6 mt-30 -102.28 157.44 16.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -99.14 158.99 15.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.51 115.89 29.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.28 110.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.33 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.481 HD13 ' CG2' ' A' ' 40' ' ' VAL . 4.9 mm -77.2 129.03 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 0.0 111.079 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.19 -37.14 6.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.59 -169.11 42.17 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.785 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.34 -161.01 30.6 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 122.266 -0.549 . . . . 0.0 112.545 -0.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -55.12 -51.18 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.054 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -55.53 -27.64 50.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.591 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.439 ' CD1' ' HB3' ' A' ' 62' ' ' LEU . 49.0 mm -79.34 -32.94 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.0 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.455 ' HA ' ' CE2' ' A' ' 3' ' ' PHE . 6.2 m-85 -54.08 -58.16 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.65 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.568 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.1 t -65.78 -9.92 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.74 -41.56 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 110' ' ' VAL . 3.0 m-85 -101.56 -2.57 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.462 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 39.0 pttt -49.8 -34.36 19.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.731 0.3 . . . . 0.0 111.767 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 4.07 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.64 -25.0 3.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.542 HG22 ' CD1' ' A' ' 3' ' ' PHE . 62.9 t -44.04 129.35 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 120.97 0.414 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.411 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 24.5 t70 -103.41 2.77 34.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.124 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.707 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 97.8 m -166.97 138.63 3.32 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.538 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 21.2 mt -120.17 144.81 47.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.9 mt -135.31 115.23 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.2 m -132.16 143.05 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.848 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.35 105.67 13.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.235 179.31 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -81.98 101.67 10.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -84.91 125.73 32.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.974 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 -56.93 12.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.312 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.16 168.26 15.85 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.87 163.19 12.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CZ ' HD11 ' A' ' 118' ' ' LEU . 4.5 m-85 -136.39 147.99 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -98.75 132.67 43.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.692 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.14 -179.7 47.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.527 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.26 -0.18 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.7 m -118.13 122.45 43.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.032 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.74 175.98 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.4 tpt -76.61 153.3 35.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.855 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.443 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.8 pp -81.23 164.14 51.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.249 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.27 101.6 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.839 2.359 . . . . 0.0 112.686 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.415 ' CD1' ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -91.25 145.42 24.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.67 75.7 4.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.247 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -55.29 -21.25 13.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.304 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -28.36 61.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.3 t0 -80.74 -17.27 51.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.177 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.476 ' HZ ' ' HB ' ' A' ' 110' ' ' VAL . 91.5 m-85 -109.1 166.35 10.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.94 0.4 . . . . 0.0 111.559 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.731 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -125.24 140.31 52.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.739 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpm? -81.19 121.35 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.615 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 34.1 m -110.21 -15.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.612 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.33 139.87 3.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.81 0.338 . . . . 0.0 110.928 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.2 p -163.09 109.79 1.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -143.65 119.27 10.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.332 . . . . 0.0 111.283 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 5.0 m -74.09 144.61 44.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.244 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 t -116.53 106.22 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.126 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.69 105.49 17.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.588 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.86 -177.18 6.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.559 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 p -59.64 -42.01 91.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.465 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.4 t30 -81.78 126.35 75.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.23 -29.18 88.44 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.295 1.997 . . . . 0.0 112.274 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.54 -24.08 23.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.037 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.7 mt -81.32 6.28 14.78 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 52.1 m -71.38 164.5 25.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.071 0.463 . . . . 0.0 110.124 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.58 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.1 p80 -174.37 160.95 3.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.13 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 26.9 m -122.69 150.16 43.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.629 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -111.05 105.21 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.54 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.502 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.1 mt-10 -105.05 121.63 44.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 111.631 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 4.1 t -112.93 111.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.696 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.2 m95 -110.89 150.33 29.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 111.487 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -128.39 120.91 27.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.496 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.5 tmmt? -45.5 125.93 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.643 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.731 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -109.79 -176.27 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.105 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.51 144.92 42.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.8 m-30 -107.66 112.9 25.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.61 HD12 ' CG2' ' A' ' 34' ' ' THR . 0.0 OUTLIER -114.33 124.92 53.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.36 0.6 . . . . 0.0 112.43 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.481 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 4.9 p90 -170.91 174.05 4.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.617 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.76 139.77 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.183 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -120.48 154.76 34.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 111.422 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 12' ' ' LEU . 1.1 p30 -108.62 -177.7 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.441 ' HG2' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -47.88 -49.63 29.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.32 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.23 -19.55 64.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.55 25.89 21.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.347 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -90.4 161.98 15.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.857 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 5' ' ' TRP . 11.4 pt -111.91 -44.69 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.202 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.67 162.73 31.35 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.386 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.9 150.69 19.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.421 . . . . 0.0 111.213 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.32 123.92 42.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.24 -81.74 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.533 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -87.32 171.71 10.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.934 0.397 . . . . 0.0 110.974 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.17 147.62 33.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.785 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.98 168.44 4.46 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.466 2.11 . . . . 0.0 112.182 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -172.73 2.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.257 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.23 75.8 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.794 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.61 136.34 48.63 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -77.71 -40.03 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.55 2.167 . . . . 0.0 112.694 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -76.93 -14.91 59.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.614 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.21 -25.1 17.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.591 0.234 . . . . 0.0 111.547 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 pp -84.03 -30.7 25.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.711 0.291 . . . . 0.0 111.202 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -48.83 -32.28 8.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.527 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.402 ' CZ ' ' OE1' ' A' ' 33' ' ' GLN . 45.4 t80 -105.27 -59.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.442 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -50.9 -40.42 56.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.613 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -69.94 -60.92 2.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.243 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.85 -22.38 24.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.521 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.402 ' OE1' ' CZ ' ' A' ' 29' ' ' TYR . 3.2 mm-40 -84.31 -7.16 59.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.828 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.61 ' CG2' HD12 ' A' ' 4' ' ' LEU . 4.2 p -138.73 1.25 2.09 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.476 ' CB ' ' HD3' ' A' ' 57' ' ' ARG . 29.3 m -107.99 147.03 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 82.78 7.5 87.23 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -147.23 -165.07 2.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.963 1.882 . . . . 0.0 109.465 179.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 58.6 mt -82.18 88.42 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.412 ' SD ' ' HB ' ' A' ' 34' ' ' THR . 1.6 ttp -97.91 116.89 31.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.801 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.414 HG21 ' CD1' ' A' ' 96' ' ' ILE . 5.8 t -86.3 125.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.09 0.471 . . . . 0.0 111.688 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 HG12 ' CE2' ' A' ' 49' ' ' PHE . 24.5 m -132.13 155.13 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.502 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.13 147.0 32.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.756 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -45.09 -49.29 11.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.72 0.26 . . . . 0.0 111.459 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 3.8 ttt180 -62.14 -36.88 83.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 0.0 110.146 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -63.34 -49.38 74.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.475 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.545 ' O ' ' HB2' ' A' ' 49' ' ' PHE . 2.9 t80 -50.3 -43.76 53.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.875 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -52.38 -63.98 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.766 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -35.08 67.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.37 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -34.98 138.52 0.35 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-O 120.905 0.384 . . . . 0.0 111.973 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.19 -29.99 18.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.253 2.635 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 149.33 31.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.387 . . . . 0.0 111.501 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -138.65 106.37 7.63 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -86.0 -166.91 4.37 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.273 -0.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.483 ' HB3' ' CD ' ' A' ' 57' ' ' ARG . 75.4 mt -100.58 142.05 23.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.92 121.17 6.77 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 112.798 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 69.98 3.09 4.18 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.771 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.483 ' CD ' ' HB3' ' A' ' 54' ' ' LEU . 3.4 mtt-85 -114.42 108.8 17.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.0 m -68.24 113.19 5.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -104.73 150.37 24.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.397 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 t -134.83 133.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.2 t -103.01 124.04 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.753 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -105.72 111.23 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.907 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.434 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -142.83 170.81 15.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 111.285 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -86.91 -14.19 42.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.683 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.6 tt0 -79.17 133.58 36.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 23.4 mt-10 -80.89 -25.61 37.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.79 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.89 6.78 48.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.492 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.2 t80 -60.08 136.24 57.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.216 0.532 . . . . 0.0 111.6 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.452 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -132.04 173.71 10.93 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.254 1.026 . . . . 0.0 112.703 179.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.07 141.41 18.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.096 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.26 101.56 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.807 0.337 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -41.39 2.92 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.638 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.44 167.74 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.52 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.78 140.77 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 19.2 t -110.03 119.87 59.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.228 0.537 . . . . 0.0 112.066 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 HG22 ' A' ' 82' ' ' VAL . 27.6 m -130.19 167.11 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.664 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.439 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 17.3 m80 -118.28 -22.51 7.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.65 -176.72 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.206 0.527 . . . . 0.0 111.507 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 106' ' ' PHE . 35.6 t -71.89 -9.36 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.661 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.13 -33.78 19.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.487 . . . . 0.0 109.785 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.85 -32.3 63.59 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.124 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.497 HG22 HG23 ' A' ' 76' ' ' VAL . 43.4 t -72.19 -52.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.412 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.3 m-85 -54.13 -28.09 37.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.27 -40.19 93.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.471 ' CE2' ' CD2' ' A' ' 89' ' ' HIS . 65.1 t80 -66.99 -57.42 6.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.33 -23.3 8.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.097 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 3.5 mmtp -69.4 -40.11 77.56 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -85.06 -4.95 59.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.529 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 93.4 m-70 -127.38 60.59 44.26 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.02 -0.03 5.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.236 2.624 . . . . 0.0 112.916 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.75 -35.7 19.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.03 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -99.5 163.92 12.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.473 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.3 160.69 14.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.926 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.3 117.06 29.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.53 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.94 117.83 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.174 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 5.4 mm -81.92 133.13 29.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.262 0.553 . . . . 0.0 111.484 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.53 -48.66 4.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.056 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.43 -164.13 36.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.165 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.15 -161.02 34.83 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.674 0.737 . . . . 0.0 112.704 -0.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.77 -48.97 59.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.323 . . . . 0.0 111.41 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -58.5 -29.85 66.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.877 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.2 mm -79.43 -29.93 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.268 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.9 m-85 -57.16 -54.14 50.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.862 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.644 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -70.12 -8.49 50.0 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.024 -0.423 . . . . 0.0 111.839 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.34 -38.98 40.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' HA ' HG23 ' A' ' 79' ' ' VAL . 29.3 m-85 -99.63 -10.03 22.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.308 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.644 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 18.5 pttp -52.17 -31.73 32.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.758 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.74 -5.1 52.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.656 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.2 -21.66 3.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 3' ' ' PHE . 76.9 t -44.81 123.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 111.302 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 3.9 t70 -103.13 7.69 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.267 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.2 m -168.39 135.84 2.09 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.821 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 17.0 mt -117.92 143.7 46.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.491 . . . . 0.0 111.531 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mt -135.28 115.08 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.664 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.481 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -134.69 144.69 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.024 0.44 . . . . 0.0 111.744 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.79 105.56 13.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.577 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 6.5 mmt85 -80.7 100.33 8.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mp -82.21 127.94 33.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.431 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.11 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.884 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -50.43 144.49 11.09 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.443 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.441 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 35.3 p -91.5 132.61 36.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.981 0.42 . . . . 0.0 111.374 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -134.23 163.57 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -116.56 150.86 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.112 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.8 -173.72 23.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.788 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -33.98 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.954 0.407 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 60.7 m -108.71 139.44 43.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.98 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -115.89 172.39 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 111.681 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -70.22 143.6 52.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.1 pt -68.45 154.33 94.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.96 97.73 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.512 2.142 . . . . 0.0 111.975 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.62 146.69 26.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 72.45 4.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.325 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -55.7 -22.37 23.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.423 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -28.81 62.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -80.64 -23.46 39.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 71.8 m-85 -102.09 174.08 6.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.479 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -137.79 142.85 40.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.474 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.6 ttpt -79.96 120.54 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.787 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.01 -21.75 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.433 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.4 m -162.74 140.69 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 16.1 p -160.62 109.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -139.43 115.2 10.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.27 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 8.4 m -74.42 144.14 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 153' ' ' HIS . 2.5 p -121.77 105.26 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.997 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -88.7 107.14 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.787 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.27 -175.77 5.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.486 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.7 p -57.45 -50.45 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.749 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.464 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -74.41 124.66 90.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.102 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.97 -27.21 84.44 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.154 1.903 . . . . 0.0 112.301 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -19.89 22.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.674 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.3 mt -84.85 7.77 19.72 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 153' ' ' HIS . 74.5 m -72.88 168.22 19.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -175.46 162.48 2.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.257 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 24.5 m -125.23 137.91 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.797 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 141' ' ' SER . 94.4 m-85 -98.4 106.3 18.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -108.69 126.61 53.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.857 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.72 115.9 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.251 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.3 m95 -111.97 151.16 29.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 0.0 111.377 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -127.02 117.13 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.828 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.518 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.1 OUTLIER -55.46 131.47 46.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.93 0.395 . . . . 0.0 111.613 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.479 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 1.8 ptmt 177.5 156.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.991 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 110' ' ' VAL . 85.2 m . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.83 148.93 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.511 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 2.6 m-30 -114.18 112.28 22.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.491 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.82 121.52 44.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 0.0 111.807 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.496 ' CZ2' HG11 ' A' ' 115' ' ' VAL . 5.0 p90 -166.85 172.73 10.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.448 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.88 134.37 50.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -119.98 155.81 32.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.952 0.406 . . . . 0.0 111.182 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.7 -172.83 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.687 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.13 63.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.06 -23.12 52.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.71 22.61 17.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.358 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.37 159.75 20.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.46 -37.38 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.22 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 165.93 174.31 35.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.547 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HG2' ' HA2' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -68.25 -179.76 1.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.67 -29.37 59.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.08 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.89 66.63 0.4 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.491 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.03 -30.12 6.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 111.109 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.64 120.26 9.42 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.868 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.57 -178.98 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.421 2.081 . . . . 0.0 112.153 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.7 121.96 44.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.71 43.33 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.24 142.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.598 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.78 -39.08 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.731 2.287 . . . . 0.0 112.965 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.09 -32.52 74.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.623 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.81 -23.64 29.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.647 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -14.75 30.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.768 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -63.92 -70.67 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 78.7 t80 -62.43 -34.77 77.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -81.49 9.35 7.56 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.514 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.19 -62.37 1.42 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.59 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.5 -40.4 50.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.43 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . 60.1 mm-40 -56.91 -20.16 21.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.944 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 39' ' ' MET . 68.7 p -119.44 -25.27 6.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 31' ' ' ARG . 1.5 m -107.98 161.75 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 111.87 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . 89.77 1.06 77.61 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.748 -0.739 . . . . 0.0 114.272 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 1.8 mtpm? -150.6 -164.82 2.11 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.396 1.098 . . . . 0.0 109.835 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.415 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.6 mt -78.62 86.75 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 34' ' ' THR . 9.4 ttp -99.99 120.31 39.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.934 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 80.3 t -77.57 156.76 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.974 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 33.6 m -162.49 141.22 2.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.43 153.45 52.92 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.506 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.493 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -51.33 -51.05 57.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.223 0.512 . . . . 0.0 110.815 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.493 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.9 tpt85 -57.88 -34.48 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.061 0.458 . . . . 0.0 110.19 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 49' ' ' PHE . 2.8 m -69.75 -55.9 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.398 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -46.63 -28.69 1.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -65.44 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.237 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -50.18 -35.4 26.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.654 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CE2' HG13 ' A' ' 41' ' ' VAL . 5.4 m-85 -40.93 157.95 0.18 Allowed Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -52.23 -71.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.611 2.207 . . . . 0.0 113.257 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -124.15 173.6 8.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.7 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.9 mtp180 -133.99 104.43 11.63 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.913 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 89.9 Cg_endo -85.19 -167.06 4.76 Favored 'Cis proline' 0 C--N 1.349 0.588 0 C-N-CA 123.912 -1.287 . . . . 0.0 112.144 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.569 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 95.4 mt -93.87 151.36 39.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.629 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.35 110.15 2.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.666 2.244 . . . . 0.0 112.972 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.18 4.27 5.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.002 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.569 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 5.7 mtt180 -112.59 101.07 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.038 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 24.0 m -66.05 107.81 2.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -103.38 156.1 17.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.243 0.544 . . . . 0.0 112.14 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.431 HG12 ' CG2' ' A' ' 76' ' ' VAL . 8.3 t -132.43 136.91 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.883 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.4 t -105.93 127.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.586 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -109.92 116.12 31.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.202 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 1.6 t -147.19 167.14 24.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.903 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -85.14 -12.01 53.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.611 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -72.93 134.83 44.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -85.2 -7.9 58.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.883 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -118.7 7.46 11.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.606 0.241 . . . . 0.0 111.522 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.9 t80 -58.14 139.57 54.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.193 0.52 . . . . 0.0 111.817 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.27 173.84 8.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.043 0.925 . . . . 0.0 111.99 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.27 142.97 19.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.495 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -77.93 97.99 5.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.745 0.307 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.41 2.99 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.234 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.89 171.72 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.443 HG22 ' CE1' ' A' ' 85' ' ' TYR . 12.4 t -97.46 139.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.476 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 68' ' ' TYR . 41.9 t -103.69 107.95 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.281 0.562 . . . . 0.0 112.193 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 28.7 m -118.23 167.79 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.973 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 63' ' ' THR . 13.1 m170 -120.38 -21.21 6.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -160.59 -173.32 3.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 106' ' ' PHE . 12.8 t -66.94 -10.18 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.765 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.0 -38.33 16.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 110.019 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.32 -30.73 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.871 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.429 HG23 HG21 ' A' ' 76' ' ' VAL . 21.5 t -71.01 -53.59 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.969 0.414 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.408 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.7 m-85 -54.09 -27.08 30.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.934 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.36 -44.99 85.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.443 ' CE1' HG22 ' A' ' 74' ' ' VAL . 85.0 t80 -64.95 -55.33 19.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.16 -22.61 17.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.875 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.4 mmpt? -70.09 -38.04 75.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.05 -6.2 59.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.622 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -126.48 67.4 65.52 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.998 0.427 . . . . 0.0 110.558 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.8 -0.23 4.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.162 2.575 . . . . 0.0 113.079 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.33 -30.3 22.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 111.039 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -112.27 156.83 21.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 111.529 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.66 174.96 6.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 1' ' ' THR . 7.8 tp -104.68 110.73 23.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 4' ' ' LEU . 80.8 t -119.52 102.46 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.694 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.427 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 11.1 mm -78.36 128.45 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 111.634 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -95.77 -47.64 6.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.0 -168.29 41.36 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.41 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.31 -160.82 34.64 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 117.824 0.812 . . . . 0.0 112.557 -0.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.14 -51.57 13.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -55.84 -33.09 64.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.536 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 39.3 mm -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.2 m-85 -60.51 -57.5 12.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.694 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.554 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 3.9 t -67.13 -9.98 45.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -74.76 -46.04 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' HA ' HG22 ' A' ' 79' ' ' VAL . 2.3 m-85 -94.53 -6.44 43.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 14.7 pttp -52.26 -30.2 26.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.912 0.386 . . . . 0.0 111.056 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.83 -7.21 58.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.269 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.43 -20.06 6.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.511 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 74.0 t -44.75 127.34 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.358 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.406 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 12.7 t70 -105.04 2.78 29.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 52.1 m -167.47 139.29 3.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 136' ' ' PHE . 11.6 mt -119.72 146.62 45.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.33 0.586 . . . . 0.0 112.164 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 4' ' ' LEU . 27.1 mt -135.6 112.39 10.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.198 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.496 HG11 ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -130.59 141.79 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 111.596 -179.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -117.43 102.8 9.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.665 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.4 ttp85 -80.42 102.77 9.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.736 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.93 123.46 28.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.26 82.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.372 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 150' ' ' ALA . . . -57.71 -163.25 0.05 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.609 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.3 p -143.41 137.83 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.057 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -128.81 162.04 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -111.87 143.08 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 15' ' ' LYS . . . -163.8 -166.67 23.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.597 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.46 -23.48 3.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -109.1 134.01 52.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.802 0.334 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 -174.0 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -164.8 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.623 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -118.31 166.27 14.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.224 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.2 Cg_endo -75.7 103.52 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.43 2.087 . . . . 0.0 112.221 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.83 145.93 26.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.6 74.6 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.236 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -57.5 -20.53 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.48 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.93 -30.87 64.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.76 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.04 -21.96 39.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 78.5 m-85 -103.44 176.6 5.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 111.326 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -138.93 141.9 38.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.441 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 3.0 ttpt -78.15 124.33 27.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 33.8 m -109.18 -18.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.511 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.3 m -168.05 140.28 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.867 0.365 . . . . 0.0 111.368 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 6.4 p -155.48 111.13 3.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -144.08 115.42 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.8 m -76.97 143.1 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.124 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 152' ' ' THR . 3.0 t -114.8 105.73 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.212 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -86.13 97.2 10.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.652 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -78.98 178.18 8.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.1 p -57.41 -52.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.699 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.476 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.32 125.68 91.3 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.806 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -28.83 87.77 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.085 1.857 . . . . 0.0 112.633 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HA ' ' CA ' ' A' ' 120' ' ' GLY . . . -90.02 -20.86 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.664 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.7 mt -83.24 7.19 17.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.597 0.237 . . . . 0.0 111.477 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 144' ' ' VAL . 62.6 m -72.43 167.0 21.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.5 p80 -175.37 162.14 2.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.641 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 19.4 m -125.79 139.11 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.588 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.9 105.17 17.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.37 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.481 ' HB2' HG21 ' A' ' 115' ' ' VAL . 2.2 mm-40 -103.56 121.55 43.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.284 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 13.7 t -115.13 114.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.709 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.432 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.6 m95 -112.35 150.63 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.462 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -127.5 117.62 22.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -54.91 132.8 47.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.299 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -114.67 -168.32 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.403 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.089 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.514 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 m . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.33 150.14 29.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.484 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 2.3 m-30 -117.95 115.83 25.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.89 124.49 51.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.469 0.652 . . . . 0.0 112.602 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.484 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 4.3 p90 -171.85 173.22 4.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.41 140.45 52.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.387 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -128.58 157.87 40.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.6 179.76 4.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.688 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.515 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.0 OUTLIER -50.94 -36.09 36.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.119 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -30.95 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.752 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.54 46.9 2.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.312 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' HG ' ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -107.34 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.559 ' N ' ' HG ' ' A' ' 12' ' ' LEU . 4.6 pt -110.68 -41.62 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.596 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.83 -155.65 27.06 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.281 -0.962 . . . . 0.0 113.03 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' CG ' ' HA2' ' A' ' 124' ' ' GLY . 7.6 mtpp -107.6 -166.67 1.17 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.72 0.295 . . . . 0.0 110.973 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.84 88.69 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.806 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.71 -76.33 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.666 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -164.85 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.042 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp 68.08 73.5 0.34 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 15.3 Cg_exo -68.03 -14.43 40.99 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.732 2.288 . . . . 0.0 112.174 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.424 ' CE3' ' HB2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -146.08 144.17 29.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.618 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 -47.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.083 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.459 HD23 HD22 ' A' ' 151' ' ' LEU . 1.2 mt -125.95 146.21 54.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.119 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.16 -46.41 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.642 2.228 . . . . 0.0 112.471 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.67 -28.43 69.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.951 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.415 ' HB2' ' HB2' ' A' ' 23' ' ' LEU . 3.8 t0 -68.82 -13.87 62.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.517 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.7 tp -93.53 -34.75 13.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 110.63 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -58.95 -26.51 64.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -62.29 -68.9 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.18 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' CD2' HG22 ' A' ' 34' ' ' THR . 1.7 p90 -91.19 31.25 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.689 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 35' ' ' VAL . 3.7 tmt_? -73.85 -53.98 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -95.75 -34.23 11.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.74 -8.61 55.27 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.479 HG22 ' CD2' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -117.7 -16.48 10.04 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.673 -179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.542 HG11 ' HD3' ' A' ' 57' ' ' ARG . 3.4 m -107.56 158.9 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.076 0.465 . . . . 0.0 111.978 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 73.09 15.78 78.57 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 115.904 1.122 . . . . 0.0 115.904 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -148.4 -170.13 3.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.068 1.934 . . . . 0.0 109.617 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 38' ' ' ILE . 80.8 mt -82.05 86.7 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.08 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.2 ttp -99.34 117.59 34.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.686 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.416 HG21 HG12 ' A' ' 82' ' ' VAL . 3.6 t -85.08 127.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.8 m -134.58 149.66 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.32 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.71 51.78 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.116 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -58.59 -52.56 65.16 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.854 0.327 . . . . 0.0 110.321 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.505 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 1.1 tpp180 -58.89 -37.27 76.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 m -69.96 -42.1 73.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.226 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -64.1 -41.65 97.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.18 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -57.8 -66.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.785 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' PHE . 88.6 p -61.23 -30.63 70.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -30.41 133.32 0.22 Allowed Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.775 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_exo -38.39 -35.08 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.129 2.553 . . . . 0.0 113.252 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.35 139.76 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -140.3 108.12 6.75 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.55 -170.51 8.46 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.519 -1.45 . . . . 0.0 112.195 -0.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.569 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 28.0 mt -99.21 155.95 35.98 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 104.63 1.45 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.576 2.184 . . . . 0.0 112.704 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 27.1 mt-10 69.8 6.89 5.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.569 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 1.8 mtt180 -109.3 113.0 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.885 0.374 . . . . 0.0 111.552 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.7 m -67.33 107.98 2.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.996 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -108.23 141.83 39.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.929 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.1 t -117.15 143.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.095 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 43' ' ' ARG . 94.2 t -110.87 124.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 0.0 111.589 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -103.58 121.08 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 7.0 t -158.58 162.52 37.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.816 0.341 . . . . 0.0 111.208 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -86.08 -3.65 58.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.335 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tp60 -77.96 131.56 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.857 0.36 . . . . 0.0 110.38 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.49 -30.27 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.275 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -98.99 10.85 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 5.9 t80 -61.84 141.98 57.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.22 0.533 . . . . 0.0 111.917 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.432 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 12.5 mm-40 -134.31 177.58 7.65 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.388 1.09 . . . . 0.0 112.899 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.54 144.69 19.62 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 112.996 -1.911 . . . . 0.0 110.641 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.03 96.92 2.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 0.0 110.46 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.53 -34.66 3.28 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.41 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.33 169.46 13.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 112.021 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 85' ' ' TYR . 21.2 t -97.93 140.4 18.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.572 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 43.3 t -106.08 109.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.401 0.62 . . . . 0.0 112.461 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 34.6 m -117.81 163.89 14.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.891 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -116.69 -24.46 7.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.727 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.93 -174.03 4.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.143 0.497 . . . . 0.0 111.495 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.431 HG21 ' CD1' ' A' ' 106' ' ' PHE . 45.5 t -70.25 -10.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.476 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.94 -31.43 18.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.023 0.44 . . . . 0.0 110.304 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.24 -28.79 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 76' ' ' VAL . 22.6 t -76.5 -52.9 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -54.55 -28.06 43.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.65 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -68.15 -39.63 82.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 88.9 t80 -66.12 -56.81 9.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.02 -22.23 14.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.923 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -67.72 -41.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -82.69 -4.88 58.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.564 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 98.1 m-70 -125.95 64.42 51.77 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 110.301 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.6 0.13 3.86 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.371 2.714 . . . . 0.0 113.011 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -30.13 21.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.725 0.298 . . . . 0.0 110.808 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.427 . . . . 0.0 111.592 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -98.45 169.41 9.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.273 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.34 115.82 30.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.306 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -123.86 106.35 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.433 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.1 mm -78.42 139.49 18.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.981 0.419 . . . . 0.0 111.265 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.463 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.2 -39.48 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.194 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.49 -168.04 41.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -81.73 -161.29 27.68 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 117.347 0.574 . . . . 0.0 112.549 -0.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.65 -42.13 74.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.978 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.72 -28.12 69.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.633 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.7 mm -80.39 -35.45 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.16 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.9 m-85 -51.76 -55.98 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.526 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.545 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.1 t -66.18 -9.66 33.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.02 -41.58 28.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.695 0.283 . . . . 0.0 111.226 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CD1' HG21 ' A' ' 79' ' ' VAL . 4.0 m-85 -95.33 -7.46 38.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.23 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.5 OUTLIER -50.85 -32.46 20.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.36 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -4.64 47.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.71 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.0 -20.6 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.514 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 90.7 t -44.74 140.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.154 0.502 . . . . 0.0 111.692 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -126.94 7.35 6.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.604 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.7 m -168.41 138.33 2.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.873 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 11.6 mt -122.8 142.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.313 0.577 . . . . 0.0 112.049 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.8 mt -130.52 114.35 15.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.2 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 156' ' ' GLU . 1.5 m -138.37 148.53 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.29 112.71 24.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 9.0 mmt180 -89.22 104.7 17.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 14.6 mt -85.96 114.6 22.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.03 -26.89 28.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.652 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 150' ' ' ALA . . . -92.22 -173.44 41.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.848 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.515 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 32.3 t -116.82 165.74 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 10.2 m-85 -152.03 168.26 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.04 170.3 16.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.433 ' HA2' ' CG ' ' A' ' 15' ' ' LYS . . . 148.97 153.99 6.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.819 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -120.07 5.11 10.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.628 0.251 . . . . 0.0 111.459 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.5 m -131.25 138.71 49.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -114.32 163.09 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.417 ' HG3' ' NE1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.93 -179.12 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.022 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 pt -101.27 159.72 28.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.21 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.59 105.14 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.794 2.329 . . . . 0.0 112.421 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mt -96.09 150.77 20.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.038 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.31 72.8 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.456 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 81.0 m95 -56.9 -23.09 42.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.32 -30.26 66.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 0.0 110.457 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.63 -19.42 45.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.99 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.477 ' CD1' HD12 ' A' ' 113' ' ' LEU . 52.0 m-85 -107.87 167.76 9.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.576 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -129.98 141.24 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -79.92 109.11 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 159' ' ' GLN . 27.2 m -90.54 -22.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.7 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.2 m -159.58 140.72 12.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -157.11 113.03 2.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.211 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -136.28 130.11 32.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 3.8 m -89.84 132.03 35.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.15 0.5 . . . . 0.0 112.194 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 t -105.15 113.0 41.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.626 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.473 ' HA ' ' CG2' ' A' ' 152' ' ' THR . 17.1 mt-10 -96.88 97.47 9.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.36 -176.04 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.267 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.4 p -63.49 -24.03 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.041 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.495 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -90.69 120.66 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.91 -18.79 59.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.529 2.153 . . . . 0.0 112.36 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.421 ' HA ' ' HA3' ' A' ' 120' ' ' GLY . . . -95.81 -25.87 15.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.816 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.2 mt -85.1 2.45 43.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.741 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 145' ' ' GLU . 16.6 m -83.47 82.46 8.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 111.083 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -98.04 -171.74 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 21.6 m -134.11 137.84 44.84 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 141' ' ' SER . 10.9 m-85 -86.06 106.76 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 115' ' ' VAL . 11.3 mt-10 -105.46 121.47 44.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 21.5 t -114.61 111.8 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.895 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 16.3 m95 -107.93 151.34 25.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.114 0.483 . . . . 0.0 112.022 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.417 ' HB2' ' CG1' ' A' ' 139' ' ' VAL . 3.3 mt-30 -132.39 131.61 41.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.364 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -49.44 123.74 8.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 111.465 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.429 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -110.1 -175.55 2.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.959 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.191 179.694 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.5 154.62 24.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.587 . . . . 0.0 112.557 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.458 ' CD1' HG23 ' A' ' 110' ' ' VAL . 1.3 m-85 -121.22 117.47 27.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.778 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 30' ' ' PHE . 9.5 tp -115.41 124.56 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.465 ' CH2' HG13 ' A' ' 115' ' ' VAL . 4.3 p90 -168.52 163.3 12.42 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.51 136.29 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -118.21 153.17 34.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -102.89 -178.17 3.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.235 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.479 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -48.82 -49.08 40.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.28 0.562 . . . . 0.0 109.843 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -69.79 -25.65 63.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.815 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.58 32.64 5.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.5 pp -100.93 166.04 11.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.49 -52.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.61 -141.38 3.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.804 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.63 -158.73 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.585 0.231 . . . . 0.0 110.789 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -160.8 36.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -162.93 -68.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.566 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -94.15 147.45 23.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.748 0.308 . . . . 0.0 111.013 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 88.74 4.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.709 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.3 -64.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.588 2.192 . . . . 0.0 112.447 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.95 137.51 33.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.037 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.47 138.23 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.982 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -86.93 124.18 69.27 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.051 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 23' ' ' LEU . 7.6 Cg_exo -72.28 -30.15 13.25 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.565 2.176 . . . . 0.0 112.472 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.63 -34.82 59.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.35 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 30' ' ' PHE . 6.7 m-20 -78.94 -43.02 25.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.085 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.546 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 4.9 tp -55.54 -14.53 2.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.179 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -84.6 -57.35 3.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.497 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 44.9 t80 -78.04 -35.98 49.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.737 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.476 ' HA ' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -62.9 -14.47 46.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -92.74 -60.37 1.83 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.665 ' H ' ' HG3' ' A' ' 31' ' ' ARG . . . -54.72 -20.57 8.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.497 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . 9.8 mm-40 -92.8 -5.79 50.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.0 p -141.49 -35.49 0.46 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.484 ' HB ' ' HD3' ' A' ' 57' ' ' ARG . 4.8 m -70.28 143.73 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.772 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.51 -7.48 26.35 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.367 -0.92 . . . . 0.0 114.016 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -154.69 -164.03 1.72 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.602 1.201 . . . . 0.0 109.788 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.506 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 54.0 mt -72.28 89.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.15 126.95 51.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 21.4 t -79.77 158.73 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.108 0.48 . . . . 0.0 112.189 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 31.1 m -160.24 150.86 5.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.852 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.7 155.87 43.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.907 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.42 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -54.87 -49.09 72.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.922 0.361 . . . . 0.0 110.776 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.42 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 15.2 tpt85 -62.88 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -69.88 -43.27 72.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.664 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -63.9 -29.26 70.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.023 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -66.15 -66.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.901 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 17.0 t -53.27 -30.73 40.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -31.13 123.37 0.34 Allowed Pre-proline 0 N--CA 1.468 0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.606 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.61 -27.46 5.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.789 2.326 . . . . 0.0 113.251 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -171.31 117.57 0.44 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.298 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -122.05 141.2 33.72 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.96 -174.41 12.2 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.261 -1.558 . . . . 0.0 111.702 -0.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.499 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 17.0 mt -95.1 154.91 39.48 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 54' ' ' LEU . 19.1 Cg_endo -57.52 -83.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.702 2.268 . . . . 0.0 113.137 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -96.42 33.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 4.0 mtt180 -132.09 100.96 5.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.326 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.506 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 51.6 m -68.23 121.85 17.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.785 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -105.83 151.09 24.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.252 0.548 . . . . 0.0 112.191 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.0 140.93 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.174 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.1 t -111.31 118.33 57.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 111.604 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.439 HD13 ' N ' ' A' ' 78' ' ' ASP . 3.4 tp -104.21 112.16 25.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 t -149.99 162.24 40.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -76.9 -6.39 52.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.594 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.759 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.6 tp60 -74.01 125.29 27.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.706 0.288 . . . . 0.0 110.441 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.1 -8.13 59.7 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.52 11.8 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.759 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.3 t80 -58.37 148.26 28.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.119 0.485 . . . . 0.0 111.45 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 25.9 mm100 -132.32 174.46 10.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.437 1.113 . . . . 0.0 112.728 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 141.96 16.78 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.375 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -82.15 96.65 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 110.147 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.33 -45.77 1.36 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.544 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.72 163.36 28.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.986 0.422 . . . . 0.0 111.759 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 85' ' ' TYR . 11.3 t -96.17 140.62 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 18.7 t -102.55 119.23 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.699 . . . . 0.0 112.26 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG21 HG22 ' A' ' 82' ' ' VAL . 30.0 m -128.32 167.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.729 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -115.43 -23.59 8.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.713 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' N ' HD13 ' A' ' 62' ' ' LEU . 1.4 t70 -153.02 179.84 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.134 0.493 . . . . 0.0 111.581 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 11.6 t -65.53 -10.15 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.751 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.5 -33.0 19.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.59 -27.23 58.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.807 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG22 HG21 ' A' ' 76' ' ' VAL . 16.5 t -74.01 -55.22 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.649 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 13.0 m-85 -55.57 -28.23 53.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.801 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.37 90.81 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.46 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 73.8 t80 -63.4 -54.05 42.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.394 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -23.81 44.18 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.328 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -71.75 -33.41 68.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.417 ' HG2' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -89.02 -9.36 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.246 179.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 94.5 m-70 -125.0 66.23 49.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.61 0.24 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.393 2.729 . . . . 0.0 113.014 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -37.17 27.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -107.75 161.79 14.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.34 174.67 6.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.253 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.2 tp -116.1 114.84 25.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.504 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 33' ' ' GLN . 23.1 t -127.58 112.65 28.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.817 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 ' CG2' ' A' ' 40' ' ' VAL . 3.4 mm -81.4 131.38 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.844 0.354 . . . . 0.0 111.416 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.78 -41.88 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.876 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.57 -168.49 41.56 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.806 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.76 -160.74 33.93 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 122.027 -0.69 . . . . 0.0 112.588 -0.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -50.52 -58.35 5.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.81 -28.13 5.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.67 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 37.2 mm -81.23 -28.66 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.386 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.438 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.3 m-85 -59.39 -58.67 7.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.007 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.502 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 13.6 t -66.79 -9.9 41.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.25 -41.62 57.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.459 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 2.2 m-85 -98.21 -3.97 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.644 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 38.7 pttt -51.61 -33.99 35.53 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.88 0.372 . . . . 0.0 111.114 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.17 -3.85 47.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.586 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.34 -21.93 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 3' ' ' PHE . 94.7 t -45.87 134.88 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.036 0.446 . . . . 0.0 111.505 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -116.66 6.01 13.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.598 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 46.2 m -168.03 141.66 3.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.311 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 13.8 mt -123.54 146.0 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.22 0.533 . . . . 0.0 111.814 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.2 mt -135.57 117.44 15.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.884 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.465 HG13 ' CH2' ' A' ' 5' ' ' TRP . 1.4 m -135.13 144.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.408 . . . . 0.0 111.49 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -112.92 113.19 25.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.802 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.37 100.7 12.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.464 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 2.2 mp -91.54 131.61 36.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.416 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.48 -52.63 64.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.047 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.24 -172.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.564 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -123.27 164.03 19.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 111.038 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.29 165.15 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 166.57 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.54 153.12 6.5 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.762 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.98 6.1 12.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.653 0.264 . . . . 0.0 111.107 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.8 m -133.94 145.23 49.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.368 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.2 pttp -122.21 173.77 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.5 tpt -69.32 153.15 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.438 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.7 pp -78.9 163.36 60.84 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.56 101.42 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.336 . . . . 0.0 112.653 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.41 149.03 21.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.636 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.49 77.31 3.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.455 ' CZ3' HD12 ' A' ' 113' ' ' LEU . 86.4 m95 -61.16 -17.83 54.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.352 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.26 -34.45 63.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 110.464 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.11 -17.79 56.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.474 ' CD1' HD11 ' A' ' 113' ' ' LEU . 59.8 m-85 -105.39 169.23 8.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 110.826 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.704 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -129.31 141.33 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 0.7 OUTLIER -82.88 119.06 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.312 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 10.0 m -101.45 -21.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.896 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.2 m -160.74 143.36 12.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.264 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.87 111.7 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.2 ttp-105 -146.66 120.41 9.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.416 . . . . 0.0 111.398 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.3 m -74.57 145.97 42.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.214 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 152' ' ' THR . 14.4 t -116.45 102.57 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.426 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -85.31 99.66 11.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.63 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.47 -176.51 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.507 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.0 p -54.36 -56.53 17.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 34.2 t-20 -74.54 124.16 89.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.796 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.8 -27.52 84.13 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.262 1.975 . . . . 0.0 112.887 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.16 -19.44 26.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.5 mt -84.32 8.0 17.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.639 0.257 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 144' ' ' VAL . 97.0 m -73.33 165.17 25.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p-80 -172.73 159.33 4.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.223 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 19.1 m -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.548 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -118.69 105.76 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.661 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' HB2' HG21 ' A' ' 115' ' ' VAL . 12.8 mt-10 -106.63 124.88 50.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.856 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 10.5 t -116.3 112.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 22.0 m95 -106.75 149.83 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.435 . . . . 0.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -132.29 129.7 39.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -46.52 123.55 5.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.523 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.704 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -105.42 178.49 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.066 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 4.7 m . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.43 154.47 22.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -122.76 116.35 23.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.505 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 30' ' ' PHE . 4.8 tp -114.95 122.5 46.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.509 ' CZ2' HG12 ' A' ' 115' ' ' VAL . 3.0 p90 -167.22 168.33 13.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.615 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.85 141.26 49.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 111.29 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.39 153.77 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.89 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.77 -177.06 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -36.2 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.15 -21.32 29.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.46 25.04 29.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -101.58 148.87 24.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.318 . . . . 0.0 111.003 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 126' ' ' THR . 1.1 pt -112.29 173.32 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.28 153.66 51.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.768 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -79.36 109.89 14.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.795 0.331 . . . . 0.0 110.874 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.25 101.53 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.002 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.01 -83.09 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.502 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -120.04 133.68 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.72 0.295 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -142.33 140.58 19.29 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.61 -65.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.407 2.071 . . . . 0.0 112.239 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -160.99 -171.53 3.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.684 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.419 ' CD2' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -131.65 170.6 14.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.84 145.27 34.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.95 -41.35 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.601 2.201 . . . . 0.0 112.486 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -78.24 -22.38 48.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.01 -20.5 24.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.399 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD13 ' CD2' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -71.15 -28.34 64.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.762 0.315 . . . . 0.0 111.29 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -66.36 -23.86 66.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.483 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.423 ' CD1' ' CD1' ' A' ' 155' ' ' TYR . 34.0 t80 -73.28 -45.36 56.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.406 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . 14.4 m-85 -86.03 4.33 38.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.796 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 4.5 ttt-85 -92.24 -62.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 0.0 111.775 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.57 -15.98 63.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -93.27 -9.4 39.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.7 p -144.79 22.22 1.61 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 31' ' ' ARG . 23.3 m -108.51 148.35 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.028 0.442 . . . . 0.0 111.968 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 54.33 34.22 53.83 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 116.868 1.507 . . . . 0.0 116.868 176.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -151.17 -165.17 2.19 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.692 2.246 . . . . 0.0 108.631 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.63 87.72 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.644 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.1 ttp -99.0 124.21 43.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.603 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 20.9 t -77.54 157.39 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.989 0.423 . . . . 0.0 111.838 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 32.6 m -161.18 147.8 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.956 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.39 155.55 53.06 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.062 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.55 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.31 -52.19 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.972 0.386 . . . . 0.0 110.126 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -57.77 -30.68 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.46 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.5 m -71.29 -49.26 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.798 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -55.03 -35.7 64.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.487 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -66.83 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.938 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 49' ' ' PHE . 99.7 p -52.8 -37.19 59.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.815 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CE1' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.49 127.35 0.25 Allowed Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.908 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.5 -27.68 19.57 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.071 2.514 . . . . 0.0 113.814 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 2.7 ttmm -151.75 147.95 27.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.966 0.412 . . . . 0.0 111.525 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.09 109.69 10.67 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.612 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 4.0 Cg_exo -86.53 168.04 46.0 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.792 -1.337 . . . . 0.0 112.048 -0.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 7.7 mt -59.45 164.86 4.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.645 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 10.9 Cg_endo -54.23 91.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 113.05 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 14.9 mm-40 64.82 23.36 12.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.262 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 23.1 mtt180 -109.57 132.19 54.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.917 0.389 . . . . 0.0 111.444 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.8 m -84.05 108.14 16.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.772 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.51 158.17 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 112.089 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 HG12 ' CG2' ' A' ' 76' ' ' VAL . 10.7 t -130.8 143.33 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.042 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 43' ' ' ARG . 99.5 t -108.84 122.08 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -104.25 122.94 46.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.272 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.453 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -156.29 165.71 35.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.217 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -84.36 -9.0 58.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.3 tt0 -76.0 133.55 40.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -88.1 6.81 34.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.938 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.98 3.15 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.4 t80 -57.27 139.19 53.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.456 . . . . 0.0 111.299 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' O ' ' CE1' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -126.67 176.37 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.92 0.866 . . . . 0.0 112.253 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.65 146.19 23.16 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.118 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -94.34 96.23 9.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.508 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.59 13.38 53.82 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.057 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.55 172.87 12.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.925 0.393 . . . . 0.0 111.627 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.429 HG23 ' CZ ' ' A' ' 85' ' ' TYR . 14.0 t -100.24 140.17 19.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.41 116.0 49.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.09 0.472 . . . . 0.0 111.992 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 27.4 m -124.83 162.2 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.656 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' THR . 3.5 m170 -111.19 -23.19 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.365 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.71 -171.39 3.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.222 0.534 . . . . 0.0 111.64 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 106' ' ' PHE . 6.0 t -69.87 -9.22 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.07 16.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.149 0.499 . . . . 0.0 109.948 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.43 -28.14 56.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.694 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.74 -51.08 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.3 m-85 -57.23 -25.51 59.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.667 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.93 -42.28 81.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.176 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.429 ' CZ ' HG23 ' A' ' 74' ' ' VAL . 68.2 t80 -65.06 -56.07 15.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.72 -22.55 36.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.954 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.9 -31.88 68.66 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 15.3 mt-30 -87.1 -7.42 58.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.443 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.19 67.92 56.2 Favored Pre-proline 0 N--CA 1.456 -0.132 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.65 -0.32 2.99 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.133 2.555 . . . . 0.0 112.928 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.94 -24.54 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.304 . . . . 0.0 111.17 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.75 155.17 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.14 167.59 10.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.994 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 tp -120.04 113.02 19.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.081 0.467 . . . . 0.0 111.499 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.49 109.72 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.188 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.479 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 3.7 mm -77.59 130.68 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -105.5 -42.89 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.492 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.7 -169.02 41.34 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.896 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.403 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -87.06 -160.92 35.75 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 122.118 -0.637 . . . . 0.0 112.7 -0.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.76 -53.5 39.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 111.404 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -27.62 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.1 mm -81.42 -22.7 10.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.1 m-85 -64.65 -55.24 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.726 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 10.6 t -66.54 -9.75 38.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.73 41.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.624 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 3.6 m-85 -95.66 -5.37 42.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.57 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 2.0 pttt -51.52 -33.57 32.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.79 0.328 . . . . 0.0 111.336 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -84.73 -0.29 53.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.739 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -124.42 -24.58 4.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' A' ' 3' ' ' PHE . 58.5 t -48.21 122.14 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.634 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.95 3.47 44.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 93.9 m -165.43 142.21 5.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.284 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 136' ' ' PHE . 8.1 mt -125.76 146.09 49.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.902 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.4 mt -134.75 119.31 18.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.697 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.509 HG12 ' CZ2' ' A' ' 5' ' ' TRP . 2.1 m -135.29 145.26 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.423 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -112.2 106.47 15.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.309 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -93.1 104.58 16.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.835 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.2 mp -91.48 128.13 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.52 -49.09 37.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.217 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.46 172.6 3.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.298 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.2 t -112.71 147.96 35.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.5 m-85 -122.02 153.0 39.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -111.13 141.0 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -169.62 -167.77 30.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.55 -16.68 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.606 0.241 . . . . 0.0 111.537 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 13' ' ' ILE . 40.7 m -109.14 131.96 54.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.697 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.57 173.44 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.755 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.429 ' HE2' ' CE2' ' A' ' 5' ' ' TRP . 17.1 tpt -78.35 147.14 34.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.632 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -64.08 166.96 8.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.632 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.1 Cg_endo -77.13 98.04 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.265 1.977 . . . . 0.0 112.674 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.71 145.08 25.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 78.58 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.448 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 91.1 m95 -60.16 -20.11 56.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.51 -32.88 66.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -24.13 51.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.013 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.47 ' CD1' HD12 ' A' ' 113' ' ' LEU . 77.3 m-85 -97.49 173.6 7.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.867 0.365 . . . . 0.0 110.76 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.13 143.36 44.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.504 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.8 ttpm? -84.0 108.64 17.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.816 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -91.37 -26.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.318 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.0 m -154.86 140.7 18.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 35.4 p -164.6 111.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.07 122.57 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.68 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 4.0 m -78.43 144.28 35.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.18 0.514 . . . . 0.0 111.54 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.423 ' O ' HG21 ' A' ' 152' ' ' THR . 3.3 t -116.27 105.12 17.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -86.12 98.97 11.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.847 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -81.33 -175.3 5.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.0 p -57.72 -57.66 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.453 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -68.56 120.17 73.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.91 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.5 -25.96 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.964 1.776 . . . . 0.0 112.324 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.47 -18.4 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.431 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.1 mt -87.15 8.86 21.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.599 0.237 . . . . 0.0 111.359 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 144' ' ' VAL . 79.7 m -71.48 169.29 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 11.0 p80 -174.34 160.79 3.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 10.4 m -127.69 133.95 49.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.627 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.423 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 67.9 m-85 -94.33 106.45 18.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.483 ' HB2' HG21 ' A' ' 115' ' ' VAL . 13.9 mt-10 -103.3 121.75 43.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.415 . . . . 0.0 111.971 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.43 111.26 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.094 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.504 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.5 m95 -107.61 148.34 29.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.979 0.418 . . . . 0.0 111.721 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -126.92 117.28 22.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.448 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.8 tmtt? -49.77 132.45 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -99.96 171.91 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.626 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.02 148.87 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.527 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -111.81 114.45 27.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.244 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.27 121.26 43.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 3.1 p90 -167.58 176.21 6.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.499 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.6 150.33 46.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 111.823 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.98 147.6 37.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.617 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -103.69 -167.91 1.43 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -48.59 66.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.842 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.68 -26.49 60.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.65 20.89 12.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.636 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.58 149.37 40.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.766 0.317 . . . . 0.0 110.645 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.16 -17.55 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.499 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.77 -157.51 29.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.424 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HG2' ' HA2' ' A' ' 124' ' ' GLY . 0.2 OUTLIER -129.6 109.35 10.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.397 . . . . 0.0 111.026 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -99.78 154.31 18.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.82 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.25 -15.1 8.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.768 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -142.35 -72.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.683 0.278 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.85 128.16 1.47 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.978 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.25 112.91 2.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.619 2.212 . . . . 0.0 112.459 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -91.09 165.48 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.768 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -89.64 145.04 25.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.274 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.31 121.0 47.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.498 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.28 -24.8 16.35 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.413 2.075 . . . . 0.0 112.746 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -95.18 -23.13 17.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.46 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -49.23 13.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.824 0.345 . . . . 0.0 111.322 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -52.26 -33.11 40.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.352 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -40.84 -32.58 0.23 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.082 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -105.7 -36.85 6.93 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.414 ' O ' ' CG2' ' A' ' 34' ' ' THR . 2.5 m-85 -91.99 30.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.647 ' HG3' ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -92.5 -45.11 8.29 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.174 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.647 ' N ' ' HG3' ' A' ' 31' ' ' ARG . . . -98.08 -40.05 8.61 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -68.93 -7.63 36.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.414 ' CG2' ' O ' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -120.95 -5.22 9.58 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.909 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.451 HG13 ' HD2' ' A' ' 57' ' ' ARG . 20.6 m -108.0 155.51 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.059 0.457 . . . . 0.0 112.092 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.99 28.64 58.39 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 116.346 1.299 . . . . 0.0 116.346 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -147.65 -178.41 6.24 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.11 1.955 . . . . 0.0 108.28 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 93' ' ' GLU . 79.0 mt -80.19 87.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.54 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.8 ttp -100.73 122.45 43.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.412 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 3.1 t -91.12 129.18 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.423 HG13 ' CZ ' ' A' ' 49' ' ' PHE . 33.7 m -129.92 147.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.115 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.79 151.76 52.44 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.932 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -48.07 -55.91 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.906 0.384 . . . . 0.0 110.385 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.35 68.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.57 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -73.68 -31.37 63.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.44 ' CD2' HG23 ' A' ' 61' ' ' VAL . 51.8 t80 -75.82 -33.04 60.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.815 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.21 -67.23 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.575 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -58.73 -30.04 67.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.738 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CZ ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -34.31 149.44 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.905 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.55 -32.73 5.93 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.187 2.591 . . . . 0.0 113.932 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.38 152.9 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 9.1 mtp180 -124.72 101.72 32.93 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.2 Cg_endo -86.25 -168.11 5.08 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.965 -1.265 . . . . 0.0 112.213 0.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.626 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 88.0 mt -95.76 159.8 31.65 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 18.9 Cg_endo -60.26 95.85 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.728 2.285 . . . . 0.0 113.638 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 10.6 mt-10 66.35 18.49 10.89 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.441 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.626 ' HG3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -109.77 107.57 17.61 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.946 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 m -62.13 106.67 0.76 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.982 0.42 . . . . 0.0 110.164 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -105.54 156.88 17.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.201 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG12 ' CG2' ' A' ' 76' ' ' VAL . 5.2 t -130.2 144.08 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.84 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' CD2' ' A' ' 46' ' ' TYR . 89.6 t -116.09 106.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -89.0 118.14 28.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.015 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -148.95 169.84 19.67 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.926 0.393 . . . . 0.0 111.352 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -88.24 -9.25 53.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.5 tp60 -78.1 128.76 34.31 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.438 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 7.5 mt-10 -79.76 -16.15 56.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.787 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.29 9.12 25.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.5 t80 -58.77 140.37 55.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.007 0.432 . . . . 0.0 111.612 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -124.96 178.34 5.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.107 0.956 . . . . 0.0 112.004 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.97 145.33 20.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.784 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.45 95.88 4.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.368 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.93 -39.35 2.96 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.051 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.29 172.33 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.688 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 9.4 t -97.38 140.21 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.98 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.55 118.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.391 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 30.5 m -127.72 165.09 27.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.845 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 5.1 m170 -116.18 -23.19 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 110.813 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.19 -167.57 2.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 111.305 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 106' ' ' PHE . 4.0 t -74.42 -8.83 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.7 -32.9 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.092 0.472 . . . . 0.0 109.922 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.89 -27.54 57.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.496 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 76' ' ' VAL . 68.7 t -73.09 -54.05 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.462 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.9 m-85 -55.98 -24.82 40.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.941 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.74 86.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.831 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -66.69 -57.26 7.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.15 11.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.028 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.91 -38.06 76.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -83.89 -4.78 58.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.563 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -127.26 66.42 68.37 Favored Pre-proline 0 N--CA 1.455 -0.182 0 CA-C-O 121.015 0.436 . . . . 0.0 110.248 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.61 -0.01 5.41 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.231 2.621 . . . . 0.0 113.058 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -27.88 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.707 0.289 . . . . 0.0 111.087 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -105.08 159.23 16.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.658 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 42.1 mt-10 -98.09 159.23 15.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.135 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.1 tp -108.54 116.39 31.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.525 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 39' ' ' MET . 38.5 t -130.43 114.61 29.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.36 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.0 mm -82.51 131.1 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.632 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.86 -45.34 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.636 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.407 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.3 -166.3 39.05 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.406 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.407 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -92.74 -160.7 35.9 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 117.821 0.81 . . . . 0.0 112.741 -0.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.98 -48.56 16.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.466 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -60.19 -30.94 69.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.67 -26.61 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.501 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.2 m-85 -60.39 -56.38 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.465 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 14.9 t -65.93 -10.1 35.79 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.54 -43.28 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 110' ' ' VAL . 5.1 m-85 -95.4 -3.61 46.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.555 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 16.5 pttp -48.91 -33.07 10.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.783 0.325 . . . . 0.0 111.397 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.05 3.85 50.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.53 -27.9 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 0.0 111.517 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 3' ' ' PHE . 92.7 t -52.04 123.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.196 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.65 8.01 43.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.426 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 76.3 m -167.56 142.97 3.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.815 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 16.2 mt -123.49 145.35 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.321 0.581 . . . . 0.0 111.723 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 mt -135.64 120.0 17.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.46 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.495 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.9 m -136.35 145.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.043 0.449 . . . . 0.0 111.864 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -111.81 108.5 17.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.038 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.9 ttm180 -80.57 99.24 8.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.98 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.59 125.93 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.21 74.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.71 163.75 6.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.497 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 59.5 p -105.87 159.47 15.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.802 0.334 . . . . 0.0 111.034 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -147.4 145.43 29.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.779 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -100.72 147.11 26.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.764 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 15' ' ' LYS . . . -179.43 174.19 46.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.733 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.9 42.83 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.204 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 m -162.38 124.81 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -112.67 172.74 6.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.964 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.414 ' HE2' ' CE2' ' A' ' 5' ' ' TRP . 17.1 tpt -72.62 157.59 37.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -79.2 163.76 58.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.289 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.58 93.76 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.749 2.3 . . . . 0.0 111.961 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -83.49 142.67 30.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.809 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.87 70.48 8.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.42 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 96.3 m95 -56.57 -21.75 28.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -73.31 -33.27 65.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.509 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 -10.49 58.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.102 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.462 ' CG ' HD11 ' A' ' 113' ' ' LEU . 45.1 m-85 -108.73 169.43 8.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.403 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -132.44 141.2 48.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.585 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 3.3 ttpp -85.11 128.99 34.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 5.7 m -115.92 -17.86 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.1 m -164.51 143.32 7.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.493 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.72 111.76 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.161 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -139.73 118.34 12.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.4 m -81.48 145.06 30.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.392 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 152' ' ' THR . 5.4 t -121.12 103.36 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.34 102.22 12.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.33 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.44 -176.46 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.3 p -53.86 -55.84 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.481 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.46 121.77 85.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.946 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.06 -27.02 83.86 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.134 1.889 . . . . 0.0 112.413 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.65 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.669 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.6 mt -86.96 9.26 20.0 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.592 0.234 . . . . 0.0 111.551 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 144' ' ' VAL . 95.9 m -70.72 165.92 21.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 11.8 p-80 -170.61 156.51 5.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.133 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 16.3 m -120.05 153.58 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.589 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.405 ' N ' HG21 ' A' ' 154' ' ' THR . 96.1 m-85 -116.3 105.04 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.414 ' HB2' HG21 ' A' ' 115' ' ' VAL . 2.8 mt-10 -101.26 153.96 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 26.7 t -142.31 107.09 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 28.8 m95 -107.54 145.5 33.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.977 0.417 . . . . 0.0 111.897 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -125.83 114.75 18.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.504 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.429 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 1.9 ttmt -46.44 134.0 9.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.08 0.467 . . . . 0.0 112.06 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.403 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -124.19 -166.08 1.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.399 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.076 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.79 154.41 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.29 0.567 . . . . 0.0 112.446 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.504 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -119.07 112.59 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.603 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.434 ' CD2' HG21 ' A' ' 34' ' ' THR . 8.4 tp -113.52 121.78 45.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.532 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 2.8 p90 -167.31 164.5 15.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.927 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.76 135.34 54.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.699 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.06 155.48 44.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -96.62 -172.49 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -38.56 59.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.023 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -32.65 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.84 37.01 2.64 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mt -98.35 151.32 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.739 0.304 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.35 -31.77 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.285 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.88 -171.84 44.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -99.18 -92.4 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.469 0.176 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.03 -53.56 2.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.814 0.34 . . . . 0.0 111.032 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -169.59 43.3 0.21 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.481 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -124.57 126.3 45.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.856 0.36 . . . . 0.0 110.868 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -157.71 94.73 2.07 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -80.69 -160.43 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.079 2.519 . . . . 0.0 112.133 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.47 125.18 39.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.266 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -96.32 -70.06 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.359 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.13 165.4 30.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.137 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.9 5.06 6.56 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.602 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -95.22 -18.4 20.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.75 -16.07 60.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.412 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -14.68 59.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.627 0.251 . . . . 0.0 111.262 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.43 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 2.0 t-160 -90.37 -32.59 16.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' A' ' 155' ' ' TYR . 18.0 t80 -106.26 -45.81 4.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.425 ' HA ' HD22 ' A' ' 4' ' ' LEU . 1.8 t80 -73.97 -33.54 63.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' HB3' HG22 ' A' ' 35' ' ' VAL . 18.6 mtt85 -92.03 -61.74 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 28' ' ' HIS . . . -45.98 -27.77 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -86.83 -8.68 57.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 39' ' ' MET . 1.4 p -132.75 -35.64 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' HB ' ' HG2' ' A' ' 57' ' ' ARG . 7.6 m -79.96 155.07 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.836 0.351 . . . . 0.0 111.53 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.97 13.73 67.02 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.766 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -151.57 -165.88 2.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.191 1.496 . . . . 0.0 109.23 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.66 87.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 34' ' ' THR . 2.2 ttp -102.04 125.76 48.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 112.155 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 20.8 t -82.19 158.81 3.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.646 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.5 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 34.5 m -165.1 141.06 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.455 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.01 154.13 53.03 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.477 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -53.16 -51.92 60.47 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.336 0.568 . . . . 0.0 110.687 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.9 tpt180 -57.64 -32.78 67.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.013 0.435 . . . . 0.0 110.112 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -70.74 -46.79 62.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.986 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.5 t80 -55.16 -40.7 70.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.112 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -66.15 0.55 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.941 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -52.26 -40.03 61.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.552 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -33.52 127.95 0.41 Allowed Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.674 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -43.88 -26.52 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.144 2.562 . . . . 0.0 113.771 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -151.59 138.02 18.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.59 107.95 6.03 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.48 166.51 81.57 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.593 -1.42 . . . . 0.0 112.244 -0.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 75.8 mt -76.23 158.95 81.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.47 112.04 3.46 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.492 2.128 . . . . 0.0 112.802 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 69.15 8.48 6.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.022 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.5 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -114.06 110.71 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.427 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.0 m -68.73 107.19 2.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -101.11 154.58 18.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.983 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 8.8 t -125.72 141.37 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.633 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.415 HG11 ' CE1' ' A' ' 68' ' ' TYR . 98.8 t -110.72 124.67 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 111.72 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' A' ' 76' ' ' VAL . 2.1 mt -105.33 118.69 37.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.102 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 1.3 t -155.51 158.67 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.284 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -75.15 -4.32 38.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.62 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -85.83 126.03 33.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.398 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 6.2 mt-10 -78.31 -29.57 47.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.547 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -92.31 6.51 46.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.418 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.467 ' CD2' ' CG2' ' A' ' 63' ' ' THR . 3.1 t80 -59.81 139.31 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -137.16 169.89 17.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.758 1.266 . . . . 0.0 113.752 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.75 134.09 11.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.267 -2.242 . . . . 0.0 109.566 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -78.97 106.51 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.108 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 -56.51 0.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.1 169.31 15.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 12.8 t -94.11 140.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.335 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 17.2 t -112.01 123.16 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 111.419 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.711 HG21 HG22 ' A' ' 82' ' ' VAL . 27.1 m -130.32 175.88 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 m80 -123.16 -25.32 4.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.012 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.47 -171.33 3.9 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.467 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 18.7 t -71.38 -10.81 14.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.732 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.86 -32.72 18.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 110.15 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.09 -27.62 59.96 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.903 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HG21 ' A' ' 76' ' ' VAL . 57.4 t -74.5 -52.48 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 9.6 m-85 -54.74 -27.93 44.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.933 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.445 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -64.13 -45.82 86.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.14 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 74' ' ' VAL . 56.1 t80 -62.64 -54.42 39.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.05 -23.28 7.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.336 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 83' ' ' PHE . 12.3 mttt -68.61 -44.11 74.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.54 -2.32 41.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.7 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -129.01 61.63 57.92 Favored Pre-proline 0 N--CA 1.456 -0.136 0 CA-C-O 120.951 0.405 . . . . 0.0 110.491 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.01 -0.75 8.97 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.011 2.474 . . . . 0.0 112.954 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.22 -38.69 26.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.92 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -107.73 168.83 8.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.23 164.67 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.321 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.78 122.91 49.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.796 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.47 118.82 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.27 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.463 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 8.0 mm -83.52 130.73 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.907 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -98.38 -48.73 4.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.82 -168.01 39.21 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.572 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -93.84 -160.86 35.1 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 117.717 0.758 . . . . 0.0 112.622 -0.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.48 -56.38 7.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.838 0.351 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -52.53 -29.81 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.5 mm -83.43 -28.52 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.982 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -59.62 -55.44 34.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.507 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 12.4 t -67.76 -10.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.961 -0.462 . . . . 0.0 112.065 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.51 -39.07 58.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.949 0.404 . . . . 0.0 110.707 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.467 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 3.3 m-85 -100.0 -5.34 28.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 11.9 pttt -51.23 -31.33 20.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 111.617 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.64 2.77 52.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -126.83 -24.86 3.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.587 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.504 HG21 ' CD1' ' A' ' 3' ' ' PHE . 77.8 t -49.07 125.75 3.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.937 0.399 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -102.96 4.38 37.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.92 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.696 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 92.1 m -166.76 139.59 3.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.518 HD12 ' CG ' ' A' ' 136' ' ' PHE . 16.2 mt -118.25 144.98 45.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.213 0.53 . . . . 0.0 111.933 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -135.34 113.82 11.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.598 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.532 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -133.98 143.88 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.782 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.32 107.49 15.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -92.21 103.9 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.3 mp -86.33 129.07 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.74 75.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.161 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.43 177.65 2.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 p -111.85 156.87 21.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 0.0 110.966 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -148.9 154.25 39.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.77 134.41 35.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 138.21 6.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.457 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.26 6.88 19.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.622 0.249 . . . . 0.0 111.339 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.4 m -128.0 124.18 36.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -94.88 136.46 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.42 ' HE1' ' CZ2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -61.26 174.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.557 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.0 OUTLIER -89.84 163.26 33.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.159 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 65.2 Cg_endo -74.85 101.04 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.41 2.073 . . . . 0.0 112.198 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.72 147.22 25.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.57 84.21 2.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -64.86 -16.35 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.083 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.85 -32.65 63.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.905 0.384 . . . . 0.0 110.73 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -79.56 -28.01 41.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.927 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.518 ' CG ' HD12 ' A' ' 113' ' ' LEU . 72.3 m-85 -97.6 169.71 9.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.666 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -134.66 143.74 47.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.501 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.3 ttpm? -81.13 119.97 24.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.6 m -103.12 -21.36 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.235 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.0 m -162.56 140.33 8.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.461 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 18.2 p -165.19 113.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -147.96 130.95 16.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.002 0.429 . . . . 0.0 111.236 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 5.1 m -84.8 146.12 27.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.073 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 152' ' ' THR . 5.0 t -117.16 102.69 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.899 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.04 97.82 7.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.096 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.96 -178.19 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.299 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -60.97 2.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 110.574 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.47 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.37 117.06 40.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.666 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.75 -26.73 58.12 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.979 1.786 . . . . 0.0 112.402 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.53 -17.16 26.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 12.7 mt -88.34 11.25 17.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.622 0.248 . . . . 0.0 111.387 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.479 HG21 ' O ' ' A' ' 144' ' ' VAL . 87.7 m -71.59 168.43 17.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -171.45 157.65 4.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.544 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 17.6 m -126.71 147.59 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 84.8 m-85 -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.441 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' HG23 ' A' ' 115' ' ' VAL . 2.4 mt-10 -104.37 124.57 49.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.808 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.3 t -118.42 115.72 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.272 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 18.5 m95 -112.61 151.21 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.508 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -125.95 110.95 14.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.863 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 4.5 tttt -49.09 138.85 11.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.666 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 39.5 mtmt -115.59 -175.11 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.409 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.103 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.25 147.12 38.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -110.28 115.59 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.574 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 30' ' ' PHE . 9.1 tp -116.06 123.93 49.17 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' CH2' HG13 ' A' ' 115' ' ' VAL . 3.8 p90 -167.99 162.77 13.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.77 131.57 56.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.114 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.44 154.33 37.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.717 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 2.2 p-10 -102.97 -176.8 3.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -47.92 -42.15 26.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.34 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 -25.99 54.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.455 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.63 25.47 9.22 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.59 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 126' ' ' THR . 0.4 OUTLIER -95.65 162.48 13.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.665 0.269 . . . . 0.0 110.736 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 pt -111.92 -42.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.343 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.1 -173.07 33.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.646 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.38 96.32 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.97 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.92 95.34 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.69 34.73 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.541 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -146.43 176.71 9.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.767 0.318 . . . . 0.0 110.786 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.572 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -95.61 -51.81 0.24 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.334 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 81.3 Cg_endo -93.16 168.04 2.37 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.819 2.346 . . . . 0.0 112.651 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -127.9 129.54 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.588 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -94.46 38.13 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.11 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mp -122.35 89.85 49.22 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.37 -11.17 20.83 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.624 2.216 . . . . 0.0 112.945 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -22.8 17.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.522 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -72.67 -49.24 32.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 111.476 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.489 ' H ' ' HG ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -56.66 -18.9 13.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.576 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -41.49 75.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.688 0.28 . . . . 0.0 111.55 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.413 ' CZ ' ' OE1' ' A' ' 33' ' ' GLN . 55.3 t80 -105.22 -15.36 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.455 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.5 t80 -81.77 -57.36 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.739 0.304 . . . . 0.0 111.766 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.508 ' HG3' ' CG1' ' A' ' 35' ' ' VAL . 0.4 OUTLIER -53.91 -62.43 1.66 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.26 -28.89 20.54 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' HB2' HD21 ' A' ' 4' ' ' LEU . 0.8 OUTLIER -92.34 -3.35 55.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' ' HG3' ' A' ' 39' ' ' MET . 34.4 p -140.57 4.52 1.96 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.508 ' CG1' ' HG3' ' A' ' 31' ' ' ARG . 34.4 m -109.0 158.84 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.038 0.447 . . . . 0.0 112.05 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 72.2 11.21 75.12 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-O 119.177 -0.79 . . . . 0.0 114.592 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 6.5 mttt -149.2 -163.9 1.9 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.145 1.472 . . . . 0.0 108.559 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.406 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 60.4 mt -84.74 88.41 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.402 ' HG3' ' HB ' ' A' ' 34' ' ' THR . 18.2 ttp -95.31 118.24 31.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.223 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG23 ' CG1' ' A' ' 82' ' ' VAL . 3.5 t -88.11 126.61 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.01 148.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.323 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.59 157.6 52.74 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.61 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.482 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -50.94 -53.13 35.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.097 0.449 . . . . 0.0 110.606 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.482 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 14.9 tpt180 -59.95 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.592 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -64.6 -38.33 90.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.508 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.56 -39.82 89.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.634 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -66.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.2 t -54.24 -34.92 61.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.576 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -35.12 124.54 0.58 Allowed Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.839 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -43.43 -29.67 2.13 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.154 2.57 . . . . 0.0 113.652 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -142.11 132.81 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.171 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -141.21 107.96 6.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.804 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 71' ' ' GLN . 55.3 Cg_endo -90.14 176.8 18.7 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.162 0.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.5 ' CD1' ' HD2' ' A' ' 57' ' ' ARG . 55.0 mt -87.38 140.03 32.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.52 -84.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.962 2.442 . . . . 0.0 113.917 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.3 mt-10 -85.19 11.66 9.46 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.5 ' HD2' ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -112.27 113.42 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.959 0.409 . . . . 0.0 111.412 -178.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 81.4 m -70.15 114.05 7.92 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.512 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 57' ' ' ARG . 2.4 m-80 -104.69 154.68 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.72 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG1' HG21 ' A' ' 76' ' ' VAL . 10.8 t -135.8 132.35 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.788 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t -105.03 125.32 60.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.827 0.346 . . . . 0.0 111.648 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -107.27 115.26 29.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 3.6 t -149.02 166.37 28.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 111.194 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -82.69 -10.19 59.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.351 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.8 tp60 -79.65 132.06 36.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.307 . . . . 0.0 110.484 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 2.4 mt-10 -82.95 -31.07 27.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.809 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.91 6.25 45.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.263 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.0 t80 -60.43 136.76 58.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 111.67 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.76 171.88 12.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.408 1.099 . . . . 0.0 112.78 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.6 139.99 16.75 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.108 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 3.4 mt-30 -71.73 100.67 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.3 -36.96 3.33 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.694 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.91 170.17 14.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.82 140.24 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.466 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.15 106.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 29.1 m -117.73 167.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.439 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 6.6 m170 -119.61 -20.66 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.73 -175.2 5.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 111.77 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.481 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 7.5 t -68.33 -9.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.004 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.17 -34.1 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.3 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.1 -29.38 60.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.718 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.489 ' CG1' HG23 ' A' ' 40' ' ' VAL . 95.8 t -73.02 -55.84 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.46 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 8.1 m-85 -53.43 -26.12 18.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.987 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.76 87.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -67.67 -58.21 5.06 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.62 -23.02 15.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.211 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.95 -36.3 72.54 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.37 -7.18 59.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.663 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -124.96 66.63 50.71 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.031 0.443 . . . . 0.0 110.578 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.21 -0.41 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.234 2.623 . . . . 0.0 113.04 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.91 -31.74 15.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 160.1 14.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 111.411 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -98.59 166.22 11.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.082 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.88 117.91 27.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.44 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.76 112.06 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.314 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 11.9 mm -77.76 118.99 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.61 11.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.083 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.8 -166.36 39.29 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.501 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.4 -160.97 36.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 117.708 0.754 . . . . 0.0 112.524 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.27 -49.38 53.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.92 -30.37 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.304 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.422 ' CD1' HD22 ' A' ' 62' ' ' LEU . 42.2 mm -81.67 -26.75 9.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 6.0 m-85 -61.35 -58.61 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 4.6 t -67.14 -9.99 45.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.07 -38.84 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.487 ' O ' HG22 ' A' ' 110' ' ' VAL . 2.1 m-85 -100.21 -3.85 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.404 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.464 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 4.2 pttp -47.71 -33.56 7.12 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 4.35 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.678 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -125.0 -28.82 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 3' ' ' PHE . 92.1 t -45.16 131.13 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.273 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -104.3 1.83 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 40.3 m -167.5 143.34 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.365 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 33.7 mt -119.93 145.01 47.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.443 0.639 . . . . 0.0 111.925 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 mt -135.47 115.05 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.333 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.52 HG13 ' CH2' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -135.16 145.36 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.68 105.4 12.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.626 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -75.01 100.14 4.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.14 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.32 120.76 26.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.89 -52.81 47.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.023 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.24 162.61 36.05 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.009 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 3.6 t -102.72 156.89 17.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.9 m-85 -136.03 138.65 42.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -112.29 144.13 42.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.81 -125.39 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.318 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.13 31.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 2.9 m -156.78 123.01 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.727 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.2 167.5 10.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.3 tpt -79.79 155.89 27.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.736 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.5 pp -81.28 162.72 57.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.81 103.59 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.052 2.502 . . . . 0.0 112.744 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.403 ' CD1' ' CZ2' ' A' ' 5' ' ' TRP . 2.0 mt -91.68 145.07 24.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.94 78.76 2.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.971 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.47 ' CZ3' HD12 ' A' ' 113' ' ' LEU . 80.2 m95 -60.44 -19.94 58.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.8 -29.47 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.554 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.6 -28.17 45.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.832 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.554 ' CD1' HD11 ' A' ' 113' ' ' LEU . 92.5 m-85 -97.58 177.13 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.693 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 1.9 m -134.89 141.03 46.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 9.0 ttpt -84.0 117.84 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.494 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 27.2 m -105.68 -16.1 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.976 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 m -164.53 140.77 6.07 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.621 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.6 p -163.46 113.54 1.33 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -148.17 120.27 8.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.5 m -73.65 144.71 45.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.309 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 t -122.34 108.93 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.378 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.23 101.0 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.45 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -80.8 -176.14 5.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.411 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.8 t30 -77.08 130.89 74.0 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.138 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.73 -30.3 78.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.218 1.945 . . . . 0.0 112.656 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -89.89 -23.94 21.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.775 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.411 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 18.8 mt -80.06 4.06 18.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.491 0.186 . . . . 0.0 111.452 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 98.9 m -69.19 163.41 24.97 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.3 p80 -176.35 163.59 2.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.182 0.515 . . . . 0.0 112.265 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 116' ' ' THR . 87.8 m -120.8 147.17 45.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.024 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.81 105.4 14.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.732 0.301 . . . . 0.0 110.905 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.418 ' HB2' HG21 ' A' ' 115' ' ' VAL . 30.4 mt-10 -108.78 125.7 52.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 15.5 t -116.5 114.79 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.597 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.5 m95 -110.5 150.57 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.646 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -126.85 116.21 20.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.881 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.526 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 8.6 ttpt -51.8 130.1 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.384 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -96.08 172.9 7.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.342 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.097 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.405 ' O ' HG11 ' A' ' 110' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -104.99 154.65 19.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 112.308 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.487 ' CD1' ' HB ' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -123.9 114.01 19.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' CD2' ' HB2' ' A' ' 33' ' ' GLN . 13.2 tp -112.86 121.57 45.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' CZ2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -165.18 163.89 20.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.525 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.86 135.97 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.966 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.29 149.71 48.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.377 . . . . 0.0 110.969 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.5 p-10 -110.78 -168.24 1.28 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.021 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -35.41 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.088 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 -28.95 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.012 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.12 12.81 22.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.879 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.93 144.96 47.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.768 0.284 . . . . 0.0 110.586 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.14 -81.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.44 133.17 6.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.586 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -166.5 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.667 0.27 . . . . 0.0 110.79 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.92 30.62 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.752 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.24 -76.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.397 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -78.41 165.39 23.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.293 . . . . 0.0 110.772 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.52 92.91 5.04 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.146 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.02 89.0 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.608 2.205 . . . . 0.0 112.388 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.03 75.98 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.858 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -113.43 -26.12 8.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.203 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.4 143.56 85.6 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.755 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.8 -27.63 3.05 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.688 2.259 . . . . 0.0 112.928 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -60.95 -18.67 58.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.543 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.98 -21.58 31.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.327 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.68 -14.69 51.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.445 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.3 -32.84 58.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.752 0.31 . . . . 0.0 110.994 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.437 ' CD1' ' HG3' ' A' ' 33' ' ' GLN . 35.0 t80 -105.41 -63.11 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.365 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -43.81 -36.36 2.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.043 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 35' ' ' VAL . 1.0 OUTLIER -92.09 -60.67 1.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -48.91 -36.77 17.99 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.437 ' HG3' ' CD1' ' A' ' 29' ' ' TYR . 20.3 mm-40 -76.33 -4.54 42.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.1 p -140.54 -0.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.469 ' HB ' ' CG ' ' A' ' 57' ' ' ARG . 34.2 m -108.17 142.88 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.518 0.199 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.556 ' H ' ' HG3' ' A' ' 57' ' ' ARG . . . 112.61 -9.09 26.05 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.231 -0.985 . . . . 0.0 114.048 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -148.43 -163.8 1.86 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.789 1.295 . . . . 0.0 109.223 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.539 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 51.6 mt -74.64 91.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.765 0.317 . . . . 0.0 111.522 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.1 ttp -101.92 120.45 40.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.483 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 15.3 t -80.3 159.19 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.869 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 28.7 m -161.72 157.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.34 155.51 43.89 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.906 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.466 ' HA ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.8 -52.68 64.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.982 0.391 . . . . 0.0 110.389 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -59.06 -32.64 69.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -71.59 -38.14 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.539 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 6.7 t80 -66.5 -25.94 66.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -72.65 -66.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 111.109 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.4 t -57.08 -31.44 65.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.43 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -26.24 135.16 0.1 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.88 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.64 -33.91 88.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.701 2.267 . . . . 0.0 112.929 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -160.08 122.41 3.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.25 135.62 15.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.252 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.77 160.41 71.42 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.14 -1.608 . . . . 0.0 111.838 -0.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.768 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 51.1 mt -75.15 156.36 85.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.05 -82.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.953 2.435 . . . . 0.0 113.653 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB2' ' NH1' ' A' ' 57' ' ' ARG . 5.3 mt-10 -93.18 27.6 2.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.411 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.768 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -125.2 111.68 15.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.403 . . . . 0.0 111.637 -178.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 53.4 m -72.35 119.53 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -102.73 151.44 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 112.083 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 17.1 t -132.07 142.76 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.392 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 43' ' ' ARG . 50.0 t -115.45 121.03 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.727 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.1 tp -104.78 117.14 33.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 0.7 OUTLIER -150.25 167.44 26.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.822 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -89.13 -10.05 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tt0 -73.79 137.06 43.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -88.46 5.96 39.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.118 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.55 5.85 4.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.607 0.241 . . . . 0.0 111.618 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.5 t80 -60.17 141.71 55.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.333 0.587 . . . . 0.0 112.014 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.45 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -131.93 173.8 10.82 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.249 1.024 . . . . 0.0 112.641 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.3 143.4 20.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.699 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.96 98.85 2.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.636 0.255 . . . . 0.0 110.799 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.57 -36.13 3.14 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.662 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.75 170.49 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 111.892 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 HG22 ' CE1' ' A' ' 85' ' ' TYR . 7.6 t -96.33 139.75 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.172 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 20.1 t -104.59 107.85 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 111.835 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 30.3 m -117.96 168.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.754 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.3 m170 -119.01 -22.37 7.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.552 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.44 -169.48 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 111.523 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 106' ' ' PHE . 4.8 t -73.44 -10.36 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.62 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.1 -34.82 19.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.231 0.539 . . . . 0.0 109.836 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.46 -30.38 61.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.419 HG21 HG23 ' A' ' 76' ' ' VAL . 17.5 t -72.16 -53.06 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.006 0.431 . . . . 0.0 109.876 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.674 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 4.3 m-85 -54.54 -28.34 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.823 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.6 96.43 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.72 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.437 ' CE1' HG22 ' A' ' 74' ' ' VAL . 65.0 t80 -65.57 -55.93 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.9 13.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.333 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 14.4 mmmt -69.35 -39.71 77.96 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -81.3 -4.61 56.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -126.86 65.58 63.21 Favored Pre-proline 0 N--CA 1.456 -0.151 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.7 -0.5 6.95 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.19 2.593 . . . . 0.0 112.775 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -91.71 -32.25 15.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -104.18 161.53 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.127 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -99.03 162.76 12.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.3 tp -109.29 115.84 30.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 39' ' ' MET . 44.7 t -131.05 115.5 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.487 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 7.0 mm -82.36 141.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.403 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.08 -44.66 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 176.01 -168.63 40.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.691 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.416 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.76 36.67 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 121.94 -0.741 . . . . 0.0 112.479 -0.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.47 -52.95 15.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.288 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -56.07 -29.27 60.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.535 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 62' ' ' LEU . 40.2 mm -81.47 -28.51 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.0 m-85 -60.2 -58.36 8.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.873 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.475 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 11.7 t -65.63 -10.12 33.08 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 121.73 -0.606 . . . . 0.0 112.228 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.58 -43.77 54.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.842 0.354 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HA ' HG23 ' A' ' 79' ' ' VAL . 3.9 m-85 -96.19 -1.37 48.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.559 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.475 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 6.9 pttt -50.91 -34.59 29.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.915 0.388 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.66 2.66 40.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.69 -27.62 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.619 0.247 . . . . 0.0 111.572 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.459 HG22 ' CD1' ' A' ' 3' ' ' PHE . 68.0 t -45.46 123.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.912 0.387 . . . . 0.0 111.284 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 13.8 t70 -107.02 7.54 29.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.24 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.5 m -168.39 140.0 2.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.365 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 ' CG ' ' A' ' 136' ' ' PHE . 7.1 mt -125.51 147.34 49.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.323 0.583 . . . . 0.0 112.079 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt -135.4 117.03 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.317 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.499 HG12 ' CZ2' ' A' ' 5' ' ' TRP . 2.1 m -131.76 141.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.94 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.409 HG21 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -114.25 109.6 18.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.198 179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 14.0 mtt180 -84.07 99.59 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.385 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.63 120.62 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.305 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.99 -47.55 44.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.83 152.1 49.97 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.378 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 173.04 8.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.817 0.341 . . . . 0.0 111.093 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 3.2 m-85 -145.52 178.37 8.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.777 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.85 170.05 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 148.96 176.88 22.65 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.771 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.12 17.56 9.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.163 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -133.65 131.74 39.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.637 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -113.14 170.41 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.4 tpt -74.13 145.83 43.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.666 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 2.0 pp -66.42 166.66 16.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.187 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.666 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.1 Cg_endo -75.1 106.71 2.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.243 1.962 . . . . 0.0 112.319 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.92 147.51 23.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.86 69.51 5.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.433 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 88.7 m95 -53.39 -24.92 13.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.36 -29.8 64.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.328 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.6 -18.57 51.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.033 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.459 ' CG ' HD13 ' A' ' 113' ' ' LEU . 85.0 m-85 -106.83 168.49 9.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.418 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -131.22 141.61 50.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.0 ttpt -81.88 109.43 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.547 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.4 m -92.27 -26.42 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.384 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.1 m -154.93 140.3 17.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.588 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 51.9 p -169.58 115.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.969 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -147.91 119.02 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.076 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.5 m -71.08 145.91 49.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.032 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 t -119.67 104.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.657 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -85.07 100.2 11.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.22 173.78 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.1 p -53.54 -44.25 69.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.631 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.463 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 9.9 t30 -82.68 132.17 52.61 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.34 -33.29 89.43 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.395 2.063 . . . . 0.0 112.613 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.55 -28.52 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.0 mt -76.74 5.05 8.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.9 m -71.56 158.4 36.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -174.12 160.59 3.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.951 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 22.2 m -122.58 138.6 54.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.946 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 141' ' ' SER . 88.6 m-85 -102.6 106.35 17.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 32.7 mt-10 -108.16 125.72 51.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.1 t -116.6 112.35 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.75 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.494 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 17.4 m95 -107.22 151.16 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 112.003 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -130.35 127.18 38.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.831 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 10.9 tttp -54.13 130.54 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 111.359 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.418 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -116.79 -168.56 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.836 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.15 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.408 ' O ' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.746 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.32 146.67 40.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.479 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.6 m-30 -110.2 111.07 22.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.551 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -108.63 118.99 38.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 4.6 p90 -167.96 172.99 8.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.32 135.67 46.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -117.58 161.51 19.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.047 0.451 . . . . 0.0 111.444 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.6 -167.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -39.5 71.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.759 0.314 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.56 -27.49 37.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.25 22.98 10.85 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.683 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.33 152.91 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.614 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.443 HG22 ' CD1' ' A' ' 5' ' ' TRP . 1.5 pp -126.26 -41.42 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.679 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.01 -166.14 11.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.904 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' HA2' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -140.18 121.61 15.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.61 0.243 . . . . 0.0 110.689 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.4 -30.17 42.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.672 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.91 -121.32 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.394 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -164.23 119.42 1.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.998 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.17 137.69 26.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.745 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -87.46 39.94 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.809 2.339 . . . . 0.0 112.86 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.81 110.29 18.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.71 109.12 21.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.02 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.41 122.14 36.06 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.799 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.75 -30.11 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.687 2.258 . . . . 0.0 112.981 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -53.63 -38.58 64.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.325 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -74.44 -61.89 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.054 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.25 -33.56 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.583 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -53.97 -66.89 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.809 0.338 . . . . 0.0 111.188 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -70.09 -9.73 56.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.405 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -85.66 -24.95 26.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.448 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 32' ' ' ALA . 10.1 ptm180 -92.02 -46.82 7.6 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 31' ' ' ARG . . . -54.73 -23.94 20.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.572 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -92.51 -3.93 54.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.7 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.46 ' CG2' ' CD1' ' A' ' 4' ' ' LEU . 25.4 p -145.8 26.67 1.24 Allowed 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 31' ' ' ARG . 11.8 m -108.15 145.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.44 29.93 57.91 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 58' ' ' THR . 17.7 mttm -147.07 -167.33 2.75 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.498 2.149 . . . . 0.0 108.417 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 93' ' ' GLU . 75.4 mt -88.93 88.55 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.302 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.2 OUTLIER -102.06 126.29 48.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.368 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 2.0 t -90.79 129.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.447 HG13 ' CE2' ' A' ' 49' ' ' PHE . 21.7 m -133.54 138.03 51.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.242 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.43 153.74 39.31 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.005 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.5 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -50.74 -53.53 30.84 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.936 0.398 . . . . 0.0 110.075 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -54.5 -42.41 70.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -65.06 -40.76 95.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 28.8 t80 -60.48 -29.57 69.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.913 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.51 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.6 t -58.49 -31.08 67.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.305 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -29.8 135.79 0.18 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.996 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 75.9 Cg_exo -48.83 -35.11 30.06 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.276 . . . . 0.0 112.85 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.07 142.78 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.35 112.04 6.55 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -81.72 178.81 29.52 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.984 -0.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.432 HD11 ' HD2' ' A' ' 57' ' ' ARG . 64.1 mt -84.21 140.69 39.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.603 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.62 110.98 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.495 2.13 . . . . 0.0 112.835 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.569 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.0 OUTLIER 74.37 -0.17 3.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.35 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HD2' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -109.57 116.23 31.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.66 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 33.3 m -70.08 111.5 5.79 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.456 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -107.14 154.86 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.947 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 18.8 t -128.02 143.42 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.389 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 76' ' ' VAL . 90.0 t -111.69 126.98 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.889 0.376 . . . . 0.0 111.069 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -105.64 123.39 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.361 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 1.2 t -157.2 158.33 36.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -79.67 -6.57 57.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.3 tt0 -78.78 131.29 36.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.817 0.341 . . . . 0.0 110.974 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 4.21 29.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.91 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.4 7.29 4.92 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.424 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.0 t80 -59.23 144.98 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.051 0.453 . . . . 0.0 111.2 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -133.94 174.27 10.65 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.368 1.08 . . . . 0.0 113.014 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.91 144.47 21.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.709 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -81.0 96.66 7.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.89 0.376 . . . . 0.0 110.643 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -44.7 2.06 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.78 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.06 168.04 17.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 111.74 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.445 HG11 ' CD1' ' A' ' 85' ' ' TYR . 28.3 t -96.26 141.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.408 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 28.4 t -108.1 120.83 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.333 0.587 . . . . 0.0 111.912 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.439 ' CG2' HG21 ' A' ' 82' ' ' VAL . 27.7 m -127.59 169.55 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.633 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' THR . 7.9 m170 -117.52 -25.58 6.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.835 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.5 -174.62 5.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.015 0.436 . . . . 0.0 111.16 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' A' ' 106' ' ' PHE . 11.2 t -67.92 -11.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.533 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -34.21 19.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.441 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.86 -26.15 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.023 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 76' ' ' VAL . 43.1 t -75.98 -54.71 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.557 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 14.5 m-85 -53.34 -27.89 25.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.885 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.53 87.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.969 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' CD1' HG11 ' A' ' 74' ' ' VAL . 86.1 t80 -65.3 -56.32 13.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.95 -24.86 59.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.034 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -68.8 -43.5 75.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -79.1 -10.7 59.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.286 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -122.88 65.6 26.92 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.15 -0.4 4.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.159 2.572 . . . . 0.0 113.166 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.92 -37.85 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.1 164.1 11.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.433 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 5.7 mm-40 -99.13 171.26 8.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 tp -115.91 116.67 28.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 39' ' ' MET . 49.1 t -128.58 114.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.527 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.411 HD11 ' CE2' ' A' ' 106' ' ' PHE . 7.6 mm -83.34 140.2 16.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.077 0.465 . . . . 0.0 111.234 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.84 -36.34 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.57 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -170.93 43.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.555 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.45 -161.23 32.81 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 117.376 0.588 . . . . 0.0 112.512 -0.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.04 -53.53 54.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -55.34 -27.3 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.5 mm -83.16 -27.47 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.854 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.431 ' HB3' HG12 ' A' ' 129' ' ' ILE . 1.9 m-85 -60.61 -56.52 20.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.38 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.426 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 1.8 t -67.71 -10.07 49.25 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.24 -47.21 20.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.343 . . . . 0.0 110.732 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 79' ' ' VAL . 9.3 m-85 -86.18 -9.38 56.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.321 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 3.2 pttp -52.42 -29.76 25.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -75.88 -7.43 54.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 22.5 m-20 -129.58 -19.89 3.32 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 53.5 t -43.81 127.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.112 0.482 . . . . 0.0 110.935 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 10.5 t0 -108.55 6.58 26.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.48 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.746 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 18.7 m -169.68 137.92 1.8 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.72 0.295 . . . . 0.0 110.6 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 6.1 mt -122.7 145.67 48.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.168 0.509 . . . . 0.0 111.605 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mt -134.84 117.41 15.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.578 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.453 HG13 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -133.96 144.0 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.009 0.433 . . . . 0.0 111.837 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.36 104.71 11.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.4 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 2.9 ttt-85 -75.8 100.75 4.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.452 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.4 108.29 19.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.087 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.45 -39.73 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.408 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.6 -167.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.701 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.81 146.8 41.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 111.007 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.3 m-85 -134.47 162.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -99.73 134.05 43.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.002 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 15' ' ' LYS . . . -164.01 -174.36 33.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.86 21.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.251 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -139.11 127.69 23.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -173.6 1.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.201 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.3 pp -112.11 160.15 31.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.88 102.48 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.831 2.354 . . . . 0.0 112.746 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.34 146.44 27.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.29 76.35 5.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -60.04 -19.12 51.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.365 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.13 -33.22 65.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -81.77 -17.19 48.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.428 ' CD2' HD12 ' A' ' 113' ' ' LEU . 79.6 m-85 -106.68 167.75 9.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.906 0.384 . . . . 0.0 111.163 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.518 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -127.68 141.02 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.516 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.638 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 12.1 ttpp -81.81 115.99 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.416 HG23 ' HB ' ' A' ' 157' ' ' VAL . 27.1 m -101.04 -18.76 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.783 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.4 m -164.25 140.54 6.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.535 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.638 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 93.0 p -164.95 113.33 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.48 126.02 13.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.9 m -80.5 145.04 32.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.294 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.79 109.05 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.91 104.5 16.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -177.2 5.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.3 p -58.02 -42.34 85.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.46 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 3.4 t30 -80.99 134.5 52.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.342 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.96 -32.31 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.202 1.934 . . . . 0.0 112.429 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.11 -25.61 22.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.5 mt -76.18 5.11 7.33 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 153' ' ' HIS . 72.0 m -72.89 162.27 29.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.565 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -175.97 162.67 2.61 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 0.0 112.033 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 38.5 m -122.5 129.82 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.33 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -93.66 107.89 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.28 152.29 20.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' A' ' 139' ' ' VAL . 19.0 t -142.41 110.22 2.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.759 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.459 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 29.8 m95 -109.8 145.74 36.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.397 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.15 129.51 39.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.373 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -49.08 122.19 5.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 111.447 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.518 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.9 OUTLIER -97.8 176.14 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.063 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 110' ' ' VAL . 87.6 m . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.747 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -107.95 154.79 21.11 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.8 m-30 -120.68 107.92 13.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.831 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.44 115.38 30.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.475 0.655 . . . . 0.0 112.231 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' CZ2' HG11 ' A' ' 115' ' ' VAL . 5.7 p90 -158.37 166.19 32.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.856 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.36 133.28 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.1 pt20 -131.63 157.03 44.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.435 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -108.18 -162.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.361 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.28 -49.96 74.41 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -33.37 72.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.23 33.15 3.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.776 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.4 mm? -73.84 127.14 32.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.423 HG23 ' CD1' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -112.45 -63.65 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.58 -168.63 11.76 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.66 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -149.06 166.1 29.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.812 0.339 . . . . 0.0 110.734 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.53 98.71 10.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.66 117.93 3.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.713 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 116.44 31.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.75 0.31 . . . . 0.0 110.719 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.546 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -160.0 -55.64 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.564 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 93.4 Cg_endo -93.72 60.81 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.648 2.232 . . . . 0.0 112.635 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -174.58 110.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.57 142.14 50.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.74 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' HG ' ' HD2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -156.17 145.16 14.93 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.791 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' HG ' ' A' ' 23' ' ' LEU . 87.4 Cg_endo -85.12 -41.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.665 2.243 . . . . 0.0 112.92 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -37.69 70.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.382 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.63 -22.83 61.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.421 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tt -90.54 -38.67 13.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 111.214 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.69 -27.66 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.638 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.412 ' CE2' HG21 ' A' ' 116' ' ' THR . 29.2 t80 -105.28 -29.43 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.516 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -76.41 -23.73 54.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.639 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.91 -61.47 1.62 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.04 -32.39 15.32 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -81.85 -6.36 59.02 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.468 ' CG2' ' CD1' ' A' ' 4' ' ' LEU . 21.1 p -142.4 13.94 1.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.581 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 33.2 m -108.25 154.69 9.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 57.48 26.28 56.55 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 115.799 1.08 . . . . 0.0 115.799 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.0 mtmm -151.38 -169.0 3.25 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.957 1.878 . . . . 0.0 108.41 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 80.7 mt -84.52 87.46 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.759 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.431 ' HE2' ' O ' ' A' ' 39' ' ' MET . 0.4 OUTLIER -100.31 122.63 43.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.922 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 21.6 t -82.84 158.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.612 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 35.1 m -164.32 144.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.36 152.9 52.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.753 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.443 ' HA ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.27 -52.26 53.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.861 0.33 . . . . 0.0 110.81 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.81 -32.18 70.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.086 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 m -70.15 -37.38 75.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.443 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -66.96 -26.28 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.034 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.73 -66.42 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -47.27 -37.97 11.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.476 ' CE2' HG13 ' A' ' 41' ' ' VAL . 2.8 m-30 -36.21 148.26 0.17 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -43.77 -69.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 0.0 112.713 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -139.09 167.57 21.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.53 117.38 29.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.65 -171.0 8.34 Favored 'Cis proline' 0 C--N 1.349 0.594 0 C-N-CA 123.716 -1.369 . . . . 0.0 112.348 -0.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mt -79.98 162.87 60.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 24.4 Cg_endo -61.56 92.47 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.744 2.296 . . . . 0.0 113.101 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 9.9 mt-10 60.29 33.8 20.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.624 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.634 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 10.7 mtp180 -124.02 114.3 19.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.203 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 41.4 m -65.14 107.21 1.48 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.124 0.488 . . . . 0.0 110.192 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.418 HD22 HD13 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.3 154.45 18.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.424 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 11.8 t -130.91 132.61 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.731 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 43' ' ' ARG . 96.0 t -104.22 127.59 58.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 111.717 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD1' HG22 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -109.32 113.3 26.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.995 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.419 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.2 t -148.6 167.37 25.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 111.279 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -84.11 -7.31 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.282 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.1 tp60 -80.46 128.8 34.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.467 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -28.01 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.8 9.62 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.65 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.2 t80 -59.86 141.08 56.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.064 0.459 . . . . 0.0 111.489 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -129.93 174.0 10.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.255 1.026 . . . . 0.0 112.54 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.47 143.72 20.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.58 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -74.31 96.24 2.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.445 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.94 -35.52 3.65 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.172 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.96 166.32 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.95 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.412 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 15.3 t -96.67 140.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.412 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 t -106.8 120.56 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.313 0.578 . . . . 0.0 112.18 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.456 ' CG2' HG23 ' A' ' 82' ' ' VAL . 24.9 m -132.77 172.04 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.965 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -122.21 -20.2 6.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.06 -175.68 5.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.101 0.476 . . . . 0.0 111.74 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.428 HG22 ' CG ' ' A' ' 106' ' ' PHE . 14.4 t -69.19 -10.24 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.614 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.48 -36.22 17.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.138 0.494 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.417 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -72.62 -33.71 66.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG23 ' CG2' ' A' ' 76' ' ' VAL . 27.2 t -70.29 -49.98 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.642 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 2.9 m-85 -54.34 -28.7 44.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.178 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.33 -39.79 85.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 50.8 t80 -66.37 -57.62 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.98 -23.06 43.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.893 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.642 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -72.08 -32.0 66.62 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 109.958 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.441 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 10.0 mt-30 -84.64 -9.02 58.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -121.21 65.17 14.54 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.027 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.36 -1.53 3.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.808 2.339 . . . . 0.0 112.647 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.03 -29.06 15.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.32 159.81 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.68 170.01 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.201 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -112.95 113.15 25.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.2 t -124.09 107.18 18.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.721 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.439 ' CD1' HG22 ' A' ' 40' ' ' VAL . 9.2 mm -76.46 134.69 28.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.137 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.434 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.96 -38.52 5.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.14 -167.35 40.31 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.09 -161.08 23.07 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 122.063 -0.669 . . . . 0.0 112.571 -0.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . -54.5 -51.63 64.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.826 0.346 . . . . 0.0 111.26 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -31.71 68.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.591 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 33.4 mm -72.67 -27.66 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 2.4 m-85 -60.85 -54.35 46.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.572 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 7.7 t -69.26 -10.38 57.54 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.872 -0.517 . . . . 0.0 111.989 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.12 -39.91 54.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.434 ' O ' HG21 ' A' ' 110' ' ' VAL . 3.4 m-85 -96.17 -8.24 33.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.552 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.84 -28.83 17.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.16 -1.46 49.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.469 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -132.01 -20.1 2.51 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.492 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 71.0 t -44.04 128.76 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.887 0.375 . . . . 0.0 111.222 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.9 t70 -106.16 1.59 26.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.301 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.747 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 72.7 m -166.99 135.09 2.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.674 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.437 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 9.6 mt -118.99 144.38 46.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 111.672 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mt -134.95 115.97 14.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.044 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.473 HG11 ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -132.77 142.74 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 111.672 -179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.8 114.4 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.5 102.29 14.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.673 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -83.47 133.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.36 -57.43 10.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.339 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.14 168.2 38.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.747 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -99.33 172.51 7.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.804 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -148.97 178.49 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.11 0.481 . . . . 0.0 111.442 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.55 171.48 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' HA3' ' CD1' ' A' ' 12' ' ' LEU . . . 161.41 -179.69 36.66 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.61 5.75 4.02 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.4 ' O ' HD11 ' A' ' 12' ' ' LEU . 5.3 m -134.24 137.22 44.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 111.108 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 165.4 11.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -173.72 0.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 111.086 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.434 HG12 ' CB ' ' A' ' 103' ' ' PHE . 2.2 pp -118.47 164.03 22.48 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.083 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.11 136.65 57.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.636 2.224 . . . . 0.0 112.006 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -128.3 148.27 50.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.07 77.47 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.437 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.3 m95 -60.32 -19.0 53.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.324 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -29.31 62.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.57 -26.73 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.455 ' HZ ' ' HB ' ' A' ' 110' ' ' VAL . 95.4 m-85 -97.71 173.95 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.18 140.5 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.483 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -79.72 111.67 16.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.833 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -93.88 -25.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.3 m -160.28 140.46 11.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 111.158 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.46 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 17.2 p -162.99 111.53 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -147.76 122.41 9.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 111.434 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 4.8 m -76.38 144.93 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.35 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 t -115.62 105.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -93.61 104.94 17.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.406 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -86.69 -177.09 6.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -54.42 -51.49 64.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.502 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -76.58 127.0 85.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.044 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.21 -31.5 93.15 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.137 1.891 . . . . 0.0 112.413 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.26 -22.41 33.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.869 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.9 mt -81.75 10.46 6.16 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.0 m -79.55 164.97 23.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 110.32 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.673 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 7.9 p80 -174.08 160.9 3.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.152 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 18.2 m -125.45 135.43 52.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -100.83 109.25 21.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' HG21 ' A' ' 115' ' ' VAL . 2.3 mt-10 -107.16 126.81 52.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.944 0.402 . . . . 0.0 111.378 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 14.4 t -118.82 116.36 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.26 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.483 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.9 m95 -112.53 150.18 31.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.058 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -128.58 118.31 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.303 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 2.6 ttpp -53.55 133.91 41.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.578 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.51 10.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.511 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.087 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 111' ' ' ASP . 91.4 m . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.52 0.2 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.79 152.64 28.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -115.45 116.26 27.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.458 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 30' ' ' PHE . 13.1 tp -115.25 122.03 44.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 2.8 p90 -168.35 165.2 12.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.88 141.65 51.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 4.9 pt20 -127.35 156.55 41.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.838 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.54 -170.52 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.54 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -50.01 -46.34 52.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.42 -21.42 59.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 90.2 47.94 3.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.16 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.439 ' CD2' ' HA3' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -87.27 174.72 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.378 -179.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.71 -42.45 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.66 162.86 34.84 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.58 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' CG ' ' HA2' ' A' ' 124' ' ' GLY . 9.4 tttm -118.45 110.97 18.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.365 . . . . 0.0 111.131 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -92.02 134.19 35.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.3 -141.84 13.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.72 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -92.98 120.95 33.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.688 0.28 . . . . 0.0 110.806 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -151.18 128.21 5.46 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.317 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 7.2 Cg_exo -72.52 -56.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.554 2.17 . . . . 0.0 111.857 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -117.25 -176.04 2.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -143.69 -173.02 3.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.12 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.88 120.33 77.33 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.32 -21.38 1.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.685 2.257 . . . . 0.0 112.93 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -74.24 -44.28 53.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -71.81 -33.23 68.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . 14.3 mt -55.07 -42.54 72.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.42 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -68.19 -14.73 63.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.937 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -71.39 -66.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.499 ' HA ' HD22 ' A' ' 4' ' ' LEU . 1.5 p90 -72.46 -41.86 65.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.478 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 6.3 mtp180 -55.37 -27.7 49.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.47 -22.41 16.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.76 -48.72 6.43 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.4 t -94.45 32.95 1.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -92.24 160.11 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.27 0.557 . . . . 0.0 111.862 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.66 27.12 54.59 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -147.23 -166.82 2.61 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 120.076 1.938 . . . . 0.0 109.009 178.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.69 87.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.68 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.4 ttp -99.94 111.94 24.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.581 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG23 HG11 ' A' ' 82' ' ' VAL . 2.8 t -86.2 129.82 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.77 153.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.648 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.95 157.05 53.49 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.213 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -53.18 -52.78 57.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.397 . . . . 0.0 110.345 179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.7 tpt180 -56.82 -44.81 82.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.325 0.583 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 m -61.16 -36.65 80.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 49' ' ' PHE . 9.5 t80 -66.02 -24.71 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -65.83 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.396 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.4 t -48.19 -31.65 6.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.222 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 46' ' ' TYR . 3.5 m-30 -46.44 166.46 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.99 -70.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.795 2.33 . . . . 0.0 112.932 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -145.72 -167.11 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.97 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -132.3 113.81 14.61 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 6.4 Cg_exo -87.83 -160.9 1.72 Allowed 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.057 -0.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.703 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 12.2 mt -86.9 168.27 18.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 37.8 Cg_endo -66.87 93.9 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.443 2.095 . . . . 0.0 113.043 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 7.0 mt-10 64.99 14.05 9.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.33 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.703 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 6.0 mtp180 -109.11 116.95 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.388 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.4 m -67.11 110.93 3.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.866 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.424 ' ND2' HD11 ' A' ' 54' ' ' LEU . 2.4 m120 -106.0 157.48 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.437 0.637 . . . . 0.0 112.641 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' CG1' HG21 ' A' ' 76' ' ' VAL . 8.2 t -136.14 135.76 49.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.33 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 43' ' ' ARG . 85.9 t -109.46 128.11 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.925 0.393 . . . . 0.0 111.636 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -107.61 119.74 40.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.434 HG22 ' CB ' ' A' ' 68' ' ' TYR . 1.9 t -150.47 170.95 17.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -95.06 -10.13 31.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.718 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.0 tt0 -68.87 132.27 46.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.8 0.334 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.22 56.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.71 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.01 14.64 18.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.628 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.1 t80 -60.95 142.1 56.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.444 0.64 . . . . 0.0 111.978 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -135.79 172.99 12.21 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.316 1.055 . . . . 0.0 112.873 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.97 140.61 17.99 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.094 -1.867 . . . . 0.0 110.106 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.8 mp0 -73.77 100.2 3.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.78 0.324 . . . . 0.0 110.85 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.415 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 87.15 -38.17 3.16 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.395 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.62 171.34 10.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.674 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.46 140.37 18.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.507 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -107.95 116.84 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 0.0 112.032 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 33.1 m -126.29 171.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -121.14 -22.54 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.736 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -155.2 -173.95 4.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.7 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.448 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 14.8 t -68.22 -10.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.14 -33.92 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.088 0.47 . . . . 0.0 110.075 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.424 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -77.19 -27.22 53.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.886 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.445 HG11 HG23 ' A' ' 40' ' ' VAL . 72.4 t -73.47 -53.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.518 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.6 m-85 -55.01 -26.74 39.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.709 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.84 97.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 38.9 t80 -67.19 -57.68 6.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.04 -25.66 5.17 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.232 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -66.58 -44.37 82.43 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -79.74 -0.3 33.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.546 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.411 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 62.9 m-70 -127.57 60.26 43.11 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.981 0.42 . . . . 0.0 110.269 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.3 -0.25 7.08 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.146 2.564 . . . . 0.0 112.812 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.5 -38.29 30.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.067 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.17 167.68 10.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 111.243 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.54 166.31 11.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.501 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.401 HD23 ' CG1' ' A' ' 82' ' ' VAL . 13.6 tp -97.43 116.64 30.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.988 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' MET . 12.3 t -122.82 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.529 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 12.7 mm -80.59 140.53 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.418 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.73 -37.99 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.405 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.75 -168.42 41.52 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.681 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.408 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.54 -160.97 34.0 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 117.561 0.681 . . . . 0.0 112.528 -0.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.54 63.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -29.06 60.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.599 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 96' ' ' ILE . 27.7 mm -84.08 -26.31 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.547 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.2 m-85 -60.45 -58.46 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 3.8 t -66.51 -9.08 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.34 -39.35 39.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.71 0.29 . . . . 0.0 111.283 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 2.3 m-85 -103.23 -5.76 22.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 7.0 pttt -42.47 -31.14 0.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -90.35 -26.76 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.1 -31.68 17.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.483 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 70.8 t -48.99 129.32 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 1' ' ' THR . 6.3 t70 -105.86 9.24 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.616 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.2 m -166.85 140.91 3.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.549 HD13 ' CG ' ' A' ' 136' ' ' PHE . 13.8 mt -121.62 144.24 48.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.305 0.574 . . . . 0.0 111.743 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mt -135.38 117.53 15.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.139 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 1.2 m -136.33 146.51 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.479 . . . . 0.0 112.108 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.97 108.47 16.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.301 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 8.3 tpt180 -79.51 101.16 8.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.317 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.49 124.89 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.258 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.3 6.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.29 175.31 3.27 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.664 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.6 p -105.72 159.37 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 110.947 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -147.31 155.17 41.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.84 170.1 10.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.652 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.439 ' HA3' ' CD2' ' A' ' 12' ' ' LEU . . . 157.57 163.85 13.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.262 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.45 -27.1 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.6 0.238 . . . . 0.0 111.348 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.4 m -109.17 146.67 33.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.742 0.306 . . . . 0.0 111.008 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 177.56 4.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.417 ' HE1' ' CE2' ' A' ' 5' ' ' TRP . 17.0 tpt -76.94 156.68 31.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.3 pp -82.84 157.79 66.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.26 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.22 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.72 2.28 . . . . 0.0 112.507 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.45 146.63 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.38 75.78 2.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.012 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -56.39 -23.45 38.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -27.81 63.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.554 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.7 -24.82 44.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.737 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.549 ' CG ' HD13 ' A' ' 113' ' ' LEU . 78.5 m-85 -104.05 173.58 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.637 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -128.72 139.79 52.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.471 ' HD2' ' CB ' ' A' ' 141' ' ' SER . 1.2 ttpp -83.7 108.0 16.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.574 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.79 -18.11 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.722 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 m -162.62 140.46 8.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.722 0.296 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.471 ' CB ' ' HD2' ' A' ' 138' ' ' LYS . 2.2 p -169.85 108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -142.66 118.12 10.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.3 m -67.11 145.28 55.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.04 103.74 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.284 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.86 102.15 14.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.32 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 174.23 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.6 p -52.53 -44.16 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 151' ' ' LEU . 3.2 t30 -80.51 128.49 72.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.352 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.43 -30.35 86.85 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.393 2.062 . . . . 0.0 112.592 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.7 -22.98 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 148' ' ' ASN . 19.4 mt -81.01 6.3 13.85 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 99.6 m -70.2 162.38 28.5 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.163 0.506 . . . . 0.0 110.396 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -172.38 159.09 4.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.836 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 116' ' ' THR . 6.8 m -119.0 150.25 40.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -113.84 105.04 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 115' ' ' VAL . 28.5 mt-10 -109.78 125.29 52.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.037 0.446 . . . . 0.0 112.183 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.84 114.22 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.211 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.462 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.1 m95 -108.31 150.59 27.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.064 0.459 . . . . 0.0 111.985 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.33 125.33 36.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.32 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.07 123.28 6.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.661 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.637 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -107.67 -177.59 3.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.133 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.738 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.77 149.2 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.48 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 3.4 m-30 -113.64 108.35 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.48 117.15 33.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.605 0.717 . . . . 0.0 112.45 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.477 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.1 p90 -161.52 166.84 26.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.261 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.86 132.55 54.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.607 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.7 pt20 -118.5 143.87 46.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -91.93 -167.82 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.42 52.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.01 -27.68 48.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.73 29.53 4.64 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.259 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' CD2' ' HA3' ' A' ' 124' ' ' GLY . 1.9 tt -84.27 157.87 21.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.962 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.448 ' N ' HD21 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -111.93 -58.53 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.459 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.0 -162.23 24.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.96 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.637 ' HG3' ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -126.24 -164.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.716 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.11 86.41 6.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.654 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.35 114.98 3.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.311 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -100.71 133.9 44.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 0.0 111.134 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.623 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -101.38 -51.38 0.17 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.219 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 19' ' ' LEU . 77.2 Cg_endo -93.62 107.95 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.764 2.309 . . . . 0.0 112.448 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -126.53 111.76 14.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.87 119.67 9.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -161.75 101.97 1.18 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.16 -48.39 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.554 2.169 . . . . 0.0 113.068 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.86 -14.75 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.488 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -57.28 -31.28 65.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 mp -62.92 -49.87 73.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.717 0.294 . . . . 0.0 111.287 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -52.86 -25.43 11.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.989 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -73.88 -62.75 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.44 ' CA ' ' HB2' ' A' ' 33' ' ' GLN . 27.5 p90 -92.49 27.68 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.491 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -53.81 25.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.849 0.357 . . . . 0.0 110.809 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.0 -19.55 51.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.538 ' HA ' ' CG ' ' A' ' 37' ' ' LYS . 1.5 mt-30 -67.36 -7.52 25.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.76 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.401 ' HB ' ' CZ ' ' A' ' 57' ' ' ARG . 18.3 p -88.9 -18.71 26.99 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 37' ' ' LYS . 3.5 m -107.8 117.67 53.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.068 0.461 . . . . 0.0 112.222 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 92' ' ' GLN . . . 57.42 -10.35 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.72 -0.673 . . . . 0.0 114.7 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 35' ' ' VAL . 6.7 mmtt -69.46 95.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.559 0.695 . . . . 0.0 110.944 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.501 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 20.4 mt -64.41 110.7 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.692 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.8 ttp -100.79 115.26 29.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.584 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.509 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 2.7 t -88.99 124.3 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.167 0.508 . . . . 0.0 112.201 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.0 144.33 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.379 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.09 156.97 51.79 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.172 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.48 -51.01 68.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 110.514 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.432 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -58.43 -34.87 71.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -68.24 -47.49 67.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -54.13 -31.91 53.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -66.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.652 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 49' ' ' PHE . 2.4 m -57.6 -30.75 65.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.42 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -32.92 122.7 0.42 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.9 -179.23 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.28 -38.2 88.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.963 2.442 . . . . 0.0 113.311 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.57 116.28 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.429 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.51 135.09 14.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.709 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.42 -171.86 8.41 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.354 -1.519 . . . . 0.0 112.161 -0.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 57' ' ' ARG . 95.7 mt -97.84 147.2 32.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.571 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.67 -86.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.091 2.527 . . . . 0.0 113.451 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.84 25.65 8.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.624 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.429 ' HB2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.142 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 80.3 m -74.7 122.0 22.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 111.873 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -102.81 152.79 20.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.9 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.509 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 2.2 t -137.38 131.71 44.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.5 t -103.47 126.19 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.272 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.416 HD13 ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -109.87 108.29 18.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.944 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.446 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 2.9 t -144.19 164.11 31.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 111.396 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -81.1 -9.83 59.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.289 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.668 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.9 tp60 -71.74 127.18 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.332 . . . . 0.0 110.392 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -27.91 55.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -105.13 16.93 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.641 0.258 . . . . 0.0 111.493 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.668 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.6 t80 -62.25 137.24 58.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.485 0.659 . . . . 0.0 112.454 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.41 171.99 11.06 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.251 1.024 . . . . 0.0 112.357 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.07 140.14 16.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -76.07 96.81 3.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.813 0.339 . . . . 0.0 110.941 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.95 -42.26 2.31 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.556 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 167.92 19.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.133 0.492 . . . . 0.0 112.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.81 140.89 15.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.127 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 t -107.01 121.61 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.386 0.612 . . . . 0.0 111.955 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.551 HG21 HG21 ' A' ' 82' ' ' VAL . 18.0 m -132.74 178.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.131 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -127.79 -21.11 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.8 -177.11 6.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.457 . . . . 0.0 111.591 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' A' ' 106' ' ' PHE . 24.2 t -70.08 -11.17 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.433 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.11 -37.24 17.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.107 0.48 . . . . 0.0 110.064 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.83 -30.63 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.665 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.551 HG21 HG21 ' A' ' 76' ' ' VAL . 23.3 t -72.35 -55.81 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.484 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 8.5 m-85 -52.49 -31.21 34.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.6 -43.81 97.87 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 87.5 t80 -61.04 -52.6 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.3 -22.33 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.35 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mtmt -70.99 -37.14 72.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.126 0.489 . . . . 0.0 109.874 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -8.7 59.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 92' ' ' GLN . 95.1 m-70 -120.01 62.45 8.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.93 -6.04 8.69 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.655 2.237 . . . . 0.0 112.226 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -99.55 -25.75 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.982 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.637 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 10.3 mt-30 -94.11 151.6 19.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 29.2 mt-10 -99.09 174.76 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.58 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 1' ' ' THR . 17.2 tp -131.23 111.17 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 111.308 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 39' ' ' MET . 83.9 t -129.23 116.14 38.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.458 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 6.3 mm -82.02 138.13 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.88 0.371 . . . . 0.0 111.082 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.76 -33.14 5.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.94 -171.89 44.41 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.462 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.62 -160.97 36.17 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 117.588 0.694 . . . . 0.0 112.632 -0.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.01 -55.75 15.9 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.8 0.333 . . . . 0.0 111.294 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -56.47 -31.92 64.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.025 0.441 . . . . 0.0 110.464 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.4 mm -77.11 -30.54 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.053 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.0 m-85 -58.02 -52.98 63.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.366 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.527 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 12.0 t -69.53 -10.22 57.19 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.36 -39.71 64.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 0.0 110.671 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 3.8 m-85 -102.35 -3.55 26.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.584 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.527 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 5.9 pttt -51.65 -31.23 24.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.7 -5.69 58.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.555 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.82 -20.65 8.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.657 0.265 . . . . 0.0 111.475 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.543 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 73.4 t -45.58 134.15 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.12 0.486 . . . . 0.0 111.427 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 18.1 t70 -111.26 -0.32 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.738 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.6 m -166.74 137.44 3.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.565 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 6.1 mt -118.13 145.64 44.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.24 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 4' ' ' LEU . 9.4 mt -134.96 112.74 10.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.062 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.1 m -127.94 137.39 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.055 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.92 119.93 36.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.182 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 100.6 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 0.9 OUTLIER -81.13 135.31 35.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.94 -53.84 52.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 122' ' ' PHE . . . -58.04 156.32 19.52 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.234 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 p -97.04 154.13 17.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -142.68 156.48 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.824 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 156.92 16.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.252 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.637 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . 178.56 175.41 45.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.911 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.22 22.08 4.45 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.3 m -133.0 126.96 33.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.75 0.31 . . . . 0.0 110.838 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -108.65 162.31 14.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.3 tpt -72.93 158.44 35.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.491 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.2 pp -88.75 164.97 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.178 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.22 96.79 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 112.655 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.1 149.49 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.997 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.02 71.35 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.479 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.476 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 95.6 m95 -58.96 -20.11 49.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.86 -32.06 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.756 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -79.39 -24.52 42.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.57 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 95.5 m-85 -101.46 171.62 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 111.076 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -134.93 141.76 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.592 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.2 ttpm? -84.76 105.81 15.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 34.9 m -89.9 -17.96 7.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.985 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -161.85 141.47 10.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 111.17 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.592 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 99.2 p -172.01 108.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -147.87 130.52 15.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.26 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 1.4 m -74.27 146.3 43.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.148 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 152' ' ' THR . 11.3 t -118.3 104.62 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.383 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -93.33 104.89 17.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.72 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.7 -174.51 4.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.498 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -54.58 -54.89 35.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.864 0.364 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.515 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.8 t30 -75.93 141.08 71.07 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.769 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.77 -36.57 18.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.819 1.679 . . . . 0.0 112.369 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.91 -23.4 44.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.878 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -77.69 9.61 3.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.566 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 153' ' ' HIS . 50.3 m -83.95 158.64 21.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.434 ' N ' HG23 ' A' ' 152' ' ' THR . 0.6 OUTLIER -170.68 155.83 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 116' ' ' THR . 39.6 m -117.69 129.44 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.404 ' OH ' ' CE1' ' A' ' 153' ' ' HIS . 57.2 m-85 -100.77 105.64 16.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.409 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.495 ' HB2' HG22 ' A' ' 115' ' ' VAL . 17.0 mt-10 -104.61 126.68 51.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.307 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.403 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 6.2 t -118.07 112.56 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.539 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 30.2 m95 -104.63 148.27 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.067 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -128.33 119.22 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.747 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.4 tttt -51.54 135.13 28.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.26 -165.86 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.575 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 9.6 m . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.698 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.93 148.64 33.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.9 m-85 -113.87 112.24 23.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.278 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.567 ' HG ' ' HB ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -115.84 127.83 55.34 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.474 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 5.5 p90 -168.63 163.8 12.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.216 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.22 131.73 53.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.862 0.363 . . . . 0.0 111.732 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.541 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 7.5 pt20 -130.61 161.54 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.415 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.11 -169.03 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HD3' ' HB3' ' A' ' 121' ' ' SER . 0.0 OUTLIER -55.34 -27.73 49.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.67 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 9.2 t70 -90.63 -33.98 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 105.17 57.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.859 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 67.1 mt -110.22 152.23 26.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 pt -112.4 -39.37 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.343 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.33 151.31 10.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.627 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.74 -73.99 0.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.815 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.75 150.23 3.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.73 173.07 12.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.561 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -87.33 -19.5 28.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.655 0.264 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 2.1 tp 65.75 63.26 1.01 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 14.8 Cg_exo -68.46 -66.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.635 2.224 . . . . 0.0 112.15 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -77.59 144.73 37.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -126.31 171.84 10.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -130.07 129.48 22.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.732 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.521 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 31.5 Cg_exo -58.84 -12.08 13.89 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.542 2.161 . . . . 0.0 112.98 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -76.2 -44.54 37.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.36 -23.64 17.09 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 3.5 mm? -78.52 -35.38 46.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.521 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 1.9 t-80 -52.75 -35.42 56.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.473 ' HB2' ' CE1' ' A' ' 155' ' ' TYR . 31.6 t80 -105.35 -7.42 18.85 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -92.32 -75.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -62.35 -54.86 34.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.515 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.76 -25.77 3.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.848 0.356 . . . . 0.0 111.953 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -92.92 -3.39 54.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.567 ' HB ' ' HG ' ' A' ' 4' ' ' LEU . 12.9 t -135.6 -35.56 0.8 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.529 ' CG1' ' HD3' ' A' ' 57' ' ' ARG . 13.0 m -74.42 161.58 4.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.525 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . 83.56 2.86 89.98 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.483 -0.865 . . . . 0.0 114.918 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -149.53 -164.23 1.97 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.29 1.545 . . . . 0.0 109.298 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.446 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 40.8 mt -76.82 88.96 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 111.579 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.487 ' HG3' ' OG1' ' A' ' 34' ' ' THR . 27.5 ttp -103.11 126.74 50.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.641 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 39.3 t -79.87 156.51 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.759 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 31.2 m -163.7 140.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.984 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.76 147.75 48.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.32 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.578 ' HG2' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -49.93 -46.39 52.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.445 0.622 . . . . 0.0 110.613 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -58.97 -39.55 82.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 109.963 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -65.98 -48.67 70.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.984 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -57.31 -27.22 61.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.79 -66.23 0.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.658 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.12 -23.88 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.437 ' CD1' ' HD2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -35.71 133.12 0.53 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.901 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 99.6 Cg_exo -46.8 -35.96 18.74 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.144 2.563 . . . . 0.0 113.534 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.84 148.55 31.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.197 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.95 111.84 6.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.252 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -81.76 179.09 28.53 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 123.408 -1.497 . . . . 0.0 111.787 -0.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.518 ' HB3' ' CD ' ' A' ' 57' ' ' ARG . 77.8 mt -78.87 143.42 62.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.766 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.81 109.2 2.06 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.514 2.143 . . . . 0.0 112.609 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 mt-10 73.19 0.12 3.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.968 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.529 ' HD3' ' CG1' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -109.89 106.88 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 -179.343 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 87.9 m -64.99 120.31 12.36 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.11 157.32 19.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.203 0.525 . . . . 0.0 112.362 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 17.7 t -134.15 143.58 37.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.765 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 43' ' ' ARG . 57.8 t -113.58 111.04 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.179 0.514 . . . . 0.0 111.891 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -91.58 118.35 30.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.304 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -155.37 148.17 24.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.936 179.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -69.02 -6.32 27.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.258 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.7 tt0 -73.29 131.6 42.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.329 . . . . 0.0 110.747 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -85.42 5.47 30.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.838 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -134.6 7.72 3.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.4 t80 -59.91 137.51 58.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.289 0.566 . . . . 0.0 111.594 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 1.3 mt-30 -133.15 171.94 13.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.454 1.121 . . . . 0.0 113.14 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.5 140.29 17.13 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.138 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.97 102.56 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.07 -41.05 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.274 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.49 170.51 14.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.017 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 21.6 t -98.53 141.33 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 14.8 t -114.37 122.37 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 0.0 112.187 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' CG2' HG21 ' A' ' 82' ' ' VAL . 27.3 m -129.91 173.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.111 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' THR . 6.0 m170 -118.44 -24.22 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.1 -171.82 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 111.165 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.6 t -68.91 -11.29 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.54 -36.84 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 110.094 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.81 -29.67 63.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.89 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 76' ' ' VAL . 21.5 t -72.3 -55.19 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 120.904 0.383 . . . . 0.0 110.039 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.519 ' O ' ' HG3' ' A' ' 87' ' ' LYS . 9.4 m-85 -53.61 -27.59 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.817 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.08 -48.64 79.28 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.846 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 83.1 t80 -58.98 -51.24 70.91 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.99 -22.84 16.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.095 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 6.6 mtmp? -67.78 -44.5 77.29 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -79.63 -2.83 44.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.596 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.424 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 61.7 m-70 -128.68 64.43 69.04 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-O 120.995 0.426 . . . . 0.0 110.388 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.19 -0.01 6.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.184 2.589 . . . . 0.0 112.935 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.89 -31.83 18.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.169 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.74 162.94 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.364 . . . . 0.0 111.34 -179.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -104.17 174.71 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.223 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 1' ' ' THR . 6.2 tp -110.5 117.08 32.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 t -121.53 107.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.093 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.406 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 16.4 mm -76.76 132.08 33.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 111.593 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.13 -37.15 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.027 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.34 -172.66 45.0 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.827 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.9 -161.11 31.7 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 122.216 -0.579 . . . . 0.0 112.535 -0.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.3 -55.36 32.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.737 0.303 . . . . 0.0 111.045 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -55.14 -26.49 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.571 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.9 mm -80.62 -26.41 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.436 ' HB3' HG12 ' A' ' 129' ' ' ILE . 3.4 m-85 -62.71 -55.84 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.472 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.529 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 4.6 t -66.72 -10.11 43.53 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.38 -41.3 48.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.118 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' O ' HG22 ' A' ' 110' ' ' VAL . 2.5 m-85 -96.69 -8.28 31.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.478 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.91 -29.24 19.23 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.856 0.36 . . . . 0.0 111.161 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.52 -3.74 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.551 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -128.8 -19.09 3.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 77.7 t -44.45 131.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.44 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 9.9 t70 -109.22 4.36 22.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.285 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 21.7 m -167.74 135.72 2.38 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.6 0.238 . . . . 0.0 110.821 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 13.8 mt -116.52 142.44 46.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 3.7 mt -135.53 115.69 13.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.474 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -138.1 147.39 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.92 105.91 13.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.022 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 18.3 ttt180 -86.39 104.71 16.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.79 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.421 HD22 ' CE1' ' A' ' 122' ' ' PHE . 6.8 mp -85.14 128.3 34.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.931 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.55 -54.0 48.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.056 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.13 168.52 19.85 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.46 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.409 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 95.3 p -105.28 141.97 35.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.683 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -137.11 175.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 162.55 29.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 164.08 133.15 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -106.05 -24.8 12.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.64 0.257 . . . . 0.0 111.237 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.36 144.73 37.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 111.198 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.56 -174.63 2.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.0 tpt -86.24 160.01 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.189 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 103' ' ' PHE . 1.6 pp -86.87 166.24 27.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.193 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.406 ' CD ' ' HB ' ' A' ' 129' ' ' ILE . 20.3 Cg_exo -66.29 94.25 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.874 2.383 . . . . 0.0 112.908 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.42 149.01 23.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.068 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.7 77.74 3.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.419 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 92.6 m95 -59.32 -18.2 35.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.532 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.57 -30.93 61.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 111.032 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.78 -25.79 49.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.274 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 95.8 m-85 -97.18 174.23 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.004 0.43 . . . . 0.0 111.541 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.409 ' CB ' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -136.88 142.74 42.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.0 OUTLIER -78.26 119.3 21.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.978 179.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.16 -23.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.219 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.7 m -163.23 140.77 7.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.607 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 80.9 p -160.7 110.12 1.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.978 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -141.64 114.54 8.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.015 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 7.4 m -73.07 143.99 47.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.481 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.48 105.3 18.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.951 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -90.73 102.15 14.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.714 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.79 -177.73 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.595 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 36.3 p -59.51 -49.52 77.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.495 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 4.3 t30 -74.41 125.44 89.83 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.774 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.5 -28.21 86.91 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.089 1.859 . . . . 0.0 112.338 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -89.3 -20.07 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.027 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.8 mt -84.91 8.75 16.44 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 80.4 m -73.25 166.27 23.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.912 0.387 . . . . 0.0 110.004 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 3.6 p80 -173.74 160.33 3.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 8.0 m -126.84 140.13 52.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.264 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 29' ' ' TYR . 51.0 m-85 -100.03 105.72 17.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.468 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -104.24 121.81 44.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.928 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.6 t -114.51 112.96 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.8 m95 -112.63 150.8 30.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.274 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -128.51 118.89 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.36 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.3 tttt -57.35 133.08 54.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.865 0.364 . . . . 0.0 111.153 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.409 ' HE2' ' CB ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 177.16 157.67 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.099 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.141 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.537 0.208 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.23 143.08 37.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.296 0.57 . . . . 0.0 112.366 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.477 ' CD1' HG23 ' A' ' 110' ' ' VAL . 1.3 m-30 -112.36 112.98 24.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.543 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -113.15 123.16 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 111.648 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 5.6 p90 -166.29 173.88 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.518 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.68 137.65 51.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 111.612 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -130.25 157.0 43.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.592 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 20.7 p-10 -108.33 -171.67 1.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -36.47 64.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.38 -28.03 34.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.702 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.6 -4.22 66.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.893 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 2.5 pp -80.59 157.46 26.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.927 0.363 . . . . 0.0 111.021 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.96 -35.91 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.1 -156.87 27.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.81 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -103.84 -139.46 0.36 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.671 -0.122 . . . . 0.0 110.671 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -149.95 107.75 3.69 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.902 0.382 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.64 -95.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.367 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -71.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.641 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt 58.24 80.69 0.27 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.339 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.41 109.8 2.36 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.256 . . . . 0.0 112.01 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.04 121.64 42.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 111.243 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -120.57 27.33 8.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.716 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.22 147.2 33.34 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.04 -24.72 23.54 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.599 2.2 . . . . 0.0 112.348 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -48.59 -27.37 2.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.552 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -90.31 -54.49 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.192 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -63.16 -14.45 49.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.914 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -91.44 -29.12 17.22 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -105.17 -39.53 6.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 111.599 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 5' ' ' TRP . 17.7 m-85 -92.2 30.37 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.369 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 4.2 ttm-85 -91.86 -61.52 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.35 -28.16 15.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.704 0.288 . . . . 0.0 111.636 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -69.14 -17.61 63.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.753 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.431 ' CG2' HD21 ' A' ' 4' ' ' LEU . 34.9 p -116.52 -31.07 5.67 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 ' HB ' ' HD3' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -107.63 151.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.183 0.516 . . . . 0.0 112.36 -178.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.27 -7.5 51.64 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.935 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.45 -164.53 1.97 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.387 1.094 . . . . 0.0 109.563 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.43 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.3 mt -81.34 88.67 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.118 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.1 ttp -99.07 123.13 43.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 4.4 t -89.22 128.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.4 ' CG1' ' HE3' ' A' ' 39' ' ' MET . 33.5 m -131.49 148.12 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.538 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.87 151.22 51.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.385 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -49.83 -51.12 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.415 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.8 tpt180 -62.18 -36.76 82.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.303 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -66.86 -36.25 81.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.942 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.53 -22.34 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.592 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -65.22 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.2 t -48.37 -36.58 14.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -43.18 157.27 0.25 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.012 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.12 -67.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.673 2.249 . . . . 0.0 112.768 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.25 164.06 36.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 16.9 mtm180 -117.12 115.08 38.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 67.6 Cg_endo -88.74 -164.99 2.78 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.005 -1.248 . . . . 0.0 112.329 0.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 55.4 mt -107.51 144.63 29.63 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 37.3 Cg_endo -65.97 118.11 5.22 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.555 2.17 . . . . 0.0 112.638 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 7.1 mt-10 68.02 7.49 5.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.944 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.511 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 1.3 mtt180 -119.24 100.31 7.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.887 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 34.9 m -67.72 109.92 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -104.39 139.51 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.305 0.574 . . . . 0.0 112.265 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 4.5 t -113.0 143.16 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.121 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.41 HG13 ' HA ' ' A' ' 43' ' ' ARG . 84.9 t -114.77 125.06 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 111.9 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.9 tp -104.66 120.36 41.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -153.62 171.18 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -91.91 -8.03 47.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.6 tt0 -77.9 130.72 36.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.339 . . . . 0.0 110.786 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -80.79 0.05 36.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.004 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -126.79 10.03 7.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.578 0.228 . . . . 0.0 111.407 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.49 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.4 t80 -59.34 141.62 54.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -132.52 174.54 10.17 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 122.343 1.068 . . . . 0.0 112.902 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.84 143.62 20.77 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.398 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -73.17 98.56 2.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.771 0.319 . . . . 0.0 110.835 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.18 -36.7 2.89 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.535 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.69 172.38 8.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 0.0 111.489 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.99 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.76 122.72 67.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.134 0.492 . . . . 0.0 111.365 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.442 ' CG2' HG23 ' A' ' 82' ' ' VAL . 30.8 m -133.61 168.61 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.334 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 65' ' ' GLN . 9.0 m80 -117.1 -22.52 8.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.358 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.06 -177.36 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 111.578 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.465 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 21.5 t -70.79 -8.57 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.99 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.76 -31.24 17.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 110.053 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.429 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -77.03 -27.26 54.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.681 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.442 HG23 ' CG2' ' A' ' 76' ' ' VAL . 95.2 t -75.67 -52.59 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 8.2 m-85 -57.39 -25.02 58.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.689 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -66.3 -57.55 7.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.4 43.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.04 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.652 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.14 -33.01 72.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 9.7 mt-30 -88.75 -4.13 58.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.26 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -126.02 63.97 50.69 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.33 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.06 -0.14 5.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.169 2.579 . . . . 0.0 112.94 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.79 -37.23 30.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -112.14 163.84 13.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -98.64 164.25 12.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -108.16 124.96 51.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.313 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 39' ' ' MET . 69.3 t -131.87 118.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.345 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 3.0 mm -82.48 138.69 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 111.408 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -102.63 -52.98 2.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.775 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.11 -166.15 38.95 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.48 -161.01 36.77 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 117.813 0.806 . . . . 0.0 112.639 -0.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.78 -44.13 38.65 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.81 0.338 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.82 -34.33 74.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.717 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.4 mm -80.97 -23.11 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -63.21 -52.06 63.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.55 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.52 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 14.5 t -68.48 -9.58 49.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.35 -39.99 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 110.68 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.465 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 4.2 m-85 -100.69 -4.8 27.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.368 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.3 pttt -48.18 -32.65 7.32 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.94 -2.16 58.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.789 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 m-20 -119.18 -26.89 5.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.585 0.231 . . . . 0.0 111.554 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 3' ' ' PHE . 82.5 t -45.91 122.48 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 111.576 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -105.85 8.35 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.022 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.7 m -168.25 138.29 2.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.969 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.432 HD11 ' CZ3' ' A' ' 133' ' ' TRP . 5.8 mt -121.46 146.2 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.319 0.581 . . . . 0.0 112.101 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.3 mt -135.15 114.67 12.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.241 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.495 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -136.89 147.33 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.128 0.489 . . . . 0.0 112.133 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -107.93 119.01 38.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.915 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -79.46 99.01 7.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.383 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mt -85.94 108.96 18.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.177 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.33 78.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.034 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.5 171.49 54.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.554 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t -110.14 162.65 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 111.018 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 6.6 m-85 -138.42 170.05 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.253 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.42 169.95 8.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.89 -170.73 24.76 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.689 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.26 29.22 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.018 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -141.62 129.83 22.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 16.5 tttm -111.55 150.24 30.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.806 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.17 179.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.54 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.6 pt -97.27 162.67 21.91 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.188 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.2 Cg_endo -73.86 99.3 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.45 2.1 . . . . 0.0 112.102 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.427 ' CD1' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt -88.46 147.84 24.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 74.19 2.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.024 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.432 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 92.7 m95 -54.52 -24.17 19.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.94 -26.29 62.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.3 t0 -83.23 -19.51 36.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.737 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 89.9 m-85 -107.93 165.9 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.626 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.544 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -126.61 139.79 52.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 110.509 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 11.2 ttpt -79.6 117.25 20.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.464 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 24.5 m -101.94 -21.84 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.927 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -163.09 140.61 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 8.6 p -155.94 111.02 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.501 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -141.42 117.1 10.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.789 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.2 m -72.62 133.48 44.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.161 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.64 109.77 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.583 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.495 ' HA ' ' CG2' ' A' ' 152' ' ' THR . 11.2 mt-10 -96.99 97.51 9.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -81.51 -161.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.191 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.2 p -74.38 -48.65 26.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.9 t30 -69.18 119.85 72.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.075 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.31 -20.57 56.29 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.083 1.856 . . . . 0.0 111.989 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -23.65 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.573 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.6 mt -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 145' ' ' GLU . 1.7 m -85.86 82.21 8.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 5.3 p80 -97.12 -171.3 2.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.565 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 55.9 m -125.55 165.26 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.079 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' SER . 1.6 m-85 -118.79 105.85 11.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.96 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.4 mt-10 -109.69 125.27 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.778 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.0 t -116.12 115.04 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.278 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.452 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 23.8 m95 -111.97 150.47 30.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.22 0.534 . . . . 0.0 111.655 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -127.28 121.12 30.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.784 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 2.3 tmmt? -54.94 130.42 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 0.0 111.62 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.544 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.59 -170.52 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.553 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.126 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 110' ' ' VAL . 21.7 m . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.72 145.36 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.515 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.8 m-85 -112.17 111.53 22.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.314 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -111.16 119.07 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.544 0.688 . . . . 0.0 112.569 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.496 ' CZ2' HG11 ' A' ' 115' ' ' VAL . 6.7 p90 -160.32 166.89 28.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.411 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.99 140.18 48.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.957 0.408 . . . . 0.0 111.769 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -138.99 141.34 38.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.675 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -100.35 -163.38 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.436 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -51.63 -48.9 63.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.345 0.593 . . . . 0.0 109.978 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.55 -32.69 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.037 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.11 43.47 3.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.4 OUTLIER -82.51 165.15 20.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.753 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.83 -37.92 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.452 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.36 -153.31 22.26 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.43 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -120.37 157.24 29.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.939 0.399 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -6.08 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.734 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.63 -51.42 1.41 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.615 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.82 179.92 4.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 0.0 111.039 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.63 145.46 71.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.972 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -86.92 -170.89 0.68 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.836 2.357 . . . . 0.0 112.342 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -93.52 177.48 6.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.906 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -113.26 117.22 31.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.33 132.98 23.94 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.646 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.09 -45.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.716 2.278 . . . . 0.0 113.24 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -64.07 -29.89 70.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.607 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -88.02 -18.02 29.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.603 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.1 mt -73.83 -34.45 64.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.752 0.311 . . . . 0.0 111.231 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -59.98 -24.65 64.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.469 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.451 ' CD2' HG22 ' A' ' 116' ' ' THR . 51.3 t80 -103.9 -21.88 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.633 0.254 . . . . 0.0 111.512 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -86.99 -28.43 22.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.684 0.278 . . . . 0.0 111.307 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 mtp-105 -91.98 -61.14 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.735 0.302 . . . . 0.0 111.655 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.87 -21.83 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -91.71 -7.69 49.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.438 ' HB ' ' HG ' ' A' ' 4' ' ' LEU . 3.6 t -129.21 -27.9 2.41 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 57' ' ' ARG . 23.1 m -93.68 150.37 3.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 37' ' ' LYS . . . 106.2 -6.81 39.95 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.419 -0.896 . . . . 0.0 114.416 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 34.6 mmtm -149.09 -165.14 2.2 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.681 1.241 . . . . 0.0 109.729 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.483 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 62.8 mt -74.43 89.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.12 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 ttp -99.61 125.0 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.651 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.483 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 21.4 t -79.14 157.36 4.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.423 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.483 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 31.2 m -162.91 153.19 3.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.13 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 154.36 47.76 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.813 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.931 0.366 . . . . 0.0 110.813 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.4 tpm_? -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.575 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -71.4 -47.5 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -58.21 -23.47 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.18 -65.82 0.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -56.45 -26.8 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.381 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -39.84 130.27 1.51 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.551 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.3 -27.96 5.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.383 . . . . 0.0 113.329 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -157.12 133.05 9.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.286 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -126.84 108.2 22.41 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 69.3 Cg_endo -80.49 -171.96 10.41 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.582 -1.424 . . . . 0.0 111.831 0.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 64.4 mt -91.55 158.19 40.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.44 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.78 -43.6 56.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.91 2.406 . . . . 0.0 113.533 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 4.6 mt-10 -140.58 46.05 1.8 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.835 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -146.53 111.37 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.339 . . . . 0.0 111.811 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.1 m -71.29 115.5 10.52 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -101.07 159.42 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.475 0.655 . . . . 0.0 112.59 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.442 ' CG1' HG21 ' A' ' 76' ' ' VAL . 5.7 t -137.17 133.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.366 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.7 126.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HG ' ' CG2' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -105.24 118.8 37.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.052 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.97 161.85 42.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.15 -10.64 59.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.723 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -81.44 134.25 35.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -82.88 -24.98 32.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -95.65 4.46 53.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.666 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.557 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.0 t80 -59.3 140.68 55.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 111.403 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.479 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 1.1 mt-30 -132.79 172.92 11.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.314 1.054 . . . . 0.0 112.846 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.38 143.83 20.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.728 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -88.2 98.05 11.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.52 62.01 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.036 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.66 166.08 17.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.88 0.372 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 HG21 ' CE1' ' A' ' 85' ' ' TYR . 16.2 t -96.17 138.17 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.986 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 38.6 t -104.4 104.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.322 0.582 . . . . 0.0 112.541 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 82' ' ' VAL . 26.5 m -117.41 166.29 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.398 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -116.35 -19.05 10.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.584 0.23 . . . . 0.0 111.062 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -157.99 -176.3 5.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.611 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 106' ' ' PHE . 18.4 t -68.41 -8.36 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.952 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -35.93 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.219 0.533 . . . . 0.0 109.794 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -73.37 -32.57 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.701 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 76' ' ' VAL . 97.6 t -70.7 -50.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -57.03 -25.54 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.202 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.39 82.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.045 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' ' NE2' ' A' ' 89' ' ' HIS . 92.5 t80 -65.49 -56.65 11.24 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.78 -21.71 11.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.96 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -69.13 -39.97 78.56 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.53 -5.6 58.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.387 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.452 ' NE2' ' CE1' ' A' ' 85' ' ' TYR . 98.1 m-70 -126.28 65.89 59.41 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.547 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.58 -0.42 5.94 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.104 2.536 . . . . 0.0 112.923 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.19 -30.91 16.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.69 158.34 16.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -98.86 164.49 12.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.8 tp -114.01 114.64 26.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.97 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.24 116.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.211 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.9 mm -77.98 134.9 27.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.087 0.47 . . . . 0.0 111.412 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.42 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -106.84 -46.92 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.87 -170.83 43.95 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.894 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.3 -160.81 36.89 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 122.002 -0.705 . . . . 0.0 112.647 -0.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.47 11.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -52.52 -28.68 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 62' ' ' LEU . 48.5 mm -85.16 -27.36 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.3 m-85 -60.28 -52.97 63.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.551 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.538 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 12.6 t -67.66 -9.76 46.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.09 -41.71 58.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.799 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.501 ' HA ' HG23 ' A' ' 79' ' ' VAL . 3.3 m-85 -101.55 -3.62 28.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.7 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 20.9 pttp -48.07 -32.21 6.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.751 0.31 . . . . 0.0 111.669 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -87.35 -19.19 28.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.552 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.8 -22.79 15.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.486 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.515 HG22 ' CD1' ' A' ' 3' ' ' PHE . 98.2 t -44.76 126.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.968 0.413 . . . . 0.0 111.61 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -101.82 -7.96 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.674 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 35.2 m -160.1 141.95 12.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.308 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 15.5 mt -120.38 145.81 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 111.649 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.98 114.89 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 156' ' ' GLU . 1.2 m -135.41 145.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.991 0.424 . . . . 0.0 111.956 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -109.94 99.12 8.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.692 179.209 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 99.82 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.796 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.6 mp -86.04 127.47 34.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.404 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.8 -47.52 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.665 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -82.24 160.44 40.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 13.7 t -91.39 166.28 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -138.55 167.55 21.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.31 167.66 13.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 161.83 166.26 20.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.7 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.29 -28.17 7.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.666 0.269 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.0 m -109.27 148.8 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.28 174.96 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.77 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.5 tpt -73.58 158.53 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.626 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -84.39 165.53 37.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.066 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.4 Cg_endo -74.97 96.11 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.323 2.015 . . . . 0.0 112.307 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.73 149.47 24.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.85 72.59 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.008 0.432 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.468 ' CZ3' HD12 ' A' ' 113' ' ' LEU . 91.1 m95 -58.49 -21.04 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -32.31 65.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.93 0.395 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -80.43 -15.67 56.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 113' ' ' LEU . 68.9 m-85 -107.43 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.095 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.44 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -127.9 142.26 51.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.634 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.513 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.8 OUTLIER -83.62 109.88 17.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 33.1 m -93.65 -22.44 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.448 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.0 m -159.45 140.62 12.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.181 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.6 p -165.4 116.08 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 -147.3 122.78 10.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 1.8 m -78.41 145.01 35.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.22 0.533 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 152' ' ' THR . 8.1 t -120.35 103.41 13.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.138 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.42 103.76 15.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.717 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.71 -172.66 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.107 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.6 p -54.72 -58.86 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 110.465 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.476 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -69.84 118.76 66.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.896 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.88 -22.35 62.12 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.112 1.875 . . . . 0.0 112.361 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -95.27 -16.03 22.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.367 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.7 mt -88.4 9.05 24.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.785 0.326 . . . . 0.0 111.164 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 144' ' ' VAL . 61.2 m -68.94 167.91 14.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.936 0.398 . . . . 0.0 109.993 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -167.99 153.9 7.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 18.4 m -122.69 128.96 51.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.826 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -90.69 104.77 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.408 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.497 ' HB2' HG22 ' A' ' 115' ' ' VAL . 33.8 mt-10 -107.41 125.54 51.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 30.6 t -116.66 114.02 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.093 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.513 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 22.7 m95 -108.77 148.91 29.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -129.14 121.0 26.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.33 130.07 6.44 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.44 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -127.2 -163.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.195 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.044 179.787 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.559 0.219 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.16 145.66 39.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.489 ' CD1' HG22 ' A' ' 110' ' ' VAL . 1.7 m-30 -109.83 114.05 27.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.551 HD11 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.15 120.75 42.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.475 -179.243 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.483 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 4.5 p90 -166.48 166.42 16.36 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.379 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.78 136.0 54.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.242 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -124.85 154.06 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.04 -179.48 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.07 -45.04 15.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 110.471 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -23.19 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.526 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 27.07 9.1 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.219 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.14 150.91 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.778 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 126' ' ' THR . 0.5 OUTLIER -124.36 178.44 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.607 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.48 150.85 52.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.77 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -58.93 -60.67 3.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.33 8.21 3.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.359 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.13 30.17 4.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.647 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.0 134.46 43.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.328 . . . . 0.0 110.893 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.97 125.92 42.32 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.779 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.29 -30.08 5.72 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.524 2.149 . . . . 0.0 112.67 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE2' HD22 ' A' ' 151' ' ' LEU . 3.7 m95 -98.67 166.4 11.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.178 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.74 27.8 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.68 127.29 84.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.721 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -44.8 -36.49 10.79 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.511 2.141 . . . . 0.0 112.778 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.95 -29.14 66.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.49 -60.05 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.222 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -17.65 58.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.325 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -67.02 -25.75 66.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.638 0.256 . . . . 0.0 111.268 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 116' ' ' THR . 73.4 t80 -105.29 -23.14 12.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.681 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.24 -39.58 17.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.579 0.228 . . . . 0.0 111.551 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -91.38 -52.13 4.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.456 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.15 -40.22 58.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.83 0.348 . . . . 0.0 111.594 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -73.41 -6.65 47.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.653 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -119.57 -19.93 7.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.701 0.286 . . . . 0.0 111.579 -179.802 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.486 ' CB ' ' HG2' ' A' ' 57' ' ' ARG . 35.6 m -107.87 138.74 32.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.49 ' H ' ' HG3' ' A' ' 57' ' ' ARG . . . 121.11 -12.22 9.82 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-O 119.159 -0.801 . . . . 0.0 114.923 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -152.43 -164.97 2.08 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.396 1.598 . . . . 0.0 109.552 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.499 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 61.3 mt -72.51 89.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 111.285 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 ttp -97.78 117.27 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.339 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.505 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 24.5 t -76.93 157.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.234 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 32.8 m -163.89 150.05 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.79 156.26 51.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.9 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.445 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.32 -50.18 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.962 0.381 . . . . 0.0 110.402 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.441 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.9 tpm_? -62.06 -29.64 70.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.323 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -74.1 -48.63 28.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.626 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -57.93 -28.32 64.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.708 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.91 -65.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.427 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.5 m -58.93 -26.59 64.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.395 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -35.74 137.83 0.44 Allowed Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HD2' ' CD2' ' A' ' 49' ' ' PHE . 58.5 Cg_exo -53.21 -32.34 59.72 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.928 2.419 . . . . 0.0 113.357 -179.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.18 137.99 18.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.383 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 5.8 ptm180 -141.43 114.84 6.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -89.25 168.2 34.51 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.657 -1.393 . . . . 0.0 111.919 -0.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 73.7 mt -78.07 149.92 77.13 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.6 -78.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.786 2.324 . . . . 0.0 113.098 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 37.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.294 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.553 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -148.33 133.19 18.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.128 0.49 . . . . 0.0 111.967 -179.246 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.1 m -92.11 119.63 31.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.153 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.09 157.43 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.608 . . . . 0.0 112.439 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 76' ' ' VAL . 3.5 t -137.37 138.34 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.333 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.9 t -114.57 120.32 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.795 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -102.16 118.97 38.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.475 ' CG2' ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.93 171.21 17.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.101 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -95.59 -12.47 25.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -62.94 133.03 54.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.885 0.374 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.28 1.69 20.86 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.45 16.63 2.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.536 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 3.0 t80 -58.5 139.32 55.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.193 0.52 . . . . 0.0 111.955 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.36 173.56 10.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.23 1.014 . . . . 0.0 112.367 178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.11 144.18 20.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -81.52 99.32 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.03 -46.79 2.45 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.2 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 172.84 6.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 0.0 111.657 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.454 HG22 ' CE1' ' A' ' 85' ' ' TYR . 10.4 t -97.98 139.73 19.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.96 115.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.116 0.484 . . . . 0.0 111.865 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' CG2' HG21 ' A' ' 82' ' ' VAL . 25.5 m -125.33 170.16 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.973 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.9 m170 -120.9 -21.91 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.344 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -153.54 -175.31 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.102 0.477 . . . . 0.0 111.54 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.432 HG13 ' CD2' ' A' ' 106' ' ' PHE . 33.7 t -69.61 -9.48 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.621 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.61 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 109.926 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.435 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . -75.88 -29.96 58.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 179.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' CG2' ' A' ' 76' ' ' VAL . 60.8 t -72.06 -52.45 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.2 m-85 -55.95 -26.79 49.6 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.986 178.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.92 -45.44 89.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.019 178.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' CE1' HG22 ' A' ' 74' ' ' VAL . 82.1 t80 -64.08 -54.49 33.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.77 -23.14 16.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.315 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 4.1 mmtp -67.28 -46.59 73.17 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -79.21 -2.83 42.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.448 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.444 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 54.7 m-70 -125.48 62.64 41.3 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.385 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.28 -0.53 5.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.064 2.51 . . . . 0.0 112.904 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -31.22 17.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.965 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -105.8 156.57 18.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -99.87 164.55 11.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.018 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tp -104.72 111.81 24.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.945 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.87 103.43 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.437 ' CD1' ' CG2' ' A' ' 40' ' ' VAL . 13.1 mm -73.71 132.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.027 0.441 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -104.01 -45.18 4.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.685 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.1 -166.81 39.71 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.695 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.39 -160.99 26.34 Favored Glycine 0 C--N 1.34 0.801 0 O-C-N 122.196 -0.59 . . . . 0.0 112.552 -0.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.05 66.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.73 0.3 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -53.91 -27.45 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.583 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 102' ' ' ILE . 32.1 mm -80.79 -29.0 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 3' ' ' PHE . 5.8 m-85 -59.64 -56.24 24.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.458 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.498 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 11.2 t -66.32 -10.16 40.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.35 -40.28 51.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.653 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.432 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.7 m-85 -99.59 -5.48 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.35 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.9 pttp -49.5 -31.67 10.6 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.756 0.313 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.25 0.48 53.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.288 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.05 -26.31 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.548 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.489 HG22 ' CD1' ' A' ' 3' ' ' PHE . 92.7 t -43.95 127.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.845 0.355 . . . . 0.0 111.55 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.429 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 11.3 t70 -105.27 3.72 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.322 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 m -167.6 137.84 2.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.599 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 9.2 mt -118.78 145.24 45.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.3 0.571 . . . . 0.0 111.819 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.26 113.05 10.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.483 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.6 m -132.58 143.09 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.6 107.05 14.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.433 179.436 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.7 OUTLIER -79.62 100.18 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.19 126.57 30.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.19 -53.14 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.004 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.46 170.68 9.31 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.353 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.2 p -106.78 147.04 30.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.7 m-85 -141.63 139.76 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -110.72 149.04 31.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.009 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.14 -143.4 3.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.554 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.33 21.94 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.424 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.6 m -159.99 134.08 7.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -107.37 158.43 17.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.963 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.8 177.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.491 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.4 pp -103.36 154.58 37.66 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.0 102.39 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.74 2.293 . . . . 0.0 112.687 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.9 147.85 22.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.008 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.74 76.25 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.451 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.415 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 86.9 m95 -57.79 -20.97 39.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.304 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.81 -29.32 63.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.844 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -78.58 -26.93 45.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.1 m-85 -99.16 176.55 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.77 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 m -137.3 141.93 41.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.246 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.479 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -80.67 119.02 22.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 -179.652 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -103.52 -11.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.7 m -171.51 140.35 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.74 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.0 p -167.93 110.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -148.11 120.64 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.0 m -69.01 145.38 53.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.236 0.541 . . . . 0.0 111.594 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.63 105.21 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.261 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -87.61 101.97 14.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.814 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.04 -171.41 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.493 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.7 p -60.19 -57.19 13.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.0 110.685 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.492 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -71.86 124.5 90.98 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.002 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.2 -28.46 86.96 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.961 1.774 . . . . 0.0 112.362 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.9 -21.1 25.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.395 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.5 mt -85.32 7.23 23.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.504 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 51.5 m -70.86 166.0 22.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.2 p80 -172.95 159.72 4.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.73 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 116' ' ' THR . 28.8 m -119.93 147.05 45.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.347 179.24 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -110.29 104.68 13.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.653 0.264 . . . . 0.0 110.827 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.46 ' HB2' HG23 ' A' ' 115' ' ' VAL . 30.9 mt-10 -106.83 124.29 49.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 111.755 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.74 114.12 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.159 179.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.479 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.5 m95 -110.03 150.7 28.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.51 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.74 115.2 19.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -56.84 131.52 49.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.673 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.57 156.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 178.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.176 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 18.0 m . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.798 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.08 154.9 25.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.493 ' CD1' HG21 ' A' ' 110' ' ' VAL . 1.5 m-30 -119.08 113.46 20.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.552 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.94 117.37 33.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 5.3 p90 -162.25 165.41 26.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.827 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 8.9 pt20 -129.99 156.25 44.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -103.66 -171.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.3 -27.66 37.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.082 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -32.89 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.032 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 101.72 46.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.528 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.91 163.99 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pp -141.04 -44.55 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.62 148.82 18.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.679 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.7 144.72 44.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -78.07 156.12 30.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.58 140.71 2.64 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.492 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -94.88 100.82 12.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mp -81.47 123.36 81.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.837 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.6 7.32 5.08 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.57 2.18 . . . . 0.0 112.867 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.4 102.8 12.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.756 0.313 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.02 138.9 39.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.17 158.29 33.39 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.38 -14.72 43.92 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.665 2.243 . . . . 0.0 112.647 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -72.75 -36.99 67.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.214 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.18 -29.03 14.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 tp -72.48 -29.34 63.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.435 -179.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -79.91 -43.16 22.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.33 . . . . 0.0 111.34 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.466 ' CE2' ' CG2' ' A' ' 116' ' ' THR . 31.1 t80 -64.92 -29.85 70.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.609 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.13 -27.76 26.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.653 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -91.98 -59.28 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.17 -33.27 5.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.941 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.469 ' HB3' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -79.52 -5.25 54.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.26 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.448 ' CG2' HD11 ' A' ' 4' ' ' LEU . 70.0 p -145.15 25.79 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.598 ' HA ' ' HD3' ' A' ' 57' ' ' ARG . 26.2 m -108.46 144.99 16.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.35 30.37 58.28 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 177.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 58' ' ' THR . 12.0 mmtt -146.99 -168.63 3.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.389 2.095 . . . . 0.0 107.786 178.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 94' ' ' LEU . 62.0 mt -86.48 88.21 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.955 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.1 ttp -97.59 118.2 33.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.691 -179.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 3.3 t -89.93 125.11 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.89 145.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.309 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.63 156.0 49.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.041 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -52.94 -52.89 56.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.479 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -59.56 -35.7 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.105 0.479 . . . . 0.0 110.291 179.154 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -64.72 -50.43 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.162 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' OH ' ' HB3' ' A' ' 53' ' ' PRO . 9.0 t80 -49.15 -34.34 14.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.702 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -63.06 -66.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.677 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -49.22 -46.26 45.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.457 ' C ' ' O ' ' A' ' 48' ' ' SER . 1.9 m-85 -26.13 138.02 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 O-C-N 123.474 0.484 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -35.64 -71.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.947 2.431 . . . . 0.0 112.806 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.37 134.53 46.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 0.0 110.619 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.77 125.2 30.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HB3' ' OH ' ' A' ' 46' ' ' TYR . 90.4 Cg_endo -83.49 -170.29 7.75 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.627 -1.406 . . . . 0.0 112.026 -0.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 35.9 mt -89.98 151.21 44.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.592 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.04 110.68 3.08 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.596 2.197 . . . . 0.0 113.08 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.607 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.1 mt-10 68.21 8.25 6.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 179.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.598 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 6.0 mtt180 -109.45 113.88 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.795 0.331 . . . . 0.0 111.545 -178.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 63.5 m -64.11 109.32 1.79 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -101.85 152.57 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 14.1 t -133.79 130.62 56.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.305 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.6 130.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.418 . . . . 0.0 111.559 -178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.425 ' HB3' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.63 119.95 40.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.451 HG22 ' CG ' ' A' ' 68' ' ' TYR . 1.1 t -150.55 158.38 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.897 0.379 . . . . 0.0 111.36 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -75.41 -11.78 60.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.4 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -88.03 132.74 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.786 0.327 . . . . 0.0 110.774 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 4.3 mp0 -82.8 -21.78 34.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.519 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -91.31 -0.59 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.582 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.451 ' CG ' HG22 ' A' ' 63' ' ' THR . 7.2 t80 -59.28 140.83 55.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.108 0.48 . . . . 0.0 111.453 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.447 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -134.31 171.98 13.52 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.442 1.115 . . . . 0.0 113.213 179.563 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.41 139.54 16.5 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.877 -1.965 . . . . 0.0 110.049 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.06 102.01 6.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.9 0.381 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.18 -44.97 1.96 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.826 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 166.7 20.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 85' ' ' TYR . 22.6 t -97.15 140.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.267 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 22.8 t -106.76 118.44 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 112.185 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 82' ' ' VAL . 30.8 m -127.54 168.14 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.69 178.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.41 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 1.6 m80 -119.86 -23.08 6.55 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.563 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.79 -177.33 6.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 111.467 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.424 HG22 ' CG ' ' A' ' 106' ' ' PHE . 11.7 t -65.45 -11.4 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.615 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.83 -37.24 16.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.236 0.541 . . . . 0.0 109.751 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.17 -34.41 70.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.694 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 76' ' ' VAL . 29.2 t -68.38 -54.27 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.981 0.42 . . . . 0.0 109.988 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 5.8 m-85 -51.84 -27.83 13.87 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.933 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.519 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -63.05 -45.33 92.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.713 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.471 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 76.1 t80 -62.76 -53.83 48.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.141 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.81 -22.88 5.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 179.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 8.3 mttt -70.23 -41.54 73.43 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.072 0.463 . . . . 0.0 109.754 178.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -4.54 56.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.625 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 90.1 m-70 -129.63 62.76 65.13 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.63 -0.35 5.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.174 2.582 . . . . 0.0 112.845 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.75 -30.16 17.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.773 0.32 . . . . 0.0 110.834 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -103.08 162.09 13.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.094 0.473 . . . . 0.0 111.624 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -97.69 174.44 6.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.906 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.445 HD12 HG21 ' A' ' 38' ' ' ILE . 1.1 tp -119.66 113.87 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 111.409 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 39' ' ' MET . 40.1 t -127.59 111.87 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.289 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 8.7 mm -82.62 141.51 14.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.67 -39.88 4.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.84 -165.48 38.29 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.556 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.04 -161.23 23.25 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 117.358 0.579 . . . . 0.0 112.48 -0.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.73 -50.88 69.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -57.03 -25.25 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.709 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 62' ' ' LEU . 42.2 mm -79.29 -36.89 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.771 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.3 m-85 -50.81 -56.76 10.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.446 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -67.22 -9.65 42.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.759 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.93 -42.25 24.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 110.977 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 5.4 m-85 -93.54 -11.53 31.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.244 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.6 OUTLIER -50.34 -28.71 8.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.235 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.12 -8.38 59.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.601 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.53 -23.58 4.39 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.493 HG21 ' CD1' ' A' ' 3' ' ' PHE . 90.7 t -44.11 128.99 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 18.0 t70 -102.51 -12.73 17.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.341 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.798 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 77.9 m -151.61 140.07 20.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.016 -179.149 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.512 HD13 ' CG ' ' A' ' 136' ' ' PHE . 13.7 mt -119.18 146.05 45.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.279 0.562 . . . . 0.0 111.56 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.6 mt -135.13 112.66 10.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.549 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.491 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -134.52 144.99 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 111.76 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.466 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -109.9 114.42 27.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.361 179.044 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -86.31 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.2 121.67 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.201 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.67 -61.72 2.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.224 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.65 -172.19 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.6 p -121.98 157.93 30.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.99 166.39 30.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.78 169.82 3.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.89 135.95 4.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.953 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -38.46 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -117.57 137.31 52.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.3 163.34 12.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.014 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -173.16 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.438 HG12 ' CB ' ' A' ' 103' ' ' PHE . 1.6 pp -108.39 163.89 15.96 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.29 99.57 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.953 2.435 . . . . 0.0 112.736 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.4 146.02 25.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.074 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.48 80.77 2.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -60.82 -20.08 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.123 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.53 -30.34 65.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.913 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.46 -27.39 41.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.512 ' CG ' HD13 ' A' ' 113' ' ' LEU . 77.2 m-85 -97.83 176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.823 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 m -136.13 141.98 44.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.623 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 8.6 ttpt -83.56 116.79 22.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 21.1 m -102.34 -18.95 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 157' ' ' VAL . 48.7 m -163.6 141.06 7.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.699 0.285 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.623 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 86.1 p -169.48 106.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -140.77 118.96 12.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.827 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 1.4 m -68.71 145.18 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.166 0.508 . . . . 0.0 111.527 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 152' ' ' THR . 9.0 t -119.61 103.94 14.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.185 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -86.83 103.68 15.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.503 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.2 -174.13 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.448 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.3 p -55.37 -56.62 18.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.722 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.49 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -72.73 121.75 85.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.57 -25.54 79.18 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.035 1.823 . . . . 0.0 112.292 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.14 -19.62 22.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -86.35 8.16 22.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.66 0.267 . . . . 0.0 111.367 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 144' ' ' VAL . 66.0 m -68.79 165.63 19.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.0 p80 -168.99 155.1 6.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 21.8 m -118.26 132.21 56.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -94.94 104.42 16.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.843 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -100.8 151.37 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.23 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 12.3 t -141.99 107.68 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.825 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 26.8 m95 -108.81 146.07 34.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -126.43 114.41 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.676 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -52.64 131.09 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.883 -179.436 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -97.45 176.31 5.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.741 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.132 179.985 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.18 145.5 40.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.494 ' CZ ' ' CG2' ' A' ' 110' ' ' VAL . 2.0 m-30 -109.3 112.3 24.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.425 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.8 123.96 51.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.757 -179.504 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 7.8 p90 -165.52 164.95 19.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.319 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' ILE . . . -120.77 138.2 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.669 0.271 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -122.41 149.81 43.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 0.0 111.253 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -103.39 -162.96 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -42.04 72.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.53 -27.86 31.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.96 26.28 5.84 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.578 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -79.61 147.59 32.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 110.621 -179.929 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.478 HD12 HG23 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -112.48 -31.05 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.771 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.92 142.83 3.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.862 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HG3' ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -77.26 -170.09 1.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.757 0.313 . . . . 0.0 110.63 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.07 36.66 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.744 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.7 -135.63 3.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.539 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -64.63 -176.35 0.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.753 0.311 . . . . 0.0 110.908 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.5 106.4 13.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 38.6 Cg_endo -68.25 -52.92 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.447 2.098 . . . . 0.0 112.661 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.481 ' CD1' ' HG2' ' A' ' 20' ' ' PRO . 13.6 p-90 -107.28 132.98 52.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.924 0.393 . . . . 0.0 111.147 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.8 106.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.603 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.1 mt -129.12 162.47 52.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.207 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.99 -41.68 16.49 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.712 2.275 . . . . 0.0 111.899 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -73.26 -20.83 60.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.995 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -77.08 -40.83 44.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.134 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.0 mt -71.74 -30.52 65.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.989 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -66.3 -14.77 62.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.354 -179.876 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -50.14 -62.29 1.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.865 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.547 ' O ' HG23 ' A' ' 34' ' ' THR . 0.5 OUTLIER -92.11 -0.87 57.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.187 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 28' ' ' HIS . 2.8 tpt180 -35.35 -60.78 0.47 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.17 -20.68 19.04 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 37' ' ' LYS . 2.7 mt-30 -79.93 -14.7 58.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.617 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 30' ' ' PHE . 15.3 t -84.41 -13.91 50.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.711 ' C ' ' H ' ' A' ' 37' ' ' LYS . 22.8 m -56.18 121.32 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.758 0.313 . . . . 0.0 110.662 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 92' ' ' GLN . . . 58.87 -24.44 0.02 OUTLIER Glycine 0 CA--C 1.532 1.123 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.418 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.711 ' H ' ' C ' ' A' ' 35' ' ' VAL . 11.1 mttp -63.14 108.06 1.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.941 0.877 . . . . 0.0 110.171 -176.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' CG2' ' CG2' ' A' ' 60' ' ' VAL . 6.8 mt -62.76 110.23 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.583 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.665 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.0 ttp -99.17 114.27 26.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.495 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.617 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 11.3 t -87.53 125.55 41.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.3 m -132.2 149.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.158 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.14 158.02 53.61 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.086 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -55.83 -45.39 78.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.404 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 17.2 tpt180 -63.55 -32.4 73.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 110.477 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 m -72.2 -42.47 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 11.2 t80 -65.86 -24.41 66.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -66.8 -19.92 65.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.65 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -34.4 134.44 0.39 Allowed Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.658 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.14 -41.29 58.21 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.936 2.424 . . . . 0.0 113.252 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -151.15 131.29 13.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.341 . . . . 0.0 111.029 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -132.22 125.29 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.028 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 83.6 Cg_endo -90.12 -179.32 12.93 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.137 -0.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 65.5 mt -75.88 152.8 84.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.62 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.82 101.7 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.552 2.168 . . . . 0.0 112.959 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 68.46 21.04 8.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.149 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 3.8 mmt180 -116.63 139.84 50.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.7 m -86.8 115.47 24.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.0 0.429 . . . . 0.0 111.435 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -101.11 156.83 17.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 12.7 t -137.13 131.74 46.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.5 t -105.99 121.93 58.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.085 -179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.29 107.18 17.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.112 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.423 HG23 ' CD2' ' A' ' 68' ' ' TYR . 6.3 t -143.7 164.81 29.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.162 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -79.74 -8.45 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.312 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.5 tp60 -79.81 124.69 28.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.354 . . . . 0.0 110.489 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.27 -30.38 54.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.93 14.5 28.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.359 . . . . 0.0 111.181 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.752 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 5.7 t80 -63.18 147.23 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.142 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.43 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.8 mm100 -124.89 174.76 7.74 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.475 1.131 . . . . 0.0 112.868 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.54 143.07 18.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.89 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -66.35 94.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.29 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.59 -20.17 2.31 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.775 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.76 170.85 15.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.12 0.485 . . . . 0.0 112.071 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 85' ' ' TYR . 19.8 t -92.95 140.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.456 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 68' ' ' TYR . 24.5 t -103.47 106.98 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.457 . . . . 0.0 111.771 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 HG21 HG22 ' A' ' 82' ' ' VAL . 30.7 m -119.67 176.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.051 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -128.94 -21.12 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.82 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.69 -174.81 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.199 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG12 ' CD2' ' A' ' 106' ' ' PHE . 25.2 t -70.02 -11.06 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.67 -38.59 16.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.091 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.19 -34.45 76.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.672 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.477 HG22 HG21 ' A' ' 76' ' ' VAL . 20.8 t -69.29 -53.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.599 179.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -53.37 -31.03 42.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.062 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.55 -47.03 87.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 69.0 t80 -60.69 -52.75 63.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.81 -26.26 57.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.609 178.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -66.44 -39.55 88.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.002 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -84.84 -1.13 56.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.148 178.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 42.5 m-70 -124.83 60.34 26.28 Favored Pre-proline 0 N--CA 1.456 -0.142 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.098 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.14 -3.25 5.8 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.866 2.377 . . . . 0.0 112.508 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -100.66 -25.6 14.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.026 179.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 4.9 mt-30 -98.83 160.13 14.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.328 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -105.9 174.89 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.412 HD13 ' CG1' ' A' ' 82' ' ' VAL . 10.0 tp -122.33 110.45 15.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 39' ' ' MET . 17.2 t -124.28 109.69 23.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 3.7 mm -82.6 131.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.398 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.473 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.26 -47.31 5.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.718 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.76 -168.1 41.19 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.392 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.27 -160.78 36.85 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 117.8 0.8 . . . . 0.0 112.814 0.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.64 -57.99 3.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 111.69 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.98 -31.98 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 102' ' ' ILE . 37.7 mm -80.97 -26.43 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.292 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -61.69 -51.93 66.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.631 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.572 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 13.9 t -68.81 -10.01 54.32 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.17 -47.07 46.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD2' HG12 ' A' ' 79' ' ' VAL . 8.0 m-85 -95.11 -2.61 49.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.726 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.572 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 37.4 pttt -54.38 -32.2 56.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -79.63 -8.46 59.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.793 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.05 -18.07 7.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.516 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 48.7 t -48.0 134.69 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.32 6.02 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.199 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 3.7 m -170.58 142.79 2.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.429 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.454 HD11 ' CZ3' ' A' ' 133' ' ' TRP . 8.3 mt -122.55 144.69 48.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.084 0.468 . . . . 0.0 111.578 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.1 mt -135.22 118.35 16.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.155 179.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 156' ' ' GLU . 1.2 m -131.54 140.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.819 0.342 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.22 121.99 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.26 101.4 10.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.661 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.8 mp -83.82 134.98 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.59 -51.99 61.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.63 170.95 9.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.0 p -105.76 170.72 7.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.1 m-85 -148.0 168.75 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.015 0.436 . . . . 0.0 111.279 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -114.1 146.89 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.315 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . 168.85 176.9 39.34 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.674 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.67 62.3 1.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.5 m -164.14 124.46 2.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.7 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.19 164.98 13.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -177.69 4.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -103.53 165.1 14.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.301 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.9 102.66 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.665 2.244 . . . . 0.0 112.071 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.8 mt -90.26 148.24 23.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.73 78.96 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.454 ' CZ3' HD11 ' A' ' 113' ' ' LEU . 86.5 m95 -61.23 -19.53 61.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.161 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.71 -32.92 66.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.652 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.72 -18.49 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.427 ' CG ' HD12 ' A' ' 113' ' ' LEU . 62.7 m-85 -106.32 167.14 10.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.483 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.492 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -131.05 141.19 50.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.9 ttpm? -82.73 113.9 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.662 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 157' ' ' VAL . 35.3 m -97.41 -25.79 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.563 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -156.06 140.55 16.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.882 0.373 . . . . 0.0 111.184 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.557 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 53.4 p -166.15 105.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.753 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -146.07 129.83 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 111.675 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.3 m -77.54 146.72 36.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.767 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 152' ' ' THR . 6.1 t -117.32 104.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.363 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.77 104.7 16.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.57 -172.96 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.442 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 60.9 p -55.69 -58.48 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.589 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.627 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 10.2 t30 -76.6 136.01 67.99 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.841 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.21 -34.38 68.43 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.986 1.79 . . . . 0.0 112.686 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.74 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.487 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.627 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.3 mt -77.65 10.31 2.78 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 153' ' ' HIS . 57.4 m -85.44 159.91 19.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.08 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.56 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -173.46 160.55 3.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 17.2 m -122.3 144.69 48.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.71 179.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.88 105.22 13.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 115' ' ' VAL . 1.9 mt-10 -99.2 121.33 40.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.902 0.382 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 18.1 t -116.2 111.62 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.484 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 32.1 m95 -106.13 148.62 27.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.959 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -129.68 123.86 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.225 179.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.45 128.82 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.542 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.492 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.16 -173.82 2.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.758 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.125 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.542 0.21 . . . . 0.0 110.491 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.61 149.3 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.348 0.594 . . . . 0.0 112.438 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.5 m-30 -116.68 113.0 22.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.58 118.57 36.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 112.014 -179.486 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.472 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 4.4 p90 -164.09 174.51 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.12 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.42 135.17 49.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 111.673 -179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.6 pt20 -132.82 154.64 50.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 15.5 p-10 -107.55 -167.62 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -40.95 68.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -28.97 47.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.05 19.51 11.66 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.754 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 3.8 mt -70.97 175.73 4.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.61 -60.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.168 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.06 132.27 1.59 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.547 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -91.17 111.06 22.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.736 0.303 . . . . 0.0 110.794 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.58 124.48 15.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.116 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.29 -115.34 0.64 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.468 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -104.22 96.99 7.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 110.792 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.08 98.48 26.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 -167.41 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.49 2.127 . . . . 0.0 112.285 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -98.81 107.84 20.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -79.71 -70.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.173 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.405 ' HG ' ' HD2' ' A' ' 24' ' ' PRO . 1.2 tp -150.52 150.92 29.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 -179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HD2' ' HG ' ' A' ' 23' ' ' LEU . 27.7 Cg_exo -61.99 -17.08 53.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.542 2.161 . . . . 0.0 112.377 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -55.0 -23.36 18.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -92.3 -30.56 15.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.274 -179.753 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.94 -15.63 43.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.757 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -59.54 -40.78 88.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.42 ' CD1' ' HG3' ' A' ' 33' ' ' GLN . 56.2 t80 -105.42 -9.63 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -92.82 -26.38 17.71 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -92.1 -61.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.832 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.8 -21.49 56.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.42 ' HG3' ' CD1' ' A' ' 29' ' ' TYR . 8.3 mm100 -90.19 -5.13 56.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.052 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.9 t -132.87 -35.15 1.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 16.7 m -79.15 154.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 112.051 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' C ' ' HG2' ' A' ' 37' ' ' LYS . . . 96.15 -1.17 62.6 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.587 -0.815 . . . . 0.0 114.662 178.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 3.6 mttm -148.82 -164.22 1.97 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.344 1.572 . . . . 0.0 109.744 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.82 90.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ttp -102.69 121.59 42.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.932 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 96' ' ' ILE . 9.7 t -89.55 131.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.28 142.06 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.184 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.94 156.83 43.5 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.095 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.489 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.3 -52.61 58.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.858 0.329 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -60.21 -34.25 73.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.075 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -67.65 -45.5 75.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -59.46 -27.27 65.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.5 -66.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.725 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -52.44 -30.37 29.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CE1' ' CD1' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -37.05 122.34 0.83 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.935 -179.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 64.3 Cg_exo -42.91 -27.24 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.233 2.622 . . . . 0.0 113.729 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.62 148.92 28.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 111.236 -179.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -141.15 107.76 6.23 Favored Pre-proline 0 CA--C 1.533 0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.5 Cg_endo -88.43 178.78 18.39 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.158 -0.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.517 ' CB ' ' HB2' ' A' ' 57' ' ' ARG . 10.6 mt -76.64 155.33 83.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.36 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HD2' ' CD2' ' A' ' 54' ' ' LEU . 9.7 Cg_endo -52.98 -74.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.703 2.268 . . . . 0.0 112.385 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -113.38 50.64 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.104 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.517 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -142.47 101.49 3.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.987 -179.618 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.3 m -62.16 113.52 2.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -107.74 148.34 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.431 0.634 . . . . 0.0 112.348 -178.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.86 139.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.389 178.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 43' ' ' ARG . 92.7 t -108.34 124.02 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.845 -178.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.41 117.98 36.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.419 HG23 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.48 162.15 41.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.727 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -83.0 -8.57 59.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 8.8 tt0 -85.13 131.19 34.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 111.057 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -25.21 42.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.59 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -94.74 5.17 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.753 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 5.9 t80 -58.98 148.05 32.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.023 0.439 . . . . 0.0 111.088 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.406 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -136.15 174.85 10.16 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.201 1.001 . . . . 0.0 112.848 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.87 145.0 21.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.793 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -74.65 95.91 2.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.311 . . . . 0.0 110.314 179.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.2 -34.95 3.18 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.305 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.76 169.64 14.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 111.916 -179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.442 HG23 ' CZ ' ' A' ' 85' ' ' TYR . 5.1 t -96.69 140.65 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.331 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 68' ' ' TYR . 20.1 t -107.63 118.54 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.186 0.517 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.44 171.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.839 178.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -122.38 -22.43 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.55 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -158.15 -175.65 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.051 0.453 . . . . 0.0 111.08 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.466 ' CG1' ' CD2' ' A' ' 106' ' ' PHE . 9.4 t -65.66 -11.34 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.72 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.49 16.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.15 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.68 -29.36 63.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.613 179.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG1' HG21 ' A' ' 40' ' ' VAL . 25.1 t -70.99 -52.63 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.6 m-85 -54.18 -26.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.586 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.34 -44.07 88.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.956 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.442 ' CZ ' HG23 ' A' ' 74' ' ' VAL . 88.3 t80 -66.7 -56.6 9.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.57 -23.65 17.69 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.561 178.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.05 -39.75 78.98 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.723 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -83.73 -5.45 59.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.403 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -129.54 64.92 73.31 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.22 1.08 3.78 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.424 2.749 . . . . 0.0 113.001 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 -33.4 25.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.969 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.5 160.72 15.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 111.621 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -98.43 156.48 16.73 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 tp -96.29 115.08 26.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.349 -179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.55 114.55 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.422 ' CD1' HG22 ' A' ' 40' ' ' VAL . 9.2 mm -81.77 139.43 17.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.068 0.461 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.479 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -108.55 -46.1 3.74 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.51 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.87 -170.4 43.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.317 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.33 -160.93 36.82 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 117.409 0.605 . . . . 0.0 112.605 0.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.38 -45.93 36.39 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -58.74 -34.34 71.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 102' ' ' ILE . 28.7 mm -82.28 -29.51 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.1 m-85 -57.67 -57.13 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.661 -179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.503 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.2 t -67.47 -9.61 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.47 -44.45 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.0 111.302 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.466 ' CD2' ' CG1' ' A' ' 79' ' ' VAL . 16.2 m-85 -91.82 -7.95 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -52.21 -31.18 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 110.918 179.869 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.452 ' N ' ' HG2' ' A' ' 107' ' ' LYS . 1.5 t0 -75.35 -10.99 59.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.554 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -122.41 -19.77 6.31 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.469 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 75.8 t -45.18 120.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.44 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 19.4 t70 -100.3 -3.9 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.269 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 49.7 m -160.07 141.91 12.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.088 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.413 HD23 ' CG1' ' A' ' 110' ' ' VAL . 7.3 mt -123.29 147.62 46.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.248 0.547 . . . . 0.0 111.859 -179.161 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.76 113.58 11.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.387 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.472 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.3 m -129.65 140.94 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -110.57 106.76 16.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.507 179.502 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 35.8 mtp180 -80.06 98.64 7.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.86 122.67 28.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.29 -66.81 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.51 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.65 162.9 5.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.604 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 p -95.1 168.16 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.899 0.381 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 3.4 m-85 -138.76 160.42 39.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.48 139.76 53.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.131 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.44 -146.41 5.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.634 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.86 -29.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.508 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -108.9 137.98 45.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -178.71 3.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -73.75 159.17 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.16 156.23 48.96 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.269 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.36 100.83 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.725 2.283 . . . . 0.0 112.459 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.8 149.14 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 69.11 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.03 0.443 . . . . 0.0 110.709 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -55.22 -22.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -31.57 66.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 110.662 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -80.81 -20.06 43.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.937 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 94.1 m-85 -104.26 168.71 8.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.075 0.464 . . . . 0.0 111.29 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.651 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -130.54 142.56 50.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.929 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.631 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 6.1 ttpt -81.97 115.03 20.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.59 -17.43 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.603 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.3 m -165.93 140.64 4.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 110.969 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.631 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.2 p -165.71 112.87 0.93 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -147.85 121.03 8.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.84 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.6 m -73.54 144.45 46.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.176 0.512 . . . . 0.0 111.916 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.5 t -117.3 105.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.968 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -90.48 103.36 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.949 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -169.7 2.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.352 179.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.6 p -60.23 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.931 0.396 . . . . 0.0 110.467 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.473 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -67.43 118.61 58.43 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.83 -25.48 61.65 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.887 1.725 . . . . 0.0 112.377 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.42 -20.27 25.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.147 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 mt -86.41 8.88 19.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.71 0.29 . . . . 0.0 111.106 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 153' ' ' HIS . 55.1 m -72.4 168.4 18.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.947 0.403 . . . . 0.0 110.001 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.433 ' N ' ' CG2' ' A' ' 152' ' ' THR . 1.5 p80 -173.52 160.18 3.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.038 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.71 ' O ' ' HA ' ' A' ' 116' ' ' THR . 18.6 m -122.04 145.41 48.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.772 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -106.41 104.64 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.767 0.318 . . . . 0.0 110.441 179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.462 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.4 mt-10 -109.08 127.54 54.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.974 0.416 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.35 114.02 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.557 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.46 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.3 m95 -108.4 148.14 30.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.123 -179.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -125.49 112.21 15.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.519 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -49.32 133.33 19.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.214 0.531 . . . . 0.0 112.259 -179.405 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.651 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 32.6 mtmt -108.48 -178.47 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.786 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.995 -179.875 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 25.4 m . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.3 151.14 30.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -116.1 111.8 20.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.346 178.933 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.541 HD11 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.31 122.81 48.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.42 0.628 . . . . 0.0 112.351 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.494 ' CH2' ' CG1' ' A' ' 115' ' ' VAL . 4.8 p90 -168.61 168.8 10.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.674 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.55 133.28 52.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -129.07 164.27 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.137 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -110.18 -171.62 1.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -30.42 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.4 -32.22 19.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.25 36.01 3.23 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.651 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.39 145.92 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.772 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.33 -54.67 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.409 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.19 -158.83 8.39 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.429 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 13.21 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.527 0.203 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.43 28.71 4.63 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.746 0.307 . . . . 0.0 111.089 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.12 -132.76 5.03 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.571 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -81.89 -173.56 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.954 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.21 135.61 59.65 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.973 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.69 162.84 7.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.548 2.165 . . . . 0.0 112.154 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -76.37 145.63 39.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -88.34 143.38 27.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.1 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 10.9 mt -156.25 123.81 2.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.58 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.59 -34.6 51.54 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.627 2.218 . . . . 0.0 113.147 -179.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.24 -25.17 36.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 30' ' ' PHE . 4.4 t0 -95.2 -28.51 15.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -67.1 -25.38 66.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.461 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -60.65 -38.2 84.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.659 0.266 . . . . 0.0 111.589 -179.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 33' ' ' GLN . 46.8 t80 -105.48 -4.76 20.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.409 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -86.86 -49.52 7.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.269 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -91.84 -51.72 5.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.622 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' H ' ' HG3' ' A' ' 31' ' ' ARG . . . -49.68 -34.76 19.5 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.421 ' HG3' ' CD1' ' A' ' 29' ' ' TYR . 12.4 mm100 -78.76 -7.03 57.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 39' ' ' MET . 0.6 OUTLIER -135.09 -36.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.762 -0.375 . . . . 0.0 112.001 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.504 ' CG1' ' HD3' ' A' ' 57' ' ' ARG . 6.2 m -74.54 161.94 4.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.437 -179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . 72.78 9.04 74.31 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 119.186 -0.786 . . . . 0.0 114.287 178.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 7.0 mmtp -150.64 -164.97 2.14 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.885 1.342 . . . . 0.0 108.46 179.294 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 52.9 mt -79.06 88.29 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.237 0.471 . . . . 0.0 111.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 34' ' ' THR . 24.1 ttp -96.13 120.13 35.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.403 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.444 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 21.4 t -81.23 153.42 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 49' ' ' PHE . 28.2 m -161.87 146.42 4.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.58 155.47 51.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.841 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.6 -51.33 56.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.938 0.369 . . . . 0.0 110.889 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 5.4 tpp180 -60.14 -31.91 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -73.5 -43.4 60.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.612 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 52' ' ' ARG . 24.5 t80 -61.94 -29.24 70.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.8 -66.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.2 p -48.21 -37.08 15.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.357 -179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.493 ' CE2' HG12 ' A' ' 41' ' ' VAL . 2.7 m-30 -37.68 149.42 0.19 Allowed Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.492 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.52 -73.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.503 2.135 . . . . 0.0 112.305 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.16 167.42 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.0 111.003 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HG2' ' CE2' ' A' ' 46' ' ' TYR . 45.4 mtp180 -129.13 111.28 18.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.959 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 66.9 Cg_endo -89.5 -171.33 5.88 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.173 -0.09 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 74.7 mt -80.53 158.96 70.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.236 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 58.2 Cg_endo -72.2 107.16 2.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.531 2.154 . . . . 0.0 113.445 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.7 OUTLIER 74.12 4.4 4.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.27 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.548 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 15.6 mtt180 -112.6 116.41 30.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 0.0 111.542 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 43.1 m -73.11 111.4 8.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 3.3 m-80 -98.92 156.94 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.247 0.546 . . . . 0.0 112.195 -178.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 7.1 t -137.05 132.17 46.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.16 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 43' ' ' ARG . 88.6 t -104.61 128.39 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.717 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -107.65 125.33 51.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.504 -179.896 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -165.68 150.46 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 179.618 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 21.5 t-80 -74.43 -2.68 26.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.702 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.837 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 8.6 tp60 -70.95 133.61 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -88.57 -3.23 58.85 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -128.25 5.98 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.569 0.223 . . . . 0.0 111.5 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.837 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.0 t80 -59.93 141.8 54.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.236 0.541 . . . . 0.0 111.968 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.434 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 13.7 mm100 -127.11 178.45 6.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.08 0.943 . . . . 0.0 112.104 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.46 144.53 19.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.607 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -76.96 96.36 4.35 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.338 179.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.88 -40.15 3.09 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.961 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 59' ' ' ASN . . . -68.61 168.46 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.732 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 t -96.88 140.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.344 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 69' ' ' GLN . 40.2 t -100.09 107.32 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 0.0 112.314 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 27.1 m -117.68 161.59 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.026 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 77' ' ' HIS . 1.3 m170 -111.67 -22.45 11.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.231 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -161.38 -168.86 2.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.174 0.512 . . . . 0.0 111.594 -179.153 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 106' ' ' PHE . 3.1 t -70.3 -10.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.539 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.87 -37.35 16.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.212 0.53 . . . . 0.0 109.768 178.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.93 -32.95 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.757 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 76' ' ' VAL . 24.3 t -70.0 -51.71 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.4 m-85 -56.33 -27.42 55.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.334 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -64.54 -44.83 89.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 179.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.27 -54.07 43.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.07 -22.84 52.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.899 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.21 -30.11 63.28 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.22 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 5.9 mt-30 -92.95 -13.0 29.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.33 178.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -125.16 65.03 47.42 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.433 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.8 0.17 5.3 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.258 2.638 . . . . 0.0 113.018 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.02 -41.42 35.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -100.51 165.89 11.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.092 0.472 . . . . 0.0 111.669 -179.436 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -98.4 170.38 8.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.034 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.58 114.21 22.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.445 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.46 113.29 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.308 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 5.7 mm -79.11 135.1 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.01 0.433 . . . . 0.0 111.183 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -110.27 -41.3 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.209 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.55 -169.7 41.88 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.738 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.3 -160.74 36.32 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 122.103 -0.645 . . . . 0.0 112.558 -0.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.49 60.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.669 0.271 . . . . 0.0 111.203 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 -60.19 -30.49 69.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.8 mm -76.88 -26.27 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.936 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 3.5 m-85 -62.58 -58.01 9.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.704 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.491 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 8.9 t -67.63 -10.27 50.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.688 -0.633 . . . . 0.0 111.751 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.56 -37.7 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.597 ' HA ' HG21 ' A' ' 79' ' ' VAL . 2.8 m-85 -101.36 -3.17 29.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.503 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 20.2 pttp -49.84 -32.5 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.73 0.3 . . . . 0.0 111.486 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -92.5 1.59 57.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.651 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.0 -26.87 4.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.705 0.288 . . . . 0.0 111.31 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 3' ' ' PHE . 58.6 t -48.96 128.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 5.5 t70 -100.99 -7.38 23.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.3 m -156.21 140.29 16.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 11.5 mt -120.29 144.71 47.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.184 0.516 . . . . 0.0 111.674 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 mt -135.61 117.02 14.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.805 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.494 ' CG1' ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -134.94 144.83 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 111.663 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.57 109.85 18.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.435 179.319 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -93.45 103.64 15.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.548 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.32 130.97 37.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -49.96 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.4 156.16 39.04 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.313 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 86.2 p -101.26 142.97 31.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -123.03 156.55 34.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -113.27 134.83 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.996 0.427 . . . . 0.0 111.409 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.34 -162.44 11.83 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.392 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 8.36 3.02 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.5 m -120.3 109.93 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.798 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -92.38 142.48 27.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -178.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.445 HG12 ' CB ' ' A' ' 103' ' ' PHE . 2.3 pp -111.75 158.68 35.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.14 135.46 66.2 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.709 2.273 . . . . 0.0 112.281 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.413 HD13 ' CH2' ' A' ' 5' ' ' TRP . 3.8 mt -120.53 143.4 48.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.129 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 79.56 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.421 ' CZ3' HD12 ' A' ' 113' ' ' LEU . 85.8 m95 -63.53 -15.03 56.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -33.46 62.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.996 0.426 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.18 -16.09 47.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.334 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 110' ' ' VAL . 66.3 m-85 -106.9 164.47 12.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.813 0.34 . . . . 0.0 111.027 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.405 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -125.6 140.87 52.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -85.06 114.56 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.677 179.654 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 159' ' ' GLN . 16.0 m -101.74 -18.96 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.52 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.69 139.98 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.398 . . . . 0.0 111.248 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -168.75 106.87 0.45 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.331 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -142.55 122.11 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.367 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 2.1 m -72.82 145.8 46.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.316 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 152' ' ' THR . 4.7 t -114.99 103.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 178.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 99.23 11.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.471 -179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.84 -177.66 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.7 p -54.33 -54.51 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.505 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -73.45 124.28 90.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.947 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 -29.53 89.33 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.124 1.882 . . . . 0.0 112.268 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.99 -18.52 28.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.801 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.5 mt -86.03 10.45 14.19 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 144' ' ' VAL . 55.1 m -74.69 166.15 24.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.516 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -172.15 158.94 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.218 179.7 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 33.4 m -123.06 133.76 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -98.77 107.86 20.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -97.17 149.69 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.081 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 139' ' ' VAL . 16.7 t -141.28 106.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.003 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 24.2 m95 -110.15 146.24 35.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.0 111.779 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.461 ' HB2' HG11 ' A' ' 139' ' ' VAL . 13.7 mt-30 -128.11 119.79 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.159 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 7.7 tttm -46.44 129.0 10.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.735 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.405 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 1.6 ptpt -109.28 -176.85 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.816 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.145 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.16 154.6 23.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 96' ' ' ILE . 0.8 OUTLIER -121.53 114.56 21.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.226 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.88 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.73 122.9 47.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.47 0.652 . . . . 0.0 112.466 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.778 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.7 p90 -164.12 165.15 22.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.189 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.39 136.06 53.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.361 . . . . 0.0 111.737 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -125.89 144.26 50.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.518 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.9 p30 -98.41 -169.29 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.489 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -49.46 -49.27 46.1 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.175 0.512 . . . . 0.0 110.59 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -29.24 63.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.288 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.02 31.09 6.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.758 HD23 ' N ' ' A' ' 13' ' ' ILE . 7.5 tt -83.43 167.9 17.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.592 0.235 . . . . 0.0 110.618 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.758 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.348 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 68.0 mt -77.82 89.29 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.854 0.359 . . . . 0.0 111.813 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.6 ttp -99.4 120.81 40.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.667 HG21 HG11 ' A' ' 82' ' ' VAL . 40.3 t -79.82 158.36 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 111.646 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.5 m -161.67 149.93 4.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.89 149.35 44.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.846 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.824 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -48.22 -52.4 21.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.116 0.458 . . . . 0.0 110.119 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.459 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -56.34 -34.64 66.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.251 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.56 HG22 ' CE2' ' A' ' 49' ' ' PHE . 4.0 m -70.36 -54.8 11.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.131 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 35.7 t80 -50.39 -28.06 7.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.457 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -66.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -57.5 -30.41 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.591 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.718 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -36.42 133.69 0.61 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.705 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 47.7 Cg_exo -38.99 -29.12 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.394 2.729 . . . . 0.0 113.766 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -162.19 152.31 16.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 111.197 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.52 108.9 10.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 88.1 Cg_endo -82.22 -179.09 22.9 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.364 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 49' ' ' PHE . 51.0 mt -82.23 145.82 53.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.774 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.402 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 56.1 Cg_endo -70.65 109.66 2.54 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.419 2.079 . . . . 0.0 112.236 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 77.55 14.68 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.8 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -132.89 112.63 12.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.638 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 46.6 m -70.51 113.03 7.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.083 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.604 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -103.38 156.66 17.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.305 0.574 . . . . 0.0 112.079 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 76' ' ' VAL . 21.6 t -133.29 141.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.152 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.824 HG13 ' HA ' ' A' ' 43' ' ' ARG . 59.9 t -109.05 123.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.916 0.388 . . . . 0.0 111.351 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.506 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -105.62 120.12 40.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.829 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.8 t -153.6 155.77 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.5 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.861 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.2 tt0 -74.12 134.05 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.97 1.83 53.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.672 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -127.79 3.6 6.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.61 0.243 . . . . 0.0 111.503 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.886 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.0 t80 -57.1 137.82 55.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 111.419 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.934 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -130.39 173.39 10.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.218 1.008 . . . . 0.0 112.613 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.52 143.3 19.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.576 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.4 101.16 7.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.791 0.329 . . . . 0.0 110.336 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.46 -40.92 2.9 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.749 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.16 166.89 18.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.551 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.13 140.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.934 HG21 ' HA ' ' A' ' 69' ' ' GLN . 15.0 t -109.3 117.66 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.924 HG21 HG22 ' A' ' 82' ' ' VAL . 26.9 m -126.96 167.36 21.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.426 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -116.82 -22.33 8.6 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.685 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -155.64 -173.62 4.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.622 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.943 HG13 ' CD2' ' A' ' 106' ' ' PHE . 19.3 t -69.72 -9.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.728 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.64 -34.72 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.443 . . . . 0.0 110.107 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.24 -30.81 62.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.991 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.924 HG22 HG21 ' A' ' 76' ' ' VAL . 23.1 t -73.52 -49.39 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 109.998 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.438 ' CE2' HG12 ' A' ' 79' ' ' VAL . 5.7 m-85 -57.08 -28.02 62.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.909 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.29 -42.22 88.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.039 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.89 -56.23 12.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.16 -22.8 30.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.976 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.72 -41.73 71.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -83.82 -10.02 58.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.546 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -123.71 64.73 32.27 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.59 -0.8 6.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.044 2.496 . . . . 0.0 112.756 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.54 26.95 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -99.4 163.57 12.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.454 . . . . 0.0 111.457 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.98 159.76 14.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.571 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.527 HD11 ' CG1' ' A' ' 82' ' ' VAL . 51.4 tp -113.52 113.58 25.33 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.837 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 4' ' ' LEU . 30.3 t -134.54 121.59 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.679 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.512 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 17.6 mm -81.0 132.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.06 0.457 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -96.9 -50.55 4.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.067 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.09 -169.35 42.46 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.425 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.75 -160.78 36.47 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 117.635 0.717 . . . . 0.0 112.493 -0.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.57 -48.76 19.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.765 0.317 . . . . 0.0 111.301 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.8 -32.46 52.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.122 0.487 . . . . 0.0 110.403 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.506 ' CD1' HD22 ' A' ' 62' ' ' LEU . 45.8 mm -85.23 -27.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.205 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -60.67 -57.46 12.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.751 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' ' 129' ' ' ILE . 1.6 t -66.81 -9.97 42.84 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.93 -0.481 . . . . 0.0 112.263 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.747 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.34 -39.87 62.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.943 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.9 m-85 -101.36 -3.18 29.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.767 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 104' ' ' THR . 1.8 pttt -49.16 -32.52 10.33 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -0.73 57.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.2 m-20 -120.48 -26.9 5.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.342 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.801 HG11 HD23 ' A' ' 113' ' ' LEU . 62.7 t -50.11 126.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.59 -12.65 19.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.04 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 95.9 m -148.28 141.79 25.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.523 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.801 HD23 HG11 ' A' ' 110' ' ' VAL . 12.9 mt -123.62 146.78 47.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.262 0.554 . . . . 0.0 111.743 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.0 mt -135.55 116.97 14.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.778 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -131.71 141.95 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.427 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.41 99.25 7.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.608 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -75.53 100.06 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.384 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mt -84.66 126.54 33.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.325 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.11 -43.51 82.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.208 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.85 167.55 48.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.514 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.2 p -101.2 150.79 22.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 111.0 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -130.37 149.32 52.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 167.38 15.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.421 . . . . 0.0 111.318 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.69 164.67 11.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.89 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -1.29 12.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.503 0.192 . . . . 0.0 111.316 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.49 HG22 HD11 ' A' ' 13' ' ' ILE . 3.7 m -109.22 128.65 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -105.24 164.07 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.54 147.4 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.1 pt -71.14 164.39 57.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.27 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.61 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.0 Cg_endo -74.92 102.9 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.357 2.038 . . . . 0.0 112.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -88.1 144.35 26.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.54 70.49 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.302 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.443 ' HH2' HG11 ' A' ' 115' ' ' VAL . 85.2 m95 -55.04 -24.98 27.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.292 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -30.3 65.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 0.0 110.474 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -80.32 -25.65 39.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 85.5 m-85 -100.26 176.58 5.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.772 0.32 . . . . 0.0 110.43 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -137.09 140.71 42.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.531 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.2 ttpm? -79.93 114.81 19.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.886 HG22 ' O ' ' A' ' 157' ' ' VAL . 17.1 m -97.64 -19.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -164.11 140.76 6.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.5 p -163.75 112.65 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.036 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.442 ' C ' HG23 ' A' ' 154' ' ' THR . 5.8 ttt-85 -148.1 125.34 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.662 HG23 ' OG1' ' A' ' 154' ' ' THR . 3.5 m -79.24 145.72 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 152' ' ' THR . 5.0 t -119.2 103.5 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -84.49 99.81 10.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 -179.92 7.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.4 p -53.41 -46.98 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 110.581 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.504 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -79.11 124.27 84.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.368 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.96 -29.44 89.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 112.599 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.37 -18.75 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.2 mt -83.94 7.06 19.5 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.579 0.228 . . . . 0.0 111.466 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 91.1 m -71.07 164.91 24.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -171.05 157.63 5.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.603 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.662 ' OG1' HG23 ' A' ' 143' ' ' THR . 45.1 m -123.2 126.56 47.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.588 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.22 105.44 17.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.75 ' HB2' HG22 ' A' ' 115' ' ' VAL . 75.3 mt-10 -106.37 124.61 49.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.196 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.886 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.8 t -116.55 113.68 43.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.259 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.531 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 20.2 m95 -108.62 150.23 27.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.937 0.399 . . . . 0.0 111.481 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.593 ' OE1' HG11 ' A' ' 139' ' ' VAL . 29.1 mt-30 -127.51 119.0 25.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -57.08 130.8 47.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -104.37 -176.06 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.137 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 52.2 m . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.68 151.11 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 96' ' ' ILE . 1.4 m-30 -118.03 107.8 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.212 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -106.36 124.78 50.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.332 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.58 ' CZ2' HG12 ' A' ' 115' ' ' VAL . 6.0 p90 -168.38 174.24 7.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.4 137.79 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.5 pt20 -119.26 156.57 29.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 111.332 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 121' ' ' SER . 45.3 t0 -102.58 169.06 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.23 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.11 -30.04 6.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.929 0.395 . . . . 0.0 110.568 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -89.02 -27.51 20.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.0 22.15 6.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.714 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.2 tt -77.27 166.46 23.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.633 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG22 ' HD1' ' A' ' 5' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.466 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mttp . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 54.2 mt -86.88 88.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 O-C-N 122.012 -0.43 . . . . 0.0 110.768 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 5.6 ttp -100.13 119.12 37.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.58 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 82' ' ' VAL . 2.7 t -87.53 128.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG11 ' CE2' ' A' ' 49' ' ' PHE . 19.1 m -132.43 154.94 40.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.378 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 162.13 53.79 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.843 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.694 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -58.5 -50.01 75.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.984 0.392 . . . . 0.0 110.654 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.47 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 tpt180 -61.03 -35.96 78.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 110.297 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 -50.41 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.387 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.3 t80 -52.59 -25.09 9.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -69.63 -65.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -28.07 61.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.33 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.62 ' CE2' HG11 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -37.69 136.86 0.72 Allowed Pre-proline 0 N--CA 1.467 0.404 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.779 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.17 -30.47 25.64 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.802 2.335 . . . . 0.0 113.074 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -159.34 151.96 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -140.98 110.93 6.61 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HG3' ' O ' ' A' ' 71' ' ' GLN . 10.9 Cg_exo -81.35 178.54 31.02 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.585 -1.423 . . . . 0.0 111.996 -0.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.566 HD13 ' HE ' ' A' ' 57' ' ' ARG . 31.8 mt -83.16 156.0 66.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 38.5 Cg_endo -67.15 107.42 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.404 2.069 . . . . 0.0 112.875 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 70.74 4.75 5.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.566 ' HE ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -108.51 122.92 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.938 0.399 . . . . 0.0 111.411 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 92.4 m -75.13 117.02 16.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.158 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.414 HD21 HD12 ' A' ' 54' ' ' LEU . 3.3 m-80 -105.58 156.04 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.445 . . . . 0.0 112.015 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 24.6 t -136.97 137.42 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.337 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.694 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.6 t -107.76 126.59 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 0.0 111.323 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.637 ' HG ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -107.65 117.2 33.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.969 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.813 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.3 t -148.43 161.36 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.959 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -79.08 -11.42 59.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.452 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.4 tp-100 -82.35 134.03 35.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.535 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 52.8 mt-10 -84.01 -29.63 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.636 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.85 2.24 54.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.159 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.875 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.2 t80 -58.83 139.5 56.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.926 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.3 mt-30 -128.7 174.37 9.49 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.219 1.009 . . . . 0.0 112.447 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.13 144.32 21.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.847 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 13.6 mt-30 -73.52 96.85 2.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.362 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.36 -37.01 3.15 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.645 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.12 171.51 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 112.024 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 60' ' ' VAL . 13.8 t -97.78 140.35 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.467 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.926 HG21 ' HA ' ' A' ' 69' ' ' GLN . 38.9 t -106.95 104.77 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.24 0.543 . . . . 0.0 112.281 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.867 HG21 HG22 ' A' ' 82' ' ' VAL . 23.6 m -117.44 166.93 11.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.366 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.406 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 3.8 m80 -121.91 -19.89 6.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.307 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.496 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.8 t70 -155.65 -178.87 7.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.209 0.528 . . . . 0.0 111.602 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.718 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.8 t -66.29 -8.97 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.767 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.73 -35.02 16.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.487 . . . . 0.0 109.869 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.91 -32.93 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.903 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.867 HG22 HG21 ' A' ' 76' ' ' VAL . 39.9 t -70.73 -49.99 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.561 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.2 m-85 -55.79 -26.24 45.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.897 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -65.61 -43.76 88.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.026 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.07 -57.14 8.39 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.96 14.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.467 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.03 -36.72 80.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 -2.59 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.222 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -128.56 68.28 77.77 Favored Pre-proline 0 N--CA 1.456 -0.161 0 CA-C-O 121.082 0.467 . . . . 0.0 110.298 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.97 0.55 3.04 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.41 2.74 . . . . 0.0 113.087 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.92 -19.69 17.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.229 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 27.3 mm-40 -109.83 154.99 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 43.9 mm-40 -98.16 174.92 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.365 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.49 109.07 18.84 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.574 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' MET . 39.2 t -124.24 108.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.298 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 40' ' ' VAL . 18.5 mm -85.55 142.36 13.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.384 0.612 . . . . 0.0 111.961 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -111.45 -44.66 3.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.371 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.91 -165.75 38.56 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.622 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -82.53 -161.19 29.28 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.401 0.6 . . . . 0.0 112.651 -0.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.71 -48.07 69.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.855 0.359 . . . . 0.0 111.078 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -58.09 -29.19 65.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.608 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -79.95 -29.28 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.358 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.428 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 3.5 m-85 -58.44 -55.91 28.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.733 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.703 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.4 t -65.17 -9.83 26.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.613 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.47 -43.41 27.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.843 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.718 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.6 m-85 -93.56 -6.79 45.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.338 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 10.9 pttp -49.8 -32.98 15.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.399 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -78.87 -6.04 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.764 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.09 -24.7 4.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 106' ' ' PHE . 76.6 t -44.43 124.58 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.94 0.4 . . . . 0.0 111.447 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 6.3 t70 -103.07 -1.22 29.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.687 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 86.3 m -161.46 142.51 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.585 0.231 . . . . 0.0 111.065 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.533 HD11 ' CG ' ' A' ' 136' ' ' PHE . 7.0 mt -123.58 144.95 49.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.213 0.53 . . . . 0.0 111.415 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 113' ' ' LEU . 12.9 mt -135.33 118.94 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.761 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.602 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.9 m -134.78 144.8 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.424 . . . . 0.0 111.688 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.84 119.31 35.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 7.1 mtm180 -102.05 104.7 15.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.418 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 153' ' ' HIS . 0.8 OUTLIER -87.8 136.46 32.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.44 -48.23 68.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.27 -138.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.406 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.7 p -144.23 168.2 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 0.0 111.335 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 80.0 m-85 -131.2 137.74 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.743 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 166.53 10.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.734 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.24 -159.12 29.18 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.13 22.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.5 m -146.08 137.82 24.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.863 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -109.34 165.82 11.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -177.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.703 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pt -104.06 156.73 35.3 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.88 99.9 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.671 2.247 . . . . 0.0 112.194 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.73 148.08 23.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.955 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.37 70.6 6.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.413 ' HH2' HG11 ' A' ' 115' ' ' VAL . 94.4 m95 -53.41 -27.64 25.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.094 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.09 -29.11 67.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.421 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.57 -20.67 42.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.533 ' CG ' HD11 ' A' ' 113' ' ' LEU . 43.5 m-85 -100.02 175.86 5.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.5 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 2.5 m -134.32 139.95 46.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.422 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.654 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 7.7 ttpt -83.94 111.56 19.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 157' ' ' VAL . 4.4 m -98.8 -17.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.487 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -163.89 140.21 6.62 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.443 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.654 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 81.0 p -168.04 105.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.464 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -142.79 121.25 12.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.649 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.684 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.2 m -71.16 145.59 49.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.21 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.77 103.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.579 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.4 mt-10 -86.61 100.27 12.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.358 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -83.24 -176.9 6.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -56.68 -54.15 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.942 0.401 . . . . 0.0 110.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.539 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.6 t30 -73.63 127.84 87.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.847 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.63 -31.6 92.34 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.037 1.825 . . . . 0.0 112.563 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.62 -21.48 28.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.8 mt -82.08 8.79 9.84 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 145' ' ' GLU . 95.5 m -75.28 164.1 26.79 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.9 p80 -175.58 162.19 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.994 0.426 . . . . 0.0 111.581 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.684 ' OG1' HG23 ' A' ' 143' ' ' THR . 7.7 m -122.12 144.85 48.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.911 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -111.65 110.06 20.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.71 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HB2' HG22 ' A' ' 115' ' ' VAL . 7.0 mm-40 -98.68 151.26 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 139' ' ' VAL . 10.7 t -141.77 106.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.009 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 25.1 m95 -108.5 146.18 33.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.106 0.479 . . . . 0.0 111.949 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -124.81 112.74 17.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.233 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.2 tttt -51.17 131.74 27.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.227 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -92.39 168.59 11.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.295 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.159 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 11.8 m . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.789 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.28 152.47 27.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.3 m-30 -118.11 112.03 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -115.21 126.34 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.673 0.749 . . . . 0.0 112.881 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.719 ' CH2' HG12 ' A' ' 115' ' ' VAL . 9.0 p90 -164.6 164.73 21.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.055 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.04 134.93 54.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 111.472 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.427 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 2.7 pt20 -115.61 140.34 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.796 ' OD2' HD12 ' A' ' 12' ' ' LEU . 4.5 p30 -97.82 -167.42 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.423 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -51.36 -34.66 35.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.784 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.63 -28.42 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 94.83 45.86 3.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.871 HD13 ' HA3' ' A' ' 124' ' ' GLY . 1.4 mt -91.11 174.31 7.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.615 HG22 ' CD1' ' A' ' 5' ' ' TRP . 1.1 pp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.653 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 mttm . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.63 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 74.3 mt -74.55 94.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 112.016 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.406 ' CE ' ' ND2' ' A' ' 59' ' ' ASN . 8.6 ttp -103.48 126.81 50.85 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.014 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.1 t -78.9 158.22 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 40' ' ' VAL . 27.3 m -165.04 142.98 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.99 158.5 51.2 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.81 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.593 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.84 -48.51 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.058 0.429 . . . . 0.0 110.77 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -62.66 -27.01 68.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 0.0 110.467 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.2 m -75.73 -44.62 40.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.589 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.462 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 15.8 t80 -61.33 -31.59 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -66.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.71 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 49' ' ' PHE . 3.9 t -54.7 -33.05 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -26.38 114.31 0.23 Allowed Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.883 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.88 -37.0 21.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.043 2.495 . . . . 0.0 113.307 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' CE ' HD23 ' A' ' 54' ' ' LEU . 2.6 tmmm? -147.13 118.93 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.777 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.86 140.16 21.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.18 -167.1 5.06 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.23 -1.571 . . . . 0.0 112.004 -0.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HB3' ' CD ' ' A' ' 57' ' ' ARG . 81.9 mt -111.61 137.47 21.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.06 -66.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.65 2.233 . . . . 0.0 113.302 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.82 19.8 1.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.488 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.577 ' CD ' ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -142.27 121.43 12.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.119 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.63 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 39.9 m -80.59 128.11 33.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.289 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.406 ' ND2' ' CE ' ' A' ' 39' ' ' MET . 6.5 m120 -115.02 147.36 40.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 111.843 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.824 HG12 HG22 ' A' ' 76' ' ' VAL . 3.3 t -131.12 132.65 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.464 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 43' ' ' ARG . 78.7 t -97.73 128.89 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.289 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.669 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.07 115.38 30.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.824 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -147.4 156.75 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -74.15 -12.4 60.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.888 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tt0 -80.39 133.5 35.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.413 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 3.1 mm-40 -84.67 -11.13 56.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.962 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.37 4.41 20.66 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.861 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.4 t80 -58.26 140.45 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.54 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.848 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -126.48 173.85 9.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 179.078 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.49 143.68 20.09 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.648 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.73 96.75 5.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.742 0.306 . . . . 0.0 110.696 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.11 2.65 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.959 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.462 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.16 167.75 17.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.071 0.462 . . . . 0.0 111.718 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HB ' HG13 ' A' ' 60' ' ' VAL . 32.3 t -97.07 140.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.421 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 68' ' ' TYR . 21.3 t -104.23 117.66 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.368 0.604 . . . . 0.0 112.477 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.824 HG22 HG12 ' A' ' 60' ' ' VAL . 28.1 m -127.31 167.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.962 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.413 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 4.7 m80 -119.13 -22.18 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.539 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.662 ' HA ' HD21 ' A' ' 62' ' ' LEU . 8.1 m-20 -159.33 -175.02 4.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.667 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.83 HG22 ' CD1' ' A' ' 106' ' ' PHE . 11.8 t -66.64 -11.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.786 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.69 -36.82 17.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 0.0 109.752 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.65 -31.74 65.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 HG21 ' A' ' 76' ' ' VAL . 31.6 t -69.68 -53.82 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.986 0.422 . . . . 0.0 109.938 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 5.6 m-85 -53.61 -27.6 27.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.971 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -62.62 -46.49 88.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.895 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.43 -54.49 31.87 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.85 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.78 -24.2 34.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -71.39 -33.63 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -83.16 -8.72 59.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.376 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -124.82 66.01 47.32 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.019 0.437 . . . . 0.0 110.277 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.3 -0.46 2.89 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.099 2.533 . . . . 0.0 112.831 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.09 -30.28 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.009 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -105.93 161.81 14.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -98.76 174.77 6.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.85 HD13 ' HB2' ' A' ' 86' ' ' ALA . 8.5 tp -122.27 118.8 29.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.383 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 2' ' ' ALA . 53.5 t -132.87 121.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.452 ' CD1' HG21 ' A' ' 40' ' ' VAL . 8.7 mm -83.25 133.39 29.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.11 0.481 . . . . 0.0 111.832 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.402 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -101.22 -50.04 3.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.21 -171.13 43.94 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.717 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.408 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.45 -160.98 36.79 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.674 0.737 . . . . 0.0 112.69 -0.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.02 10.18 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.733 0.301 . . . . 0.0 111.508 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -52.62 -30.52 31.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.553 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.669 ' CD1' HD22 ' A' ' 62' ' ' LEU . 28.2 mm -82.89 -21.62 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . 2.7 m-85 -66.29 -51.75 54.25 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.518 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -70.75 -9.59 57.65 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 111.916 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.763 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.47 -37.87 35.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.83 ' CD1' HG22 ' A' ' 79' ' ' VAL . 6.3 m-85 -95.87 -11.12 27.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.682 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 9.4 pttp -51.4 -29.14 14.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.97 -12.45 60.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.411 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.89 -20.73 5.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 106' ' ' PHE . 81.0 t -44.53 128.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.063 0.458 . . . . 0.0 111.317 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 6.2 t0 -110.47 -3.87 15.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.582 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.789 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.9 m -155.7 134.47 11.92 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.598 0.237 . . . . 0.0 111.08 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.683 HD11 ' CD2' ' A' ' 136' ' ' PHE . 11.7 mt -117.01 144.08 44.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 4' ' ' LEU . 4.2 mt -135.91 115.51 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.502 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.719 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -131.4 141.34 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.39 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.44 112.78 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -96.26 100.44 12.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.366 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.0 OUTLIER -86.66 131.21 34.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -61.54 -46.47 89.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.67 -173.3 0.08 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 p -124.54 136.58 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -138.15 157.49 46.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.91 170.37 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.871 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . -161.26 125.87 1.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.701 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.56 14.05 24.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.509 0.195 . . . . 0.0 111.42 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -162.85 137.27 6.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.939 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.33 160.78 14.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.202 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.554 ' SD ' HG21 ' A' ' 13' ' ' ILE . 15.9 tpt -81.51 159.34 24.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.425 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pp -91.81 165.07 21.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.415 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.63 128.37 23.23 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.628 2.218 . . . . 0.0 112.043 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.68 HD13 ' CZ2' ' A' ' 133' ' ' TRP . 2.5 mt -112.36 139.67 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.19 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 63.05 7.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.68 ' CZ2' HD13 ' A' ' 131' ' ' LEU . 89.8 m95 -53.9 -24.37 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -31.14 65.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.03 -16.39 47.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.397 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 113' ' ' LEU . 77.9 m-85 -103.45 168.28 9.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 110.69 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.676 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -132.59 140.93 48.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.978 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 5.6 ttpt -79.93 119.41 22.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 157' ' ' VAL . 32.8 m -105.41 -19.37 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.0 m -167.07 140.45 3.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 5.2 p -169.27 108.68 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -147.84 125.39 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.779 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.643 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.1 m -71.2 146.11 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.728 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 152' ' ' THR . 10.5 t -118.78 103.47 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.592 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.5 mt-10 -88.29 102.02 14.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.576 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.76 -174.4 4.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.654 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.9 p -58.0 -51.21 70.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.9 t30 -76.5 134.02 70.25 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.871 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.56 -35.29 60.48 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.985 1.79 . . . . 0.0 112.393 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.5 mt -78.45 8.91 4.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 144' ' ' VAL . 93.6 m -78.71 161.11 27.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.482 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -172.11 157.81 4.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.008 0.432 . . . . 0.0 111.594 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.643 ' OG1' HG23 ' A' ' 143' ' ' THR . 7.5 m -119.06 131.48 55.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.574 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 144' ' ' VAL . 45.1 m-85 -99.79 105.21 16.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.755 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.59 ' HB2' HG22 ' A' ' 115' ' ' VAL . 4.3 mt-10 -102.81 122.11 43.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.477 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.721 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.8 t -116.79 114.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 138' ' ' LYS . 30.5 m95 -112.15 150.56 30.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 111.556 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -126.8 115.02 18.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.829 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 3.0 ttpt -51.73 138.22 23.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.287 0.565 . . . . 0.0 112.434 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.676 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -125.87 -164.03 1.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.339 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.063 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.446 HG23 HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.723 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.93 146.35 39.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.57 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.5 m-85 -110.2 115.79 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.531 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 tp -113.73 120.96 42.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.702 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.1 p90 -166.17 164.65 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.274 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.32 55.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 111.48 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 pt20 -123.29 153.05 40.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.157 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -103.18 -174.07 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.717 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -24.92 19.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -91.99 -31.17 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.744 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.98 22.74 7.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.669 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -87.22 153.09 21.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.409 HG23 ' HD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.9 mmtt . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 71.8 mt -86.6 85.27 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.051 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ttp -102.12 123.07 45.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.39 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 41' ' ' VAL . 43.3 t -76.01 156.51 5.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.522 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 40' ' ' VAL . 34.9 m -164.18 137.46 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.74 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.21 161.37 34.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.933 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.642 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.99 -47.2 81.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.861 0.33 . . . . 0.0 110.767 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.419 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.8 tpp180 -66.36 -30.48 70.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.388 . . . . 0.0 110.336 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.711 HG22 ' CE2' ' A' ' 49' ' ' PHE . 7.0 m -68.2 -43.73 77.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.204 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.452 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 13.7 t80 -59.05 -31.14 68.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.42 -66.1 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.1 t -50.07 -41.61 48.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.9 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.711 ' CE2' HG22 ' A' ' 45' ' ' THR . 6.9 m-85 -42.44 152.92 0.32 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-O 120.781 0.324 . . . . 0.0 111.448 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -41.73 -72.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.063 2.509 . . . . 0.0 113.542 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.66 177.15 8.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.45 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 2.4 ptp180 -122.1 105.76 36.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 86.9 Cg_endo -87.89 -179.96 17.07 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.457 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 49' ' ' PHE . 34.2 mt -61.18 158.53 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 12.9 Cg_endo -56.72 87.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.412 2.075 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 42.8 mt-10 69.62 47.55 0.64 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.351 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HD2' ' CD1' ' A' ' 54' ' ' LEU . 17.0 mtt180 -140.79 126.05 18.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.671 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 92.0 m -76.5 105.84 7.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.479 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 1.8 m-80 -104.6 145.86 29.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.224 -178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 76' ' ' VAL . 12.1 t -117.63 141.78 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.097 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.642 HG13 ' HA ' ' A' ' 43' ' ' ARG . 58.8 t -108.32 124.42 64.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.116 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.28 121.05 44.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.484 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.536 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.5 t -157.17 160.13 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -75.52 -5.51 45.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.19 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.4 tp60 -78.71 129.85 35.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 3.8 mm-40 -82.63 -28.06 31.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.139 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.56 7.55 46.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.68 ' O ' HG11 ' A' ' 75' ' ' VAL . 7.7 t80 -60.57 142.49 55.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.348 0.594 . . . . 0.0 111.897 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.939 ' HA ' HG21 ' A' ' 75' ' ' VAL . 14.9 mm100 -134.77 175.72 9.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.39 1.09 . . . . 0.0 112.888 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 142.64 19.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -78.11 100.94 6.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.35 -43.0 2.8 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.807 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -70.08 170.18 11.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.446 . . . . 0.0 111.709 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.5 t -99.48 140.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.939 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.5 t -111.36 119.97 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.357 0.599 . . . . 0.0 112.121 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.973 HG21 HG22 ' A' ' 82' ' ' VAL . 34.1 m -126.61 168.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.409 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.41 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 12.4 m-70 -119.14 -25.46 6.17 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.794 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 t70 -149.07 -176.13 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.641 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.912 HG13 ' CD2' ' A' ' 106' ' ' PHE . 21.7 t -69.63 -10.73 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.688 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.72 -30.99 18.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 110.364 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.26 -26.59 52.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.133 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.973 HG22 HG21 ' A' ' 76' ' ' VAL . 16.7 t -78.41 -50.81 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 109.806 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.592 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.2 m-85 -57.33 -28.78 63.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.913 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.77 -38.29 79.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.7 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -68.12 -59.23 3.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.51 -22.84 14.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.202 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.89 -37.38 75.99 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.035 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 37.0 mt-30 -83.81 -4.49 58.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.233 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -124.76 65.04 43.77 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.563 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.8 -0.99 6.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.925 2.417 . . . . 0.0 112.829 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.7 -31.67 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 54.6 mt-30 -102.28 157.44 16.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -99.14 158.99 15.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.446 HD23 HG23 ' A' ' 1' ' ' THR . 29.9 tp -111.51 115.89 29.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.28 110.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.33 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.471 HD12 HG21 ' A' ' 40' ' ' VAL . 4.9 mm -77.2 129.03 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 0.0 111.079 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.19 -37.14 6.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.59 -169.11 42.17 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.785 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.34 -161.01 30.6 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 122.266 -0.549 . . . . 0.0 112.545 -0.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -55.12 -51.18 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.054 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -55.53 -27.64 50.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.591 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 62' ' ' LEU . 49.0 mm -79.34 -32.94 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.0 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 3' ' ' PHE . 6.2 m-85 -54.08 -58.16 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.65 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.568 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.1 t -65.78 -9.92 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.811 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.74 -41.56 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.912 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.0 m-85 -101.56 -2.57 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.462 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 39.0 pttt -49.8 -34.36 19.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.731 0.3 . . . . 0.0 111.767 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 4.07 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.64 -25.0 3.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.856 HG11 HD23 ' A' ' 113' ' ' LEU . 62.9 t -44.04 129.35 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 120.97 0.414 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 24.5 t70 -103.41 2.77 34.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.124 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 97.8 m -166.97 138.63 3.32 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.538 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.856 HD23 HG11 ' A' ' 110' ' ' VAL . 21.2 mt -120.17 144.81 47.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 113' ' ' LEU . 19.9 mt -135.31 115.23 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.2 m -132.16 143.05 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.848 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.35 105.67 13.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.235 179.31 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -81.98 101.67 10.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.748 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -84.91 125.73 32.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.974 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 -56.93 12.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.312 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.16 168.26 15.85 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.87 163.19 12.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.748 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 4.5 m-85 -136.39 147.99 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -98.75 132.67 43.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.692 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.14 -179.7 47.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.527 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.26 -0.18 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.7 m -118.13 122.45 43.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.032 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.407 ' O ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.74 175.98 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.4 tpt -76.61 153.3 35.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.855 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.519 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.8 pp -81.23 164.14 51.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.249 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.27 101.6 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.839 2.359 . . . . 0.0 112.686 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.415 ' CD1' ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -91.25 145.42 24.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.67 75.7 4.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.247 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.553 ' HH2' HG11 ' A' ' 115' ' ' VAL . 93.7 m95 -55.29 -21.25 13.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.304 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -28.36 61.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.3 t0 -80.74 -17.27 51.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.177 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.648 ' CD1' HD11 ' A' ' 113' ' ' LEU . 91.5 m-85 -109.1 166.35 10.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.94 0.4 . . . . 0.0 111.559 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.748 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -125.24 140.31 52.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.739 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.545 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpm? -81.19 121.35 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.615 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.1 m -110.21 -15.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.612 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.407 ' OG ' HG23 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -167.33 139.87 3.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.81 0.338 . . . . 0.0 110.928 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.2 p -163.09 109.79 1.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -143.65 119.27 10.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.332 . . . . 0.0 111.283 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.742 HG23 ' OG1' ' A' ' 154' ' ' THR . 5.0 m -74.09 144.61 44.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.244 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 t -116.53 106.22 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.126 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.69 105.49 17.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.588 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.86 -177.18 6.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.559 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 p -59.64 -42.01 91.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.498 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -81.78 126.35 75.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.23 -29.18 88.44 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.295 1.997 . . . . 0.0 112.274 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.54 -24.08 23.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.037 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.7 mt -81.32 6.28 14.78 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.571 ' O ' HD23 ' A' ' 118' ' ' LEU . 52.1 m -71.38 164.5 25.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.071 0.463 . . . . 0.0 110.124 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.1 p80 -174.37 160.95 3.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.13 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.742 ' OG1' HG23 ' A' ' 143' ' ' THR . 26.9 m -122.69 150.16 43.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.629 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -111.05 105.21 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.54 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.713 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.1 mt-10 -105.05 121.63 44.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 111.631 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 139' ' ' VAL . 4.1 t -112.93 111.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.696 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.2 m95 -110.89 150.33 29.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 111.487 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -128.39 120.91 27.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.496 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.5 tmmt? -45.5 125.93 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.643 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.748 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -109.79 -176.27 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.105 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.508 HG22 HG12 ' A' ' 96' ' ' ILE . 2.9 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.743 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.51 144.92 42.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 1.8 m-30 -107.66 112.9 25.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.846 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.33 124.92 53.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.36 0.6 . . . . 0.0 112.43 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.76 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.9 p90 -170.91 174.05 4.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.617 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -121.76 139.77 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -120.48 154.76 34.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 111.422 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 122' ' ' PHE . 1.1 p30 -108.62 -177.7 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HG2' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -47.88 -49.63 29.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.32 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.23 -19.55 64.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.55 25.89 21.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.347 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -90.4 161.98 15.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.857 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.679 HG22 ' CD1' ' A' ' 5' ' ' TRP . 11.4 pt . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.202 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.509 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 58.6 mt -82.18 88.42 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.413 ' HE3' HG13 ' A' ' 41' ' ' VAL . 1.6 ttp -97.91 116.89 31.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.801 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 82' ' ' VAL . 5.8 t -86.3 125.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.09 0.471 . . . . 0.0 111.688 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 49' ' ' PHE . 24.5 m -132.13 155.13 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.502 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.13 147.0 32.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.756 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.7 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -45.09 -49.29 11.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.72 0.26 . . . . 0.0 111.459 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.442 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 3.8 ttt180 -62.14 -36.88 83.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 0.0 110.146 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -63.34 -49.38 74.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.475 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.83 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 2.9 t80 -50.3 -43.76 53.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.875 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -52.38 -63.98 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.766 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -35.08 67.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.37 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -34.98 138.52 0.35 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-O 120.905 0.384 . . . . 0.0 111.973 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.19 -29.99 18.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.253 2.635 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 149.33 31.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.387 . . . . 0.0 111.501 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.4 mtm180 -138.65 106.37 7.63 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 95.1 Cg_endo -86.0 -166.91 4.37 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.273 -0.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.616 HD12 HD21 ' A' ' 59' ' ' ASN . 75.4 mt -100.58 142.05 23.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.92 121.17 6.77 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 112.798 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 69.98 3.09 4.18 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.771 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HD2' HD13 ' A' ' 54' ' ' LEU . 3.4 mtt-85 -114.42 108.8 17.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.0 m -68.24 113.19 5.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.616 HD21 HD12 ' A' ' 54' ' ' LEU . 2.5 m-80 -104.73 150.37 24.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.397 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 76' ' ' VAL . 6.6 t -134.83 133.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.7 HG13 ' HA ' ' A' ' 43' ' ' ARG . 79.2 t -103.01 124.04 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.753 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -105.72 111.23 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.907 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.954 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -142.83 170.81 15.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 111.285 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -86.91 -14.19 42.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.683 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 45.2 tt0 -79.17 133.58 36.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.455 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 23.4 mt-10 -80.89 -25.61 37.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.79 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.89 6.78 48.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.954 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.2 t80 -60.08 136.24 57.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.216 0.532 . . . . 0.0 111.6 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.95 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -132.04 173.71 10.93 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.254 1.026 . . . . 0.0 112.703 179.306 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.07 141.41 18.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.096 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.26 101.56 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.807 0.337 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -41.39 2.92 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.638 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.83 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -69.44 167.74 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.52 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.78 140.77 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.95 HG21 ' HA ' ' A' ' 69' ' ' GLN . 19.2 t -110.03 119.87 59.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.228 0.537 . . . . 0.0 112.066 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.821 HG21 HG22 ' A' ' 82' ' ' VAL . 27.6 m -130.19 167.11 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.664 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.455 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 17.3 m80 -118.28 -22.51 7.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.642 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.65 -176.72 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.206 0.527 . . . . 0.0 111.507 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.873 HG13 ' CD2' ' A' ' 106' ' ' PHE . 35.6 t -71.89 -9.36 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.661 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.13 -33.78 19.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.487 . . . . 0.0 109.785 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.542 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.85 -32.3 63.59 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.124 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.821 HG22 HG21 ' A' ' 76' ' ' VAL . 43.4 t -72.19 -52.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.3 m-85 -54.13 -28.09 37.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.27 -40.19 93.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.471 ' CE2' ' CD2' ' A' ' 89' ' ' HIS . 65.1 t80 -66.99 -57.42 6.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -53.33 -23.3 8.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.097 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 3.5 mmtp -69.4 -40.11 77.56 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -85.06 -4.95 59.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.529 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 93.4 m-70 -127.38 60.59 44.26 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.02 -0.03 5.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.236 2.624 . . . . 0.0 112.916 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.75 -35.7 19.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.03 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.401 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 12.1 mt-30 -99.5 163.92 12.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.473 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.3 160.69 14.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.926 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.795 HD11 HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -115.3 117.06 29.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.53 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.451 HG12 HD12 ' A' ' 4' ' ' LEU . 59.3 t -131.94 117.83 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.174 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 1' ' ' THR . 5.4 mm -81.92 133.13 29.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.262 0.553 . . . . 0.0 111.484 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.53 -48.66 4.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.056 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.404 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.43 -164.13 36.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.404 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -86.15 -161.02 34.83 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.674 0.737 . . . . 0.0 112.704 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -50.77 -48.97 59.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.323 . . . . 0.0 111.41 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -58.5 -29.85 66.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.877 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.2 mm -79.43 -29.93 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.268 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.9 m-85 -57.16 -54.14 50.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.862 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -70.12 -8.49 50.0 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.024 -0.423 . . . . 0.0 111.839 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.814 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.34 -38.98 40.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.873 ' CD2' HG13 ' A' ' 79' ' ' VAL . 29.3 m-85 -99.63 -10.03 22.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.308 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 18.5 pttp -52.17 -31.73 32.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.758 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.74 -5.1 52.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.656 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.2 -21.66 3.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 106' ' ' PHE . 76.9 t -44.81 123.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 111.302 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.433 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 3.9 t70 -103.13 7.69 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.267 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.2 m -168.39 135.84 2.09 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.821 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.63 HD23 HG11 ' A' ' 110' ' ' VAL . 17.0 mt -117.92 143.7 46.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.491 . . . . 0.0 111.531 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 4' ' ' LEU . 6.5 mt -135.28 115.08 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.664 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.76 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -134.69 144.69 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.024 0.44 . . . . 0.0 111.744 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.79 105.56 13.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.577 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 6.5 mmt85 -80.7 100.33 8.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.489 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.5 mp -82.21 127.94 33.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.431 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -63.08 -52.11 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -50.43 144.49 11.09 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.443 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.467 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 35.3 p -91.5 132.61 36.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.981 0.42 . . . . 0.0 111.374 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -134.23 163.57 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -116.56 150.86 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.112 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.8 -173.72 23.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.788 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -33.98 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.954 0.407 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 60.7 m -108.71 139.44 43.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.98 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -115.89 172.39 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 111.681 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -70.22 143.6 52.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.488 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pt -68.45 154.33 94.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.96 97.73 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.512 2.142 . . . . 0.0 111.975 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.62 146.69 26.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 72.45 4.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.325 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.475 ' HH2' HG11 ' A' ' 115' ' ' VAL . 89.8 m95 -55.7 -22.37 23.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.423 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -28.81 62.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -80.64 -23.46 39.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 71.8 m-85 -102.09 174.08 6.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -137.79 142.85 40.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.6 ttpt -79.96 120.54 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.787 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.6 m -103.01 -21.75 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.433 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.4 m -162.74 140.69 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 16.1 p -160.62 109.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -139.43 115.2 10.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.27 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 8.4 m -74.42 144.14 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.432 HG11 ' HE2' ' A' ' 155' ' ' TYR . 2.5 p -121.77 105.26 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.997 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.53 ' HA ' HG23 ' A' ' 152' ' ' THR . 19.6 mt-10 -88.7 107.14 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.787 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.27 -175.77 5.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.486 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.7 p -57.45 -50.45 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.749 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.494 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -74.41 124.66 90.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.102 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.97 -27.21 84.44 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.154 1.903 . . . . 0.0 112.301 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -19.89 22.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.674 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.3 mt -84.85 7.77 19.72 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 74.5 m -72.88 168.22 19.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -175.46 162.48 2.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.257 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 24.5 m -125.23 137.91 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.797 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.432 ' HE2' HG11 ' A' ' 144' ' ' VAL . 94.4 m-85 -98.4 106.3 18.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.493 ' HB2' HG22 ' A' ' 115' ' ' VAL . 62.7 mt-10 -108.69 126.61 53.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.857 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.7 t -118.72 115.9 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.251 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.3 m95 -111.97 151.16 29.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 0.0 111.377 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -127.02 117.13 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.828 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.1 OUTLIER -55.46 131.47 46.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.93 0.395 . . . . 0.0 111.613 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.493 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 1.8 ptmt 177.5 156.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.991 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 85.2 m . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.83 148.93 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.597 ' C ' HD13 ' A' ' 4' ' ' LEU . 2.6 m-30 -114.18 112.28 22.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.491 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.078 HD11 HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -112.82 121.52 44.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 0.0 111.807 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.86 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.0 p90 -166.85 172.73 10.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.448 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.88 134.37 50.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -119.98 155.81 32.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.952 0.406 . . . . 0.0 111.182 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.7 -172.83 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.687 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.13 63.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.06 -23.12 52.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.71 22.61 17.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.358 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.37 159.75 20.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.22 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.6 mt -78.62 86.75 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.4 ttp -99.99 120.31 39.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.934 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.498 HG21 HG11 ' A' ' 82' ' ' VAL . 80.3 t -77.57 156.76 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.974 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 60' ' ' VAL . 33.6 m -162.49 141.22 2.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.43 153.45 52.92 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.506 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.765 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.33 -51.05 57.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.223 0.512 . . . . 0.0 110.815 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.489 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.9 tpt85 -57.88 -34.48 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.061 0.458 . . . . 0.0 110.19 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.577 HG22 ' CE2' ' A' ' 49' ' ' PHE . 2.8 m -69.75 -55.9 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.398 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -46.63 -28.69 1.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -65.44 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.237 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -50.18 -35.4 26.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.654 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 45' ' ' THR . 5.4 m-85 -40.93 157.95 0.18 Allowed Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD2' HD21 ' A' ' 54' ' ' LEU . 68.5 Cg_exo -52.23 -71.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.611 2.207 . . . . 0.0 113.257 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -124.15 173.6 8.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.7 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.9 mtp180 -133.99 104.43 11.63 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.913 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 89.9 Cg_endo -85.19 -167.06 4.76 Favored 'Cis proline' 0 C--N 1.349 0.588 0 C-N-CA 123.912 -1.287 . . . . 0.0 112.144 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 HD21 ' A' ' 59' ' ' ASN . 95.4 mt -93.87 151.36 39.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.629 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.35 110.15 2.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.666 2.244 . . . . 0.0 112.972 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.18 4.27 5.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.002 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.574 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 5.7 mtt180 -112.59 101.07 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.038 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 24.0 m -66.05 107.81 2.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.706 HD21 HD12 ' A' ' 54' ' ' LEU . 2.3 m-80 -103.38 156.1 17.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.243 0.544 . . . . 0.0 112.14 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.642 HG12 HG22 ' A' ' 76' ' ' VAL . 8.3 t -132.43 136.91 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.883 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.765 HG13 ' HA ' ' A' ' 43' ' ' ARG . 66.4 t -105.93 127.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.586 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.92 116.12 31.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.202 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.847 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.6 t -147.19 167.14 24.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.903 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -85.14 -12.01 53.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -72.93 134.83 44.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -85.2 -7.9 58.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.883 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -118.7 7.46 11.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.606 0.241 . . . . 0.0 111.522 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.925 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.9 t80 -58.14 139.57 54.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.193 0.52 . . . . 0.0 111.817 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.888 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -126.27 173.84 8.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.043 0.925 . . . . 0.0 111.99 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.27 142.97 19.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.495 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -77.93 97.99 5.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.745 0.307 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.41 2.99 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.234 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.89 171.72 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 60' ' ' VAL . 12.4 t -97.46 139.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.476 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.925 HG11 ' O ' ' A' ' 68' ' ' TYR . 41.9 t -103.69 107.95 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.281 0.562 . . . . 0.0 112.193 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 82' ' ' VAL . 28.7 m -118.23 167.79 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.973 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 63' ' ' THR . 13.1 m170 -120.38 -21.21 6.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 m-20 -160.59 -173.32 3.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.839 HG13 ' CD2' ' A' ' 106' ' ' PHE . 12.8 t -66.94 -10.18 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.765 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.0 -38.33 16.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 110.019 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.32 -30.73 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.749 HG22 HG21 ' A' ' 76' ' ' VAL . 21.5 t -71.01 -53.59 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.969 0.414 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.436 ' CE2' HG12 ' A' ' 79' ' ' VAL . 6.7 m-85 -54.09 -27.08 30.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.934 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.36 -44.99 85.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.95 -55.33 19.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.16 -22.61 17.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.875 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.4 mmpt? -70.09 -38.04 75.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -83.05 -6.2 59.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.622 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -126.48 67.4 65.52 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.998 0.427 . . . . 0.0 110.558 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.8 -0.23 4.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.162 2.575 . . . . 0.0 113.079 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.33 -30.3 22.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 111.039 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -112.27 156.83 21.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 111.529 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.66 174.96 6.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.699 HD11 HG12 ' A' ' 82' ' ' VAL . 7.8 tp -104.68 110.73 23.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.078 HG13 HD11 ' A' ' 4' ' ' LEU . 80.8 t -119.52 102.46 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.694 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.505 ' O ' HD22 ' A' ' 4' ' ' LEU . 11.1 mm -78.36 128.45 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 111.634 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -95.77 -47.64 6.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.0 -168.29 41.36 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.41 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -94.31 -160.82 34.64 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 117.824 0.812 . . . . 0.0 112.557 -0.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.14 -51.57 13.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -55.84 -33.09 64.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.536 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.535 ' CD1' HD22 ' A' ' 62' ' ' LEU . 39.3 mm -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.2 m-85 -60.51 -57.5 12.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.694 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.837 ' HA ' HD13 ' A' ' 129' ' ' ILE . 3.9 t -67.13 -9.98 45.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.609 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.76 -46.04 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.839 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.3 m-85 -94.53 -6.44 43.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 14.7 pttp -52.26 -30.2 26.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.912 0.386 . . . . 0.0 111.056 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.83 -7.21 58.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.269 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.43 -20.06 6.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.728 HG11 HD23 ' A' ' 113' ' ' LEU . 74.0 t -44.75 127.34 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.358 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.423 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 12.7 t70 -105.04 2.78 29.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 52.1 m -167.47 139.29 3.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.728 HD23 HG11 ' A' ' 110' ' ' VAL . 11.6 mt -119.72 146.62 45.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.33 0.586 . . . . 0.0 112.164 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.061 HD12 HD12 ' A' ' 4' ' ' LEU . 27.1 mt -135.6 112.39 10.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.198 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.86 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -130.59 141.79 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 111.596 -179.272 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -117.43 102.8 9.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.665 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.4 ttp85 -80.42 102.77 9.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.736 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 152' ' ' THR . 0.5 OUTLIER -80.93 123.46 28.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.17 -46.26 82.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.372 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 150' ' ' ALA . . . -57.71 -163.25 0.05 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.609 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.3 p -143.41 137.83 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.057 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.567 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -128.81 162.04 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -111.87 143.08 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.8 -166.67 23.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.597 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.46 -23.48 3.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -109.1 134.01 52.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.802 0.334 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -112.88 -174.0 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -164.8 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.837 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.1 pt -118.31 166.27 14.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.224 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.2 Cg_endo -75.7 103.52 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.43 2.087 . . . . 0.0 112.221 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.83 145.93 26.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.6 74.6 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.236 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -57.5 -20.53 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.48 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.93 -30.87 64.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.76 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.04 -21.96 39.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 78.5 m-85 -103.44 176.6 5.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 111.326 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -138.93 141.9 38.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.441 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 3.0 ttpt -78.15 124.33 27.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.8 m -109.18 -18.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.511 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.3 m -168.05 140.28 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.867 0.365 . . . . 0.0 111.368 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 6.4 p -155.48 111.13 3.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -144.08 115.42 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.8 m -76.97 143.1 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.124 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 105.73 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.212 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.651 ' HA ' HG23 ' A' ' 152' ' ' THR . 23.2 mt-10 -86.13 97.2 10.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.652 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -78.98 178.18 8.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.1 p -57.41 -52.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.699 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.501 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.32 125.68 91.3 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.806 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -28.83 87.77 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.085 1.857 . . . . 0.0 112.633 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HA ' ' CA ' ' A' ' 120' ' ' GLY . . . -90.02 -20.86 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.664 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.7 mt -83.24 7.19 17.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.597 0.237 . . . . 0.0 111.477 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.835 ' O ' HD23 ' A' ' 118' ' ' LEU . 62.6 m -72.43 167.0 21.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 7.8 p-80 -175.37 162.14 2.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.641 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 19.4 m -125.79 139.11 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.588 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.9 105.17 17.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.37 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.721 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.2 mm-40 -103.56 121.55 43.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.284 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.785 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.7 t -115.13 114.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.709 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.442 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.6 m95 -112.35 150.63 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.462 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.409 ' HG3' HG11 ' A' ' 139' ' ' VAL . 7.9 mt-30 -127.5 117.62 22.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -54.91 132.8 47.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.299 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -114.67 -168.32 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.403 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.089 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 m . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.33 150.14 29.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.506 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 2.3 m-30 -117.95 115.83 25.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.89 124.49 51.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.469 0.652 . . . . 0.0 112.602 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.61 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.3 p90 -171.85 173.22 4.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.41 140.45 52.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.387 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -128.58 157.87 40.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.6 179.76 4.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.688 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.0 OUTLIER -50.94 -36.09 36.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.119 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -30.95 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.752 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.54 46.9 2.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.312 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.89 HD11 ' HA3' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -107.34 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.58 ' N ' ' HG ' ' A' ' 12' ' ' LEU . 4.6 pt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.596 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 80.8 mt -82.05 86.7 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.2 ttp -99.34 117.59 34.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.686 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.857 HG21 HG11 ' A' ' 82' ' ' VAL . 3.6 t -85.08 127.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.8 m -134.58 149.66 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.32 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.71 51.78 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.116 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.701 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -58.59 -52.56 65.16 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.854 0.327 . . . . 0.0 110.321 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.503 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 1.1 tpp180 -58.89 -37.27 76.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 m -69.96 -42.1 73.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.226 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CG ' HG22 ' A' ' 61' ' ' VAL . 53.1 t80 -64.1 -41.65 97.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.18 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -57.8 -66.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.785 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' PHE . 88.6 p -61.23 -30.63 70.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.78 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -30.41 133.32 0.22 Allowed Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.775 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_exo -38.39 -35.08 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.129 2.553 . . . . 0.0 113.252 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.786 ' HB3' HD23 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -152.35 139.76 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -140.3 108.12 6.75 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 91.6 Cg_endo -75.55 -170.51 8.46 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.519 -1.45 . . . . 0.0 112.195 -0.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.786 HD23 ' HB3' ' A' ' 51' ' ' LYS . 28.0 mt -99.21 155.95 35.98 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 104.63 1.45 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.576 2.184 . . . . 0.0 112.704 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 69.8 6.89 5.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.783 ' HD2' HD13 ' A' ' 54' ' ' LEU . 1.8 mtt180 -109.3 113.0 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.885 0.374 . . . . 0.0 111.552 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.7 m -67.33 107.98 2.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.996 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.409 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.7 m120 -108.23 141.83 39.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.929 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 76' ' ' VAL . 16.1 t -117.15 143.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.095 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 43' ' ' ARG . 94.2 t -110.87 124.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 0.0 111.589 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -103.58 121.08 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.742 HG21 ' CD2' ' A' ' 68' ' ' TYR . 7.0 t -158.58 162.52 37.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.816 0.341 . . . . 0.0 111.208 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -86.08 -3.65 58.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.335 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tp60 -77.96 131.56 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.857 0.36 . . . . 0.0 110.38 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.49 -30.27 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.275 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -98.99 10.85 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.742 ' CD2' HG21 ' A' ' 63' ' ' THR . 5.9 t80 -61.84 141.98 57.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.22 0.533 . . . . 0.0 111.917 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.903 ' HA ' HG21 ' A' ' 75' ' ' VAL . 12.5 mm-40 -134.31 177.58 7.65 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.388 1.09 . . . . 0.0 112.899 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.54 144.69 19.62 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 112.996 -1.911 . . . . 0.0 110.641 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.03 96.92 2.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 0.0 110.46 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.53 -34.66 3.28 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.41 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.33 169.46 13.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 112.021 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.93 140.4 18.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.572 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.903 HG21 ' HA ' ' A' ' 69' ' ' GLN . 43.3 t -106.08 109.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.401 0.62 . . . . 0.0 112.461 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.891 HG21 HG22 ' A' ' 82' ' ' VAL . 34.6 m -117.81 163.89 14.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.891 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -116.69 -24.46 7.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.727 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -150.93 -174.03 4.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.143 0.497 . . . . 0.0 111.495 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.793 HG21 ' O ' ' A' ' 105' ' ' ALA . 45.5 t -70.25 -10.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.476 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.94 -31.43 18.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.023 0.44 . . . . 0.0 110.304 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.24 -28.79 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.891 HG22 HG21 ' A' ' 76' ' ' VAL . 22.6 t -76.5 -52.9 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -54.55 -28.06 43.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.65 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -68.15 -39.63 82.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 88.9 t80 -66.12 -56.81 9.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.02 -22.23 14.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.923 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -67.72 -41.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -82.69 -4.88 58.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.564 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 98.1 m-70 -125.95 64.42 51.77 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 110.301 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.6 0.13 3.86 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.371 2.714 . . . . 0.0 113.011 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -30.13 21.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.725 0.298 . . . . 0.0 110.808 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.427 . . . . 0.0 111.592 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -98.45 169.41 9.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.273 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 86' ' ' ALA . 5.5 tp -105.34 115.82 30.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.306 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -123.86 106.35 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.433 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.1 mm -78.42 139.49 18.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.981 0.419 . . . . 0.0 111.265 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.463 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.2 -39.48 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.194 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.49 -168.04 41.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -81.73 -161.29 27.68 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 117.347 0.574 . . . . 0.0 112.549 -0.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -55.65 -42.13 74.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.978 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.72 -28.12 69.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.633 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.7 mm -80.39 -35.45 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.16 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.9 m-85 -51.76 -55.98 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.526 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.778 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.1 t -66.18 -9.66 33.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.793 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.02 -41.58 28.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.695 0.283 . . . . 0.0 111.226 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.784 ' CD2' HG13 ' A' ' 79' ' ' VAL . 4.0 m-85 -95.33 -7.46 38.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.23 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.566 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.5 OUTLIER -50.85 -32.46 20.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.36 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -4.64 47.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.71 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.0 -20.6 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.561 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 90.7 t -44.74 140.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.154 0.502 . . . . 0.0 111.692 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -126.94 7.35 6.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.604 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.7 m -168.41 138.33 2.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.873 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.573 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 11.6 mt -122.8 142.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.313 0.577 . . . . 0.0 112.049 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.8 mt -130.52 114.35 15.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.2 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.61 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.5 m -138.37 148.53 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.29 112.71 24.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 9.0 mmt180 -89.22 104.7 17.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.627 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 14.6 mt -85.96 114.6 22.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.03 -26.89 28.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.652 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 150' ' ' ALA . . . -92.22 -173.44 41.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.848 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 32.3 t -116.82 165.74 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.627 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 10.2 m-85 -152.03 168.26 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.04 170.3 16.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.89 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 148.97 153.99 6.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.819 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -120.07 5.11 10.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.628 0.251 . . . . 0.0 111.459 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.508 HG22 HD11 ' A' ' 13' ' ' ILE . 12.5 m -131.25 138.71 49.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.7 mttt -114.32 163.09 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.415 ' HG3' ' NE1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.93 -179.12 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.022 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.778 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.5 pt -101.27 159.72 28.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.21 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.59 105.14 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.794 2.329 . . . . 0.0 112.421 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mt -96.09 150.77 20.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.038 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.31 72.8 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.574 ' HH2' HG11 ' A' ' 115' ' ' VAL . 81.0 m95 -56.9 -23.09 42.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.32 -30.26 66.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 0.0 110.457 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.63 -19.42 45.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.99 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.402 ' CD1' HD11 ' A' ' 113' ' ' LEU . 52.0 m-85 -107.87 167.76 9.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.576 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -129.98 141.24 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -79.92 109.11 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.767 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.2 m -90.54 -22.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.7 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.2 m -159.58 140.72 12.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -157.11 113.03 2.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.211 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.757 ' C ' HG23 ' A' ' 154' ' ' THR . 1.4 ttp180 -136.28 130.11 32.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 3.8 m -89.84 132.03 35.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.15 0.5 . . . . 0.0 112.194 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 t -105.15 113.0 41.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.626 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.683 ' HA ' HG23 ' A' ' 152' ' ' THR . 17.1 mt-10 -96.88 97.47 9.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.36 -176.04 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.267 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.4 p -63.49 -24.03 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.041 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.529 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -90.69 120.66 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.91 -18.79 59.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.529 2.153 . . . . 0.0 112.36 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 120' ' ' GLY . . . -95.81 -25.87 15.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.816 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.2 mt -85.1 2.45 43.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.741 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 145' ' ' GLU . 16.6 m -83.47 82.46 8.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 111.083 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.584 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -98.04 -171.74 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.757 HG23 ' C ' ' A' ' 142' ' ' ARG . 21.6 m -134.11 137.84 44.84 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' SER . 10.9 m-85 -86.06 106.76 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.561 ' HB2' HG22 ' A' ' 115' ' ' VAL . 11.3 mt-10 -105.46 121.47 44.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.767 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.5 t -114.61 111.8 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.895 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 16.3 m95 -107.93 151.34 25.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.114 0.483 . . . . 0.0 112.022 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.421 ' HB2' ' CG1' ' A' ' 139' ' ' VAL . 6.2 mt-30 -132.39 131.61 41.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.364 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -49.44 123.74 8.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 111.465 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.429 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -110.1 -175.55 2.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.959 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.191 179.694 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 13.8 m . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.5 154.62 24.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.587 . . . . 0.0 112.557 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.501 ' HB2' HD23 ' A' ' 113' ' ' LEU . 1.3 m-85 -121.22 117.47 27.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.778 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 tp -115.41 124.56 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.707 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.3 p90 -168.52 163.3 12.42 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.51 136.29 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -118.21 153.17 34.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -102.89 -178.17 3.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.235 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.453 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -48.82 -49.08 40.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.28 0.562 . . . . 0.0 109.843 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' HB3' HD23 ' A' ' 12' ' ' LEU . 7.6 t70 -69.79 -25.65 63.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.58 32.64 5.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.5 pp -100.93 166.04 11.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mttm . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.551 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 54.0 mt -72.28 89.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.15 126.95 51.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.62 HG21 HG11 ' A' ' 82' ' ' VAL . 21.4 t -79.77 158.73 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.108 0.48 . . . . 0.0 112.189 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' HG12 ' A' ' 40' ' ' VAL . 31.1 m -160.24 150.86 5.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.852 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.7 155.87 43.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.907 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -54.87 -49.09 72.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.922 0.361 . . . . 0.0 110.776 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 15.2 tpt85 -62.88 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -69.88 -43.27 72.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.664 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -63.9 -29.26 70.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.023 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -66.15 -66.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.901 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 17.0 t -53.27 -30.73 40.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -31.13 123.37 0.34 Allowed Pre-proline 0 N--CA 1.468 0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.606 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.61 -27.46 5.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.789 2.326 . . . . 0.0 113.251 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -171.31 117.57 0.44 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.298 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -122.05 141.2 33.72 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.96 -174.41 12.2 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.261 -1.558 . . . . 0.0 111.702 -0.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.697 HD13 ' HD2' ' A' ' 57' ' ' ARG . 17.0 mt -95.1 154.91 39.48 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.52 -83.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.702 2.268 . . . . 0.0 113.137 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -96.42 33.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HD2' HD13 ' A' ' 54' ' ' LEU . 4.0 mtt180 -132.09 100.96 5.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.326 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.551 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 51.6 m -68.23 121.85 17.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.785 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -105.83 151.09 24.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.252 0.548 . . . . 0.0 112.191 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 76' ' ' VAL . 11.3 t -128.0 140.93 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.174 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.1 t -111.31 118.33 57.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 111.604 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.883 HD12 HG23 ' A' ' 76' ' ' VAL . 3.4 tp -104.21 112.16 25.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.537 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.9 t -149.99 162.24 40.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -76.9 -6.39 52.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.594 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.777 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.7 tp-100 -74.01 125.29 27.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.706 0.288 . . . . 0.0 110.441 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.1 -8.13 59.7 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' H ' ' HG3' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -127.52 11.8 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.777 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.3 t80 -58.37 148.26 28.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.119 0.485 . . . . 0.0 111.45 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.893 ' HA ' HG21 ' A' ' 75' ' ' VAL . 25.9 mm100 -132.32 174.46 10.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.437 1.113 . . . . 0.0 112.728 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 141.96 16.78 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.375 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -82.15 96.65 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 110.147 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.33 -45.77 1.36 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.544 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -72.72 163.36 28.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.986 0.422 . . . . 0.0 111.759 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -96.17 140.62 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 69' ' ' GLN . 18.7 t -102.55 119.23 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.699 . . . . 0.0 112.26 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.883 HG23 HD12 ' A' ' 62' ' ' LEU . 30.0 m -128.32 167.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.729 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -115.43 -23.59 8.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.713 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.728 ' CA ' HD11 ' A' ' 62' ' ' LEU . 1.4 t70 -153.02 179.84 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.134 0.493 . . . . 0.0 111.581 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.964 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.6 t -65.53 -10.15 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.751 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.5 -33.0 19.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.679 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.59 -27.23 58.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.807 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.839 HG22 HG21 ' A' ' 76' ' ' VAL . 16.5 t -74.01 -55.22 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 13.0 m-85 -55.57 -28.23 53.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.801 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.37 90.81 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.46 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 73.8 t80 -63.4 -54.05 42.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.394 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -23.81 44.18 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.328 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -71.75 -33.41 68.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.406 ' HG2' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -89.02 -9.36 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.246 179.059 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 94.5 m-70 -125.0 66.23 49.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.61 0.24 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.393 2.729 . . . . 0.0 113.014 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -37.17 27.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.75 161.79 14.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.34 174.67 6.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.253 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.464 HD11 ' CG1' ' A' ' 82' ' ' VAL . 13.2 tp -116.1 114.84 25.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.504 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.58 112.65 28.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 96' ' ' ILE . 3.4 mm -81.4 131.38 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.844 0.354 . . . . 0.0 111.416 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.78 -41.88 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.876 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.57 -168.49 41.56 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.806 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.421 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.76 -160.74 33.93 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 122.027 -0.69 . . . . 0.0 112.588 -0.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.434 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -50.52 -58.35 5.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.81 -28.13 5.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.67 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 62' ' ' LEU . 37.2 mm -81.23 -28.66 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.3 m-85 -59.39 -58.67 7.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.007 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.629 ' CA ' HD13 ' A' ' 129' ' ' ILE . 13.6 t -66.79 -9.9 41.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.771 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.25 -41.62 57.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.964 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.2 m-85 -98.21 -3.97 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.644 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 38.7 pttt -51.61 -33.99 35.53 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.88 0.372 . . . . 0.0 111.114 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.17 -3.85 47.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.586 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.34 -21.93 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 106' ' ' PHE . 94.7 t -45.87 134.88 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.036 0.446 . . . . 0.0 111.505 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -116.66 6.01 13.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.598 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 46.2 m -168.03 141.66 3.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.311 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.708 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 13.8 mt -123.54 146.0 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.22 0.533 . . . . 0.0 111.814 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.2 mt -135.57 117.44 15.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.884 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.707 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.4 m -135.13 144.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.408 . . . . 0.0 111.49 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -112.92 113.19 25.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.802 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.37 100.7 12.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.464 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 2.2 mp -91.54 131.61 36.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.416 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.48 -52.63 64.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.047 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.24 -172.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.564 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -123.27 164.03 19.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 111.038 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.29 165.15 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 166.57 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.54 153.12 6.5 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.762 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.98 6.1 12.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.653 0.264 . . . . 0.0 111.107 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.8 m -133.94 145.23 49.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.368 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.2 pttp -122.21 173.77 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.5 tpt -69.32 153.15 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.629 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.7 pp -78.9 163.36 60.84 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.56 101.42 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.336 . . . . 0.0 112.653 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.41 149.03 21.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.636 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.49 77.31 3.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.708 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.4 m95 -61.16 -17.83 54.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.352 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.26 -34.45 63.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 110.464 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.11 -17.79 56.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.39 169.23 8.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 110.826 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.721 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -129.31 141.33 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 0.7 OUTLIER -82.88 119.06 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.312 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 157' ' ' VAL . 10.0 m -101.45 -21.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.896 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.2 m -160.74 143.36 12.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.264 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.87 111.7 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.463 ' C ' HG23 ' A' ' 154' ' ' THR . 9.2 ttp-105 -146.66 120.41 9.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.416 . . . . 0.0 111.398 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.649 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -74.57 145.97 42.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.214 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.525 HG21 ' HE2' ' A' ' 155' ' ' TYR . 14.4 t -116.45 102.57 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.426 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -85.31 99.66 11.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.63 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.47 -176.51 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.507 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.0 p -54.36 -56.53 17.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.515 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 34.2 t-20 -74.54 124.16 89.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.796 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.8 -27.52 84.13 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.262 1.975 . . . . 0.0 112.887 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.16 -19.44 26.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.5 mt -84.32 8.0 17.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.639 0.257 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 144' ' ' VAL . 97.0 m -73.33 165.17 25.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p-80 -172.73 159.33 4.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.223 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.649 ' OG1' HG23 ' A' ' 143' ' ' THR . 19.1 m -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.548 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.525 ' HE2' HG21 ' A' ' 144' ' ' VAL . 98.5 m-85 -118.69 105.76 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.661 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HB2' HG22 ' A' ' 115' ' ' VAL . 12.8 mt-10 -106.63 124.88 50.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.856 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 139' ' ' VAL . 10.5 t -116.3 112.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 22.0 m95 -106.75 149.83 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.435 . . . . 0.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -132.29 129.7 39.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -46.52 123.55 5.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.523 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.721 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -105.42 178.49 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.066 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.647 HG23 HD23 ' A' ' 94' ' ' LEU . 4.7 m . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.43 154.47 22.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -122.76 116.35 23.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.505 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 tp -114.95 122.5 46.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.673 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.0 p90 -167.22 168.33 13.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.615 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.85 141.26 49.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 111.29 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.39 153.77 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.89 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.77 -177.06 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -36.2 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.15 -21.32 29.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.46 25.04 29.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.596 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.5 tt -101.58 148.87 24.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.318 . . . . 0.0 111.003 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 126' ' ' THR . 1.1 pt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.63 87.72 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.644 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.1 ttp -99.0 124.21 43.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.603 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.593 HG21 HG11 ' A' ' 82' ' ' VAL . 20.9 t -77.54 157.39 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.989 0.423 . . . . 0.0 111.838 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 60' ' ' VAL . 32.6 m -161.18 147.8 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.956 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.39 155.55 53.06 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.062 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.7 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.31 -52.19 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.972 0.386 . . . . 0.0 110.126 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -57.77 -30.68 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.46 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.47 HG22 ' CE2' ' A' ' 49' ' ' PHE . 21.5 m -71.29 -49.26 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.798 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 13.1 t80 -55.03 -35.7 64.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.487 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -66.83 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.938 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 49' ' ' PHE . 99.7 p -52.8 -37.19 59.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.815 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.971 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.49 127.35 0.25 Allowed Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.908 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.5 -27.68 19.57 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.071 2.514 . . . . 0.0 113.814 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 2.7 ttmm -151.75 147.95 27.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.966 0.412 . . . . 0.0 111.525 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.09 109.69 10.67 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.612 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 4.0 Cg_exo -86.53 168.04 46.0 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.792 -1.337 . . . . 0.0 112.048 -0.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.971 HD11 ' CE1' ' A' ' 49' ' ' PHE . 7.7 mt -59.45 164.86 4.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.645 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 10.9 Cg_endo -54.23 91.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 113.05 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 64.82 23.36 12.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.262 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 23.1 mtt180 -109.57 132.19 54.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.917 0.389 . . . . 0.0 111.444 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.8 m -84.05 108.14 16.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.772 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.51 158.17 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 112.089 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.775 HG12 HG22 ' A' ' 76' ' ' VAL . 10.7 t -130.8 143.33 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.042 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.7 HG13 ' HA ' ' A' ' 43' ' ' ARG . 99.5 t -108.84 122.08 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -104.25 122.94 46.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.272 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.586 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -156.29 165.71 35.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.217 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -84.36 -9.0 58.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.3 tt0 -76.0 133.55 40.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -88.1 6.81 34.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.938 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.98 3.15 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.887 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.4 t80 -57.27 139.19 53.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.456 . . . . 0.0 111.299 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.877 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -126.67 176.37 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.92 0.866 . . . . 0.0 112.253 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.65 146.19 23.16 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.118 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -94.34 96.23 9.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.508 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.59 13.38 53.82 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.057 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.694 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -136.55 172.87 12.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.925 0.393 . . . . 0.0 111.627 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 14.0 t -100.24 140.17 19.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 68' ' ' TYR . 21.6 t -106.41 116.0 49.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.09 0.472 . . . . 0.0 111.992 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.928 HG21 HG22 ' A' ' 82' ' ' VAL . 27.4 m -124.83 162.2 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.656 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.9 m-70 -111.19 -23.19 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.365 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -155.71 -171.39 3.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.222 0.534 . . . . 0.0 111.64 -179.303 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.894 HG13 ' CD2' ' A' ' 106' ' ' PHE . 6.0 t -69.87 -9.22 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.07 16.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.149 0.499 . . . . 0.0 109.948 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -76.43 -28.14 56.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.694 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 76' ' ' VAL . 22.0 t -74.74 -51.08 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.545 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.3 m-85 -57.23 -25.51 59.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.667 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.93 -42.28 81.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.176 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 68.2 t80 -65.06 -56.07 15.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.72 -22.55 36.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.954 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.9 -31.88 68.66 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.001 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.457 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 15.3 mt-30 -87.1 -7.42 58.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.443 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.19 67.92 56.2 Favored Pre-proline 0 N--CA 1.456 -0.132 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.65 -0.32 2.99 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.133 2.555 . . . . 0.0 112.928 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.94 -24.54 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.304 . . . . 0.0 111.17 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -101.75 155.17 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.14 167.59 10.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.994 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.68 HD11 ' CG1' ' A' ' 82' ' ' VAL . 9.7 tp -120.04 113.02 19.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.081 0.467 . . . . 0.0 111.499 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.49 109.72 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.188 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 40' ' ' VAL . 3.7 mm -77.59 130.68 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -105.5 -42.89 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.492 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.7 -169.02 41.34 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.896 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.417 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -87.06 -160.92 35.75 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 122.118 -0.637 . . . . 0.0 112.7 -0.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.76 -53.5 39.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 111.404 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -27.62 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.1 mm -81.42 -22.7 10.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.1 m-85 -64.65 -55.24 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.726 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.617 ' CA ' HD13 ' A' ' 129' ' ' ILE . 10.6 t -66.54 -9.75 38.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.01 -41.73 41.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.894 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.6 m-85 -95.66 -5.37 42.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.57 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 2.0 pttt -51.52 -33.57 32.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.79 0.328 . . . . 0.0 111.336 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -84.73 -0.29 53.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.739 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -124.42 -24.58 4.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.872 HG11 HD23 ' A' ' 113' ' ' LEU . 58.5 t -48.21 122.14 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.634 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.95 3.47 44.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 93.9 m -165.43 142.21 5.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.284 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.872 HD23 HG11 ' A' ' 110' ' ' VAL . 8.1 mt -125.76 146.09 49.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.902 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.4 mt -134.75 119.31 18.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.697 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.673 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -135.29 145.26 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 106.47 15.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.309 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -93.1 104.58 16.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.835 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 1.2 mp -91.48 128.13 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.52 -49.09 37.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.217 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.46 172.6 3.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.298 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.2 t -112.71 147.96 35.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 1.5 m-85 -122.02 153.0 39.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -111.13 141.0 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -169.62 -167.77 30.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.55 -16.68 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.606 0.241 . . . . 0.0 111.537 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 13' ' ' ILE . 40.7 m -109.14 131.96 54.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.697 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.57 173.44 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.755 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.455 ' HE2' ' CE2' ' A' ' 5' ' ' TRP . 17.1 tpt -78.35 147.14 34.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.662 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -64.08 166.96 8.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.662 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.1 Cg_endo -77.13 98.04 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.265 1.977 . . . . 0.0 112.674 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.71 145.08 25.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 78.58 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.469 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.1 m95 -60.16 -20.11 56.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.51 -32.88 66.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -24.13 51.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.013 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.621 ' CD1' HD11 ' A' ' 113' ' ' LEU . 77.3 m-85 -97.49 173.6 7.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.867 0.365 . . . . 0.0 110.76 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.13 143.36 44.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.522 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.8 ttpm? -84.0 108.64 17.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.816 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 157' ' ' VAL . 28.2 m -91.37 -26.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.318 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.0 m -154.86 140.7 18.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 35.4 p -164.6 111.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.445 ' C ' HG23 ' A' ' 154' ' ' THR . 0.3 OUTLIER -143.07 122.57 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.68 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.731 HG23 ' OG1' ' A' ' 154' ' ' THR . 4.0 m -78.43 144.28 35.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.18 0.514 . . . . 0.0 111.54 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.492 HG21 ' HE2' ' A' ' 155' ' ' TYR . 3.3 t -116.27 105.12 17.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.48 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.2 mt-10 -86.12 98.97 11.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.847 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -81.33 -175.3 5.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.0 p -57.72 -57.66 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.487 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -68.56 120.17 73.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.91 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.5 -25.96 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.964 1.776 . . . . 0.0 112.324 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.47 -18.4 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.431 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.1 mt -87.15 8.86 21.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.599 0.237 . . . . 0.0 111.359 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.491 HG22 ' N ' ' A' ' 153' ' ' HIS . 79.7 m -71.48 169.29 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.491 ' N ' HG22 ' A' ' 152' ' ' THR . 3.9 p-80 -174.34 160.79 3.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.731 ' OG1' HG23 ' A' ' 143' ' ' THR . 10.4 m -127.69 133.95 49.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.627 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.492 ' HE2' HG21 ' A' ' 144' ' ' VAL . 67.9 m-85 -94.33 106.45 18.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.627 ' HB2' HG22 ' A' ' 115' ' ' VAL . 13.9 mt-10 -103.3 121.75 43.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.415 . . . . 0.0 111.971 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 139' ' ' VAL . 17.9 t -113.43 111.26 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.094 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.522 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.5 m95 -107.61 148.34 29.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.979 0.418 . . . . 0.0 111.721 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -126.92 117.28 22.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.8 tmtt? -49.77 132.45 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -99.96 171.91 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.626 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.02 148.87 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.518 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -111.81 114.45 27.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.244 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.27 121.26 43.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.66 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.1 p90 -167.58 176.21 6.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.499 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.6 150.33 46.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 111.823 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.98 147.6 37.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.617 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -103.69 -167.91 1.43 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.421 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -52.6 -48.59 66.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.842 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.68 -26.49 60.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.65 20.89 12.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.636 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.656 HD11 ' HA3' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -74.58 149.37 40.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.766 0.317 . . . . 0.0 110.645 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.499 -179.649 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.0 mtmt . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 79.0 mt -80.19 87.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.54 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.8 ttp -100.73 122.45 43.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.412 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.784 HG13 ' HB ' ' A' ' 60' ' ' VAL . 3.1 t -91.12 129.18 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.92 147.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.115 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.79 151.76 52.44 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.932 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.799 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -48.07 -55.91 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.906 0.384 . . . . 0.0 110.385 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.35 68.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.57 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -73.68 -31.37 63.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CG ' HG22 ' A' ' 61' ' ' VAL . 51.8 t80 -75.82 -33.04 60.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.815 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.0 mt-10 -64.21 -67.23 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.575 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -58.73 -30.04 67.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.738 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.766 ' CE2' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -34.31 149.44 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.905 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.55 -32.73 5.93 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.187 2.591 . . . . 0.0 113.932 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.38 152.9 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 9.1 mtp180 -124.72 101.72 32.93 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.2 Cg_endo -86.25 -168.11 5.08 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.965 -1.265 . . . . 0.0 112.213 0.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 49' ' ' PHE . 88.0 mt -95.76 159.8 31.65 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 18.9 Cg_endo -60.26 95.85 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.728 2.285 . . . . 0.0 113.638 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 66.35 18.49 10.89 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.441 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HG3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -109.77 107.57 17.61 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.946 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.4 m -62.13 106.67 0.76 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.982 0.42 . . . . 0.0 110.164 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.524 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -105.54 156.88 17.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.201 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.784 ' HB ' HG13 ' A' ' 40' ' ' VAL . 5.2 t -130.2 144.08 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.84 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.799 HG13 ' HA ' ' A' ' 43' ' ' ARG . 89.6 t -116.09 106.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -89.0 118.14 28.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.015 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.864 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -148.95 169.84 19.67 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.926 0.393 . . . . 0.0 111.352 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -88.24 -9.25 53.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.2 tp-100 -78.1 128.76 34.31 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -79.76 -16.15 56.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.787 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.29 9.12 25.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.865 ' O ' HG11 ' A' ' 75' ' ' VAL . 3.5 t80 -58.77 140.37 55.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.007 0.432 . . . . 0.0 111.612 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.913 ' HA ' HG21 ' A' ' 75' ' ' VAL . 18.6 mm100 -124.96 178.34 5.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.107 0.956 . . . . 0.0 112.004 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.97 145.33 20.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.784 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.45 95.88 4.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.368 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.93 -39.35 2.96 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.051 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -69.29 172.33 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.688 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 85' ' ' TYR . 9.4 t -97.38 140.21 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.98 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.913 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.9 t -105.55 118.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.391 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.7 HG21 HG22 ' A' ' 82' ' ' VAL . 30.5 m -127.72 165.09 27.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.845 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' THR . 5.3 m-70 -116.18 -23.19 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 110.813 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -154.19 -167.57 2.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 111.305 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.936 HG13 ' CD2' ' A' ' 106' ' ' PHE . 4.0 t -74.42 -8.83 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.7 -32.9 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.092 0.472 . . . . 0.0 109.922 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.667 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.89 -27.54 57.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.7 HG22 HG21 ' A' ' 76' ' ' VAL . 68.7 t -73.09 -54.05 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.467 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.9 m-85 -55.98 -24.82 40.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.941 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.74 86.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.831 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 74' ' ' VAL . 81.9 t80 -66.69 -57.26 7.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.15 11.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.028 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.91 -38.06 76.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -83.89 -4.78 58.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.563 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -127.26 66.42 68.37 Favored Pre-proline 0 N--CA 1.455 -0.182 0 CA-C-O 121.015 0.436 . . . . 0.0 110.248 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.61 -0.01 5.41 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.231 2.621 . . . . 0.0 113.058 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -27.88 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.707 0.289 . . . . 0.0 111.087 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 6.1 mm-40 -105.08 159.23 16.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.658 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 42.1 mt-10 -98.09 159.23 15.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.135 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.623 HD21 HG12 ' A' ' 82' ' ' VAL . 20.1 tp -108.54 116.39 31.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.525 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 39' ' ' MET . 38.5 t -130.43 114.61 29.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.36 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.0 mm -82.51 131.1 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.632 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.86 -45.34 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.636 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.3 -166.3 39.05 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.406 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.42 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -92.74 -160.7 35.9 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 117.821 0.81 . . . . 0.0 112.741 -0.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.98 -48.56 16.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.466 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -60.19 -30.94 69.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.67 -26.61 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.501 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.467 ' HB3' HG12 ' A' ' 129' ' ' ILE . 4.2 m-85 -60.39 -56.38 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.811 ' CA ' HD13 ' A' ' 129' ' ' ILE . 14.9 t -65.93 -10.1 35.79 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.539 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.54 -43.28 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.936 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.1 m-85 -95.4 -3.61 46.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.555 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 16.5 pttp -48.91 -33.07 10.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.783 0.325 . . . . 0.0 111.397 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.05 3.85 50.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.44 ' HB2' HG11 ' A' ' 79' ' ' VAL . 1.4 m-20 -127.53 -27.9 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 0.0 111.517 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.66 HG11 HD23 ' A' ' 113' ' ' LEU . 92.7 t -52.04 123.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.196 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.65 8.01 43.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.426 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 76.3 m -167.56 142.97 3.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.815 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.66 HD23 HG11 ' A' ' 110' ' ' VAL . 16.2 mt -123.49 145.35 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.321 0.581 . . . . 0.0 111.723 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 mt -135.64 120.0 17.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.46 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.66 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.9 m -136.35 145.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.043 0.449 . . . . 0.0 111.864 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -111.81 108.5 17.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.038 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.9 ttm180 -80.57 99.24 8.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.98 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.59 125.93 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.21 74.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.71 163.75 6.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.497 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 59.5 p -105.87 159.47 15.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.802 0.334 . . . . 0.0 111.034 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -147.4 145.43 29.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.779 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -100.72 147.11 26.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.764 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . -179.43 174.19 46.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.733 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.9 42.83 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.204 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 m -162.38 124.81 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -112.67 172.74 6.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.964 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.1 tpt -72.62 157.59 37.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.811 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -79.2 163.76 58.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.289 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.58 93.76 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.749 2.3 . . . . 0.0 111.961 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -83.49 142.67 30.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.809 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.87 70.48 8.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -56.57 -21.75 28.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -73.31 -33.27 65.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.509 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 -10.49 58.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.102 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 45.1 m-85 -108.73 169.43 8.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.425 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -132.44 141.2 48.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.585 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 3.3 ttpp -85.11 128.99 34.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 157' ' ' VAL . 5.7 m -115.92 -17.86 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.1 m -164.51 143.32 7.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.493 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.72 111.76 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.161 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.552 ' C ' HG23 ' A' ' 154' ' ' THR . 10.2 ttt180 -139.73 118.34 12.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.747 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.4 m -81.48 145.06 30.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.392 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' A' ' 155' ' ' TYR . 5.4 t -121.12 103.36 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.5 mt-10 -84.34 102.22 12.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.33 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.44 -176.46 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.3 p -53.86 -55.84 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.504 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.46 121.77 85.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.946 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.06 -27.02 83.86 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.134 1.889 . . . . 0.0 112.413 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.65 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.669 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.6 mt -86.96 9.26 20.0 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.592 0.234 . . . . 0.0 111.551 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 145' ' ' GLU . 95.9 m -70.72 165.92 21.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 11.8 p-80 -170.61 156.51 5.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.133 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.747 ' OG1' HG23 ' A' ' 143' ' ' THR . 16.3 m -120.05 153.58 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.589 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.452 ' HE1' HG21 ' A' ' 144' ' ' VAL . 96.1 m-85 -116.3 105.04 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.8 mt-10 -101.26 153.96 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.903 ' O ' HG22 ' A' ' 139' ' ' VAL . 26.7 t -142.31 107.09 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 28.8 m95 -107.54 145.5 33.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.977 0.417 . . . . 0.0 111.897 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -125.83 114.75 18.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.504 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 1.9 ttmt -46.44 134.0 9.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.08 0.467 . . . . 0.0 112.06 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.425 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -124.19 -166.08 1.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.399 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.076 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.79 154.41 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.29 0.567 . . . . 0.0 112.446 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -119.07 112.59 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.603 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.4 tp -113.52 121.78 45.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.81 ' CH2' HG12 ' A' ' 115' ' ' VAL . 2.8 p90 -167.31 164.5 15.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.927 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.76 135.34 54.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.699 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.4 pt20 -128.06 155.48 44.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -96.62 -172.49 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -38.56 59.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.023 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -32.65 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.84 37.01 2.64 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 9.3 mt -98.35 151.32 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.739 0.304 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.285 -179.741 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 58' ' ' THR . 7.0 mtmt . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.66 87.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.425 ' HE1' ' OD1' ' A' ' 59' ' ' ASN . 2.2 ttp -102.04 125.76 48.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 112.155 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 41' ' ' VAL . 20.8 t -82.19 158.81 3.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.646 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.5 m -165.1 141.06 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.455 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.01 154.13 53.03 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.477 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.16 -51.92 60.47 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.336 0.568 . . . . 0.0 110.687 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.424 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.9 tpt180 -57.64 -32.78 67.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.013 0.435 . . . . 0.0 110.112 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.409 HG22 ' CE2' ' A' ' 49' ' ' PHE . 8.7 m -70.74 -46.79 62.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.986 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.5 t80 -55.16 -40.7 70.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.112 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -66.15 0.55 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.941 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -52.26 -40.03 61.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.552 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.409 ' CE2' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER -33.52 127.95 0.41 Allowed Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.674 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -43.88 -26.52 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.144 2.562 . . . . 0.0 113.771 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.745 ' HB3' HD23 ' A' ' 54' ' ' LEU . 5.0 ttpt -151.59 138.02 18.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.59 107.95 6.03 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 71.6 Cg_endo -77.48 166.51 81.57 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.593 -1.42 . . . . 0.0 112.244 -0.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 51' ' ' LYS . 75.8 mt -76.23 158.95 81.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.47 112.04 3.46 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.492 2.128 . . . . 0.0 112.802 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 69.15 8.48 6.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.022 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -114.06 110.71 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.427 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 25.0 m -68.73 107.19 2.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.551 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -101.11 154.58 18.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.983 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 HG22 ' A' ' 76' ' ' VAL . 8.8 t -125.72 141.37 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.633 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 68' ' ' TYR . 98.8 t -110.72 124.67 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 111.72 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.913 HD13 HD12 ' A' ' 102' ' ' ILE . 2.1 mt -105.33 118.69 37.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.102 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.997 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.3 t -155.51 158.67 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.284 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -75.15 -4.32 38.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.62 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.7 tp-100 -85.83 126.03 33.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.398 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 6.2 mt-10 -78.31 -29.57 47.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.547 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -92.31 6.51 46.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.418 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.997 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.1 t80 -59.81 139.31 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.935 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -137.16 169.89 17.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.758 1.266 . . . . 0.0 113.752 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.75 134.09 11.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.267 -2.242 . . . . 0.0 109.566 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -78.97 106.51 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.108 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 -56.51 0.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -71.1 169.31 15.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 12.8 t -94.11 140.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.335 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.935 HG21 ' HA ' ' A' ' 69' ' ' GLN . 17.2 t -112.01 123.16 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 111.419 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 27.1 m -130.32 175.88 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 m80 -123.16 -25.32 4.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.012 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.47 -171.33 3.9 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.969 HG13 ' CD2' ' A' ' 106' ' ' PHE . 18.7 t -71.38 -10.81 14.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.732 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.86 -32.72 18.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 110.15 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.09 -27.62 59.96 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.903 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.055 HG12 HD11 ' A' ' 94' ' ' LEU . 57.4 t -74.5 -52.48 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 9.6 m-85 -54.74 -27.93 44.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.933 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -64.13 -45.82 86.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.14 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.48 ' CD1' HG11 ' A' ' 74' ' ' VAL . 56.1 t80 -62.64 -54.42 39.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -53.05 -23.28 7.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 83' ' ' PHE . 12.3 mttt -68.61 -44.11 74.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -79.54 -2.32 41.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.7 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -129.01 61.63 57.92 Favored Pre-proline 0 N--CA 1.456 -0.136 0 CA-C-O 120.951 0.405 . . . . 0.0 110.491 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.01 -0.75 8.97 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.011 2.474 . . . . 0.0 112.954 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.22 -38.69 26.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.92 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -107.73 168.83 8.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.23 164.67 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.321 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.055 HD11 HG12 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -110.78 122.91 49.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.796 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.47 118.82 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.27 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 40' ' ' VAL . 8.0 mm -83.52 130.73 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.907 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.412 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -98.38 -48.73 4.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.82 -168.01 39.21 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.572 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.427 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -93.84 -160.86 35.1 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 117.717 0.758 . . . . 0.0 112.622 -0.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.48 -56.38 7.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.838 0.351 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -52.53 -29.81 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.913 HD12 HD13 ' A' ' 62' ' ' LEU . 46.5 mm -83.43 -28.52 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.982 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -59.62 -55.44 34.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.699 ' HA ' HD13 ' A' ' 129' ' ' ILE . 12.4 t -67.76 -10.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.961 -0.462 . . . . 0.0 112.065 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.774 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.51 -39.07 58.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.949 0.404 . . . . 0.0 110.707 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.969 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.3 m-85 -100.0 -5.34 28.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 11.9 pttt -51.23 -31.33 20.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 111.617 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.64 2.77 52.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 41.4 m-20 -126.83 -24.86 3.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.587 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 106' ' ' PHE . 77.8 t -49.07 125.75 3.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.937 0.399 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -102.96 4.38 37.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.92 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 92.1 m -166.76 139.59 3.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.638 HD23 HG11 ' A' ' 110' ' ' VAL . 16.2 mt -118.25 144.98 45.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.213 0.53 . . . . 0.0 111.933 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -135.34 113.82 11.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.598 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.81 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -133.98 143.88 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.782 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.32 107.49 15.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -92.21 103.9 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.3 mp -86.33 129.07 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.91 -49.74 75.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.161 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.41 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -59.43 177.65 2.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 p -111.85 156.87 21.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 0.0 110.966 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -148.9 154.25 39.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.77 134.41 35.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 138.21 6.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.457 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.26 6.88 19.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.622 0.249 . . . . 0.0 111.339 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.4 m -128.0 124.18 36.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -94.88 136.46 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.448 ' HE3' ' CZ2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -61.26 174.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.84 163.26 33.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.159 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 65.2 Cg_endo -74.85 101.04 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.41 2.073 . . . . 0.0 112.198 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.72 147.22 25.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.57 84.21 2.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.406 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 88.7 m95 -64.86 -16.35 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.083 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.85 -32.65 63.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.905 0.384 . . . . 0.0 110.73 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -79.56 -28.01 41.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.927 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 72.3 m-85 -97.6 169.71 9.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.653 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -134.66 143.74 47.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.521 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.3 ttpm? -81.13 119.97 24.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 157' ' ' VAL . 25.6 m -103.12 -21.36 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.235 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.0 m -162.56 140.33 8.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.473 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 18.2 p -165.19 113.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.741 ' C ' HG23 ' A' ' 154' ' ' THR . 5.8 ttt180 -147.96 130.95 16.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.002 0.429 . . . . 0.0 111.236 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.704 HG23 ' OG1' ' A' ' 154' ' ' THR . 5.1 m -84.8 146.12 27.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.073 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.424 HG21 ' HE2' ' A' ' 155' ' ' TYR . 5.0 t -117.16 102.69 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.899 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.562 ' HA ' HG23 ' A' ' 152' ' ' THR . 35.4 mt-10 -81.04 97.82 7.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.096 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.96 -178.19 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.299 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -60.97 2.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 110.574 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.494 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.37 117.06 40.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.666 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 11.6 Cg_endo -55.75 -26.73 58.12 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.979 1.786 . . . . 0.0 112.402 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.41 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -91.53 -17.16 26.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 12.7 mt -88.34 11.25 17.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.622 0.248 . . . . 0.0 111.387 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.562 HG23 ' HA ' ' A' ' 145' ' ' GLU . 87.7 m -71.59 168.43 17.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.486 ' N ' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -171.45 157.65 4.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.544 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 142' ' ' ARG . 17.6 m -126.71 147.59 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.424 ' HE2' HG21 ' A' ' 144' ' ' VAL . 84.8 m-85 -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.441 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.583 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.4 mt-10 -104.37 124.57 49.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.808 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.684 ' O ' HG22 ' A' ' 139' ' ' VAL . 12.3 t -118.42 115.72 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.272 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.521 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 18.5 m95 -112.61 151.21 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.508 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -125.95 110.95 14.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.863 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 4.5 tttt -49.09 138.85 11.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.653 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 39.5 mtmt -115.59 -175.11 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.409 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.103 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.77 HG23 HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.25 147.12 38.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.708 ' HB2' HD23 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -110.28 115.59 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.574 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tp -116.06 123.93 49.17 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.664 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.8 p90 -167.99 162.77 13.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.668 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -114.77 131.57 56.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.114 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.44 154.33 37.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.717 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 2.2 p-10 -102.97 -176.8 3.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -47.92 -42.15 26.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.34 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 -25.99 54.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.455 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.63 25.47 9.22 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.59 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -95.65 162.48 13.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.665 0.269 . . . . 0.0 110.736 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 pt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.343 -179.767 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 mttt . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.463 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 60.4 mt -84.74 88.41 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.558 ' HE3' HG11 ' A' ' 41' ' ' VAL . 18.2 ttp -95.31 118.24 31.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.223 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.605 HG21 HG11 ' A' ' 82' ' ' VAL . 3.5 t -88.11 126.61 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.558 HG11 ' HE3' ' A' ' 39' ' ' MET . 15.9 m -133.01 148.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.323 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.59 157.6 52.74 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.61 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.639 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -50.94 -53.13 35.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.097 0.449 . . . . 0.0 110.606 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.477 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 14.9 tpt180 -59.95 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.592 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -64.6 -38.33 90.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.508 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.53 ' HD1' HG21 ' A' ' 41' ' ' VAL . 2.0 t80 -60.56 -39.82 89.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.634 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -66.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.2 t -54.24 -34.92 61.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.576 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.807 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -35.12 124.54 0.58 Allowed Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.839 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -43.43 -29.67 2.13 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.154 2.57 . . . . 0.0 113.652 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.589 ' HB3' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -142.11 132.81 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.171 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -141.21 107.96 6.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.804 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -90.14 176.8 18.7 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.162 0.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.863 HD13 ' HD2' ' A' ' 57' ' ' ARG . 55.0 mt -87.38 140.03 32.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.52 -84.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.962 2.442 . . . . 0.0 113.917 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -85.19 11.66 9.46 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.863 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -112.27 113.42 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.959 0.409 . . . . 0.0 111.412 -178.468 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 81.4 m -70.15 114.05 7.92 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.512 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.765 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -104.69 154.68 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.72 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 74' ' ' VAL . 10.8 t -135.8 132.35 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.788 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 43' ' ' ARG . 58.1 t -105.03 125.32 60.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.827 0.346 . . . . 0.0 111.648 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.27 115.26 29.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.884 HG21 ' CD2' ' A' ' 68' ' ' TYR . 3.6 t -149.02 166.37 28.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 111.194 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -82.69 -10.19 59.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.351 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.0 tp-100 -79.65 132.06 36.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.307 . . . . 0.0 110.484 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 2.4 mt-10 -82.95 -31.07 27.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.809 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.91 6.25 45.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.263 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.884 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.0 t80 -60.43 136.76 58.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 111.67 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.852 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -129.76 171.88 12.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.408 1.099 . . . . 0.0 112.78 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.6 139.99 16.75 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.108 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 3.4 mt-30 -71.73 100.67 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.3 -36.96 3.33 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.694 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.91 170.17 14.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.483 HG21 ' CE1' ' A' ' 85' ' ' TYR . 25.2 t -98.82 140.24 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.466 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.852 HG21 ' HA ' ' A' ' 69' ' ' GLN . 24.4 t -107.15 106.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.739 HG21 HG22 ' A' ' 82' ' ' VAL . 29.1 m -117.73 167.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 6.6 m170 -119.61 -20.66 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -155.73 -175.2 5.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 111.77 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.963 HG13 ' CD2' ' A' ' 106' ' ' PHE . 7.5 t -68.33 -9.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.004 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.17 -34.1 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.3 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.686 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.1 -29.38 60.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.718 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 76' ' ' VAL . 95.8 t -73.02 -55.84 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.519 ' CE2' HG12 ' A' ' 79' ' ' VAL . 8.1 m-85 -53.43 -26.12 18.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.987 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.76 87.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.483 ' CE1' HG21 ' A' ' 74' ' ' VAL . 59.7 t80 -67.67 -58.21 5.06 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.62 -23.02 15.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.211 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.95 -36.3 72.54 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.37 -7.18 59.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.663 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -124.96 66.63 50.71 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.031 0.443 . . . . 0.0 110.578 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.21 -0.41 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.234 2.623 . . . . 0.0 113.04 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.91 -31.74 15.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -102.07 160.1 14.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 111.411 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -98.59 166.22 11.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.082 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.77 HD23 HG23 ' A' ' 1' ' ' THR . 7.4 tp -121.88 117.91 27.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.44 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.76 112.06 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.314 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.493 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 11.9 mm -77.76 118.99 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.61 11.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.083 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.8 -166.36 39.29 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.501 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.455 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.4 -160.97 36.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 117.708 0.754 . . . . 0.0 112.524 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.27 -49.38 53.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.92 -30.37 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.304 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.528 HD12 HD22 ' A' ' 62' ' ' LEU . 42.2 mm -81.67 -26.75 9.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 6.0 m-85 -61.35 -58.61 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.731 ' HA ' HD13 ' A' ' 129' ' ' ILE . 4.6 t -67.14 -9.99 45.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.697 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.07 -38.84 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.089 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.963 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.1 m-85 -100.21 -3.85 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.404 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.466 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 4.2 pttp -47.71 -33.56 7.12 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 4.35 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.678 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -125.0 -28.82 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 106' ' ' PHE . 92.1 t -45.16 131.13 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.273 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.7 t70 -104.3 1.83 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 40.3 m -167.5 143.34 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.365 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.763 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 33.7 mt -119.93 145.01 47.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.443 0.639 . . . . 0.0 111.925 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -135.47 115.05 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.333 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' CH2' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -135.16 145.36 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.68 105.4 12.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.626 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -75.01 100.14 4.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.14 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.668 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.2 mt -84.32 120.76 26.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.89 -52.81 47.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.023 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.24 162.61 36.05 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.009 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 3.6 t -102.72 156.89 17.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.9 m-85 -136.03 138.65 42.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -112.29 144.13 42.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.81 -125.39 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.318 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.13 31.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 2.9 m -156.78 123.01 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.727 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HG2' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -99.2 167.5 10.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.418 ' HE2' HD12 ' A' ' 131' ' ' LEU . 17.3 tpt -79.79 155.89 27.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.736 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.731 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.5 pp -81.28 162.72 57.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.81 103.59 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.052 2.502 . . . . 0.0 112.744 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.418 HD12 ' HE2' ' A' ' 128' ' ' MET . 2.0 mt -91.68 145.07 24.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.94 78.76 2.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.971 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.763 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 80.2 m95 -60.44 -19.94 58.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.8 -29.47 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.554 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.6 -28.17 45.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.832 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 92.5 m-85 -97.58 177.13 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.693 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 1.9 m -134.89 141.03 46.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 9.0 ttpt -84.0 117.84 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.494 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.2 m -105.68 -16.1 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.976 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 m -164.53 140.77 6.07 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.6 p -163.46 113.54 1.33 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.409 ' C ' HG23 ' A' ' 154' ' ' THR . 19.1 ttt-85 -148.17 120.27 8.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.787 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.5 m -73.65 144.71 45.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.309 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.468 HG21 ' HE2' ' A' ' 155' ' ' TYR . 3.8 t -122.34 108.93 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.378 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.566 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.7 OUTLIER -88.23 101.0 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.45 -179.07 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -80.8 -176.14 5.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.431 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.8 t30 -77.08 130.89 74.0 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.138 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.73 -30.3 78.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.218 1.945 . . . . 0.0 112.656 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -89.89 -23.94 21.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.775 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.431 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 18.8 mt -80.06 4.06 18.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.491 0.186 . . . . 0.0 111.452 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 145' ' ' GLU . 98.9 m -69.19 163.41 24.97 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.9 OUTLIER -176.35 163.59 2.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.182 0.515 . . . . 0.0 112.265 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.787 ' OG1' HG23 ' A' ' 143' ' ' THR . 87.8 m -120.8 147.17 45.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.024 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.468 ' HE2' HG21 ' A' ' 144' ' ' VAL . 96.9 m-85 -108.81 105.4 14.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.732 0.301 . . . . 0.0 110.905 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.433 ' HB2' HG22 ' A' ' 115' ' ' VAL . 30.4 mt-10 -108.78 125.7 52.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.809 ' O ' HG22 ' A' ' 139' ' ' VAL . 15.5 t -116.5 114.79 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.597 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.5 m95 -110.5 150.57 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.646 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -126.85 116.21 20.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.881 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 8.6 ttpt -51.8 130.1 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.384 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HG3' ' OG1' ' A' ' 137' ' ' THR . 3.8 mmpt? -96.08 172.9 7.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.097 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.44 HG23 HD23 ' A' ' 94' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -104.99 154.65 19.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 112.308 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.506 ' CD1' ' HB ' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -123.9 114.01 19.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.2 tp -112.86 121.57 45.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.646 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -165.18 163.89 20.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.525 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 118' ' ' LEU . . . -113.86 135.97 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.966 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.29 149.71 48.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.377 . . . . 0.0 110.969 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.5 p-10 -110.78 -168.24 1.28 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.021 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.428 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.78 -35.41 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.088 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 -28.95 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.012 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.12 12.81 22.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.879 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 126' ' ' THR . 2.8 mm? -59.93 144.96 47.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.768 0.284 . . . . 0.0 110.586 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 51.6 mt -74.64 91.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.765 0.317 . . . . 0.0 111.522 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.1 ttp -101.92 120.45 40.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 HG11 ' A' ' 82' ' ' VAL . 15.3 t -80.3 159.19 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.869 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' HG12 ' A' ' 40' ' ' VAL . 28.7 m -161.72 157.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.34 155.51 43.89 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.906 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.8 -52.68 64.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.982 0.391 . . . . 0.0 110.389 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -59.06 -32.64 69.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -71.59 -38.14 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.539 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.448 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 6.7 t80 -66.5 -25.94 66.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -72.65 -66.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 111.109 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.4 t -57.08 -31.44 65.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.43 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -26.24 135.16 0.1 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.88 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.64 -33.91 88.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.701 2.267 . . . . 0.0 112.929 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -160.08 122.41 3.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.25 135.62 15.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.252 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.77 160.41 71.42 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.14 -1.608 . . . . 0.0 111.838 -0.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.803 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 51.1 mt -75.15 156.36 85.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.05 -82.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.953 2.435 . . . . 0.0 113.653 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' HB2' ' NH1' ' A' ' 57' ' ' ARG . 5.3 mt-10 -93.18 27.6 2.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.411 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.803 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -125.2 111.68 15.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.403 . . . . 0.0 111.637 -178.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 53.4 m -72.35 119.53 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -102.73 151.44 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 112.083 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.623 HG12 HG22 ' A' ' 76' ' ' VAL . 17.1 t -132.07 142.76 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.392 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 43' ' ' ARG . 50.0 t -115.45 121.03 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.727 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.913 HD12 HG23 ' A' ' 76' ' ' VAL . 1.1 tp -104.78 117.14 33.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.722 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.25 167.44 26.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.822 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -89.13 -10.05 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tt0 -73.79 137.06 43.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -88.46 5.96 39.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.118 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.55 5.85 4.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.607 0.241 . . . . 0.0 111.618 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.901 ' O ' HG11 ' A' ' 75' ' ' VAL . 3.5 t80 -60.17 141.71 55.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.333 0.587 . . . . 0.0 112.014 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.85 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -131.93 173.8 10.82 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.249 1.024 . . . . 0.0 112.641 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.3 143.4 20.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.699 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.96 98.85 2.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.636 0.255 . . . . 0.0 110.799 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.57 -36.13 3.14 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.662 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -69.75 170.49 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 111.892 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.33 139.75 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.172 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.901 HG11 ' O ' ' A' ' 68' ' ' TYR . 20.1 t -104.59 107.85 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 111.835 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.913 HG23 HD12 ' A' ' 62' ' ' LEU . 30.3 m -117.96 168.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.754 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.3 m170 -119.01 -22.37 7.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.552 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.711 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -155.44 -169.48 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 111.523 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.977 HG13 ' CD2' ' A' ' 106' ' ' PHE . 4.8 t -73.44 -10.36 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.62 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.1 -34.82 19.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.231 0.539 . . . . 0.0 109.836 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.46 -30.38 61.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.762 HG22 HG21 ' A' ' 76' ' ' VAL . 17.5 t -72.16 -53.06 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.006 0.431 . . . . 0.0 109.876 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.67 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 4.3 m-85 -54.54 -28.34 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.823 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.6 96.43 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.72 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.57 -55.93 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.9 13.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.333 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 14.4 mmmt -69.35 -39.71 77.96 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -81.3 -4.61 56.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -126.86 65.58 63.21 Favored Pre-proline 0 N--CA 1.456 -0.151 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.7 -0.5 6.95 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.19 2.593 . . . . 0.0 112.775 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -91.71 -32.25 15.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -104.18 161.53 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.127 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -99.03 162.76 12.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.454 HD11 ' CG1' ' A' ' 82' ' ' VAL . 46.3 tp -109.29 115.84 30.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 2' ' ' ALA . 44.7 t -131.05 115.5 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 40' ' ' VAL . 7.0 mm -82.36 141.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.403 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.08 -44.66 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.433 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.01 -168.63 40.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.691 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.433 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.76 36.67 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 121.94 -0.741 . . . . 0.0 112.479 -0.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.47 -52.95 15.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.288 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -56.07 -29.27 60.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.535 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 62' ' ' LEU . 40.2 mm -81.47 -28.51 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.0 m-85 -60.2 -58.36 8.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.873 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.63 ' HA ' HD13 ' A' ' 129' ' ' ILE . 11.7 t -65.63 -10.12 33.08 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 121.73 -0.606 . . . . 0.0 112.228 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.698 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.58 -43.77 54.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.842 0.354 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.977 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.9 m-85 -96.19 -1.37 48.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.559 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 6.9 pttt -50.91 -34.59 29.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.915 0.388 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.66 2.66 40.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.69 -27.62 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.619 0.247 . . . . 0.0 111.572 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 106' ' ' PHE . 68.0 t -45.46 123.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.912 0.387 . . . . 0.0 111.284 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 13.8 t70 -107.02 7.54 29.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.24 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.5 m -168.39 140.0 2.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.365 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.821 HD23 HG11 ' A' ' 110' ' ' VAL . 7.1 mt -125.51 147.34 49.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.323 0.583 . . . . 0.0 112.079 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt -135.4 117.03 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.317 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -131.76 141.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.94 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.25 109.6 18.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.198 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 14.0 mtt180 -84.07 99.59 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.385 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.449 ' CD1' ' HB1' ' A' ' 6' ' ' ALA . 1.3 mp -82.63 120.62 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.305 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.504 ' HB2' ' HB ' ' A' ' 152' ' ' THR . . . -48.99 -47.55 44.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.83 152.1 49.97 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.378 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 173.04 8.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.817 0.341 . . . . 0.0 111.093 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 3.2 m-85 -145.52 178.37 8.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.777 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.85 170.05 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 148.96 176.88 22.65 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.771 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.12 17.56 9.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.163 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.531 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.8 m -133.65 131.74 39.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.637 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -113.14 170.41 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.413 ' HE3' ' HB3' ' A' ' 103' ' ' PHE . 16.4 tpt -74.13 145.83 43.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.678 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 2.0 pp -66.42 166.66 16.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.187 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.678 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.1 Cg_endo -75.1 106.71 2.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.243 1.962 . . . . 0.0 112.319 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.92 147.51 23.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.86 69.51 5.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.448 ' HH2' HG11 ' A' ' 115' ' ' VAL . 88.7 m95 -53.39 -24.92 13.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.36 -29.8 64.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.328 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 7.5 t0 -79.6 -18.57 51.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.033 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.465 ' CG ' HD11 ' A' ' 113' ' ' LEU . 85.0 m-85 -106.83 168.49 9.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.438 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -131.22 141.61 50.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.599 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.0 ttpt -81.88 109.43 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.547 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 157' ' ' VAL . 35.4 m -92.27 -26.42 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.384 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.1 m -154.93 140.3 17.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 51.9 p -169.58 115.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.969 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.409 ' NH1' ' HB2' ' A' ' 142' ' ' ARG . 8.9 ttm105 -147.91 119.02 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.076 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.783 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.5 m -71.08 145.91 49.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.032 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 t -119.67 104.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.657 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.668 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.6 mt-10 -85.07 100.2 11.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.22 173.78 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.1 p -53.54 -44.25 69.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.631 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 3.7 t-20 -82.68 132.17 52.61 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.34 -33.29 89.43 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.395 2.063 . . . . 0.0 112.613 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.55 -28.52 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.0 mt -76.74 5.05 8.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.668 HG23 ' HA ' ' A' ' 145' ' ' GLU . 31.9 m -71.56 158.4 36.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -174.12 160.59 3.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.951 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.783 ' OG1' HG23 ' A' ' 143' ' ' THR . 22.2 m -122.58 138.6 54.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.946 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' SER . 88.6 m-85 -102.6 106.35 17.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HB2' HG22 ' A' ' 115' ' ' VAL . 32.7 mt-10 -108.16 125.72 51.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 139' ' ' VAL . 25.1 t -116.6 112.35 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.75 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.511 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 17.4 m95 -107.22 151.16 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 112.003 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -130.35 127.18 38.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.831 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 10.9 tttp -54.13 130.54 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 111.359 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -116.79 -168.56 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.836 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.15 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.702 HG23 HD23 ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.32 146.67 40.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.503 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.6 m-30 -110.2 111.07 22.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.551 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.767 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -108.63 118.99 38.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.775 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.6 p90 -167.96 172.99 8.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -132.32 135.67 46.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -117.58 161.51 19.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.047 0.451 . . . . 0.0 111.444 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.6 -167.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -39.5 71.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.759 0.314 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.56 -27.49 37.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.25 22.98 10.85 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.683 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.1 tp -70.33 152.91 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.691 HG21 ' HG3' ' A' ' 128' ' ' MET . 1.5 pp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.679 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 58' ' ' THR . 17.7 mttm . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 93' ' ' GLU . 75.4 mt -88.93 88.55 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.302 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.2 OUTLIER -102.06 126.29 48.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.368 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.884 HG21 HG11 ' A' ' 82' ' ' VAL . 2.0 t -90.79 129.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.531 HG11 ' CE2' ' A' ' 49' ' ' PHE . 21.7 m -133.54 138.03 51.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.242 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.43 153.74 39.31 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.005 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.696 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -50.74 -53.53 30.84 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.936 0.398 . . . . 0.0 110.075 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -54.5 -42.41 70.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -65.06 -40.76 95.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 28.8 t80 -60.48 -29.57 69.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.913 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.51 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.6 t -58.49 -31.08 67.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.305 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.74 ' HE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.8 135.79 0.18 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.996 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 75.9 Cg_exo -48.83 -35.11 30.06 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.276 . . . . 0.0 112.85 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.07 142.78 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.35 112.04 6.55 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -81.72 178.81 29.52 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.984 -0.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.74 HD11 ' HE1' ' A' ' 49' ' ' PHE . 64.1 mt -84.21 140.69 39.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.603 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.62 110.98 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.495 2.13 . . . . 0.0 112.835 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 74.37 -0.17 3.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.35 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.683 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -109.57 116.23 31.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.66 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 33.3 m -70.08 111.5 5.79 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.456 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.648 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -107.14 154.86 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.947 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.687 HG12 HG22 ' A' ' 76' ' ' VAL . 18.8 t -128.02 143.42 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.389 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' A' ' 43' ' ' ARG . 90.0 t -111.69 126.98 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.889 0.376 . . . . 0.0 111.069 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -105.64 123.39 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.361 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.873 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -157.2 158.33 36.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -79.67 -6.57 57.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 23.3 tt0 -78.78 131.29 36.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.817 0.341 . . . . 0.0 110.974 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 4.21 29.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.91 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.4 7.29 4.92 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.424 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.873 ' CG ' HG21 ' A' ' 63' ' ' THR . 6.0 t80 -59.23 144.98 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.051 0.453 . . . . 0.0 111.2 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.971 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -133.94 174.27 10.65 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.368 1.08 . . . . 0.0 113.014 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.91 144.47 21.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.709 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -81.0 96.66 7.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.89 0.376 . . . . 0.0 110.643 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -44.7 2.06 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.78 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.06 168.04 17.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 111.74 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 28.3 t -96.26 141.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.971 HG21 ' HA ' ' A' ' 69' ' ' GLN . 28.4 t -108.1 120.83 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.333 0.587 . . . . 0.0 111.912 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.919 HG21 HG22 ' A' ' 82' ' ' VAL . 27.7 m -127.59 169.55 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.633 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' THR . 7.9 m170 -117.52 -25.58 6.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.835 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.5 -174.62 5.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.015 0.436 . . . . 0.0 111.16 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.2 t -67.92 -11.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.533 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -34.21 19.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.441 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.86 -26.15 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.023 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.919 HG22 HG21 ' A' ' 76' ' ' VAL . 43.1 t -75.98 -54.71 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 14.5 m-85 -53.34 -27.89 25.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.885 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.53 87.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.969 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.43 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 86.1 t80 -65.3 -56.32 13.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.892 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -57.95 -24.86 59.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.034 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -68.8 -43.5 75.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -79.1 -10.7 59.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.286 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -122.88 65.6 26.92 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.15 -0.4 4.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.159 2.572 . . . . 0.0 113.166 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.92 -37.85 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 2.1 mm-40 -104.1 164.1 11.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.433 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 5.7 mm-40 -99.13 171.26 8.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 86' ' ' ALA . 8.1 tp -115.91 116.67 28.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' MET . 49.1 t -128.58 114.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.527 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 7.6 mm -83.34 140.2 16.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.077 0.465 . . . . 0.0 111.234 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.84 -36.34 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.57 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -170.93 43.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.555 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.45 -161.23 32.81 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 117.376 0.588 . . . . 0.0 112.512 -0.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.04 -53.53 54.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -55.34 -27.3 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.602 ' CD1' HD22 ' A' ' 62' ' ' LEU . 32.5 mm -83.16 -27.47 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.854 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.466 ' HB3' HG12 ' A' ' 129' ' ' ILE . 1.9 m-85 -60.61 -56.52 20.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.38 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.816 ' CA ' HD13 ' A' ' 129' ' ' ILE . 1.8 t -67.71 -10.07 49.25 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.24 -47.21 20.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.343 . . . . 0.0 110.732 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.9 ' CD2' HG13 ' A' ' 79' ' ' VAL . 9.3 m-85 -86.18 -9.38 56.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.321 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 3.2 pttp -52.42 -29.76 25.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -75.88 -7.43 54.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 22.5 m-20 -129.58 -19.89 3.32 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 113' ' ' LEU . 53.5 t -43.81 127.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.112 0.482 . . . . 0.0 110.935 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 10.5 t0 -108.55 6.58 26.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.48 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.756 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 18.7 m -169.68 137.92 1.8 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.72 0.295 . . . . 0.0 110.6 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.604 HD23 HG11 ' A' ' 110' ' ' VAL . 6.1 mt -122.7 145.67 48.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.168 0.509 . . . . 0.0 111.605 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mt -134.84 117.41 15.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.578 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.775 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -133.96 144.0 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.009 0.433 . . . . 0.0 111.837 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -116.36 104.71 11.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.4 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 2.9 ttt-85 -75.8 100.75 4.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.452 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.706 HD22 ' HZ ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -92.4 108.29 19.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.087 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.45 -39.73 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.408 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.6 -167.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.701 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.81 146.8 41.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 111.007 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.706 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 1.3 m-85 -134.47 162.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -99.73 134.05 43.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.002 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.604 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.01 -174.36 33.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.86 21.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.251 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -139.11 127.69 23.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.691 ' HG3' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -74.02 -173.6 1.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.201 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.816 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.3 pp -112.11 160.15 31.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.88 102.48 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.831 2.354 . . . . 0.0 112.746 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.34 146.44 27.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.29 76.35 5.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.44 ' HH2' HG11 ' A' ' 115' ' ' VAL . 84.4 m95 -60.04 -19.12 51.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.365 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.13 -33.22 65.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -81.77 -17.19 48.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.521 ' CD2' HD11 ' A' ' 113' ' ' LEU . 79.6 m-85 -106.68 167.75 9.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.906 0.384 . . . . 0.0 111.163 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.542 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -127.68 141.02 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.516 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 12.1 ttpp -81.81 115.99 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.1 m -101.04 -18.76 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.783 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.4 m -164.25 140.54 6.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.535 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.657 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 93.0 p -164.95 113.33 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.512 ' C ' HG23 ' A' ' 154' ' ' THR . 0.2 OUTLIER -146.48 126.02 13.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.681 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.9 m -80.5 145.04 32.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.294 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 152' ' ' THR . 3.5 t -122.79 109.05 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.792 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.91 104.5 16.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -177.2 5.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.3 p -58.02 -42.34 85.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.481 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.4 t-20 -80.99 134.5 52.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.342 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.96 -32.31 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.202 1.934 . . . . 0.0 112.429 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.11 -25.61 22.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.5 mt -76.18 5.11 7.33 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 153' ' ' HIS . 72.0 m -72.89 162.27 29.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -175.97 162.67 2.61 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 0.0 112.033 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.681 ' OG1' HG23 ' A' ' 143' ' ' THR . 38.5 m -122.5 129.82 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.33 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -93.66 107.89 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.496 ' HB2' HG22 ' A' ' 115' ' ' VAL . 4.6 mt-10 -101.28 152.29 20.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.818 ' O ' HG22 ' A' ' 139' ' ' VAL . 19.0 t -142.41 110.22 2.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.759 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.468 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 29.8 m95 -109.8 145.74 36.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.397 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.15 129.51 39.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.373 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -49.08 122.19 5.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 111.447 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.542 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.9 OUTLIER -97.8 176.14 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.063 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 87.6 m . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.758 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -107.95 154.79 21.11 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.8 m-30 -120.68 107.92 13.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.831 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.791 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.44 115.38 30.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.475 0.655 . . . . 0.0 112.231 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.667 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.7 p90 -158.37 166.19 32.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.856 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.36 133.28 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.0 pt20 -131.63 157.03 44.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.435 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -108.18 -162.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.361 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.28 -49.96 74.41 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -33.37 72.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.23 33.15 3.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.776 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.4 mm? -73.84 127.14 32.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.681 HG21 ' HG3' ' A' ' 128' ' ' MET . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.0 mtmm . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 80.7 mt -84.52 87.46 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.759 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.439 ' HE1' ' OD1' ' A' ' 59' ' ' ASN . 0.4 OUTLIER -100.31 122.63 43.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.922 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.642 HG21 HG11 ' A' ' 82' ' ' VAL . 21.6 t -82.84 158.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.612 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 40' ' ' VAL . 35.1 m -164.32 144.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.36 152.9 52.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.753 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.593 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.27 -52.26 53.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.861 0.33 . . . . 0.0 110.81 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.81 -32.18 70.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.086 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.419 HG22 ' CE1' ' A' ' 49' ' ' PHE . 10.5 m -70.15 -37.38 75.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.443 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -66.96 -26.28 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.034 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.73 -66.42 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -47.27 -37.97 11.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.469 ' CE2' HG11 ' A' ' 41' ' ' VAL . 2.8 m-30 -36.21 148.26 0.17 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -43.77 -69.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 0.0 112.713 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -139.09 167.57 21.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -122.53 117.38 29.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 95.6 Cg_endo -83.65 -171.0 8.34 Favored 'Cis proline' 0 C--N 1.349 0.594 0 C-N-CA 123.716 -1.369 . . . . 0.0 112.348 -0.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.648 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mt -79.98 162.87 60.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 24.4 Cg_endo -61.56 92.47 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.744 2.296 . . . . 0.0 113.101 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 60.29 33.8 20.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.624 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.648 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 10.7 mtp180 -124.02 114.3 19.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.203 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 41.4 m -65.14 107.21 1.48 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.124 0.488 . . . . 0.0 110.192 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.483 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.3 154.45 18.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.424 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 11.8 t -130.91 132.61 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.731 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.0 t -104.22 127.59 58.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 111.717 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -109.32 113.3 26.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.995 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.801 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.2 t -148.6 167.37 25.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 111.279 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -84.11 -7.31 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.282 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.8 tp-100 -80.46 128.8 34.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.467 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -79.35 -28.01 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.8 9.62 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.801 ' CD2' HG21 ' A' ' 63' ' ' THR . 4.2 t80 -59.86 141.08 56.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.064 0.459 . . . . 0.0 111.489 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.825 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.2 mt-30 -129.93 174.0 10.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.255 1.026 . . . . 0.0 112.54 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.557 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.47 143.72 20.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.58 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -74.31 96.24 2.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.445 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.94 -35.52 3.65 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.172 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.96 166.32 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.95 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 15.3 t -96.67 140.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.412 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.825 HG21 ' HA ' ' A' ' 69' ' ' GLN . 23.2 t -106.8 120.56 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.313 0.578 . . . . 0.0 112.18 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.929 HG21 HG22 ' A' ' 82' ' ' VAL . 24.9 m -132.77 172.04 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.965 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.414 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 11.2 m80 -122.21 -20.2 6.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -156.06 -175.68 5.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.101 0.476 . . . . 0.0 111.74 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.862 HG13 ' CD2' ' A' ' 106' ' ' PHE . 14.4 t -69.19 -10.24 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.614 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.48 -36.22 17.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.138 0.494 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.62 -33.71 66.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.929 HG22 HG21 ' A' ' 76' ' ' VAL . 27.2 t -70.29 -49.98 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 2.9 m-85 -54.34 -28.7 44.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.178 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.33 -39.79 85.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 50.8 t80 -66.37 -57.62 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.98 -23.06 43.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.893 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.652 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -72.08 -32.0 66.62 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 109.958 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 10.0 mt-30 -84.64 -9.02 58.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -121.21 65.17 14.54 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.027 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.36 -1.53 3.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.808 2.339 . . . . 0.0 112.647 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.03 -29.06 15.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.402 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 6.3 mm-40 -104.32 159.81 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.68 170.01 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.201 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -112.95 113.15 25.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.2 t -124.09 107.18 18.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.721 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.2 mm -76.46 134.69 28.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.434 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.96 -38.52 5.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.14 -167.35 40.31 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.09 -161.08 23.07 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 122.063 -0.669 . . . . 0.0 112.571 -0.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . -54.5 -51.63 64.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.826 0.346 . . . . 0.0 111.26 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -31.71 68.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.591 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 33.4 mm -72.67 -27.66 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 129' ' ' ILE . 2.4 m-85 -60.85 -54.35 46.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.572 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.553 ' CA ' HD13 ' A' ' 129' ' ' ILE . 7.7 t -69.26 -10.38 57.54 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.872 -0.517 . . . . 0.0 111.989 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.694 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.12 -39.91 54.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.862 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.4 m-85 -96.17 -8.24 33.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.552 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.84 -28.83 17.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.16 -1.46 49.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.469 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -132.01 -20.1 2.51 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.868 HG11 HD23 ' A' ' 113' ' ' LEU . 71.0 t -44.04 128.76 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.887 0.375 . . . . 0.0 111.222 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.436 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.9 t70 -106.16 1.59 26.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.301 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.758 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 72.7 m -166.99 135.09 2.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.674 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.868 HD23 HG11 ' A' ' 110' ' ' VAL . 9.6 mt -118.99 144.38 46.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 111.672 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mt -134.95 115.97 14.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.044 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.667 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -132.77 142.74 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 111.672 -179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.8 114.4 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.5 102.29 14.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.706 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -83.47 133.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.36 -57.43 10.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.339 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.14 168.2 38.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.747 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -99.33 172.51 7.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.804 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.604 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 3.0 m-85 -148.97 178.49 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.11 0.481 . . . . 0.0 111.442 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.55 171.48 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.435 ' HA3' ' CD1' ' A' ' 12' ' ' LEU . . . 161.41 -179.69 36.66 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.61 5.75 4.02 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.3 m -134.24 137.22 44.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 111.108 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 165.4 11.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.681 ' HG3' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -71.39 -173.72 0.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 111.086 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.553 HD13 ' CA ' ' A' ' 104' ' ' THR . 2.2 pp -118.47 164.03 22.48 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.083 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.529 ' O ' HD12 ' A' ' 129' ' ' ILE . 24.8 Cg_exo -63.11 136.65 57.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.636 2.224 . . . . 0.0 112.006 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -128.3 148.27 50.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.07 77.47 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -60.32 -19.0 53.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -29.31 62.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.57 -26.73 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.577 ' CD1' HD11 ' A' ' 113' ' ' LEU . 95.4 m-85 -97.71 173.95 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.18 140.5 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.505 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -79.72 111.67 16.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.833 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.4 m -93.88 -25.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.3 m -160.28 140.46 11.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 111.158 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 17.2 p -162.99 111.53 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -147.76 122.41 9.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 111.434 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.703 HG23 ' OG1' ' A' ' 154' ' ' THR . 4.8 m -76.38 144.93 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.35 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 t -115.62 105.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -93.61 104.94 17.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.406 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -86.69 -177.09 6.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -54.42 -51.49 64.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -76.58 127.0 85.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.044 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.21 -31.5 93.15 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.137 1.891 . . . . 0.0 112.413 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.26 -22.41 33.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.869 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.9 mt -81.75 10.46 6.16 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.511 ' O ' HD23 ' A' ' 118' ' ' LEU . 46.0 m -79.55 164.97 23.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 110.32 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.706 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 7.9 p80 -174.08 160.9 3.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.152 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.703 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.2 m -125.45 135.43 52.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -100.83 109.25 21.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.3 mt-10 -107.16 126.81 52.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.944 0.402 . . . . 0.0 111.378 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.757 ' O ' HG22 ' A' ' 139' ' ' VAL . 14.4 t -118.82 116.36 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.26 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.505 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.9 m95 -112.53 150.18 31.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.058 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.464 ' HG3' HG11 ' A' ' 139' ' ' VAL . 5.6 mt-30 -128.58 118.31 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.303 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.6 ttpp -53.55 133.91 41.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.578 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.51 10.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.511 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.087 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' LEU . 91.4 m . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.52 0.2 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.79 152.64 28.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.648 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -115.45 116.26 27.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.458 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 114' ' ' LEU . 13.1 tp -115.25 122.03 44.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.686 ' CH2' HG12 ' A' ' 115' ' ' VAL . 2.8 p90 -168.35 165.2 12.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.569 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -126.88 141.65 51.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 4.9 pt20 -127.35 156.55 41.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.838 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.54 -170.52 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.54 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -50.01 -46.34 52.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.42 -21.42 59.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 90.2 47.94 3.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.16 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -87.27 174.72 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.378 -179.47 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 126' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 92' ' ' GLN . 86.5 mt -81.69 87.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.68 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.4 ttp -99.94 111.94 24.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.581 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.737 HG13 ' HB ' ' A' ' 60' ' ' VAL . 2.8 t -86.2 129.82 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.561 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 27.6 m -135.77 153.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.95 157.05 53.49 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.213 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.814 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.18 -52.78 57.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.397 . . . . 0.0 110.345 179.539 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.449 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.7 tpt180 -56.82 -44.81 82.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.325 0.583 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 m -61.16 -36.65 80.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 9.5 t80 -66.02 -24.71 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -65.83 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.396 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.4 t -48.19 -31.65 6.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.222 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.561 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 3.5 m-30 -46.44 166.46 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.99 -70.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.795 2.33 . . . . 0.0 112.932 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -145.72 -167.11 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.97 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -132.3 113.81 14.61 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 6.4 Cg_exo -87.83 -160.9 1.72 Allowed 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.057 -0.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.727 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 12.2 mt -86.9 168.27 18.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 37.8 Cg_endo -66.87 93.9 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.443 2.095 . . . . 0.0 113.043 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 64.99 14.05 9.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.33 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.727 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 6.0 mtp180 -109.11 116.95 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.388 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.4 m -67.11 110.93 3.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.866 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.479 HD21 ' HB2' ' A' ' 57' ' ' ARG . 2.4 m120 -106.0 157.48 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.437 0.637 . . . . 0.0 112.641 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.737 ' HB ' HG13 ' A' ' 40' ' ' VAL . 8.2 t -136.14 135.76 49.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.33 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 43' ' ' ARG . 85.9 t -109.46 128.11 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.925 0.393 . . . . 0.0 111.636 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -107.61 119.74 40.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.595 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.936 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.9 t -150.47 170.95 17.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -95.06 -10.13 31.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.718 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.0 tt0 -68.87 132.27 46.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.8 0.334 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.22 56.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.71 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.01 14.64 18.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.936 ' CG ' HG21 ' A' ' 63' ' ' THR . 6.1 t80 -60.95 142.1 56.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.444 0.64 . . . . 0.0 111.978 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.834 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.2 mt-30 -135.79 172.99 12.21 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.316 1.055 . . . . 0.0 112.873 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.97 140.61 17.99 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.094 -1.867 . . . . 0.0 110.106 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.8 mp0 -73.77 100.2 3.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.78 0.324 . . . . 0.0 110.85 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 87.15 -38.17 3.16 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.395 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.514 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.62 171.34 10.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.674 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.726 HG21 ' CE2' ' A' ' 85' ' ' TYR . 22.4 t -99.46 140.37 18.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.507 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 69' ' ' GLN . 30.3 t -107.95 116.84 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 0.0 112.032 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 33.1 m -126.29 171.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -121.14 -22.54 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.736 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.461 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -155.2 -173.95 4.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.7 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.937 HG13 ' CD2' ' A' ' 106' ' ' PHE . 14.8 t -68.22 -10.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.14 -33.92 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.088 0.47 . . . . 0.0 110.075 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.19 -27.22 53.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.886 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 76' ' ' VAL . 72.4 t -73.47 -53.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.525 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.6 m-85 -55.01 -26.74 39.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.709 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.84 97.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 74' ' ' VAL . 38.9 t80 -67.19 -57.68 6.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.553 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -51.04 -25.66 5.17 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.232 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -66.58 -44.37 82.43 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -79.74 -0.3 33.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.546 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.602 ' CE1' ' CZ ' ' A' ' 85' ' ' TYR . 73.2 m80 -127.57 60.26 43.11 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.981 0.42 . . . . 0.0 110.269 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.3 -0.25 7.08 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.146 2.564 . . . . 0.0 112.812 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.5 -38.29 30.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.067 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.463 ' HG3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -114.17 167.68 10.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 111.243 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.54 166.31 11.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.501 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.625 HD11 ' CG1' ' A' ' 82' ' ' VAL . 13.6 tp -97.43 116.64 30.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.988 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 39' ' ' MET . 12.3 t -122.82 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.529 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 12.7 mm -80.59 140.53 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.418 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.73 -37.99 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.405 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.75 -168.42 41.52 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.681 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.42 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.54 -160.97 34.0 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 117.561 0.681 . . . . 0.0 112.528 -0.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.54 63.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.3 -29.06 60.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.599 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 62' ' ' LEU . 27.7 mm -84.08 -26.31 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.547 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.2 m-85 -60.45 -58.46 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.734 ' CA ' HD13 ' A' ' 129' ' ' ILE . 3.8 t -66.51 -9.08 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.762 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.34 -39.35 39.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.71 0.29 . . . . 0.0 111.283 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.937 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.3 m-85 -103.23 -5.76 22.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 7.0 pttt -42.47 -31.14 0.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -90.35 -26.76 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.733 ' OD2' HG11 ' A' ' 79' ' ' VAL . 12.0 m-20 -89.1 -31.68 17.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 3' ' ' PHE . 70.8 t -48.99 129.32 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 6.3 t70 -105.86 9.24 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.2 m -166.85 140.91 3.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 110' ' ' VAL . 13.8 mt -121.62 144.24 48.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.305 0.574 . . . . 0.0 111.743 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.489 ' HB2' HD12 ' A' ' 4' ' ' LEU . 5.4 mt -135.38 117.53 15.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.139 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.686 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -136.33 146.51 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.479 . . . . 0.0 112.108 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.97 108.47 16.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.301 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 8.3 tpt180 -79.51 101.16 8.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.317 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.583 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 3.2 mt -82.49 124.89 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.3 6.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.29 175.31 3.27 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.664 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.6 p -105.72 159.37 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 110.947 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.583 ' CZ ' HD22 ' A' ' 118' ' ' LEU . 6.3 m-85 -147.31 155.17 41.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.84 170.1 10.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.652 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.587 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 157.57 163.85 13.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.262 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.45 -27.1 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.6 0.238 . . . . 0.0 111.348 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.489 HG22 HD11 ' A' ' 13' ' ' ILE . 90.4 m -109.17 146.67 33.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.742 0.306 . . . . 0.0 111.008 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 177.56 4.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.0 tpt -76.94 156.68 31.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.734 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.3 pp -82.84 157.79 66.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.26 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.22 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.72 2.28 . . . . 0.0 112.507 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.45 146.63 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.38 75.78 2.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.012 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.571 ' HH2' HG11 ' A' ' 115' ' ' VAL . 88.0 m95 -56.39 -23.45 38.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -27.81 63.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.554 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.5 t70 -78.7 -24.82 44.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.737 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.459 ' CD1' HD11 ' A' ' 113' ' ' LEU . 78.5 m-85 -104.05 173.58 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.654 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -128.72 139.79 52.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpp -83.7 108.0 16.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.574 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.3 m -95.79 -18.11 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.722 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 m -162.62 140.46 8.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.722 0.296 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.484 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 2.2 p -169.85 108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -142.66 118.12 10.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.753 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -67.11 145.28 55.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.04 103.74 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.284 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.86 102.15 14.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.32 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 174.23 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.6 p -52.53 -44.16 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.495 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.3 t-20 -80.51 128.49 72.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.352 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.43 -30.35 86.85 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.393 2.062 . . . . 0.0 112.592 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.7 -22.98 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.4 mt -81.01 6.3 13.85 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 153' ' ' HIS . 99.6 m -70.2 162.38 28.5 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.163 0.506 . . . . 0.0 110.396 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -172.38 159.09 4.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.836 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.753 ' OG1' HG23 ' A' ' 143' ' ' THR . 6.8 m -119.0 150.25 40.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' SER . 48.9 m-85 -113.84 105.04 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.498 ' HB2' HG22 ' A' ' 115' ' ' VAL . 28.5 mt-10 -109.78 125.29 52.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.037 0.446 . . . . 0.0 112.183 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.685 ' O ' HG22 ' A' ' 139' ' ' VAL . 16.3 t -116.84 114.22 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.211 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.471 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.1 m95 -108.31 150.59 27.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.064 0.459 . . . . 0.0 111.985 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.489 ' CD ' HG11 ' A' ' 139' ' ' VAL . 31.3 mt-30 -129.33 125.33 36.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.32 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -48.07 123.28 6.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.661 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.654 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -107.67 -177.59 3.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.133 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.748 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.77 149.2 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.499 ' CE1' HG22 ' A' ' 110' ' ' VAL . 3.4 m-30 -113.64 108.35 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.845 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.48 117.15 33.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.605 0.717 . . . . 0.0 112.45 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.677 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.1 p90 -161.52 166.84 26.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.261 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.86 132.55 54.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.607 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.1 pt20 -118.5 143.87 46.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -91.93 -167.82 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.42 52.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.01 -27.68 48.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 106.73 29.53 4.64 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.259 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.66 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.9 tt -84.27 157.87 21.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.962 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.536 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.459 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 93' ' ' GLU . 6.7 mmtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.559 0.695 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.544 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 20.4 mt -64.41 110.7 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.692 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.8 ttp -100.79 115.26 29.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.584 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.806 HG21 HG11 ' A' ' 82' ' ' VAL . 2.7 t -88.99 124.3 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.167 0.508 . . . . 0.0 112.201 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 15.7 m -130.0 144.33 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.379 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.09 156.97 51.79 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.172 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.45 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -55.48 -51.01 68.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 110.514 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -58.43 -34.87 71.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -68.24 -47.49 67.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -54.13 -31.91 53.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -66.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.652 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 49' ' ' PHE . 2.4 m -57.6 -30.75 65.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.42 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -32.92 122.7 0.42 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.9 -179.23 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.28 -38.2 88.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.963 2.442 . . . . 0.0 113.311 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.57 116.28 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.429 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.51 135.09 14.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.709 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.42 -171.86 8.41 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.354 -1.519 . . . . 0.0 112.161 -0.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 57' ' ' ARG . 95.7 mt -97.84 147.2 32.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.571 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.67 -86.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.091 2.527 . . . . 0.0 113.451 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.84 25.65 8.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.624 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.142 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 80.3 m -74.7 122.0 22.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 111.873 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.416 HD21 HD12 ' A' ' 54' ' ' LEU . 2.6 m-80 -102.81 152.79 20.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.718 ' HB ' HG13 ' A' ' 40' ' ' VAL . 2.2 t -137.38 131.71 44.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.5 t -103.47 126.19 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.272 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -109.87 108.29 18.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.944 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.981 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.9 t -144.19 164.11 31.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 111.396 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -81.1 -9.83 59.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.289 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.664 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.9 tp-100 -71.74 127.18 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.332 . . . . 0.0 110.392 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -27.91 55.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -105.13 16.93 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.641 0.258 . . . . 0.0 111.493 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.981 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.6 t80 -62.25 137.24 58.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.485 0.659 . . . . 0.0 112.454 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.832 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -127.41 171.99 11.06 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.251 1.024 . . . . 0.0 112.357 178.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.07 140.14 16.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -76.07 96.81 3.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.813 0.339 . . . . 0.0 110.941 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.95 -42.26 2.31 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.556 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 167.92 19.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.133 0.492 . . . . 0.0 112.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' HG13 ' A' ' 60' ' ' VAL . 21.9 t -94.81 140.89 15.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.127 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.875 HG11 ' O ' ' A' ' 68' ' ' TYR . 33.8 t -107.01 121.61 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.386 0.612 . . . . 0.0 111.955 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.718 HG21 HG22 ' A' ' 82' ' ' VAL . 18.0 m -132.74 178.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.131 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -127.79 -21.11 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.648 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -153.8 -177.11 6.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.457 . . . . 0.0 111.591 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 106' ' ' PHE . 24.2 t -70.08 -11.17 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.433 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.11 -37.24 17.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.107 0.48 . . . . 0.0 110.064 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -68.83 -30.63 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.665 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.806 HG11 HG21 ' A' ' 40' ' ' VAL . 23.3 t -72.35 -55.81 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.484 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 8.5 m-85 -52.49 -31.21 34.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.6 -43.81 97.87 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 87.5 t80 -61.04 -52.6 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.3 -22.33 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.35 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mtmt -70.99 -37.14 72.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.126 0.489 . . . . 0.0 109.874 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -8.7 59.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 92' ' ' GLN . 95.1 m-70 -120.01 62.45 8.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.93 -6.04 8.69 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.655 2.237 . . . . 0.0 112.226 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -99.55 -25.75 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.982 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 89' ' ' HIS . 38.5 mt-30 -94.11 151.6 19.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 29.2 mt-10 -99.09 174.76 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.58 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 1' ' ' THR . 17.2 tp -131.23 111.17 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 111.308 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 39' ' ' MET . 83.9 t -129.23 116.14 38.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 40' ' ' VAL . 6.3 mm -82.02 138.13 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.88 0.371 . . . . 0.0 111.082 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.76 -33.14 5.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.94 -171.89 44.41 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.462 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.62 -160.97 36.17 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 117.588 0.694 . . . . 0.0 112.632 -0.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.01 -55.75 15.9 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.8 0.333 . . . . 0.0 111.294 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -56.47 -31.92 64.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.025 0.441 . . . . 0.0 110.464 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.4 mm -77.11 -30.54 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.053 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.0 m-85 -58.02 -52.98 63.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.366 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.696 ' CA ' HD13 ' A' ' 129' ' ' ILE . 12.0 t -69.53 -10.22 57.19 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -73.36 -39.71 64.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.9 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.8 m-85 -102.35 -3.55 26.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.584 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 5.9 pttt -51.65 -31.23 24.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.7 -5.69 58.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.555 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.82 -20.65 8.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.657 0.265 . . . . 0.0 111.475 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 106' ' ' PHE . 73.4 t -45.58 134.15 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.12 0.486 . . . . 0.0 111.427 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 18.1 t70 -111.26 -0.32 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.748 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.6 m -166.74 137.44 3.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.565 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 6.1 mt -118.13 145.64 44.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.24 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 4' ' ' LEU . 9.4 mt -134.96 112.74 10.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.062 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.677 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -127.94 137.39 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.055 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.92 119.93 36.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.182 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 100.6 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 0.9 OUTLIER -81.13 135.31 35.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -55.94 -53.84 52.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 122' ' ' PHE . . . -58.04 156.32 19.52 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.234 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 p -97.04 154.13 17.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -142.68 156.48 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.824 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 156.92 16.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.252 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.66 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 178.56 175.41 45.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.911 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.22 22.08 4.45 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.463 HG22 HD11 ' A' ' 13' ' ' ILE . 1.3 m -133.0 126.96 33.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.75 0.31 . . . . 0.0 110.838 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -108.65 162.31 14.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.3 tpt -72.93 158.44 35.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.696 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.2 pp -88.75 164.97 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.178 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.22 96.79 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 112.655 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.1 149.49 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.997 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.02 71.35 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.479 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HH2' HG11 ' A' ' 115' ' ' VAL . 95.6 m95 -58.96 -20.11 49.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.86 -32.06 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.756 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -79.39 -24.52 42.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.57 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 95.5 m-85 -101.46 171.62 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 111.076 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -134.93 141.76 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.2 ttpm? -84.76 105.81 15.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.9 m -89.9 -17.96 7.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.985 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -161.85 141.47 10.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 111.17 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.607 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 99.2 p -172.01 108.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.412 ' C ' HG23 ' A' ' 154' ' ' THR . 1.7 ttt-85 -147.87 130.52 15.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.26 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.756 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.4 m -74.27 146.3 43.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.148 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' THR . 11.3 t -118.3 104.62 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.383 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -93.33 104.89 17.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.72 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.7 -174.51 4.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.498 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -54.58 -54.89 35.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.864 0.364 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.554 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.8 t30 -75.93 141.08 71.07 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.769 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.77 -36.57 18.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.819 1.679 . . . . 0.0 112.369 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.91 -23.4 44.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.878 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -77.69 9.61 3.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.566 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 144' ' ' VAL . 50.3 m -83.95 158.64 21.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -170.68 155.83 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.756 ' OG1' HG23 ' A' ' 143' ' ' THR . 39.6 m -117.69 129.44 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.404 ' OH ' ' CE1' ' A' ' 153' ' ' HIS . 57.2 m-85 -100.77 105.64 16.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.409 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.548 ' HB2' HG22 ' A' ' 115' ' ' VAL . 17.0 mt-10 -104.61 126.68 51.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.307 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.745 ' O ' HG22 ' A' ' 139' ' ' VAL . 6.2 t -118.07 112.56 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.552 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 30.2 m95 -104.63 148.27 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.067 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -128.33 119.22 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.747 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.452 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.4 tttt -51.54 135.13 28.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.26 -165.86 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.575 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 9.6 m . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.93 148.64 33.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.9 m-85 -113.87 112.24 23.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.278 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.807 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.84 127.83 55.34 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.664 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.5 p90 -168.63 163.8 12.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.216 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.22 131.73 53.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.862 0.363 . . . . 0.0 111.732 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.544 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 7.5 pt20 -130.61 161.54 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.415 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.11 -169.03 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HD3' ' HB3' ' A' ' 121' ' ' SER . 0.0 OUTLIER -55.34 -27.73 49.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.67 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 9.2 t70 -90.63 -33.98 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 105.17 57.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.859 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 67.1 mt -110.22 152.23 26.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.343 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.506 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 40.8 mt -76.82 88.96 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 111.579 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.492 ' HE2' HD12 ' A' ' 54' ' ' LEU . 27.5 ttp -103.11 126.74 50.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.641 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.597 HG21 HG11 ' A' ' 82' ' ' VAL . 39.3 t -79.87 156.51 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.759 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 31.2 m -163.7 140.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.984 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.76 147.75 48.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.32 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.614 ' HG2' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -49.93 -46.39 52.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.445 0.622 . . . . 0.0 110.613 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -58.97 -39.55 82.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 109.963 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -65.98 -48.67 70.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.984 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 4.5 t80 -57.31 -27.22 61.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.79 -66.23 0.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.658 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.12 -23.88 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.787 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -35.71 133.12 0.53 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.901 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 99.6 Cg_exo -46.8 -35.96 18.74 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.144 2.563 . . . . 0.0 113.534 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.84 148.55 31.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.197 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.95 111.84 6.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.252 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 12.9 Cg_exo -81.76 179.09 28.53 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 123.408 -1.497 . . . . 0.0 111.787 -0.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.787 HD11 ' CE1' ' A' ' 49' ' ' PHE . 77.8 mt -78.87 143.42 62.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.766 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.81 109.2 2.06 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.514 2.143 . . . . 0.0 112.609 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 73.19 0.12 3.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.968 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.776 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -109.89 106.88 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 -179.343 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.506 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 87.9 m -64.99 120.31 12.36 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.613 ' ND2' HD12 ' A' ' 54' ' ' LEU . 4.8 m120 -110.11 157.32 19.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.203 0.525 . . . . 0.0 112.362 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 76' ' ' VAL . 17.7 t -134.15 143.58 37.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.765 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.8 t -113.58 111.04 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.179 0.514 . . . . 0.0 111.891 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -91.58 118.35 30.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.304 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.895 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -155.37 148.17 24.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.936 179.472 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -69.02 -6.32 27.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.258 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.8 tt0 -73.29 131.6 42.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.329 . . . . 0.0 110.747 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -85.42 5.47 30.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.838 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -134.6 7.72 3.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.895 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.4 t80 -59.91 137.51 58.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.289 0.566 . . . . 0.0 111.594 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.956 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.3 mt-30 -133.15 171.94 13.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.454 1.121 . . . . 0.0 113.14 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.5 140.29 17.13 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.138 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.97 102.56 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.07 -41.05 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.274 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -72.49 170.51 14.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.017 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 60' ' ' VAL . 21.6 t -98.53 141.33 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.956 HG21 ' HA ' ' A' ' 69' ' ' GLN . 14.8 t -114.37 122.37 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 0.0 112.187 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.008 HG21 HG22 ' A' ' 82' ' ' VAL . 27.3 m -129.91 173.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.111 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' THR . 6.0 m170 -118.44 -24.22 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -157.1 -171.82 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 111.165 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.841 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.6 t -68.91 -11.29 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.54 -36.84 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 110.094 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.81 -29.67 63.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.89 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.008 HG22 HG21 ' A' ' 76' ' ' VAL . 21.5 t -72.3 -55.19 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 120.904 0.383 . . . . 0.0 110.039 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.552 ' O ' ' HG3' ' A' ' 87' ' ' LYS . 9.4 m-85 -53.61 -27.59 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.817 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.08 -48.64 79.28 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.846 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.624 ' CZ ' ' CE1' ' A' ' 89' ' ' HIS . 83.1 t80 -58.98 -51.24 70.91 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.99 -22.84 16.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.095 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' PHE . 6.6 mtmp? -67.78 -44.5 77.29 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -79.63 -2.83 44.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.596 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.624 ' CE1' ' CZ ' ' A' ' 85' ' ' TYR . 73.0 m80 -128.68 64.43 69.04 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-O 120.995 0.426 . . . . 0.0 110.388 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.19 -0.01 6.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.184 2.589 . . . . 0.0 112.935 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.89 -31.83 18.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.169 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.74 162.94 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.364 . . . . 0.0 111.34 -179.673 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -104.17 174.71 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.223 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.676 HD21 ' CG1' ' A' ' 82' ' ' VAL . 6.2 tp -110.5 117.08 32.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 t -121.53 107.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.093 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.479 HD12 ' HB ' ' A' ' 40' ' ' VAL . 16.4 mm -76.76 132.08 33.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 111.593 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.405 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.13 -37.15 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.027 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.34 -172.66 45.0 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.827 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.9 -161.11 31.7 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 122.216 -0.579 . . . . 0.0 112.535 -0.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.3 -55.36 32.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.737 0.303 . . . . 0.0 111.045 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -55.14 -26.49 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.571 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.9 mm -80.62 -26.41 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' HB3' HG12 ' A' ' 129' ' ' ILE . 3.4 m-85 -62.71 -55.84 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.472 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.729 ' CA ' HD13 ' A' ' 129' ' ' ILE . 4.6 t -66.72 -10.11 43.53 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.772 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.38 -41.3 48.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.841 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.5 m-85 -96.69 -8.28 31.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.478 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.91 -29.24 19.23 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.856 0.36 . . . . 0.0 111.161 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.52 -3.74 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.551 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -128.8 -19.09 3.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 106' ' ' PHE . 77.7 t -44.45 131.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.459 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 9.9 t70 -109.22 4.36 22.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.285 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.709 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 21.7 m -167.74 135.72 2.38 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.6 0.238 . . . . 0.0 110.821 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 13.8 mt -116.52 142.44 46.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 4' ' ' LEU . 3.7 mt -135.53 115.69 13.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -138.1 147.39 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.92 105.91 13.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.022 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 18.3 ttt180 -86.39 104.71 16.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.79 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 6.8 mp -85.14 128.3 34.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.931 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -61.55 -54.0 48.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.463 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -63.13 168.52 19.85 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.46 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 95.3 p -105.28 141.97 35.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.683 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -137.11 175.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 162.55 29.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.48 ' CA ' HD13 ' A' ' 12' ' ' LEU . . . 164.08 133.15 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -106.05 -24.8 12.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.64 0.257 . . . . 0.0 111.237 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.36 144.73 37.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 111.198 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.56 -174.63 2.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.0 tpt -86.24 160.01 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.189 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.729 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.6 pp -86.87 166.24 27.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.193 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' A' ' 129' ' ' ILE . 20.3 Cg_exo -66.29 94.25 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.874 2.383 . . . . 0.0 112.908 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.42 149.01 23.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.068 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.7 77.74 3.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -59.32 -18.2 35.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.532 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.57 -30.93 61.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 111.032 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.78 -25.79 49.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.274 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.506 ' CD1' HD11 ' A' ' 113' ' ' LEU . 95.8 m-85 -97.18 174.23 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.004 0.43 . . . . 0.0 111.541 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.453 HG21 ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -136.88 142.74 42.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.0 OUTLIER -78.26 119.3 21.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.978 179.575 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 157' ' ' VAL . 29.2 m -102.16 -23.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.219 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.7 m -163.23 140.77 7.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 80.9 p -160.7 110.12 1.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.978 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -141.64 114.54 8.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.015 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.737 HG23 ' OG1' ' A' ' 154' ' ' THR . 7.4 m -73.07 143.99 47.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.481 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.48 105.3 18.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.951 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.437 ' HA ' HG23 ' A' ' 152' ' ' THR . 1.7 mt-10 -90.73 102.15 14.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.714 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.79 -177.73 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.595 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 36.3 p -59.51 -49.52 77.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.53 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t-20 -74.41 125.44 89.83 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.774 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.5 -28.21 86.91 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.089 1.859 . . . . 0.0 112.338 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.463 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -89.3 -20.07 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.027 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.8 mt -84.91 8.75 16.44 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 80.4 m -73.25 166.27 23.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.912 0.387 . . . . 0.0 110.004 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 10.5 p-80 -173.74 160.33 3.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.737 ' OG1' HG23 ' A' ' 143' ' ' THR . 8.0 m -126.84 140.13 52.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.264 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -100.03 105.72 17.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.468 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.438 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.3 mt-10 -104.24 121.81 44.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.928 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.805 ' O ' HG22 ' A' ' 139' ' ' VAL . 9.6 t -114.51 112.96 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.8 m95 -112.63 150.8 30.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.274 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.526 ' CD ' HG11 ' A' ' 139' ' ' VAL . 26.6 mt-30 -128.51 118.89 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.36 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.3 tttt -57.35 133.08 54.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.865 0.364 . . . . 0.0 111.153 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.453 ' HE2' HG21 ' A' ' 137' ' ' THR . 0.0 OUTLIER 177.16 157.67 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.099 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.141 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.459 ' CG2' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.537 0.208 . . . . 0.0 110.539 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.23 143.08 37.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.296 0.57 . . . . 0.0 112.366 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.494 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.3 m-30 -112.36 112.98 24.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.543 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.816 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -113.15 123.16 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 111.648 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.646 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.6 p90 -166.29 173.88 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.518 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -128.68 137.65 51.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -130.25 157.0 43.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.592 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 20.7 p-10 -108.33 -171.67 1.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.71 -36.47 64.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.38 -28.03 34.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.702 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.6 -4.22 66.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.893 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 2.5 pp -80.59 157.46 26.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.927 0.363 . . . . 0.0 111.021 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.656 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.3 mt -81.34 88.67 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.118 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.472 ' HE3' ' CG1' ' A' ' 41' ' ' VAL . 4.1 ttp -99.07 123.13 43.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.766 HG21 HG11 ' A' ' 82' ' ' VAL . 4.4 t -89.22 128.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.472 ' CG1' ' HE3' ' A' ' 39' ' ' MET . 33.5 m -131.49 148.12 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.538 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.87 151.22 51.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.385 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.524 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -49.83 -51.12 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.8 tpt180 -62.18 -36.76 82.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.303 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -66.86 -36.25 81.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.942 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.476 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t80 -65.53 -22.34 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.592 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -65.22 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.2 t -48.37 -36.58 14.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -43.18 157.27 0.25 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.012 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.12 -67.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.673 2.249 . . . . 0.0 112.768 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.25 164.06 36.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 16.9 mtm180 -117.12 115.08 38.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 67.6 Cg_endo -88.74 -164.99 2.78 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.005 -1.248 . . . . 0.0 112.329 0.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.644 HD12 HD21 ' A' ' 59' ' ' ASN . 55.4 mt -107.51 144.63 29.63 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 37.3 Cg_endo -65.97 118.11 5.22 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.555 2.17 . . . . 0.0 112.638 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 7.1 mt-10 68.02 7.49 5.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.944 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 1.3 mtt180 -119.24 100.31 7.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.887 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 34.9 m -67.72 109.92 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.744 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.3 m-80 -104.39 139.51 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.305 0.574 . . . . 0.0 112.265 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' HG13 ' A' ' 40' ' ' VAL . 4.5 t -113.0 143.16 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.121 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 68' ' ' TYR . 84.9 t -114.77 125.06 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 111.9 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.937 HD12 HG23 ' A' ' 76' ' ' VAL . 1.9 tp -104.66 120.36 41.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.92 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -153.62 171.18 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -91.91 -8.03 47.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.6 tt0 -77.9 130.72 36.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.339 . . . . 0.0 110.786 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -80.79 0.05 36.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.004 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -126.79 10.03 7.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.578 0.228 . . . . 0.0 111.407 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.92 ' CD2' HG21 ' A' ' 63' ' ' THR . 4.4 t80 -59.34 141.62 54.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.95 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.7 mt-30 -132.52 174.54 10.17 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 122.343 1.068 . . . . 0.0 112.902 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.84 143.62 20.77 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.398 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -73.17 98.56 2.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.771 0.319 . . . . 0.0 110.835 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.18 -36.7 2.89 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.535 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -70.69 172.38 8.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 0.0 111.489 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.99 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.95 HG21 ' HA ' ' A' ' 69' ' ' GLN . 25.1 t -112.76 122.72 67.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.134 0.492 . . . . 0.0 111.365 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.937 HG23 HD12 ' A' ' 62' ' ' LEU . 30.8 m -133.61 168.61 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.334 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 65' ' ' GLN . 9.0 m80 -117.1 -22.52 8.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.358 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -150.06 -177.36 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 111.578 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.915 HG13 ' CD2' ' A' ' 106' ' ' PHE . 21.5 t -70.79 -8.57 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.99 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.76 -31.24 17.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 110.053 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.736 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.03 -27.26 54.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.681 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 76' ' ' VAL . 95.2 t -75.67 -52.59 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.659 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 8.2 m-85 -57.39 -25.02 58.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.689 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -66.3 -57.55 7.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.635 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -56.82 -23.4 43.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.04 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.14 -33.01 72.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 9.7 mt-30 -88.75 -4.13 58.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.26 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -126.02 63.97 50.69 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.33 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.06 -0.14 5.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.169 2.579 . . . . 0.0 112.94 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.79 -37.23 30.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -112.14 163.84 13.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -98.64 164.25 12.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.639 HD11 HG12 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -108.16 124.96 51.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.313 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' MET . 69.3 t -131.87 118.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.345 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 94' ' ' LEU . 3.0 mm -82.48 138.69 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 111.408 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -102.63 -52.98 2.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.775 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.11 -166.15 38.95 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.48 -161.01 36.77 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 117.813 0.806 . . . . 0.0 112.639 -0.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.78 -44.13 38.65 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.81 0.338 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.82 -34.33 74.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.717 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 62' ' ' LEU . 28.4 mm -80.97 -23.11 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -63.21 -52.06 63.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.55 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 14.5 t -68.48 -9.58 49.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.738 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.35 -39.99 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 110.68 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.915 ' CD2' HG13 ' A' ' 79' ' ' VAL . 4.2 m-85 -100.69 -4.8 27.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.368 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.3 pttt -48.18 -32.65 7.32 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.94 -2.16 58.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.789 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 m-20 -119.18 -26.89 5.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.585 0.231 . . . . 0.0 111.554 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.761 HG11 HD23 ' A' ' 113' ' ' LEU . 82.5 t -45.91 122.48 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 111.576 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 14.9 t70 -105.85 8.35 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.022 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.7 m -168.25 138.29 2.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.969 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.761 HD23 HG11 ' A' ' 110' ' ' VAL . 5.8 mt -121.46 146.2 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.319 0.581 . . . . 0.0 112.101 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 113' ' ' LEU . 14.3 mt -135.15 114.67 12.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.241 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -136.89 147.33 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.128 0.489 . . . . 0.0 112.133 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -107.93 119.01 38.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.915 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -79.46 99.01 7.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.383 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 6' ' ' ALA . 6.0 mt -85.94 108.96 18.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.177 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.33 78.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.034 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.5 171.49 54.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.554 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t -110.14 162.65 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 111.018 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 6.6 m-85 -138.42 170.05 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.253 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.42 169.95 8.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.89 -170.73 24.76 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.689 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.26 29.22 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.018 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -141.62 129.83 22.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 16.5 tttm -111.55 150.24 30.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.806 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -52.17 179.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.544 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.6 pt -97.27 162.67 21.91 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.188 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.2 Cg_endo -73.86 99.3 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.45 2.1 . . . . 0.0 112.102 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.427 ' CD1' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt -88.46 147.84 24.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 74.19 2.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.024 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.527 ' HH2' HG11 ' A' ' 115' ' ' VAL . 92.7 m95 -54.52 -24.17 19.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.94 -26.29 62.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.3 t0 -83.23 -19.51 36.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.737 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.699 ' CD1' HD11 ' A' ' 113' ' ' LEU . 89.9 m-85 -107.93 165.9 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.626 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.568 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -126.61 139.79 52.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 110.509 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 11.2 ttpt -79.6 117.25 20.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.464 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 157' ' ' VAL . 24.5 m -101.94 -21.84 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.927 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -163.09 140.61 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 8.6 p -155.94 111.02 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.501 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -141.42 117.1 10.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.789 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.787 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.2 m -72.62 133.48 44.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.161 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.64 109.77 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.583 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.779 ' HA ' HG23 ' A' ' 152' ' ' THR . 11.2 mt-10 -96.99 97.51 9.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -81.51 -161.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.191 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.2 p -74.38 -48.65 26.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.502 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -69.18 119.85 72.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.075 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.31 -20.57 56.29 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.083 1.856 . . . . 0.0 111.989 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -23.65 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.573 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.6 mt -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.779 HG23 ' HA ' ' A' ' 145' ' ' GLU . 1.7 m -85.86 82.21 8.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 5.3 p80 -97.12 -171.3 2.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.565 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.787 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 55.9 m -125.55 165.26 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.079 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.473 ' N ' HG22 ' A' ' 154' ' ' THR . 1.6 m-85 -118.79 105.85 11.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.96 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.4 mt-10 -109.69 125.27 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.778 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.752 ' O ' HG22 ' A' ' 139' ' ' VAL . 7.0 t -116.12 115.04 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.278 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.508 ' O ' HG23 ' A' ' 112' ' ' THR . 23.8 m95 -111.97 150.47 30.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.22 0.534 . . . . 0.0 111.655 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -127.28 121.12 30.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.784 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 2.3 tmmt? -54.94 130.42 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 0.0 111.62 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.568 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.59 -170.52 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.553 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.126 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 21.7 m . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.689 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.72 145.36 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.8 m-85 -112.17 111.53 22.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.314 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.849 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -111.16 119.07 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.544 0.688 . . . . 0.0 112.569 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.603 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.7 p90 -160.32 166.89 28.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.411 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.99 140.18 48.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.957 0.408 . . . . 0.0 111.769 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 1.9 pt20 -138.99 141.34 38.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.675 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 5.7 p-10 -100.35 -163.38 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -51.63 -48.9 63.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.345 0.593 . . . . 0.0 109.978 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.55 -32.69 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.037 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.11 43.47 3.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -82.51 165.15 20.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.753 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.452 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.519 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 62.8 mt -74.43 89.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.12 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 ttp -99.61 125.0 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.651 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.4 t -79.14 157.36 4.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.423 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 31.2 m -162.91 153.19 3.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.13 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 154.36 47.76 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.813 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.805 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.931 0.366 . . . . 0.0 110.813 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.4 tpm_? -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.575 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -71.4 -47.5 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 73' ' ' ALA . 9.7 t80 -58.21 -23.47 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.18 -65.82 0.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -56.45 -26.8 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.381 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -39.84 130.27 1.51 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.551 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.3 -27.96 5.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.383 . . . . 0.0 113.329 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -157.12 133.05 9.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.286 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -126.84 108.2 22.41 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 69.3 Cg_endo -80.49 -171.96 10.41 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.582 -1.424 . . . . 0.0 111.831 0.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.701 HD11 ' CE1' ' A' ' 49' ' ' PHE . 64.4 mt -91.55 158.19 40.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.44 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.78 -43.6 56.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.91 2.406 . . . . 0.0 113.533 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 4.6 mt-10 -140.58 46.05 1.8 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.835 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.6 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -146.53 111.37 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.339 . . . . 0.0 111.811 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.519 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.1 m -71.29 115.5 10.52 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.554 HD21 HD12 ' A' ' 54' ' ' LEU . 3.5 m-80 -101.07 159.42 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.475 0.655 . . . . 0.0 112.59 -178.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 74' ' ' VAL . 5.7 t -137.17 133.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.366 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 43' ' ' ARG . 86.8 t -104.7 126.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.691 HD13 HD12 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -105.24 118.8 37.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.052 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.811 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.97 161.85 42.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.15 -10.64 59.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.723 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 14.5 tt0 -81.44 134.25 35.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 1.2 mp0 -82.88 -24.98 32.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -95.65 4.46 53.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.666 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.865 ' O ' HG11 ' A' ' 75' ' ' VAL . 6.0 t80 -59.3 140.68 55.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 111.403 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.966 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.1 mt-30 -132.79 172.92 11.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.314 1.054 . . . . 0.0 112.846 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . . . -155.38 143.83 20.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.728 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -88.2 98.05 11.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.52 62.01 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.036 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 46' ' ' TYR . . . -125.66 166.08 17.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.88 0.372 . . . . 0.0 111.182 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 60' ' ' VAL . 16.2 t -96.17 138.17 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.986 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.966 HG21 ' HA ' ' A' ' 69' ' ' GLN . 38.6 t -104.4 104.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.322 0.582 . . . . 0.0 112.541 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.831 HG21 ' CG2' ' A' ' 82' ' ' VAL . 26.5 m -117.41 166.29 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.398 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.407 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 6.8 m170 -116.35 -19.05 10.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.584 0.23 . . . . 0.0 111.062 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -157.99 -176.3 5.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.611 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.875 HG13 ' CD2' ' A' ' 106' ' ' PHE . 18.4 t -68.41 -8.36 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.952 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -35.93 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.219 0.533 . . . . 0.0 109.794 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.37 -32.57 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.701 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.831 ' CG2' HG21 ' A' ' 76' ' ' VAL . 97.6 t -70.7 -50.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -57.03 -25.54 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.202 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -67.65 -42.39 82.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.045 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' ' NE2' ' A' ' 89' ' ' HIS . 92.5 t80 -65.49 -56.65 11.24 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.78 -21.71 11.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.96 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.3 mmmt -69.13 -39.97 78.56 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 84' ' ' ALA . 10.6 mp0 -82.53 -5.6 58.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.387 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.452 ' NE2' ' CE1' ' A' ' 85' ' ' TYR . 98.1 m-70 -126.28 65.89 59.41 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.547 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.58 -0.42 5.94 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.104 2.536 . . . . 0.0 112.923 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.19 -30.91 16.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -102.69 158.34 16.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -98.86 164.49 12.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.683 HD11 ' CG1' ' A' ' 82' ' ' VAL . 8.8 tp -114.01 114.64 26.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.97 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.24 116.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.211 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.439 HD12 ' HB ' ' A' ' 40' ' ' VAL . 6.9 mm -77.98 134.9 27.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.087 0.47 . . . . 0.0 111.412 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.42 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -106.84 -46.92 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.87 -170.83 43.95 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.894 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -90.3 -160.81 36.89 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 122.002 -0.705 . . . . 0.0 112.647 -0.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.47 11.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -52.52 -28.68 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.691 HD12 HD13 ' A' ' 62' ' ' LEU . 48.5 mm -85.16 -27.36 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.3 m-85 -60.28 -52.97 63.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.551 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.536 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 12.6 t -67.66 -9.76 46.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.677 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.09 -41.71 58.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.799 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.875 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.3 m-85 -101.55 -3.62 28.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.7 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 20.9 pttp -48.07 -32.21 6.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.751 0.31 . . . . 0.0 111.669 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -87.35 -19.19 28.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.552 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.8 -22.79 15.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.486 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.914 HG11 HD23 ' A' ' 113' ' ' LEU . 98.2 t -44.76 126.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.968 0.413 . . . . 0.0 111.61 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -101.82 -7.96 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 35.2 m -160.1 141.95 12.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.308 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.914 HD23 HG11 ' A' ' 110' ' ' VAL . 15.5 mt -120.38 145.81 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 111.649 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.98 114.89 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.603 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -135.41 145.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.991 0.424 . . . . 0.0 111.956 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -109.94 99.12 8.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.692 179.209 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 99.82 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.796 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 1.6 mp -86.04 127.47 34.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.404 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -52.8 -47.52 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.665 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -82.24 160.44 40.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 13.7 t -91.39 166.28 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.584 ' CZ ' HD22 ' A' ' 118' ' ' LEU . 11.3 m-85 -138.55 167.55 21.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.31 167.66 13.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 161.83 166.26 20.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.7 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.29 -28.17 7.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.666 0.269 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.0 m -109.27 148.8 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.28 174.96 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.77 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.546 ' HE2' HG13 ' A' ' 129' ' ' ILE . 14.5 tpt -73.58 158.53 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.646 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -84.39 165.53 37.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.066 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.4 Cg_endo -74.97 96.11 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.323 2.015 . . . . 0.0 112.307 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.73 149.47 24.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.85 72.59 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.008 0.432 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.49 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.1 m95 -58.49 -21.04 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -32.31 65.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.93 0.395 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.5 t0 -80.43 -15.67 56.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 113' ' ' LEU . 68.9 m-85 -107.43 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.095 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.44 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -127.9 142.26 51.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.634 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.533 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.8 OUTLIER -83.62 109.88 17.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.1 m -93.65 -22.44 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.448 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.0 m -159.45 140.62 12.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.181 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.6 p -165.4 116.08 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.521 ' C ' HG23 ' A' ' 154' ' ' THR . 2.6 ttm-85 -147.3 122.78 10.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.832 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.8 m -78.41 145.01 35.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.22 0.533 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.528 HG21 ' HE2' ' A' ' 155' ' ' TYR . 8.1 t -120.35 103.41 13.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.138 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.42 103.76 15.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.717 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.71 -172.66 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.107 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.6 p -54.72 -58.86 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 110.465 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.509 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -69.84 118.76 66.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.896 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.88 -22.35 62.12 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.112 1.875 . . . . 0.0 112.361 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -95.27 -16.03 22.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.367 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.7 mt -88.4 9.05 24.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.785 0.326 . . . . 0.0 111.164 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.473 HG22 ' N ' ' A' ' 153' ' ' HIS . 61.2 m -68.94 167.91 14.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.936 0.398 . . . . 0.0 109.993 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.473 ' N ' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -167.99 153.9 7.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.832 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.4 m -122.69 128.96 51.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.826 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.528 ' HE2' HG21 ' A' ' 144' ' ' VAL . 67.2 m-85 -90.69 104.77 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.408 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.511 ' HB2' HG22 ' A' ' 115' ' ' VAL . 33.8 mt-10 -107.41 125.54 51.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.8 ' O ' HG22 ' A' ' 139' ' ' VAL . 30.6 t -116.66 114.02 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.093 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.533 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 22.7 m95 -108.77 148.91 29.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -129.14 121.0 26.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.33 130.07 6.44 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.44 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -127.2 -163.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.195 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.044 179.787 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 24.3 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.559 0.219 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.16 145.66 39.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.7 m-30 -109.83 114.05 27.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.824 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.15 120.75 42.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.475 -179.243 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.704 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -166.48 166.42 16.36 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.379 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.78 136.0 54.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.242 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -124.85 154.06 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.04 -179.48 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.07 -45.04 15.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 110.471 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -23.19 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.526 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 27.07 9.1 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.219 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -82.14 150.91 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.778 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.3 mttt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.555 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 61.3 mt -72.51 89.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 111.285 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 ttp -97.78 117.27 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.339 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.569 HG21 HG11 ' A' ' 82' ' ' VAL . 24.5 t -76.93 157.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.234 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 32.8 m -163.89 150.05 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.79 156.26 51.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.9 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.63 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.32 -50.18 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.962 0.381 . . . . 0.0 110.402 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.439 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.9 tpm_? -62.06 -29.64 70.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.323 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -74.1 -48.63 28.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.626 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -57.93 -28.32 64.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.708 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.91 -65.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.427 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.5 m -58.93 -26.59 64.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.395 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -35.74 137.83 0.44 Allowed Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 49' ' ' PHE . 58.5 Cg_exo -53.21 -32.34 59.72 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.928 2.419 . . . . 0.0 113.357 -179.207 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.18 137.99 18.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.383 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 5.8 ptm180 -141.43 114.84 6.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -89.25 168.2 34.51 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.657 -1.393 . . . . 0.0 111.919 -0.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 73.7 mt -78.07 149.92 77.13 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HG2' ' NH1' ' A' ' 57' ' ' ARG . 27.4 Cg_endo -63.6 -78.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.786 2.324 . . . . 0.0 113.098 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 37.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.294 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -148.33 133.19 18.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.128 0.49 . . . . 0.0 111.967 -179.246 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.1 m -92.11 119.63 31.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.153 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -100.09 157.43 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.608 . . . . 0.0 112.439 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG12 HG22 ' A' ' 76' ' ' VAL . 3.5 t -137.37 138.34 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.333 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.63 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.9 t -114.57 120.32 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.795 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -102.16 118.97 38.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.963 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.93 171.21 17.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.101 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -95.59 -12.47 25.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -62.94 133.03 54.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.885 0.374 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.28 1.69 20.86 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.45 16.63 2.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.963 ' CG ' HG21 ' A' ' 63' ' ' THR . 3.0 t80 -58.5 139.32 55.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.193 0.52 . . . . 0.0 111.955 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.919 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -130.36 173.56 10.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.23 1.014 . . . . 0.0 112.367 178.949 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.11 144.18 20.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -81.52 99.32 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.03 -46.79 2.45 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.2 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 172.84 6.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 0.0 111.657 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.4 t -97.98 139.73 19.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.919 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.8 t -105.96 115.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.116 0.484 . . . . 0.0 111.865 -179.449 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.826 HG21 HG22 ' A' ' 82' ' ' VAL . 25.5 m -125.33 170.16 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.973 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.461 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.9 m170 -120.9 -21.91 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.344 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 t70 -153.54 -175.31 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.102 0.477 . . . . 0.0 111.54 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.8 HG21 ' O ' ' A' ' 105' ' ' ALA . 33.7 t -69.61 -9.48 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.621 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.61 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 109.926 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.706 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.88 -29.96 58.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 76' ' ' VAL . 60.8 t -72.06 -52.45 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.501 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.2 m-85 -55.95 -26.79 49.6 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.986 178.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.92 -45.44 89.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.019 178.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.651 ' CZ ' ' CE1' ' A' ' 89' ' ' HIS . 82.1 t80 -64.08 -54.49 33.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.41 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.579 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.77 -23.14 16.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.315 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 4.1 mmtp -67.28 -46.59 73.17 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -79.21 -2.83 42.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.448 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.651 ' CE1' ' CZ ' ' A' ' 85' ' ' TYR . 69.4 m80 -125.48 62.64 41.3 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.385 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.28 -0.53 5.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.064 2.51 . . . . 0.0 112.904 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -31.22 17.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.965 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 53.9 mt-30 -105.8 156.57 18.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -99.87 164.55 11.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.018 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 HG12 ' A' ' 82' ' ' VAL . 9.0 tp -104.72 111.81 24.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.87 103.43 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.438 ' CD1' HG21 ' A' ' 40' ' ' VAL . 13.1 mm -73.71 132.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.027 0.441 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -104.01 -45.18 4.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.685 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.1 -166.81 39.71 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.695 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.39 -160.99 26.34 Favored Glycine 0 C--N 1.34 0.801 0 O-C-N 122.196 -0.59 . . . . 0.0 112.552 -0.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.05 66.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.73 0.3 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -53.91 -27.45 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.583 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 mm -80.79 -29.0 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 129' ' ' ILE . 5.8 m-85 -59.64 -56.24 24.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.458 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.825 ' HA ' HD13 ' A' ' 129' ' ' ILE . 11.2 t -66.32 -10.16 40.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.8 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.35 -40.28 51.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.653 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.787 ' CD1' HG22 ' A' ' 79' ' ' VAL . 1.7 m-85 -99.59 -5.48 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.35 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.9 pttp -49.5 -31.67 10.6 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.756 0.313 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.25 0.48 53.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.288 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.05 -26.31 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.548 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 106' ' ' PHE . 92.7 t -43.95 127.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.845 0.355 . . . . 0.0 111.55 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 11.3 t70 -105.27 3.72 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.322 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 m -167.6 137.84 2.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.599 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.515 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 9.2 mt -118.78 145.24 45.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.3 0.571 . . . . 0.0 111.819 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.26 113.05 10.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.704 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.6 m -132.58 143.09 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.6 107.05 14.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.433 179.436 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.7 OUTLIER -79.62 100.18 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.19 126.57 30.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.19 -53.14 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.004 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.46 170.68 9.31 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.353 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.2 p -106.78 147.04 30.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.7 m-85 -141.63 139.76 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -110.72 149.04 31.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.009 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.14 -143.4 3.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.554 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.33 21.94 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.6 m -159.99 134.08 7.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -107.37 158.43 17.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.963 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.8 177.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.491 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.4 pp -103.36 154.58 37.66 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.0 102.39 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.74 2.293 . . . . 0.0 112.687 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.9 147.85 22.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.008 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.74 76.25 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.451 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.515 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.9 m95 -57.79 -20.97 39.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.304 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.81 -29.32 63.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.844 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -78.58 -26.93 45.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.1 m-85 -99.16 176.55 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.77 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 m -137.3 141.93 41.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.246 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -80.67 119.02 22.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 -179.652 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.1 m -103.52 -11.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.7 m -171.51 140.35 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.74 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.0 p -167.93 110.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -148.11 120.64 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.814 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.0 m -69.01 145.38 53.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.236 0.541 . . . . 0.0 111.594 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.63 105.21 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.261 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 152' ' ' THR . 18.4 mt-10 -87.61 101.97 14.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.814 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.04 -171.41 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.493 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.7 p -60.19 -57.19 13.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.0 110.685 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.525 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -71.86 124.5 90.98 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.002 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.2 -28.46 86.96 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.961 1.774 . . . . 0.0 112.362 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.9 -21.1 25.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.395 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.5 mt -85.32 7.23 23.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.504 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 153' ' ' HIS . 51.5 m -70.86 166.0 22.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.2 p80 -172.95 159.72 4.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.73 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.814 ' OG1' HG23 ' A' ' 143' ' ' THR . 28.8 m -119.93 147.05 45.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.347 179.24 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -110.29 104.68 13.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.653 0.264 . . . . 0.0 110.827 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.608 ' HB2' HG22 ' A' ' 115' ' ' VAL . 30.9 mt-10 -106.83 124.29 49.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 111.755 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.8 t -116.74 114.12 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.159 179.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.5 m95 -110.03 150.7 28.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.51 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -125.74 115.2 19.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -56.84 131.52 49.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.673 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.57 156.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 178.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.176 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 18.0 m . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.805 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.08 154.9 25.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.457 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.475 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 1.5 m-30 -119.08 113.46 20.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.552 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.866 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.94 117.37 33.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.709 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.3 p90 -162.25 165.41 26.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.827 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 7.9 pt20 -129.99 156.25 44.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.711 ' OD2' HD12 ' A' ' 12' ' ' LEU . 2.6 p30 -103.66 -171.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.506 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.3 -27.66 37.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.082 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -32.89 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.032 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 101.72 46.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.528 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD12 ' OD2' ' A' ' 8' ' ' ASP . 8.9 mt -95.91 163.99 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.827 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 58' ' ' THR . 12.0 mmtt . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 92' ' ' GLN . 62.0 mt -86.48 88.21 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.955 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.432 ' HE3' HG13 ' A' ' 41' ' ' VAL . 1.1 ttp -97.59 118.2 33.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.691 -179.378 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.882 HG21 HG11 ' A' ' 82' ' ' VAL . 3.3 t -89.93 125.11 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.669 HG11 ' CE2' ' A' ' 49' ' ' PHE . 25.5 m -133.89 145.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.309 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.63 156.0 49.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.041 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.758 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.94 -52.89 56.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.479 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -59.56 -35.7 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.105 0.479 . . . . 0.0 110.291 179.154 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.44 HG22 ' CE2' ' A' ' 49' ' ' PHE . 7.3 m -64.72 -50.43 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.162 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -49.15 -34.34 14.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -63.06 -66.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.677 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -49.22 -46.26 45.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.669 ' CE2' HG11 ' A' ' 41' ' ' VAL . 1.9 m-85 -26.13 138.02 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 O-C-N 123.474 0.484 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -35.64 -71.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.947 2.431 . . . . 0.0 112.806 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.37 134.53 46.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 0.0 110.619 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -112.77 125.2 30.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.49 -170.29 7.75 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.627 -1.406 . . . . 0.0 112.026 -0.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.783 HD13 ' HD2' ' A' ' 57' ' ' ARG . 35.9 mt -89.98 151.21 44.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.592 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.04 110.68 3.08 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.596 2.197 . . . . 0.0 113.08 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 68.21 8.25 6.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.783 ' HD2' HD13 ' A' ' 54' ' ' LEU . 6.0 mtt180 -109.45 113.88 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.795 0.331 . . . . 0.0 111.545 -178.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 63.5 m -64.11 109.32 1.79 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.676 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.85 152.57 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.609 HG12 HG22 ' A' ' 76' ' ' VAL . 14.1 t -133.79 130.62 56.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.305 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.758 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.2 t -102.6 130.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.418 . . . . 0.0 111.559 -178.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.833 HD22 HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.63 119.95 40.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.832 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.1 t -150.55 158.38 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.897 0.379 . . . . 0.0 111.36 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -75.41 -11.78 60.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.4 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 26.7 tt0 -88.03 132.74 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.786 0.327 . . . . 0.0 110.774 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 4.3 mp0 -82.8 -21.78 34.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.519 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -91.31 -0.59 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.582 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 63' ' ' THR . 7.2 t80 -59.28 140.83 55.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.108 0.48 . . . . 0.0 111.453 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.97 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -134.31 171.98 13.52 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.442 1.115 . . . . 0.0 113.213 179.563 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.41 139.54 16.5 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.877 -1.965 . . . . 0.0 110.049 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.06 102.01 6.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.9 0.381 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.18 -44.97 1.96 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.826 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 166.7 20.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 85' ' ' TYR . 22.6 t -97.15 140.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.267 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.97 HG21 ' HA ' ' A' ' 69' ' ' GLN . 22.8 t -106.76 118.44 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 112.185 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.863 HG21 HG22 ' A' ' 82' ' ' VAL . 30.8 m -127.54 168.14 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.69 178.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 1.6 m80 -119.86 -23.08 6.55 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.563 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -157.79 -177.33 6.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 111.467 -179.464 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.94 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.7 t -65.45 -11.4 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.615 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.83 -37.24 16.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.236 0.541 . . . . 0.0 109.751 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 84' ' ' ALA . . . -71.17 -34.41 70.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.694 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.882 HG11 HG21 ' A' ' 40' ' ' VAL . 29.2 t -68.38 -54.27 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.981 0.42 . . . . 0.0 109.988 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 5.8 m-85 -51.84 -27.83 13.87 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.933 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -63.05 -45.33 92.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.713 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 74' ' ' VAL . 76.1 t80 -62.76 -53.83 48.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.141 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.81 -22.88 5.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 179.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 8.3 mttt -70.23 -41.54 73.43 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.072 0.463 . . . . 0.0 109.754 178.637 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -81.41 -4.54 56.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.625 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 90.1 m-70 -129.63 62.76 65.13 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.63 -0.35 5.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.174 2.582 . . . . 0.0 112.845 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.75 -30.16 17.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.773 0.32 . . . . 0.0 110.834 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HB2' HD11 ' A' ' 38' ' ' ILE . 1.2 mm100 -103.08 162.09 13.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.094 0.473 . . . . 0.0 111.624 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 7.5 mt-10 -97.69 174.44 6.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.591 HD11 ' CG2' ' A' ' 40' ' ' VAL . 1.1 tp -119.66 113.87 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 111.409 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' MET . 40.1 t -127.59 111.87 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.289 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.506 HD12 ' HB ' ' A' ' 40' ' ' VAL . 8.7 mm -82.62 141.51 14.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.67 -39.88 4.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.402 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.84 -165.48 38.29 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.556 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -80.04 -161.23 23.25 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 117.358 0.579 . . . . 0.0 112.48 -0.099 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.73 -50.88 69.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -57.03 -25.25 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.709 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.833 HD12 HD22 ' A' ' 62' ' ' LEU . 42.2 mm -79.29 -36.89 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.771 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.475 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.3 m-85 -50.81 -56.76 10.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.446 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.763 ' CA ' HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -67.22 -9.65 42.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.713 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.93 -42.25 24.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 110.977 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.94 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.4 m-85 -93.54 -11.53 31.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.244 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.6 OUTLIER -50.34 -28.71 8.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.235 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.12 -8.38 59.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.601 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.53 -23.58 4.39 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 106' ' ' PHE . 90.7 t -44.11 128.99 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.431 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 18.0 t70 -102.51 -12.73 17.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.341 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.805 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 77.9 m -151.61 140.07 20.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.016 -179.149 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.664 HD23 HG11 ' A' ' 110' ' ' VAL . 13.7 mt -119.18 146.05 45.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.279 0.562 . . . . 0.0 111.56 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 113' ' ' LEU . 19.6 mt -135.13 112.66 10.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.549 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.668 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -134.52 144.99 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 111.76 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -109.9 114.42 27.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.361 179.044 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -86.31 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.2 121.67 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.201 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -60.67 -61.72 2.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.224 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.65 -172.19 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.6 p -121.98 157.93 30.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.99 166.39 30.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.78 169.82 3.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . -163.89 135.95 4.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -38.46 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -117.57 137.31 52.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.3 163.34 12.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.014 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -173.16 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.763 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.6 pp -108.39 163.89 15.96 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.29 99.57 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.953 2.435 . . . . 0.0 112.736 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.4 146.02 25.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.074 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.48 80.77 2.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.44 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.4 m95 -60.82 -20.08 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.123 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.53 -30.34 65.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.913 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.46 -27.39 41.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.2 m-85 -97.83 176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.823 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 m -136.13 141.98 44.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.637 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 8.6 ttpt -83.56 116.79 22.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 157' ' ' VAL . 21.1 m -102.34 -18.95 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 157' ' ' VAL . 48.7 m -163.6 141.06 7.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.699 0.285 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.637 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 86.1 p -169.48 106.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -140.77 118.96 12.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.827 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.812 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.4 m -68.71 145.18 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.166 0.508 . . . . 0.0 111.527 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 153' ' ' HIS . 9.0 t -119.61 103.94 14.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.185 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.44 ' HA ' HG23 ' A' ' 152' ' ' THR . 7.3 mt-10 -86.83 103.68 15.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.503 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.2 -174.13 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.448 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.3 p -55.37 -56.62 18.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.722 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.6 OUTLIER -72.73 121.75 85.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.707 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.57 -25.54 79.18 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.035 1.823 . . . . 0.0 112.292 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.14 -19.62 22.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -86.35 8.16 22.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.66 0.267 . . . . 0.0 111.367 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 153' ' ' HIS . 66.0 m -68.79 165.63 19.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.452 ' N ' HG22 ' A' ' 152' ' ' THR . 2.0 p80 -168.99 155.1 6.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.812 ' OG1' HG23 ' A' ' 143' ' ' THR . 21.8 m -118.26 132.21 56.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -94.94 104.42 16.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.843 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -100.8 151.37 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.23 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.84 ' O ' HG22 ' A' ' 139' ' ' VAL . 12.3 t -141.99 107.68 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.825 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 26.8 m95 -108.81 146.07 34.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -126.43 114.41 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.676 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.478 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -52.64 131.09 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.883 -179.436 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -97.45 176.31 5.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.741 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.132 179.985 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.537 HG23 ' HB3' ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.18 145.5 40.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.838 ' CE2' HG21 ' A' ' 110' ' ' VAL . 2.0 m-30 -109.3 112.3 24.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.425 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.992 HD12 HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -112.8 123.96 51.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.757 -179.504 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.622 ' CH2' HG12 ' A' ' 115' ' ' VAL . 7.8 p90 -165.52 164.95 19.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.319 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' ILE . . . -120.77 138.2 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.669 0.271 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -122.41 149.81 43.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 0.0 111.253 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -103.39 -162.96 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -42.04 72.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.53 -27.86 31.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.96 26.28 5.84 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.578 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -79.61 147.59 32.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 110.621 -179.929 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.768 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.1 mttp . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 121.941 0.877 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.575 HG12 HG21 ' A' ' 58' ' ' THR . 6.8 mt -62.76 110.23 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.583 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.685 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.0 ttp -99.17 114.27 26.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.495 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.75 HG21 HG11 ' A' ' 82' ' ' VAL . 11.3 t -87.53 125.55 41.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.57 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 32.3 m -132.2 149.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.158 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.14 158.02 53.61 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.086 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -55.83 -45.39 78.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -63.55 -32.4 73.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 110.477 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 m -72.2 -42.47 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.459 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 11.2 t80 -65.86 -24.41 66.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -66.8 -19.92 65.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.65 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.57 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -34.4 134.44 0.39 Allowed Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.658 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.14 -41.29 58.21 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.936 2.424 . . . . 0.0 113.252 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -151.15 131.29 13.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.341 . . . . 0.0 111.029 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -132.22 125.29 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.028 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 83.6 Cg_endo -90.12 -179.32 12.93 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.137 -0.392 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 65.5 mt -75.88 152.8 84.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.62 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.82 101.7 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.552 2.168 . . . . 0.0 112.959 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 68.46 21.04 8.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.149 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.523 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 3.8 mmt180 -116.63 139.84 50.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.575 HG21 HG12 ' A' ' 38' ' ' ILE . 55.7 m -86.8 115.47 24.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.0 0.429 . . . . 0.0 111.435 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -101.11 156.83 17.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.625 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 12.7 t -137.13 131.74 46.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.545 HG21 ' HB2' ' A' ' 70' ' ' ALA . 90.5 t -105.99 121.93 58.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.085 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -107.29 107.18 17.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.112 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.731 HG21 ' CD2' ' A' ' 68' ' ' TYR . 6.3 t -143.7 164.81 29.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.162 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -79.74 -8.45 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.312 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.0 tp-100 -79.81 124.69 28.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.354 . . . . 0.0 110.489 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 3.3 mt-10 -77.27 -30.38 54.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.93 14.5 28.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.359 . . . . 0.0 111.181 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.783 ' O ' HG11 ' A' ' 75' ' ' VAL . 5.7 t80 -63.18 147.23 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.142 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.663 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.8 mm100 -124.89 174.76 7.74 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.475 1.131 . . . . 0.0 112.868 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.54 143.07 18.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.89 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -66.35 94.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.29 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.59 -20.17 2.31 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.775 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.693 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -76.76 170.85 15.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.12 0.485 . . . . 0.0 112.071 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.95 140.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.456 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 68' ' ' TYR . 24.5 t -103.47 106.98 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.457 . . . . 0.0 111.771 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.799 HG21 HG22 ' A' ' 82' ' ' VAL . 30.7 m -119.67 176.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.051 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 10.6 m170 -128.94 -21.12 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.82 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -155.69 -174.81 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.199 -179.719 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.825 HG21 ' O ' ' A' ' 105' ' ' ALA . 25.2 t -70.02 -11.06 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.67 -38.59 16.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.091 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -68.19 -34.45 76.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.672 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.799 HG22 HG21 ' A' ' 76' ' ' VAL . 20.8 t -69.29 -53.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.599 179.473 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -53.37 -31.03 42.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.062 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.55 -47.03 87.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.198 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 69.0 t80 -60.69 -52.75 63.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.81 -26.26 57.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.609 178.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -66.44 -39.55 88.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.002 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -84.84 -1.13 56.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.148 178.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 42.5 m-70 -124.83 60.34 26.28 Favored Pre-proline 0 N--CA 1.456 -0.142 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.098 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.14 -3.25 5.8 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.866 2.377 . . . . 0.0 112.508 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -100.66 -25.6 14.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.026 179.087 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -98.83 160.13 14.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.328 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -105.9 174.89 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.537 ' HB3' HG23 ' A' ' 1' ' ' THR . 10.0 tp -122.33 110.45 15.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.96 HG12 HD21 ' A' ' 4' ' ' LEU . 17.2 t -124.28 109.69 23.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 40' ' ' VAL . 3.7 mm -82.6 131.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.398 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.473 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.26 -47.31 5.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.718 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.76 -168.1 41.19 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.392 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -90.27 -160.78 36.85 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 117.8 0.8 . . . . 0.0 112.814 0.004 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.64 -57.99 3.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 111.69 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.98 -31.98 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 37.7 mm -80.97 -26.43 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.292 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -61.69 -51.93 66.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.631 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.771 ' HA ' HD13 ' A' ' 129' ' ' ILE . 13.9 t -68.81 -10.01 54.32 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.825 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -73.17 -47.07 46.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.803 ' CD2' HG13 ' A' ' 79' ' ' VAL . 8.0 m-85 -95.11 -2.61 49.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.726 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.575 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 37.4 pttt -54.38 -32.2 56.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -79.63 -8.46 59.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.793 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.05 -18.07 7.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.838 HG21 ' CE2' ' A' ' 3' ' ' PHE . 48.7 t -48.0 134.69 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 4.7 t70 -113.32 6.02 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.199 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 3.7 m -170.58 142.79 2.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.429 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 114' ' ' LEU . 8.3 mt -122.55 144.69 48.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.084 0.468 . . . . 0.0 111.578 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.992 HD12 HD12 ' A' ' 4' ' ' LEU . 22.1 mt -135.22 118.35 16.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.155 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 156' ' ' GLU . 1.2 m -131.54 140.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.819 0.342 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.22 121.99 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.26 101.4 10.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.661 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.578 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.8 mp -83.82 134.98 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.59 -51.99 61.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.63 170.95 9.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.0 p -105.76 170.72 7.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.1 m-85 -148.0 168.75 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.015 0.436 . . . . 0.0 111.279 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -114.1 146.89 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.315 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.449 ' O ' HD11 ' A' ' 12' ' ' LEU . . . 168.85 176.9 39.34 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.674 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.67 62.3 1.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.649 HG22 HD11 ' A' ' 13' ' ' ILE . 4.5 m -164.14 124.46 2.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.19 164.98 13.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.4 ' SD ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -76.75 -177.69 4.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.771 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -103.53 165.1 14.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.301 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.9 102.66 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.665 2.244 . . . . 0.0 112.071 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.4 HD12 ' SD ' ' A' ' 128' ' ' MET . 1.8 mt -90.26 148.24 23.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.73 78.96 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -61.23 -19.53 61.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.71 -32.92 66.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.652 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 4.5 t70 -81.72 -18.49 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 113' ' ' LEU . 62.7 m-85 -106.32 167.14 10.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.483 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.515 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -131.05 141.19 50.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.571 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.9 ttpm? -82.73 113.9 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.662 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 157' ' ' VAL . 35.3 m -97.41 -25.79 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.563 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -156.06 140.55 16.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.882 0.373 . . . . 0.0 111.184 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.571 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 53.4 p -166.15 105.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.753 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.589 ' C ' HG23 ' A' ' 154' ' ' THR . 7.2 ttt85 -146.07 129.83 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.755 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -77.54 146.72 36.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.767 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 152' ' ' THR . 6.1 t -117.32 104.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.363 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.77 104.7 16.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.133 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.57 -172.96 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.442 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 60.9 p -55.69 -58.48 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.589 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.658 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 10.2 t30 -76.6 136.01 67.99 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.841 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.21 -34.38 68.43 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.986 1.79 . . . . 0.0 112.686 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.74 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.487 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.3 mt -77.65 10.31 2.78 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 144' ' ' VAL . 57.4 m -85.44 159.91 19.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.08 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.578 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -173.46 160.55 3.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.755 ' OG1' HG23 ' A' ' 143' ' ' THR . 17.2 m -122.3 144.69 48.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.71 179.161 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.88 105.22 13.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.69 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.9 mt-10 -99.2 121.33 40.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.902 0.382 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.742 ' O ' HG22 ' A' ' 139' ' ' VAL . 18.1 t -116.2 111.62 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.499 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 32.1 m95 -106.13 148.62 27.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.959 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -129.68 123.86 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.225 179.062 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -51.45 128.82 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.542 -179.343 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.515 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.16 -173.82 2.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.758 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.125 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.542 0.21 . . . . 0.0 110.491 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.61 149.3 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.348 0.594 . . . . 0.0 112.438 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.486 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.5 m-30 -116.68 113.0 22.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.873 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.58 118.57 36.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 112.014 -179.486 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.792 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.4 p90 -164.09 174.51 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.12 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -128.42 135.17 49.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 111.673 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.0 pt20 -132.82 154.64 50.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 15.5 p-10 -107.55 -167.62 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -40.95 68.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -28.97 47.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.05 19.51 11.66 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.754 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 126' ' ' THR . 3.8 mt -70.97 175.73 4.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.168 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mttm . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.82 90.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ttp -102.69 121.59 42.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.932 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.734 HG13 ' HB ' ' A' ' 60' ' ' VAL . 9.7 t -89.55 131.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.731 HG11 ' HE2' ' A' ' 49' ' ' PHE . 21.6 m -132.28 142.06 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.184 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.94 156.83 43.5 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.095 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.64 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.3 -52.61 58.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.858 0.329 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -60.21 -34.25 73.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.075 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -67.65 -45.5 75.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 33.1 t80 -59.46 -27.27 65.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.5 -66.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.725 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -52.44 -30.37 29.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.925 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -37.05 122.34 0.83 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.935 -179.511 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 64.3 Cg_exo -42.91 -27.24 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.233 2.622 . . . . 0.0 113.729 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.62 148.92 28.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 111.236 -179.055 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.15 107.76 6.23 Favored Pre-proline 0 CA--C 1.533 0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.5 Cg_endo -88.43 178.78 18.39 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.158 -0.15 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 49' ' ' PHE . 10.6 mt -76.64 155.33 83.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.36 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.421 ' HD2' HD23 ' A' ' 54' ' ' LEU . 9.7 Cg_endo -52.98 -74.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.703 2.268 . . . . 0.0 112.385 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -113.38 50.64 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.104 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -142.47 101.49 3.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.987 -179.618 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.3 m -62.16 113.52 2.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.169 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.508 HD21 HD12 ' A' ' 54' ' ' LEU . 2.0 m-80 -107.74 148.34 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.431 0.634 . . . . 0.0 112.348 -178.263 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.751 HG12 HG22 ' A' ' 76' ' ' VAL . 21.8 t -122.86 139.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.389 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 43' ' ' ARG . 92.7 t -108.34 124.02 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.845 -178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.711 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -101.41 117.98 36.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.852 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.48 162.15 41.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.727 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -83.0 -8.57 59.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 48.9 tt0 -85.13 131.19 34.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 111.057 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -25.21 42.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.59 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -94.74 5.17 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.753 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.852 ' CG ' HG21 ' A' ' 63' ' ' THR . 5.9 t80 -58.98 148.05 32.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.023 0.439 . . . . 0.0 111.088 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.856 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -136.15 174.85 10.16 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.201 1.001 . . . . 0.0 112.848 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.87 145.0 21.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.793 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -74.65 95.91 2.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.311 . . . . 0.0 110.314 179.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.2 -34.95 3.18 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.305 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.558 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.76 169.64 14.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG11 ' CD1' ' A' ' 85' ' ' TYR . 5.1 t -96.69 140.65 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.331 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.856 HG21 ' HA ' ' A' ' 69' ' ' GLN . 20.1 t -107.63 118.54 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.186 0.517 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.896 HG21 HG22 ' A' ' 82' ' ' VAL . 35.6 m -128.44 171.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.839 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -122.38 -22.43 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.55 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 t70 -158.15 -175.65 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.051 0.453 . . . . 0.0 111.08 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.97 HG13 ' CD2' ' A' ' 106' ' ' PHE . 9.4 t -65.66 -11.34 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.72 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.49 16.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.15 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.68 -29.36 63.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.613 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.896 HG22 HG21 ' A' ' 76' ' ' VAL . 25.1 t -70.99 -52.63 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.443 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.6 m-85 -54.18 -26.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.586 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -65.34 -44.07 88.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.956 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.531 ' CD1' HG11 ' A' ' 74' ' ' VAL . 88.3 t80 -66.7 -56.6 9.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.367 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.57 -23.65 17.69 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.561 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.05 -39.75 78.98 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.723 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -83.73 -5.45 59.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.403 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -129.54 64.92 73.31 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.22 1.08 3.78 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.424 2.749 . . . . 0.0 113.001 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 -33.4 25.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.969 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.5 160.72 15.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 111.621 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -98.43 156.48 16.73 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.788 HD11 HG12 ' A' ' 82' ' ' VAL . 7.7 tp -96.29 115.08 26.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.349 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.55 114.55 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.2 mm -81.77 139.43 17.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.068 0.461 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.479 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -108.55 -46.1 3.74 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.51 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.87 -170.4 43.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.317 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.93 36.82 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 117.409 0.605 . . . . 0.0 112.605 0.018 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.38 -45.93 36.39 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -58.74 -34.34 71.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.711 ' CD1' HD22 ' A' ' 62' ' ' LEU . 28.7 mm -82.28 -29.51 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.1 m-85 -57.67 -57.13 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.661 -179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.741 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.2 t -67.47 -9.61 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.648 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.47 -44.45 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.0 111.302 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.97 ' CD2' HG13 ' A' ' 79' ' ' VAL . 16.2 m-85 -91.82 -7.95 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.524 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -52.21 -31.18 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 110.918 179.869 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 107' ' ' LYS . 1.5 t0 -75.35 -10.99 59.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.554 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -122.41 -19.77 6.31 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.857 HG11 HD23 ' A' ' 113' ' ' LEU . 75.8 t -45.18 120.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.44 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.421 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 19.4 t70 -100.3 -3.9 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.269 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 49.7 m -160.07 141.91 12.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.088 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.857 HD23 HG11 ' A' ' 110' ' ' VAL . 7.3 mt -123.29 147.62 46.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.248 0.547 . . . . 0.0 111.859 -179.161 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.76 113.58 11.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.387 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.792 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.3 m -129.65 140.94 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -110.57 106.76 16.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.507 179.502 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 35.8 mtp180 -80.06 98.64 7.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.2 mp -81.86 122.67 28.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.29 -66.81 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.51 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.65 162.9 5.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.604 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 p -95.1 168.16 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.899 0.381 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 3.4 m-85 -138.76 160.42 39.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.48 139.76 53.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.131 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.44 -146.41 5.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.634 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.86 -29.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.508 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.494 ' O ' HD23 ' A' ' 12' ' ' LEU . 5.6 m -108.9 137.98 45.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -178.71 3.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -73.75 159.17 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.741 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.16 156.23 48.96 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.269 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.36 100.83 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.725 2.283 . . . . 0.0 112.459 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.8 149.14 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 69.11 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.03 0.443 . . . . 0.0 110.709 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.547 ' HH2' HG11 ' A' ' 115' ' ' VAL . 89.9 m95 -55.22 -22.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -31.57 66.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 110.662 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -80.81 -20.06 43.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.937 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.581 ' CD1' HD11 ' A' ' 113' ' ' LEU . 94.1 m-85 -104.26 168.71 8.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.075 0.464 . . . . 0.0 111.29 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.634 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -130.54 142.56 50.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.929 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 6.1 ttpt -81.97 115.03 20.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.4 m -101.59 -17.43 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.603 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.3 m -165.93 140.64 4.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 110.969 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.2 p -165.71 112.87 0.93 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.404 ' C ' HG23 ' A' ' 154' ' ' THR . 7.7 ttt85 -147.85 121.03 8.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.84 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.81 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.6 m -73.54 144.45 46.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.176 0.512 . . . . 0.0 111.916 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 155' ' ' TYR . 6.5 t -117.3 105.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.968 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.438 ' HA ' HG23 ' A' ' 152' ' ' THR . 47.8 mt-10 -90.48 103.36 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.949 -178.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -169.7 2.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.352 179.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.6 p -60.23 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.931 0.396 . . . . 0.0 110.467 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.505 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -67.43 118.61 58.43 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.83 -25.48 61.65 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.887 1.725 . . . . 0.0 112.377 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.42 -20.27 25.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.147 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 mt -86.41 8.88 19.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.71 0.29 . . . . 0.0 111.106 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 153' ' ' HIS . 55.1 m -72.4 168.4 18.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.947 0.403 . . . . 0.0 110.001 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.49 ' N ' HG22 ' A' ' 152' ' ' THR . 1.5 p80 -173.52 160.18 3.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.038 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.81 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.6 m -122.04 145.41 48.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.772 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 144' ' ' VAL . 29.6 m-85 -106.41 104.64 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.767 0.318 . . . . 0.0 110.441 179.331 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.587 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.4 mt-10 -109.08 127.54 54.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.974 0.416 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.772 ' O ' HG22 ' A' ' 139' ' ' VAL . 25.0 t -117.35 114.02 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.557 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.475 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.3 m95 -108.4 148.14 30.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.123 -179.496 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.455 ' CD ' HG11 ' A' ' 139' ' ' VAL . 24.7 mt-30 -125.49 112.21 15.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -49.32 133.33 19.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.214 0.531 . . . . 0.0 112.259 -179.405 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.634 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 32.6 mtmt -108.48 -178.47 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.786 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.995 -179.875 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 25.4 m . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.3 151.14 30.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.669 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -116.1 111.8 20.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.346 178.933 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.746 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.31 122.81 48.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.42 0.628 . . . . 0.0 112.351 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.808 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.8 p90 -168.61 168.8 10.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.674 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.55 133.28 52.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -129.07 164.27 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.137 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.442 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -110.18 -171.62 1.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -54.96 -30.42 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.407 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -87.4 -32.22 19.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.903 -179.95 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.25 36.01 3.23 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.651 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.577 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -93.39 145.92 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.772 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 126' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.409 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 92' ' ' GLN . 7.0 mmtp . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.455 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 52.9 mt -79.06 88.29 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.237 0.471 . . . . 0.0 111.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.1 ttp -96.13 120.13 35.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.403 -179.031 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.4 t -81.23 153.42 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 40' ' ' VAL . 28.2 m -161.87 146.42 4.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.58 155.47 51.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.841 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.496 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.6 -51.33 56.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.938 0.369 . . . . 0.0 110.889 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 44' ' ' ARG . 5.4 tpp180 -60.14 -31.91 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -73.5 -43.4 60.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.612 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 52' ' ' ARG . 24.5 t80 -61.94 -29.24 70.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.8 -66.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.2 p -48.21 -37.08 15.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.357 -179.652 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' HG11 ' A' ' 41' ' ' VAL . 2.7 m-30 -37.68 149.42 0.19 Allowed Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.492 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.52 -73.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.503 2.135 . . . . 0.0 112.305 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.16 167.42 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.0 111.003 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 45.4 mtp180 -129.13 111.28 18.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.959 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 66.9 Cg_endo -89.5 -171.33 5.88 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.173 -0.09 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 74.7 mt -80.53 158.96 70.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.236 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 58.2 Cg_endo -72.2 107.16 2.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.531 2.154 . . . . 0.0 113.445 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 74.12 4.4 4.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.27 178.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.55 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 15.6 mtt180 -112.6 116.41 30.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 0.0 111.542 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 43.1 m -73.11 111.4 8.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.449 HD21 HD12 ' A' ' 54' ' ' LEU . 3.3 m-80 -98.92 156.94 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.247 0.546 . . . . 0.0 112.195 -178.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 76' ' ' VAL . 7.1 t -137.05 132.17 46.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.16 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 43' ' ' ARG . 88.6 t -104.61 128.39 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.717 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -107.65 125.33 51.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.504 -179.896 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.6 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -165.68 150.46 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 179.618 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.427 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 21.5 t-80 -74.43 -2.68 26.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.702 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.869 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.0 tp-100 -70.95 133.61 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -88.57 -3.23 58.85 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 65' ' ' GLN . 4.9 m-20 -128.25 5.98 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.569 0.223 . . . . 0.0 111.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.869 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.0 t80 -59.93 141.8 54.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.236 0.541 . . . . 0.0 111.968 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.862 ' HA ' HG21 ' A' ' 75' ' ' VAL . 20.5 mm-40 -127.11 178.45 6.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.08 0.943 . . . . 0.0 112.104 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.46 144.53 19.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.607 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -76.96 96.36 4.35 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.338 179.199 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.88 -40.15 3.09 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.961 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -68.61 168.46 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.732 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 60' ' ' VAL . 15.6 t -96.88 140.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.862 HG21 ' HA ' ' A' ' 69' ' ' GLN . 40.2 t -100.09 107.32 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 0.0 112.314 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.81 HG21 HG22 ' A' ' 82' ' ' VAL . 27.1 m -117.68 161.59 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.026 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.67 -22.45 11.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.231 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.878 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -161.38 -168.86 2.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.174 0.512 . . . . 0.0 111.594 -179.153 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.858 HG13 ' CD2' ' A' ' 106' ' ' PHE . 3.1 t -70.3 -10.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.539 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.87 -37.35 16.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.212 0.53 . . . . 0.0 109.768 178.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.93 -32.95 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.757 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.811 HG12 HD11 ' A' ' 94' ' ' LEU . 24.3 t -70.0 -51.71 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.4 m-85 -56.33 -27.42 55.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.334 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -64.54 -44.83 89.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 179.11 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.27 -54.07 43.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.974 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -58.07 -22.84 52.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.899 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.21 -30.11 63.28 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.22 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.411 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 5.9 mt-30 -92.95 -13.0 29.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.33 178.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -125.16 65.03 47.42 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.433 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.8 0.17 5.3 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.258 2.638 . . . . 0.0 113.018 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.02 -41.42 35.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -100.51 165.89 11.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.092 0.472 . . . . 0.0 111.669 -179.436 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -98.4 170.38 8.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.034 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.974 HD12 ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -118.58 114.21 22.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.445 -179.465 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.46 113.29 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.308 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 5.7 mm -79.11 135.1 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.01 0.433 . . . . 0.0 111.183 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -110.27 -41.3 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.209 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.55 -169.7 41.88 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.738 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.3 -160.74 36.32 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 122.103 -0.645 . . . . 0.0 112.558 -0.151 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.49 60.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.669 0.271 . . . . 0.0 111.203 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 -60.19 -30.49 69.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.8 mm -76.88 -26.27 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.936 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 3.5 m-85 -62.58 -58.01 9.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.704 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.501 ' CA ' HD13 ' A' ' 129' ' ' ILE . 8.9 t -67.63 -10.27 50.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.688 -0.633 . . . . 0.0 111.751 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.56 -37.7 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.888 ' O ' HG23 ' A' ' 110' ' ' VAL . 2.8 m-85 -101.36 -3.17 29.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.503 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.49 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 20.2 pttp -49.84 -32.5 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.73 0.3 . . . . 0.0 111.486 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -92.5 1.59 57.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.651 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.662 ' CB ' HG11 ' A' ' 79' ' ' VAL . 2.5 m-20 -122.0 -26.87 4.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.705 0.288 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 106' ' ' PHE . 58.6 t -48.96 128.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 5.5 t70 -100.99 -7.38 23.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.734 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.3 m -156.21 140.29 16.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 HG11 ' A' ' 110' ' ' VAL . 11.5 mt -120.29 144.71 47.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.184 0.516 . . . . 0.0 111.674 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 113' ' ' LEU . 9.5 mt -135.61 117.02 14.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.805 179.149 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.808 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -134.94 144.83 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 111.663 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.57 109.85 18.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.435 179.319 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -93.45 103.64 15.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.548 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 1.2 mt -91.32 130.97 37.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.182 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -49.96 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.4 156.16 39.04 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.313 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 86.2 p -101.26 142.97 31.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -123.03 156.55 34.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -113.27 134.83 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.996 0.427 . . . . 0.0 111.409 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.577 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -158.34 -162.44 11.83 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.392 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 8.36 3.02 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.404 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.5 m -120.3 109.93 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.798 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -92.38 142.48 27.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -178.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.501 HD13 ' CA ' ' A' ' 104' ' ' THR . 2.3 pp -111.75 158.68 35.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 129' ' ' ILE . 31.2 Cg_exo -59.14 135.46 66.2 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.709 2.273 . . . . 0.0 112.281 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.419 HD11 ' CH2' ' A' ' 5' ' ' TRP . 3.8 mt -120.53 143.4 48.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.129 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 79.56 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -63.53 -15.03 56.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -33.46 62.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.996 0.426 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.6 t70 -83.18 -16.09 47.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.334 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.532 ' CD2' HD11 ' A' ' 113' ' ' LEU . 66.3 m-85 -106.9 164.47 12.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.813 0.34 . . . . 0.0 111.027 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.423 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -125.6 140.87 52.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -85.06 114.56 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.677 179.654 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 157' ' ' VAL . 16.0 m -101.74 -18.96 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.52 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.69 139.98 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.398 . . . . 0.0 111.248 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -168.75 106.87 0.45 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.331 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -142.55 122.11 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.367 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.1 m -72.82 145.8 46.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.316 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 152' ' ' THR . 4.7 t -114.99 103.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 178.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 99.23 11.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.471 -179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.84 -177.66 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.7 p -54.33 -54.51 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -73.45 124.28 90.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.947 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 -29.53 89.33 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.124 1.882 . . . . 0.0 112.268 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.99 -18.52 28.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.801 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.5 mt -86.03 10.45 14.19 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 153' ' ' HIS . 55.1 m -74.69 166.15 24.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -172.15 158.94 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.218 179.7 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 143' ' ' THR . 33.4 m -123.06 133.76 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -98.77 107.86 20.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.551 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.3 mt-10 -97.17 149.69 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.081 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 139' ' ' VAL . 16.7 t -141.28 106.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.003 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.49 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 24.2 m95 -110.15 146.24 35.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.0 111.779 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -128.11 119.79 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.159 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 7.7 tttm -46.44 129.0 10.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.735 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 1.6 ptpt -109.28 -176.85 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.816 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.145 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.16 154.6 23.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 96' ' ' ILE . 0.8 OUTLIER -121.53 114.56 21.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.226 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.88 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.73 122.9 47.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.47 0.652 . . . . 0.0 112.466 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.778 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.7 p90 -164.12 165.15 22.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.189 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.39 136.06 53.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.361 . . . . 0.0 111.737 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -125.89 144.26 50.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.518 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.9 p30 -98.41 -169.29 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.489 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -49.46 -49.27 46.1 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.175 0.512 . . . . 0.0 110.59 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -29.24 63.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.288 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.02 31.09 6.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.758 HD23 ' N ' ' A' ' 13' ' ' ILE . 7.5 tt -83.43 167.9 17.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.592 0.235 . . . . 0.0 110.618 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.758 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -128.22 -64.59 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.348 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.64 ' H ' HD12 ' A' ' 13' ' ' ILE . . . -157.4 -163.59 12.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.642 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -105.64 168.64 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 0.0 110.917 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.93 -36.79 6.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.99 62.58 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.662 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.34 -43.14 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 110.659 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 62.92 51.19 1.45 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.55 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 42.8 Cg_endo -76.51 -67.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.103 1.869 . . . . 0.0 111.979 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.572 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 0.0 OUTLIER 175.82 164.43 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.395 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -123.15 145.61 48.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.843 0.354 . . . . 0.0 111.022 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.14 150.21 60.57 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.29 -39.89 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.574 2.183 . . . . 0.0 112.676 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -75.09 -43.14 54.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.294 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.89 -18.03 60.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.475 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 tp -84.62 -36.24 22.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.161 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -59.03 -39.59 82.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.243 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.62 -41.4 62.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.198 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -51.41 -39.31 57.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.238 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.918 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.54 -57.48 2.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.683 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.497 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -46.17 -24.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HB3' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -52.63 -56.33 16.15 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.504 ' OG1' ' HB ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -121.81 3.62 10.02 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.918 HG13 ' O ' ' A' ' 31' ' ' ARG . 9.4 m -47.34 162.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.7 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 77.85 9.88 86.61 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.963 -0.91 . . . . 0.0 115.09 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -152.12 -164.62 2.01 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.654 1.727 . . . . 0.0 109.081 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 68.0 mt -77.82 89.29 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.854 0.359 . . . . 0.0 111.813 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HG3' ' CG2' ' A' ' 34' ' ' THR . 9.6 ttp -99.4 120.81 40.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.667 HG21 HG11 ' A' ' 82' ' ' VAL . 40.3 t -79.82 158.36 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 111.646 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.5 m -161.67 149.93 4.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.89 149.35 44.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.846 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.824 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -48.22 -52.4 21.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.116 0.458 . . . . 0.0 110.119 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.459 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -56.34 -34.64 66.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.251 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.56 HG22 ' CE2' ' A' ' 49' ' ' PHE . 4.0 m -70.36 -54.8 11.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.131 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 35.7 t80 -50.39 -28.06 7.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.457 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -66.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -57.5 -30.41 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.591 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.718 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -36.42 133.69 0.61 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.705 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 47.7 Cg_exo -38.99 -29.12 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.394 2.729 . . . . 0.0 113.766 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -162.19 152.31 16.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 111.197 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.52 108.9 10.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 88.1 Cg_endo -82.22 -179.09 22.9 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.364 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 49' ' ' PHE . 51.0 mt -82.23 145.82 53.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.774 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.402 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 56.1 Cg_endo -70.65 109.66 2.54 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.419 2.079 . . . . 0.0 112.236 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.468 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 2.9 mt-10 77.55 14.68 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.8 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -132.89 112.63 12.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.638 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 46.6 m -70.51 113.03 7.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.083 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.604 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -103.38 156.66 17.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.305 0.574 . . . . 0.0 112.079 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 76' ' ' VAL . 21.6 t -133.29 141.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.152 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.824 HG13 ' HA ' ' A' ' 43' ' ' ARG . 59.9 t -109.05 123.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.916 0.388 . . . . 0.0 111.351 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.506 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -105.62 120.12 40.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.829 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.8 t -153.6 155.77 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.5 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.861 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.2 tt0 -74.12 134.05 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.97 1.83 53.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.672 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -127.79 3.6 6.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.61 0.243 . . . . 0.0 111.503 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.886 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.0 t80 -57.1 137.82 55.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 111.419 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.934 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -130.39 173.39 10.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.218 1.008 . . . . 0.0 112.613 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.52 143.3 19.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.576 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.4 101.16 7.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.791 0.329 . . . . 0.0 110.336 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.46 -40.92 2.9 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.749 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.16 166.89 18.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.551 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.13 140.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.934 HG21 ' HA ' ' A' ' 69' ' ' GLN . 15.0 t -109.3 117.66 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.924 HG21 HG22 ' A' ' 82' ' ' VAL . 26.9 m -126.96 167.36 21.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.426 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -116.82 -22.33 8.6 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.685 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -155.64 -173.62 4.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.622 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.943 HG13 ' CD2' ' A' ' 106' ' ' PHE . 19.3 t -69.72 -9.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.728 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.64 -34.72 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.443 . . . . 0.0 110.107 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.24 -30.81 62.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.991 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.924 HG22 HG21 ' A' ' 76' ' ' VAL . 23.1 t -73.52 -49.39 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 109.998 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.438 ' CE2' HG12 ' A' ' 79' ' ' VAL . 5.7 m-85 -57.08 -28.02 62.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.909 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.29 -42.22 88.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.039 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.89 -56.23 12.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.16 -22.8 30.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.976 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.72 -41.73 71.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -83.82 -10.02 58.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.546 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -123.71 64.73 32.27 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.59 -0.8 6.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.044 2.496 . . . . 0.0 112.756 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.54 26.95 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -99.4 163.57 12.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.454 . . . . 0.0 111.457 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.98 159.76 14.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.571 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.527 HD11 ' CG1' ' A' ' 82' ' ' VAL . 51.4 tp -113.52 113.58 25.33 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.837 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.504 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 30.3 t -134.54 121.59 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.679 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.512 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 17.6 mm -81.0 132.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.06 0.457 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -96.9 -50.55 4.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.067 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.09 -169.35 42.46 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.425 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.75 -160.78 36.47 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 117.635 0.717 . . . . 0.0 112.493 -0.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.57 -48.76 19.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.765 0.317 . . . . 0.0 111.301 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.8 -32.46 52.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.122 0.487 . . . . 0.0 110.403 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.506 ' CD1' HD22 ' A' ' 62' ' ' LEU . 45.8 mm -85.23 -27.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.205 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -60.67 -57.46 12.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.751 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' ' 129' ' ' ILE . 1.6 t -66.81 -9.97 42.84 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.93 -0.481 . . . . 0.0 112.263 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.747 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.34 -39.87 62.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.943 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.9 m-85 -101.36 -3.18 29.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.767 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 104' ' ' THR . 1.8 pttt -49.16 -32.52 10.33 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -0.73 57.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.2 m-20 -120.48 -26.9 5.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.342 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.801 HG11 HD23 ' A' ' 113' ' ' LEU . 62.7 t -50.11 126.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.59 -12.65 19.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.04 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 95.9 m -148.28 141.79 25.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.523 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.801 HD23 HG11 ' A' ' 110' ' ' VAL . 12.9 mt -123.62 146.78 47.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.262 0.554 . . . . 0.0 111.743 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.0 mt -135.55 116.97 14.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.778 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -131.71 141.95 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.427 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.41 99.25 7.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.608 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -75.53 100.06 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.384 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mt -84.66 126.54 33.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.325 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.11 -43.51 82.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.208 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.85 167.55 48.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.514 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.2 p -101.2 150.79 22.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 111.0 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -130.37 149.32 52.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 167.38 15.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.421 . . . . 0.0 111.318 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.43 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . 146.69 164.67 11.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.89 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -1.29 12.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.503 0.192 . . . . 0.0 111.316 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.49 HG22 HD11 ' A' ' 13' ' ' ILE . 3.7 m -109.22 128.65 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -105.24 164.07 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.54 147.4 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.1 pt -71.14 164.39 57.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.27 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.61 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.0 Cg_endo -74.92 102.9 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.357 2.038 . . . . 0.0 112.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -88.1 144.35 26.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.54 70.49 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.302 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.443 ' HH2' HG11 ' A' ' 115' ' ' VAL . 85.2 m95 -55.04 -24.98 27.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.292 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -30.3 65.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 0.0 110.474 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -80.32 -25.65 39.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 85.5 m-85 -100.26 176.58 5.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.772 0.32 . . . . 0.0 110.43 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -137.09 140.71 42.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.531 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.2 ttpm? -79.93 114.81 19.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.886 HG22 ' O ' ' A' ' 157' ' ' VAL . 17.1 m -97.64 -19.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -164.11 140.76 6.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.5 p -163.75 112.65 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.036 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.442 ' C ' HG23 ' A' ' 154' ' ' THR . 5.8 ttt-85 -148.1 125.34 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.662 HG23 ' OG1' ' A' ' 154' ' ' THR . 3.5 m -79.24 145.72 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 152' ' ' THR . 5.0 t -119.2 103.5 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -84.49 99.81 10.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 -179.92 7.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.4 p -53.41 -46.98 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 110.581 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.504 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -79.11 124.27 84.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.368 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.96 -29.44 89.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 112.599 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.37 -18.75 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.2 mt -83.94 7.06 19.5 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.579 0.228 . . . . 0.0 111.466 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 91.1 m -71.07 164.91 24.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -171.05 157.63 5.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.603 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.662 ' OG1' HG23 ' A' ' 143' ' ' THR . 45.1 m -123.2 126.56 47.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.588 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.22 105.44 17.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.75 ' HB2' HG22 ' A' ' 115' ' ' VAL . 75.3 mt-10 -106.37 124.61 49.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.196 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.886 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.8 t -116.55 113.68 43.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.259 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.531 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 20.2 m95 -108.62 150.23 27.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.937 0.399 . . . . 0.0 111.481 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.593 ' OE1' HG11 ' A' ' 139' ' ' VAL . 29.1 mt-30 -127.51 119.0 25.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -57.08 130.8 47.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -104.37 -176.06 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.137 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 52.2 m . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.68 151.11 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 96' ' ' ILE . 1.4 m-30 -118.03 107.8 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.212 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -106.36 124.78 50.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.332 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.58 ' CZ2' HG12 ' A' ' 115' ' ' VAL . 6.0 p90 -168.38 174.24 7.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.4 137.79 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.5 pt20 -119.26 156.57 29.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 111.332 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 121' ' ' SER . 45.3 t0 -102.58 169.06 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.23 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.11 -30.04 6.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.929 0.395 . . . . 0.0 110.568 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -89.02 -27.51 20.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.0 22.15 6.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.714 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.2 tt -77.27 166.46 23.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.633 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG22 ' HD1' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -131.59 -51.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.466 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.48 -167.13 39.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.585 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -92.9 -172.78 3.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 110.795 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.98 20.07 7.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.33 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.78 96.61 2.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.581 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -149.28 -36.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.651 0.262 . . . . 0.0 111.316 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 mt 65.72 69.34 0.62 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.44 -167.97 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.555 2.17 . . . . 0.0 112.277 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -66.18 93.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -87.6 144.75 26.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.011 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mt -105.05 158.11 32.78 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.782 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.52 1.52 8.35 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.664 2.243 . . . . 0.0 113.019 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -85.57 -37.54 19.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.698 0.285 . . . . 0.0 111.268 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.17 -57.43 2.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.277 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -40.49 -35.19 0.42 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.195 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.94 -32.31 72.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.366 . . . . 0.0 111.438 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -81.3 -40.77 23.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -68.64 -40.88 80.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.902 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.851 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -63.39 -61.88 2.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.749 0.309 . . . . 0.0 111.772 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.58 -23.12 5.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -91.01 -6.46 53.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.653 HG23 ' HG ' ' A' ' 4' ' ' LEU . 37.4 p -146.0 24.99 1.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.851 HG13 ' O ' ' A' ' 31' ' ' ARG . 20.6 m -108.3 150.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.73 29.01 57.73 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 116.827 1.491 . . . . 0.0 116.827 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 5.5 mttp -145.74 -166.47 2.46 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.419 2.109 . . . . 0.0 108.732 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 54.2 mt -86.88 88.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 O-C-N 122.012 -0.43 . . . . 0.0 110.768 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 5.6 ttp -100.13 119.12 37.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.58 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 82' ' ' VAL . 2.7 t -87.53 128.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG11 ' CE2' ' A' ' 49' ' ' PHE . 19.1 m -132.43 154.94 40.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.378 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 162.13 53.79 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.843 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.694 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -58.5 -50.01 75.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.984 0.392 . . . . 0.0 110.654 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 tpt180 -61.03 -35.96 78.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 110.297 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 -50.41 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.387 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.3 t80 -52.59 -25.09 9.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -69.63 -65.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -28.07 61.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.33 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.62 ' CE2' HG11 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -37.69 136.86 0.72 Allowed Pre-proline 0 N--CA 1.467 0.404 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.779 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.17 -30.47 25.64 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.802 2.335 . . . . 0.0 113.074 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -159.34 151.96 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -140.98 110.93 6.61 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HG3' ' O ' ' A' ' 71' ' ' GLN . 10.9 Cg_exo -81.35 178.54 31.02 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.585 -1.423 . . . . 0.0 111.996 -0.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.566 HD13 ' HE ' ' A' ' 57' ' ' ARG . 31.8 mt -83.16 156.0 66.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 38.5 Cg_endo -67.15 107.42 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.404 2.069 . . . . 0.0 112.875 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.6 mm-40 70.74 4.75 5.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.566 ' HE ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -108.51 122.92 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.938 0.399 . . . . 0.0 111.411 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 92.4 m -75.13 117.02 16.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.158 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.414 HD21 HD12 ' A' ' 54' ' ' LEU . 3.3 m-80 -105.58 156.04 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.445 . . . . 0.0 112.015 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 24.6 t -136.97 137.42 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.337 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.694 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.6 t -107.76 126.59 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 0.0 111.323 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.637 ' HG ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -107.65 117.2 33.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.969 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.813 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.3 t -148.43 161.36 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.959 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -79.08 -11.42 59.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.452 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.4 tp-100 -82.35 134.03 35.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.535 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 52.8 mt-10 -84.01 -29.63 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.636 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.85 2.24 54.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.159 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.875 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.2 t80 -58.83 139.5 56.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.926 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.3 mt-30 -128.7 174.37 9.49 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.219 1.009 . . . . 0.0 112.447 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.13 144.32 21.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.847 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 13.6 mt-30 -73.52 96.85 2.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.362 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.36 -37.01 3.15 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.645 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.12 171.51 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 112.024 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 60' ' ' VAL . 13.8 t -97.78 140.35 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.467 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.926 HG21 ' HA ' ' A' ' 69' ' ' GLN . 38.9 t -106.95 104.77 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.24 0.543 . . . . 0.0 112.281 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.867 HG21 HG22 ' A' ' 82' ' ' VAL . 23.6 m -117.44 166.93 11.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.366 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.406 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 3.8 m80 -121.91 -19.89 6.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.307 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.8 t70 -155.65 -178.87 7.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.209 0.528 . . . . 0.0 111.602 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.718 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.8 t -66.29 -8.97 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.767 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.73 -35.02 16.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.487 . . . . 0.0 109.869 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.91 -32.93 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.903 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.867 HG22 HG21 ' A' ' 76' ' ' VAL . 39.9 t -70.73 -49.99 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.561 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.2 m-85 -55.79 -26.24 45.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.897 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -65.61 -43.76 88.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.026 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.07 -57.14 8.39 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.96 14.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.467 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.03 -36.72 80.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 -2.59 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.222 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -128.56 68.28 77.77 Favored Pre-proline 0 N--CA 1.456 -0.161 0 CA-C-O 121.082 0.467 . . . . 0.0 110.298 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.97 0.55 3.04 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.41 2.74 . . . . 0.0 113.087 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.92 -19.69 17.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.229 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 27.3 mm-40 -109.83 154.99 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 43.9 mm-40 -98.16 174.92 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.365 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.49 109.07 18.84 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.574 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' MET . 39.2 t -124.24 108.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.298 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 40' ' ' VAL . 18.5 mm -85.55 142.36 13.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.384 0.612 . . . . 0.0 111.961 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -111.45 -44.66 3.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.371 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.91 -165.75 38.56 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.622 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -82.53 -161.19 29.28 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.401 0.6 . . . . 0.0 112.651 -0.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.71 -48.07 69.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.855 0.359 . . . . 0.0 111.078 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -58.09 -29.19 65.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.608 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -79.95 -29.28 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.358 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.428 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 3.5 m-85 -58.44 -55.91 28.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.733 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.703 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.4 t -65.17 -9.83 26.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.613 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.47 -43.41 27.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.843 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.718 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.6 m-85 -93.56 -6.79 45.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.338 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 10.9 pttp -49.8 -32.98 15.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.399 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -78.87 -6.04 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.764 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.09 -24.7 4.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 106' ' ' PHE . 76.6 t -44.43 124.58 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.94 0.4 . . . . 0.0 111.447 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 6.3 t70 -103.07 -1.22 29.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.687 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 86.3 m -161.46 142.51 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.585 0.231 . . . . 0.0 111.065 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.533 HD11 ' CG ' ' A' ' 136' ' ' PHE . 7.0 mt -123.58 144.95 49.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.213 0.53 . . . . 0.0 111.415 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 113' ' ' LEU . 12.9 mt -135.33 118.94 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.761 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.602 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.9 m -134.78 144.8 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.424 . . . . 0.0 111.688 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.84 119.31 35.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 7.1 mtm180 -102.05 104.7 15.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.418 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 153' ' ' HIS . 0.8 OUTLIER -87.8 136.46 32.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.44 -48.23 68.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.27 -138.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.406 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.7 p -144.23 168.2 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 0.0 111.335 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 80.0 m-85 -131.2 137.74 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.743 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 166.53 10.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.734 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.24 -159.12 29.18 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.13 22.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.5 m -146.08 137.82 24.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.863 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -109.34 165.82 11.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -177.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.703 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pt -104.06 156.73 35.3 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.88 99.9 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.671 2.247 . . . . 0.0 112.194 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.73 148.08 23.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.955 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.37 70.6 6.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.413 ' HH2' HG11 ' A' ' 115' ' ' VAL . 94.4 m95 -53.41 -27.64 25.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.094 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.09 -29.11 67.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.421 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.57 -20.67 42.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.533 ' CG ' HD11 ' A' ' 113' ' ' LEU . 43.5 m-85 -100.02 175.86 5.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.5 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 2.5 m -134.32 139.95 46.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.422 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.654 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 7.7 ttpt -83.94 111.56 19.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 157' ' ' VAL . 4.4 m -98.8 -17.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.487 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -163.89 140.21 6.62 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.443 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.654 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 81.0 p -168.04 105.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.464 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -142.79 121.25 12.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.649 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.684 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.2 m -71.16 145.59 49.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.21 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.77 103.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.579 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.4 mt-10 -86.61 100.27 12.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.358 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -83.24 -176.9 6.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -56.68 -54.15 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.942 0.401 . . . . 0.0 110.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.539 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.6 t30 -73.63 127.84 87.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.847 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.63 -31.6 92.34 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.037 1.825 . . . . 0.0 112.563 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.62 -21.48 28.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.8 mt -82.08 8.79 9.84 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 145' ' ' GLU . 95.5 m -75.28 164.1 26.79 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.9 p80 -175.58 162.19 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.994 0.426 . . . . 0.0 111.581 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.684 ' OG1' HG23 ' A' ' 143' ' ' THR . 7.7 m -122.12 144.85 48.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.911 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -111.65 110.06 20.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.71 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HB2' HG22 ' A' ' 115' ' ' VAL . 7.0 mm-40 -98.68 151.26 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 139' ' ' VAL . 10.7 t -141.77 106.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.009 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 25.1 m95 -108.5 146.18 33.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.106 0.479 . . . . 0.0 111.949 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -124.81 112.74 17.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.233 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.2 tttt -51.17 131.74 27.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.227 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -92.39 168.59 11.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.295 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.159 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 11.8 m . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.789 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.28 152.47 27.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.3 m-30 -118.11 112.03 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -115.21 126.34 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.673 0.749 . . . . 0.0 112.881 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.719 ' CH2' HG12 ' A' ' 115' ' ' VAL . 9.0 p90 -164.6 164.73 21.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.055 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.04 134.93 54.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 111.472 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 2.7 pt20 -115.61 140.34 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.796 ' OD2' HD12 ' A' ' 12' ' ' LEU . 4.5 p30 -97.82 -167.42 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.423 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -51.36 -34.66 35.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.784 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.63 -28.42 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 94.83 45.86 3.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.871 HD13 ' HA3' ' A' ' 124' ' ' GLY . 1.4 mt -91.11 174.31 7.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.615 HG22 ' CD1' ' A' ' 5' ' ' TRP . 1.1 pp -139.72 -58.07 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.653 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 126' ' ' THR . . . -79.94 152.32 34.78 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.425 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 125' ' ' ASP . 0.0 OUTLIER -166.99 149.46 6.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 111.115 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.67 107.02 15.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.821 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.61 137.39 2.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.591 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.42 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 10.2 t60 -106.48 111.35 23.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.619 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.56 109.24 27.79 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.937 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 18' ' ' HIS . 69.7 Cg_endo -92.5 58.28 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.948 2.432 . . . . 0.0 112.511 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -90.82 178.48 6.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.157 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.9 -7.43 14.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.67 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.4 mt -94.4 112.48 57.79 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.592 0.234 . . . . 0.0 110.916 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -81.31 54.13 5.03 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.735 2.29 . . . . 0.0 112.416 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.75 -68.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.15 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -95.29 -21.85 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.536 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.87 -25.05 66.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.739 0.304 . . . . 0.0 111.338 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -84.53 -68.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.241 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.514 ' CE2' ' CE1' ' A' ' 155' ' ' TYR . 12.4 t80 -42.98 -26.27 0.13 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.082 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -69.09 0.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.687 0.28 . . . . 0.0 110.994 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.8 ' O ' HG13 ' A' ' 35' ' ' VAL . 13.8 ttm105 -92.59 -40.62 10.68 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -59.59 -13.03 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' NE2' ' CE1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -81.16 -50.53 9.49 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.583 ' HB ' ' HG ' ' A' ' 4' ' ' LEU . 5.4 t -83.18 -24.43 32.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 31' ' ' ARG . 35.5 m -60.89 142.97 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 0.0 110.977 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.549 ' H ' ' CG ' ' A' ' 57' ' ' ARG . . . 119.82 -10.18 11.28 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.82 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -151.65 -164.51 2.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.503 1.151 . . . . 0.0 109.555 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.63 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 74.3 mt -74.55 94.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 112.016 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.433 ' HG3' ' OG1' ' A' ' 34' ' ' THR . 8.6 ttp -103.48 126.81 50.85 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.014 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.1 t -78.9 158.22 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 40' ' ' VAL . 27.3 m -165.04 142.98 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.99 158.5 51.2 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.81 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.593 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.84 -48.51 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.058 0.429 . . . . 0.0 110.77 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -62.66 -27.01 68.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 0.0 110.467 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.2 m -75.73 -44.62 40.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.589 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.462 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 15.8 t80 -61.33 -31.59 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -66.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.71 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 49' ' ' PHE . 3.9 t -54.7 -33.05 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -26.38 114.31 0.23 Allowed Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.883 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.88 -37.0 21.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.043 2.495 . . . . 0.0 113.307 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' CE ' HD23 ' A' ' 54' ' ' LEU . 2.6 tmmm? -147.13 118.93 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.777 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.86 140.16 21.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.18 -167.1 5.06 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.23 -1.571 . . . . 0.0 112.004 -0.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HB3' ' CD ' ' A' ' 57' ' ' ARG . 81.9 mt -111.61 137.47 21.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.06 -66.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.65 2.233 . . . . 0.0 113.302 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.82 19.8 1.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.488 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.612 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -142.27 121.43 12.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.119 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.63 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 39.9 m -80.59 128.11 33.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.289 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.406 ' ND2' ' CE ' ' A' ' 39' ' ' MET . 6.5 m120 -115.02 147.36 40.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 111.843 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.824 HG12 HG22 ' A' ' 76' ' ' VAL . 3.3 t -131.12 132.65 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.464 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 43' ' ' ARG . 78.7 t -97.73 128.89 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.289 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.669 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.07 115.38 30.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.824 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -147.4 156.75 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -74.15 -12.4 60.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.888 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tt0 -80.39 133.5 35.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.413 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 3.1 mm-40 -84.67 -11.13 56.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.962 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.37 4.41 20.66 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.861 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.4 t80 -58.26 140.45 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.54 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.848 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -126.48 173.85 9.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 179.078 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.49 143.68 20.09 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.648 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.73 96.75 5.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.742 0.306 . . . . 0.0 110.696 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.11 2.65 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.959 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.462 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.16 167.75 17.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.071 0.462 . . . . 0.0 111.718 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HB ' HG13 ' A' ' 60' ' ' VAL . 32.3 t -97.07 140.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.421 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 68' ' ' TYR . 21.3 t -104.23 117.66 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.368 0.604 . . . . 0.0 112.477 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.824 HG22 HG12 ' A' ' 60' ' ' VAL . 28.1 m -127.31 167.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.962 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.413 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 4.7 m80 -119.13 -22.18 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.539 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.662 ' HA ' HD21 ' A' ' 62' ' ' LEU . 8.1 m-20 -159.33 -175.02 4.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.667 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.83 HG22 ' CD1' ' A' ' 106' ' ' PHE . 11.8 t -66.64 -11.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.786 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.69 -36.82 17.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 0.0 109.752 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.65 -31.74 65.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 HG21 ' A' ' 76' ' ' VAL . 31.6 t -69.68 -53.82 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.986 0.422 . . . . 0.0 109.938 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 5.6 m-85 -53.61 -27.6 27.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.971 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -62.62 -46.49 88.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.895 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.43 -54.49 31.87 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.85 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.78 -24.2 34.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -71.39 -33.63 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -83.16 -8.72 59.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.376 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -124.82 66.01 47.32 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.019 0.437 . . . . 0.0 110.277 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.3 -0.46 2.89 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.099 2.533 . . . . 0.0 112.831 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.09 -30.28 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.009 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -105.93 161.81 14.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -98.76 174.77 6.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.85 HD13 ' HB2' ' A' ' 86' ' ' ALA . 8.5 tp -122.27 118.8 29.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.383 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 2' ' ' ALA . 53.5 t -132.87 121.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.452 ' CD1' HG21 ' A' ' 40' ' ' VAL . 8.7 mm -83.25 133.39 29.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.11 0.481 . . . . 0.0 111.832 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.402 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -101.22 -50.04 3.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.21 -171.13 43.94 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.717 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.408 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.45 -160.98 36.79 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.674 0.737 . . . . 0.0 112.69 -0.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.02 10.18 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.733 0.301 . . . . 0.0 111.508 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -52.62 -30.52 31.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.553 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.669 ' CD1' HD22 ' A' ' 62' ' ' LEU . 28.2 mm -82.89 -21.62 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . 2.7 m-85 -66.29 -51.75 54.25 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.518 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -70.75 -9.59 57.65 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 111.916 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.763 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.47 -37.87 35.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.83 ' CD1' HG22 ' A' ' 79' ' ' VAL . 6.3 m-85 -95.87 -11.12 27.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.682 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 9.4 pttp -51.4 -29.14 14.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.97 -12.45 60.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.411 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.89 -20.73 5.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 106' ' ' PHE . 81.0 t -44.53 128.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.063 0.458 . . . . 0.0 111.317 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 6.2 t0 -110.47 -3.87 15.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.582 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.789 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.9 m -155.7 134.47 11.92 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.598 0.237 . . . . 0.0 111.08 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.683 HD11 ' CD2' ' A' ' 136' ' ' PHE . 11.7 mt -117.01 144.08 44.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 4' ' ' LEU . 4.2 mt -135.91 115.51 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.502 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.719 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -131.4 141.34 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.39 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.44 112.78 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -96.26 100.44 12.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.366 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.0 OUTLIER -86.66 131.21 34.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -61.54 -46.47 89.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.67 -173.3 0.08 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 p -124.54 136.58 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -138.15 157.49 46.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 3.8 mt-10 -70.91 170.37 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.871 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . -161.26 125.87 1.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.701 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -108.56 14.05 24.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.509 0.195 . . . . 0.0 111.42 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 14' ' ' GLY . 1.8 m -162.85 137.27 6.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.939 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.33 160.78 14.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.202 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.554 ' SD ' HG21 ' A' ' 13' ' ' ILE . 15.9 tpt -81.51 159.34 24.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.425 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pp -91.81 165.07 21.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.415 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.63 128.37 23.23 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.628 2.218 . . . . 0.0 112.043 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.68 HD13 ' CZ2' ' A' ' 133' ' ' TRP . 2.5 mt -112.36 139.67 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.19 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 63.05 7.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.68 ' CZ2' HD13 ' A' ' 131' ' ' LEU . 89.8 m95 -53.9 -24.37 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -31.14 65.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.03 -16.39 47.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.397 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 113' ' ' LEU . 77.9 m-85 -103.45 168.28 9.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 110.69 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.676 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -132.59 140.93 48.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.978 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 5.6 ttpt -79.93 119.41 22.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 157' ' ' VAL . 32.8 m -105.41 -19.37 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.0 m -167.07 140.45 3.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 5.2 p -169.27 108.68 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -147.84 125.39 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.779 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.643 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.1 m -71.2 146.11 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.728 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 152' ' ' THR . 10.5 t -118.78 103.47 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.592 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.5 mt-10 -88.29 102.02 14.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.576 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.76 -174.4 4.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.654 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.9 p -58.0 -51.21 70.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.9 t30 -76.5 134.02 70.25 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.871 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.56 -35.29 60.48 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.985 1.79 . . . . 0.0 112.393 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.5 mt -78.45 8.91 4.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 144' ' ' VAL . 93.6 m -78.71 161.11 27.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.482 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -172.11 157.81 4.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.008 0.432 . . . . 0.0 111.594 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.643 ' OG1' HG23 ' A' ' 143' ' ' THR . 7.5 m -119.06 131.48 55.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.574 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.514 ' CE1' ' CE2' ' A' ' 29' ' ' TYR . 45.1 m-85 -99.79 105.21 16.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.755 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.59 ' HB2' HG22 ' A' ' 115' ' ' VAL . 4.3 mt-10 -102.81 122.11 43.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.477 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.721 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.8 t -116.79 114.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 138' ' ' LYS . 30.5 m95 -112.15 150.56 30.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 111.556 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -126.8 115.02 18.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.829 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 3.0 ttpt -51.73 138.22 23.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.287 0.565 . . . . 0.0 112.434 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.676 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -125.87 -164.03 1.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.339 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.063 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.446 HG23 HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.723 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.93 146.35 39.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.57 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.5 m-85 -110.2 115.79 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.531 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.542 HD21 ' HB3' ' A' ' 30' ' ' PHE . 12.1 tp -113.73 120.96 42.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.702 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.1 p90 -166.17 164.65 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.274 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.32 55.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 111.48 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 pt20 -123.29 153.05 40.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.157 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -103.18 -174.07 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.717 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -24.92 19.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -91.99 -31.17 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.744 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.98 22.74 7.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.669 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -87.22 153.09 21.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.409 HG23 ' HD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -112.02 -75.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.931 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.85 -154.55 6.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HB3' HD12 ' A' ' 19' ' ' LEU . 18.9 tttm -163.58 102.81 0.93 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.68 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -87.93 58.16 4.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.42 -101.62 0.26 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.442 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -139.25 85.98 2.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.656 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.83 156.74 40.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.963 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.8 -41.9 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.578 2.186 . . . . 0.0 112.642 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.11 176.69 9.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -130.9 -167.58 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.787 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -136.42 129.44 17.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.834 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.06 -24.75 9.42 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.504 2.136 . . . . 0.0 112.638 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.27 -28.66 59.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.219 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.23 -44.9 92.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 0.0 110.979 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.95 -69.21 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.537 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -17.58 64.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.89 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -62.21 -74.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.742 0.306 . . . . 0.0 111.424 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' HB3' HD21 ' A' ' 4' ' ' LEU . 3.7 p90 -91.91 30.38 1.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.826 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.72 ' O ' HG13 ' A' ' 35' ' ' VAL . 28.0 ttp85 -73.29 -61.35 1.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.832 0.349 . . . . 0.0 110.958 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -85.29 -11.41 54.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.818 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -84.26 -8.04 59.16 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.7 p -145.19 11.25 1.33 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.742 HG12 ' CD ' ' A' ' 57' ' ' ARG . 6.9 m -94.32 150.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.628 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 54.15 35.33 54.52 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 116.136 1.215 . . . . 0.0 116.136 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.9 mmtt -149.46 -176.2 5.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 120.262 2.031 . . . . 0.0 107.721 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 71.8 mt -86.6 85.27 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.051 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ttp -102.12 123.07 45.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.39 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 41' ' ' VAL . 43.3 t -76.01 156.51 5.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.522 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 40' ' ' VAL . 34.9 m -164.18 137.46 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.74 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.21 161.37 34.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.933 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.642 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.99 -47.2 81.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.861 0.33 . . . . 0.0 110.767 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.419 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.8 tpp180 -66.36 -30.48 70.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.388 . . . . 0.0 110.336 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.711 HG22 ' CE2' ' A' ' 49' ' ' PHE . 7.0 m -68.2 -43.73 77.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.204 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.452 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 13.7 t80 -59.05 -31.14 68.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.42 -66.1 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.1 t -50.07 -41.61 48.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.9 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.711 ' CE2' HG22 ' A' ' 45' ' ' THR . 6.9 m-85 -42.44 152.92 0.32 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-O 120.781 0.324 . . . . 0.0 111.448 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -41.73 -72.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.063 2.509 . . . . 0.0 113.542 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.66 177.15 8.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.45 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 2.4 ptp180 -122.1 105.76 36.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 86.9 Cg_endo -87.89 -179.96 17.07 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.457 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 49' ' ' PHE . 34.2 mt -61.18 158.53 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 12.9 Cg_endo -56.72 87.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.412 2.075 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 42.8 mt-10 69.62 47.55 0.64 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.351 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.742 ' CD ' HG12 ' A' ' 35' ' ' VAL . 17.0 mtt180 -140.79 126.05 18.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.671 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 92.0 m -76.5 105.84 7.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.479 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 1.8 m-80 -104.6 145.86 29.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.224 -178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 76' ' ' VAL . 12.1 t -117.63 141.78 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.097 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.642 HG13 ' HA ' ' A' ' 43' ' ' ARG . 58.8 t -108.32 124.42 64.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.116 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.28 121.05 44.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.484 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.536 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.5 t -157.17 160.13 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -75.52 -5.51 45.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.19 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.4 tp60 -78.71 129.85 35.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 3.8 mm-40 -82.63 -28.06 31.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.139 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.56 7.55 46.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.68 ' O ' HG11 ' A' ' 75' ' ' VAL . 7.7 t80 -60.57 142.49 55.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.348 0.594 . . . . 0.0 111.897 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.939 ' HA ' HG21 ' A' ' 75' ' ' VAL . 14.9 mm100 -134.77 175.72 9.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.39 1.09 . . . . 0.0 112.888 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 142.64 19.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -78.11 100.94 6.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.35 -43.0 2.8 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.807 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -70.08 170.18 11.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.446 . . . . 0.0 111.709 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.5 t -99.48 140.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.939 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.5 t -111.36 119.97 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.357 0.599 . . . . 0.0 112.121 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.973 HG21 HG22 ' A' ' 82' ' ' VAL . 34.1 m -126.61 168.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.409 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.41 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 12.4 m-70 -119.14 -25.46 6.17 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.794 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 t70 -149.07 -176.13 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.641 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.912 HG13 ' CD2' ' A' ' 106' ' ' PHE . 21.7 t -69.63 -10.73 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.688 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.72 -30.99 18.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 110.364 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.26 -26.59 52.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.133 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.973 HG22 HG21 ' A' ' 76' ' ' VAL . 16.7 t -78.41 -50.81 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 109.806 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.592 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.2 m-85 -57.33 -28.78 63.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.913 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.77 -38.29 79.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.7 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -68.12 -59.23 3.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.51 -22.84 14.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.202 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.89 -37.38 75.99 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.035 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 37.0 mt-30 -83.81 -4.49 58.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.233 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -124.76 65.04 43.77 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.563 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.8 -0.99 6.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.925 2.417 . . . . 0.0 112.829 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.7 -31.67 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 54.6 mt-30 -102.28 157.44 16.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -99.14 158.99 15.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.446 HD23 HG23 ' A' ' 1' ' ' THR . 29.9 tp -111.51 115.89 29.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.28 110.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.33 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.471 HD12 HG21 ' A' ' 40' ' ' VAL . 4.9 mm -77.2 129.03 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 0.0 111.079 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.19 -37.14 6.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.59 -169.11 42.17 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.785 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.34 -161.01 30.6 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 122.266 -0.549 . . . . 0.0 112.545 -0.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -55.12 -51.18 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.054 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -55.53 -27.64 50.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.591 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 62' ' ' LEU . 49.0 mm -79.34 -32.94 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.0 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 3' ' ' PHE . 6.2 m-85 -54.08 -58.16 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.65 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.568 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.1 t -65.78 -9.92 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.811 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.74 -41.56 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.912 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.0 m-85 -101.56 -2.57 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.462 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 39.0 pttt -49.8 -34.36 19.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.731 0.3 . . . . 0.0 111.767 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 4.07 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.64 -25.0 3.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.856 HG11 HD23 ' A' ' 113' ' ' LEU . 62.9 t -44.04 129.35 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 120.97 0.414 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 24.5 t70 -103.41 2.77 34.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.124 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 97.8 m -166.97 138.63 3.32 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.538 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.856 HD23 HG11 ' A' ' 110' ' ' VAL . 21.2 mt -120.17 144.81 47.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 113' ' ' LEU . 19.9 mt -135.31 115.23 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.2 m -132.16 143.05 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.848 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.35 105.67 13.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.235 179.31 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -81.98 101.67 10.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.748 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -84.91 125.73 32.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.974 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 -56.93 12.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.312 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.16 168.26 15.85 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.87 163.19 12.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.748 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 4.5 m-85 -136.39 147.99 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -98.75 132.67 43.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.692 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.14 -179.7 47.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.527 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.26 -0.18 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.7 m -118.13 122.45 43.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.032 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.407 ' O ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.74 175.98 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.4 tpt -76.61 153.3 35.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.855 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.519 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.8 pp -81.23 164.14 51.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.249 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.27 101.6 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.839 2.359 . . . . 0.0 112.686 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.415 ' CD1' ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -91.25 145.42 24.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.67 75.7 4.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.247 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.553 ' HH2' HG11 ' A' ' 115' ' ' VAL . 93.7 m95 -55.29 -21.25 13.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.304 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -28.36 61.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.3 t0 -80.74 -17.27 51.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.177 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.648 ' CD1' HD11 ' A' ' 113' ' ' LEU . 91.5 m-85 -109.1 166.35 10.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.94 0.4 . . . . 0.0 111.559 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.748 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -125.24 140.31 52.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.739 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.545 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpm? -81.19 121.35 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.615 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.1 m -110.21 -15.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.612 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.407 ' OG ' HG23 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -167.33 139.87 3.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.81 0.338 . . . . 0.0 110.928 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.2 p -163.09 109.79 1.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -143.65 119.27 10.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.332 . . . . 0.0 111.283 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.742 HG23 ' OG1' ' A' ' 154' ' ' THR . 5.0 m -74.09 144.61 44.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.244 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 t -116.53 106.22 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.126 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.69 105.49 17.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.588 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.86 -177.18 6.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.559 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 p -59.64 -42.01 91.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.498 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -81.78 126.35 75.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.23 -29.18 88.44 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.295 1.997 . . . . 0.0 112.274 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.54 -24.08 23.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.037 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.7 mt -81.32 6.28 14.78 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.571 ' O ' HD23 ' A' ' 118' ' ' LEU . 52.1 m -71.38 164.5 25.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.071 0.463 . . . . 0.0 110.124 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.1 p80 -174.37 160.95 3.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.13 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.742 ' OG1' HG23 ' A' ' 143' ' ' THR . 26.9 m -122.69 150.16 43.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.629 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -111.05 105.21 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.54 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.713 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.1 mt-10 -105.05 121.63 44.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 111.631 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 139' ' ' VAL . 4.1 t -112.93 111.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.696 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.2 m95 -110.89 150.33 29.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 111.487 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -128.39 120.91 27.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.496 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.5 tmmt? -45.5 125.93 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.643 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.748 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -109.79 -176.27 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.105 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.508 HG22 HG12 ' A' ' 96' ' ' ILE . 2.9 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.743 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.51 144.92 42.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 1.8 m-30 -107.66 112.9 25.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.846 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.33 124.92 53.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.36 0.6 . . . . 0.0 112.43 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.76 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.9 p90 -170.91 174.05 4.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.617 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -121.76 139.77 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -120.48 154.76 34.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 111.422 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 122' ' ' PHE . 1.1 p30 -108.62 -177.7 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HG2' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -47.88 -49.63 29.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.32 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.23 -19.55 64.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.55 25.89 21.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.347 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -90.4 161.98 15.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.857 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.679 HG22 ' CD1' ' A' ' 5' ' ' TRP . 11.4 pt -111.91 -44.69 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.202 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 13' ' ' ILE . . . -155.67 162.73 31.35 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.386 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.9 150.69 19.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.421 . . . . 0.0 111.213 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.32 123.92 42.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.24 -81.74 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.533 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -87.32 171.71 10.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.934 0.397 . . . . 0.0 110.974 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -97.17 147.62 33.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.785 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 31.2 Cg_exo -58.98 168.44 4.46 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.466 2.11 . . . . 0.0 112.182 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -172.73 2.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.257 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.23 75.8 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.794 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.61 136.34 48.63 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.517 ' HA ' HD23 ' A' ' 27' ' ' LEU . 80.0 Cg_endo -77.71 -40.03 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.55 2.167 . . . . 0.0 112.694 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -76.93 -14.91 59.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.614 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.21 -25.1 17.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.591 0.234 . . . . 0.0 111.547 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 24' ' ' PRO . 1.7 pp -84.03 -30.7 25.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.711 0.291 . . . . 0.0 111.202 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -48.83 -32.28 8.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.527 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.402 ' CZ ' ' OE1' ' A' ' 33' ' ' GLN . 45.4 t80 -105.27 -59.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.442 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -50.9 -40.42 56.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.613 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.802 ' O ' HG22 ' A' ' 35' ' ' VAL . 55.0 ttt-85 -69.94 -60.92 2.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.243 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -55.85 -22.38 24.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.521 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.402 ' OE1' ' CZ ' ' A' ' 29' ' ' TYR . 3.2 mm-40 -84.31 -7.16 59.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.828 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.597 ' CG2' HD11 ' A' ' 4' ' ' LEU . 4.2 p -138.73 1.25 2.09 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 31' ' ' ARG . 29.3 m -107.99 147.03 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 82.78 7.5 87.23 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -147.23 -165.07 2.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.963 1.882 . . . . 0.0 109.465 179.437 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.509 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 58.6 mt -82.18 88.42 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.418 ' SD ' ' HB ' ' A' ' 34' ' ' THR . 1.6 ttp -97.91 116.89 31.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.801 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 82' ' ' VAL . 5.8 t -86.3 125.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.09 0.471 . . . . 0.0 111.688 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 49' ' ' PHE . 24.5 m -132.13 155.13 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.502 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.13 147.0 32.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.756 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.7 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -45.09 -49.29 11.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.72 0.26 . . . . 0.0 111.459 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.442 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 3.8 ttt180 -62.14 -36.88 83.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 0.0 110.146 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -63.34 -49.38 74.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.475 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.83 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 2.9 t80 -50.3 -43.76 53.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.875 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -52.38 -63.98 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.766 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -35.08 67.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.37 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -34.98 138.52 0.35 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-O 120.905 0.384 . . . . 0.0 111.973 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.19 -29.99 18.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.253 2.635 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 149.33 31.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.387 . . . . 0.0 111.501 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.4 mtm180 -138.65 106.37 7.63 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 95.1 Cg_endo -86.0 -166.91 4.37 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.273 -0.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.616 HD12 HD21 ' A' ' 59' ' ' ASN . 75.4 mt -100.58 142.05 23.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.92 121.17 6.77 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 112.798 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 69.98 3.09 4.18 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.771 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HD2' HD13 ' A' ' 54' ' ' LEU . 3.4 mtt-85 -114.42 108.8 17.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.0 m -68.24 113.19 5.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.616 HD21 HD12 ' A' ' 54' ' ' LEU . 2.5 m-80 -104.73 150.37 24.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.397 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 76' ' ' VAL . 6.6 t -134.83 133.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.7 HG13 ' HA ' ' A' ' 43' ' ' ARG . 79.2 t -103.01 124.04 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.753 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -105.72 111.23 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.907 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.954 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -142.83 170.81 15.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 111.285 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -86.91 -14.19 42.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.683 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 45.2 tt0 -79.17 133.58 36.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.455 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 23.4 mt-10 -80.89 -25.61 37.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.79 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.89 6.78 48.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.954 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.2 t80 -60.08 136.24 57.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.216 0.532 . . . . 0.0 111.6 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.95 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -132.04 173.71 10.93 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.254 1.026 . . . . 0.0 112.703 179.306 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.07 141.41 18.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.096 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.26 101.56 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.807 0.337 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -41.39 2.92 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.638 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.83 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -69.44 167.74 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.52 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.78 140.77 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.95 HG21 ' HA ' ' A' ' 69' ' ' GLN . 19.2 t -110.03 119.87 59.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.228 0.537 . . . . 0.0 112.066 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.821 HG21 HG22 ' A' ' 82' ' ' VAL . 27.6 m -130.19 167.11 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.664 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.455 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 17.3 m80 -118.28 -22.51 7.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.642 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.65 -176.72 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.206 0.527 . . . . 0.0 111.507 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.873 HG13 ' CD2' ' A' ' 106' ' ' PHE . 35.6 t -71.89 -9.36 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.661 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.13 -33.78 19.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.487 . . . . 0.0 109.785 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.542 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.85 -32.3 63.59 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.124 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.821 HG22 HG21 ' A' ' 76' ' ' VAL . 43.4 t -72.19 -52.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.3 m-85 -54.13 -28.09 37.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.27 -40.19 93.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.471 ' CE2' ' CD2' ' A' ' 89' ' ' HIS . 65.1 t80 -66.99 -57.42 6.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -53.33 -23.3 8.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.097 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 3.5 mmtp -69.4 -40.11 77.56 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -85.06 -4.95 59.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.529 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 93.4 m-70 -127.38 60.59 44.26 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.02 -0.03 5.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.236 2.624 . . . . 0.0 112.916 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.75 -35.7 19.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.03 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.401 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 12.1 mt-30 -99.5 163.92 12.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.473 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.3 160.69 14.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.926 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.795 HD11 HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -115.3 117.06 29.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.53 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.451 HG12 HD12 ' A' ' 4' ' ' LEU . 59.3 t -131.94 117.83 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.174 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 1' ' ' THR . 5.4 mm -81.92 133.13 29.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.262 0.553 . . . . 0.0 111.484 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.53 -48.66 4.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.056 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.404 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.43 -164.13 36.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.404 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -86.15 -161.02 34.83 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.674 0.737 . . . . 0.0 112.704 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -50.77 -48.97 59.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.323 . . . . 0.0 111.41 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -58.5 -29.85 66.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.877 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.2 mm -79.43 -29.93 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.268 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.9 m-85 -57.16 -54.14 50.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.862 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -70.12 -8.49 50.0 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.024 -0.423 . . . . 0.0 111.839 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.814 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.34 -38.98 40.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.873 ' CD2' HG13 ' A' ' 79' ' ' VAL . 29.3 m-85 -99.63 -10.03 22.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.308 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 18.5 pttp -52.17 -31.73 32.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.758 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.74 -5.1 52.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.656 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.2 -21.66 3.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 106' ' ' PHE . 76.9 t -44.81 123.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 111.302 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.433 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 3.9 t70 -103.13 7.69 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.267 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.2 m -168.39 135.84 2.09 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.821 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.63 HD23 HG11 ' A' ' 110' ' ' VAL . 17.0 mt -117.92 143.7 46.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.491 . . . . 0.0 111.531 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 4' ' ' LEU . 6.5 mt -135.28 115.08 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.664 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.76 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -134.69 144.69 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.024 0.44 . . . . 0.0 111.744 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.79 105.56 13.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.577 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 6.5 mmt85 -80.7 100.33 8.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.489 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.5 mp -82.21 127.94 33.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.431 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -63.08 -52.11 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -50.43 144.49 11.09 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.443 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.467 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 35.3 p -91.5 132.61 36.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.981 0.42 . . . . 0.0 111.374 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -134.23 163.57 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -116.56 150.86 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.112 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.8 -173.72 23.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.788 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -33.98 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.954 0.407 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 60.7 m -108.71 139.44 43.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.98 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -115.89 172.39 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 111.681 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -70.22 143.6 52.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.488 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pt -68.45 154.33 94.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.96 97.73 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.512 2.142 . . . . 0.0 111.975 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.62 146.69 26.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 72.45 4.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.325 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.475 ' HH2' HG11 ' A' ' 115' ' ' VAL . 89.8 m95 -55.7 -22.37 23.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.423 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -28.81 62.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -80.64 -23.46 39.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 71.8 m-85 -102.09 174.08 6.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -137.79 142.85 40.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.6 ttpt -79.96 120.54 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.787 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.6 m -103.01 -21.75 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.433 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.4 m -162.74 140.69 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 16.1 p -160.62 109.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -139.43 115.2 10.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.27 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 8.4 m -74.42 144.14 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.432 HG11 ' HE2' ' A' ' 155' ' ' TYR . 2.5 p -121.77 105.26 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.997 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.53 ' HA ' HG23 ' A' ' 152' ' ' THR . 19.6 mt-10 -88.7 107.14 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.787 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.27 -175.77 5.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.486 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.7 p -57.45 -50.45 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.749 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.494 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -74.41 124.66 90.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.102 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.97 -27.21 84.44 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.154 1.903 . . . . 0.0 112.301 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -19.89 22.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.674 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.3 mt -84.85 7.77 19.72 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 74.5 m -72.88 168.22 19.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -175.46 162.48 2.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.257 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 24.5 m -125.23 137.91 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.797 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.432 ' HE2' HG11 ' A' ' 144' ' ' VAL . 94.4 m-85 -98.4 106.3 18.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.493 ' HB2' HG22 ' A' ' 115' ' ' VAL . 62.7 mt-10 -108.69 126.61 53.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.857 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.7 t -118.72 115.9 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.251 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.3 m95 -111.97 151.16 29.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 0.0 111.377 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -127.02 117.13 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.828 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.1 OUTLIER -55.46 131.47 46.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.93 0.395 . . . . 0.0 111.613 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.493 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 1.8 ptmt 177.5 156.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.991 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 85.2 m . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.83 148.93 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.597 ' C ' HD13 ' A' ' 4' ' ' LEU . 2.6 m-30 -114.18 112.28 22.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.491 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.078 HD11 HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -112.82 121.52 44.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 0.0 111.807 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.86 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.0 p90 -166.85 172.73 10.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.448 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.88 134.37 50.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -119.98 155.81 32.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.952 0.406 . . . . 0.0 111.182 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.7 -172.83 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.687 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.13 63.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.06 -23.12 52.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.71 22.61 17.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.358 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.37 159.75 20.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.46 -37.38 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.22 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 165.93 174.31 35.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.547 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HG2' ' HA2' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -68.25 -179.76 1.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.67 -29.37 59.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.08 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.89 66.63 0.4 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.491 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.03 -30.12 6.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 111.109 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.64 120.26 9.42 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.868 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.57 -178.98 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.421 2.081 . . . . 0.0 112.153 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.7 121.96 44.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.71 43.33 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.24 142.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.598 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.78 -39.08 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.731 2.287 . . . . 0.0 112.965 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.09 -32.52 74.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.623 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.81 -23.64 29.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.647 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -14.75 30.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.768 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -63.92 -70.67 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.441 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 78.7 t80 -62.43 -34.77 77.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -81.49 9.35 7.56 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.859 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.19 -62.37 1.42 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.59 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.5 -40.4 50.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . 60.1 mm-40 -56.91 -20.16 21.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.944 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.83 HG22 HD23 ' A' ' 4' ' ' LEU . 68.7 p -119.44 -25.27 6.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 31' ' ' ARG . 1.5 m -107.98 161.75 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 111.87 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . 89.77 1.06 77.61 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.748 -0.739 . . . . 0.0 114.272 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 1.8 mtpm? -150.6 -164.82 2.11 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.396 1.098 . . . . 0.0 109.835 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.6 mt -78.62 86.75 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 34' ' ' THR . 9.4 ttp -99.99 120.31 39.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.934 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.498 HG21 HG11 ' A' ' 82' ' ' VAL . 80.3 t -77.57 156.76 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.974 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 60' ' ' VAL . 33.6 m -162.49 141.22 2.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.43 153.45 52.92 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.506 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.765 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.33 -51.05 57.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.223 0.512 . . . . 0.0 110.815 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.489 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.9 tpt85 -57.88 -34.48 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.061 0.458 . . . . 0.0 110.19 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.577 HG22 ' CE2' ' A' ' 49' ' ' PHE . 2.8 m -69.75 -55.9 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.398 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -46.63 -28.69 1.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -65.44 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.237 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -50.18 -35.4 26.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.654 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 45' ' ' THR . 5.4 m-85 -40.93 157.95 0.18 Allowed Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD2' HD21 ' A' ' 54' ' ' LEU . 68.5 Cg_exo -52.23 -71.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.611 2.207 . . . . 0.0 113.257 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -124.15 173.6 8.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.7 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.9 mtp180 -133.99 104.43 11.63 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.913 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 89.9 Cg_endo -85.19 -167.06 4.76 Favored 'Cis proline' 0 C--N 1.349 0.588 0 C-N-CA 123.912 -1.287 . . . . 0.0 112.144 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 HD21 ' A' ' 59' ' ' ASN . 95.4 mt -93.87 151.36 39.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.629 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.35 110.15 2.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.666 2.244 . . . . 0.0 112.972 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.18 4.27 5.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.002 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.574 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 5.7 mtt180 -112.59 101.07 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.038 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 24.0 m -66.05 107.81 2.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.706 HD21 HD12 ' A' ' 54' ' ' LEU . 2.3 m-80 -103.38 156.1 17.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.243 0.544 . . . . 0.0 112.14 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.642 HG12 HG22 ' A' ' 76' ' ' VAL . 8.3 t -132.43 136.91 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.883 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.765 HG13 ' HA ' ' A' ' 43' ' ' ARG . 66.4 t -105.93 127.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.586 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.92 116.12 31.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.202 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.847 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.6 t -147.19 167.14 24.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.903 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -85.14 -12.01 53.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -72.93 134.83 44.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -85.2 -7.9 58.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.883 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -118.7 7.46 11.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.606 0.241 . . . . 0.0 111.522 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.925 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.9 t80 -58.14 139.57 54.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.193 0.52 . . . . 0.0 111.817 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.888 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -126.27 173.84 8.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.043 0.925 . . . . 0.0 111.99 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.27 142.97 19.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.495 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -77.93 97.99 5.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.745 0.307 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.41 2.99 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.234 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.89 171.72 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 60' ' ' VAL . 12.4 t -97.46 139.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.476 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.925 HG11 ' O ' ' A' ' 68' ' ' TYR . 41.9 t -103.69 107.95 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.281 0.562 . . . . 0.0 112.193 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 82' ' ' VAL . 28.7 m -118.23 167.79 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.973 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 63' ' ' THR . 13.1 m170 -120.38 -21.21 6.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 m-20 -160.59 -173.32 3.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.839 HG13 ' CD2' ' A' ' 106' ' ' PHE . 12.8 t -66.94 -10.18 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.765 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.0 -38.33 16.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 110.019 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.32 -30.73 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG22 HG21 ' A' ' 76' ' ' VAL . 21.5 t -71.01 -53.59 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.969 0.414 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' CE2' HG12 ' A' ' 79' ' ' VAL . 6.7 m-85 -54.09 -27.08 30.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.934 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.36 -44.99 85.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.95 -55.33 19.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.16 -22.61 17.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.875 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.4 mmpt? -70.09 -38.04 75.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -83.05 -6.2 59.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.622 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -126.48 67.4 65.52 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.998 0.427 . . . . 0.0 110.558 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.8 -0.23 4.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.162 2.575 . . . . 0.0 113.079 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.33 -30.3 22.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 111.039 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -112.27 156.83 21.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 111.529 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.66 174.96 6.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.699 HD11 HG12 ' A' ' 82' ' ' VAL . 7.8 tp -104.68 110.73 23.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.078 HG13 HD11 ' A' ' 4' ' ' LEU . 80.8 t -119.52 102.46 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.694 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.505 ' O ' HD22 ' A' ' 4' ' ' LEU . 11.1 mm -78.36 128.45 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 111.634 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -95.77 -47.64 6.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.0 -168.29 41.36 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.41 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -94.31 -160.82 34.64 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 117.824 0.812 . . . . 0.0 112.557 -0.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.14 -51.57 13.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -55.84 -33.09 64.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.536 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.535 ' CD1' HD22 ' A' ' 62' ' ' LEU . 39.3 mm -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.2 m-85 -60.51 -57.5 12.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.694 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.837 ' HA ' HD13 ' A' ' 129' ' ' ILE . 3.9 t -67.13 -9.98 45.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.609 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.76 -46.04 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.839 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.3 m-85 -94.53 -6.44 43.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 14.7 pttp -52.26 -30.2 26.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.912 0.386 . . . . 0.0 111.056 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.83 -7.21 58.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.269 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.43 -20.06 6.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.728 HG11 HD23 ' A' ' 113' ' ' LEU . 74.0 t -44.75 127.34 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.358 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.423 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 12.7 t70 -105.04 2.78 29.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 52.1 m -167.47 139.29 3.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.728 HD23 HG11 ' A' ' 110' ' ' VAL . 11.6 mt -119.72 146.62 45.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.33 0.586 . . . . 0.0 112.164 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.061 HD12 HD12 ' A' ' 4' ' ' LEU . 27.1 mt -135.6 112.39 10.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.198 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.86 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -130.59 141.79 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 111.596 -179.272 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -117.43 102.8 9.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.665 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.4 ttp85 -80.42 102.77 9.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.736 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 152' ' ' THR . 0.5 OUTLIER -80.93 123.46 28.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.17 -46.26 82.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.372 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 150' ' ' ALA . . . -57.71 -163.25 0.05 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.609 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.3 p -143.41 137.83 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.057 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.567 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -128.81 162.04 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -111.87 143.08 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' A' ' 15' ' ' LYS . . . -163.8 -166.67 23.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.597 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.46 -23.48 3.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -109.1 134.01 52.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.802 0.334 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -112.88 -174.0 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -164.8 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.837 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.1 pt -118.31 166.27 14.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.224 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.2 Cg_endo -75.7 103.52 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.43 2.087 . . . . 0.0 112.221 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.83 145.93 26.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.6 74.6 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.236 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -57.5 -20.53 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.48 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.93 -30.87 64.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.76 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.04 -21.96 39.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 78.5 m-85 -103.44 176.6 5.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 111.326 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -138.93 141.9 38.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.441 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 3.0 ttpt -78.15 124.33 27.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.8 m -109.18 -18.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.511 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.3 m -168.05 140.28 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.867 0.365 . . . . 0.0 111.368 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 6.4 p -155.48 111.13 3.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -144.08 115.42 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.8 m -76.97 143.1 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.124 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 105.73 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.212 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.651 ' HA ' HG23 ' A' ' 152' ' ' THR . 23.2 mt-10 -86.13 97.2 10.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.652 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -78.98 178.18 8.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.1 p -57.41 -52.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.699 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.501 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.32 125.68 91.3 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.806 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -28.83 87.77 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.085 1.857 . . . . 0.0 112.633 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HA ' ' CA ' ' A' ' 120' ' ' GLY . . . -90.02 -20.86 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.664 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.7 mt -83.24 7.19 17.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.597 0.237 . . . . 0.0 111.477 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.835 ' O ' HD23 ' A' ' 118' ' ' LEU . 62.6 m -72.43 167.0 21.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 7.8 p-80 -175.37 162.14 2.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.641 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 19.4 m -125.79 139.11 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.588 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.9 105.17 17.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.37 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.721 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.2 mm-40 -103.56 121.55 43.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.284 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.785 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.7 t -115.13 114.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.709 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.442 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.6 m95 -112.35 150.63 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.462 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.409 ' HG3' HG11 ' A' ' 139' ' ' VAL . 7.9 mt-30 -127.5 117.62 22.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -54.91 132.8 47.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.299 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -114.67 -168.32 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.403 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.089 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 m . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.33 150.14 29.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.506 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 2.3 m-30 -117.95 115.83 25.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.89 124.49 51.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.469 0.652 . . . . 0.0 112.602 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.61 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.3 p90 -171.85 173.22 4.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.41 140.45 52.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.387 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -128.58 157.87 40.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.6 179.76 4.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.688 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.0 OUTLIER -50.94 -36.09 36.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.119 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -30.95 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.752 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.54 46.9 2.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.312 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.89 HD11 ' HA3' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -107.34 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.58 ' N ' ' HG ' ' A' ' 12' ' ' LEU . 4.6 pt -110.68 -41.62 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.596 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.83 -155.65 27.06 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.281 -0.962 . . . . 0.0 113.03 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CG ' ' HA2' ' A' ' 124' ' ' GLY . 7.6 mtpp -107.6 -166.67 1.17 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.72 0.295 . . . . 0.0 110.973 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.84 88.69 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.806 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.71 -76.33 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.666 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -164.85 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.042 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp 68.08 73.5 0.34 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 15.3 Cg_exo -68.03 -14.43 40.99 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.732 2.288 . . . . 0.0 112.174 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.431 ' CE3' ' HB2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -146.08 144.17 29.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.618 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 -47.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.083 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.504 HD22 HD21 ' A' ' 151' ' ' LEU . 1.2 mt -125.95 146.21 54.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.119 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.16 -46.41 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.642 2.228 . . . . 0.0 112.471 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.67 -28.43 69.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.951 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 23' ' ' LEU . 3.8 t0 -68.82 -13.87 62.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.517 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.7 tp -93.53 -34.75 13.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 110.63 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -58.95 -26.51 64.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -62.29 -68.9 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.18 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.484 ' HB2' ' CD2' ' A' ' 4' ' ' LEU . 1.7 p90 -91.19 31.25 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.689 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.502 ' O ' HG13 ' A' ' 35' ' ' VAL . 3.7 tmt_? -73.85 -53.98 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -95.75 -34.23 11.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.74 -8.61 55.27 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.463 HG21 ' CD2' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -117.7 -16.48 10.04 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.673 -179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.532 HG12 ' HD3' ' A' ' 57' ' ' ARG . 3.4 m -107.56 158.9 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.076 0.465 . . . . 0.0 111.978 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 73.09 15.78 78.57 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 115.904 1.122 . . . . 0.0 115.904 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -148.4 -170.13 3.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.068 1.934 . . . . 0.0 109.617 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 80.8 mt -82.05 86.7 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.2 ttp -99.34 117.59 34.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.686 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.857 HG21 HG11 ' A' ' 82' ' ' VAL . 3.6 t -85.08 127.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.8 m -134.58 149.66 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.32 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.71 51.78 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.116 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.701 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -58.59 -52.56 65.16 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.854 0.327 . . . . 0.0 110.321 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.503 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 1.1 tpp180 -58.89 -37.27 76.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 m -69.96 -42.1 73.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.226 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CG ' HG22 ' A' ' 61' ' ' VAL . 53.1 t80 -64.1 -41.65 97.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.18 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -57.8 -66.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.785 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' PHE . 88.6 p -61.23 -30.63 70.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.78 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -30.41 133.32 0.22 Allowed Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.775 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_exo -38.39 -35.08 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.129 2.553 . . . . 0.0 113.252 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.786 ' HB3' HD23 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -152.35 139.76 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -140.3 108.12 6.75 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 91.6 Cg_endo -75.55 -170.51 8.46 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.519 -1.45 . . . . 0.0 112.195 -0.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.786 HD23 ' HB3' ' A' ' 51' ' ' LYS . 28.0 mt -99.21 155.95 35.98 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 104.63 1.45 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.576 2.184 . . . . 0.0 112.704 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.521 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 27.1 mt-10 69.8 6.89 5.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.783 ' HD2' HD13 ' A' ' 54' ' ' LEU . 1.8 mtt180 -109.3 113.0 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.885 0.374 . . . . 0.0 111.552 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.7 m -67.33 107.98 2.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.996 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.409 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.7 m120 -108.23 141.83 39.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.929 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 76' ' ' VAL . 16.1 t -117.15 143.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.095 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 43' ' ' ARG . 94.2 t -110.87 124.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 0.0 111.589 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -103.58 121.08 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.742 HG21 ' CD2' ' A' ' 68' ' ' TYR . 7.0 t -158.58 162.52 37.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.816 0.341 . . . . 0.0 111.208 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -86.08 -3.65 58.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.335 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tp60 -77.96 131.56 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.857 0.36 . . . . 0.0 110.38 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.49 -30.27 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.275 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -98.99 10.85 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.742 ' CD2' HG21 ' A' ' 63' ' ' THR . 5.9 t80 -61.84 141.98 57.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.22 0.533 . . . . 0.0 111.917 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.903 ' HA ' HG21 ' A' ' 75' ' ' VAL . 12.5 mm-40 -134.31 177.58 7.65 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.388 1.09 . . . . 0.0 112.899 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.54 144.69 19.62 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 112.996 -1.911 . . . . 0.0 110.641 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.03 96.92 2.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 0.0 110.46 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.53 -34.66 3.28 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.41 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.33 169.46 13.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 112.021 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.93 140.4 18.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.572 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.903 HG21 ' HA ' ' A' ' 69' ' ' GLN . 43.3 t -106.08 109.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.401 0.62 . . . . 0.0 112.461 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.891 HG21 HG22 ' A' ' 82' ' ' VAL . 34.6 m -117.81 163.89 14.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.891 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -116.69 -24.46 7.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.727 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -150.93 -174.03 4.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.143 0.497 . . . . 0.0 111.495 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.793 HG21 ' O ' ' A' ' 105' ' ' ALA . 45.5 t -70.25 -10.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.476 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.94 -31.43 18.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.023 0.44 . . . . 0.0 110.304 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.24 -28.79 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.891 HG22 HG21 ' A' ' 76' ' ' VAL . 22.6 t -76.5 -52.9 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -54.55 -28.06 43.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.65 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -68.15 -39.63 82.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 88.9 t80 -66.12 -56.81 9.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.02 -22.23 14.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.923 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -67.72 -41.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -82.69 -4.88 58.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.564 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 98.1 m-70 -125.95 64.42 51.77 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 110.301 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.6 0.13 3.86 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.371 2.714 . . . . 0.0 113.011 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -30.13 21.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.725 0.298 . . . . 0.0 110.808 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.427 . . . . 0.0 111.592 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -98.45 169.41 9.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.273 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 86' ' ' ALA . 5.5 tp -105.34 115.82 30.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.306 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -123.86 106.35 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.433 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.1 mm -78.42 139.49 18.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.981 0.419 . . . . 0.0 111.265 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.463 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.2 -39.48 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.194 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.49 -168.04 41.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -81.73 -161.29 27.68 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 117.347 0.574 . . . . 0.0 112.549 -0.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -55.65 -42.13 74.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.978 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.72 -28.12 69.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.633 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.7 mm -80.39 -35.45 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.16 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.9 m-85 -51.76 -55.98 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.526 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.778 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.1 t -66.18 -9.66 33.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.793 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.02 -41.58 28.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.695 0.283 . . . . 0.0 111.226 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.784 ' CD2' HG13 ' A' ' 79' ' ' VAL . 4.0 m-85 -95.33 -7.46 38.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.23 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.566 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.5 OUTLIER -50.85 -32.46 20.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.36 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -4.64 47.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.71 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.0 -20.6 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.561 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 90.7 t -44.74 140.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.154 0.502 . . . . 0.0 111.692 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -126.94 7.35 6.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.604 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.7 m -168.41 138.33 2.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.873 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.573 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 11.6 mt -122.8 142.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.313 0.577 . . . . 0.0 112.049 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.8 mt -130.52 114.35 15.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.2 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.61 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.5 m -138.37 148.53 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.29 112.71 24.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 9.0 mmt180 -89.22 104.7 17.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.627 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 14.6 mt -85.96 114.6 22.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.03 -26.89 28.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.652 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 150' ' ' ALA . . . -92.22 -173.44 41.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.848 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 32.3 t -116.82 165.74 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.627 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 10.2 m-85 -152.03 168.26 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.04 170.3 16.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.89 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 148.97 153.99 6.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.819 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -120.07 5.11 10.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.628 0.251 . . . . 0.0 111.459 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.508 HG22 HD11 ' A' ' 13' ' ' ILE . 12.5 m -131.25 138.71 49.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.7 mttt -114.32 163.09 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.415 ' HG3' ' NE1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.93 -179.12 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.022 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.778 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.5 pt -101.27 159.72 28.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.21 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.59 105.14 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.794 2.329 . . . . 0.0 112.421 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mt -96.09 150.77 20.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.038 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.31 72.8 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.574 ' HH2' HG11 ' A' ' 115' ' ' VAL . 81.0 m95 -56.9 -23.09 42.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.32 -30.26 66.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 0.0 110.457 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.63 -19.42 45.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.99 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.402 ' CD1' HD11 ' A' ' 113' ' ' LEU . 52.0 m-85 -107.87 167.76 9.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.576 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -129.98 141.24 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -79.92 109.11 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.767 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.2 m -90.54 -22.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.7 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.2 m -159.58 140.72 12.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -157.11 113.03 2.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.211 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.757 ' C ' HG23 ' A' ' 154' ' ' THR . 1.4 ttp180 -136.28 130.11 32.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 3.8 m -89.84 132.03 35.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.15 0.5 . . . . 0.0 112.194 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 t -105.15 113.0 41.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.626 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.683 ' HA ' HG23 ' A' ' 152' ' ' THR . 17.1 mt-10 -96.88 97.47 9.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.36 -176.04 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.267 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.4 p -63.49 -24.03 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.041 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.529 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -90.69 120.66 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.91 -18.79 59.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.529 2.153 . . . . 0.0 112.36 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 120' ' ' GLY . . . -95.81 -25.87 15.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.816 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.2 mt -85.1 2.45 43.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.741 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 145' ' ' GLU . 16.6 m -83.47 82.46 8.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 111.083 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.584 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -98.04 -171.74 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.757 HG23 ' C ' ' A' ' 142' ' ' ARG . 21.6 m -134.11 137.84 44.84 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' SER . 10.9 m-85 -86.06 106.76 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.561 ' HB2' HG22 ' A' ' 115' ' ' VAL . 11.3 mt-10 -105.46 121.47 44.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.767 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.5 t -114.61 111.8 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.895 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 16.3 m95 -107.93 151.34 25.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.114 0.483 . . . . 0.0 112.022 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.421 ' HB2' ' CG1' ' A' ' 139' ' ' VAL . 6.2 mt-30 -132.39 131.61 41.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.364 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -49.44 123.74 8.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 111.465 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.429 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -110.1 -175.55 2.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.959 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.191 179.694 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 13.8 m . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.5 154.62 24.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.587 . . . . 0.0 112.557 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.501 ' HB2' HD23 ' A' ' 113' ' ' LEU . 1.3 m-85 -121.22 117.47 27.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.778 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.833 HD21 ' HA ' ' A' ' 30' ' ' PHE . 9.5 tp -115.41 124.56 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.707 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.3 p90 -168.52 163.3 12.42 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.51 136.29 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -118.21 153.17 34.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -102.89 -178.17 3.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.235 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -48.82 -49.08 40.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.28 0.562 . . . . 0.0 109.843 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' HB3' HD23 ' A' ' 12' ' ' LEU . 7.6 t70 -69.79 -25.65 63.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.58 32.64 5.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.5 pp -100.93 166.04 11.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -121.49 -52.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' H ' HD12 ' A' ' 13' ' ' ILE . . . -167.61 -141.38 3.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.804 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.63 -158.73 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.585 0.231 . . . . 0.0 110.789 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -160.8 36.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -162.93 -68.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.566 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.775 ' O ' HD23 ' A' ' 19' ' ' LEU . 2.8 m80 -94.15 147.45 23.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.748 0.308 . . . . 0.0 111.013 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -150.55 88.74 4.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.709 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.3 -64.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.588 2.192 . . . . 0.0 112.447 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.95 137.51 33.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.037 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.47 138.23 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.982 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.498 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -86.93 124.18 69.27 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.051 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.498 ' HD2' HD23 ' A' ' 23' ' ' LEU . 7.6 Cg_exo -72.28 -30.15 13.25 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.565 2.176 . . . . 0.0 112.472 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.63 -34.82 59.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.35 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 30' ' ' PHE . 6.7 m-20 -78.94 -43.02 25.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.085 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.549 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 4.9 tp -55.54 -14.53 2.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.179 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -84.6 -57.35 3.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.515 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 44.9 t80 -78.04 -35.98 49.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.737 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.833 ' HA ' HD21 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -62.9 -14.47 46.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.887 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -92.74 -60.37 1.83 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.656 ' H ' ' HG3' ' A' ' 31' ' ' ARG . . . -54.72 -20.57 8.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.644 ' HB2' HD22 ' A' ' 4' ' ' LEU . 9.8 mm-40 -92.8 -5.79 50.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.843 HG22 HG12 ' A' ' 95' ' ' VAL . 21.0 p -141.49 -35.49 0.46 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.887 HG22 ' O ' ' A' ' 31' ' ' ARG . 4.8 m -70.28 143.73 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.772 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.51 -7.48 26.35 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.367 -0.92 . . . . 0.0 114.016 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -154.69 -164.03 1.72 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.602 1.201 . . . . 0.0 109.788 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.551 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 54.0 mt -72.28 89.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.15 126.95 51.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.62 HG21 HG11 ' A' ' 82' ' ' VAL . 21.4 t -79.77 158.73 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.108 0.48 . . . . 0.0 112.189 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' HG12 ' A' ' 40' ' ' VAL . 31.1 m -160.24 150.86 5.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.852 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.7 155.87 43.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.907 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -54.87 -49.09 72.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.922 0.361 . . . . 0.0 110.776 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 15.2 tpt85 -62.88 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -69.88 -43.27 72.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.664 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -63.9 -29.26 70.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.023 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -66.15 -66.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.901 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 17.0 t -53.27 -30.73 40.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -31.13 123.37 0.34 Allowed Pre-proline 0 N--CA 1.468 0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.606 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.61 -27.46 5.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.789 2.326 . . . . 0.0 113.251 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -171.31 117.57 0.44 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.298 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -122.05 141.2 33.72 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.96 -174.41 12.2 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.261 -1.558 . . . . 0.0 111.702 -0.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.697 HD13 ' HD2' ' A' ' 57' ' ' ARG . 17.0 mt -95.1 154.91 39.48 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.52 -83.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.702 2.268 . . . . 0.0 113.137 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -96.42 33.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HD2' HD13 ' A' ' 54' ' ' LEU . 4.0 mtt180 -132.09 100.96 5.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.326 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.551 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 51.6 m -68.23 121.85 17.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.785 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -105.83 151.09 24.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.252 0.548 . . . . 0.0 112.191 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 76' ' ' VAL . 11.3 t -128.0 140.93 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.174 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.1 t -111.31 118.33 57.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 111.604 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.883 HD12 HG23 ' A' ' 76' ' ' VAL . 3.4 tp -104.21 112.16 25.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.537 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.9 t -149.99 162.24 40.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -76.9 -6.39 52.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.594 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.777 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.7 tp-100 -74.01 125.29 27.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.706 0.288 . . . . 0.0 110.441 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.1 -8.13 59.7 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' H ' ' HG3' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -127.52 11.8 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.777 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.3 t80 -58.37 148.26 28.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.119 0.485 . . . . 0.0 111.45 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.893 ' HA ' HG21 ' A' ' 75' ' ' VAL . 25.9 mm100 -132.32 174.46 10.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.437 1.113 . . . . 0.0 112.728 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 141.96 16.78 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.375 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -82.15 96.65 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 110.147 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.33 -45.77 1.36 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.544 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -72.72 163.36 28.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.986 0.422 . . . . 0.0 111.759 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -96.17 140.62 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 69' ' ' GLN . 18.7 t -102.55 119.23 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.699 . . . . 0.0 112.26 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.883 HG23 HD12 ' A' ' 62' ' ' LEU . 30.0 m -128.32 167.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.729 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -115.43 -23.59 8.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.713 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.728 ' CA ' HD11 ' A' ' 62' ' ' LEU . 1.4 t70 -153.02 179.84 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.134 0.493 . . . . 0.0 111.581 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.964 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.6 t -65.53 -10.15 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.751 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.5 -33.0 19.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.679 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.59 -27.23 58.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.807 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.839 HG22 HG21 ' A' ' 76' ' ' VAL . 16.5 t -74.01 -55.22 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 13.0 m-85 -55.57 -28.23 53.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.801 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.37 90.81 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.46 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 73.8 t80 -63.4 -54.05 42.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.394 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -23.81 44.18 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.328 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -71.75 -33.41 68.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.406 ' HG2' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -89.02 -9.36 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.246 179.059 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 94.5 m-70 -125.0 66.23 49.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.61 0.24 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.393 2.729 . . . . 0.0 113.014 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -37.17 27.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.75 161.79 14.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.34 174.67 6.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.253 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.464 HD11 ' CG1' ' A' ' 82' ' ' VAL . 13.2 tp -116.1 114.84 25.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.504 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.843 HG12 HG22 ' A' ' 34' ' ' THR . 23.1 t -127.58 112.65 28.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.817 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 96' ' ' ILE . 3.4 mm -81.4 131.38 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.844 0.354 . . . . 0.0 111.416 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.463 ' HB1' ' HE1' ' A' ' 30' ' ' PHE . . . -105.78 -41.88 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.876 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.57 -168.49 41.56 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.806 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.421 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.76 -160.74 33.93 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 122.027 -0.69 . . . . 0.0 112.588 -0.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.434 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -50.52 -58.35 5.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.81 -28.13 5.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.67 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 62' ' ' LEU . 37.2 mm -81.23 -28.66 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.3 m-85 -59.39 -58.67 7.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.007 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.629 ' CA ' HD13 ' A' ' 129' ' ' ILE . 13.6 t -66.79 -9.9 41.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.771 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.25 -41.62 57.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.964 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.2 m-85 -98.21 -3.97 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.644 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 38.7 pttt -51.61 -33.99 35.53 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.88 0.372 . . . . 0.0 111.114 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.17 -3.85 47.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.586 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.34 -21.93 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 106' ' ' PHE . 94.7 t -45.87 134.88 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.036 0.446 . . . . 0.0 111.505 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -116.66 6.01 13.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.598 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 46.2 m -168.03 141.66 3.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.311 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.708 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 13.8 mt -123.54 146.0 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.22 0.533 . . . . 0.0 111.814 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.491 HD13 ' OE1' ' A' ' 33' ' ' GLN . 13.2 mt -135.57 117.44 15.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.884 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.707 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.4 m -135.13 144.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.408 . . . . 0.0 111.49 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -112.92 113.19 25.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.802 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.37 100.7 12.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.464 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 2.2 mp -91.54 131.61 36.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.416 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.48 -52.63 64.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.047 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.24 -172.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.564 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -123.27 164.03 19.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 111.038 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.29 165.15 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 166.57 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.54 153.12 6.5 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.762 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.98 6.1 12.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.653 0.264 . . . . 0.0 111.107 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.8 m -133.94 145.23 49.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.368 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.2 pttp -122.21 173.77 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.5 tpt -69.32 153.15 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.629 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.7 pp -78.9 163.36 60.84 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.56 101.42 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.336 . . . . 0.0 112.653 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.41 149.03 21.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.636 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.49 77.31 3.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.708 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.4 m95 -61.16 -17.83 54.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.352 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.26 -34.45 63.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 110.464 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.11 -17.79 56.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.39 169.23 8.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 110.826 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.721 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -129.31 141.33 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 0.7 OUTLIER -82.88 119.06 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.312 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 157' ' ' VAL . 10.0 m -101.45 -21.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.896 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.2 m -160.74 143.36 12.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.264 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.87 111.7 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.463 ' C ' HG23 ' A' ' 154' ' ' THR . 9.2 ttp-105 -146.66 120.41 9.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.416 . . . . 0.0 111.398 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.649 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -74.57 145.97 42.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.214 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.525 HG21 ' HE2' ' A' ' 155' ' ' TYR . 14.4 t -116.45 102.57 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.426 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -85.31 99.66 11.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.63 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.47 -176.51 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.507 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.0 p -54.36 -56.53 17.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.515 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 34.2 t-20 -74.54 124.16 89.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.796 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.8 -27.52 84.13 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.262 1.975 . . . . 0.0 112.887 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.16 -19.44 26.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.5 mt -84.32 8.0 17.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.639 0.257 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 144' ' ' VAL . 97.0 m -73.33 165.17 25.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p-80 -172.73 159.33 4.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.223 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.649 ' OG1' HG23 ' A' ' 143' ' ' THR . 19.1 m -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.548 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.525 ' HE2' HG21 ' A' ' 144' ' ' VAL . 98.5 m-85 -118.69 105.76 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.661 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HB2' HG22 ' A' ' 115' ' ' VAL . 12.8 mt-10 -106.63 124.88 50.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.856 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 139' ' ' VAL . 10.5 t -116.3 112.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 22.0 m95 -106.75 149.83 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.435 . . . . 0.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -132.29 129.7 39.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -46.52 123.55 5.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.523 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.721 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -105.42 178.49 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.066 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.647 HG23 HD23 ' A' ' 94' ' ' LEU . 4.7 m . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.43 154.47 22.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -122.76 116.35 23.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.505 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 30' ' ' PHE . 4.8 tp -114.95 122.5 46.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.673 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.0 p90 -167.22 168.33 13.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.615 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HB2' ' HZ ' ' A' ' 30' ' ' PHE . . . -119.85 141.26 49.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 111.29 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.39 153.77 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.89 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.77 -177.06 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -36.2 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.15 -21.32 29.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.46 25.04 29.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.596 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.5 tt -101.58 148.87 24.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.318 . . . . 0.0 111.003 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 126' ' ' THR . 1.1 pt -112.29 173.32 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.28 153.66 51.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.768 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -79.36 109.89 14.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.795 0.331 . . . . 0.0 110.874 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.25 101.53 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.002 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.01 -83.09 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.502 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 19' ' ' LEU . 7.3 m170 -120.04 133.68 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.72 0.295 . . . . 0.0 110.853 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 18' ' ' HIS . 3.6 mp -142.33 140.58 19.29 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.61 -65.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.407 2.071 . . . . 0.0 112.239 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -160.99 -171.53 3.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.684 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.65 170.6 14.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.976 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.442 HD11 HD22 ' A' ' 151' ' ' LEU . 4.4 mm? -88.84 145.27 34.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.95 -41.35 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.601 2.201 . . . . 0.0 112.486 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -78.24 -22.38 48.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.01 -20.5 24.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.399 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -28.34 64.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.762 0.315 . . . . 0.0 111.29 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -66.36 -23.86 66.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.483 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.423 ' CD1' ' CD1' ' A' ' 155' ' ' TYR . 34.0 t80 -73.28 -45.36 56.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.406 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.747 ' HZ ' ' HB2' ' A' ' 6' ' ' ALA . 14.4 m-85 -86.03 4.33 38.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.796 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.777 ' O ' HG13 ' A' ' 35' ' ' VAL . 4.5 ttt-85 -92.24 -62.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 0.0 111.775 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.57 -15.98 63.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.579 ' O ' HG11 ' A' ' 95' ' ' VAL . 6.7 mm-40 -93.27 -9.4 39.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.461 HG23 HD22 ' A' ' 4' ' ' LEU . 54.7 p -144.79 22.22 1.61 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 31' ' ' ARG . 23.3 m -108.51 148.35 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.028 0.442 . . . . 0.0 111.968 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 54.33 34.22 53.83 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 116.868 1.507 . . . . 0.0 116.868 176.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -151.17 -165.17 2.19 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.692 2.246 . . . . 0.0 108.631 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.63 87.72 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.644 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.1 ttp -99.0 124.21 43.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.603 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.593 HG21 HG11 ' A' ' 82' ' ' VAL . 20.9 t -77.54 157.39 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.989 0.423 . . . . 0.0 111.838 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 60' ' ' VAL . 32.6 m -161.18 147.8 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.956 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.39 155.55 53.06 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.062 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.7 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.31 -52.19 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.972 0.386 . . . . 0.0 110.126 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -57.77 -30.68 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.46 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.47 HG22 ' CE2' ' A' ' 49' ' ' PHE . 21.5 m -71.29 -49.26 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.798 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 13.1 t80 -55.03 -35.7 64.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.487 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -66.83 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.938 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 49' ' ' PHE . 99.7 p -52.8 -37.19 59.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.815 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.971 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.49 127.35 0.25 Allowed Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.908 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.5 -27.68 19.57 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.071 2.514 . . . . 0.0 113.814 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 2.7 ttmm -151.75 147.95 27.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.966 0.412 . . . . 0.0 111.525 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.09 109.69 10.67 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.612 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 4.0 Cg_exo -86.53 168.04 46.0 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.792 -1.337 . . . . 0.0 112.048 -0.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.971 HD11 ' CE1' ' A' ' 49' ' ' PHE . 7.7 mt -59.45 164.86 4.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.645 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 10.9 Cg_endo -54.23 91.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 113.05 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 14.9 mm-40 64.82 23.36 12.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.262 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 23.1 mtt180 -109.57 132.19 54.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.917 0.389 . . . . 0.0 111.444 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.8 m -84.05 108.14 16.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.772 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.51 158.17 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 112.089 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.775 HG12 HG22 ' A' ' 76' ' ' VAL . 10.7 t -130.8 143.33 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.042 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.7 HG13 ' HA ' ' A' ' 43' ' ' ARG . 99.5 t -108.84 122.08 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -104.25 122.94 46.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.272 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.586 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -156.29 165.71 35.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.217 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -84.36 -9.0 58.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.3 tt0 -76.0 133.55 40.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -88.1 6.81 34.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.938 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.98 3.15 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.887 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.4 t80 -57.27 139.19 53.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.456 . . . . 0.0 111.299 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.877 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -126.67 176.37 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.92 0.866 . . . . 0.0 112.253 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.65 146.19 23.16 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.118 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -94.34 96.23 9.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.508 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.59 13.38 53.82 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.057 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.694 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -136.55 172.87 12.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.925 0.393 . . . . 0.0 111.627 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 14.0 t -100.24 140.17 19.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 68' ' ' TYR . 21.6 t -106.41 116.0 49.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.09 0.472 . . . . 0.0 111.992 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.928 HG21 HG22 ' A' ' 82' ' ' VAL . 27.4 m -124.83 162.2 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.656 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.9 m-70 -111.19 -23.19 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.365 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -155.71 -171.39 3.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.222 0.534 . . . . 0.0 111.64 -179.303 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.894 HG13 ' CD2' ' A' ' 106' ' ' PHE . 6.0 t -69.87 -9.22 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.07 16.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.149 0.499 . . . . 0.0 109.948 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -76.43 -28.14 56.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.694 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 76' ' ' VAL . 22.0 t -74.74 -51.08 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.545 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.3 m-85 -57.23 -25.51 59.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.667 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.93 -42.28 81.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.176 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 68.2 t80 -65.06 -56.07 15.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.72 -22.55 36.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.954 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.9 -31.88 68.66 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.457 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 15.3 mt-30 -87.1 -7.42 58.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.443 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.19 67.92 56.2 Favored Pre-proline 0 N--CA 1.456 -0.132 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.65 -0.32 2.99 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.133 2.555 . . . . 0.0 112.928 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.94 -24.54 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.304 . . . . 0.0 111.17 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -101.75 155.17 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.14 167.59 10.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.994 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.68 HD11 ' CG1' ' A' ' 82' ' ' VAL . 9.7 tp -120.04 113.02 19.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.081 0.467 . . . . 0.0 111.499 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 33' ' ' GLN . 9.0 t -127.49 109.72 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.188 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 40' ' ' VAL . 3.7 mm -77.59 130.68 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -105.5 -42.89 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.492 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.7 -169.02 41.34 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.896 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.417 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -87.06 -160.92 35.75 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 122.118 -0.637 . . . . 0.0 112.7 -0.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.76 -53.5 39.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 111.404 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -27.62 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.1 mm -81.42 -22.7 10.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.1 m-85 -64.65 -55.24 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.726 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.617 ' CA ' HD13 ' A' ' 129' ' ' ILE . 10.6 t -66.54 -9.75 38.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.01 -41.73 41.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.894 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.6 m-85 -95.66 -5.37 42.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.57 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 2.0 pttt -51.52 -33.57 32.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.79 0.328 . . . . 0.0 111.336 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -84.73 -0.29 53.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.739 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -124.42 -24.58 4.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.872 HG11 HD23 ' A' ' 113' ' ' LEU . 58.5 t -48.21 122.14 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.634 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.95 3.47 44.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 93.9 m -165.43 142.21 5.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.284 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.872 HD23 HG11 ' A' ' 110' ' ' VAL . 8.1 mt -125.76 146.09 49.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.902 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.4 mt -134.75 119.31 18.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.697 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.673 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -135.29 145.26 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 106.47 15.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.309 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -93.1 104.58 16.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.835 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 1.2 mp -91.48 128.13 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.52 -49.09 37.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.217 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.46 172.6 3.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.298 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.2 t -112.71 147.96 35.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 1.5 m-85 -122.02 153.0 39.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -111.13 141.0 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -169.62 -167.77 30.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.55 -16.68 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.606 0.241 . . . . 0.0 111.537 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 13' ' ' ILE . 40.7 m -109.14 131.96 54.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.697 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.57 173.44 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.755 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.455 ' HE2' ' CE2' ' A' ' 5' ' ' TRP . 17.1 tpt -78.35 147.14 34.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.662 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -64.08 166.96 8.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.662 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.1 Cg_endo -77.13 98.04 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.265 1.977 . . . . 0.0 112.674 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.71 145.08 25.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 78.58 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.469 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.1 m95 -60.16 -20.11 56.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.51 -32.88 66.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -24.13 51.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.013 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.621 ' CD1' HD11 ' A' ' 113' ' ' LEU . 77.3 m-85 -97.49 173.6 7.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.867 0.365 . . . . 0.0 110.76 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.13 143.36 44.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.522 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.8 ttpm? -84.0 108.64 17.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.816 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 157' ' ' VAL . 28.2 m -91.37 -26.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.318 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.0 m -154.86 140.7 18.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 35.4 p -164.6 111.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.445 ' C ' HG23 ' A' ' 154' ' ' THR . 0.3 OUTLIER -143.07 122.57 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.68 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.731 HG23 ' OG1' ' A' ' 154' ' ' THR . 4.0 m -78.43 144.28 35.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.18 0.514 . . . . 0.0 111.54 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.492 HG21 ' HE2' ' A' ' 155' ' ' TYR . 3.3 t -116.27 105.12 17.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.48 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.2 mt-10 -86.12 98.97 11.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.847 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -81.33 -175.3 5.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.0 p -57.72 -57.66 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.487 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -68.56 120.17 73.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.91 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.5 -25.96 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.964 1.776 . . . . 0.0 112.324 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.47 -18.4 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.431 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.1 mt -87.15 8.86 21.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.599 0.237 . . . . 0.0 111.359 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.491 HG22 ' N ' ' A' ' 153' ' ' HIS . 79.7 m -71.48 169.29 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.491 ' N ' HG22 ' A' ' 152' ' ' THR . 3.9 p-80 -174.34 160.79 3.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.731 ' OG1' HG23 ' A' ' 143' ' ' THR . 10.4 m -127.69 133.95 49.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.627 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.492 ' HE2' HG21 ' A' ' 144' ' ' VAL . 67.9 m-85 -94.33 106.45 18.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.627 ' HB2' HG22 ' A' ' 115' ' ' VAL . 13.9 mt-10 -103.3 121.75 43.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.415 . . . . 0.0 111.971 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 139' ' ' VAL . 17.9 t -113.43 111.26 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.094 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.522 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.5 m95 -107.61 148.34 29.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.979 0.418 . . . . 0.0 111.721 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -126.92 117.28 22.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.8 tmtt? -49.77 132.45 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -99.96 171.91 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.626 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.02 148.87 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.518 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -111.81 114.45 27.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.244 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.27 121.26 43.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.66 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.1 p90 -167.58 176.21 6.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.499 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . . . -124.6 150.33 46.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 111.823 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.98 147.6 37.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.617 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -103.69 -167.91 1.43 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.421 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -52.6 -48.59 66.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.842 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.68 -26.49 60.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.65 20.89 12.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.636 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.656 HD11 ' HA3' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -74.58 149.37 40.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.766 0.317 . . . . 0.0 110.645 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.16 -17.55 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.499 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' HD21 ' A' ' 12' ' ' LEU . . . 164.77 -157.51 29.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.424 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HG2' ' HA2' ' A' ' 124' ' ' GLY . 0.2 OUTLIER -129.6 109.35 10.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.397 . . . . 0.0 111.026 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -99.78 154.31 18.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.82 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.25 -15.1 8.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.768 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -142.35 -72.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.683 0.278 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.85 128.16 1.47 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.978 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.25 112.91 2.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.619 2.212 . . . . 0.0 112.459 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -91.09 165.48 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.768 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -89.64 145.04 25.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.274 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -105.31 121.0 47.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.498 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 23' ' ' LEU . 69.5 Cg_exo -51.28 -24.8 16.35 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.413 2.075 . . . . 0.0 112.746 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -95.18 -23.13 17.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.46 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -49.23 13.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.824 0.345 . . . . 0.0 111.322 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -52.26 -33.11 40.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.352 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -40.84 -32.58 0.23 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.082 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -105.7 -36.85 6.93 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 34' ' ' THR . 2.5 m-85 -91.99 30.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.659 ' HG3' ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -92.5 -45.11 8.29 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.174 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.659 ' N ' ' HG3' ' A' ' 31' ' ' ARG . . . -98.08 -40.05 8.61 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' OE1' HD13 ' A' ' 114' ' ' LEU . 2.3 mt-30 -68.93 -7.63 36.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -120.95 -5.22 9.58 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.909 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 32' ' ' ALA . 20.6 m -108.0 155.51 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.059 0.457 . . . . 0.0 112.092 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.99 28.64 58.39 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 116.346 1.299 . . . . 0.0 116.346 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.0 mtmt -147.65 -178.41 6.24 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.11 1.955 . . . . 0.0 108.28 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 79.0 mt -80.19 87.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.54 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.8 ttp -100.73 122.45 43.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.412 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.784 HG13 ' HB ' ' A' ' 60' ' ' VAL . 3.1 t -91.12 129.18 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.92 147.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.115 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.79 151.76 52.44 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.932 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.799 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -48.07 -55.91 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.906 0.384 . . . . 0.0 110.385 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.35 68.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.57 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -73.68 -31.37 63.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CG ' HG22 ' A' ' 61' ' ' VAL . 51.8 t80 -75.82 -33.04 60.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.815 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.0 mt-10 -64.21 -67.23 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.575 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -58.73 -30.04 67.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.738 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.766 ' CE2' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -34.31 149.44 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.905 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.55 -32.73 5.93 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.187 2.591 . . . . 0.0 113.932 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.38 152.9 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 9.1 mtp180 -124.72 101.72 32.93 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.2 Cg_endo -86.25 -168.11 5.08 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.965 -1.265 . . . . 0.0 112.213 0.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 49' ' ' PHE . 88.0 mt -95.76 159.8 31.65 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 18.9 Cg_endo -60.26 95.85 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.728 2.285 . . . . 0.0 113.638 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.534 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 10.6 mt-10 66.35 18.49 10.89 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.441 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HG3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -109.77 107.57 17.61 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.946 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.4 m -62.13 106.67 0.76 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.982 0.42 . . . . 0.0 110.164 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.524 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -105.54 156.88 17.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.201 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.784 ' HB ' HG13 ' A' ' 40' ' ' VAL . 5.2 t -130.2 144.08 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.84 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.799 HG13 ' HA ' ' A' ' 43' ' ' ARG . 89.6 t -116.09 106.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -89.0 118.14 28.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.015 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.864 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -148.95 169.84 19.67 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.926 0.393 . . . . 0.0 111.352 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -88.24 -9.25 53.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.2 tp-100 -78.1 128.76 34.31 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -79.76 -16.15 56.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.787 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.29 9.12 25.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.865 ' O ' HG11 ' A' ' 75' ' ' VAL . 3.5 t80 -58.77 140.37 55.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.007 0.432 . . . . 0.0 111.612 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.913 ' HA ' HG21 ' A' ' 75' ' ' VAL . 18.6 mm100 -124.96 178.34 5.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.107 0.956 . . . . 0.0 112.004 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.97 145.33 20.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.784 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.45 95.88 4.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.368 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.93 -39.35 2.96 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.051 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -69.29 172.33 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.688 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 85' ' ' TYR . 9.4 t -97.38 140.21 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.98 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.913 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.9 t -105.55 118.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.391 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.7 HG21 HG22 ' A' ' 82' ' ' VAL . 30.5 m -127.72 165.09 27.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.845 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' THR . 5.3 m-70 -116.18 -23.19 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 110.813 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -154.19 -167.57 2.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 111.305 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.936 HG13 ' CD2' ' A' ' 106' ' ' PHE . 4.0 t -74.42 -8.83 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.7 -32.9 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.092 0.472 . . . . 0.0 109.922 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.667 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.89 -27.54 57.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.7 HG22 HG21 ' A' ' 76' ' ' VAL . 68.7 t -73.09 -54.05 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.467 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.9 m-85 -55.98 -24.82 40.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.941 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.74 86.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.831 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 74' ' ' VAL . 81.9 t80 -66.69 -57.26 7.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.15 11.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.028 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.91 -38.06 76.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -83.89 -4.78 58.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.563 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -127.26 66.42 68.37 Favored Pre-proline 0 N--CA 1.455 -0.182 0 CA-C-O 121.015 0.436 . . . . 0.0 110.248 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.61 -0.01 5.41 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.231 2.621 . . . . 0.0 113.058 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -27.88 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.707 0.289 . . . . 0.0 111.087 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 6.1 mm-40 -105.08 159.23 16.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.658 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 42.1 mt-10 -98.09 159.23 15.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.135 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.623 HD21 HG12 ' A' ' 82' ' ' VAL . 20.1 tp -108.54 116.39 31.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.525 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 39' ' ' MET . 38.5 t -130.43 114.61 29.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.36 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.0 mm -82.51 131.1 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.632 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.86 -45.34 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.636 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.3 -166.3 39.05 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.406 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.42 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -92.74 -160.7 35.9 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 117.821 0.81 . . . . 0.0 112.741 -0.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.98 -48.56 16.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.466 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -60.19 -30.94 69.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.67 -26.61 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.501 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.467 ' HB3' HG12 ' A' ' 129' ' ' ILE . 4.2 m-85 -60.39 -56.38 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.811 ' CA ' HD13 ' A' ' 129' ' ' ILE . 14.9 t -65.93 -10.1 35.79 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.539 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.54 -43.28 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.936 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.1 m-85 -95.4 -3.61 46.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.555 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 16.5 pttp -48.91 -33.07 10.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.783 0.325 . . . . 0.0 111.397 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.05 3.85 50.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' HB2' HG11 ' A' ' 79' ' ' VAL . 1.4 m-20 -127.53 -27.9 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 0.0 111.517 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.66 HG11 HD23 ' A' ' 113' ' ' LEU . 92.7 t -52.04 123.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.196 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.65 8.01 43.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.426 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 76.3 m -167.56 142.97 3.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.815 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.66 HD23 HG11 ' A' ' 110' ' ' VAL . 16.2 mt -123.49 145.35 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.321 0.581 . . . . 0.0 111.723 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.4 HD13 ' OE1' ' A' ' 33' ' ' GLN . 9.5 mt -135.64 120.0 17.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.46 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.66 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.9 m -136.35 145.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.043 0.449 . . . . 0.0 111.864 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -111.81 108.5 17.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.038 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.9 ttm180 -80.57 99.24 8.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.98 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.59 125.93 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.21 74.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.71 163.75 6.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.497 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 59.5 p -105.87 159.47 15.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.802 0.334 . . . . 0.0 111.034 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -147.4 145.43 29.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.779 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -100.72 147.11 26.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.764 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . -179.43 174.19 46.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.733 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.9 42.83 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.204 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 m -162.38 124.81 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -112.67 172.74 6.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.964 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.1 tpt -72.62 157.59 37.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.811 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -79.2 163.76 58.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.289 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.58 93.76 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.749 2.3 . . . . 0.0 111.961 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -83.49 142.67 30.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.809 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.87 70.48 8.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -56.57 -21.75 28.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -73.31 -33.27 65.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.509 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 -10.49 58.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.102 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 45.1 m-85 -108.73 169.43 8.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.425 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -132.44 141.2 48.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.585 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 3.3 ttpp -85.11 128.99 34.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 157' ' ' VAL . 5.7 m -115.92 -17.86 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.1 m -164.51 143.32 7.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.493 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.72 111.76 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.161 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.552 ' C ' HG23 ' A' ' 154' ' ' THR . 10.2 ttt180 -139.73 118.34 12.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.747 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.4 m -81.48 145.06 30.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.392 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' A' ' 155' ' ' TYR . 5.4 t -121.12 103.36 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.5 mt-10 -84.34 102.22 12.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.33 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.44 -176.46 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.3 p -53.86 -55.84 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.504 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.46 121.77 85.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.946 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.06 -27.02 83.86 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.134 1.889 . . . . 0.0 112.413 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.65 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.669 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.6 mt -86.96 9.26 20.0 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.592 0.234 . . . . 0.0 111.551 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 145' ' ' GLU . 95.9 m -70.72 165.92 21.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 11.8 p-80 -170.61 156.51 5.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.133 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.747 ' OG1' HG23 ' A' ' 143' ' ' THR . 16.3 m -120.05 153.58 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.589 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.452 ' HE1' HG21 ' A' ' 144' ' ' VAL . 96.1 m-85 -116.3 105.04 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.8 mt-10 -101.26 153.96 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.903 ' O ' HG22 ' A' ' 139' ' ' VAL . 26.7 t -142.31 107.09 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 28.8 m95 -107.54 145.5 33.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.977 0.417 . . . . 0.0 111.897 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -125.83 114.75 18.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.504 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 1.9 ttmt -46.44 134.0 9.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.08 0.467 . . . . 0.0 112.06 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.425 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -124.19 -166.08 1.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.399 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.076 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.79 154.41 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.29 0.567 . . . . 0.0 112.446 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -119.07 112.59 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.603 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 30' ' ' PHE . 8.4 tp -113.52 121.78 45.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.81 ' CH2' HG12 ' A' ' 115' ' ' VAL . 2.8 p90 -167.31 164.5 15.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.927 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.76 135.34 54.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.699 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.4 pt20 -128.06 155.48 44.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -96.62 -172.49 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -38.56 59.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.023 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -32.65 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.84 37.01 2.64 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 9.3 mt -98.35 151.32 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.739 0.304 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.35 -31.77 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.285 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.88 -171.84 44.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -99.18 -92.4 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.469 0.176 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.03 -53.56 2.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.814 0.34 . . . . 0.0 111.032 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -169.59 43.3 0.21 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.481 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -124.57 126.3 45.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.856 0.36 . . . . 0.0 110.868 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -157.71 94.73 2.07 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -80.69 -160.43 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.079 2.519 . . . . 0.0 112.133 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.47 125.18 39.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.266 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.523 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.8 t60 -96.32 -70.06 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.359 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -140.13 165.4 30.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.137 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.672 ' HA ' HD21 ' A' ' 27' ' ' LEU . 88.8 Cg_endo -81.9 5.06 6.56 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.602 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -95.22 -18.4 20.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.75 -16.07 60.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.412 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -76.98 -14.68 59.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.627 0.251 . . . . 0.0 111.262 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -90.37 -32.59 16.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' A' ' 155' ' ' TYR . 18.0 t80 -106.26 -45.81 4.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.505 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.8 t80 -73.97 -33.54 63.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.632 ' O ' HG22 ' A' ' 35' ' ' VAL . 18.6 mtt85 -92.03 -61.74 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.98 -27.77 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.554 ' O ' HG11 ' A' ' 95' ' ' VAL . 1.4 mt-30 -86.83 -8.68 57.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.614 HG22 ' HG3' ' A' ' 39' ' ' MET . 1.4 p -132.75 -35.64 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 31' ' ' ARG . 7.6 m -79.96 155.07 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.836 0.351 . . . . 0.0 111.53 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.97 13.73 67.02 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.766 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 58' ' ' THR . 7.0 mtmt -151.57 -165.88 2.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.191 1.496 . . . . 0.0 109.23 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.66 87.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.614 ' HG3' HG22 ' A' ' 34' ' ' THR . 2.2 ttp -102.04 125.76 48.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 112.155 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 41' ' ' VAL . 20.8 t -82.19 158.81 3.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.646 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.5 m -165.1 141.06 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.455 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.01 154.13 53.03 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.477 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.16 -51.92 60.47 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.336 0.568 . . . . 0.0 110.687 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.424 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.9 tpt180 -57.64 -32.78 67.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.013 0.435 . . . . 0.0 110.112 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.409 HG22 ' CE2' ' A' ' 49' ' ' PHE . 8.7 m -70.74 -46.79 62.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.986 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.5 t80 -55.16 -40.7 70.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.112 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -66.15 0.55 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.941 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -52.26 -40.03 61.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.552 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.409 ' CE2' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER -33.52 127.95 0.41 Allowed Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.674 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -43.88 -26.52 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.144 2.562 . . . . 0.0 113.771 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.745 ' HB3' HD23 ' A' ' 54' ' ' LEU . 5.0 ttpt -151.59 138.02 18.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.59 107.95 6.03 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 71.6 Cg_endo -77.48 166.51 81.57 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.593 -1.42 . . . . 0.0 112.244 -0.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 51' ' ' LYS . 75.8 mt -76.23 158.95 81.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.47 112.04 3.46 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.492 2.128 . . . . 0.0 112.802 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 69.15 8.48 6.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.022 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.545 ' HD3' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -114.06 110.71 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.427 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 25.0 m -68.73 107.19 2.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.551 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -101.11 154.58 18.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.983 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 HG22 ' A' ' 76' ' ' VAL . 8.8 t -125.72 141.37 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.633 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 68' ' ' TYR . 98.8 t -110.72 124.67 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 111.72 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.913 HD13 HD12 ' A' ' 102' ' ' ILE . 2.1 mt -105.33 118.69 37.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.102 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.997 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.3 t -155.51 158.67 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.284 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -75.15 -4.32 38.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.62 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.7 tp-100 -85.83 126.03 33.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.398 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 6.2 mt-10 -78.31 -29.57 47.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.547 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -92.31 6.51 46.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.418 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.997 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.1 t80 -59.81 139.31 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.935 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -137.16 169.89 17.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.758 1.266 . . . . 0.0 113.752 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.75 134.09 11.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.267 -2.242 . . . . 0.0 109.566 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -78.97 106.51 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.108 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 -56.51 0.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -71.1 169.31 15.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 12.8 t -94.11 140.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.335 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.935 HG21 ' HA ' ' A' ' 69' ' ' GLN . 17.2 t -112.01 123.16 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 111.419 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 27.1 m -130.32 175.88 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 m80 -123.16 -25.32 4.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.012 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.47 -171.33 3.9 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.969 HG13 ' CD2' ' A' ' 106' ' ' PHE . 18.7 t -71.38 -10.81 14.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.732 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.86 -32.72 18.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 110.15 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.09 -27.62 59.96 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.903 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.055 HG12 HD11 ' A' ' 94' ' ' LEU . 57.4 t -74.5 -52.48 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 9.6 m-85 -54.74 -27.93 44.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.933 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -64.13 -45.82 86.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.14 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.48 ' CD1' HG11 ' A' ' 74' ' ' VAL . 56.1 t80 -62.64 -54.42 39.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -53.05 -23.28 7.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 83' ' ' PHE . 12.3 mttt -68.61 -44.11 74.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -79.54 -2.32 41.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.7 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -129.01 61.63 57.92 Favored Pre-proline 0 N--CA 1.456 -0.136 0 CA-C-O 120.951 0.405 . . . . 0.0 110.491 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.01 -0.75 8.97 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.011 2.474 . . . . 0.0 112.954 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.22 -38.69 26.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.92 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -107.73 168.83 8.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.23 164.67 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.321 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.055 HD11 HG12 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -110.78 122.91 49.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.796 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG11 ' O ' ' A' ' 33' ' ' GLN . 41.4 t -132.47 118.82 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.27 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 40' ' ' VAL . 8.0 mm -83.52 130.73 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.907 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -98.38 -48.73 4.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.82 -168.01 39.21 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.572 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.427 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -93.84 -160.86 35.1 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 117.717 0.758 . . . . 0.0 112.622 -0.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.48 -56.38 7.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.838 0.351 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -52.53 -29.81 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.913 HD12 HD13 ' A' ' 62' ' ' LEU . 46.5 mm -83.43 -28.52 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.982 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -59.62 -55.44 34.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.699 ' HA ' HD13 ' A' ' 129' ' ' ILE . 12.4 t -67.76 -10.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.961 -0.462 . . . . 0.0 112.065 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.774 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.51 -39.07 58.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.949 0.404 . . . . 0.0 110.707 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.969 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.3 m-85 -100.0 -5.34 28.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 11.9 pttt -51.23 -31.33 20.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 111.617 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.64 2.77 52.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 41.4 m-20 -126.83 -24.86 3.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.587 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 106' ' ' PHE . 77.8 t -49.07 125.75 3.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.937 0.399 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -102.96 4.38 37.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.92 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 92.1 m -166.76 139.59 3.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.638 HD23 HG11 ' A' ' 110' ' ' VAL . 16.2 mt -118.25 144.98 45.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.213 0.53 . . . . 0.0 111.933 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -135.34 113.82 11.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.598 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.81 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -133.98 143.88 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.782 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.32 107.49 15.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -92.21 103.9 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.3 mp -86.33 129.07 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.91 -49.74 75.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.161 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.41 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -59.43 177.65 2.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 p -111.85 156.87 21.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 0.0 110.966 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -148.9 154.25 39.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.77 134.41 35.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 138.21 6.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.457 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.26 6.88 19.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.622 0.249 . . . . 0.0 111.339 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.4 m -128.0 124.18 36.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -94.88 136.46 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.448 ' HE3' ' CZ2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -61.26 174.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.84 163.26 33.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.159 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 65.2 Cg_endo -74.85 101.04 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.41 2.073 . . . . 0.0 112.198 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.72 147.22 25.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.57 84.21 2.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.406 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 88.7 m95 -64.86 -16.35 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.083 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.85 -32.65 63.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.905 0.384 . . . . 0.0 110.73 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -79.56 -28.01 41.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.927 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 72.3 m-85 -97.6 169.71 9.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.653 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -134.66 143.74 47.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.521 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.3 ttpm? -81.13 119.97 24.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 157' ' ' VAL . 25.6 m -103.12 -21.36 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.235 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.0 m -162.56 140.33 8.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.473 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 18.2 p -165.19 113.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.741 ' C ' HG23 ' A' ' 154' ' ' THR . 5.8 ttt180 -147.96 130.95 16.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.002 0.429 . . . . 0.0 111.236 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.704 HG23 ' OG1' ' A' ' 154' ' ' THR . 5.1 m -84.8 146.12 27.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.073 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.424 HG21 ' HE2' ' A' ' 155' ' ' TYR . 5.0 t -117.16 102.69 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.899 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.562 ' HA ' HG23 ' A' ' 152' ' ' THR . 35.4 mt-10 -81.04 97.82 7.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.096 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.96 -178.19 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.299 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -60.97 2.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 110.574 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.494 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.37 117.06 40.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.666 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 11.6 Cg_endo -55.75 -26.73 58.12 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.979 1.786 . . . . 0.0 112.402 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.41 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -91.53 -17.16 26.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 12.7 mt -88.34 11.25 17.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.622 0.248 . . . . 0.0 111.387 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.562 HG23 ' HA ' ' A' ' 145' ' ' GLU . 87.7 m -71.59 168.43 17.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.486 ' N ' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -171.45 157.65 4.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.544 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 142' ' ' ARG . 17.6 m -126.71 147.59 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 84.8 m-85 -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.441 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.583 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.4 mt-10 -104.37 124.57 49.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.808 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.684 ' O ' HG22 ' A' ' 139' ' ' VAL . 12.3 t -118.42 115.72 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.272 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.521 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 18.5 m95 -112.61 151.21 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.508 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -125.95 110.95 14.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.863 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 4.5 tttt -49.09 138.85 11.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.653 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 39.5 mtmt -115.59 -175.11 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.409 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.103 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.77 HG23 HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.25 147.12 38.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.708 ' HB2' HD23 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -110.28 115.59 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.574 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.794 HD21 ' HA ' ' A' ' 30' ' ' PHE . 9.1 tp -116.06 123.93 49.17 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.664 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.8 p90 -167.99 162.77 13.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.668 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -114.77 131.57 56.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.114 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.44 154.33 37.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.717 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 2.2 p-10 -102.97 -176.8 3.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -47.92 -42.15 26.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.34 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 -25.99 54.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.455 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.63 25.47 9.22 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.59 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -95.65 162.48 13.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.665 0.269 . . . . 0.0 110.736 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 pt -111.92 -42.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.343 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.1 -173.07 33.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.646 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.38 96.32 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.97 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.92 95.34 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.69 34.73 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.541 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -146.43 176.71 9.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.767 0.318 . . . . 0.0 110.786 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -95.61 -51.81 0.24 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.334 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 81.3 Cg_endo -93.16 168.04 2.37 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.819 2.346 . . . . 0.0 112.651 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -127.9 129.54 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.588 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -94.46 38.13 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.11 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mp -122.35 89.85 49.22 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 27' ' ' LEU . 74.4 Cg_endo -75.37 -11.17 20.83 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.624 2.216 . . . . 0.0 112.945 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -22.8 17.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.522 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -72.67 -49.24 32.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 111.476 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.66 -18.9 13.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.576 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -41.49 75.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.688 0.28 . . . . 0.0 111.55 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.413 ' CZ ' ' OE1' ' A' ' 33' ' ' GLN . 55.3 t80 -105.22 -15.36 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.794 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.5 t80 -81.77 -57.36 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.739 0.304 . . . . 0.0 111.766 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.864 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -53.91 -62.43 1.66 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.26 -28.89 20.54 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.466 ' CB ' HD22 ' A' ' 4' ' ' LEU . 0.8 OUTLIER -92.34 -3.35 55.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.494 HG23 ' CD2' ' A' ' 4' ' ' LEU . 34.4 p -140.57 4.52 1.96 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 31' ' ' ARG . 34.4 m -109.0 158.84 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.038 0.447 . . . . 0.0 112.05 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 72.2 11.21 75.12 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-O 119.177 -0.79 . . . . 0.0 114.592 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 6.5 mttt -149.2 -163.9 1.9 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.145 1.472 . . . . 0.0 108.559 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.463 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 60.4 mt -84.74 88.41 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.558 ' HE3' HG11 ' A' ' 41' ' ' VAL . 18.2 ttp -95.31 118.24 31.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.223 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.605 HG21 HG11 ' A' ' 82' ' ' VAL . 3.5 t -88.11 126.61 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.558 HG11 ' HE3' ' A' ' 39' ' ' MET . 15.9 m -133.01 148.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.323 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.59 157.6 52.74 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.61 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.639 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -50.94 -53.13 35.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.097 0.449 . . . . 0.0 110.606 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.477 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 14.9 tpt180 -59.95 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.592 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -64.6 -38.33 90.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.508 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.53 ' HD1' HG21 ' A' ' 41' ' ' VAL . 2.0 t80 -60.56 -39.82 89.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.634 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -66.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.2 t -54.24 -34.92 61.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.576 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.807 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -35.12 124.54 0.58 Allowed Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.839 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -43.43 -29.67 2.13 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.154 2.57 . . . . 0.0 113.652 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.589 ' HB3' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -142.11 132.81 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.171 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -141.21 107.96 6.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.804 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -90.14 176.8 18.7 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.162 0.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.863 HD13 ' HD2' ' A' ' 57' ' ' ARG . 55.0 mt -87.38 140.03 32.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.52 -84.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.962 2.442 . . . . 0.0 113.917 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.3 mt-10 -85.19 11.66 9.46 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.863 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -112.27 113.42 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.959 0.409 . . . . 0.0 111.412 -178.468 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 81.4 m -70.15 114.05 7.92 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.512 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.765 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -104.69 154.68 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.72 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 74' ' ' VAL . 10.8 t -135.8 132.35 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.788 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 43' ' ' ARG . 58.1 t -105.03 125.32 60.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.827 0.346 . . . . 0.0 111.648 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.27 115.26 29.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.884 HG21 ' CD2' ' A' ' 68' ' ' TYR . 3.6 t -149.02 166.37 28.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 111.194 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -82.69 -10.19 59.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.351 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.0 tp-100 -79.65 132.06 36.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.307 . . . . 0.0 110.484 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 2.4 mt-10 -82.95 -31.07 27.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.809 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.91 6.25 45.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.263 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.884 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.0 t80 -60.43 136.76 58.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 111.67 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.852 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -129.76 171.88 12.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.408 1.099 . . . . 0.0 112.78 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.6 139.99 16.75 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.108 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 3.4 mt-30 -71.73 100.67 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.3 -36.96 3.33 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.694 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.91 170.17 14.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.483 HG21 ' CE1' ' A' ' 85' ' ' TYR . 25.2 t -98.82 140.24 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.466 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.852 HG21 ' HA ' ' A' ' 69' ' ' GLN . 24.4 t -107.15 106.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.739 HG21 HG22 ' A' ' 82' ' ' VAL . 29.1 m -117.73 167.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 6.6 m170 -119.61 -20.66 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -155.73 -175.2 5.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 111.77 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.963 HG13 ' CD2' ' A' ' 106' ' ' PHE . 7.5 t -68.33 -9.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.004 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.17 -34.1 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.3 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.686 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.1 -29.38 60.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.718 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 76' ' ' VAL . 95.8 t -73.02 -55.84 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.519 ' CE2' HG12 ' A' ' 79' ' ' VAL . 8.1 m-85 -53.43 -26.12 18.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.987 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.76 87.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.483 ' CE1' HG21 ' A' ' 74' ' ' VAL . 59.7 t80 -67.67 -58.21 5.06 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.62 -23.02 15.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.211 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.95 -36.3 72.54 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.37 -7.18 59.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.663 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -124.96 66.63 50.71 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.031 0.443 . . . . 0.0 110.578 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.21 -0.41 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.234 2.623 . . . . 0.0 113.04 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.91 -31.74 15.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -102.07 160.1 14.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 111.411 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -98.59 166.22 11.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.082 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.77 HD23 HG23 ' A' ' 1' ' ' THR . 7.4 tp -121.88 117.91 27.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.44 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.76 112.06 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.314 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.493 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 11.9 mm -77.76 118.99 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.496 ' HB1' ' CZ ' ' A' ' 30' ' ' PHE . . . -91.43 -40.61 11.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.083 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.8 -166.36 39.29 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.501 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.455 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.4 -160.97 36.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 117.708 0.754 . . . . 0.0 112.524 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.27 -49.38 53.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.92 -30.37 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.304 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.528 HD12 HD22 ' A' ' 62' ' ' LEU . 42.2 mm -81.67 -26.75 9.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 6.0 m-85 -61.35 -58.61 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.731 ' HA ' HD13 ' A' ' 129' ' ' ILE . 4.6 t -67.14 -9.99 45.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.697 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.07 -38.84 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.089 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.963 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.1 m-85 -100.21 -3.85 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.404 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.466 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 4.2 pttp -47.71 -33.56 7.12 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 4.35 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.678 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -125.0 -28.82 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 106' ' ' PHE . 92.1 t -45.16 131.13 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.273 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.7 t70 -104.3 1.83 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 40.3 m -167.5 143.34 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.365 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.763 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 33.7 mt -119.93 145.01 47.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.443 0.639 . . . . 0.0 111.925 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -135.47 115.05 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.333 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' CH2' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -135.16 145.36 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.68 105.4 12.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.626 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -75.01 100.14 4.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.14 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.668 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.2 mt -84.32 120.76 26.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.89 -52.81 47.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.023 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.24 162.61 36.05 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.009 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 3.6 t -102.72 156.89 17.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.9 m-85 -136.03 138.65 42.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -112.29 144.13 42.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.81 -125.39 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.318 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.13 31.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 2.9 m -156.78 123.01 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.727 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HG2' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -99.2 167.5 10.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.418 ' HE2' HD12 ' A' ' 131' ' ' LEU . 17.3 tpt -79.79 155.89 27.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.736 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.731 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.5 pp -81.28 162.72 57.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.81 103.59 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.052 2.502 . . . . 0.0 112.744 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.418 HD12 ' HE2' ' A' ' 128' ' ' MET . 2.0 mt -91.68 145.07 24.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.94 78.76 2.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.971 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.763 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 80.2 m95 -60.44 -19.94 58.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.8 -29.47 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.554 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.6 -28.17 45.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.832 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 92.5 m-85 -97.58 177.13 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.693 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 1.9 m -134.89 141.03 46.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 9.0 ttpt -84.0 117.84 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.494 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.2 m -105.68 -16.1 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.976 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 m -164.53 140.77 6.07 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.6 p -163.46 113.54 1.33 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.409 ' C ' HG23 ' A' ' 154' ' ' THR . 19.1 ttt-85 -148.17 120.27 8.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.787 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.5 m -73.65 144.71 45.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.309 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.468 HG21 ' HE2' ' A' ' 155' ' ' TYR . 3.8 t -122.34 108.93 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.378 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.566 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.7 OUTLIER -88.23 101.0 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.45 -179.07 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -80.8 -176.14 5.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.431 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.8 t30 -77.08 130.89 74.0 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.138 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.73 -30.3 78.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.218 1.945 . . . . 0.0 112.656 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -89.89 -23.94 21.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.775 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.431 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 18.8 mt -80.06 4.06 18.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.491 0.186 . . . . 0.0 111.452 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 145' ' ' GLU . 98.9 m -69.19 163.41 24.97 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.3 p80 -176.35 163.59 2.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.182 0.515 . . . . 0.0 112.265 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.787 ' OG1' HG23 ' A' ' 143' ' ' THR . 87.8 m -120.8 147.17 45.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.024 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.468 ' HE2' HG21 ' A' ' 144' ' ' VAL . 96.9 m-85 -108.81 105.4 14.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.732 0.301 . . . . 0.0 110.905 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.433 ' HB2' HG22 ' A' ' 115' ' ' VAL . 30.4 mt-10 -108.78 125.7 52.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.809 ' O ' HG22 ' A' ' 139' ' ' VAL . 15.5 t -116.5 114.79 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.597 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.5 m95 -110.5 150.57 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.646 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -126.85 116.21 20.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.881 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 8.6 ttpt -51.8 130.1 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.384 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HG3' ' OG1' ' A' ' 137' ' ' THR . 3.8 mmpt? -96.08 172.9 7.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.097 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.44 HG23 HD23 ' A' ' 94' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -104.99 154.65 19.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 112.308 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.506 ' CD1' ' HB ' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -123.9 114.01 19.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.632 HD13 ' HB3' ' A' ' 33' ' ' GLN . 13.2 tp -112.86 121.57 45.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.646 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -165.18 163.89 20.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.525 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 118' ' ' LEU . . . -113.86 135.97 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.966 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.29 149.71 48.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.377 . . . . 0.0 110.969 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.5 p-10 -110.78 -168.24 1.28 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.021 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.428 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.78 -35.41 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.088 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 -28.95 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.012 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.12 12.81 22.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.879 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 126' ' ' THR . 2.8 mm? -59.93 144.96 47.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.768 0.284 . . . . 0.0 110.586 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.14 -81.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.44 133.17 6.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.586 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -166.5 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.667 0.27 . . . . 0.0 110.79 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.92 30.62 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.752 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.24 -76.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.397 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -78.41 165.39 23.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.293 . . . . 0.0 110.772 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 21' ' ' TRP . 0.6 OUTLIER -146.52 92.91 5.04 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.146 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.02 89.0 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.608 2.205 . . . . 0.0 112.388 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.515 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -145.03 75.98 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.858 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -113.43 -26.12 8.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.203 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.4 143.56 85.6 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.755 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HA ' HD13 ' A' ' 27' ' ' LEU . 90.2 Cg_endo -80.8 -27.63 3.05 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.688 2.259 . . . . 0.0 112.928 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -60.95 -18.67 58.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.543 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.98 -21.58 31.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.327 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' NH2' ' A' ' 31' ' ' ARG . 7.8 mp -83.68 -14.69 51.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.445 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.545 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -76.3 -32.84 58.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.752 0.31 . . . . 0.0 110.994 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.466 ' CE2' HD11 ' A' ' 4' ' ' LEU . 35.0 t80 -105.41 -63.11 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.365 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -43.81 -36.36 2.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.043 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.755 ' O ' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -92.09 -60.67 1.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -48.91 -36.77 17.99 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.632 ' HB3' HD13 ' A' ' 4' ' ' LEU . 20.3 mm-40 -76.33 -4.54 42.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 4' ' ' LEU . 1.1 p -140.54 -0.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 31' ' ' ARG . 34.2 m -108.17 142.88 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.518 0.199 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.569 ' H ' ' HG3' ' A' ' 57' ' ' ARG . . . 112.61 -9.09 26.05 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.231 -0.985 . . . . 0.0 114.048 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.479 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -148.43 -163.8 1.86 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.789 1.295 . . . . 0.0 109.223 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 51.6 mt -74.64 91.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.765 0.317 . . . . 0.0 111.522 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.1 ttp -101.92 120.45 40.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 HG11 ' A' ' 82' ' ' VAL . 15.3 t -80.3 159.19 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.869 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' HG12 ' A' ' 40' ' ' VAL . 28.7 m -161.72 157.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.34 155.51 43.89 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.906 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.8 -52.68 64.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.982 0.391 . . . . 0.0 110.389 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -59.06 -32.64 69.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -71.59 -38.14 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.539 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.448 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 6.7 t80 -66.5 -25.94 66.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -72.65 -66.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 111.109 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.4 t -57.08 -31.44 65.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.43 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -26.24 135.16 0.1 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.88 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.64 -33.91 88.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.701 2.267 . . . . 0.0 112.929 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -160.08 122.41 3.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.25 135.62 15.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.252 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.77 160.41 71.42 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.14 -1.608 . . . . 0.0 111.838 -0.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.803 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 51.1 mt -75.15 156.36 85.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.05 -82.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.953 2.435 . . . . 0.0 113.653 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' HB2' ' NH1' ' A' ' 57' ' ' ARG . 5.3 mt-10 -93.18 27.6 2.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.411 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.803 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -125.2 111.68 15.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.403 . . . . 0.0 111.637 -178.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 53.4 m -72.35 119.53 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -102.73 151.44 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 112.083 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.623 HG12 HG22 ' A' ' 76' ' ' VAL . 17.1 t -132.07 142.76 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.392 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 43' ' ' ARG . 50.0 t -115.45 121.03 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.727 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.913 HD12 HG23 ' A' ' 76' ' ' VAL . 1.1 tp -104.78 117.14 33.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.722 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.25 167.44 26.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.822 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -89.13 -10.05 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tt0 -73.79 137.06 43.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -88.46 5.96 39.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.118 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.55 5.85 4.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.607 0.241 . . . . 0.0 111.618 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.901 ' O ' HG11 ' A' ' 75' ' ' VAL . 3.5 t80 -60.17 141.71 55.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.333 0.587 . . . . 0.0 112.014 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.85 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -131.93 173.8 10.82 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.249 1.024 . . . . 0.0 112.641 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.3 143.4 20.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.699 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.96 98.85 2.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.636 0.255 . . . . 0.0 110.799 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.57 -36.13 3.14 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.662 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -69.75 170.49 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 111.892 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.33 139.75 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.172 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.901 HG11 ' O ' ' A' ' 68' ' ' TYR . 20.1 t -104.59 107.85 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 111.835 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.913 HG23 HD12 ' A' ' 62' ' ' LEU . 30.3 m -117.96 168.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.754 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.3 m170 -119.01 -22.37 7.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.552 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.711 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -155.44 -169.48 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 111.523 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.977 HG13 ' CD2' ' A' ' 106' ' ' PHE . 4.8 t -73.44 -10.36 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.62 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.1 -34.82 19.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.231 0.539 . . . . 0.0 109.836 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.46 -30.38 61.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.762 HG22 HG21 ' A' ' 76' ' ' VAL . 17.5 t -72.16 -53.06 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.006 0.431 . . . . 0.0 109.876 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.67 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 4.3 m-85 -54.54 -28.34 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.823 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.6 96.43 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.72 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.57 -55.93 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.9 13.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.333 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 14.4 mmmt -69.35 -39.71 77.96 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -81.3 -4.61 56.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -126.86 65.58 63.21 Favored Pre-proline 0 N--CA 1.456 -0.151 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.7 -0.5 6.95 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.19 2.593 . . . . 0.0 112.775 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -91.71 -32.25 15.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -104.18 161.53 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.127 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -99.03 162.76 12.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.454 HD11 ' CG1' ' A' ' 82' ' ' VAL . 46.3 tp -109.29 115.84 30.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 2' ' ' ALA . 44.7 t -131.05 115.5 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 40' ' ' VAL . 7.0 mm -82.36 141.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.403 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.08 -44.66 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.433 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.01 -168.63 40.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.691 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.433 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.76 36.67 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 121.94 -0.741 . . . . 0.0 112.479 -0.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.47 -52.95 15.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.288 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -56.07 -29.27 60.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.535 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 62' ' ' LEU . 40.2 mm -81.47 -28.51 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.0 m-85 -60.2 -58.36 8.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.873 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.63 ' HA ' HD13 ' A' ' 129' ' ' ILE . 11.7 t -65.63 -10.12 33.08 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 121.73 -0.606 . . . . 0.0 112.228 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.698 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.58 -43.77 54.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.842 0.354 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.977 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.9 m-85 -96.19 -1.37 48.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.559 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 6.9 pttt -50.91 -34.59 29.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.915 0.388 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.66 2.66 40.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.69 -27.62 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.619 0.247 . . . . 0.0 111.572 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 106' ' ' PHE . 68.0 t -45.46 123.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.912 0.387 . . . . 0.0 111.284 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 13.8 t70 -107.02 7.54 29.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.24 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.5 m -168.39 140.0 2.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.365 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.821 HD23 HG11 ' A' ' 110' ' ' VAL . 7.1 mt -125.51 147.34 49.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.323 0.583 . . . . 0.0 112.079 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt -135.4 117.03 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.317 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -131.76 141.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.94 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.25 109.6 18.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.198 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 14.0 mtt180 -84.07 99.59 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.385 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.449 ' CD1' ' HB1' ' A' ' 6' ' ' ALA . 1.3 mp -82.63 120.62 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.305 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.504 ' HB2' ' HB ' ' A' ' 152' ' ' THR . . . -48.99 -47.55 44.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.83 152.1 49.97 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.378 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 173.04 8.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.817 0.341 . . . . 0.0 111.093 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 3.2 m-85 -145.52 178.37 8.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.777 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.85 170.05 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 148.96 176.88 22.65 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.771 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.12 17.56 9.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.163 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.531 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.8 m -133.65 131.74 39.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.637 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -113.14 170.41 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.413 ' HE3' ' HB3' ' A' ' 103' ' ' PHE . 16.4 tpt -74.13 145.83 43.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.678 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 2.0 pp -66.42 166.66 16.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.187 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.678 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.1 Cg_endo -75.1 106.71 2.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.243 1.962 . . . . 0.0 112.319 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.92 147.51 23.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.86 69.51 5.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.448 ' HH2' HG11 ' A' ' 115' ' ' VAL . 88.7 m95 -53.39 -24.92 13.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.36 -29.8 64.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.328 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 7.5 t0 -79.6 -18.57 51.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.033 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.465 ' CG ' HD11 ' A' ' 113' ' ' LEU . 85.0 m-85 -106.83 168.49 9.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.438 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -131.22 141.61 50.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.599 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.0 ttpt -81.88 109.43 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.547 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 157' ' ' VAL . 35.4 m -92.27 -26.42 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.384 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.1 m -154.93 140.3 17.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 51.9 p -169.58 115.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.969 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.409 ' NH1' ' HB2' ' A' ' 142' ' ' ARG . 8.9 ttm105 -147.91 119.02 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.076 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.783 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.5 m -71.08 145.91 49.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.032 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 t -119.67 104.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.657 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.668 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.6 mt-10 -85.07 100.2 11.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.22 173.78 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.1 p -53.54 -44.25 69.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.631 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 3.7 t-20 -82.68 132.17 52.61 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.34 -33.29 89.43 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.395 2.063 . . . . 0.0 112.613 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.55 -28.52 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.0 mt -76.74 5.05 8.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.668 HG23 ' HA ' ' A' ' 145' ' ' GLU . 31.9 m -71.56 158.4 36.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -174.12 160.59 3.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.951 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.783 ' OG1' HG23 ' A' ' 143' ' ' THR . 22.2 m -122.58 138.6 54.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.946 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' SER . 88.6 m-85 -102.6 106.35 17.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HB2' HG22 ' A' ' 115' ' ' VAL . 32.7 mt-10 -108.16 125.72 51.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 139' ' ' VAL . 25.1 t -116.6 112.35 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.75 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.511 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 17.4 m95 -107.22 151.16 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 112.003 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -130.35 127.18 38.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.831 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 10.9 tttp -54.13 130.54 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 111.359 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -116.79 -168.56 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.836 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.15 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.702 HG23 HD23 ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.32 146.67 40.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.503 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.6 m-30 -110.2 111.07 22.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.551 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.767 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -108.63 118.99 38.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.775 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.6 p90 -167.96 172.99 8.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -132.32 135.67 46.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -117.58 161.51 19.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.047 0.451 . . . . 0.0 111.444 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.6 -167.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -39.5 71.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.759 0.314 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.56 -27.49 37.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.25 22.98 10.85 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.683 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.1 tp -70.33 152.91 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.691 HG21 ' HG3' ' A' ' 128' ' ' MET . 1.5 pp -126.26 -41.42 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.679 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.01 -166.14 11.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.904 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.48 ' HG2' ' HA2' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -140.18 121.61 15.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.61 0.243 . . . . 0.0 110.689 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.4 -30.17 42.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.672 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.91 -121.32 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.394 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -164.23 119.42 1.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.998 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -120.17 137.69 26.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.745 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -87.46 39.94 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.809 2.339 . . . . 0.0 112.86 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.492 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -115.81 110.29 18.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.71 109.12 21.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.02 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.542 HD22 ' OD2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -113.41 122.14 36.06 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.799 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.75 -30.11 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.687 2.258 . . . . 0.0 112.981 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' HB3' HD21 ' A' ' 23' ' ' LEU . 5.1 t70 -53.63 -38.58 64.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.325 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.542 ' OD2' HD22 ' A' ' 23' ' ' LEU . 72.3 m-20 -74.44 -61.89 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.054 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.25 -33.56 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.583 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -53.97 -66.89 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.809 0.338 . . . . 0.0 111.188 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -70.09 -9.73 56.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.405 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -85.66 -24.95 26.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.448 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 35' ' ' VAL . 10.1 ptm180 -92.02 -46.82 7.6 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 31' ' ' ARG . . . -54.73 -23.94 20.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.572 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.658 ' NE2' HD13 ' A' ' 114' ' ' LEU . 2.8 mt-30 -92.51 -3.93 54.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.7 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.758 HG23 ' HG ' ' A' ' 4' ' ' LEU . 25.4 p -145.8 26.67 1.24 Allowed 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 31' ' ' ARG . 11.8 m -108.15 145.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.44 29.93 57.91 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 58' ' ' THR . 17.7 mttm -147.07 -167.33 2.75 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.498 2.149 . . . . 0.0 108.417 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 93' ' ' GLU . 75.4 mt -88.93 88.55 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.302 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.2 OUTLIER -102.06 126.29 48.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.368 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.884 HG21 HG11 ' A' ' 82' ' ' VAL . 2.0 t -90.79 129.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.531 HG11 ' CE2' ' A' ' 49' ' ' PHE . 21.7 m -133.54 138.03 51.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.242 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.43 153.74 39.31 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.005 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.696 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -50.74 -53.53 30.84 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.936 0.398 . . . . 0.0 110.075 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -54.5 -42.41 70.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -65.06 -40.76 95.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 28.8 t80 -60.48 -29.57 69.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.913 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.51 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.6 t -58.49 -31.08 67.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.305 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.74 ' HE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.8 135.79 0.18 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.996 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 75.9 Cg_exo -48.83 -35.11 30.06 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.276 . . . . 0.0 112.85 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.07 142.78 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.35 112.04 6.55 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -81.72 178.81 29.52 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.984 -0.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.74 HD11 ' HE1' ' A' ' 49' ' ' PHE . 64.1 mt -84.21 140.69 39.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.603 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.62 110.98 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.495 2.13 . . . . 0.0 112.835 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.0 OUTLIER 74.37 -0.17 3.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.35 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.683 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -109.57 116.23 31.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.66 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 33.3 m -70.08 111.5 5.79 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.456 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.648 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -107.14 154.86 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.947 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.687 HG12 HG22 ' A' ' 76' ' ' VAL . 18.8 t -128.02 143.42 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.389 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' A' ' 43' ' ' ARG . 90.0 t -111.69 126.98 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.889 0.376 . . . . 0.0 111.069 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -105.64 123.39 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.361 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.873 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -157.2 158.33 36.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -79.67 -6.57 57.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 23.3 tt0 -78.78 131.29 36.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.817 0.341 . . . . 0.0 110.974 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 4.21 29.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.91 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.4 7.29 4.92 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.424 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.873 ' CG ' HG21 ' A' ' 63' ' ' THR . 6.0 t80 -59.23 144.98 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.051 0.453 . . . . 0.0 111.2 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.971 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -133.94 174.27 10.65 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.368 1.08 . . . . 0.0 113.014 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.91 144.47 21.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.709 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -81.0 96.66 7.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.89 0.376 . . . . 0.0 110.643 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -44.7 2.06 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.78 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.06 168.04 17.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 111.74 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 28.3 t -96.26 141.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.971 HG21 ' HA ' ' A' ' 69' ' ' GLN . 28.4 t -108.1 120.83 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.333 0.587 . . . . 0.0 111.912 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.919 HG21 HG22 ' A' ' 82' ' ' VAL . 27.7 m -127.59 169.55 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.633 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' THR . 7.9 m170 -117.52 -25.58 6.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.835 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.5 -174.62 5.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.015 0.436 . . . . 0.0 111.16 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.2 t -67.92 -11.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.533 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -34.21 19.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.441 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.86 -26.15 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.023 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.919 HG22 HG21 ' A' ' 76' ' ' VAL . 43.1 t -75.98 -54.71 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 14.5 m-85 -53.34 -27.89 25.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.885 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.53 87.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.969 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.43 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 86.1 t80 -65.3 -56.32 13.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.892 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -57.95 -24.86 59.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.034 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -68.8 -43.5 75.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -79.1 -10.7 59.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.286 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -122.88 65.6 26.92 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.15 -0.4 4.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.159 2.572 . . . . 0.0 113.166 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.92 -37.85 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 2.1 mm-40 -104.1 164.1 11.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.433 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 5.7 mm-40 -99.13 171.26 8.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 86' ' ' ALA . 8.1 tp -115.91 116.67 28.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' MET . 49.1 t -128.58 114.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.527 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 7.6 mm -83.34 140.2 16.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.077 0.465 . . . . 0.0 111.234 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 34' ' ' THR . . . -114.84 -36.34 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.57 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -170.93 43.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.555 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.45 -161.23 32.81 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 117.376 0.588 . . . . 0.0 112.512 -0.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.04 -53.53 54.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -55.34 -27.3 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.602 ' CD1' HD22 ' A' ' 62' ' ' LEU . 32.5 mm -83.16 -27.47 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.854 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.466 ' HB3' HG12 ' A' ' 129' ' ' ILE . 1.9 m-85 -60.61 -56.52 20.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.38 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.816 ' CA ' HD13 ' A' ' 129' ' ' ILE . 1.8 t -67.71 -10.07 49.25 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.24 -47.21 20.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.343 . . . . 0.0 110.732 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.9 ' CD2' HG13 ' A' ' 79' ' ' VAL . 9.3 m-85 -86.18 -9.38 56.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.321 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 3.2 pttp -52.42 -29.76 25.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -75.88 -7.43 54.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 22.5 m-20 -129.58 -19.89 3.32 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 113' ' ' LEU . 53.5 t -43.81 127.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.112 0.482 . . . . 0.0 110.935 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 10.5 t0 -108.55 6.58 26.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.48 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.756 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 18.7 m -169.68 137.92 1.8 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.72 0.295 . . . . 0.0 110.6 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.604 HD23 HG11 ' A' ' 110' ' ' VAL . 6.1 mt -122.7 145.67 48.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.168 0.509 . . . . 0.0 111.605 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.658 HD13 ' NE2' ' A' ' 33' ' ' GLN . 5.6 mt -134.84 117.41 15.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.578 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.775 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -133.96 144.0 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.009 0.433 . . . . 0.0 111.837 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -116.36 104.71 11.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.4 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 2.9 ttt-85 -75.8 100.75 4.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.452 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.706 HD22 ' HZ ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -92.4 108.29 19.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.087 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.45 -39.73 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.408 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.6 -167.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.701 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.81 146.8 41.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 111.007 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.706 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 1.3 m-85 -134.47 162.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -99.73 134.05 43.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.002 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.604 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.01 -174.36 33.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.86 21.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.251 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -139.11 127.69 23.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.691 ' HG3' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -74.02 -173.6 1.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.201 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.816 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.3 pp -112.11 160.15 31.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.88 102.48 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.831 2.354 . . . . 0.0 112.746 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.34 146.44 27.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.29 76.35 5.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.44 ' HH2' HG11 ' A' ' 115' ' ' VAL . 84.4 m95 -60.04 -19.12 51.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.365 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.13 -33.22 65.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -81.77 -17.19 48.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.521 ' CD2' HD11 ' A' ' 113' ' ' LEU . 79.6 m-85 -106.68 167.75 9.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.906 0.384 . . . . 0.0 111.163 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.542 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -127.68 141.02 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.516 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 12.1 ttpp -81.81 115.99 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.1 m -101.04 -18.76 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.783 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.4 m -164.25 140.54 6.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.535 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.657 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 93.0 p -164.95 113.33 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.512 ' C ' HG23 ' A' ' 154' ' ' THR . 0.2 OUTLIER -146.48 126.02 13.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.681 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.9 m -80.5 145.04 32.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.294 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 152' ' ' THR . 3.5 t -122.79 109.05 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.792 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.91 104.5 16.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -177.2 5.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.3 p -58.02 -42.34 85.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.481 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.4 t-20 -80.99 134.5 52.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.342 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.96 -32.31 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.202 1.934 . . . . 0.0 112.429 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.11 -25.61 22.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.5 mt -76.18 5.11 7.33 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 153' ' ' HIS . 72.0 m -72.89 162.27 29.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -175.97 162.67 2.61 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 0.0 112.033 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.681 ' OG1' HG23 ' A' ' 143' ' ' THR . 38.5 m -122.5 129.82 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.33 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -93.66 107.89 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.496 ' HB2' HG22 ' A' ' 115' ' ' VAL . 4.6 mt-10 -101.28 152.29 20.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.818 ' O ' HG22 ' A' ' 139' ' ' VAL . 19.0 t -142.41 110.22 2.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.759 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.468 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 29.8 m95 -109.8 145.74 36.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.397 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.15 129.51 39.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.373 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -49.08 122.19 5.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 111.447 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.542 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.9 OUTLIER -97.8 176.14 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.063 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 87.6 m . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.758 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -107.95 154.79 21.11 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.8 m-30 -120.68 107.92 13.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.831 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.791 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.44 115.38 30.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.475 0.655 . . . . 0.0 112.231 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.667 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.7 p90 -158.37 166.19 32.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.856 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.36 133.28 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.0 pt20 -131.63 157.03 44.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.435 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -108.18 -162.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.361 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.28 -49.96 74.41 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -33.37 72.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.23 33.15 3.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.776 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.4 mm? -73.84 127.14 32.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.681 HG21 ' HG3' ' A' ' 128' ' ' MET . 0.7 OUTLIER -112.45 -63.65 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.58 -168.63 11.76 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.66 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -149.06 166.1 29.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.812 0.339 . . . . 0.0 110.734 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.53 98.71 10.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.66 117.93 3.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.713 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 116.44 31.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.75 0.31 . . . . 0.0 110.719 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.568 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -160.0 -55.64 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.564 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 93.4 Cg_endo -93.72 60.81 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.648 2.232 . . . . 0.0 112.635 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -174.58 110.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.519 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -129.57 142.14 50.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.74 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -156.17 145.16 14.93 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.791 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HG ' ' A' ' 23' ' ' LEU . 87.4 Cg_endo -85.12 -41.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.665 2.243 . . . . 0.0 112.92 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -37.69 70.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.382 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.63 -22.83 61.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.421 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tt -90.54 -38.67 13.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 111.214 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.69 -27.66 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.638 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -105.28 -29.43 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.516 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -76.41 -23.73 54.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.639 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.813 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -91.91 -61.47 1.62 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -50.04 -32.39 15.32 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -81.85 -6.36 59.02 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.692 ' CG2' HD11 ' A' ' 4' ' ' LEU . 21.1 p -142.4 13.94 1.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 31' ' ' ARG . 33.2 m -108.25 154.69 9.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 57.48 26.28 56.55 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 115.799 1.08 . . . . 0.0 115.799 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.0 mtmm -151.38 -169.0 3.25 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.957 1.878 . . . . 0.0 108.41 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 80.7 mt -84.52 87.46 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.759 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.439 ' HE1' ' OD1' ' A' ' 59' ' ' ASN . 0.4 OUTLIER -100.31 122.63 43.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.922 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.642 HG21 HG11 ' A' ' 82' ' ' VAL . 21.6 t -82.84 158.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.612 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 40' ' ' VAL . 35.1 m -164.32 144.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.36 152.9 52.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.753 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.593 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.27 -52.26 53.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.861 0.33 . . . . 0.0 110.81 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.81 -32.18 70.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.086 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.419 HG22 ' CE1' ' A' ' 49' ' ' PHE . 10.5 m -70.15 -37.38 75.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.443 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -66.96 -26.28 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.034 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.73 -66.42 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -47.27 -37.97 11.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.469 ' CE2' HG11 ' A' ' 41' ' ' VAL . 2.8 m-30 -36.21 148.26 0.17 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -43.77 -69.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 0.0 112.713 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -139.09 167.57 21.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -122.53 117.38 29.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 95.6 Cg_endo -83.65 -171.0 8.34 Favored 'Cis proline' 0 C--N 1.349 0.594 0 C-N-CA 123.716 -1.369 . . . . 0.0 112.348 -0.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.648 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mt -79.98 162.87 60.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 24.4 Cg_endo -61.56 92.47 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.744 2.296 . . . . 0.0 113.101 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 9.9 mt-10 60.29 33.8 20.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.624 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.648 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 10.7 mtp180 -124.02 114.3 19.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.203 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 41.4 m -65.14 107.21 1.48 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.124 0.488 . . . . 0.0 110.192 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.483 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.3 154.45 18.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.424 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 11.8 t -130.91 132.61 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.731 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.0 t -104.22 127.59 58.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 111.717 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -109.32 113.3 26.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.995 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.801 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.2 t -148.6 167.37 25.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 111.279 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -84.11 -7.31 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.282 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.8 tp-100 -80.46 128.8 34.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.467 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -79.35 -28.01 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.8 9.62 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.801 ' CD2' HG21 ' A' ' 63' ' ' THR . 4.2 t80 -59.86 141.08 56.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.064 0.459 . . . . 0.0 111.489 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.825 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.2 mt-30 -129.93 174.0 10.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.255 1.026 . . . . 0.0 112.54 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.47 143.72 20.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.58 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -74.31 96.24 2.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.445 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.94 -35.52 3.65 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.172 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.96 166.32 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.95 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 15.3 t -96.67 140.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.412 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.825 HG21 ' HA ' ' A' ' 69' ' ' GLN . 23.2 t -106.8 120.56 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.313 0.578 . . . . 0.0 112.18 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.929 HG21 HG22 ' A' ' 82' ' ' VAL . 24.9 m -132.77 172.04 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.965 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.414 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 11.2 m80 -122.21 -20.2 6.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -156.06 -175.68 5.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.101 0.476 . . . . 0.0 111.74 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.862 HG13 ' CD2' ' A' ' 106' ' ' PHE . 14.4 t -69.19 -10.24 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.614 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.48 -36.22 17.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.138 0.494 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.62 -33.71 66.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.929 HG22 HG21 ' A' ' 76' ' ' VAL . 27.2 t -70.29 -49.98 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 2.9 m-85 -54.34 -28.7 44.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.178 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.33 -39.79 85.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 50.8 t80 -66.37 -57.62 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.98 -23.06 43.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.893 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.652 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -72.08 -32.0 66.62 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 109.958 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 10.0 mt-30 -84.64 -9.02 58.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -121.21 65.17 14.54 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.027 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.36 -1.53 3.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.808 2.339 . . . . 0.0 112.647 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.03 -29.06 15.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.402 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 6.3 mm-40 -104.32 159.81 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.68 170.01 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.201 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -112.95 113.15 25.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.2 t -124.09 107.18 18.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.721 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.2 mm -76.46 134.69 28.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.434 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.96 -38.52 5.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.14 -167.35 40.31 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.09 -161.08 23.07 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 122.063 -0.669 . . . . 0.0 112.571 -0.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . -54.5 -51.63 64.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.826 0.346 . . . . 0.0 111.26 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -31.71 68.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.591 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 33.4 mm -72.67 -27.66 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 129' ' ' ILE . 2.4 m-85 -60.85 -54.35 46.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.572 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.553 ' CA ' HD13 ' A' ' 129' ' ' ILE . 7.7 t -69.26 -10.38 57.54 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.872 -0.517 . . . . 0.0 111.989 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.694 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.12 -39.91 54.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.862 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.4 m-85 -96.17 -8.24 33.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.552 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.84 -28.83 17.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.16 -1.46 49.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.469 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -132.01 -20.1 2.51 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.868 HG11 HD23 ' A' ' 113' ' ' LEU . 71.0 t -44.04 128.76 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.887 0.375 . . . . 0.0 111.222 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.436 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.9 t70 -106.16 1.59 26.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.301 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.758 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 72.7 m -166.99 135.09 2.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.674 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.868 HD23 HG11 ' A' ' 110' ' ' VAL . 9.6 mt -118.99 144.38 46.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 111.672 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mt -134.95 115.97 14.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.044 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.667 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -132.77 142.74 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 111.672 -179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.8 114.4 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.5 102.29 14.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.706 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -83.47 133.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.36 -57.43 10.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.339 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.14 168.2 38.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.747 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -99.33 172.51 7.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.804 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.604 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 3.0 m-85 -148.97 178.49 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.11 0.481 . . . . 0.0 111.442 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.55 171.48 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.435 ' HA3' ' CD1' ' A' ' 12' ' ' LEU . . . 161.41 -179.69 36.66 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.61 5.75 4.02 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.3 m -134.24 137.22 44.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 111.108 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 165.4 11.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.681 ' HG3' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -71.39 -173.72 0.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 111.086 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.553 HD13 ' CA ' ' A' ' 104' ' ' THR . 2.2 pp -118.47 164.03 22.48 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.083 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.529 ' O ' HD12 ' A' ' 129' ' ' ILE . 24.8 Cg_exo -63.11 136.65 57.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.636 2.224 . . . . 0.0 112.006 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -128.3 148.27 50.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.07 77.47 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -60.32 -19.0 53.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -29.31 62.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.57 -26.73 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.577 ' CD1' HD11 ' A' ' 113' ' ' LEU . 95.4 m-85 -97.71 173.95 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.18 140.5 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.505 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -79.72 111.67 16.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.833 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.4 m -93.88 -25.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.3 m -160.28 140.46 11.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 111.158 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 17.2 p -162.99 111.53 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -147.76 122.41 9.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 111.434 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.703 HG23 ' OG1' ' A' ' 154' ' ' THR . 4.8 m -76.38 144.93 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.35 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 t -115.62 105.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -93.61 104.94 17.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.406 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -86.69 -177.09 6.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -54.42 -51.49 64.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -76.58 127.0 85.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.044 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.21 -31.5 93.15 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.137 1.891 . . . . 0.0 112.413 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.26 -22.41 33.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.869 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.9 mt -81.75 10.46 6.16 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.511 ' O ' HD23 ' A' ' 118' ' ' LEU . 46.0 m -79.55 164.97 23.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 110.32 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.706 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 7.9 p80 -174.08 160.9 3.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.152 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.703 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.2 m -125.45 135.43 52.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -100.83 109.25 21.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.3 mt-10 -107.16 126.81 52.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.944 0.402 . . . . 0.0 111.378 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.757 ' O ' HG22 ' A' ' 139' ' ' VAL . 14.4 t -118.82 116.36 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.26 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.505 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.9 m95 -112.53 150.18 31.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.058 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.464 ' HG3' HG11 ' A' ' 139' ' ' VAL . 5.6 mt-30 -128.58 118.31 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.303 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.6 ttpp -53.55 133.91 41.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.578 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.51 10.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.511 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.087 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' LEU . 91.4 m . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.52 0.2 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.79 152.64 28.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.648 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -115.45 116.26 27.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.458 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' A' ' 30' ' ' PHE . 13.1 tp -115.25 122.03 44.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.686 ' CH2' HG12 ' A' ' 115' ' ' VAL . 2.8 p90 -168.35 165.2 12.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.569 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -126.88 141.65 51.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 4.9 pt20 -127.35 156.55 41.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.838 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.54 -170.52 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.54 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -50.01 -46.34 52.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.42 -21.42 59.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 90.2 47.94 3.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.16 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -87.27 174.72 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.378 -179.47 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 126' ' ' THR . 1.0 OUTLIER -146.71 -42.45 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.66 162.86 34.84 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.58 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HD3' HD21 ' A' ' 19' ' ' LEU . 9.4 tttm -118.45 110.97 18.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.365 . . . . 0.0 111.131 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -92.02 134.19 35.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.3 -141.84 13.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.72 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -92.98 120.95 33.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.688 0.28 . . . . 0.0 110.806 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.605 HD21 ' HD3' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -151.18 128.21 5.46 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.317 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 7.2 Cg_exo -72.52 -56.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.554 2.17 . . . . 0.0 111.857 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -117.25 -176.04 2.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -143.69 -173.02 3.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.12 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.88 120.33 77.33 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.32 -21.38 1.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.685 2.257 . . . . 0.0 112.93 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -74.24 -44.28 53.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 29' ' ' TYR . 7.3 t0 -71.81 -33.23 68.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . 14.3 mt -55.07 -42.54 72.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.42 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -68.19 -14.73 63.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.937 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CZ ' HD11 ' A' ' 4' ' ' LEU . 19.3 t80 -71.39 -66.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.636 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.5 p90 -72.46 -41.86 65.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' O ' HG13 ' A' ' 35' ' ' VAL . 6.3 mtp180 -55.37 -27.7 49.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.47 -22.41 16.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.76 -48.72 6.43 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 30' ' ' PHE . 14.4 t -94.45 32.95 1.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -92.24 160.11 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.27 0.557 . . . . 0.0 111.862 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.66 27.12 54.59 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -147.23 -166.82 2.61 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 120.076 1.938 . . . . 0.0 109.009 178.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 92' ' ' GLN . 86.5 mt -81.69 87.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.68 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.4 ttp -99.94 111.94 24.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.581 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.737 HG13 ' HB ' ' A' ' 60' ' ' VAL . 2.8 t -86.2 129.82 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.561 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 27.6 m -135.77 153.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.95 157.05 53.49 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.213 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.814 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.18 -52.78 57.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.397 . . . . 0.0 110.345 179.539 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.449 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.7 tpt180 -56.82 -44.81 82.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.325 0.583 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 m -61.16 -36.65 80.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 9.5 t80 -66.02 -24.71 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -65.83 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.396 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.4 t -48.19 -31.65 6.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.222 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.561 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 3.5 m-30 -46.44 166.46 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.99 -70.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.795 2.33 . . . . 0.0 112.932 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -145.72 -167.11 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.97 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -132.3 113.81 14.61 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 6.4 Cg_exo -87.83 -160.9 1.72 Allowed 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.057 -0.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.727 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 12.2 mt -86.9 168.27 18.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 37.8 Cg_endo -66.87 93.9 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.443 2.095 . . . . 0.0 113.043 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 7.0 mt-10 64.99 14.05 9.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.33 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.727 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 6.0 mtp180 -109.11 116.95 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.388 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.4 m -67.11 110.93 3.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.866 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.479 HD21 ' HB2' ' A' ' 57' ' ' ARG . 2.4 m120 -106.0 157.48 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.437 0.637 . . . . 0.0 112.641 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.737 ' HB ' HG13 ' A' ' 40' ' ' VAL . 8.2 t -136.14 135.76 49.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.33 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 43' ' ' ARG . 85.9 t -109.46 128.11 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.925 0.393 . . . . 0.0 111.636 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -107.61 119.74 40.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.595 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.936 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.9 t -150.47 170.95 17.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -95.06 -10.13 31.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.718 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.0 tt0 -68.87 132.27 46.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.8 0.334 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.22 56.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.71 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.01 14.64 18.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.936 ' CG ' HG21 ' A' ' 63' ' ' THR . 6.1 t80 -60.95 142.1 56.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.444 0.64 . . . . 0.0 111.978 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.834 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.2 mt-30 -135.79 172.99 12.21 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.316 1.055 . . . . 0.0 112.873 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.97 140.61 17.99 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.094 -1.867 . . . . 0.0 110.106 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.8 mp0 -73.77 100.2 3.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.78 0.324 . . . . 0.0 110.85 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 87.15 -38.17 3.16 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.395 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.514 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.62 171.34 10.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.674 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.726 HG21 ' CE2' ' A' ' 85' ' ' TYR . 22.4 t -99.46 140.37 18.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.507 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 69' ' ' GLN . 30.3 t -107.95 116.84 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 0.0 112.032 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 33.1 m -126.29 171.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -121.14 -22.54 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.736 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -155.2 -173.95 4.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.7 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.937 HG13 ' CD2' ' A' ' 106' ' ' PHE . 14.8 t -68.22 -10.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.14 -33.92 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.088 0.47 . . . . 0.0 110.075 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.19 -27.22 53.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.886 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 76' ' ' VAL . 72.4 t -73.47 -53.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.525 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.6 m-85 -55.01 -26.74 39.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.709 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.84 97.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 74' ' ' VAL . 38.9 t80 -67.19 -57.68 6.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.553 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -51.04 -25.66 5.17 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.232 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -66.58 -44.37 82.43 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -79.74 -0.3 33.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.546 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.602 ' CE1' ' CZ ' ' A' ' 85' ' ' TYR . 73.2 m80 -127.57 60.26 43.11 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.981 0.42 . . . . 0.0 110.269 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.3 -0.25 7.08 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.146 2.564 . . . . 0.0 112.812 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.5 -38.29 30.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.067 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.463 ' HG3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -114.17 167.68 10.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 111.243 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.54 166.31 11.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.501 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.625 HD11 ' CG1' ' A' ' 82' ' ' VAL . 13.6 tp -97.43 116.64 30.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.988 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 39' ' ' MET . 12.3 t -122.82 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.529 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 12.7 mm -80.59 140.53 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.418 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.73 -37.99 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.405 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.75 -168.42 41.52 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.681 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.42 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.54 -160.97 34.0 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 117.561 0.681 . . . . 0.0 112.528 -0.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.54 63.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.3 -29.06 60.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.599 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 62' ' ' LEU . 27.7 mm -84.08 -26.31 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.547 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.2 m-85 -60.45 -58.46 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.734 ' CA ' HD13 ' A' ' 129' ' ' ILE . 3.8 t -66.51 -9.08 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.762 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.34 -39.35 39.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.71 0.29 . . . . 0.0 111.283 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.937 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.3 m-85 -103.23 -5.76 22.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 7.0 pttt -42.47 -31.14 0.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -90.35 -26.76 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.733 ' OD2' HG11 ' A' ' 79' ' ' VAL . 12.0 m-20 -89.1 -31.68 17.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 3' ' ' PHE . 70.8 t -48.99 129.32 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 6.3 t70 -105.86 9.24 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.2 m -166.85 140.91 3.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 110' ' ' VAL . 13.8 mt -121.62 144.24 48.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.305 0.574 . . . . 0.0 111.743 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.489 ' HB2' HD12 ' A' ' 4' ' ' LEU . 5.4 mt -135.38 117.53 15.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.139 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.686 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -136.33 146.51 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.479 . . . . 0.0 112.108 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.97 108.47 16.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.301 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 8.3 tpt180 -79.51 101.16 8.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.317 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.583 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 3.2 mt -82.49 124.89 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.3 6.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.29 175.31 3.27 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.664 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.6 p -105.72 159.37 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 110.947 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.583 ' CZ ' HD22 ' A' ' 118' ' ' LEU . 6.3 m-85 -147.31 155.17 41.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.84 170.1 10.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.652 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.587 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 157.57 163.85 13.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.262 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.45 -27.1 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.6 0.238 . . . . 0.0 111.348 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.489 HG22 HD11 ' A' ' 13' ' ' ILE . 90.4 m -109.17 146.67 33.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.742 0.306 . . . . 0.0 111.008 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 177.56 4.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.0 tpt -76.94 156.68 31.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.734 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.3 pp -82.84 157.79 66.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.26 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.22 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.72 2.28 . . . . 0.0 112.507 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.45 146.63 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.38 75.78 2.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.012 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.571 ' HH2' HG11 ' A' ' 115' ' ' VAL . 88.0 m95 -56.39 -23.45 38.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -27.81 63.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.554 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.5 t70 -78.7 -24.82 44.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.737 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.459 ' CD1' HD11 ' A' ' 113' ' ' LEU . 78.5 m-85 -104.05 173.58 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.654 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -128.72 139.79 52.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpp -83.7 108.0 16.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.574 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.3 m -95.79 -18.11 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.722 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 m -162.62 140.46 8.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.722 0.296 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.484 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 2.2 p -169.85 108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -142.66 118.12 10.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.753 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -67.11 145.28 55.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.04 103.74 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.284 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.86 102.15 14.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.32 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 174.23 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.6 p -52.53 -44.16 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.495 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.3 t-20 -80.51 128.49 72.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.352 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.43 -30.35 86.85 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.393 2.062 . . . . 0.0 112.592 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.7 -22.98 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.4 mt -81.01 6.3 13.85 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 153' ' ' HIS . 99.6 m -70.2 162.38 28.5 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.163 0.506 . . . . 0.0 110.396 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -172.38 159.09 4.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.836 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.753 ' OG1' HG23 ' A' ' 143' ' ' THR . 6.8 m -119.0 150.25 40.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' SER . 48.9 m-85 -113.84 105.04 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.498 ' HB2' HG22 ' A' ' 115' ' ' VAL . 28.5 mt-10 -109.78 125.29 52.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.037 0.446 . . . . 0.0 112.183 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.685 ' O ' HG22 ' A' ' 139' ' ' VAL . 16.3 t -116.84 114.22 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.211 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.471 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.1 m95 -108.31 150.59 27.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.064 0.459 . . . . 0.0 111.985 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.489 ' CD ' HG11 ' A' ' 139' ' ' VAL . 31.3 mt-30 -129.33 125.33 36.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.32 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -48.07 123.28 6.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.661 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.654 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -107.67 -177.59 3.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.133 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.748 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.77 149.2 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.499 ' CE1' HG22 ' A' ' 110' ' ' VAL . 3.4 m-30 -113.64 108.35 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.845 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.48 117.15 33.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.605 0.717 . . . . 0.0 112.45 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.677 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.1 p90 -161.52 166.84 26.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.261 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.86 132.55 54.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.607 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.1 pt20 -118.5 143.87 46.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -91.93 -167.82 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.42 52.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.01 -27.68 48.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 106.73 29.53 4.64 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.259 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.66 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.9 tt -84.27 157.87 21.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.962 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.536 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -111.93 -58.53 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.459 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.0 -162.23 24.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.96 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.673 ' HG3' ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -126.24 -164.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.716 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.11 86.41 6.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.654 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.35 114.98 3.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.311 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -100.71 133.9 44.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 0.0 111.134 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.632 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -101.38 -51.38 0.17 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.219 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 19' ' ' LEU . 77.2 Cg_endo -93.62 107.95 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.764 2.309 . . . . 0.0 112.448 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -126.53 111.76 14.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.87 119.67 9.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.774 HD22 ' OD1' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -161.75 101.97 1.18 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.16 -48.39 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.554 2.169 . . . . 0.0 113.068 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.86 -14.75 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.488 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.774 ' OD1' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -57.28 -31.28 65.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 mp -62.92 -49.87 73.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.717 0.294 . . . . 0.0 111.287 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -52.86 -25.43 11.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.989 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -73.88 -62.75 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.455 ' CA ' ' HB2' ' A' ' 33' ' ' GLN . 27.5 p90 -92.49 27.68 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.491 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -53.81 25.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.849 0.357 . . . . 0.0 110.809 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.0 -19.55 51.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.559 ' HA ' ' CG ' ' A' ' 37' ' ' LYS . 1.5 mt-30 -67.36 -7.52 25.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.76 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 57' ' ' ARG . 18.3 p -88.9 -18.71 26.99 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 37' ' ' LYS . 3.5 m -107.8 117.67 53.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.068 0.461 . . . . 0.0 112.222 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 92' ' ' GLN . . . 57.42 -10.35 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.72 -0.673 . . . . 0.0 114.7 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 33' ' ' GLN . 6.7 mmtt -69.46 95.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.559 0.695 . . . . 0.0 110.944 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.544 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 20.4 mt -64.41 110.7 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.692 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.8 ttp -100.79 115.26 29.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.584 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.806 HG21 HG11 ' A' ' 82' ' ' VAL . 2.7 t -88.99 124.3 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.167 0.508 . . . . 0.0 112.201 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 15.7 m -130.0 144.33 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.379 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.09 156.97 51.79 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.172 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.45 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -55.48 -51.01 68.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 110.514 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -58.43 -34.87 71.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -68.24 -47.49 67.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -54.13 -31.91 53.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -66.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.652 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 49' ' ' PHE . 2.4 m -57.6 -30.75 65.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.42 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -32.92 122.7 0.42 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.9 -179.23 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.28 -38.2 88.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.963 2.442 . . . . 0.0 113.311 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.57 116.28 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.429 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.51 135.09 14.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.709 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.42 -171.86 8.41 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.354 -1.519 . . . . 0.0 112.161 -0.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 57' ' ' ARG . 95.7 mt -97.84 147.2 32.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.571 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.67 -86.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.091 2.527 . . . . 0.0 113.451 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.84 25.65 8.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.624 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.142 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 80.3 m -74.7 122.0 22.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 111.873 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.416 HD21 HD12 ' A' ' 54' ' ' LEU . 2.6 m-80 -102.81 152.79 20.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.718 ' HB ' HG13 ' A' ' 40' ' ' VAL . 2.2 t -137.38 131.71 44.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.5 t -103.47 126.19 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.272 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -109.87 108.29 18.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.944 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.981 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.9 t -144.19 164.11 31.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 111.396 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -81.1 -9.83 59.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.289 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.664 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 3.9 tp-100 -71.74 127.18 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.332 . . . . 0.0 110.392 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -27.91 55.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -105.13 16.93 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.641 0.258 . . . . 0.0 111.493 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.981 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.6 t80 -62.25 137.24 58.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.485 0.659 . . . . 0.0 112.454 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.832 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -127.41 171.99 11.06 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.251 1.024 . . . . 0.0 112.357 178.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.07 140.14 16.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -76.07 96.81 3.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.813 0.339 . . . . 0.0 110.941 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.95 -42.26 2.31 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.556 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 167.92 19.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.133 0.492 . . . . 0.0 112.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' HG13 ' A' ' 60' ' ' VAL . 21.9 t -94.81 140.89 15.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.127 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.875 HG11 ' O ' ' A' ' 68' ' ' TYR . 33.8 t -107.01 121.61 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.386 0.612 . . . . 0.0 111.955 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.718 HG21 HG22 ' A' ' 82' ' ' VAL . 18.0 m -132.74 178.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.131 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -127.79 -21.11 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.648 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -153.8 -177.11 6.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.457 . . . . 0.0 111.591 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 106' ' ' PHE . 24.2 t -70.08 -11.17 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.433 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.11 -37.24 17.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.107 0.48 . . . . 0.0 110.064 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -68.83 -30.63 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.665 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.806 HG11 HG21 ' A' ' 40' ' ' VAL . 23.3 t -72.35 -55.81 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.484 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 8.5 m-85 -52.49 -31.21 34.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.6 -43.81 97.87 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 87.5 t80 -61.04 -52.6 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.3 -22.33 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.35 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mtmt -70.99 -37.14 72.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.126 0.489 . . . . 0.0 109.874 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -8.7 59.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 92' ' ' GLN . 95.1 m-70 -120.01 62.45 8.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.93 -6.04 8.69 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.655 2.237 . . . . 0.0 112.226 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -99.55 -25.75 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.982 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.643 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 38.5 mt-30 -94.11 151.6 19.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 29.2 mt-10 -99.09 174.76 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.58 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 1' ' ' THR . 17.2 tp -131.23 111.17 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 111.308 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 39' ' ' MET . 83.9 t -129.23 116.14 38.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 40' ' ' VAL . 6.3 mm -82.02 138.13 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.88 0.371 . . . . 0.0 111.082 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.76 -33.14 5.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.94 -171.89 44.41 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.462 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.62 -160.97 36.17 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 117.588 0.694 . . . . 0.0 112.632 -0.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.01 -55.75 15.9 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.8 0.333 . . . . 0.0 111.294 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -56.47 -31.92 64.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.025 0.441 . . . . 0.0 110.464 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.4 mm -77.11 -30.54 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.053 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.0 m-85 -58.02 -52.98 63.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.366 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.696 ' CA ' HD13 ' A' ' 129' ' ' ILE . 12.0 t -69.53 -10.22 57.19 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -73.36 -39.71 64.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.9 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.8 m-85 -102.35 -3.55 26.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.584 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 5.9 pttt -51.65 -31.23 24.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.7 -5.69 58.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.555 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.82 -20.65 8.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.657 0.265 . . . . 0.0 111.475 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 106' ' ' PHE . 73.4 t -45.58 134.15 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.12 0.486 . . . . 0.0 111.427 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 18.1 t70 -111.26 -0.32 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.748 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.6 m -166.74 137.44 3.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.565 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 6.1 mt -118.13 145.64 44.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.24 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 4' ' ' LEU . 9.4 mt -134.96 112.74 10.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.062 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.677 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -127.94 137.39 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.055 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.92 119.93 36.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.182 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 100.6 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 0.9 OUTLIER -81.13 135.31 35.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -55.94 -53.84 52.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 122' ' ' PHE . . . -58.04 156.32 19.52 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.234 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 p -97.04 154.13 17.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -142.68 156.48 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.824 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 156.92 16.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.252 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.673 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . 178.56 175.41 45.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.911 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.22 22.08 4.45 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.463 HG22 HD11 ' A' ' 13' ' ' ILE . 1.3 m -133.0 126.96 33.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.75 0.31 . . . . 0.0 110.838 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -108.65 162.31 14.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.3 tpt -72.93 158.44 35.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.696 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.2 pp -88.75 164.97 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.178 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.22 96.79 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 112.655 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.1 149.49 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.997 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.02 71.35 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.479 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HH2' HG11 ' A' ' 115' ' ' VAL . 95.6 m95 -58.96 -20.11 49.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.86 -32.06 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.756 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -79.39 -24.52 42.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.57 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 95.5 m-85 -101.46 171.62 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 111.076 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -134.93 141.76 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.2 ttpm? -84.76 105.81 15.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.9 m -89.9 -17.96 7.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.985 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -161.85 141.47 10.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 111.17 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.607 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 99.2 p -172.01 108.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.412 ' C ' HG23 ' A' ' 154' ' ' THR . 1.7 ttt-85 -147.87 130.52 15.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.26 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.756 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.4 m -74.27 146.3 43.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.148 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' THR . 11.3 t -118.3 104.62 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.383 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -93.33 104.89 17.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.72 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.7 -174.51 4.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.498 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -54.58 -54.89 35.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.864 0.364 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.554 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.8 t30 -75.93 141.08 71.07 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.769 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.77 -36.57 18.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.819 1.679 . . . . 0.0 112.369 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.91 -23.4 44.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.878 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -77.69 9.61 3.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.566 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 144' ' ' VAL . 50.3 m -83.95 158.64 21.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -170.68 155.83 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.756 ' OG1' HG23 ' A' ' 143' ' ' THR . 39.6 m -117.69 129.44 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.404 ' OH ' ' CE1' ' A' ' 153' ' ' HIS . 57.2 m-85 -100.77 105.64 16.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.409 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.548 ' HB2' HG22 ' A' ' 115' ' ' VAL . 17.0 mt-10 -104.61 126.68 51.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.307 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.745 ' O ' HG22 ' A' ' 139' ' ' VAL . 6.2 t -118.07 112.56 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.552 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 30.2 m95 -104.63 148.27 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.067 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -128.33 119.22 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.747 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.452 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.4 tttt -51.54 135.13 28.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.26 -165.86 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.575 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 9.6 m . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.93 148.64 33.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.9 m-85 -113.87 112.24 23.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.278 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.807 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.84 127.83 55.34 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.664 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.5 p90 -168.63 163.8 12.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.216 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.22 131.73 53.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.862 0.363 . . . . 0.0 111.732 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.544 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 7.5 pt20 -130.61 161.54 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.415 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.11 -169.03 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HD3' ' HB3' ' A' ' 121' ' ' SER . 0.0 OUTLIER -55.34 -27.73 49.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.67 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 9.2 t70 -90.63 -33.98 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 105.17 57.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.859 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 67.1 mt -110.22 152.23 26.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 pt -112.4 -39.37 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.343 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.33 151.31 10.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.627 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.74 -73.99 0.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.815 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.75 150.23 3.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.73 173.07 12.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.561 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -87.33 -19.5 28.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.655 0.264 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.451 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 2.1 tp 65.75 63.26 1.01 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 14.8 Cg_exo -68.46 -66.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.635 2.224 . . . . 0.0 112.15 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -77.59 144.73 37.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -126.31 171.84 10.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -130.07 129.48 22.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.732 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 31.5 Cg_exo -58.84 -12.08 13.89 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.542 2.161 . . . . 0.0 112.98 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.474 ' OD2' ' CE1' ' A' ' 153' ' ' HIS . 2.7 t70 -76.2 -44.54 37.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.36 -23.64 17.09 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.585 HD12 ' HG2' ' A' ' 31' ' ' ARG . 3.5 mm? -78.52 -35.38 46.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 1.9 t-80 -52.75 -35.42 56.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.482 ' HB2' ' CE1' ' A' ' 155' ' ' TYR . 31.6 t80 -105.35 -7.42 18.85 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.455 ' HA ' HD23 ' A' ' 4' ' ' LEU . 53.3 t80 -92.32 -75.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.805 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -62.35 -54.86 34.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.515 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.76 -25.77 3.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.848 0.356 . . . . 0.0 111.953 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.679 ' OE1' HD13 ' A' ' 114' ' ' LEU . 1.8 mm-40 -92.92 -3.39 54.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.599 ' HB ' ' HG ' ' A' ' 4' ' ' LEU . 12.9 t -135.6 -35.56 0.8 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 31' ' ' ARG . 13.0 m -74.42 161.58 4.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.525 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . 83.56 2.86 89.98 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.483 -0.865 . . . . 0.0 114.918 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -149.53 -164.23 1.97 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.29 1.545 . . . . 0.0 109.298 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.506 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 40.8 mt -76.82 88.96 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 111.579 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.492 ' HE2' HD12 ' A' ' 54' ' ' LEU . 27.5 ttp -103.11 126.74 50.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.641 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.597 HG21 HG11 ' A' ' 82' ' ' VAL . 39.3 t -79.87 156.51 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.759 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 31.2 m -163.7 140.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.984 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.76 147.75 48.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.32 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.614 ' HG2' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -49.93 -46.39 52.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.445 0.622 . . . . 0.0 110.613 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -58.97 -39.55 82.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 109.963 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -65.98 -48.67 70.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.984 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 4.5 t80 -57.31 -27.22 61.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.79 -66.23 0.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.658 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.12 -23.88 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.787 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -35.71 133.12 0.53 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.901 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 99.6 Cg_exo -46.8 -35.96 18.74 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.144 2.563 . . . . 0.0 113.534 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.84 148.55 31.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.197 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.95 111.84 6.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.252 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 12.9 Cg_exo -81.76 179.09 28.53 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 123.408 -1.497 . . . . 0.0 111.787 -0.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.787 HD11 ' CE1' ' A' ' 49' ' ' PHE . 77.8 mt -78.87 143.42 62.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.766 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.81 109.2 2.06 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.514 2.143 . . . . 0.0 112.609 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 mt-10 73.19 0.12 3.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.968 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.776 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -109.89 106.88 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 -179.343 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.506 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 87.9 m -64.99 120.31 12.36 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.613 ' ND2' HD12 ' A' ' 54' ' ' LEU . 4.8 m120 -110.11 157.32 19.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.203 0.525 . . . . 0.0 112.362 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 76' ' ' VAL . 17.7 t -134.15 143.58 37.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.765 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.8 t -113.58 111.04 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.179 0.514 . . . . 0.0 111.891 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -91.58 118.35 30.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.304 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.895 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -155.37 148.17 24.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.936 179.472 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -69.02 -6.32 27.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.258 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.8 tt0 -73.29 131.6 42.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.329 . . . . 0.0 110.747 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -85.42 5.47 30.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.838 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -134.6 7.72 3.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.895 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.4 t80 -59.91 137.51 58.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.289 0.566 . . . . 0.0 111.594 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.956 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.3 mt-30 -133.15 171.94 13.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.454 1.121 . . . . 0.0 113.14 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.5 140.29 17.13 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.138 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.97 102.56 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.07 -41.05 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.274 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -72.49 170.51 14.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.017 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 60' ' ' VAL . 21.6 t -98.53 141.33 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.956 HG21 ' HA ' ' A' ' 69' ' ' GLN . 14.8 t -114.37 122.37 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 0.0 112.187 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.008 HG21 HG22 ' A' ' 82' ' ' VAL . 27.3 m -129.91 173.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.111 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' THR . 6.0 m170 -118.44 -24.22 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -157.1 -171.82 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 111.165 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.841 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.6 t -68.91 -11.29 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.54 -36.84 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 110.094 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.81 -29.67 63.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.89 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.008 HG22 HG21 ' A' ' 76' ' ' VAL . 21.5 t -72.3 -55.19 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 120.904 0.383 . . . . 0.0 110.039 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.552 ' O ' ' HG3' ' A' ' 87' ' ' LYS . 9.4 m-85 -53.61 -27.59 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.817 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.08 -48.64 79.28 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.846 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.624 ' CZ ' ' CE1' ' A' ' 89' ' ' HIS . 83.1 t80 -58.98 -51.24 70.91 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.99 -22.84 16.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.095 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' PHE . 6.6 mtmp? -67.78 -44.5 77.29 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -79.63 -2.83 44.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.596 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.624 ' CE1' ' CZ ' ' A' ' 85' ' ' TYR . 73.0 m80 -128.68 64.43 69.04 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-O 120.995 0.426 . . . . 0.0 110.388 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.19 -0.01 6.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.184 2.589 . . . . 0.0 112.935 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.89 -31.83 18.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.169 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.74 162.94 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.364 . . . . 0.0 111.34 -179.673 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -104.17 174.71 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.223 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.676 HD21 ' CG1' ' A' ' 82' ' ' VAL . 6.2 tp -110.5 117.08 32.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.586 HG11 ' O ' ' A' ' 33' ' ' GLN . 11.3 t -121.53 107.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.093 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.479 HD12 ' HB ' ' A' ' 40' ' ' VAL . 16.4 mm -76.76 132.08 33.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 111.593 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.13 -37.15 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.027 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.34 -172.66 45.0 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.827 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.9 -161.11 31.7 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 122.216 -0.579 . . . . 0.0 112.535 -0.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.3 -55.36 32.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.737 0.303 . . . . 0.0 111.045 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -55.14 -26.49 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.571 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.9 mm -80.62 -26.41 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' HB3' HG12 ' A' ' 129' ' ' ILE . 3.4 m-85 -62.71 -55.84 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.472 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.729 ' CA ' HD13 ' A' ' 129' ' ' ILE . 4.6 t -66.72 -10.11 43.53 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.772 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.38 -41.3 48.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.841 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.5 m-85 -96.69 -8.28 31.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.478 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.91 -29.24 19.23 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.856 0.36 . . . . 0.0 111.161 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.52 -3.74 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.551 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -128.8 -19.09 3.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 106' ' ' PHE . 77.7 t -44.45 131.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.459 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 9.9 t70 -109.22 4.36 22.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.285 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.709 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 21.7 m -167.74 135.72 2.38 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.6 0.238 . . . . 0.0 110.821 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 13.8 mt -116.52 142.44 46.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.679 HD13 ' OE1' ' A' ' 33' ' ' GLN . 3.7 mt -135.53 115.69 13.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -138.1 147.39 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.92 105.91 13.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.022 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 18.3 ttt180 -86.39 104.71 16.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.79 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 6.8 mp -85.14 128.3 34.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.931 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -61.55 -54.0 48.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.463 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -63.13 168.52 19.85 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.46 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 95.3 p -105.28 141.97 35.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.683 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -137.11 175.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 162.55 29.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.48 ' CA ' HD13 ' A' ' 12' ' ' LEU . . . 164.08 133.15 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -106.05 -24.8 12.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.64 0.257 . . . . 0.0 111.237 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.36 144.73 37.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 111.198 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.56 -174.63 2.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.0 tpt -86.24 160.01 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.189 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.729 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.6 pp -86.87 166.24 27.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.193 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' A' ' 129' ' ' ILE . 20.3 Cg_exo -66.29 94.25 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.874 2.383 . . . . 0.0 112.908 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.42 149.01 23.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.068 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.7 77.74 3.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -59.32 -18.2 35.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.532 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.57 -30.93 61.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 111.032 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.78 -25.79 49.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.274 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.506 ' CD1' HD11 ' A' ' 113' ' ' LEU . 95.8 m-85 -97.18 174.23 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.004 0.43 . . . . 0.0 111.541 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.453 HG21 ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -136.88 142.74 42.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.0 OUTLIER -78.26 119.3 21.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.978 179.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 157' ' ' VAL . 29.2 m -102.16 -23.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.219 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.7 m -163.23 140.77 7.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 80.9 p -160.7 110.12 1.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.978 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -141.64 114.54 8.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.015 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.737 HG23 ' OG1' ' A' ' 154' ' ' THR . 7.4 m -73.07 143.99 47.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.481 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.48 105.3 18.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.951 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.437 ' HA ' HG23 ' A' ' 152' ' ' THR . 1.7 mt-10 -90.73 102.15 14.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.714 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.79 -177.73 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.595 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 36.3 p -59.51 -49.52 77.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.53 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t-20 -74.41 125.44 89.83 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.774 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.5 -28.21 86.91 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.089 1.859 . . . . 0.0 112.338 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.463 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -89.3 -20.07 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.027 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.8 mt -84.91 8.75 16.44 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 80.4 m -73.25 166.27 23.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.912 0.387 . . . . 0.0 110.004 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 10.5 p-80 -173.74 160.33 3.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.737 ' OG1' HG23 ' A' ' 143' ' ' THR . 8.0 m -126.84 140.13 52.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.264 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.482 ' CE1' ' HB2' ' A' ' 29' ' ' TYR . 51.0 m-85 -100.03 105.72 17.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.468 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.438 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.3 mt-10 -104.24 121.81 44.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.928 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.805 ' O ' HG22 ' A' ' 139' ' ' VAL . 9.6 t -114.51 112.96 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.8 m95 -112.63 150.8 30.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.274 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.526 ' CD ' HG11 ' A' ' 139' ' ' VAL . 26.6 mt-30 -128.51 118.89 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.36 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.3 tttt -57.35 133.08 54.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.865 0.364 . . . . 0.0 111.153 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.453 ' HE2' HG21 ' A' ' 137' ' ' THR . 0.0 OUTLIER 177.16 157.67 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.099 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.141 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.459 ' CG2' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.537 0.208 . . . . 0.0 110.539 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.23 143.08 37.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.296 0.57 . . . . 0.0 112.366 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.494 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.3 m-30 -112.36 112.98 24.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.543 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.816 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -113.15 123.16 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 111.648 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.646 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.6 p90 -166.29 173.88 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.518 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -128.68 137.65 51.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -130.25 157.0 43.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.592 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 20.7 p-10 -108.33 -171.67 1.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.71 -36.47 64.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.38 -28.03 34.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.702 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.6 -4.22 66.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.893 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 2.5 pp -80.59 157.46 26.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.927 0.363 . . . . 0.0 111.021 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.656 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -120.96 -35.91 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.1 -156.87 27.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.81 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.501 ' H ' HD21 ' A' ' 19' ' ' LEU . 14.0 mttm -103.84 -139.46 0.36 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.671 -0.122 . . . . 0.0 110.671 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -149.95 107.75 3.69 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.902 0.382 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.64 -95.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.367 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -71.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.641 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.501 HD21 ' H ' ' A' ' 15' ' ' LYS . 86.2 mt 58.24 80.69 0.27 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.339 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.41 109.8 2.36 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.256 . . . . 0.0 112.01 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.04 121.64 42.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 111.243 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -120.57 27.33 8.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.716 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.22 147.2 33.34 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.04 -24.72 23.54 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.599 2.2 . . . . 0.0 112.348 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -48.59 -27.37 2.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.552 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -90.31 -54.49 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.192 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.7 tp -63.16 -14.45 49.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.914 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -91.44 -29.12 17.22 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -105.17 -39.53 6.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 111.599 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 5' ' ' TRP . 17.7 m-85 -92.2 30.37 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.369 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.831 ' O ' HG22 ' A' ' 35' ' ' VAL . 4.2 ttm-85 -91.86 -61.52 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.35 -28.16 15.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.704 0.288 . . . . 0.0 111.636 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -69.14 -17.61 63.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.753 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.688 ' CG2' HD21 ' A' ' 4' ' ' LEU . 34.9 p -116.52 -31.07 5.67 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.831 HG22 ' O ' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -107.63 151.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.183 0.516 . . . . 0.0 112.36 -178.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 103.27 -7.5 51.64 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.935 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -145.45 -164.53 1.97 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.387 1.094 . . . . 0.0 109.563 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.3 mt -81.34 88.67 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.118 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.472 ' HE3' ' CG1' ' A' ' 41' ' ' VAL . 4.1 ttp -99.07 123.13 43.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.766 HG21 HG11 ' A' ' 82' ' ' VAL . 4.4 t -89.22 128.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.472 ' CG1' ' HE3' ' A' ' 39' ' ' MET . 33.5 m -131.49 148.12 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.538 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.87 151.22 51.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.385 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.524 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -49.83 -51.12 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.8 tpt180 -62.18 -36.76 82.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.303 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -66.86 -36.25 81.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.942 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.476 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t80 -65.53 -22.34 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.592 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -65.22 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.2 t -48.37 -36.58 14.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -43.18 157.27 0.25 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.012 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.12 -67.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.673 2.249 . . . . 0.0 112.768 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.25 164.06 36.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 16.9 mtm180 -117.12 115.08 38.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 67.6 Cg_endo -88.74 -164.99 2.78 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.005 -1.248 . . . . 0.0 112.329 0.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.644 HD12 HD21 ' A' ' 59' ' ' ASN . 55.4 mt -107.51 144.63 29.63 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 37.3 Cg_endo -65.97 118.11 5.22 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.555 2.17 . . . . 0.0 112.638 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 7.1 mt-10 68.02 7.49 5.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.944 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 1.3 mtt180 -119.24 100.31 7.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.887 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 34.9 m -67.72 109.92 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.744 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.3 m-80 -104.39 139.51 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.305 0.574 . . . . 0.0 112.265 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' HG13 ' A' ' 40' ' ' VAL . 4.5 t -113.0 143.16 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.121 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 68' ' ' TYR . 84.9 t -114.77 125.06 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 111.9 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.937 HD12 HG23 ' A' ' 76' ' ' VAL . 1.9 tp -104.66 120.36 41.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.92 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -153.62 171.18 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -91.91 -8.03 47.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.6 tt0 -77.9 130.72 36.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.339 . . . . 0.0 110.786 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -80.79 0.05 36.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.004 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -126.79 10.03 7.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.578 0.228 . . . . 0.0 111.407 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.92 ' CD2' HG21 ' A' ' 63' ' ' THR . 4.4 t80 -59.34 141.62 54.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.95 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.7 mt-30 -132.52 174.54 10.17 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 122.343 1.068 . . . . 0.0 112.902 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.84 143.62 20.77 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.398 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -73.17 98.56 2.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.771 0.319 . . . . 0.0 110.835 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.18 -36.7 2.89 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.535 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -70.69 172.38 8.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 0.0 111.489 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.99 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.95 HG21 ' HA ' ' A' ' 69' ' ' GLN . 25.1 t -112.76 122.72 67.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.134 0.492 . . . . 0.0 111.365 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.937 HG23 HD12 ' A' ' 62' ' ' LEU . 30.8 m -133.61 168.61 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.334 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 65' ' ' GLN . 9.0 m80 -117.1 -22.52 8.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.358 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -150.06 -177.36 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 111.578 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.915 HG13 ' CD2' ' A' ' 106' ' ' PHE . 21.5 t -70.79 -8.57 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.99 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.76 -31.24 17.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 110.053 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.736 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.03 -27.26 54.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.681 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 76' ' ' VAL . 95.2 t -75.67 -52.59 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.659 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 8.2 m-85 -57.39 -25.02 58.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.689 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -66.3 -57.55 7.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.635 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -56.82 -23.4 43.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.04 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.14 -33.01 72.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 9.7 mt-30 -88.75 -4.13 58.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.26 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -126.02 63.97 50.69 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.33 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.06 -0.14 5.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.169 2.579 . . . . 0.0 112.94 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.79 -37.23 30.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -112.14 163.84 13.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -98.64 164.25 12.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.639 HD11 HG12 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -108.16 124.96 51.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.313 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' MET . 69.3 t -131.87 118.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.345 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 94' ' ' LEU . 3.0 mm -82.48 138.69 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 111.408 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -102.63 -52.98 2.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.775 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.11 -166.15 38.95 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.48 -161.01 36.77 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 117.813 0.806 . . . . 0.0 112.639 -0.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.78 -44.13 38.65 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.81 0.338 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.82 -34.33 74.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.717 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 62' ' ' LEU . 28.4 mm -80.97 -23.11 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -63.21 -52.06 63.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.55 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 14.5 t -68.48 -9.58 49.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.738 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.35 -39.99 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 110.68 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.915 ' CD2' HG13 ' A' ' 79' ' ' VAL . 4.2 m-85 -100.69 -4.8 27.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.368 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.3 pttt -48.18 -32.65 7.32 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.94 -2.16 58.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.789 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 m-20 -119.18 -26.89 5.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.585 0.231 . . . . 0.0 111.554 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.761 HG11 HD23 ' A' ' 113' ' ' LEU . 82.5 t -45.91 122.48 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 111.576 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 14.9 t70 -105.85 8.35 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.022 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.7 m -168.25 138.29 2.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.969 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.761 HD23 HG11 ' A' ' 110' ' ' VAL . 5.8 mt -121.46 146.2 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.319 0.581 . . . . 0.0 112.101 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 113' ' ' LEU . 14.3 mt -135.15 114.67 12.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.241 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -136.89 147.33 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.128 0.489 . . . . 0.0 112.133 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -107.93 119.01 38.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.915 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -79.46 99.01 7.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.383 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 6' ' ' ALA . 6.0 mt -85.94 108.96 18.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.177 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.33 78.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.034 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.5 171.49 54.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.554 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t -110.14 162.65 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 111.018 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 6.6 m-85 -138.42 170.05 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.253 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.42 169.95 8.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.89 -170.73 24.76 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.689 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.26 29.22 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.018 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -141.62 129.83 22.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 16.5 tttm -111.55 150.24 30.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.806 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -52.17 179.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.544 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.6 pt -97.27 162.67 21.91 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.188 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.2 Cg_endo -73.86 99.3 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.45 2.1 . . . . 0.0 112.102 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.427 ' CD1' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt -88.46 147.84 24.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 74.19 2.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.024 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.527 ' HH2' HG11 ' A' ' 115' ' ' VAL . 92.7 m95 -54.52 -24.17 19.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.94 -26.29 62.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.3 t0 -83.23 -19.51 36.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.737 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.699 ' CD1' HD11 ' A' ' 113' ' ' LEU . 89.9 m-85 -107.93 165.9 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.626 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.568 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -126.61 139.79 52.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 110.509 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 11.2 ttpt -79.6 117.25 20.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.464 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 157' ' ' VAL . 24.5 m -101.94 -21.84 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.927 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -163.09 140.61 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 8.6 p -155.94 111.02 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.501 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -141.42 117.1 10.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.789 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.787 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.2 m -72.62 133.48 44.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.161 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.64 109.77 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.583 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.779 ' HA ' HG23 ' A' ' 152' ' ' THR . 11.2 mt-10 -96.99 97.51 9.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -81.51 -161.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.191 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.2 p -74.38 -48.65 26.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.502 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -69.18 119.85 72.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.075 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.31 -20.57 56.29 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.083 1.856 . . . . 0.0 111.989 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -23.65 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.573 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.6 mt -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.779 HG23 ' HA ' ' A' ' 145' ' ' GLU . 1.7 m -85.86 82.21 8.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 5.3 p80 -97.12 -171.3 2.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.565 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.787 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 55.9 m -125.55 165.26 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.079 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.473 ' N ' HG22 ' A' ' 154' ' ' THR . 1.6 m-85 -118.79 105.85 11.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.96 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.4 mt-10 -109.69 125.27 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.778 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.752 ' O ' HG22 ' A' ' 139' ' ' VAL . 7.0 t -116.12 115.04 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.278 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.508 ' O ' HG23 ' A' ' 112' ' ' THR . 23.8 m95 -111.97 150.47 30.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.22 0.534 . . . . 0.0 111.655 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -127.28 121.12 30.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.784 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 2.3 tmmt? -54.94 130.42 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 0.0 111.62 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.568 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.59 -170.52 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.553 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.126 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 21.7 m . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.689 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.72 145.36 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.8 m-85 -112.17 111.53 22.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.314 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.849 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -111.16 119.07 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.544 0.688 . . . . 0.0 112.569 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.603 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.7 p90 -160.32 166.89 28.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.411 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.99 140.18 48.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.957 0.408 . . . . 0.0 111.769 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 1.9 pt20 -138.99 141.34 38.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.675 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 5.7 p-10 -100.35 -163.38 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -51.63 -48.9 63.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.345 0.593 . . . . 0.0 109.978 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.55 -32.69 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.037 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.11 43.47 3.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -82.51 165.15 20.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.753 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.83 -37.92 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.452 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 12' ' ' LEU . . . 168.36 -153.31 22.26 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.43 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -120.37 157.24 29.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.939 0.399 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -6.08 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.734 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.63 -51.42 1.41 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.615 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.82 179.92 4.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 0.0 111.039 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.413 ' HG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -77.63 145.46 71.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.972 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD2' ' HG ' ' A' ' 19' ' ' LEU . 93.5 Cg_endo -86.92 -170.89 0.68 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.836 2.357 . . . . 0.0 112.342 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -93.52 177.48 6.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.906 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -113.26 117.22 31.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.603 HD22 ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -120.33 132.98 23.94 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.646 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.09 -45.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.716 2.278 . . . . 0.0 113.24 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -64.07 -29.89 70.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.607 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.603 ' HB2' HD22 ' A' ' 23' ' ' LEU . 1.3 t0 -88.02 -18.02 29.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.603 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.425 HD22 ' CD ' ' A' ' 31' ' ' ARG . 7.1 mt -73.83 -34.45 64.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.752 0.311 . . . . 0.0 111.231 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -59.98 -24.65 64.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.469 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -103.9 -21.88 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.633 0.254 . . . . 0.0 111.512 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -86.99 -28.43 22.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.684 0.278 . . . . 0.0 111.307 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.903 ' O ' HG22 ' A' ' 35' ' ' VAL . 9.8 mtp-105 -91.98 -61.14 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.735 0.302 . . . . 0.0 111.655 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.87 -21.83 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.464 ' O ' HG11 ' A' ' 95' ' ' VAL . 6.3 mm-40 -91.71 -7.69 49.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.498 ' OG1' ' HB2' ' A' ' 97' ' ' ALA . 3.6 t -129.21 -27.9 2.41 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 31' ' ' ARG . 23.1 m -93.68 150.37 3.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' C ' ' HG2' ' A' ' 37' ' ' LYS . . . 106.2 -6.81 39.95 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.419 -0.896 . . . . 0.0 114.416 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 34.6 mmtm -149.09 -165.14 2.2 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.681 1.241 . . . . 0.0 109.729 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.519 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 62.8 mt -74.43 89.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.12 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 ttp -99.61 125.0 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.651 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.4 t -79.14 157.36 4.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.423 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 31.2 m -162.91 153.19 3.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.13 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 154.36 47.76 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.813 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.805 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.931 0.366 . . . . 0.0 110.813 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.4 tpm_? -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.575 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -71.4 -47.5 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 73' ' ' ALA . 9.7 t80 -58.21 -23.47 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.18 -65.82 0.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -56.45 -26.8 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.381 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -39.84 130.27 1.51 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.551 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.3 -27.96 5.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.383 . . . . 0.0 113.329 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -157.12 133.05 9.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.286 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -126.84 108.2 22.41 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 69.3 Cg_endo -80.49 -171.96 10.41 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.582 -1.424 . . . . 0.0 111.831 0.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.701 HD11 ' CE1' ' A' ' 49' ' ' PHE . 64.4 mt -91.55 158.19 40.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.44 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.78 -43.6 56.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.91 2.406 . . . . 0.0 113.533 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 4.6 mt-10 -140.58 46.05 1.8 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.835 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.6 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -146.53 111.37 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.339 . . . . 0.0 111.811 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.519 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.1 m -71.29 115.5 10.52 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.554 HD21 HD12 ' A' ' 54' ' ' LEU . 3.5 m-80 -101.07 159.42 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.475 0.655 . . . . 0.0 112.59 -178.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 74' ' ' VAL . 5.7 t -137.17 133.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.366 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 43' ' ' ARG . 86.8 t -104.7 126.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.691 HD13 HD12 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -105.24 118.8 37.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.052 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.811 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.97 161.85 42.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.15 -10.64 59.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.723 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 14.5 tt0 -81.44 134.25 35.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 1.2 mp0 -82.88 -24.98 32.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -95.65 4.46 53.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.666 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.865 ' O ' HG11 ' A' ' 75' ' ' VAL . 6.0 t80 -59.3 140.68 55.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 111.403 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.966 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.1 mt-30 -132.79 172.92 11.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.314 1.054 . . . . 0.0 112.846 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . . . -155.38 143.83 20.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.728 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -88.2 98.05 11.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.52 62.01 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.036 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 46' ' ' TYR . . . -125.66 166.08 17.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.88 0.372 . . . . 0.0 111.182 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 60' ' ' VAL . 16.2 t -96.17 138.17 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.986 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.966 HG21 ' HA ' ' A' ' 69' ' ' GLN . 38.6 t -104.4 104.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.322 0.582 . . . . 0.0 112.541 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.831 HG21 ' CG2' ' A' ' 82' ' ' VAL . 26.5 m -117.41 166.29 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.398 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.407 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 6.8 m170 -116.35 -19.05 10.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.584 0.23 . . . . 0.0 111.062 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -157.99 -176.3 5.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.611 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.875 HG13 ' CD2' ' A' ' 106' ' ' PHE . 18.4 t -68.41 -8.36 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.952 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -35.93 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.219 0.533 . . . . 0.0 109.794 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.37 -32.57 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.701 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.831 ' CG2' HG21 ' A' ' 76' ' ' VAL . 97.6 t -70.7 -50.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -57.03 -25.54 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.202 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -67.65 -42.39 82.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.045 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' ' NE2' ' A' ' 89' ' ' HIS . 92.5 t80 -65.49 -56.65 11.24 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.78 -21.71 11.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.96 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.3 mmmt -69.13 -39.97 78.56 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 84' ' ' ALA . 10.6 mp0 -82.53 -5.6 58.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.387 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.452 ' NE2' ' CE1' ' A' ' 85' ' ' TYR . 98.1 m-70 -126.28 65.89 59.41 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.547 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.58 -0.42 5.94 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.104 2.536 . . . . 0.0 112.923 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.19 -30.91 16.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -102.69 158.34 16.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -98.86 164.49 12.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.683 HD11 ' CG1' ' A' ' 82' ' ' VAL . 8.8 tp -114.01 114.64 26.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.97 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 33' ' ' GLN . 59.9 t -130.24 116.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.211 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.439 HD12 ' HB ' ' A' ' 40' ' ' VAL . 6.9 mm -77.98 134.9 27.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.087 0.47 . . . . 0.0 111.412 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.498 ' HB2' ' OG1' ' A' ' 34' ' ' THR . . . -106.84 -46.92 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.87 -170.83 43.95 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.894 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -90.3 -160.81 36.89 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 122.002 -0.705 . . . . 0.0 112.647 -0.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.47 11.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -52.52 -28.68 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.691 HD12 HD13 ' A' ' 62' ' ' LEU . 48.5 mm -85.16 -27.36 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.3 m-85 -60.28 -52.97 63.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.551 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.536 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 12.6 t -67.66 -9.76 46.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.677 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.09 -41.71 58.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.799 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.875 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.3 m-85 -101.55 -3.62 28.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.7 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 20.9 pttp -48.07 -32.21 6.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.751 0.31 . . . . 0.0 111.669 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -87.35 -19.19 28.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.552 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.8 -22.79 15.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.486 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.914 HG11 HD23 ' A' ' 113' ' ' LEU . 98.2 t -44.76 126.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.968 0.413 . . . . 0.0 111.61 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -101.82 -7.96 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 35.2 m -160.1 141.95 12.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.308 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.914 HD23 HG11 ' A' ' 110' ' ' VAL . 15.5 mt -120.38 145.81 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 111.649 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.98 114.89 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.603 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -135.41 145.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.991 0.424 . . . . 0.0 111.956 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -109.94 99.12 8.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.692 179.209 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 99.82 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.796 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 1.6 mp -86.04 127.47 34.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.404 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -52.8 -47.52 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.665 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -82.24 160.44 40.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 13.7 t -91.39 166.28 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.584 ' CZ ' HD22 ' A' ' 118' ' ' LEU . 11.3 m-85 -138.55 167.55 21.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.31 167.66 13.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 161.83 166.26 20.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.7 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.29 -28.17 7.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.666 0.269 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.0 m -109.27 148.8 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.28 174.96 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.77 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.546 ' HE2' HG13 ' A' ' 129' ' ' ILE . 14.5 tpt -73.58 158.53 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.646 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -84.39 165.53 37.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.066 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.4 Cg_endo -74.97 96.11 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.323 2.015 . . . . 0.0 112.307 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.73 149.47 24.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.85 72.59 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.008 0.432 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.49 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.1 m95 -58.49 -21.04 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -32.31 65.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.93 0.395 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.5 t0 -80.43 -15.67 56.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 113' ' ' LEU . 68.9 m-85 -107.43 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.095 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.44 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -127.9 142.26 51.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.634 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.533 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.8 OUTLIER -83.62 109.88 17.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.1 m -93.65 -22.44 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.448 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.0 m -159.45 140.62 12.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.181 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.6 p -165.4 116.08 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.521 ' C ' HG23 ' A' ' 154' ' ' THR . 2.6 ttm-85 -147.3 122.78 10.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.832 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.8 m -78.41 145.01 35.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.22 0.533 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.528 HG21 ' HE2' ' A' ' 155' ' ' TYR . 8.1 t -120.35 103.41 13.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.138 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.42 103.76 15.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.717 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.71 -172.66 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.107 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.6 p -54.72 -58.86 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 110.465 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.509 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -69.84 118.76 66.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.896 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.88 -22.35 62.12 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.112 1.875 . . . . 0.0 112.361 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -95.27 -16.03 22.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.367 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.7 mt -88.4 9.05 24.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.785 0.326 . . . . 0.0 111.164 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.473 HG22 ' N ' ' A' ' 153' ' ' HIS . 61.2 m -68.94 167.91 14.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.936 0.398 . . . . 0.0 109.993 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.473 ' N ' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -167.99 153.9 7.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.832 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.4 m -122.69 128.96 51.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.826 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.528 ' HE2' HG21 ' A' ' 144' ' ' VAL . 67.2 m-85 -90.69 104.77 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.408 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.511 ' HB2' HG22 ' A' ' 115' ' ' VAL . 33.8 mt-10 -107.41 125.54 51.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.8 ' O ' HG22 ' A' ' 139' ' ' VAL . 30.6 t -116.66 114.02 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.093 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.533 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 22.7 m95 -108.77 148.91 29.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -129.14 121.0 26.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.33 130.07 6.44 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.44 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -127.2 -163.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.195 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.044 179.787 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 24.3 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.559 0.219 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.16 145.66 39.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.7 m-30 -109.83 114.05 27.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.824 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.15 120.75 42.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.475 -179.243 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.704 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -166.48 166.42 16.36 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.379 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.78 136.0 54.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.242 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -124.85 154.06 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.04 -179.48 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.07 -45.04 15.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 110.471 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -23.19 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.526 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 27.07 9.1 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.219 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -82.14 150.91 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.778 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -124.36 178.44 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.607 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.48 150.85 52.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.77 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 125' ' ' ASP . 1.1 mmtm -58.93 -60.67 3.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.33 8.21 3.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.359 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.13 30.17 4.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.647 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.0 134.46 43.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.328 . . . . 0.0 110.893 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -97.97 125.92 42.32 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.779 179.967 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.29 -30.08 5.72 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.524 2.149 . . . . 0.0 112.67 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.526 ' CZ2' HD11 ' A' ' 151' ' ' LEU . 3.7 m95 -98.67 166.4 11.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.178 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.74 27.8 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.52 HD12 ' CZ3' ' A' ' 21' ' ' TRP . 0.4 OUTLIER -76.68 127.29 84.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.721 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -44.8 -36.49 10.79 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.511 2.141 . . . . 0.0 112.778 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.95 -29.14 66.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.49 -60.05 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.222 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -17.65 58.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.325 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.692 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 74.0 t60 -67.02 -25.75 66.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.638 0.256 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -105.29 -23.14 12.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.681 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CG ' HD11 ' A' ' 19' ' ' LEU . 1.1 t80 -85.24 -39.58 17.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.579 0.228 . . . . 0.0 111.551 -179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 35' ' ' VAL . 17.8 mtt180 -91.38 -52.13 4.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.456 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -51.15 -40.22 58.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.83 0.348 . . . . 0.0 111.594 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.438 ' OE1' HD13 ' A' ' 114' ' ' LEU . 5.7 mm-40 -73.41 -6.65 47.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.653 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.702 HG23 HD21 ' A' ' 4' ' ' LEU . 0.7 OUTLIER -119.57 -19.93 7.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.701 0.286 . . . . 0.0 111.579 -179.802 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 31' ' ' ARG . 35.6 m -107.87 138.74 32.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.513 ' H ' ' HG3' ' A' ' 57' ' ' ARG . . . 121.11 -12.22 9.82 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-O 119.159 -0.801 . . . . 0.0 114.923 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -152.43 -164.97 2.08 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.396 1.598 . . . . 0.0 109.552 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.555 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 61.3 mt -72.51 89.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 111.285 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.401 ' SD ' ' HB ' ' A' ' 34' ' ' THR . 1.9 ttp -97.78 117.27 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.339 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.569 HG21 HG11 ' A' ' 82' ' ' VAL . 24.5 t -76.93 157.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.234 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 32.8 m -163.89 150.05 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.79 156.26 51.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.9 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.63 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.32 -50.18 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.962 0.381 . . . . 0.0 110.402 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.439 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.9 tpm_? -62.06 -29.64 70.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.323 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -74.1 -48.63 28.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.626 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -57.93 -28.32 64.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.708 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.91 -65.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.427 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.5 m -58.93 -26.59 64.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.395 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -35.74 137.83 0.44 Allowed Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 49' ' ' PHE . 58.5 Cg_exo -53.21 -32.34 59.72 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.928 2.419 . . . . 0.0 113.357 -179.207 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.18 137.99 18.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.383 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 5.8 ptm180 -141.43 114.84 6.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -89.25 168.2 34.51 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.657 -1.393 . . . . 0.0 111.919 -0.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 73.7 mt -78.07 149.92 77.13 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HG2' ' NH1' ' A' ' 57' ' ' ARG . 27.4 Cg_endo -63.6 -78.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.786 2.324 . . . . 0.0 113.098 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 37.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.294 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -148.33 133.19 18.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.128 0.49 . . . . 0.0 111.967 -179.246 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.1 m -92.11 119.63 31.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.153 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -100.09 157.43 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.608 . . . . 0.0 112.439 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG12 HG22 ' A' ' 76' ' ' VAL . 3.5 t -137.37 138.34 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.333 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.63 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.9 t -114.57 120.32 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.795 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -102.16 118.97 38.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.963 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.93 171.21 17.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.101 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -95.59 -12.47 25.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -62.94 133.03 54.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.885 0.374 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.28 1.69 20.86 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.45 16.63 2.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.963 ' CG ' HG21 ' A' ' 63' ' ' THR . 3.0 t80 -58.5 139.32 55.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.193 0.52 . . . . 0.0 111.955 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.919 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -130.36 173.56 10.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.23 1.014 . . . . 0.0 112.367 178.949 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.11 144.18 20.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -81.52 99.32 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.03 -46.79 2.45 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.2 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 172.84 6.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 0.0 111.657 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.4 t -97.98 139.73 19.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.919 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.8 t -105.96 115.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.116 0.484 . . . . 0.0 111.865 -179.449 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.826 HG21 HG22 ' A' ' 82' ' ' VAL . 25.5 m -125.33 170.16 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.973 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.461 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.9 m170 -120.9 -21.91 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.344 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 t70 -153.54 -175.31 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.102 0.477 . . . . 0.0 111.54 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.8 HG21 ' O ' ' A' ' 105' ' ' ALA . 33.7 t -69.61 -9.48 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.621 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.61 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 109.926 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.706 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.88 -29.96 58.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 76' ' ' VAL . 60.8 t -72.06 -52.45 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.501 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.2 m-85 -55.95 -26.79 49.6 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.986 178.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.92 -45.44 89.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.019 178.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.651 ' CZ ' ' CE1' ' A' ' 89' ' ' HIS . 82.1 t80 -64.08 -54.49 33.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.41 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.579 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.77 -23.14 16.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.315 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 4.1 mmtp -67.28 -46.59 73.17 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -79.21 -2.83 42.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.448 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.651 ' CE1' ' CZ ' ' A' ' 85' ' ' TYR . 69.4 m80 -125.48 62.64 41.3 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.385 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.28 -0.53 5.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.064 2.51 . . . . 0.0 112.904 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -31.22 17.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.965 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 53.9 mt-30 -105.8 156.57 18.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -99.87 164.55 11.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.018 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 HG12 ' A' ' 82' ' ' VAL . 9.0 tp -104.72 111.81 24.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.87 103.43 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.438 ' CD1' HG21 ' A' ' 40' ' ' VAL . 13.1 mm -73.71 132.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.027 0.441 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 34' ' ' THR . . . -104.01 -45.18 4.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.685 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.1 -166.81 39.71 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.695 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.39 -160.99 26.34 Favored Glycine 0 C--N 1.34 0.801 0 O-C-N 122.196 -0.59 . . . . 0.0 112.552 -0.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.05 66.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.73 0.3 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -53.91 -27.45 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.583 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 mm -80.79 -29.0 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 129' ' ' ILE . 5.8 m-85 -59.64 -56.24 24.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.458 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.825 ' HA ' HD13 ' A' ' 129' ' ' ILE . 11.2 t -66.32 -10.16 40.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.8 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.35 -40.28 51.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.653 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.787 ' CD1' HG22 ' A' ' 79' ' ' VAL . 1.7 m-85 -99.59 -5.48 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.35 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.9 pttp -49.5 -31.67 10.6 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.756 0.313 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.25 0.48 53.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.288 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.05 -26.31 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.548 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 106' ' ' PHE . 92.7 t -43.95 127.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.845 0.355 . . . . 0.0 111.55 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 11.3 t70 -105.27 3.72 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.322 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 m -167.6 137.84 2.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.599 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.515 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 9.2 mt -118.78 145.24 45.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.3 0.571 . . . . 0.0 111.819 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.438 HD13 ' OE1' ' A' ' 33' ' ' GLN . 5.8 mt -135.26 113.05 10.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.483 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.704 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.6 m -132.58 143.09 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.6 107.05 14.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.433 179.436 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.7 OUTLIER -79.62 100.18 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.19 126.57 30.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.19 -53.14 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.004 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.46 170.68 9.31 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.353 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.2 p -106.78 147.04 30.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.7 m-85 -141.63 139.76 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -110.72 149.04 31.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.009 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.14 -143.4 3.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.554 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 5.7 t70 -142.33 21.94 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.6 m -159.99 134.08 7.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -107.37 158.43 17.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.963 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.8 177.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.491 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.4 pp -103.36 154.58 37.66 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.0 102.39 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.74 2.293 . . . . 0.0 112.687 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.9 147.85 22.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.008 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.74 76.25 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.451 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.515 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.9 m95 -57.79 -20.97 39.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.304 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.81 -29.32 63.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.844 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -78.58 -26.93 45.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.1 m-85 -99.16 176.55 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.77 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 m -137.3 141.93 41.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.246 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -80.67 119.02 22.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 -179.652 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.1 m -103.52 -11.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.7 m -171.51 140.35 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.74 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.0 p -167.93 110.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -148.11 120.64 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.814 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.0 m -69.01 145.38 53.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.236 0.541 . . . . 0.0 111.594 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.63 105.21 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.261 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 152' ' ' THR . 18.4 mt-10 -87.61 101.97 14.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.814 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.04 -171.41 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.493 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.7 p -60.19 -57.19 13.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.0 110.685 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.525 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -71.86 124.5 90.98 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.002 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.2 -28.46 86.96 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.961 1.774 . . . . 0.0 112.362 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.9 -21.1 25.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.395 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.526 HD11 ' CZ2' ' A' ' 21' ' ' TRP . 17.5 mt -85.32 7.23 23.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.504 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 153' ' ' HIS . 51.5 m -70.86 166.0 22.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.2 p80 -172.95 159.72 4.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.73 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.814 ' OG1' HG23 ' A' ' 143' ' ' THR . 28.8 m -119.93 147.05 45.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.347 179.24 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -110.29 104.68 13.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.653 0.264 . . . . 0.0 110.827 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.608 ' HB2' HG22 ' A' ' 115' ' ' VAL . 30.9 mt-10 -106.83 124.29 49.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 111.755 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.8 t -116.74 114.12 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.159 179.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.5 m95 -110.03 150.7 28.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.51 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -125.74 115.2 19.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -56.84 131.52 49.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.673 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.57 156.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 178.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.176 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 18.0 m . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.805 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.08 154.9 25.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.475 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 1.5 m-30 -119.08 113.46 20.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.552 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.866 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.94 117.37 33.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.709 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.3 p90 -162.25 165.41 26.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.827 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 7.9 pt20 -129.99 156.25 44.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.711 ' OD2' HD12 ' A' ' 12' ' ' LEU . 2.6 p30 -103.66 -171.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.506 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.3 -27.66 37.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.082 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -32.89 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.032 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 101.72 46.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.528 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD12 ' OD2' ' A' ' 8' ' ' ASP . 8.9 mt -95.91 163.99 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pp -141.04 -44.55 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.62 148.82 18.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.679 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.7 144.72 44.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -78.07 156.12 30.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.58 140.71 2.64 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.492 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -94.88 100.82 12.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mp -81.47 123.36 81.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.837 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.6 7.32 5.08 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.57 2.18 . . . . 0.0 112.867 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.4 102.8 12.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.756 0.313 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.02 138.9 39.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.17 158.29 33.39 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.38 -14.72 43.92 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.665 2.243 . . . . 0.0 112.647 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -72.75 -36.99 67.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.214 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.18 -29.03 14.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 tp -72.48 -29.34 63.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.435 -179.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -79.91 -43.16 22.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.33 . . . . 0.0 111.34 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.527 ' HE2' ' HG1' ' A' ' 116' ' ' THR . 31.1 t80 -64.92 -29.85 70.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.609 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.13 -27.76 26.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.653 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.854 ' O ' HG13 ' A' ' 35' ' ' VAL . 11.8 mtp180 -91.98 -59.28 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -47.17 -33.27 5.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.941 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.483 ' HB3' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -79.52 -5.25 54.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.26 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.0 p -145.15 25.79 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 31' ' ' ARG . 26.2 m -108.46 144.99 16.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.35 30.37 58.28 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 177.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 58' ' ' THR . 12.0 mmtt -146.99 -168.63 3.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.389 2.095 . . . . 0.0 107.786 178.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 92' ' ' GLN . 62.0 mt -86.48 88.21 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.955 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.432 ' HE3' HG13 ' A' ' 41' ' ' VAL . 1.1 ttp -97.59 118.2 33.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.691 -179.378 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.882 HG21 HG11 ' A' ' 82' ' ' VAL . 3.3 t -89.93 125.11 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.669 HG11 ' CE2' ' A' ' 49' ' ' PHE . 25.5 m -133.89 145.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.309 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.63 156.0 49.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.041 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.758 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.94 -52.89 56.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.479 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -59.56 -35.7 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.105 0.479 . . . . 0.0 110.291 179.154 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.44 HG22 ' CE2' ' A' ' 49' ' ' PHE . 7.3 m -64.72 -50.43 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.162 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -49.15 -34.34 14.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -63.06 -66.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.677 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -49.22 -46.26 45.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.669 ' CE2' HG11 ' A' ' 41' ' ' VAL . 1.9 m-85 -26.13 138.02 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 O-C-N 123.474 0.484 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -35.64 -71.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.947 2.431 . . . . 0.0 112.806 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.37 134.53 46.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 0.0 110.619 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -112.77 125.2 30.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.49 -170.29 7.75 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.627 -1.406 . . . . 0.0 112.026 -0.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.783 HD13 ' HD2' ' A' ' 57' ' ' ARG . 35.9 mt -89.98 151.21 44.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.592 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.04 110.68 3.08 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.596 2.197 . . . . 0.0 113.08 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.625 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.1 mt-10 68.21 8.25 6.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 179.216 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.783 ' HD2' HD13 ' A' ' 54' ' ' LEU . 6.0 mtt180 -109.45 113.88 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.795 0.331 . . . . 0.0 111.545 -178.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 63.5 m -64.11 109.32 1.79 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.676 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.85 152.57 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.609 HG12 HG22 ' A' ' 76' ' ' VAL . 14.1 t -133.79 130.62 56.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.305 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.758 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.2 t -102.6 130.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.418 . . . . 0.0 111.559 -178.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.833 HD22 HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.63 119.95 40.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.832 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.1 t -150.55 158.38 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.897 0.379 . . . . 0.0 111.36 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -75.41 -11.78 60.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.4 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 26.7 tt0 -88.03 132.74 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.786 0.327 . . . . 0.0 110.774 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 4.3 mp0 -82.8 -21.78 34.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.519 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -91.31 -0.59 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.582 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 63' ' ' THR . 7.2 t80 -59.28 140.83 55.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.108 0.48 . . . . 0.0 111.453 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.97 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -134.31 171.98 13.52 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.442 1.115 . . . . 0.0 113.213 179.563 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.41 139.54 16.5 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.877 -1.965 . . . . 0.0 110.049 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.06 102.01 6.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.9 0.381 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.18 -44.97 1.96 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.826 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 166.7 20.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 85' ' ' TYR . 22.6 t -97.15 140.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.267 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.97 HG21 ' HA ' ' A' ' 69' ' ' GLN . 22.8 t -106.76 118.44 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 112.185 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.863 HG21 HG22 ' A' ' 82' ' ' VAL . 30.8 m -127.54 168.14 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.69 178.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 1.6 m80 -119.86 -23.08 6.55 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.563 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -157.79 -177.33 6.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 111.467 -179.464 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.94 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.7 t -65.45 -11.4 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.615 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.83 -37.24 16.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.236 0.541 . . . . 0.0 109.751 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 84' ' ' ALA . . . -71.17 -34.41 70.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.694 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.882 HG11 HG21 ' A' ' 40' ' ' VAL . 29.2 t -68.38 -54.27 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.981 0.42 . . . . 0.0 109.988 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 5.8 m-85 -51.84 -27.83 13.87 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.933 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -63.05 -45.33 92.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.713 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 74' ' ' VAL . 76.1 t80 -62.76 -53.83 48.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.141 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.81 -22.88 5.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 179.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 8.3 mttt -70.23 -41.54 73.43 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.072 0.463 . . . . 0.0 109.754 178.637 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -81.41 -4.54 56.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.625 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 90.1 m-70 -129.63 62.76 65.13 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.63 -0.35 5.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.174 2.582 . . . . 0.0 112.845 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.75 -30.16 17.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.773 0.32 . . . . 0.0 110.834 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HB2' HD11 ' A' ' 38' ' ' ILE . 1.2 mm100 -103.08 162.09 13.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.094 0.473 . . . . 0.0 111.624 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 7.5 mt-10 -97.69 174.44 6.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.591 HD11 ' CG2' ' A' ' 40' ' ' VAL . 1.1 tp -119.66 113.87 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 111.409 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' MET . 40.1 t -127.59 111.87 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.289 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.506 HD12 ' HB ' ' A' ' 40' ' ' VAL . 8.7 mm -82.62 141.51 14.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.67 -39.88 4.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.402 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.84 -165.48 38.29 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.556 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -80.04 -161.23 23.25 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 117.358 0.579 . . . . 0.0 112.48 -0.099 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.73 -50.88 69.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -57.03 -25.25 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.709 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.833 HD12 HD22 ' A' ' 62' ' ' LEU . 42.2 mm -79.29 -36.89 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.771 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.475 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.3 m-85 -50.81 -56.76 10.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.446 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.763 ' CA ' HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -67.22 -9.65 42.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.713 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.93 -42.25 24.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 110.977 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.94 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.4 m-85 -93.54 -11.53 31.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.244 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.6 OUTLIER -50.34 -28.71 8.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.235 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.12 -8.38 59.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.601 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.53 -23.58 4.39 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 106' ' ' PHE . 90.7 t -44.11 128.99 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.431 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 18.0 t70 -102.51 -12.73 17.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.341 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.805 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 77.9 m -151.61 140.07 20.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.016 -179.149 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.664 HD23 HG11 ' A' ' 110' ' ' VAL . 13.7 mt -119.18 146.05 45.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.279 0.562 . . . . 0.0 111.56 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 113' ' ' LEU . 19.6 mt -135.13 112.66 10.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.549 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.668 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -134.52 144.99 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 111.76 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.527 ' HG1' ' HE2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -109.9 114.42 27.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.361 179.044 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -86.31 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.2 121.67 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.201 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -60.67 -61.72 2.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.224 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.65 -172.19 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.6 p -121.98 157.93 30.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.99 166.39 30.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.78 169.82 3.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . -163.89 135.95 4.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -38.46 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -117.57 137.31 52.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.3 163.34 12.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.014 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -173.16 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.763 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.6 pp -108.39 163.89 15.96 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.29 99.57 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.953 2.435 . . . . 0.0 112.736 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.4 146.02 25.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.074 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.48 80.77 2.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.44 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.4 m95 -60.82 -20.08 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.123 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.53 -30.34 65.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.913 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.46 -27.39 41.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.2 m-85 -97.83 176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.823 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 m -136.13 141.98 44.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.637 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 8.6 ttpt -83.56 116.79 22.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 157' ' ' VAL . 21.1 m -102.34 -18.95 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 157' ' ' VAL . 48.7 m -163.6 141.06 7.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.699 0.285 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.637 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 86.1 p -169.48 106.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -140.77 118.96 12.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.827 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.812 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.4 m -68.71 145.18 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.166 0.508 . . . . 0.0 111.527 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 153' ' ' HIS . 9.0 t -119.61 103.94 14.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.185 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.44 ' HA ' HG23 ' A' ' 152' ' ' THR . 7.3 mt-10 -86.83 103.68 15.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.503 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.2 -174.13 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.448 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.3 p -55.37 -56.62 18.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.722 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.6 OUTLIER -72.73 121.75 85.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.707 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.57 -25.54 79.18 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.035 1.823 . . . . 0.0 112.292 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.14 -19.62 22.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -86.35 8.16 22.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.66 0.267 . . . . 0.0 111.367 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 153' ' ' HIS . 66.0 m -68.79 165.63 19.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.452 ' N ' HG22 ' A' ' 152' ' ' THR . 2.0 p80 -168.99 155.1 6.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.812 ' OG1' HG23 ' A' ' 143' ' ' THR . 21.8 m -118.26 132.21 56.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -94.94 104.42 16.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.843 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -100.8 151.37 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.23 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.84 ' O ' HG22 ' A' ' 139' ' ' VAL . 12.3 t -141.99 107.68 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.825 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 26.8 m95 -108.81 146.07 34.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -126.43 114.41 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.676 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.478 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -52.64 131.09 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.883 -179.436 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -97.45 176.31 5.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.741 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.132 179.985 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.537 HG23 ' HB3' ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.18 145.5 40.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.838 ' CE2' HG21 ' A' ' 110' ' ' VAL . 2.0 m-30 -109.3 112.3 24.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.425 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.992 HD12 HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -112.8 123.96 51.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.757 -179.504 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.622 ' CH2' HG12 ' A' ' 115' ' ' VAL . 7.8 p90 -165.52 164.95 19.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.319 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' ILE . . . -120.77 138.2 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.669 0.271 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -122.41 149.81 43.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 0.0 111.253 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -103.39 -162.96 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -42.04 72.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.53 -27.86 31.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.96 26.28 5.84 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.578 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -79.61 147.59 32.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 110.621 -179.929 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.768 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -112.48 -31.05 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.771 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.92 142.83 3.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.862 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -77.26 -170.09 1.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.757 0.313 . . . . 0.0 110.63 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.07 36.66 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.744 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.7 -135.63 3.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.539 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -176.35 0.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.753 0.311 . . . . 0.0 110.908 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.588 HD21 ' HG3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -89.5 106.4 13.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.939 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.493 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 38.6 Cg_endo -68.25 -52.92 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.447 2.098 . . . . 0.0 112.661 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 20' ' ' PRO . 13.6 p-90 -107.28 132.98 52.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.924 0.393 . . . . 0.0 111.147 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.543 ' NE2' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -159.8 106.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.603 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.1 mt -129.12 162.47 52.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.207 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.99 -41.68 16.49 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.712 2.275 . . . . 0.0 111.899 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -73.26 -20.83 60.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.995 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -77.08 -40.83 44.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.134 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.543 HD21 ' NE2' ' A' ' 22' ' ' HIS . 86.0 mt -71.74 -30.52 65.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.989 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -66.3 -14.77 62.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.354 -179.876 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -50.14 -62.29 1.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.865 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.47 ' O ' HG22 ' A' ' 34' ' ' THR . 0.5 OUTLIER -92.11 -0.87 57.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.187 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.61 ' HB2' ' HA ' ' A' ' 28' ' ' HIS . 2.8 tpt180 -35.35 -60.78 0.47 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.1 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.17 -20.68 19.04 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 37' ' ' LYS . 2.7 mt-30 -79.93 -14.7 58.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.617 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 57' ' ' ARG . 15.3 t -84.41 -13.91 50.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.642 ' C ' ' H ' ' A' ' 37' ' ' LYS . 22.8 m -56.18 121.32 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.758 0.313 . . . . 0.0 110.662 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 92' ' ' GLN . . . 58.87 -24.44 0.02 OUTLIER Glycine 0 CA--C 1.532 1.123 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.418 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 35' ' ' VAL . 11.1 mttp -63.14 108.06 1.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.941 0.877 . . . . 0.0 110.171 -176.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.575 HG12 HG21 ' A' ' 58' ' ' THR . 6.8 mt -62.76 110.23 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.583 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.685 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.0 ttp -99.17 114.27 26.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.495 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.75 HG21 HG11 ' A' ' 82' ' ' VAL . 11.3 t -87.53 125.55 41.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.57 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 32.3 m -132.2 149.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.158 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.14 158.02 53.61 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.086 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -55.83 -45.39 78.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -63.55 -32.4 73.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 110.477 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 m -72.2 -42.47 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.459 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 11.2 t80 -65.86 -24.41 66.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -66.8 -19.92 65.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.65 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.57 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -34.4 134.44 0.39 Allowed Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.658 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.588 ' HG3' HD21 ' A' ' 19' ' ' LEU . 71.3 Cg_exo -51.14 -41.29 58.21 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.936 2.424 . . . . 0.0 113.252 -179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -151.15 131.29 13.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.341 . . . . 0.0 111.029 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -132.22 125.29 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.028 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 83.6 Cg_endo -90.12 -179.32 12.93 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.137 -0.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 65.5 mt -75.88 152.8 84.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.62 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.82 101.7 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.552 2.168 . . . . 0.0 112.959 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 68.46 21.04 8.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.149 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.691 ' HD2' HG23 ' A' ' 34' ' ' THR . 3.8 mmt180 -116.63 139.84 50.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.575 HG21 HG12 ' A' ' 38' ' ' ILE . 55.7 m -86.8 115.47 24.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.0 0.429 . . . . 0.0 111.435 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -101.11 156.83 17.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.625 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 12.7 t -137.13 131.74 46.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.545 HG21 ' HB2' ' A' ' 70' ' ' ALA . 90.5 t -105.99 121.93 58.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.085 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -107.29 107.18 17.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.112 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.731 HG21 ' CD2' ' A' ' 68' ' ' TYR . 6.3 t -143.7 164.81 29.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.162 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -79.74 -8.45 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.312 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.0 tp-100 -79.81 124.69 28.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.354 . . . . 0.0 110.489 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 3.3 mt-10 -77.27 -30.38 54.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.93 14.5 28.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.359 . . . . 0.0 111.181 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.783 ' O ' HG11 ' A' ' 75' ' ' VAL . 5.7 t80 -63.18 147.23 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.142 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.663 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.8 mm100 -124.89 174.76 7.74 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.475 1.131 . . . . 0.0 112.868 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.54 143.07 18.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.89 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -66.35 94.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.29 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.59 -20.17 2.31 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.775 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.693 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -76.76 170.85 15.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.12 0.485 . . . . 0.0 112.071 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.95 140.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.456 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 68' ' ' TYR . 24.5 t -103.47 106.98 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.457 . . . . 0.0 111.771 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.799 HG21 HG22 ' A' ' 82' ' ' VAL . 30.7 m -119.67 176.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.051 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 10.6 m170 -128.94 -21.12 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.82 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -155.69 -174.81 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.199 -179.719 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.825 HG21 ' O ' ' A' ' 105' ' ' ALA . 25.2 t -70.02 -11.06 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.67 -38.59 16.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.091 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -68.19 -34.45 76.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.672 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.799 HG22 HG21 ' A' ' 76' ' ' VAL . 20.8 t -69.29 -53.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.599 179.473 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -53.37 -31.03 42.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.062 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.55 -47.03 87.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.198 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 69.0 t80 -60.69 -52.75 63.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.81 -26.26 57.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.609 178.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -66.44 -39.55 88.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.002 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -84.84 -1.13 56.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.148 178.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 42.5 m-70 -124.83 60.34 26.28 Favored Pre-proline 0 N--CA 1.456 -0.142 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.098 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.14 -3.25 5.8 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.866 2.377 . . . . 0.0 112.508 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -100.66 -25.6 14.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.026 179.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 16.9 mt-30 -98.83 160.13 14.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.328 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -105.9 174.89 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.537 ' HB3' HG23 ' A' ' 1' ' ' THR . 10.0 tp -122.33 110.45 15.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.96 HG12 HD21 ' A' ' 4' ' ' LEU . 17.2 t -124.28 109.69 23.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 40' ' ' VAL . 3.7 mm -82.6 131.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.398 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.473 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.26 -47.31 5.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.718 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.76 -168.1 41.19 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.392 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -90.27 -160.78 36.85 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 117.8 0.8 . . . . 0.0 112.814 0.004 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.64 -57.99 3.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 111.69 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.98 -31.98 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 37.7 mm -80.97 -26.43 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.292 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -61.69 -51.93 66.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.631 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.771 ' HA ' HD13 ' A' ' 129' ' ' ILE . 13.9 t -68.81 -10.01 54.32 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.825 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -73.17 -47.07 46.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.803 ' CD2' HG13 ' A' ' 79' ' ' VAL . 8.0 m-85 -95.11 -2.61 49.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.726 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.575 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 37.4 pttt -54.38 -32.2 56.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -79.63 -8.46 59.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.793 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.05 -18.07 7.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.838 HG21 ' CE2' ' A' ' 3' ' ' PHE . 48.7 t -48.0 134.69 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 4.7 t70 -113.32 6.02 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.199 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 3.7 m -170.58 142.79 2.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.429 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 114' ' ' LEU . 8.3 mt -122.55 144.69 48.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.084 0.468 . . . . 0.0 111.578 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.992 HD12 HD12 ' A' ' 4' ' ' LEU . 22.1 mt -135.22 118.35 16.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.155 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 156' ' ' GLU . 1.2 m -131.54 140.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.819 0.342 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.22 121.99 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.26 101.4 10.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.661 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.578 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.8 mp -83.82 134.98 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.59 -51.99 61.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.63 170.95 9.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.0 p -105.76 170.72 7.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.1 m-85 -148.0 168.75 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.015 0.436 . . . . 0.0 111.279 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -114.1 146.89 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.315 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.449 ' O ' HD11 ' A' ' 12' ' ' LEU . . . 168.85 176.9 39.34 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.674 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.67 62.3 1.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.649 HG22 HD11 ' A' ' 13' ' ' ILE . 4.5 m -164.14 124.46 2.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.19 164.98 13.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.4 ' SD ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -76.75 -177.69 4.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.771 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -103.53 165.1 14.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.301 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.9 102.66 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.665 2.244 . . . . 0.0 112.071 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.4 HD12 ' SD ' ' A' ' 128' ' ' MET . 1.8 mt -90.26 148.24 23.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.73 78.96 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -61.23 -19.53 61.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.71 -32.92 66.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.652 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 4.5 t70 -81.72 -18.49 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 113' ' ' LEU . 62.7 m-85 -106.32 167.14 10.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.483 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.515 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -131.05 141.19 50.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.571 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.9 ttpm? -82.73 113.9 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.662 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 157' ' ' VAL . 35.3 m -97.41 -25.79 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.563 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -156.06 140.55 16.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.882 0.373 . . . . 0.0 111.184 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.571 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 53.4 p -166.15 105.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.753 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.589 ' C ' HG23 ' A' ' 154' ' ' THR . 7.2 ttt85 -146.07 129.83 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.755 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -77.54 146.72 36.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.767 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 152' ' ' THR . 6.1 t -117.32 104.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.363 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.77 104.7 16.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.133 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.57 -172.96 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.442 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 60.9 p -55.69 -58.48 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.589 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.658 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 10.2 t30 -76.6 136.01 67.99 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.841 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.21 -34.38 68.43 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.986 1.79 . . . . 0.0 112.686 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.74 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.487 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.3 mt -77.65 10.31 2.78 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 144' ' ' VAL . 57.4 m -85.44 159.91 19.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.08 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.578 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -173.46 160.55 3.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.755 ' OG1' HG23 ' A' ' 143' ' ' THR . 17.2 m -122.3 144.69 48.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.71 179.161 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.88 105.22 13.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.69 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.9 mt-10 -99.2 121.33 40.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.902 0.382 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.742 ' O ' HG22 ' A' ' 139' ' ' VAL . 18.1 t -116.2 111.62 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.499 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 32.1 m95 -106.13 148.62 27.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.959 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -129.68 123.86 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.225 179.062 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -51.45 128.82 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.542 -179.343 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.515 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.16 -173.82 2.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.758 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.125 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.542 0.21 . . . . 0.0 110.491 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.61 149.3 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.348 0.594 . . . . 0.0 112.438 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.486 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.5 m-30 -116.68 113.0 22.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.873 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.58 118.57 36.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 112.014 -179.486 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.792 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.4 p90 -164.09 174.51 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.12 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -128.42 135.17 49.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 111.673 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.0 pt20 -132.82 154.64 50.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 15.5 p-10 -107.55 -167.62 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -40.95 68.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -28.97 47.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.05 19.51 11.66 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.754 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 126' ' ' THR . 3.8 mt -70.97 175.73 4.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.61 -60.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.168 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.06 132.27 1.59 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.547 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -91.17 111.06 22.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.736 0.303 . . . . 0.0 110.794 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.58 124.48 15.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.116 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.29 -115.34 0.64 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.468 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -104.22 96.99 7.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 110.792 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.08 98.48 26.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 -167.41 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.49 2.127 . . . . 0.0 112.285 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -98.81 107.84 20.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -79.71 -70.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.173 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HG ' ' HD2' ' A' ' 24' ' ' PRO . 1.2 tp -150.52 150.92 29.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 -179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HG ' ' A' ' 23' ' ' LEU . 27.7 Cg_exo -61.99 -17.08 53.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.542 2.161 . . . . 0.0 112.377 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -55.0 -23.36 18.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -92.3 -30.56 15.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.274 -179.753 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.458 HD23 ' HD3' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -84.94 -15.63 43.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.757 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -59.54 -40.78 88.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CD1' ' HG3' ' A' ' 33' ' ' GLN . 56.2 t80 -105.42 -9.63 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.618 ' O ' HG22 ' A' ' 34' ' ' THR . 0.3 OUTLIER -92.82 -26.38 17.71 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.895 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -92.1 -61.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.832 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.8 -21.49 56.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.43 ' HG3' ' CD1' ' A' ' 29' ' ' TYR . 40.9 mm-40 -90.19 -5.13 56.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.052 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 30' ' ' PHE . 13.9 t -132.87 -35.15 1.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 31' ' ' ARG . 16.7 m -79.15 154.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 112.051 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.527 ' C ' ' HG2' ' A' ' 37' ' ' LYS . . . 96.15 -1.17 62.6 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.587 -0.815 . . . . 0.0 114.662 178.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.527 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 3.6 mttm -148.82 -164.22 1.97 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.344 1.572 . . . . 0.0 109.744 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.82 90.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ttp -102.69 121.59 42.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.932 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.734 HG13 ' HB ' ' A' ' 60' ' ' VAL . 9.7 t -89.55 131.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.731 HG11 ' HE2' ' A' ' 49' ' ' PHE . 21.6 m -132.28 142.06 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.184 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.94 156.83 43.5 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.095 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.64 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.3 -52.61 58.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.858 0.329 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -60.21 -34.25 73.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.075 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -67.65 -45.5 75.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 33.1 t80 -59.46 -27.27 65.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.5 -66.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.725 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -52.44 -30.37 29.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.925 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -37.05 122.34 0.83 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.935 -179.511 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 64.3 Cg_exo -42.91 -27.24 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.233 2.622 . . . . 0.0 113.729 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.62 148.92 28.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 111.236 -179.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.15 107.76 6.23 Favored Pre-proline 0 CA--C 1.533 0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.5 Cg_endo -88.43 178.78 18.39 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.158 -0.15 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 49' ' ' PHE . 10.6 mt -76.64 155.33 83.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.36 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.421 ' HD2' HD23 ' A' ' 54' ' ' LEU . 9.7 Cg_endo -52.98 -74.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.703 2.268 . . . . 0.0 112.385 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -113.38 50.64 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.104 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -142.47 101.49 3.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.987 -179.618 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.3 m -62.16 113.52 2.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.169 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.508 HD21 HD12 ' A' ' 54' ' ' LEU . 2.0 m-80 -107.74 148.34 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.431 0.634 . . . . 0.0 112.348 -178.263 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.751 HG12 HG22 ' A' ' 76' ' ' VAL . 21.8 t -122.86 139.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.389 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 43' ' ' ARG . 92.7 t -108.34 124.02 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.845 -178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.711 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -101.41 117.98 36.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.852 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.48 162.15 41.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.727 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -83.0 -8.57 59.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 48.9 tt0 -85.13 131.19 34.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 111.057 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -25.21 42.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.59 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -94.74 5.17 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.753 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.852 ' CG ' HG21 ' A' ' 63' ' ' THR . 5.9 t80 -58.98 148.05 32.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.023 0.439 . . . . 0.0 111.088 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.856 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -136.15 174.85 10.16 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.201 1.001 . . . . 0.0 112.848 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.87 145.0 21.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.793 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -74.65 95.91 2.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.311 . . . . 0.0 110.314 179.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.2 -34.95 3.18 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.305 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.558 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.76 169.64 14.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG11 ' CD1' ' A' ' 85' ' ' TYR . 5.1 t -96.69 140.65 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.331 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.856 HG21 ' HA ' ' A' ' 69' ' ' GLN . 20.1 t -107.63 118.54 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.186 0.517 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.896 HG21 HG22 ' A' ' 82' ' ' VAL . 35.6 m -128.44 171.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.839 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -122.38 -22.43 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.55 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 t70 -158.15 -175.65 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.051 0.453 . . . . 0.0 111.08 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.97 HG13 ' CD2' ' A' ' 106' ' ' PHE . 9.4 t -65.66 -11.34 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.72 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.49 16.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.15 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.68 -29.36 63.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.613 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.896 HG22 HG21 ' A' ' 76' ' ' VAL . 25.1 t -70.99 -52.63 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.443 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.6 m-85 -54.18 -26.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.586 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -65.34 -44.07 88.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.956 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.531 ' CD1' HG11 ' A' ' 74' ' ' VAL . 88.3 t80 -66.7 -56.6 9.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.367 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.57 -23.65 17.69 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.561 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.05 -39.75 78.98 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.723 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -83.73 -5.45 59.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.403 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -129.54 64.92 73.31 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.22 1.08 3.78 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.424 2.749 . . . . 0.0 113.001 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 -33.4 25.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.969 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.5 160.72 15.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 111.621 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -98.43 156.48 16.73 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.788 HD11 HG12 ' A' ' 82' ' ' VAL . 7.7 tp -96.29 115.08 26.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.349 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.55 114.55 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.2 mm -81.77 139.43 17.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.068 0.461 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.479 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -108.55 -46.1 3.74 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.51 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.87 -170.4 43.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.317 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.93 36.82 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 117.409 0.605 . . . . 0.0 112.605 0.018 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.38 -45.93 36.39 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -58.74 -34.34 71.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.711 ' CD1' HD22 ' A' ' 62' ' ' LEU . 28.7 mm -82.28 -29.51 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.1 m-85 -57.67 -57.13 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.661 -179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.741 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.2 t -67.47 -9.61 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.648 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.47 -44.45 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.0 111.302 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.97 ' CD2' HG13 ' A' ' 79' ' ' VAL . 16.2 m-85 -91.82 -7.95 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.524 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -52.21 -31.18 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 110.918 179.869 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 107' ' ' LYS . 1.5 t0 -75.35 -10.99 59.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.554 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -122.41 -19.77 6.31 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.857 HG11 HD23 ' A' ' 113' ' ' LEU . 75.8 t -45.18 120.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.44 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.421 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 19.4 t70 -100.3 -3.9 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.269 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 49.7 m -160.07 141.91 12.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.088 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.857 HD23 HG11 ' A' ' 110' ' ' VAL . 7.3 mt -123.29 147.62 46.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.248 0.547 . . . . 0.0 111.859 -179.161 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.76 113.58 11.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.387 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.792 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.3 m -129.65 140.94 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -110.57 106.76 16.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.507 179.502 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 35.8 mtp180 -80.06 98.64 7.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.2 mp -81.86 122.67 28.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.29 -66.81 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.51 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.65 162.9 5.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.604 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 p -95.1 168.16 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.899 0.381 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 3.4 m-85 -138.76 160.42 39.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.48 139.76 53.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.131 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.44 -146.41 5.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.634 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.86 -29.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.508 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.494 ' O ' HD23 ' A' ' 12' ' ' LEU . 5.6 m -108.9 137.98 45.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -178.71 3.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -73.75 159.17 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.741 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.16 156.23 48.96 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.269 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.36 100.83 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.725 2.283 . . . . 0.0 112.459 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.8 149.14 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 69.11 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.03 0.443 . . . . 0.0 110.709 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.547 ' HH2' HG11 ' A' ' 115' ' ' VAL . 89.9 m95 -55.22 -22.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -31.57 66.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 110.662 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -80.81 -20.06 43.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.937 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.581 ' CD1' HD11 ' A' ' 113' ' ' LEU . 94.1 m-85 -104.26 168.71 8.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.075 0.464 . . . . 0.0 111.29 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.634 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -130.54 142.56 50.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.929 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 6.1 ttpt -81.97 115.03 20.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.4 m -101.59 -17.43 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.603 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.3 m -165.93 140.64 4.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 110.969 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.2 p -165.71 112.87 0.93 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.404 ' C ' HG23 ' A' ' 154' ' ' THR . 7.7 ttt85 -147.85 121.03 8.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.84 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.81 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.6 m -73.54 144.45 46.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.176 0.512 . . . . 0.0 111.916 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 155' ' ' TYR . 6.5 t -117.3 105.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.968 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.438 ' HA ' HG23 ' A' ' 152' ' ' THR . 47.8 mt-10 -90.48 103.36 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.949 -178.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -169.7 2.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.352 179.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.6 p -60.23 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.931 0.396 . . . . 0.0 110.467 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.505 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -67.43 118.61 58.43 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.83 -25.48 61.65 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.887 1.725 . . . . 0.0 112.377 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.42 -20.27 25.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.147 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 mt -86.41 8.88 19.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.71 0.29 . . . . 0.0 111.106 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 153' ' ' HIS . 55.1 m -72.4 168.4 18.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.947 0.403 . . . . 0.0 110.001 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.49 ' N ' HG22 ' A' ' 152' ' ' THR . 1.5 p80 -173.52 160.18 3.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.038 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.81 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.6 m -122.04 145.41 48.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.772 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 144' ' ' VAL . 29.6 m-85 -106.41 104.64 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.767 0.318 . . . . 0.0 110.441 179.331 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.587 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.4 mt-10 -109.08 127.54 54.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.974 0.416 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.772 ' O ' HG22 ' A' ' 139' ' ' VAL . 25.0 t -117.35 114.02 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.557 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.475 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.3 m95 -108.4 148.14 30.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.123 -179.496 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.455 ' CD ' HG11 ' A' ' 139' ' ' VAL . 24.7 mt-30 -125.49 112.21 15.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -49.32 133.33 19.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.214 0.531 . . . . 0.0 112.259 -179.405 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.634 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 32.6 mtmt -108.48 -178.47 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.786 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.995 -179.875 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 25.4 m . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.3 151.14 30.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.669 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -116.1 111.8 20.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.346 178.933 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.746 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.31 122.81 48.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.42 0.628 . . . . 0.0 112.351 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.808 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.8 p90 -168.61 168.8 10.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.674 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.55 133.28 52.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -129.07 164.27 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.137 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -110.18 -171.62 1.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -54.96 -30.42 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.407 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -87.4 -32.22 19.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.903 -179.95 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.25 36.01 3.23 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.651 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.577 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -93.39 145.92 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.772 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 126' ' ' THR . 0.6 OUTLIER -112.33 -54.67 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.409 -179.769 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.19 -158.83 8.39 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.429 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 13.21 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.527 0.203 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.43 28.71 4.63 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.746 0.307 . . . . 0.0 111.089 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.12 -132.76 5.03 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.571 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -81.89 -173.56 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.954 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.21 135.61 59.65 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.973 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.69 162.84 7.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.548 2.165 . . . . 0.0 112.154 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -76.37 145.63 39.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -88.34 143.38 27.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.1 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 10.9 mt -156.25 123.81 2.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.58 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 23' ' ' LEU . 22.8 Cg_exo -64.59 -34.6 51.54 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.627 2.218 . . . . 0.0 113.147 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.24 -25.17 36.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' PHE . 4.4 t0 -95.2 -28.51 15.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' HG ' ' HG2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -67.1 -25.38 66.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.461 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -60.65 -38.2 84.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.659 0.266 . . . . 0.0 111.589 -179.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.529 ' OH ' HD22 ' A' ' 114' ' ' LEU . 46.8 t80 -105.48 -4.76 20.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.409 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -86.86 -49.52 7.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.269 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.828 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -91.84 -51.72 5.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.622 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.406 ' H ' ' HG3' ' A' ' 31' ' ' ARG . . . -49.68 -34.76 19.5 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.439 ' HG3' ' CD1' ' A' ' 29' ' ' TYR . 58.6 mm-40 -78.76 -7.03 57.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.647 HG21 HD11 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -135.09 -36.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.762 -0.375 . . . . 0.0 112.001 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 31' ' ' ARG . 6.2 m -74.54 161.94 4.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.437 -179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . 72.78 9.04 74.31 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 119.186 -0.786 . . . . 0.0 114.287 178.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 7.0 mmtp -150.64 -164.97 2.14 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.885 1.342 . . . . 0.0 108.46 179.294 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.455 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 52.9 mt -79.06 88.29 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.237 0.471 . . . . 0.0 111.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 34' ' ' THR . 24.1 ttp -96.13 120.13 35.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.403 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.4 t -81.23 153.42 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 40' ' ' VAL . 28.2 m -161.87 146.42 4.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.58 155.47 51.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.841 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.496 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.6 -51.33 56.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.938 0.369 . . . . 0.0 110.889 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 44' ' ' ARG . 5.4 tpp180 -60.14 -31.91 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -73.5 -43.4 60.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.612 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 52' ' ' ARG . 24.5 t80 -61.94 -29.24 70.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.8 -66.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.2 p -48.21 -37.08 15.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.357 -179.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' HG11 ' A' ' 41' ' ' VAL . 2.7 m-30 -37.68 149.42 0.19 Allowed Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.492 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.52 -73.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.503 2.135 . . . . 0.0 112.305 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.16 167.42 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.0 111.003 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 45.4 mtp180 -129.13 111.28 18.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.959 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 66.9 Cg_endo -89.5 -171.33 5.88 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.173 -0.09 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 74.7 mt -80.53 158.96 70.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.236 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 58.2 Cg_endo -72.2 107.16 2.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.531 2.154 . . . . 0.0 113.445 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.7 OUTLIER 74.12 4.4 4.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.27 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.55 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 15.6 mtt180 -112.6 116.41 30.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 0.0 111.542 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 43.1 m -73.11 111.4 8.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.449 HD21 HD12 ' A' ' 54' ' ' LEU . 3.3 m-80 -98.92 156.94 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.247 0.546 . . . . 0.0 112.195 -178.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 76' ' ' VAL . 7.1 t -137.05 132.17 46.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.16 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 43' ' ' ARG . 88.6 t -104.61 128.39 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.717 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -107.65 125.33 51.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.504 -179.896 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.6 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -165.68 150.46 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 179.618 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.427 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 21.5 t-80 -74.43 -2.68 26.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.702 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.869 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.0 tp-100 -70.95 133.61 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -88.57 -3.23 58.85 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 65' ' ' GLN . 4.9 m-20 -128.25 5.98 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.569 0.223 . . . . 0.0 111.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.869 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.0 t80 -59.93 141.8 54.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.236 0.541 . . . . 0.0 111.968 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.862 ' HA ' HG21 ' A' ' 75' ' ' VAL . 20.5 mm-40 -127.11 178.45 6.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.08 0.943 . . . . 0.0 112.104 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.46 144.53 19.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.607 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -76.96 96.36 4.35 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.338 179.199 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.88 -40.15 3.09 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.961 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -68.61 168.46 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.732 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 60' ' ' VAL . 15.6 t -96.88 140.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.862 HG21 ' HA ' ' A' ' 69' ' ' GLN . 40.2 t -100.09 107.32 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 0.0 112.314 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.81 HG21 HG22 ' A' ' 82' ' ' VAL . 27.1 m -117.68 161.59 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.026 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.67 -22.45 11.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.231 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.878 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -161.38 -168.86 2.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.174 0.512 . . . . 0.0 111.594 -179.153 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.858 HG13 ' CD2' ' A' ' 106' ' ' PHE . 3.1 t -70.3 -10.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.539 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.87 -37.35 16.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.212 0.53 . . . . 0.0 109.768 178.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.93 -32.95 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.757 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.811 HG12 HD11 ' A' ' 94' ' ' LEU . 24.3 t -70.0 -51.71 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.4 m-85 -56.33 -27.42 55.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.334 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -64.54 -44.83 89.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 179.11 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.27 -54.07 43.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.974 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -58.07 -22.84 52.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.899 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.21 -30.11 63.28 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.22 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.411 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 5.9 mt-30 -92.95 -13.0 29.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.33 178.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -125.16 65.03 47.42 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.433 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.8 0.17 5.3 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.258 2.638 . . . . 0.0 113.018 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.02 -41.42 35.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -100.51 165.89 11.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.092 0.472 . . . . 0.0 111.669 -179.436 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -98.4 170.38 8.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.034 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.974 HD12 ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -118.58 114.21 22.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.445 -179.465 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 33' ' ' GLN . 21.8 t -128.46 113.29 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.308 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 5.7 mm -79.11 135.1 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.01 0.433 . . . . 0.0 111.183 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -110.27 -41.3 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.209 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.55 -169.7 41.88 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.738 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.3 -160.74 36.32 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 122.103 -0.645 . . . . 0.0 112.558 -0.151 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.49 60.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.669 0.271 . . . . 0.0 111.203 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 -60.19 -30.49 69.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.8 mm -76.88 -26.27 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.936 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 3.5 m-85 -62.58 -58.01 9.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.704 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.501 ' CA ' HD13 ' A' ' 129' ' ' ILE . 8.9 t -67.63 -10.27 50.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.688 -0.633 . . . . 0.0 111.751 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.56 -37.7 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.888 ' O ' HG23 ' A' ' 110' ' ' VAL . 2.8 m-85 -101.36 -3.17 29.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.503 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.49 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 20.2 pttp -49.84 -32.5 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.73 0.3 . . . . 0.0 111.486 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -92.5 1.59 57.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.651 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.662 ' CB ' HG11 ' A' ' 79' ' ' VAL . 2.5 m-20 -122.0 -26.87 4.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.705 0.288 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 106' ' ' PHE . 58.6 t -48.96 128.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 5.5 t70 -100.99 -7.38 23.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.734 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.3 m -156.21 140.29 16.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 HG11 ' A' ' 110' ' ' VAL . 11.5 mt -120.29 144.71 47.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.184 0.516 . . . . 0.0 111.674 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.529 HD22 ' OH ' ' A' ' 29' ' ' TYR . 9.5 mt -135.61 117.02 14.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.805 179.149 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.808 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -134.94 144.83 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 111.663 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.57 109.85 18.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.435 179.319 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -93.45 103.64 15.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.548 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 1.2 mt -91.32 130.97 37.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.182 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -49.96 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.4 156.16 39.04 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.313 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 86.2 p -101.26 142.97 31.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -123.03 156.55 34.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -113.27 134.83 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.996 0.427 . . . . 0.0 111.409 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.577 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -158.34 -162.44 11.83 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.392 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 8.36 3.02 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.404 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.5 m -120.3 109.93 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.798 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -92.38 142.48 27.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -178.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.501 HD13 ' CA ' ' A' ' 104' ' ' THR . 2.3 pp -111.75 158.68 35.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 129' ' ' ILE . 31.2 Cg_exo -59.14 135.46 66.2 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.709 2.273 . . . . 0.0 112.281 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.419 HD11 ' CH2' ' A' ' 5' ' ' TRP . 3.8 mt -120.53 143.4 48.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.129 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 79.56 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -63.53 -15.03 56.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -33.46 62.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.996 0.426 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.6 t70 -83.18 -16.09 47.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.334 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.532 ' CD2' HD11 ' A' ' 113' ' ' LEU . 66.3 m-85 -106.9 164.47 12.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.813 0.34 . . . . 0.0 111.027 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.423 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -125.6 140.87 52.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -85.06 114.56 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.677 179.654 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 157' ' ' VAL . 16.0 m -101.74 -18.96 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.52 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.69 139.98 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.398 . . . . 0.0 111.248 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -168.75 106.87 0.45 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.331 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -142.55 122.11 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.367 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.1 m -72.82 145.8 46.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.316 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 152' ' ' THR . 4.7 t -114.99 103.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 178.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 99.23 11.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.471 -179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.84 -177.66 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.7 p -54.33 -54.51 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -73.45 124.28 90.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.947 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 -29.53 89.33 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.124 1.882 . . . . 0.0 112.268 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.99 -18.52 28.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.801 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.5 mt -86.03 10.45 14.19 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 153' ' ' HIS . 55.1 m -74.69 166.15 24.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -172.15 158.94 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.218 179.7 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 143' ' ' THR . 33.4 m -123.06 133.76 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -98.77 107.86 20.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.551 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.3 mt-10 -97.17 149.69 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.081 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 139' ' ' VAL . 16.7 t -141.28 106.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.003 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.49 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 24.2 m95 -110.15 146.24 35.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.0 111.779 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -128.11 119.79 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.159 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 7.7 tttm -46.44 129.0 10.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.735 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 1.6 ptpt -109.28 -176.85 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.816 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.145 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.16 154.6 23.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 96' ' ' ILE . 0.8 OUTLIER -121.53 114.56 21.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.226 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.88 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.73 122.9 47.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.47 0.652 . . . . 0.0 112.466 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.778 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.7 p90 -164.12 165.15 22.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.189 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.39 136.06 53.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.361 . . . . 0.0 111.737 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -125.89 144.26 50.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.518 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.9 p30 -98.41 -169.29 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.489 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -49.46 -49.27 46.1 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.175 0.512 . . . . 0.0 110.59 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -29.24 63.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.288 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.02 31.09 6.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.758 HD23 ' N ' ' A' ' 13' ' ' ILE . 7.5 tt -83.43 167.9 17.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.592 0.235 . . . . 0.0 110.618 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.758 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.348 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HA ' ' NE2' ' A' ' 92' ' ' GLN . 12.5 mmtp . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 68.0 mt -77.82 89.29 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.854 0.359 . . . . 0.0 111.813 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.6 ttp -99.4 120.81 40.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.667 HG21 HG11 ' A' ' 82' ' ' VAL . 40.3 t -79.82 158.36 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 111.646 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.5 m -161.67 149.93 4.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.89 149.35 44.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.846 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.824 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -48.22 -52.4 21.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.116 0.458 . . . . 0.0 110.119 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.459 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -56.34 -34.64 66.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.251 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.56 HG22 ' CE2' ' A' ' 49' ' ' PHE . 4.0 m -70.36 -54.8 11.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.131 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 35.7 t80 -50.39 -28.06 7.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.457 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -66.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -57.5 -30.41 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.591 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.718 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -36.42 133.69 0.61 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.705 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 47.7 Cg_exo -38.99 -29.12 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.394 2.729 . . . . 0.0 113.766 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -162.19 152.31 16.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 111.197 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.52 108.9 10.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 88.1 Cg_endo -82.22 -179.09 22.9 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.364 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 49' ' ' PHE . 51.0 mt -82.23 145.82 53.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.774 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.402 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 56.1 Cg_endo -70.65 109.66 2.54 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.419 2.079 . . . . 0.0 112.236 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 77.55 14.68 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.8 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -132.89 112.63 12.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.638 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 46.6 m -70.51 113.03 7.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.083 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.604 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -103.38 156.66 17.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.305 0.574 . . . . 0.0 112.079 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 76' ' ' VAL . 21.6 t -133.29 141.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.152 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.824 HG13 ' HA ' ' A' ' 43' ' ' ARG . 59.9 t -109.05 123.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.916 0.388 . . . . 0.0 111.351 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.506 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -105.62 120.12 40.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.829 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.8 t -153.6 155.77 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.5 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.861 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.2 tt0 -74.12 134.05 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.97 1.83 53.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.672 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -127.79 3.6 6.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.61 0.243 . . . . 0.0 111.503 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.886 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.0 t80 -57.1 137.82 55.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 111.419 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.934 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -130.39 173.39 10.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.218 1.008 . . . . 0.0 112.613 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.52 143.3 19.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.576 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.4 101.16 7.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.791 0.329 . . . . 0.0 110.336 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.46 -40.92 2.9 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.749 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.16 166.89 18.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.551 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.13 140.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.934 HG21 ' HA ' ' A' ' 69' ' ' GLN . 15.0 t -109.3 117.66 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.924 HG21 HG22 ' A' ' 82' ' ' VAL . 26.9 m -126.96 167.36 21.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.426 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -116.82 -22.33 8.6 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.685 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -155.64 -173.62 4.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.622 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.943 HG13 ' CD2' ' A' ' 106' ' ' PHE . 19.3 t -69.72 -9.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.728 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.64 -34.72 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.443 . . . . 0.0 110.107 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.24 -30.81 62.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.991 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.924 HG22 HG21 ' A' ' 76' ' ' VAL . 23.1 t -73.52 -49.39 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 109.998 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.438 ' CE2' HG12 ' A' ' 79' ' ' VAL . 5.7 m-85 -57.08 -28.02 62.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.909 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.29 -42.22 88.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.039 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.89 -56.23 12.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.16 -22.8 30.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.976 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.72 -41.73 71.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -83.82 -10.02 58.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.546 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -123.71 64.73 32.27 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.59 -0.8 6.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.044 2.496 . . . . 0.0 112.756 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.54 26.95 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -99.4 163.57 12.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.454 . . . . 0.0 111.457 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.98 159.76 14.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.571 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.527 HD11 ' CG1' ' A' ' 82' ' ' VAL . 51.4 tp -113.52 113.58 25.33 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.837 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 4' ' ' LEU . 30.3 t -134.54 121.59 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.679 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.512 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 17.6 mm -81.0 132.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.06 0.457 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -96.9 -50.55 4.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.067 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.09 -169.35 42.46 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.425 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.75 -160.78 36.47 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 117.635 0.717 . . . . 0.0 112.493 -0.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.57 -48.76 19.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.765 0.317 . . . . 0.0 111.301 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.8 -32.46 52.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.122 0.487 . . . . 0.0 110.403 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.506 ' CD1' HD22 ' A' ' 62' ' ' LEU . 45.8 mm -85.23 -27.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.205 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -60.67 -57.46 12.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.751 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' ' 129' ' ' ILE . 1.6 t -66.81 -9.97 42.84 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.93 -0.481 . . . . 0.0 112.263 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.747 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.34 -39.87 62.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.943 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.9 m-85 -101.36 -3.18 29.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.767 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 104' ' ' THR . 1.8 pttt -49.16 -32.52 10.33 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -0.73 57.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.2 m-20 -120.48 -26.9 5.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.342 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.801 HG11 HD23 ' A' ' 113' ' ' LEU . 62.7 t -50.11 126.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.59 -12.65 19.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.04 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 95.9 m -148.28 141.79 25.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.523 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.801 HD23 HG11 ' A' ' 110' ' ' VAL . 12.9 mt -123.62 146.78 47.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.262 0.554 . . . . 0.0 111.743 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.0 mt -135.55 116.97 14.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.778 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -131.71 141.95 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.427 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.41 99.25 7.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.608 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -75.53 100.06 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.384 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mt -84.66 126.54 33.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.325 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.11 -43.51 82.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.208 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.85 167.55 48.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.514 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.2 p -101.2 150.79 22.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 111.0 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -130.37 149.32 52.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 167.38 15.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.421 . . . . 0.0 111.318 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.69 164.67 11.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.89 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -1.29 12.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.503 0.192 . . . . 0.0 111.316 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.49 HG22 HD11 ' A' ' 13' ' ' ILE . 3.7 m -109.22 128.65 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -105.24 164.07 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.54 147.4 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.1 pt -71.14 164.39 57.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.27 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.61 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.0 Cg_endo -74.92 102.9 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.357 2.038 . . . . 0.0 112.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -88.1 144.35 26.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.54 70.49 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.302 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.443 ' HH2' HG11 ' A' ' 115' ' ' VAL . 85.2 m95 -55.04 -24.98 27.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.292 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -30.3 65.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 0.0 110.474 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -80.32 -25.65 39.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 85.5 m-85 -100.26 176.58 5.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.772 0.32 . . . . 0.0 110.43 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -137.09 140.71 42.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.531 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.2 ttpm? -79.93 114.81 19.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.886 HG22 ' O ' ' A' ' 157' ' ' VAL . 17.1 m -97.64 -19.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -164.11 140.76 6.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.5 p -163.75 112.65 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.036 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.442 ' C ' HG23 ' A' ' 154' ' ' THR . 5.8 ttt-85 -148.1 125.34 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.662 HG23 ' OG1' ' A' ' 154' ' ' THR . 3.5 m -79.24 145.72 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 152' ' ' THR . 5.0 t -119.2 103.5 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -84.49 99.81 10.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 -179.92 7.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.4 p -53.41 -46.98 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 110.581 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.504 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -79.11 124.27 84.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.368 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.96 -29.44 89.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 112.599 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.37 -18.75 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.2 mt -83.94 7.06 19.5 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.579 0.228 . . . . 0.0 111.466 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 91.1 m -71.07 164.91 24.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -171.05 157.63 5.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.603 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.662 ' OG1' HG23 ' A' ' 143' ' ' THR . 45.1 m -123.2 126.56 47.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.588 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.22 105.44 17.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.75 ' HB2' HG22 ' A' ' 115' ' ' VAL . 75.3 mt-10 -106.37 124.61 49.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.196 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.886 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.8 t -116.55 113.68 43.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.259 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.531 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 20.2 m95 -108.62 150.23 27.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.937 0.399 . . . . 0.0 111.481 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.593 ' OE1' HG11 ' A' ' 139' ' ' VAL . 29.1 mt-30 -127.51 119.0 25.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -57.08 130.8 47.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -104.37 -176.06 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.137 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 52.2 m . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.68 151.11 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 96' ' ' ILE . 1.4 m-30 -118.03 107.8 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.212 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -106.36 124.78 50.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.332 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.58 ' CZ2' HG12 ' A' ' 115' ' ' VAL . 6.0 p90 -168.38 174.24 7.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.4 137.79 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.5 pt20 -119.26 156.57 29.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 111.332 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 121' ' ' SER . 45.3 t0 -102.58 169.06 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.23 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.11 -30.04 6.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.929 0.395 . . . . 0.0 110.568 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -89.02 -27.51 20.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.0 22.15 6.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.714 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.2 tt -77.27 166.46 23.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.633 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG22 ' HD1' ' A' ' 5' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.466 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mttp . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 54.2 mt -86.88 88.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 O-C-N 122.012 -0.43 . . . . 0.0 110.768 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 5.6 ttp -100.13 119.12 37.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.58 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 82' ' ' VAL . 2.7 t -87.53 128.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG11 ' CE2' ' A' ' 49' ' ' PHE . 19.1 m -132.43 154.94 40.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.378 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 162.13 53.79 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.843 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.694 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -58.5 -50.01 75.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.984 0.392 . . . . 0.0 110.654 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.47 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 tpt180 -61.03 -35.96 78.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 110.297 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 -50.41 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.387 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.3 t80 -52.59 -25.09 9.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -69.63 -65.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -28.07 61.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.33 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.62 ' CE2' HG11 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -37.69 136.86 0.72 Allowed Pre-proline 0 N--CA 1.467 0.404 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.779 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.17 -30.47 25.64 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.802 2.335 . . . . 0.0 113.074 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -159.34 151.96 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -140.98 110.93 6.61 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HG3' ' O ' ' A' ' 71' ' ' GLN . 10.9 Cg_exo -81.35 178.54 31.02 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.585 -1.423 . . . . 0.0 111.996 -0.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.566 HD13 ' HE ' ' A' ' 57' ' ' ARG . 31.8 mt -83.16 156.0 66.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 38.5 Cg_endo -67.15 107.42 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.404 2.069 . . . . 0.0 112.875 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 70.74 4.75 5.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.566 ' HE ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -108.51 122.92 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.938 0.399 . . . . 0.0 111.411 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 92.4 m -75.13 117.02 16.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.158 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.414 HD21 HD12 ' A' ' 54' ' ' LEU . 3.3 m-80 -105.58 156.04 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.445 . . . . 0.0 112.015 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 24.6 t -136.97 137.42 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.337 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.694 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.6 t -107.76 126.59 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 0.0 111.323 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.637 ' HG ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -107.65 117.2 33.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.969 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.813 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.3 t -148.43 161.36 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.959 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -79.08 -11.42 59.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.452 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tp60 -82.35 134.03 35.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.535 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 52.8 mt-10 -84.01 -29.63 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.636 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.85 2.24 54.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.159 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.875 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.2 t80 -58.83 139.5 56.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.926 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.3 mt-30 -128.7 174.37 9.49 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.219 1.009 . . . . 0.0 112.447 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.13 144.32 21.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.847 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 13.6 mt-30 -73.52 96.85 2.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.362 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.36 -37.01 3.15 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.645 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.12 171.51 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 112.024 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 60' ' ' VAL . 13.8 t -97.78 140.35 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.467 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.926 HG21 ' HA ' ' A' ' 69' ' ' GLN . 38.9 t -106.95 104.77 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.24 0.543 . . . . 0.0 112.281 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.867 HG21 HG22 ' A' ' 82' ' ' VAL . 23.6 m -117.44 166.93 11.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.366 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.406 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 3.8 m80 -121.91 -19.89 6.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.307 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.496 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.8 t70 -155.65 -178.87 7.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.209 0.528 . . . . 0.0 111.602 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.718 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.8 t -66.29 -8.97 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.767 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.73 -35.02 16.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.487 . . . . 0.0 109.869 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.91 -32.93 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.903 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.867 HG22 HG21 ' A' ' 76' ' ' VAL . 39.9 t -70.73 -49.99 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.561 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.2 m-85 -55.79 -26.24 45.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.897 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -65.61 -43.76 88.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.026 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.07 -57.14 8.39 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.96 14.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.467 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.03 -36.72 80.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 -2.59 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.222 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -128.56 68.28 77.77 Favored Pre-proline 0 N--CA 1.456 -0.161 0 CA-C-O 121.082 0.467 . . . . 0.0 110.298 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.97 0.55 3.04 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.41 2.74 . . . . 0.0 113.087 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.92 -19.69 17.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.229 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 5.0 mm100 -109.83 154.99 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 43.9 mm-40 -98.16 174.92 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.365 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.49 109.07 18.84 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.574 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' MET . 39.2 t -124.24 108.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.298 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 40' ' ' VAL . 18.5 mm -85.55 142.36 13.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.384 0.612 . . . . 0.0 111.961 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -111.45 -44.66 3.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.371 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.91 -165.75 38.56 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.622 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -82.53 -161.19 29.28 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.401 0.6 . . . . 0.0 112.651 -0.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.71 -48.07 69.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.855 0.359 . . . . 0.0 111.078 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -58.09 -29.19 65.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.608 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -79.95 -29.28 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.358 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.428 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 3.5 m-85 -58.44 -55.91 28.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.733 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.703 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.4 t -65.17 -9.83 26.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.613 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.47 -43.41 27.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.843 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.718 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.6 m-85 -93.56 -6.79 45.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.338 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 10.9 pttp -49.8 -32.98 15.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.399 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -78.87 -6.04 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.764 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.09 -24.7 4.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 106' ' ' PHE . 76.6 t -44.43 124.58 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.94 0.4 . . . . 0.0 111.447 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 6.3 t70 -103.07 -1.22 29.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.687 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 86.3 m -161.46 142.51 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.585 0.231 . . . . 0.0 111.065 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.533 HD11 ' CG ' ' A' ' 136' ' ' PHE . 7.0 mt -123.58 144.95 49.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.213 0.53 . . . . 0.0 111.415 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 113' ' ' LEU . 12.9 mt -135.33 118.94 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.761 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.602 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.9 m -134.78 144.8 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.424 . . . . 0.0 111.688 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.84 119.31 35.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 7.1 mtm180 -102.05 104.7 15.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.418 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 153' ' ' HIS . 0.8 OUTLIER -87.8 136.46 32.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.44 -48.23 68.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.27 -138.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.406 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.7 p -144.23 168.2 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 0.0 111.335 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 80.0 m-85 -131.2 137.74 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.743 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 166.53 10.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.734 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.24 -159.12 29.18 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.13 22.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.5 m -146.08 137.82 24.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.863 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -109.34 165.82 11.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -177.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.703 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pt -104.06 156.73 35.3 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.88 99.9 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.671 2.247 . . . . 0.0 112.194 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.73 148.08 23.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.955 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.37 70.6 6.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.413 ' HH2' HG11 ' A' ' 115' ' ' VAL . 94.4 m95 -53.41 -27.64 25.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.094 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.09 -29.11 67.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.421 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.57 -20.67 42.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.533 ' CG ' HD11 ' A' ' 113' ' ' LEU . 43.5 m-85 -100.02 175.86 5.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.5 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 2.5 m -134.32 139.95 46.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.422 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.654 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 7.7 ttpt -83.94 111.56 19.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 157' ' ' VAL . 4.4 m -98.8 -17.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.487 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -163.89 140.21 6.62 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.443 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.654 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 81.0 p -168.04 105.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.464 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -142.79 121.25 12.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.649 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.684 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.2 m -71.16 145.59 49.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.21 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.77 103.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.579 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.4 mt-10 -86.61 100.27 12.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.358 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -83.24 -176.9 6.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -56.68 -54.15 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.942 0.401 . . . . 0.0 110.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.539 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.6 t30 -73.63 127.84 87.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.847 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.63 -31.6 92.34 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.037 1.825 . . . . 0.0 112.563 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.62 -21.48 28.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.8 mt -82.08 8.79 9.84 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 145' ' ' GLU . 95.5 m -75.28 164.1 26.79 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.9 p80 -175.58 162.19 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.994 0.426 . . . . 0.0 111.581 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.684 ' OG1' HG23 ' A' ' 143' ' ' THR . 7.7 m -122.12 144.85 48.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.911 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -111.65 110.06 20.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.71 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HB2' HG22 ' A' ' 115' ' ' VAL . 7.0 mm-40 -98.68 151.26 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 139' ' ' VAL . 10.7 t -141.77 106.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.009 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 25.1 m95 -108.5 146.18 33.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.106 0.479 . . . . 0.0 111.949 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -124.81 112.74 17.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.233 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.2 tttt -51.17 131.74 27.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.227 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -92.39 168.59 11.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.295 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.159 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 11.8 m . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.789 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.28 152.47 27.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.3 m-30 -118.11 112.03 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -115.21 126.34 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.673 0.749 . . . . 0.0 112.881 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.719 ' CH2' HG12 ' A' ' 115' ' ' VAL . 9.0 p90 -164.6 164.73 21.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.055 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.04 134.93 54.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 111.472 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.427 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 2.7 pt20 -115.61 140.34 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.796 ' OD2' HD12 ' A' ' 12' ' ' LEU . 4.5 p30 -97.82 -167.42 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.423 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -51.36 -34.66 35.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.784 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.63 -28.42 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 94.83 45.86 3.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.871 HD13 ' HA3' ' A' ' 124' ' ' GLY . 1.4 mt -91.11 174.31 7.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.615 HG22 ' CD1' ' A' ' 5' ' ' TRP . 1.1 pp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.653 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 mttm . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.63 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 74.3 mt -74.55 94.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 112.016 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.6 ttp -103.48 126.81 50.85 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.014 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.1 t -78.9 158.22 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 40' ' ' VAL . 27.3 m -165.04 142.98 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.99 158.5 51.2 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.81 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.593 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.84 -48.51 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.058 0.429 . . . . 0.0 110.77 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -62.66 -27.01 68.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 0.0 110.467 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.2 m -75.73 -44.62 40.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.589 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.462 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 15.8 t80 -61.33 -31.59 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -66.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.71 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 49' ' ' PHE . 3.9 t -54.7 -33.05 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -26.38 114.31 0.23 Allowed Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.883 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.88 -37.0 21.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.043 2.495 . . . . 0.0 113.307 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' CE ' HD23 ' A' ' 54' ' ' LEU . 2.6 tmmm? -147.13 118.93 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.777 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.86 140.16 21.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.18 -167.1 5.06 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.23 -1.571 . . . . 0.0 112.004 -0.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.63 HD12 HD21 ' A' ' 59' ' ' ASN . 81.9 mt -111.61 137.47 21.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.06 -66.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.65 2.233 . . . . 0.0 113.302 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.82 19.8 1.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.488 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.577 ' CD ' ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -142.27 121.43 12.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.119 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.63 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 39.9 m -80.59 128.11 33.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.289 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.63 HD21 HD12 ' A' ' 54' ' ' LEU . 2.8 m-80 -115.02 147.36 40.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 111.843 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.824 HG12 HG22 ' A' ' 76' ' ' VAL . 3.3 t -131.12 132.65 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.464 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 43' ' ' ARG . 78.7 t -97.73 128.89 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.289 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.669 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.07 115.38 30.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.824 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -147.4 156.75 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -74.15 -12.4 60.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.888 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tt0 -80.39 133.5 35.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.413 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 3.1 mm-40 -84.67 -11.13 56.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.962 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.37 4.41 20.66 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.861 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.4 t80 -58.26 140.45 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.54 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.848 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -126.48 173.85 9.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 179.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.49 143.68 20.09 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.648 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.73 96.75 5.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.742 0.306 . . . . 0.0 110.696 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.11 2.65 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.959 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.462 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.16 167.75 17.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.071 0.462 . . . . 0.0 111.718 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HB ' HG13 ' A' ' 60' ' ' VAL . 32.3 t -97.07 140.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.421 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 68' ' ' TYR . 21.3 t -104.23 117.66 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.368 0.604 . . . . 0.0 112.477 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.824 HG22 HG12 ' A' ' 60' ' ' VAL . 28.1 m -127.31 167.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.962 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.413 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 4.7 m80 -119.13 -22.18 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.539 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.662 ' HA ' HD21 ' A' ' 62' ' ' LEU . 8.1 m-20 -159.33 -175.02 4.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.667 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.83 HG22 ' CD1' ' A' ' 106' ' ' PHE . 11.8 t -66.64 -11.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.786 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.69 -36.82 17.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 0.0 109.752 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.65 -31.74 65.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 HG21 ' A' ' 76' ' ' VAL . 31.6 t -69.68 -53.82 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.986 0.422 . . . . 0.0 109.938 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 5.6 m-85 -53.61 -27.6 27.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.971 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -62.62 -46.49 88.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.895 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.43 -54.49 31.87 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.85 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.78 -24.2 34.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -71.39 -33.63 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -83.16 -8.72 59.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.376 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -124.82 66.01 47.32 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.019 0.437 . . . . 0.0 110.277 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.3 -0.46 2.89 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.099 2.533 . . . . 0.0 112.831 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.09 -30.28 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.009 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.93 161.81 14.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -98.76 174.77 6.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.85 HD13 ' HB2' ' A' ' 86' ' ' ALA . 8.5 tp -122.27 118.8 29.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.383 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 2' ' ' ALA . 53.5 t -132.87 121.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.452 ' CD1' HG21 ' A' ' 40' ' ' VAL . 8.7 mm -83.25 133.39 29.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.11 0.481 . . . . 0.0 111.832 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.402 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -101.22 -50.04 3.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.21 -171.13 43.94 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.717 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.408 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.45 -160.98 36.79 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.674 0.737 . . . . 0.0 112.69 -0.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.02 10.18 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.733 0.301 . . . . 0.0 111.508 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -52.62 -30.52 31.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.553 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.669 ' CD1' HD22 ' A' ' 62' ' ' LEU . 28.2 mm -82.89 -21.62 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . 2.7 m-85 -66.29 -51.75 54.25 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.518 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -70.75 -9.59 57.65 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 111.916 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.763 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.47 -37.87 35.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.83 ' CD1' HG22 ' A' ' 79' ' ' VAL . 6.3 m-85 -95.87 -11.12 27.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.682 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.518 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 9.4 pttp -51.4 -29.14 14.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.97 -12.45 60.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.411 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.89 -20.73 5.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 106' ' ' PHE . 81.0 t -44.53 128.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.063 0.458 . . . . 0.0 111.317 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 6.2 t0 -110.47 -3.87 15.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.582 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.789 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.9 m -155.7 134.47 11.92 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.598 0.237 . . . . 0.0 111.08 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.683 HD11 ' CD2' ' A' ' 136' ' ' PHE . 11.7 mt -117.01 144.08 44.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 4' ' ' LEU . 4.2 mt -135.91 115.51 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.502 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.719 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -131.4 141.34 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.39 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.44 112.78 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -96.26 100.44 12.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.366 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.0 OUTLIER -86.66 131.21 34.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -61.54 -46.47 89.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.67 -173.3 0.08 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 p -124.54 136.58 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -138.15 157.49 46.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.91 170.37 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.871 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . -161.26 125.87 1.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.701 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.56 14.05 24.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.509 0.195 . . . . 0.0 111.42 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -162.85 137.27 6.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.939 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.33 160.78 14.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.202 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.554 ' SD ' HG21 ' A' ' 13' ' ' ILE . 15.9 tpt -81.51 159.34 24.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.425 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pp -91.81 165.07 21.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.415 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.63 128.37 23.23 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.628 2.218 . . . . 0.0 112.043 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.68 HD13 ' CZ2' ' A' ' 133' ' ' TRP . 2.5 mt -112.36 139.67 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.19 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 63.05 7.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.68 ' CZ2' HD13 ' A' ' 131' ' ' LEU . 89.8 m95 -53.9 -24.37 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -31.14 65.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.03 -16.39 47.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.397 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 113' ' ' LEU . 77.9 m-85 -103.45 168.28 9.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 110.69 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.676 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -132.59 140.93 48.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.978 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 5.6 ttpt -79.93 119.41 22.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 157' ' ' VAL . 32.8 m -105.41 -19.37 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.0 m -167.07 140.45 3.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 5.2 p -169.27 108.68 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -147.84 125.39 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.779 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.643 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.1 m -71.2 146.11 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.728 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 152' ' ' THR . 10.5 t -118.78 103.47 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.592 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.5 mt-10 -88.29 102.02 14.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.576 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.76 -174.4 4.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.654 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.9 p -58.0 -51.21 70.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.9 t30 -76.5 134.02 70.25 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.871 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.56 -35.29 60.48 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.985 1.79 . . . . 0.0 112.393 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.5 mt -78.45 8.91 4.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 144' ' ' VAL . 93.6 m -78.71 161.11 27.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.482 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -172.11 157.81 4.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.008 0.432 . . . . 0.0 111.594 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.643 ' OG1' HG23 ' A' ' 143' ' ' THR . 7.5 m -119.06 131.48 55.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.574 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 144' ' ' VAL . 45.1 m-85 -99.79 105.21 16.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.755 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.59 ' HB2' HG22 ' A' ' 115' ' ' VAL . 4.3 mt-10 -102.81 122.11 43.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.477 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.721 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.8 t -116.79 114.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 138' ' ' LYS . 30.5 m95 -112.15 150.56 30.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 111.556 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -126.8 115.02 18.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.829 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 3.0 ttpt -51.73 138.22 23.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.287 0.565 . . . . 0.0 112.434 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.676 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -125.87 -164.03 1.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.339 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.063 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.446 HG23 HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.723 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.93 146.35 39.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.57 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.5 m-85 -110.2 115.79 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.531 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 tp -113.73 120.96 42.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.702 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.1 p90 -166.17 164.65 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.274 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.32 55.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 111.48 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 pt20 -123.29 153.05 40.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.157 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -103.18 -174.07 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.717 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -24.92 19.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -91.99 -31.17 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.744 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.98 22.74 7.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.669 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -87.22 153.09 21.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.409 HG23 ' HD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.9 mmtt . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 71.8 mt -86.6 85.27 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.051 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ttp -102.12 123.07 45.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.39 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 41' ' ' VAL . 43.3 t -76.01 156.51 5.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.522 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 40' ' ' VAL . 34.9 m -164.18 137.46 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.74 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.21 161.37 34.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.933 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.642 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.99 -47.2 81.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.861 0.33 . . . . 0.0 110.767 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.419 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.8 tpp180 -66.36 -30.48 70.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.388 . . . . 0.0 110.336 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.711 HG22 ' CE2' ' A' ' 49' ' ' PHE . 7.0 m -68.2 -43.73 77.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.204 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.452 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 13.7 t80 -59.05 -31.14 68.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.42 -66.1 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.1 t -50.07 -41.61 48.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.9 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.711 ' CE2' HG22 ' A' ' 45' ' ' THR . 6.9 m-85 -42.44 152.92 0.32 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-O 120.781 0.324 . . . . 0.0 111.448 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -41.73 -72.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.063 2.509 . . . . 0.0 113.542 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.66 177.15 8.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.45 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 2.4 ptp180 -122.1 105.76 36.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 86.9 Cg_endo -87.89 -179.96 17.07 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.457 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 49' ' ' PHE . 34.2 mt -61.18 158.53 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 12.9 Cg_endo -56.72 87.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.412 2.075 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 42.8 mt-10 69.62 47.55 0.64 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.351 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HD2' ' CD1' ' A' ' 54' ' ' LEU . 17.0 mtt180 -140.79 126.05 18.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.671 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 92.0 m -76.5 105.84 7.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.479 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 1.8 m-80 -104.6 145.86 29.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.224 -178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 76' ' ' VAL . 12.1 t -117.63 141.78 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.097 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.642 HG13 ' HA ' ' A' ' 43' ' ' ARG . 58.8 t -108.32 124.42 64.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.116 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.28 121.05 44.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.484 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.536 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.5 t -157.17 160.13 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -75.52 -5.51 45.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.19 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.4 tp60 -78.71 129.85 35.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.63 -28.06 31.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.139 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.56 7.55 46.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.68 ' O ' HG11 ' A' ' 75' ' ' VAL . 7.7 t80 -60.57 142.49 55.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.348 0.594 . . . . 0.0 111.897 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.939 ' HA ' HG21 ' A' ' 75' ' ' VAL . 14.9 mm100 -134.77 175.72 9.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.39 1.09 . . . . 0.0 112.888 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 142.64 19.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -78.11 100.94 6.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.35 -43.0 2.8 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.807 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -70.08 170.18 11.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.446 . . . . 0.0 111.709 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.5 t -99.48 140.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.939 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.5 t -111.36 119.97 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.357 0.599 . . . . 0.0 112.121 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.973 HG21 HG22 ' A' ' 82' ' ' VAL . 34.1 m -126.61 168.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.409 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -119.14 -25.46 6.17 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.794 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 t70 -149.07 -176.13 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.641 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.912 HG13 ' CD2' ' A' ' 106' ' ' PHE . 21.7 t -69.63 -10.73 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.688 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.72 -30.99 18.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 110.364 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.26 -26.59 52.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.133 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.973 HG22 HG21 ' A' ' 76' ' ' VAL . 16.7 t -78.41 -50.81 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 109.806 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.592 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.2 m-85 -57.33 -28.78 63.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.913 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.77 -38.29 79.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.7 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -68.12 -59.23 3.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.51 -22.84 14.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.202 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.89 -37.38 75.99 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.035 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 7.5 mt-30 -83.81 -4.49 58.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.233 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -124.76 65.04 43.77 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.563 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.8 -0.99 6.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.925 2.417 . . . . 0.0 112.829 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.7 -31.67 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 20.6 mt-30 -102.28 157.44 16.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -99.14 158.99 15.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.446 HD23 HG23 ' A' ' 1' ' ' THR . 29.9 tp -111.51 115.89 29.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.28 110.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.33 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.471 HD12 HG21 ' A' ' 40' ' ' VAL . 4.9 mm -77.2 129.03 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 0.0 111.079 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.19 -37.14 6.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.59 -169.11 42.17 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.785 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.34 -161.01 30.6 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 122.266 -0.549 . . . . 0.0 112.545 -0.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -55.12 -51.18 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.054 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -55.53 -27.64 50.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.591 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 62' ' ' LEU . 49.0 mm -79.34 -32.94 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.0 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 3' ' ' PHE . 6.2 m-85 -54.08 -58.16 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.65 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.568 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.1 t -65.78 -9.92 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.811 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.74 -41.56 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.912 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.0 m-85 -101.56 -2.57 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.462 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 39.0 pttt -49.8 -34.36 19.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.731 0.3 . . . . 0.0 111.767 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 4.07 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.64 -25.0 3.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.856 HG11 HD23 ' A' ' 113' ' ' LEU . 62.9 t -44.04 129.35 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 120.97 0.414 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 24.5 t70 -103.41 2.77 34.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.124 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 97.8 m -166.97 138.63 3.32 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.538 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.856 HD23 HG11 ' A' ' 110' ' ' VAL . 21.2 mt -120.17 144.81 47.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 113' ' ' LEU . 19.9 mt -135.31 115.23 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.2 m -132.16 143.05 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.848 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.35 105.67 13.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.235 179.31 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -81.98 101.67 10.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.748 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -84.91 125.73 32.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.974 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 -56.93 12.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.312 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.16 168.26 15.85 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.87 163.19 12.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.748 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 4.5 m-85 -136.39 147.99 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -98.75 132.67 43.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.692 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.14 -179.7 47.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.527 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.26 -0.18 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.7 m -118.13 122.45 43.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.032 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.407 ' O ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.74 175.98 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.4 tpt -76.61 153.3 35.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.855 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.519 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.8 pp -81.23 164.14 51.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.249 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.27 101.6 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.839 2.359 . . . . 0.0 112.686 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.415 ' CD1' ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -91.25 145.42 24.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.67 75.7 4.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.247 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.553 ' HH2' HG11 ' A' ' 115' ' ' VAL . 93.7 m95 -55.29 -21.25 13.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.304 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -28.36 61.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.3 t0 -80.74 -17.27 51.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.177 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.648 ' CD1' HD11 ' A' ' 113' ' ' LEU . 91.5 m-85 -109.1 166.35 10.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.94 0.4 . . . . 0.0 111.559 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.748 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -125.24 140.31 52.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.739 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.545 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpm? -81.19 121.35 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.615 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.1 m -110.21 -15.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.612 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.407 ' OG ' HG23 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -167.33 139.87 3.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.81 0.338 . . . . 0.0 110.928 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.2 p -163.09 109.79 1.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -143.65 119.27 10.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.332 . . . . 0.0 111.283 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.742 HG23 ' OG1' ' A' ' 154' ' ' THR . 5.0 m -74.09 144.61 44.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.244 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 t -116.53 106.22 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.126 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.69 105.49 17.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.588 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.86 -177.18 6.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.559 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 p -59.64 -42.01 91.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.498 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.4 t30 -81.78 126.35 75.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.23 -29.18 88.44 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.295 1.997 . . . . 0.0 112.274 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.54 -24.08 23.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.037 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.7 mt -81.32 6.28 14.78 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.571 ' O ' HD23 ' A' ' 118' ' ' LEU . 52.1 m -71.38 164.5 25.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.071 0.463 . . . . 0.0 110.124 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.1 p80 -174.37 160.95 3.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.13 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.742 ' OG1' HG23 ' A' ' 143' ' ' THR . 26.9 m -122.69 150.16 43.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.629 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -111.05 105.21 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.54 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.713 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.1 mt-10 -105.05 121.63 44.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 111.631 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 139' ' ' VAL . 4.1 t -112.93 111.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.696 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.2 m95 -110.89 150.33 29.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 111.487 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -128.39 120.91 27.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.496 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.5 tmmt? -45.5 125.93 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.643 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.748 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -109.79 -176.27 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.105 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.508 HG22 HG12 ' A' ' 96' ' ' ILE . 2.9 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.743 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.51 144.92 42.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 1.8 m-30 -107.66 112.9 25.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.846 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.33 124.92 53.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.36 0.6 . . . . 0.0 112.43 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.76 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.9 p90 -170.91 174.05 4.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.617 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -121.76 139.77 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -120.48 154.76 34.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 111.422 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 122' ' ' PHE . 1.1 p30 -108.62 -177.7 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HG2' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -47.88 -49.63 29.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.32 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.23 -19.55 64.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.55 25.89 21.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.347 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -90.4 161.98 15.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.857 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.679 HG22 ' CD1' ' A' ' 5' ' ' TRP . 11.4 pt . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.202 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.509 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 58.6 mt -82.18 88.42 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.413 ' HE3' HG13 ' A' ' 41' ' ' VAL . 1.6 ttp -97.91 116.89 31.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.801 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 82' ' ' VAL . 5.8 t -86.3 125.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.09 0.471 . . . . 0.0 111.688 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 49' ' ' PHE . 24.5 m -132.13 155.13 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.502 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.13 147.0 32.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.756 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.7 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -45.09 -49.29 11.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.72 0.26 . . . . 0.0 111.459 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.442 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 3.8 ttt180 -62.14 -36.88 83.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 0.0 110.146 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -63.34 -49.38 74.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.475 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.83 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 2.9 t80 -50.3 -43.76 53.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.875 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -52.38 -63.98 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.766 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -35.08 67.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.37 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -34.98 138.52 0.35 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-O 120.905 0.384 . . . . 0.0 111.973 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.19 -29.99 18.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.253 2.635 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 149.33 31.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.387 . . . . 0.0 111.501 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.4 mtm180 -138.65 106.37 7.63 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 95.1 Cg_endo -86.0 -166.91 4.37 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.273 -0.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.616 HD12 HD21 ' A' ' 59' ' ' ASN . 75.4 mt -100.58 142.05 23.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.92 121.17 6.77 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 112.798 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 69.98 3.09 4.18 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.771 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HD2' HD13 ' A' ' 54' ' ' LEU . 3.4 mtt-85 -114.42 108.8 17.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.0 m -68.24 113.19 5.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.616 HD21 HD12 ' A' ' 54' ' ' LEU . 2.5 m-80 -104.73 150.37 24.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.397 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 76' ' ' VAL . 6.6 t -134.83 133.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.7 HG13 ' HA ' ' A' ' 43' ' ' ARG . 79.2 t -103.01 124.04 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.753 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -105.72 111.23 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.907 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.954 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -142.83 170.81 15.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 111.285 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -86.91 -14.19 42.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.683 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.6 tt0 -79.17 133.58 36.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.455 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 23.4 mt-10 -80.89 -25.61 37.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.79 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.89 6.78 48.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.954 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.2 t80 -60.08 136.24 57.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.216 0.532 . . . . 0.0 111.6 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.95 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -132.04 173.71 10.93 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.254 1.026 . . . . 0.0 112.703 179.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.07 141.41 18.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.096 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.26 101.56 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.807 0.337 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -41.39 2.92 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.638 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.83 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -69.44 167.74 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.52 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.78 140.77 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.95 HG21 ' HA ' ' A' ' 69' ' ' GLN . 19.2 t -110.03 119.87 59.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.228 0.537 . . . . 0.0 112.066 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.821 HG21 HG22 ' A' ' 82' ' ' VAL . 27.6 m -130.19 167.11 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.664 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.455 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 17.3 m80 -118.28 -22.51 7.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.642 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.65 -176.72 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.206 0.527 . . . . 0.0 111.507 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.873 HG13 ' CD2' ' A' ' 106' ' ' PHE . 35.6 t -71.89 -9.36 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.661 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.13 -33.78 19.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.487 . . . . 0.0 109.785 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.542 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.85 -32.3 63.59 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.124 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.821 HG22 HG21 ' A' ' 76' ' ' VAL . 43.4 t -72.19 -52.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.3 m-85 -54.13 -28.09 37.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.27 -40.19 93.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.471 ' CE2' ' CD2' ' A' ' 89' ' ' HIS . 65.1 t80 -66.99 -57.42 6.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -53.33 -23.3 8.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.097 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 3.5 mmtp -69.4 -40.11 77.56 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -85.06 -4.95 59.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.529 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 93.4 m-70 -127.38 60.59 44.26 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.02 -0.03 5.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.236 2.624 . . . . 0.0 112.916 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.75 -35.7 19.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.03 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.401 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 12.1 mt-30 -99.5 163.92 12.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.473 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.3 160.69 14.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.926 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.795 HD11 HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -115.3 117.06 29.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.53 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.451 HG12 HD12 ' A' ' 4' ' ' LEU . 59.3 t -131.94 117.83 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.174 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 1' ' ' THR . 5.4 mm -81.92 133.13 29.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.262 0.553 . . . . 0.0 111.484 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.53 -48.66 4.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.056 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.404 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.43 -164.13 36.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.404 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -86.15 -161.02 34.83 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.674 0.737 . . . . 0.0 112.704 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -50.77 -48.97 59.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.323 . . . . 0.0 111.41 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -58.5 -29.85 66.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.877 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.2 mm -79.43 -29.93 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.268 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.9 m-85 -57.16 -54.14 50.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.862 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -70.12 -8.49 50.0 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.024 -0.423 . . . . 0.0 111.839 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.814 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.34 -38.98 40.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.873 ' CD2' HG13 ' A' ' 79' ' ' VAL . 29.3 m-85 -99.63 -10.03 22.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.308 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 18.5 pttp -52.17 -31.73 32.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.758 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.74 -5.1 52.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.656 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.2 -21.66 3.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 106' ' ' PHE . 76.9 t -44.81 123.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 111.302 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.433 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 3.9 t70 -103.13 7.69 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.267 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.2 m -168.39 135.84 2.09 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.821 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.63 HD23 HG11 ' A' ' 110' ' ' VAL . 17.0 mt -117.92 143.7 46.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.491 . . . . 0.0 111.531 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 4' ' ' LEU . 6.5 mt -135.28 115.08 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.664 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.76 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -134.69 144.69 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.024 0.44 . . . . 0.0 111.744 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.79 105.56 13.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.577 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 6.5 mmt85 -80.7 100.33 8.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.489 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.5 mp -82.21 127.94 33.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.431 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -63.08 -52.11 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -50.43 144.49 11.09 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.443 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.467 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 35.3 p -91.5 132.61 36.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.981 0.42 . . . . 0.0 111.374 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -134.23 163.57 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -116.56 150.86 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.112 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.8 -173.72 23.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.788 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -33.98 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.954 0.407 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 60.7 m -108.71 139.44 43.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.98 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -115.89 172.39 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 111.681 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -70.22 143.6 52.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.488 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pt -68.45 154.33 94.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.96 97.73 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.512 2.142 . . . . 0.0 111.975 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.62 146.69 26.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 72.45 4.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.325 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.475 ' HH2' HG11 ' A' ' 115' ' ' VAL . 89.8 m95 -55.7 -22.37 23.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.423 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -28.81 62.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -80.64 -23.46 39.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 71.8 m-85 -102.09 174.08 6.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -137.79 142.85 40.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.6 ttpt -79.96 120.54 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.787 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.6 m -103.01 -21.75 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.433 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.4 m -162.74 140.69 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 16.1 p -160.62 109.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -139.43 115.2 10.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.27 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 8.4 m -74.42 144.14 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.432 HG11 ' HE2' ' A' ' 155' ' ' TYR . 2.5 p -121.77 105.26 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.997 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.53 ' HA ' HG23 ' A' ' 152' ' ' THR . 19.6 mt-10 -88.7 107.14 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.787 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.27 -175.77 5.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.486 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.7 p -57.45 -50.45 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.749 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.494 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -74.41 124.66 90.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.102 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.97 -27.21 84.44 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.154 1.903 . . . . 0.0 112.301 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -19.89 22.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.674 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.3 mt -84.85 7.77 19.72 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 74.5 m -72.88 168.22 19.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -175.46 162.48 2.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.257 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 24.5 m -125.23 137.91 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.797 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.432 ' HE2' HG11 ' A' ' 144' ' ' VAL . 94.4 m-85 -98.4 106.3 18.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.493 ' HB2' HG22 ' A' ' 115' ' ' VAL . 62.7 mt-10 -108.69 126.61 53.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.857 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.7 t -118.72 115.9 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.251 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.3 m95 -111.97 151.16 29.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 0.0 111.377 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -127.02 117.13 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.828 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.1 OUTLIER -55.46 131.47 46.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.93 0.395 . . . . 0.0 111.613 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.493 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 1.8 ptmt 177.5 156.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.991 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 85.2 m . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.83 148.93 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.597 ' C ' HD13 ' A' ' 4' ' ' LEU . 2.6 m-30 -114.18 112.28 22.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.491 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.078 HD11 HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -112.82 121.52 44.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 0.0 111.807 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.86 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.0 p90 -166.85 172.73 10.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.448 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.88 134.37 50.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -119.98 155.81 32.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.952 0.406 . . . . 0.0 111.182 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.7 -172.83 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.687 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.13 63.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.06 -23.12 52.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.71 22.61 17.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.358 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.37 159.75 20.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.22 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.6 mt -78.62 86.75 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.4 ttp -99.99 120.31 39.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.934 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.498 HG21 HG11 ' A' ' 82' ' ' VAL . 80.3 t -77.57 156.76 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.974 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 60' ' ' VAL . 33.6 m -162.49 141.22 2.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.43 153.45 52.92 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.506 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.765 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.33 -51.05 57.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.223 0.512 . . . . 0.0 110.815 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.489 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.9 tpt85 -57.88 -34.48 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.061 0.458 . . . . 0.0 110.19 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.577 HG22 ' CE2' ' A' ' 49' ' ' PHE . 2.8 m -69.75 -55.9 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.398 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -46.63 -28.69 1.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -65.44 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.237 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -50.18 -35.4 26.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.654 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 45' ' ' THR . 5.4 m-85 -40.93 157.95 0.18 Allowed Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD2' HD21 ' A' ' 54' ' ' LEU . 68.5 Cg_exo -52.23 -71.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.611 2.207 . . . . 0.0 113.257 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -124.15 173.6 8.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.7 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.9 mtp180 -133.99 104.43 11.63 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.913 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 89.9 Cg_endo -85.19 -167.06 4.76 Favored 'Cis proline' 0 C--N 1.349 0.588 0 C-N-CA 123.912 -1.287 . . . . 0.0 112.144 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 HD21 ' A' ' 59' ' ' ASN . 95.4 mt -93.87 151.36 39.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.629 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.35 110.15 2.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.666 2.244 . . . . 0.0 112.972 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.18 4.27 5.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.002 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.574 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 5.7 mtt180 -112.59 101.07 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.038 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 24.0 m -66.05 107.81 2.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.706 HD21 HD12 ' A' ' 54' ' ' LEU . 2.3 m-80 -103.38 156.1 17.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.243 0.544 . . . . 0.0 112.14 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.642 HG12 HG22 ' A' ' 76' ' ' VAL . 8.3 t -132.43 136.91 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.883 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.765 HG13 ' HA ' ' A' ' 43' ' ' ARG . 66.4 t -105.93 127.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.586 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.92 116.12 31.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.202 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.847 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.6 t -147.19 167.14 24.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.903 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -85.14 -12.01 53.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -72.93 134.83 44.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -85.2 -7.9 58.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.883 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -118.7 7.46 11.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.606 0.241 . . . . 0.0 111.522 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.925 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.9 t80 -58.14 139.57 54.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.193 0.52 . . . . 0.0 111.817 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.888 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -126.27 173.84 8.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.043 0.925 . . . . 0.0 111.99 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.27 142.97 19.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.495 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -77.93 97.99 5.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.745 0.307 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.41 2.99 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.234 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.89 171.72 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 60' ' ' VAL . 12.4 t -97.46 139.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.476 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.925 HG11 ' O ' ' A' ' 68' ' ' TYR . 41.9 t -103.69 107.95 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.281 0.562 . . . . 0.0 112.193 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 82' ' ' VAL . 28.7 m -118.23 167.79 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.973 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 63' ' ' THR . 13.1 m170 -120.38 -21.21 6.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 m-20 -160.59 -173.32 3.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.839 HG13 ' CD2' ' A' ' 106' ' ' PHE . 12.8 t -66.94 -10.18 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.765 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.0 -38.33 16.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 110.019 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.32 -30.73 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.749 HG22 HG21 ' A' ' 76' ' ' VAL . 21.5 t -71.01 -53.59 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.969 0.414 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.436 ' CE2' HG12 ' A' ' 79' ' ' VAL . 6.7 m-85 -54.09 -27.08 30.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.934 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.36 -44.99 85.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.95 -55.33 19.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.16 -22.61 17.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.875 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.4 mmpt? -70.09 -38.04 75.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.05 -6.2 59.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.622 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -126.48 67.4 65.52 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.998 0.427 . . . . 0.0 110.558 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.8 -0.23 4.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.162 2.575 . . . . 0.0 113.079 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.33 -30.3 22.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 111.039 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.405 ' NE2' HG13 ' A' ' 38' ' ' ILE . 12.3 mt-30 -112.27 156.83 21.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 111.529 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.66 174.96 6.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.699 HD11 HG12 ' A' ' 82' ' ' VAL . 7.8 tp -104.68 110.73 23.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.078 HG13 HD11 ' A' ' 4' ' ' LEU . 80.8 t -119.52 102.46 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.694 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.505 ' O ' HD22 ' A' ' 4' ' ' LEU . 11.1 mm -78.36 128.45 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 111.634 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -95.77 -47.64 6.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.0 -168.29 41.36 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.41 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -94.31 -160.82 34.64 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 117.824 0.812 . . . . 0.0 112.557 -0.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.14 -51.57 13.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -55.84 -33.09 64.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.536 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.535 ' CD1' HD22 ' A' ' 62' ' ' LEU . 39.3 mm -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.2 m-85 -60.51 -57.5 12.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.694 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.837 ' HA ' HD13 ' A' ' 129' ' ' ILE . 3.9 t -67.13 -9.98 45.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.609 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.76 -46.04 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.839 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.3 m-85 -94.53 -6.44 43.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 14.7 pttp -52.26 -30.2 26.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.912 0.386 . . . . 0.0 111.056 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.83 -7.21 58.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.269 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.43 -20.06 6.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.728 HG11 HD23 ' A' ' 113' ' ' LEU . 74.0 t -44.75 127.34 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.358 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.423 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 12.7 t70 -105.04 2.78 29.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 52.1 m -167.47 139.29 3.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.728 HD23 HG11 ' A' ' 110' ' ' VAL . 11.6 mt -119.72 146.62 45.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.33 0.586 . . . . 0.0 112.164 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.061 HD12 HD12 ' A' ' 4' ' ' LEU . 27.1 mt -135.6 112.39 10.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.198 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.86 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -130.59 141.79 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 111.596 -179.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -117.43 102.8 9.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.665 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.4 ttp85 -80.42 102.77 9.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.736 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 152' ' ' THR . 0.5 OUTLIER -80.93 123.46 28.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.17 -46.26 82.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.372 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 150' ' ' ALA . . . -57.71 -163.25 0.05 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.609 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.3 p -143.41 137.83 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.057 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.567 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -128.81 162.04 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -111.87 143.08 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.8 -166.67 23.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.597 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.46 -23.48 3.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -109.1 134.01 52.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.802 0.334 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -112.88 -174.0 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -164.8 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.837 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.1 pt -118.31 166.27 14.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.224 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.2 Cg_endo -75.7 103.52 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.43 2.087 . . . . 0.0 112.221 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.83 145.93 26.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.6 74.6 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.236 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -57.5 -20.53 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.48 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.93 -30.87 64.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.76 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.04 -21.96 39.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 78.5 m-85 -103.44 176.6 5.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 111.326 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -138.93 141.9 38.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.441 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 3.0 ttpt -78.15 124.33 27.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.8 m -109.18 -18.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.511 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.3 m -168.05 140.28 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.867 0.365 . . . . 0.0 111.368 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 6.4 p -155.48 111.13 3.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -144.08 115.42 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.8 m -76.97 143.1 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.124 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 105.73 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.212 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.651 ' HA ' HG23 ' A' ' 152' ' ' THR . 23.2 mt-10 -86.13 97.2 10.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.652 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -78.98 178.18 8.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.1 p -57.41 -52.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.699 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.501 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.32 125.68 91.3 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.806 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -28.83 87.77 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.085 1.857 . . . . 0.0 112.633 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HA ' ' CA ' ' A' ' 120' ' ' GLY . . . -90.02 -20.86 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.664 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.7 mt -83.24 7.19 17.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.597 0.237 . . . . 0.0 111.477 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.835 ' O ' HD23 ' A' ' 118' ' ' LEU . 62.6 m -72.43 167.0 21.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.5 p80 -175.37 162.14 2.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.641 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 19.4 m -125.79 139.11 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.588 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.9 105.17 17.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.37 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.721 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.2 mm-40 -103.56 121.55 43.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.284 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.785 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.7 t -115.13 114.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.709 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.442 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.6 m95 -112.35 150.63 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.462 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.409 ' HG3' HG11 ' A' ' 139' ' ' VAL . 7.9 mt-30 -127.5 117.62 22.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -54.91 132.8 47.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.299 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -114.67 -168.32 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.403 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.089 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 m . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.33 150.14 29.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.506 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 2.3 m-30 -117.95 115.83 25.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.89 124.49 51.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.469 0.652 . . . . 0.0 112.602 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.61 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.3 p90 -171.85 173.22 4.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.41 140.45 52.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.387 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -128.58 157.87 40.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.6 179.76 4.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.688 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.0 OUTLIER -50.94 -36.09 36.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.119 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -30.95 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.752 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.54 46.9 2.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.312 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.89 HD11 ' HA3' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -107.34 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.58 ' N ' ' HG ' ' A' ' 12' ' ' LEU . 4.6 pt . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.596 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 80.8 mt -82.05 86.7 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.476 ' HE3' HG11 ' A' ' 41' ' ' VAL . 17.2 ttp -99.34 117.59 34.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.686 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.857 HG21 HG11 ' A' ' 82' ' ' VAL . 3.6 t -85.08 127.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG11 ' HE3' ' A' ' 39' ' ' MET . 19.8 m -134.58 149.66 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.32 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.71 51.78 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.116 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.701 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -58.59 -52.56 65.16 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.854 0.327 . . . . 0.0 110.321 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.503 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 1.1 tpp180 -58.89 -37.27 76.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 m -69.96 -42.1 73.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.226 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CG ' HG22 ' A' ' 61' ' ' VAL . 53.1 t80 -64.1 -41.65 97.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.18 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -57.8 -66.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.785 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' PHE . 88.6 p -61.23 -30.63 70.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.78 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -30.41 133.32 0.22 Allowed Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.775 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_exo -38.39 -35.08 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.129 2.553 . . . . 0.0 113.252 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.786 ' HB3' HD23 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -152.35 139.76 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -140.3 108.12 6.75 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 91.6 Cg_endo -75.55 -170.51 8.46 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.519 -1.45 . . . . 0.0 112.195 -0.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.786 HD23 ' HB3' ' A' ' 51' ' ' LYS . 28.0 mt -99.21 155.95 35.98 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 104.63 1.45 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.576 2.184 . . . . 0.0 112.704 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 69.8 6.89 5.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.783 ' HD2' HD13 ' A' ' 54' ' ' LEU . 1.8 mtt180 -109.3 113.0 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.885 0.374 . . . . 0.0 111.552 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.7 m -67.33 107.98 2.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.996 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.734 HD21 HD12 ' A' ' 54' ' ' LEU . 1.6 m-80 -108.23 141.83 39.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.929 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 76' ' ' VAL . 16.1 t -117.15 143.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.095 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 43' ' ' ARG . 94.2 t -110.87 124.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 0.0 111.589 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -103.58 121.08 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.742 HG21 ' CD2' ' A' ' 68' ' ' TYR . 7.0 t -158.58 162.52 37.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.816 0.341 . . . . 0.0 111.208 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -86.08 -3.65 58.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.335 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tp60 -77.96 131.56 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.857 0.36 . . . . 0.0 110.38 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.49 -30.27 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.275 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -98.99 10.85 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.742 ' CD2' HG21 ' A' ' 63' ' ' THR . 5.9 t80 -61.84 141.98 57.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.22 0.533 . . . . 0.0 111.917 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.903 ' HA ' HG21 ' A' ' 75' ' ' VAL . 12.5 mm-40 -134.31 177.58 7.65 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.388 1.09 . . . . 0.0 112.899 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.54 144.69 19.62 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 112.996 -1.911 . . . . 0.0 110.641 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.03 96.92 2.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 0.0 110.46 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.53 -34.66 3.28 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.41 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.33 169.46 13.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 112.021 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.93 140.4 18.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.572 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.903 HG21 ' HA ' ' A' ' 69' ' ' GLN . 43.3 t -106.08 109.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.401 0.62 . . . . 0.0 112.461 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.891 HG21 HG22 ' A' ' 82' ' ' VAL . 34.6 m -117.81 163.89 14.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.891 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -116.69 -24.46 7.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.727 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -150.93 -174.03 4.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.143 0.497 . . . . 0.0 111.495 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.793 HG21 ' O ' ' A' ' 105' ' ' ALA . 45.5 t -70.25 -10.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.476 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.94 -31.43 18.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.023 0.44 . . . . 0.0 110.304 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.24 -28.79 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.891 HG22 HG21 ' A' ' 76' ' ' VAL . 22.6 t -76.5 -52.9 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -54.55 -28.06 43.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.65 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -68.15 -39.63 82.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 88.9 t80 -66.12 -56.81 9.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.02 -22.23 14.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.923 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -67.72 -41.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -82.69 -4.88 58.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.564 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 98.1 m-70 -125.95 64.42 51.77 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 110.301 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.6 0.13 3.86 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.371 2.714 . . . . 0.0 113.011 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -30.13 21.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.725 0.298 . . . . 0.0 110.808 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.427 . . . . 0.0 111.592 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -98.45 169.41 9.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.273 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 86' ' ' ALA . 5.5 tp -105.34 115.82 30.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.306 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -123.86 106.35 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.433 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.1 mm -78.42 139.49 18.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.981 0.419 . . . . 0.0 111.265 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.463 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.2 -39.48 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.194 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.49 -168.04 41.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -81.73 -161.29 27.68 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 117.347 0.574 . . . . 0.0 112.549 -0.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -55.65 -42.13 74.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.978 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.72 -28.12 69.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.633 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.7 mm -80.39 -35.45 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.16 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.9 m-85 -51.76 -55.98 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.526 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.778 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.1 t -66.18 -9.66 33.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.793 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.02 -41.58 28.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.695 0.283 . . . . 0.0 111.226 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.784 ' CD2' HG13 ' A' ' 79' ' ' VAL . 4.0 m-85 -95.33 -7.46 38.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.23 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.566 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.5 OUTLIER -50.85 -32.46 20.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.36 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -4.64 47.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.71 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.0 -20.6 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.561 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 90.7 t -44.74 140.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.154 0.502 . . . . 0.0 111.692 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -126.94 7.35 6.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.604 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.7 m -168.41 138.33 2.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.873 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.573 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 11.6 mt -122.8 142.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.313 0.577 . . . . 0.0 112.049 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.8 mt -130.52 114.35 15.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.2 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.61 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.5 m -138.37 148.53 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.29 112.71 24.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 9.0 mmt180 -89.22 104.7 17.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.627 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 14.6 mt -85.96 114.6 22.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.03 -26.89 28.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.652 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 150' ' ' ALA . . . -92.22 -173.44 41.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.848 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 32.3 t -116.82 165.74 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.627 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 10.2 m-85 -152.03 168.26 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.04 170.3 16.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.89 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 148.97 153.99 6.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.819 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -120.07 5.11 10.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.628 0.251 . . . . 0.0 111.459 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.508 HG22 HD11 ' A' ' 13' ' ' ILE . 12.5 m -131.25 138.71 49.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.7 mttt -114.32 163.09 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.415 ' HG3' ' NE1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.93 -179.12 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.022 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.778 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.5 pt -101.27 159.72 28.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.21 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.59 105.14 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.794 2.329 . . . . 0.0 112.421 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mt -96.09 150.77 20.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.038 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.31 72.8 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.574 ' HH2' HG11 ' A' ' 115' ' ' VAL . 81.0 m95 -56.9 -23.09 42.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.32 -30.26 66.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 0.0 110.457 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.63 -19.42 45.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.99 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.402 ' CD1' HD11 ' A' ' 113' ' ' LEU . 52.0 m-85 -107.87 167.76 9.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.576 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -129.98 141.24 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -79.92 109.11 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.767 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.2 m -90.54 -22.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.7 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.2 m -159.58 140.72 12.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -157.11 113.03 2.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.211 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.757 ' C ' HG23 ' A' ' 154' ' ' THR . 1.4 ttp180 -136.28 130.11 32.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 3.8 m -89.84 132.03 35.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.15 0.5 . . . . 0.0 112.194 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 t -105.15 113.0 41.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.626 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.683 ' HA ' HG23 ' A' ' 152' ' ' THR . 17.1 mt-10 -96.88 97.47 9.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.36 -176.04 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.267 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.4 p -63.49 -24.03 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.041 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.529 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -90.69 120.66 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.91 -18.79 59.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.529 2.153 . . . . 0.0 112.36 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 120' ' ' GLY . . . -95.81 -25.87 15.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.816 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.2 mt -85.1 2.45 43.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.741 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 145' ' ' GLU . 16.6 m -83.47 82.46 8.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 111.083 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.584 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -98.04 -171.74 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.757 HG23 ' C ' ' A' ' 142' ' ' ARG . 21.6 m -134.11 137.84 44.84 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' SER . 10.9 m-85 -86.06 106.76 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.561 ' HB2' HG22 ' A' ' 115' ' ' VAL . 11.3 mt-10 -105.46 121.47 44.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.767 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.5 t -114.61 111.8 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.895 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 16.3 m95 -107.93 151.34 25.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.114 0.483 . . . . 0.0 112.022 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.421 ' HB2' ' CG1' ' A' ' 139' ' ' VAL . 3.3 mt-30 -132.39 131.61 41.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.364 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -49.44 123.74 8.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 111.465 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.429 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -110.1 -175.55 2.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.959 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.191 179.694 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 13.8 m . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.5 154.62 24.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.587 . . . . 0.0 112.557 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.501 ' HB2' HD23 ' A' ' 113' ' ' LEU . 1.3 m-85 -121.22 117.47 27.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.778 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 tp -115.41 124.56 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.707 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.3 p90 -168.52 163.3 12.42 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.51 136.29 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -118.21 153.17 34.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -102.89 -178.17 3.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.235 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.453 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -48.82 -49.08 40.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.28 0.562 . . . . 0.0 109.843 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' HB3' HD23 ' A' ' 12' ' ' LEU . 7.6 t70 -69.79 -25.65 63.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.58 32.64 5.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.5 pp -100.93 166.04 11.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mttm . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.551 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 54.0 mt -72.28 89.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.15 126.95 51.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.62 HG21 HG11 ' A' ' 82' ' ' VAL . 21.4 t -79.77 158.73 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.108 0.48 . . . . 0.0 112.189 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' HG12 ' A' ' 40' ' ' VAL . 31.1 m -160.24 150.86 5.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.852 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.7 155.87 43.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.907 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -54.87 -49.09 72.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.922 0.361 . . . . 0.0 110.776 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 15.2 tpt85 -62.88 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -69.88 -43.27 72.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.664 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -63.9 -29.26 70.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.023 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -66.15 -66.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.901 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 17.0 t -53.27 -30.73 40.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -31.13 123.37 0.34 Allowed Pre-proline 0 N--CA 1.468 0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.606 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.61 -27.46 5.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.789 2.326 . . . . 0.0 113.251 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -171.31 117.57 0.44 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.298 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -122.05 141.2 33.72 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.96 -174.41 12.2 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.261 -1.558 . . . . 0.0 111.702 -0.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.762 HD12 HD21 ' A' ' 59' ' ' ASN . 17.0 mt -95.1 154.91 39.48 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.52 -83.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.702 2.268 . . . . 0.0 113.137 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -96.42 33.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HD2' HD13 ' A' ' 54' ' ' LEU . 4.0 mtt180 -132.09 100.96 5.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.326 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.551 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 51.6 m -68.23 121.85 17.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.785 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.762 HD21 HD12 ' A' ' 54' ' ' LEU . 2.1 m-80 -105.83 151.09 24.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.252 0.548 . . . . 0.0 112.191 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 76' ' ' VAL . 11.3 t -128.0 140.93 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.174 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.1 t -111.31 118.33 57.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 111.604 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.883 HD12 HG23 ' A' ' 76' ' ' VAL . 3.4 tp -104.21 112.16 25.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.537 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.9 t -149.99 162.24 40.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -76.9 -6.39 52.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.594 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.777 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.6 tp60 -74.01 125.29 27.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.706 0.288 . . . . 0.0 110.441 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.1 -8.13 59.7 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' H ' ' HG3' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -127.52 11.8 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.777 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.3 t80 -58.37 148.26 28.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.119 0.485 . . . . 0.0 111.45 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.893 ' HA ' HG21 ' A' ' 75' ' ' VAL . 25.9 mm100 -132.32 174.46 10.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.437 1.113 . . . . 0.0 112.728 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 141.96 16.78 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.375 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -82.15 96.65 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 110.147 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.33 -45.77 1.36 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.544 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -72.72 163.36 28.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.986 0.422 . . . . 0.0 111.759 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -96.17 140.62 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 69' ' ' GLN . 18.7 t -102.55 119.23 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.699 . . . . 0.0 112.26 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.883 HG23 HD12 ' A' ' 62' ' ' LEU . 30.0 m -128.32 167.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.729 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -115.43 -23.59 8.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.713 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.728 ' CA ' HD11 ' A' ' 62' ' ' LEU . 1.4 t70 -153.02 179.84 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.134 0.493 . . . . 0.0 111.581 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.964 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.6 t -65.53 -10.15 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.751 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.5 -33.0 19.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.679 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.59 -27.23 58.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.807 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.839 HG22 HG21 ' A' ' 76' ' ' VAL . 16.5 t -74.01 -55.22 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 13.0 m-85 -55.57 -28.23 53.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.801 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.37 90.81 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.46 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 73.8 t80 -63.4 -54.05 42.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.394 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -23.81 44.18 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.328 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -71.75 -33.41 68.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.406 ' HG2' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -89.02 -9.36 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.246 179.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 94.5 m-70 -125.0 66.23 49.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.61 0.24 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.393 2.729 . . . . 0.0 113.014 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -37.17 27.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.409 ' NE2' HG13 ' A' ' 38' ' ' ILE . 9.1 mt-30 -107.75 161.79 14.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.34 174.67 6.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.253 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.464 HD11 ' CG1' ' A' ' 82' ' ' VAL . 13.2 tp -116.1 114.84 25.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.504 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.58 112.65 28.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 96' ' ' ILE . 3.4 mm -81.4 131.38 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.844 0.354 . . . . 0.0 111.416 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.78 -41.88 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.876 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.57 -168.49 41.56 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.806 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.421 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.76 -160.74 33.93 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 122.027 -0.69 . . . . 0.0 112.588 -0.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.434 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -50.52 -58.35 5.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.81 -28.13 5.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.67 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 62' ' ' LEU . 37.2 mm -81.23 -28.66 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.3 m-85 -59.39 -58.67 7.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.007 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.629 ' CA ' HD13 ' A' ' 129' ' ' ILE . 13.6 t -66.79 -9.9 41.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.771 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.25 -41.62 57.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.964 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.2 m-85 -98.21 -3.97 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.644 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 38.7 pttt -51.61 -33.99 35.53 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.88 0.372 . . . . 0.0 111.114 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.17 -3.85 47.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.586 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.34 -21.93 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 106' ' ' PHE . 94.7 t -45.87 134.88 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.036 0.446 . . . . 0.0 111.505 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -116.66 6.01 13.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.598 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 46.2 m -168.03 141.66 3.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.311 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.708 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 13.8 mt -123.54 146.0 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.22 0.533 . . . . 0.0 111.814 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.2 mt -135.57 117.44 15.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.884 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.707 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.4 m -135.13 144.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.408 . . . . 0.0 111.49 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -112.92 113.19 25.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.802 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.37 100.7 12.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.464 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 2.2 mp -91.54 131.61 36.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.416 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.48 -52.63 64.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.047 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.24 -172.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.564 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -123.27 164.03 19.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 111.038 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.29 165.15 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 166.57 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.54 153.12 6.5 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.762 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.98 6.1 12.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.653 0.264 . . . . 0.0 111.107 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.8 m -133.94 145.23 49.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.368 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.2 pttp -122.21 173.77 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.5 tpt -69.32 153.15 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.629 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.7 pp -78.9 163.36 60.84 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.56 101.42 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.336 . . . . 0.0 112.653 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.41 149.03 21.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.636 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.49 77.31 3.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.708 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.4 m95 -61.16 -17.83 54.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.352 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.26 -34.45 63.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 110.464 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.11 -17.79 56.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.39 169.23 8.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 110.826 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.721 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -129.31 141.33 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 0.7 OUTLIER -82.88 119.06 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.312 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 157' ' ' VAL . 10.0 m -101.45 -21.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.896 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.2 m -160.74 143.36 12.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.264 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.87 111.7 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.463 ' C ' HG23 ' A' ' 154' ' ' THR . 9.2 ttp-105 -146.66 120.41 9.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.416 . . . . 0.0 111.398 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.649 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -74.57 145.97 42.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.214 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.525 HG21 ' HE2' ' A' ' 155' ' ' TYR . 14.4 t -116.45 102.57 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.426 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -85.31 99.66 11.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.63 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.47 -176.51 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.507 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.0 p -54.36 -56.53 17.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.515 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 34.2 t-20 -74.54 124.16 89.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.796 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.8 -27.52 84.13 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.262 1.975 . . . . 0.0 112.887 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.16 -19.44 26.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.5 mt -84.32 8.0 17.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.639 0.257 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 144' ' ' VAL . 97.0 m -73.33 165.17 25.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p-80 -172.73 159.33 4.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.223 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.649 ' OG1' HG23 ' A' ' 143' ' ' THR . 19.1 m -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.548 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.525 ' HE2' HG21 ' A' ' 144' ' ' VAL . 98.5 m-85 -118.69 105.76 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.661 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HB2' HG22 ' A' ' 115' ' ' VAL . 12.8 mt-10 -106.63 124.88 50.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.856 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 139' ' ' VAL . 10.5 t -116.3 112.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 22.0 m95 -106.75 149.83 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.435 . . . . 0.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.713 HE21 HG11 ' A' ' 139' ' ' VAL . 14.5 mt-30 -132.29 129.7 39.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -46.52 123.55 5.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.523 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.721 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -105.42 178.49 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.066 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.647 HG23 HD23 ' A' ' 94' ' ' LEU . 4.7 m . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.43 154.47 22.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -122.76 116.35 23.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.505 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 tp -114.95 122.5 46.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.673 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.0 p90 -167.22 168.33 13.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.615 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.85 141.26 49.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 111.29 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.39 153.77 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.89 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.77 -177.06 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -36.2 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.15 -21.32 29.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.46 25.04 29.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.596 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.5 tt -101.58 148.87 24.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.318 . . . . 0.0 111.003 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 126' ' ' THR . 1.1 pt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mttt . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.63 87.72 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.644 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.1 ttp -99.0 124.21 43.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.603 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.593 HG21 HG11 ' A' ' 82' ' ' VAL . 20.9 t -77.54 157.39 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.989 0.423 . . . . 0.0 111.838 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 60' ' ' VAL . 32.6 m -161.18 147.8 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.956 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.39 155.55 53.06 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.062 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.7 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.31 -52.19 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.972 0.386 . . . . 0.0 110.126 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -57.77 -30.68 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.46 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.47 HG22 ' CE2' ' A' ' 49' ' ' PHE . 21.5 m -71.29 -49.26 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.798 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 13.1 t80 -55.03 -35.7 64.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.487 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -66.83 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.938 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 49' ' ' PHE . 99.7 p -52.8 -37.19 59.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.815 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.971 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.49 127.35 0.25 Allowed Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.908 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.5 -27.68 19.57 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.071 2.514 . . . . 0.0 113.814 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 2.7 ttmm -151.75 147.95 27.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.966 0.412 . . . . 0.0 111.525 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.09 109.69 10.67 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.612 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 4.0 Cg_exo -86.53 168.04 46.0 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.792 -1.337 . . . . 0.0 112.048 -0.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.971 HD11 ' CE1' ' A' ' 49' ' ' PHE . 7.7 mt -59.45 164.86 4.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.645 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 10.9 Cg_endo -54.23 91.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 113.05 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 64.82 23.36 12.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.262 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 23.1 mtt180 -109.57 132.19 54.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.917 0.389 . . . . 0.0 111.444 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.8 m -84.05 108.14 16.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.772 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.51 158.17 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 112.089 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.775 HG12 HG22 ' A' ' 76' ' ' VAL . 10.7 t -130.8 143.33 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.042 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.7 HG13 ' HA ' ' A' ' 43' ' ' ARG . 99.5 t -108.84 122.08 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -104.25 122.94 46.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.272 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.586 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -156.29 165.71 35.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.217 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -84.36 -9.0 58.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.3 tt0 -76.0 133.55 40.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -88.1 6.81 34.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.938 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.98 3.15 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.887 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.4 t80 -57.27 139.19 53.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.456 . . . . 0.0 111.299 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.877 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -126.67 176.37 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.92 0.866 . . . . 0.0 112.253 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.65 146.19 23.16 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.118 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -94.34 96.23 9.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.508 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.59 13.38 53.82 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.057 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.694 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -136.55 172.87 12.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.925 0.393 . . . . 0.0 111.627 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 14.0 t -100.24 140.17 19.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 68' ' ' TYR . 21.6 t -106.41 116.0 49.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.09 0.472 . . . . 0.0 111.992 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.928 HG21 HG22 ' A' ' 82' ' ' VAL . 27.4 m -124.83 162.2 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.656 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' THR . 3.5 m170 -111.19 -23.19 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.365 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -155.71 -171.39 3.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.222 0.534 . . . . 0.0 111.64 -179.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.894 HG13 ' CD2' ' A' ' 106' ' ' PHE . 6.0 t -69.87 -9.22 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.07 16.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.149 0.499 . . . . 0.0 109.948 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -76.43 -28.14 56.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.694 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 76' ' ' VAL . 22.0 t -74.74 -51.08 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.545 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.3 m-85 -57.23 -25.51 59.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.667 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.93 -42.28 81.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.176 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 68.2 t80 -65.06 -56.07 15.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.72 -22.55 36.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.954 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.9 -31.88 68.66 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.457 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 15.3 mt-30 -87.1 -7.42 58.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.443 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.19 67.92 56.2 Favored Pre-proline 0 N--CA 1.456 -0.132 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.65 -0.32 2.99 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.133 2.555 . . . . 0.0 112.928 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.94 -24.54 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.304 . . . . 0.0 111.17 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.75 155.17 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.14 167.59 10.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.994 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.68 HD11 ' CG1' ' A' ' 82' ' ' VAL . 9.7 tp -120.04 113.02 19.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.081 0.467 . . . . 0.0 111.499 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.49 109.72 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.188 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 40' ' ' VAL . 3.7 mm -77.59 130.68 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -105.5 -42.89 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.492 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.7 -169.02 41.34 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.896 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.417 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -87.06 -160.92 35.75 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 122.118 -0.637 . . . . 0.0 112.7 -0.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.76 -53.5 39.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 111.404 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -27.62 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.1 mm -81.42 -22.7 10.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.1 m-85 -64.65 -55.24 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.726 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.617 ' CA ' HD13 ' A' ' 129' ' ' ILE . 10.6 t -66.54 -9.75 38.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.01 -41.73 41.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.894 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.6 m-85 -95.66 -5.37 42.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.57 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 2.0 pttt -51.52 -33.57 32.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.79 0.328 . . . . 0.0 111.336 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -84.73 -0.29 53.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.739 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -124.42 -24.58 4.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.872 HG11 HD23 ' A' ' 113' ' ' LEU . 58.5 t -48.21 122.14 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.634 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.95 3.47 44.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 93.9 m -165.43 142.21 5.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.284 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.872 HD23 HG11 ' A' ' 110' ' ' VAL . 8.1 mt -125.76 146.09 49.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.902 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.4 mt -134.75 119.31 18.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.697 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.673 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -135.29 145.26 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 106.47 15.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.309 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -93.1 104.58 16.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.835 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 1.2 mp -91.48 128.13 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.52 -49.09 37.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.217 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.46 172.6 3.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.298 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.2 t -112.71 147.96 35.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 1.5 m-85 -122.02 153.0 39.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -111.13 141.0 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -169.62 -167.77 30.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.55 -16.68 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.606 0.241 . . . . 0.0 111.537 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 13' ' ' ILE . 40.7 m -109.14 131.96 54.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.697 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.57 173.44 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.755 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.455 ' HE2' ' CE2' ' A' ' 5' ' ' TRP . 17.1 tpt -78.35 147.14 34.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.662 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -64.08 166.96 8.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.662 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.1 Cg_endo -77.13 98.04 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.265 1.977 . . . . 0.0 112.674 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.71 145.08 25.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 78.58 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.469 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.1 m95 -60.16 -20.11 56.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.51 -32.88 66.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -24.13 51.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.013 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.621 ' CD1' HD11 ' A' ' 113' ' ' LEU . 77.3 m-85 -97.49 173.6 7.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.867 0.365 . . . . 0.0 110.76 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.13 143.36 44.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.522 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.8 ttpm? -84.0 108.64 17.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.816 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 157' ' ' VAL . 28.2 m -91.37 -26.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.318 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.0 m -154.86 140.7 18.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 35.4 p -164.6 111.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.445 ' C ' HG23 ' A' ' 154' ' ' THR . 0.3 OUTLIER -143.07 122.57 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.68 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.731 HG23 ' OG1' ' A' ' 154' ' ' THR . 4.0 m -78.43 144.28 35.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.18 0.514 . . . . 0.0 111.54 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.492 HG21 ' HE2' ' A' ' 155' ' ' TYR . 3.3 t -116.27 105.12 17.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.48 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.2 mt-10 -86.12 98.97 11.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.847 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -81.33 -175.3 5.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.0 p -57.72 -57.66 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.487 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -68.56 120.17 73.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.91 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.5 -25.96 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.964 1.776 . . . . 0.0 112.324 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.47 -18.4 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.431 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.1 mt -87.15 8.86 21.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.599 0.237 . . . . 0.0 111.359 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.491 HG22 ' N ' ' A' ' 153' ' ' HIS . 79.7 m -71.48 169.29 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.491 ' N ' HG22 ' A' ' 152' ' ' THR . 11.0 p80 -174.34 160.79 3.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.731 ' OG1' HG23 ' A' ' 143' ' ' THR . 10.4 m -127.69 133.95 49.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.627 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.492 ' HE2' HG21 ' A' ' 144' ' ' VAL . 67.9 m-85 -94.33 106.45 18.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.627 ' HB2' HG22 ' A' ' 115' ' ' VAL . 13.9 mt-10 -103.3 121.75 43.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.415 . . . . 0.0 111.971 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 139' ' ' VAL . 17.9 t -113.43 111.26 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.094 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.522 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.5 m95 -107.61 148.34 29.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.979 0.418 . . . . 0.0 111.721 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -126.92 117.28 22.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.8 tmtt? -49.77 132.45 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -99.96 171.91 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.626 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.02 148.87 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.518 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -111.81 114.45 27.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.244 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.27 121.26 43.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.66 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.1 p90 -167.58 176.21 6.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.499 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.6 150.33 46.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 111.823 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.98 147.6 37.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.617 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -103.69 -167.91 1.43 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.421 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -52.6 -48.59 66.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.842 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.68 -26.49 60.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.65 20.89 12.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.636 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.656 HD11 ' HA3' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -74.58 149.37 40.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.766 0.317 . . . . 0.0 110.645 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.499 -179.649 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.0 mtmt . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 79.0 mt -80.19 87.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.54 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.8 ttp -100.73 122.45 43.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.412 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.784 HG13 ' HB ' ' A' ' 60' ' ' VAL . 3.1 t -91.12 129.18 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.92 147.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.115 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.79 151.76 52.44 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.932 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.799 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -48.07 -55.91 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.906 0.384 . . . . 0.0 110.385 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.35 68.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.57 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -73.68 -31.37 63.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CG ' HG22 ' A' ' 61' ' ' VAL . 51.8 t80 -75.82 -33.04 60.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.815 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.0 mt-10 -64.21 -67.23 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.575 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -58.73 -30.04 67.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.738 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.766 ' CE2' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -34.31 149.44 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.905 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.55 -32.73 5.93 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.187 2.591 . . . . 0.0 113.932 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.38 152.9 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 9.1 mtp180 -124.72 101.72 32.93 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.2 Cg_endo -86.25 -168.11 5.08 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.965 -1.265 . . . . 0.0 112.213 0.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 49' ' ' PHE . 88.0 mt -95.76 159.8 31.65 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 18.9 Cg_endo -60.26 95.85 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.728 2.285 . . . . 0.0 113.638 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 66.35 18.49 10.89 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.441 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HG3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -109.77 107.57 17.61 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.946 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.4 m -62.13 106.67 0.76 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.982 0.42 . . . . 0.0 110.164 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.524 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -105.54 156.88 17.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.201 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.784 ' HB ' HG13 ' A' ' 40' ' ' VAL . 5.2 t -130.2 144.08 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.84 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.799 HG13 ' HA ' ' A' ' 43' ' ' ARG . 89.6 t -116.09 106.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -89.0 118.14 28.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.015 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.864 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -148.95 169.84 19.67 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.926 0.393 . . . . 0.0 111.352 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -88.24 -9.25 53.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.5 tp60 -78.1 128.76 34.31 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.45 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 7.5 mt-10 -79.76 -16.15 56.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.787 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.29 9.12 25.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.865 ' O ' HG11 ' A' ' 75' ' ' VAL . 3.5 t80 -58.77 140.37 55.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.007 0.432 . . . . 0.0 111.612 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.913 ' HA ' HG21 ' A' ' 75' ' ' VAL . 18.6 mm100 -124.96 178.34 5.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.107 0.956 . . . . 0.0 112.004 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.97 145.33 20.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.784 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.45 95.88 4.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.368 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.93 -39.35 2.96 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.051 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -69.29 172.33 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.688 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 85' ' ' TYR . 9.4 t -97.38 140.21 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.98 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.913 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.9 t -105.55 118.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.391 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.7 HG21 HG22 ' A' ' 82' ' ' VAL . 30.5 m -127.72 165.09 27.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.845 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 5.1 m170 -116.18 -23.19 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 110.813 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -154.19 -167.57 2.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 111.305 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.936 HG13 ' CD2' ' A' ' 106' ' ' PHE . 4.0 t -74.42 -8.83 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.7 -32.9 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.092 0.472 . . . . 0.0 109.922 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.667 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.89 -27.54 57.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.7 HG22 HG21 ' A' ' 76' ' ' VAL . 68.7 t -73.09 -54.05 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.467 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.9 m-85 -55.98 -24.82 40.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.941 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.74 86.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.831 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 74' ' ' VAL . 81.9 t80 -66.69 -57.26 7.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.15 11.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.028 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.91 -38.06 76.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -83.89 -4.78 58.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.563 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -127.26 66.42 68.37 Favored Pre-proline 0 N--CA 1.455 -0.182 0 CA-C-O 121.015 0.436 . . . . 0.0 110.248 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.61 -0.01 5.41 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.231 2.621 . . . . 0.0 113.058 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -27.88 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.707 0.289 . . . . 0.0 111.087 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -105.08 159.23 16.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.658 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 42.1 mt-10 -98.09 159.23 15.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.135 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.623 HD21 HG12 ' A' ' 82' ' ' VAL . 20.1 tp -108.54 116.39 31.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.525 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 39' ' ' MET . 38.5 t -130.43 114.61 29.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.36 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.0 mm -82.51 131.1 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.632 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.86 -45.34 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.636 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.3 -166.3 39.05 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.406 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.42 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -92.74 -160.7 35.9 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 117.821 0.81 . . . . 0.0 112.741 -0.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.98 -48.56 16.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.466 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -60.19 -30.94 69.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.67 -26.61 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.501 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.467 ' HB3' HG12 ' A' ' 129' ' ' ILE . 4.2 m-85 -60.39 -56.38 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.811 ' CA ' HD13 ' A' ' 129' ' ' ILE . 14.9 t -65.93 -10.1 35.79 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.539 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.54 -43.28 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.936 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.1 m-85 -95.4 -3.61 46.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.555 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 16.5 pttp -48.91 -33.07 10.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.783 0.325 . . . . 0.0 111.397 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.05 3.85 50.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.44 ' HB2' HG11 ' A' ' 79' ' ' VAL . 1.4 m-20 -127.53 -27.9 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 0.0 111.517 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.66 HG11 HD23 ' A' ' 113' ' ' LEU . 92.7 t -52.04 123.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.196 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.65 8.01 43.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.426 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 76.3 m -167.56 142.97 3.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.815 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.66 HD23 HG11 ' A' ' 110' ' ' VAL . 16.2 mt -123.49 145.35 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.321 0.581 . . . . 0.0 111.723 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 mt -135.64 120.0 17.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.46 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.66 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.9 m -136.35 145.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.043 0.449 . . . . 0.0 111.864 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -111.81 108.5 17.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.038 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.9 ttm180 -80.57 99.24 8.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.98 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.59 125.93 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.21 74.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.71 163.75 6.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.497 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 59.5 p -105.87 159.47 15.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.802 0.334 . . . . 0.0 111.034 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -147.4 145.43 29.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.779 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -100.72 147.11 26.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.764 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . -179.43 174.19 46.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.733 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.9 42.83 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.204 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 m -162.38 124.81 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -112.67 172.74 6.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.964 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.1 tpt -72.62 157.59 37.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.811 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -79.2 163.76 58.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.289 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.58 93.76 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.749 2.3 . . . . 0.0 111.961 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -83.49 142.67 30.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.809 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.87 70.48 8.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -56.57 -21.75 28.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -73.31 -33.27 65.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.509 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 -10.49 58.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.102 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 45.1 m-85 -108.73 169.43 8.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.425 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -132.44 141.2 48.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.585 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 3.3 ttpp -85.11 128.99 34.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 157' ' ' VAL . 5.7 m -115.92 -17.86 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.1 m -164.51 143.32 7.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.493 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.72 111.76 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.161 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.552 ' C ' HG23 ' A' ' 154' ' ' THR . 10.2 ttt180 -139.73 118.34 12.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.747 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.4 m -81.48 145.06 30.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.392 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' A' ' 155' ' ' TYR . 5.4 t -121.12 103.36 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.5 mt-10 -84.34 102.22 12.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.33 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.44 -176.46 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.3 p -53.86 -55.84 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.504 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.46 121.77 85.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.946 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.06 -27.02 83.86 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.134 1.889 . . . . 0.0 112.413 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.65 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.669 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.6 mt -86.96 9.26 20.0 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.592 0.234 . . . . 0.0 111.551 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 145' ' ' GLU . 95.9 m -70.72 165.92 21.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 11.8 p-80 -170.61 156.51 5.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.133 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.747 ' OG1' HG23 ' A' ' 143' ' ' THR . 16.3 m -120.05 153.58 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.589 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.452 ' HE1' HG21 ' A' ' 144' ' ' VAL . 96.1 m-85 -116.3 105.04 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.8 mt-10 -101.26 153.96 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.903 ' O ' HG22 ' A' ' 139' ' ' VAL . 26.7 t -142.31 107.09 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 28.8 m95 -107.54 145.5 33.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.977 0.417 . . . . 0.0 111.897 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -125.83 114.75 18.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.504 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 1.9 ttmt -46.44 134.0 9.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.08 0.467 . . . . 0.0 112.06 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.425 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -124.19 -166.08 1.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.399 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.076 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.79 154.41 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.29 0.567 . . . . 0.0 112.446 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -119.07 112.59 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.603 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.4 tp -113.52 121.78 45.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.81 ' CH2' HG12 ' A' ' 115' ' ' VAL . 2.8 p90 -167.31 164.5 15.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.927 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.76 135.34 54.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.699 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 11.7 pt20 -128.06 155.48 44.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -96.62 -172.49 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -38.56 59.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.023 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -32.65 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.84 37.01 2.64 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 9.3 mt -98.35 151.32 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.739 0.304 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.285 -179.741 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 58' ' ' THR . 7.0 mtmt . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.66 87.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.425 ' HE1' ' OD1' ' A' ' 59' ' ' ASN . 2.2 ttp -102.04 125.76 48.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 112.155 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 41' ' ' VAL . 20.8 t -82.19 158.81 3.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.646 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.5 m -165.1 141.06 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.455 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.01 154.13 53.03 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.477 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.16 -51.92 60.47 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.336 0.568 . . . . 0.0 110.687 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.424 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.9 tpt180 -57.64 -32.78 67.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.013 0.435 . . . . 0.0 110.112 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.409 HG22 ' CE2' ' A' ' 49' ' ' PHE . 8.7 m -70.74 -46.79 62.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.986 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.5 t80 -55.16 -40.7 70.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.112 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -66.15 0.55 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.941 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -52.26 -40.03 61.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.552 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.409 ' CE2' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER -33.52 127.95 0.41 Allowed Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.674 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -43.88 -26.52 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.144 2.562 . . . . 0.0 113.771 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.745 ' HB3' HD23 ' A' ' 54' ' ' LEU . 5.0 ttpt -151.59 138.02 18.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.59 107.95 6.03 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 71.6 Cg_endo -77.48 166.51 81.57 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.593 -1.42 . . . . 0.0 112.244 -0.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 51' ' ' LYS . 75.8 mt -76.23 158.95 81.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.47 112.04 3.46 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.492 2.128 . . . . 0.0 112.802 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 69.15 8.48 6.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.022 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -114.06 110.71 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.427 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 25.0 m -68.73 107.19 2.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.551 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -101.11 154.58 18.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.983 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 HG22 ' A' ' 76' ' ' VAL . 8.8 t -125.72 141.37 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.633 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 68' ' ' TYR . 98.8 t -110.72 124.67 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 111.72 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.913 HD13 HD12 ' A' ' 102' ' ' ILE . 2.1 mt -105.33 118.69 37.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.102 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.997 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.3 t -155.51 158.67 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.284 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -75.15 -4.32 38.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.62 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -85.83 126.03 33.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.398 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 6.2 mt-10 -78.31 -29.57 47.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.547 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -92.31 6.51 46.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.418 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.997 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.1 t80 -59.81 139.31 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.935 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -137.16 169.89 17.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.758 1.266 . . . . 0.0 113.752 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.75 134.09 11.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.267 -2.242 . . . . 0.0 109.566 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -78.97 106.51 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.108 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 -56.51 0.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -71.1 169.31 15.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 12.8 t -94.11 140.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.335 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.935 HG21 ' HA ' ' A' ' 69' ' ' GLN . 17.2 t -112.01 123.16 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 111.419 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 27.1 m -130.32 175.88 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.458 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.5 m80 -123.16 -25.32 4.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.012 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.47 -171.33 3.9 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.969 HG13 ' CD2' ' A' ' 106' ' ' PHE . 18.7 t -71.38 -10.81 14.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.732 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.86 -32.72 18.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 110.15 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.09 -27.62 59.96 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.903 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.055 HG12 HD11 ' A' ' 94' ' ' LEU . 57.4 t -74.5 -52.48 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 9.6 m-85 -54.74 -27.93 44.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.933 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -64.13 -45.82 86.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.14 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.48 ' CD1' HG11 ' A' ' 74' ' ' VAL . 56.1 t80 -62.64 -54.42 39.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -53.05 -23.28 7.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 83' ' ' PHE . 12.3 mttt -68.61 -44.11 74.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.54 -2.32 41.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.7 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -129.01 61.63 57.92 Favored Pre-proline 0 N--CA 1.456 -0.136 0 CA-C-O 120.951 0.405 . . . . 0.0 110.491 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.01 -0.75 8.97 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.011 2.474 . . . . 0.0 112.954 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.22 -38.69 26.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.92 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -107.73 168.83 8.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.23 164.67 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.321 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.055 HD11 HG12 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -110.78 122.91 49.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.796 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.47 118.82 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.27 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 40' ' ' VAL . 8.0 mm -83.52 130.73 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.907 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.412 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -98.38 -48.73 4.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.82 -168.01 39.21 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.572 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.427 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -93.84 -160.86 35.1 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 117.717 0.758 . . . . 0.0 112.622 -0.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.48 -56.38 7.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.838 0.351 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -52.53 -29.81 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.913 HD12 HD13 ' A' ' 62' ' ' LEU . 46.5 mm -83.43 -28.52 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.982 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -59.62 -55.44 34.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.699 ' HA ' HD13 ' A' ' 129' ' ' ILE . 12.4 t -67.76 -10.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.961 -0.462 . . . . 0.0 112.065 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.774 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.51 -39.07 58.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.949 0.404 . . . . 0.0 110.707 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.969 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.3 m-85 -100.0 -5.34 28.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 11.9 pttt -51.23 -31.33 20.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 111.617 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.64 2.77 52.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 41.4 m-20 -126.83 -24.86 3.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.587 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 106' ' ' PHE . 77.8 t -49.07 125.75 3.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.937 0.399 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -102.96 4.38 37.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.92 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 92.1 m -166.76 139.59 3.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.638 HD23 HG11 ' A' ' 110' ' ' VAL . 16.2 mt -118.25 144.98 45.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.213 0.53 . . . . 0.0 111.933 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -135.34 113.82 11.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.598 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.81 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -133.98 143.88 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.782 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.32 107.49 15.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -92.21 103.9 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.3 mp -86.33 129.07 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.91 -49.74 75.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.161 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.41 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -59.43 177.65 2.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 p -111.85 156.87 21.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 0.0 110.966 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -148.9 154.25 39.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.77 134.41 35.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 138.21 6.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.457 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.26 6.88 19.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.622 0.249 . . . . 0.0 111.339 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.4 m -128.0 124.18 36.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -94.88 136.46 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.448 ' HE3' ' CZ2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -61.26 174.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.84 163.26 33.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.159 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 65.2 Cg_endo -74.85 101.04 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.41 2.073 . . . . 0.0 112.198 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.72 147.22 25.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.57 84.21 2.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.406 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 88.7 m95 -64.86 -16.35 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.083 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.85 -32.65 63.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.905 0.384 . . . . 0.0 110.73 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -79.56 -28.01 41.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.927 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 72.3 m-85 -97.6 169.71 9.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.653 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -134.66 143.74 47.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.521 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.3 ttpm? -81.13 119.97 24.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 157' ' ' VAL . 25.6 m -103.12 -21.36 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.235 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.0 m -162.56 140.33 8.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.473 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 18.2 p -165.19 113.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.741 ' C ' HG23 ' A' ' 154' ' ' THR . 5.8 ttt180 -147.96 130.95 16.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.002 0.429 . . . . 0.0 111.236 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.704 HG23 ' OG1' ' A' ' 154' ' ' THR . 5.1 m -84.8 146.12 27.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.073 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 153' ' ' HIS . 5.0 t -117.16 102.69 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.899 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.562 ' HA ' HG23 ' A' ' 152' ' ' THR . 35.4 mt-10 -81.04 97.82 7.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.096 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.96 -178.19 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.299 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -60.97 2.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 110.574 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.494 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.37 117.06 40.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.666 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 11.6 Cg_endo -55.75 -26.73 58.12 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.979 1.786 . . . . 0.0 112.402 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.41 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -91.53 -17.16 26.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 12.7 mt -88.34 11.25 17.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.622 0.248 . . . . 0.0 111.387 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.562 HG23 ' HA ' ' A' ' 145' ' ' GLU . 87.7 m -71.59 168.43 17.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.486 ' N ' HG22 ' A' ' 152' ' ' THR . 0.4 OUTLIER -171.45 157.65 4.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.544 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 142' ' ' ARG . 17.6 m -126.71 147.59 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.424 ' HE2' HG21 ' A' ' 144' ' ' VAL . 84.8 m-85 -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.441 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.583 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.4 mt-10 -104.37 124.57 49.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.808 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.684 ' O ' HG22 ' A' ' 139' ' ' VAL . 12.3 t -118.42 115.72 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.272 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.521 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 18.5 m95 -112.61 151.21 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.508 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.402 HE21 HG11 ' A' ' 139' ' ' VAL . 8.3 mt-30 -125.95 110.95 14.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.863 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 4.5 tttt -49.09 138.85 11.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.653 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 39.5 mtmt -115.59 -175.11 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.409 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.103 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.77 HG23 HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.25 147.12 38.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.708 ' HB2' HD23 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -110.28 115.59 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.574 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tp -116.06 123.93 49.17 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.664 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.8 p90 -167.99 162.77 13.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.668 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -114.77 131.57 56.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.114 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.44 154.33 37.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.717 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 2.2 p-10 -102.97 -176.8 3.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -47.92 -42.15 26.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.34 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 -25.99 54.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.455 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.63 25.47 9.22 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.59 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -95.65 162.48 13.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.665 0.269 . . . . 0.0 110.736 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 pt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.343 -179.767 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 mttt . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.463 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 60.4 mt -84.74 88.41 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.558 ' HE3' HG11 ' A' ' 41' ' ' VAL . 18.2 ttp -95.31 118.24 31.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.223 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.605 HG21 HG11 ' A' ' 82' ' ' VAL . 3.5 t -88.11 126.61 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.558 HG11 ' HE3' ' A' ' 39' ' ' MET . 15.9 m -133.01 148.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.323 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.59 157.6 52.74 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.61 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.639 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -50.94 -53.13 35.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.097 0.449 . . . . 0.0 110.606 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.477 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 14.9 tpt180 -59.95 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.592 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -64.6 -38.33 90.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.508 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.53 ' HD1' HG21 ' A' ' 41' ' ' VAL . 2.0 t80 -60.56 -39.82 89.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.634 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -66.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.2 t -54.24 -34.92 61.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.576 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.807 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -35.12 124.54 0.58 Allowed Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.839 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -43.43 -29.67 2.13 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.154 2.57 . . . . 0.0 113.652 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.589 ' HB3' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -142.11 132.81 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.171 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -141.21 107.96 6.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.804 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -90.14 176.8 18.7 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.162 0.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.863 HD13 ' HD2' ' A' ' 57' ' ' ARG . 55.0 mt -87.38 140.03 32.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.52 -84.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.962 2.442 . . . . 0.0 113.917 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -85.19 11.66 9.46 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.863 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -112.27 113.42 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.959 0.409 . . . . 0.0 111.412 -178.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 81.4 m -70.15 114.05 7.92 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.512 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.765 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -104.69 154.68 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.72 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 74' ' ' VAL . 10.8 t -135.8 132.35 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.788 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 43' ' ' ARG . 58.1 t -105.03 125.32 60.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.827 0.346 . . . . 0.0 111.648 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.27 115.26 29.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.884 HG21 ' CD2' ' A' ' 68' ' ' TYR . 3.6 t -149.02 166.37 28.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 111.194 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -82.69 -10.19 59.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.351 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.8 tp60 -79.65 132.06 36.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.307 . . . . 0.0 110.484 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 2.4 mt-10 -82.95 -31.07 27.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.809 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.91 6.25 45.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.263 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.884 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.0 t80 -60.43 136.76 58.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 111.67 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.852 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -129.76 171.88 12.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.408 1.099 . . . . 0.0 112.78 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.6 139.99 16.75 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.108 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 3.4 mt-30 -71.73 100.67 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.3 -36.96 3.33 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.694 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.91 170.17 14.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.483 HG21 ' CE1' ' A' ' 85' ' ' TYR . 25.2 t -98.82 140.24 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.466 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.852 HG21 ' HA ' ' A' ' 69' ' ' GLN . 24.4 t -107.15 106.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.739 HG21 HG22 ' A' ' 82' ' ' VAL . 29.1 m -117.73 167.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 6.6 m170 -119.61 -20.66 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -155.73 -175.2 5.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 111.77 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.963 HG13 ' CD2' ' A' ' 106' ' ' PHE . 7.5 t -68.33 -9.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.004 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.17 -34.1 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.3 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.686 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.1 -29.38 60.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.718 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 76' ' ' VAL . 95.8 t -73.02 -55.84 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.519 ' CE2' HG12 ' A' ' 79' ' ' VAL . 8.1 m-85 -53.43 -26.12 18.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.987 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.76 87.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.483 ' CE1' HG21 ' A' ' 74' ' ' VAL . 59.7 t80 -67.67 -58.21 5.06 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.62 -23.02 15.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.211 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.95 -36.3 72.54 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.37 -7.18 59.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.663 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -124.96 66.63 50.71 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.031 0.443 . . . . 0.0 110.578 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.21 -0.41 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.234 2.623 . . . . 0.0 113.04 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.91 -31.74 15.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 160.1 14.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 111.411 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -98.59 166.22 11.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.082 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.77 HD23 HG23 ' A' ' 1' ' ' THR . 7.4 tp -121.88 117.91 27.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.44 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.76 112.06 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.314 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.493 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 11.9 mm -77.76 118.99 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.43 -40.61 11.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.083 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.8 -166.36 39.29 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.501 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.455 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.4 -160.97 36.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 117.708 0.754 . . . . 0.0 112.524 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.27 -49.38 53.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.92 -30.37 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.304 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.528 HD12 HD22 ' A' ' 62' ' ' LEU . 42.2 mm -81.67 -26.75 9.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 6.0 m-85 -61.35 -58.61 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.731 ' HA ' HD13 ' A' ' 129' ' ' ILE . 4.6 t -67.14 -9.99 45.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.697 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.07 -38.84 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.089 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.963 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.1 m-85 -100.21 -3.85 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.404 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.466 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 4.2 pttp -47.71 -33.56 7.12 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 4.35 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.678 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -125.0 -28.82 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 106' ' ' PHE . 92.1 t -45.16 131.13 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.273 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.7 t70 -104.3 1.83 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 40.3 m -167.5 143.34 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.365 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.763 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 33.7 mt -119.93 145.01 47.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.443 0.639 . . . . 0.0 111.925 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -135.47 115.05 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.333 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' CH2' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -135.16 145.36 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.68 105.4 12.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.626 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -75.01 100.14 4.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.14 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.668 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.2 mt -84.32 120.76 26.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.89 -52.81 47.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.023 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.24 162.61 36.05 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.009 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 3.6 t -102.72 156.89 17.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.9 m-85 -136.03 138.65 42.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -112.29 144.13 42.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.81 -125.39 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.318 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.13 31.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 2.9 m -156.78 123.01 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.727 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HG2' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -99.2 167.5 10.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.418 ' HE2' HD12 ' A' ' 131' ' ' LEU . 17.3 tpt -79.79 155.89 27.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.736 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.731 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.5 pp -81.28 162.72 57.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.81 103.59 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.052 2.502 . . . . 0.0 112.744 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.418 HD12 ' HE2' ' A' ' 128' ' ' MET . 2.0 mt -91.68 145.07 24.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.94 78.76 2.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.971 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.763 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 80.2 m95 -60.44 -19.94 58.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.8 -29.47 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.554 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.6 -28.17 45.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.832 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 92.5 m-85 -97.58 177.13 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.693 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 1.9 m -134.89 141.03 46.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 9.0 ttpt -84.0 117.84 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.494 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.2 m -105.68 -16.1 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.976 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 m -164.53 140.77 6.07 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.6 p -163.46 113.54 1.33 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.409 ' C ' HG23 ' A' ' 154' ' ' THR . 19.1 ttt-85 -148.17 120.27 8.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.787 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.5 m -73.65 144.71 45.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.309 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.468 HG21 ' HE2' ' A' ' 155' ' ' TYR . 3.8 t -122.34 108.93 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.378 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.566 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.7 OUTLIER -88.23 101.0 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.45 -179.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -80.8 -176.14 5.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.431 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.8 t30 -77.08 130.89 74.0 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.138 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.73 -30.3 78.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.218 1.945 . . . . 0.0 112.656 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -89.89 -23.94 21.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.775 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.431 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 18.8 mt -80.06 4.06 18.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.491 0.186 . . . . 0.0 111.452 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 145' ' ' GLU . 98.9 m -69.19 163.41 24.97 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.3 p80 -176.35 163.59 2.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.182 0.515 . . . . 0.0 112.265 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.787 ' OG1' HG23 ' A' ' 143' ' ' THR . 87.8 m -120.8 147.17 45.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.024 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.468 ' HE2' HG21 ' A' ' 144' ' ' VAL . 96.9 m-85 -108.81 105.4 14.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.732 0.301 . . . . 0.0 110.905 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.433 ' HB2' HG22 ' A' ' 115' ' ' VAL . 30.4 mt-10 -108.78 125.7 52.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.809 ' O ' HG22 ' A' ' 139' ' ' VAL . 15.5 t -116.5 114.79 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.597 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.5 m95 -110.5 150.57 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.646 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -126.85 116.21 20.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.881 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 8.6 ttpt -51.8 130.1 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.384 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HG3' ' OG1' ' A' ' 137' ' ' THR . 3.8 mmpt? -96.08 172.9 7.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.097 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.44 HG23 HD23 ' A' ' 94' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -104.99 154.65 19.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 112.308 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.506 ' CD1' ' HB ' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -123.9 114.01 19.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.2 tp -112.86 121.57 45.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.646 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -165.18 163.89 20.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.525 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 118' ' ' LEU . . . -113.86 135.97 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.966 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.29 149.71 48.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.377 . . . . 0.0 110.969 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.5 p-10 -110.78 -168.24 1.28 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.021 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.428 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.78 -35.41 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.088 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 -28.95 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.012 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.12 12.81 22.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.879 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 126' ' ' THR . 2.8 mm? -59.93 144.96 47.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.768 0.284 . . . . 0.0 110.586 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 51.6 mt -74.64 91.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.765 0.317 . . . . 0.0 111.522 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.1 ttp -101.92 120.45 40.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 HG11 ' A' ' 82' ' ' VAL . 15.3 t -80.3 159.19 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.869 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' HG12 ' A' ' 40' ' ' VAL . 28.7 m -161.72 157.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.34 155.51 43.89 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.906 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.8 -52.68 64.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.982 0.391 . . . . 0.0 110.389 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -59.06 -32.64 69.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -71.59 -38.14 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.539 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.448 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 6.7 t80 -66.5 -25.94 66.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -72.65 -66.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 111.109 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.4 t -57.08 -31.44 65.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.43 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -26.24 135.16 0.1 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.88 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.64 -33.91 88.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.701 2.267 . . . . 0.0 112.929 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -160.08 122.41 3.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.25 135.62 15.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.252 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.77 160.41 71.42 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.14 -1.608 . . . . 0.0 111.838 -0.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.803 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 51.1 mt -75.15 156.36 85.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.05 -82.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.953 2.435 . . . . 0.0 113.653 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' HB2' ' NH1' ' A' ' 57' ' ' ARG . 5.3 mt-10 -93.18 27.6 2.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.411 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.803 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -125.2 111.68 15.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.403 . . . . 0.0 111.637 -178.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 53.4 m -72.35 119.53 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -102.73 151.44 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 112.083 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.623 HG12 HG22 ' A' ' 76' ' ' VAL . 17.1 t -132.07 142.76 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.392 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 43' ' ' ARG . 50.0 t -115.45 121.03 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.727 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.913 HD12 HG23 ' A' ' 76' ' ' VAL . 1.1 tp -104.78 117.14 33.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.722 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.25 167.44 26.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.822 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -89.13 -10.05 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tt0 -73.79 137.06 43.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -88.46 5.96 39.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.118 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.55 5.85 4.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.607 0.241 . . . . 0.0 111.618 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.901 ' O ' HG11 ' A' ' 75' ' ' VAL . 3.5 t80 -60.17 141.71 55.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.333 0.587 . . . . 0.0 112.014 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.85 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -131.93 173.8 10.82 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.249 1.024 . . . . 0.0 112.641 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.3 143.4 20.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.699 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.96 98.85 2.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.636 0.255 . . . . 0.0 110.799 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.57 -36.13 3.14 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.662 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -69.75 170.49 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 111.892 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.33 139.75 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.172 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.901 HG11 ' O ' ' A' ' 68' ' ' TYR . 20.1 t -104.59 107.85 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 111.835 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.913 HG23 HD12 ' A' ' 62' ' ' LEU . 30.3 m -117.96 168.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.754 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.3 m170 -119.01 -22.37 7.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.552 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.711 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -155.44 -169.48 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 111.523 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.977 HG13 ' CD2' ' A' ' 106' ' ' PHE . 4.8 t -73.44 -10.36 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.62 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.1 -34.82 19.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.231 0.539 . . . . 0.0 109.836 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.46 -30.38 61.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.762 HG22 HG21 ' A' ' 76' ' ' VAL . 17.5 t -72.16 -53.06 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.006 0.431 . . . . 0.0 109.876 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.67 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 4.3 m-85 -54.54 -28.34 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.823 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.6 96.43 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.72 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.57 -55.93 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.9 13.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.333 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 14.4 mmmt -69.35 -39.71 77.96 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -81.3 -4.61 56.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -126.86 65.58 63.21 Favored Pre-proline 0 N--CA 1.456 -0.151 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.7 -0.5 6.95 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.19 2.593 . . . . 0.0 112.775 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -91.71 -32.25 15.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -104.18 161.53 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.127 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -99.03 162.76 12.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.454 HD11 ' CG1' ' A' ' 82' ' ' VAL . 46.3 tp -109.29 115.84 30.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 2' ' ' ALA . 44.7 t -131.05 115.5 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 40' ' ' VAL . 7.0 mm -82.36 141.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.403 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.08 -44.66 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.433 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.01 -168.63 40.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.691 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.433 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.76 36.67 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 121.94 -0.741 . . . . 0.0 112.479 -0.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.47 -52.95 15.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.288 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -56.07 -29.27 60.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.535 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 62' ' ' LEU . 40.2 mm -81.47 -28.51 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.0 m-85 -60.2 -58.36 8.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.873 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.63 ' HA ' HD13 ' A' ' 129' ' ' ILE . 11.7 t -65.63 -10.12 33.08 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 121.73 -0.606 . . . . 0.0 112.228 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.698 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.58 -43.77 54.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.842 0.354 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.977 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.9 m-85 -96.19 -1.37 48.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.559 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 6.9 pttt -50.91 -34.59 29.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.915 0.388 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.66 2.66 40.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.69 -27.62 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.619 0.247 . . . . 0.0 111.572 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 106' ' ' PHE . 68.0 t -45.46 123.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.912 0.387 . . . . 0.0 111.284 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 13.8 t70 -107.02 7.54 29.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.24 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.5 m -168.39 140.0 2.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.365 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.821 HD23 HG11 ' A' ' 110' ' ' VAL . 7.1 mt -125.51 147.34 49.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.323 0.583 . . . . 0.0 112.079 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt -135.4 117.03 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.317 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -131.76 141.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.94 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.25 109.6 18.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.198 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 14.0 mtt180 -84.07 99.59 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.385 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.449 ' CD1' ' HB1' ' A' ' 6' ' ' ALA . 1.3 mp -82.63 120.62 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.305 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.504 ' HB2' ' HB ' ' A' ' 152' ' ' THR . . . -48.99 -47.55 44.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.83 152.1 49.97 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.378 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 173.04 8.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.817 0.341 . . . . 0.0 111.093 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 3.2 m-85 -145.52 178.37 8.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.777 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.85 170.05 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 148.96 176.88 22.65 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.771 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.12 17.56 9.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.163 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.531 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.8 m -133.65 131.74 39.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.637 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -113.14 170.41 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.413 ' HE3' ' HB3' ' A' ' 103' ' ' PHE . 16.4 tpt -74.13 145.83 43.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.678 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 2.0 pp -66.42 166.66 16.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.187 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.678 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.1 Cg_endo -75.1 106.71 2.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.243 1.962 . . . . 0.0 112.319 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.92 147.51 23.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.86 69.51 5.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.448 ' HH2' HG11 ' A' ' 115' ' ' VAL . 88.7 m95 -53.39 -24.92 13.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.36 -29.8 64.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.328 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 7.5 t0 -79.6 -18.57 51.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.033 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.465 ' CG ' HD11 ' A' ' 113' ' ' LEU . 85.0 m-85 -106.83 168.49 9.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.438 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -131.22 141.61 50.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.599 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.0 ttpt -81.88 109.43 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.547 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 157' ' ' VAL . 35.4 m -92.27 -26.42 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.384 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.1 m -154.93 140.3 17.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 51.9 p -169.58 115.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.969 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.409 ' HB2' ' NH1' ' A' ' 142' ' ' ARG . 8.9 ttm105 -147.91 119.02 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.076 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.783 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.5 m -71.08 145.91 49.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.032 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 t -119.67 104.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.657 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.668 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.6 mt-10 -85.07 100.2 11.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.22 173.78 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.1 p -53.54 -44.25 69.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.631 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 9.9 t30 -82.68 132.17 52.61 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.34 -33.29 89.43 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.395 2.063 . . . . 0.0 112.613 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.55 -28.52 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.0 mt -76.74 5.05 8.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.668 HG23 ' HA ' ' A' ' 145' ' ' GLU . 31.9 m -71.56 158.4 36.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -174.12 160.59 3.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.951 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.783 ' OG1' HG23 ' A' ' 143' ' ' THR . 22.2 m -122.58 138.6 54.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.946 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' SER . 88.6 m-85 -102.6 106.35 17.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HB2' HG22 ' A' ' 115' ' ' VAL . 32.7 mt-10 -108.16 125.72 51.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 139' ' ' VAL . 25.1 t -116.6 112.35 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.75 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.511 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 17.4 m95 -107.22 151.16 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 112.003 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -130.35 127.18 38.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.831 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 10.9 tttp -54.13 130.54 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 111.359 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -116.79 -168.56 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.836 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.15 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.702 HG23 HD23 ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.32 146.67 40.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.503 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.6 m-30 -110.2 111.07 22.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.551 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.767 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -108.63 118.99 38.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.775 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.6 p90 -167.96 172.99 8.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -132.32 135.67 46.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -117.58 161.51 19.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.047 0.451 . . . . 0.0 111.444 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.6 -167.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -39.5 71.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.759 0.314 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.56 -27.49 37.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.25 22.98 10.85 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.683 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.1 tp -70.33 152.91 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.691 HG21 ' HG3' ' A' ' 128' ' ' MET . 1.5 pp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.679 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 58' ' ' THR . 17.7 mttm . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 93' ' ' GLU . 75.4 mt -88.93 88.55 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.302 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.2 OUTLIER -102.06 126.29 48.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.368 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.884 HG21 HG11 ' A' ' 82' ' ' VAL . 2.0 t -90.79 129.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.531 HG11 ' CE2' ' A' ' 49' ' ' PHE . 21.7 m -133.54 138.03 51.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.242 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.43 153.74 39.31 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.005 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.696 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -50.74 -53.53 30.84 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.936 0.398 . . . . 0.0 110.075 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -54.5 -42.41 70.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -65.06 -40.76 95.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 28.8 t80 -60.48 -29.57 69.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.913 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.51 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.6 t -58.49 -31.08 67.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.305 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.74 ' HE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.8 135.79 0.18 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.996 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 75.9 Cg_exo -48.83 -35.11 30.06 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.276 . . . . 0.0 112.85 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.07 142.78 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.35 112.04 6.55 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -81.72 178.81 29.52 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.984 -0.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.74 HD11 ' HE1' ' A' ' 49' ' ' PHE . 64.1 mt -84.21 140.69 39.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.603 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.62 110.98 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.495 2.13 . . . . 0.0 112.835 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 74.37 -0.17 3.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.35 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.683 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -109.57 116.23 31.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.66 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 33.3 m -70.08 111.5 5.79 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.456 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.648 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -107.14 154.86 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.947 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.687 HG12 HG22 ' A' ' 76' ' ' VAL . 18.8 t -128.02 143.42 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.389 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' A' ' 43' ' ' ARG . 90.0 t -111.69 126.98 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.889 0.376 . . . . 0.0 111.069 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -105.64 123.39 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.361 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.873 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -157.2 158.33 36.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -79.67 -6.57 57.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.3 tt0 -78.78 131.29 36.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.817 0.341 . . . . 0.0 110.974 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 4.21 29.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.91 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.4 7.29 4.92 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.424 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.873 ' CG ' HG21 ' A' ' 63' ' ' THR . 6.0 t80 -59.23 144.98 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.051 0.453 . . . . 0.0 111.2 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.971 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -133.94 174.27 10.65 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.368 1.08 . . . . 0.0 113.014 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.91 144.47 21.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.709 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -81.0 96.66 7.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.89 0.376 . . . . 0.0 110.643 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -44.7 2.06 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.78 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.06 168.04 17.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 111.74 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 28.3 t -96.26 141.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.971 HG21 ' HA ' ' A' ' 69' ' ' GLN . 28.4 t -108.1 120.83 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.333 0.587 . . . . 0.0 111.912 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.919 HG21 HG22 ' A' ' 82' ' ' VAL . 27.7 m -127.59 169.55 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.633 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' THR . 7.9 m170 -117.52 -25.58 6.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.835 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.5 -174.62 5.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.015 0.436 . . . . 0.0 111.16 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.2 t -67.92 -11.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.533 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -34.21 19.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.441 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.86 -26.15 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.023 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.919 HG22 HG21 ' A' ' 76' ' ' VAL . 43.1 t -75.98 -54.71 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 14.5 m-85 -53.34 -27.89 25.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.885 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.53 87.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.969 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.43 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 86.1 t80 -65.3 -56.32 13.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.892 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -57.95 -24.86 59.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.034 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -68.8 -43.5 75.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -79.1 -10.7 59.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.286 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -122.88 65.6 26.92 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.15 -0.4 4.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.159 2.572 . . . . 0.0 113.166 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.92 -37.85 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.1 164.1 11.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.433 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 5.7 mm-40 -99.13 171.26 8.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 86' ' ' ALA . 8.1 tp -115.91 116.67 28.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' MET . 49.1 t -128.58 114.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.527 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 7.6 mm -83.34 140.2 16.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.077 0.465 . . . . 0.0 111.234 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.84 -36.34 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.57 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -170.93 43.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.555 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.45 -161.23 32.81 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 117.376 0.588 . . . . 0.0 112.512 -0.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.04 -53.53 54.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -55.34 -27.3 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.602 ' CD1' HD22 ' A' ' 62' ' ' LEU . 32.5 mm -83.16 -27.47 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.854 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.466 ' HB3' HG12 ' A' ' 129' ' ' ILE . 1.9 m-85 -60.61 -56.52 20.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.38 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.816 ' CA ' HD13 ' A' ' 129' ' ' ILE . 1.8 t -67.71 -10.07 49.25 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.24 -47.21 20.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.343 . . . . 0.0 110.732 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.9 ' CD2' HG13 ' A' ' 79' ' ' VAL . 9.3 m-85 -86.18 -9.38 56.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.321 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 3.2 pttp -52.42 -29.76 25.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -75.88 -7.43 54.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 22.5 m-20 -129.58 -19.89 3.32 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 113' ' ' LEU . 53.5 t -43.81 127.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.112 0.482 . . . . 0.0 110.935 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 10.5 t0 -108.55 6.58 26.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.48 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.756 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 18.7 m -169.68 137.92 1.8 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.72 0.295 . . . . 0.0 110.6 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.604 HD23 HG11 ' A' ' 110' ' ' VAL . 6.1 mt -122.7 145.67 48.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.168 0.509 . . . . 0.0 111.605 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mt -134.84 117.41 15.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.578 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.775 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -133.96 144.0 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.009 0.433 . . . . 0.0 111.837 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -116.36 104.71 11.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.4 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 2.9 ttt-85 -75.8 100.75 4.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.452 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.706 HD22 ' HZ ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -92.4 108.29 19.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.087 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.45 -39.73 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.408 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.6 -167.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.701 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.81 146.8 41.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 111.007 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.706 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 1.3 m-85 -134.47 162.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -99.73 134.05 43.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.002 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.604 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.01 -174.36 33.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.86 21.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.251 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -139.11 127.69 23.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.691 ' HG3' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -74.02 -173.6 1.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.201 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.816 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.3 pp -112.11 160.15 31.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.88 102.48 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.831 2.354 . . . . 0.0 112.746 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.34 146.44 27.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.29 76.35 5.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.44 ' HH2' HG11 ' A' ' 115' ' ' VAL . 84.4 m95 -60.04 -19.12 51.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.365 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.13 -33.22 65.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -81.77 -17.19 48.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.521 ' CD2' HD11 ' A' ' 113' ' ' LEU . 79.6 m-85 -106.68 167.75 9.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.906 0.384 . . . . 0.0 111.163 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.542 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -127.68 141.02 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.516 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 12.1 ttpp -81.81 115.99 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.1 m -101.04 -18.76 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.783 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.4 m -164.25 140.54 6.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.535 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.657 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 93.0 p -164.95 113.33 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.512 ' C ' HG23 ' A' ' 154' ' ' THR . 0.2 OUTLIER -146.48 126.02 13.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.681 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.9 m -80.5 145.04 32.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.294 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 152' ' ' THR . 3.5 t -122.79 109.05 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.792 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.91 104.5 16.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -177.2 5.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.3 p -58.02 -42.34 85.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.481 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 3.4 t30 -80.99 134.5 52.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.342 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.96 -32.31 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.202 1.934 . . . . 0.0 112.429 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.11 -25.61 22.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.5 mt -76.18 5.11 7.33 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 153' ' ' HIS . 72.0 m -72.89 162.27 29.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -175.97 162.67 2.61 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 0.0 112.033 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.681 ' OG1' HG23 ' A' ' 143' ' ' THR . 38.5 m -122.5 129.82 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.33 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -93.66 107.89 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.496 ' HB2' HG22 ' A' ' 115' ' ' VAL . 4.6 mt-10 -101.28 152.29 20.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.818 ' O ' HG22 ' A' ' 139' ' ' VAL . 19.0 t -142.41 110.22 2.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.759 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.468 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 29.8 m95 -109.8 145.74 36.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.397 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.15 129.51 39.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.373 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -49.08 122.19 5.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 111.447 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.542 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.9 OUTLIER -97.8 176.14 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.063 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 87.6 m . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.758 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -107.95 154.79 21.11 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.8 m-30 -120.68 107.92 13.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.831 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.791 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.44 115.38 30.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.475 0.655 . . . . 0.0 112.231 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.667 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.7 p90 -158.37 166.19 32.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.856 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.36 133.28 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.1 pt20 -131.63 157.03 44.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.435 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -108.18 -162.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.361 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.28 -49.96 74.41 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -33.37 72.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.23 33.15 3.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.776 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.4 mm? -73.84 127.14 32.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.681 HG21 ' HG3' ' A' ' 128' ' ' MET . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.0 mtmm . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 80.7 mt -84.52 87.46 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.759 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.439 ' HE1' ' OD1' ' A' ' 59' ' ' ASN . 0.4 OUTLIER -100.31 122.63 43.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.922 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.642 HG21 HG11 ' A' ' 82' ' ' VAL . 21.6 t -82.84 158.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.612 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 40' ' ' VAL . 35.1 m -164.32 144.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.36 152.9 52.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.753 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.593 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.27 -52.26 53.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.861 0.33 . . . . 0.0 110.81 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.81 -32.18 70.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.086 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.419 HG22 ' CE1' ' A' ' 49' ' ' PHE . 10.5 m -70.15 -37.38 75.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.443 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -66.96 -26.28 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.034 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.73 -66.42 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -47.27 -37.97 11.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.469 ' CE2' HG11 ' A' ' 41' ' ' VAL . 2.8 m-30 -36.21 148.26 0.17 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -43.77 -69.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 0.0 112.713 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -139.09 167.57 21.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -122.53 117.38 29.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 95.6 Cg_endo -83.65 -171.0 8.34 Favored 'Cis proline' 0 C--N 1.349 0.594 0 C-N-CA 123.716 -1.369 . . . . 0.0 112.348 -0.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.648 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mt -79.98 162.87 60.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 24.4 Cg_endo -61.56 92.47 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.744 2.296 . . . . 0.0 113.101 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 60.29 33.8 20.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.624 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.648 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 10.7 mtp180 -124.02 114.3 19.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.203 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 41.4 m -65.14 107.21 1.48 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.124 0.488 . . . . 0.0 110.192 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.483 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.3 154.45 18.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.424 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 11.8 t -130.91 132.61 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.731 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.0 t -104.22 127.59 58.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 111.717 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -109.32 113.3 26.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.995 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.801 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.2 t -148.6 167.37 25.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 111.279 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -84.11 -7.31 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.282 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.1 tp60 -80.46 128.8 34.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.467 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -79.35 -28.01 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.8 9.62 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.801 ' CD2' HG21 ' A' ' 63' ' ' THR . 4.2 t80 -59.86 141.08 56.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.064 0.459 . . . . 0.0 111.489 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.825 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.2 mt-30 -129.93 174.0 10.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.255 1.026 . . . . 0.0 112.54 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.557 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.47 143.72 20.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.58 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -74.31 96.24 2.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.445 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.94 -35.52 3.65 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.172 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.96 166.32 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.95 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 15.3 t -96.67 140.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.412 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.825 HG21 ' HA ' ' A' ' 69' ' ' GLN . 23.2 t -106.8 120.56 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.313 0.578 . . . . 0.0 112.18 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.929 HG21 HG22 ' A' ' 82' ' ' VAL . 24.9 m -132.77 172.04 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.965 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.414 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 11.2 m80 -122.21 -20.2 6.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -156.06 -175.68 5.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.101 0.476 . . . . 0.0 111.74 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.862 HG13 ' CD2' ' A' ' 106' ' ' PHE . 14.4 t -69.19 -10.24 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.614 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.48 -36.22 17.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.138 0.494 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.62 -33.71 66.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.929 HG22 HG21 ' A' ' 76' ' ' VAL . 27.2 t -70.29 -49.98 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 2.9 m-85 -54.34 -28.7 44.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.178 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.33 -39.79 85.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 50.8 t80 -66.37 -57.62 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.98 -23.06 43.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.893 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.652 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -72.08 -32.0 66.62 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 109.958 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 10.0 mt-30 -84.64 -9.02 58.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -121.21 65.17 14.54 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.027 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.36 -1.53 3.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.808 2.339 . . . . 0.0 112.647 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.03 -29.06 15.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.402 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -104.32 159.81 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.68 170.01 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.201 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -112.95 113.15 25.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.2 t -124.09 107.18 18.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.721 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.2 mm -76.46 134.69 28.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.434 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.96 -38.52 5.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.14 -167.35 40.31 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.09 -161.08 23.07 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 122.063 -0.669 . . . . 0.0 112.571 -0.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . -54.5 -51.63 64.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.826 0.346 . . . . 0.0 111.26 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -31.71 68.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.591 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 33.4 mm -72.67 -27.66 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 129' ' ' ILE . 2.4 m-85 -60.85 -54.35 46.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.572 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.553 ' CA ' HD13 ' A' ' 129' ' ' ILE . 7.7 t -69.26 -10.38 57.54 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.872 -0.517 . . . . 0.0 111.989 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.694 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.12 -39.91 54.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.862 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.4 m-85 -96.17 -8.24 33.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.552 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.84 -28.83 17.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.16 -1.46 49.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.469 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -132.01 -20.1 2.51 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.868 HG11 HD23 ' A' ' 113' ' ' LEU . 71.0 t -44.04 128.76 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.887 0.375 . . . . 0.0 111.222 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.436 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.9 t70 -106.16 1.59 26.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.301 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.758 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 72.7 m -166.99 135.09 2.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.674 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.868 HD23 HG11 ' A' ' 110' ' ' VAL . 9.6 mt -118.99 144.38 46.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 111.672 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mt -134.95 115.97 14.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.044 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.667 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -132.77 142.74 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 111.672 -179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.8 114.4 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.5 102.29 14.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.706 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -83.47 133.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.36 -57.43 10.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.339 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.14 168.2 38.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.747 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -99.33 172.51 7.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.804 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.604 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 3.0 m-85 -148.97 178.49 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.11 0.481 . . . . 0.0 111.442 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.55 171.48 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.435 ' HA3' ' CD1' ' A' ' 12' ' ' LEU . . . 161.41 -179.69 36.66 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.61 5.75 4.02 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.3 m -134.24 137.22 44.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 111.108 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 165.4 11.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.681 ' HG3' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -71.39 -173.72 0.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 111.086 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.553 HD13 ' CA ' ' A' ' 104' ' ' THR . 2.2 pp -118.47 164.03 22.48 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.083 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.529 ' O ' HD12 ' A' ' 129' ' ' ILE . 24.8 Cg_exo -63.11 136.65 57.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.636 2.224 . . . . 0.0 112.006 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -128.3 148.27 50.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.07 77.47 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -60.32 -19.0 53.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -29.31 62.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.57 -26.73 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.577 ' CD1' HD11 ' A' ' 113' ' ' LEU . 95.4 m-85 -97.71 173.95 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.18 140.5 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.505 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -79.72 111.67 16.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.833 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.4 m -93.88 -25.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.3 m -160.28 140.46 11.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 111.158 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 17.2 p -162.99 111.53 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -147.76 122.41 9.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 111.434 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.703 HG23 ' OG1' ' A' ' 154' ' ' THR . 4.8 m -76.38 144.93 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.35 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 t -115.62 105.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -93.61 104.94 17.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.406 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -86.69 -177.09 6.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -54.42 -51.49 64.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -76.58 127.0 85.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.044 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.21 -31.5 93.15 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.137 1.891 . . . . 0.0 112.413 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.26 -22.41 33.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.869 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.9 mt -81.75 10.46 6.16 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.511 ' O ' HD23 ' A' ' 118' ' ' LEU . 46.0 m -79.55 164.97 23.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 110.32 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.706 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 7.9 p80 -174.08 160.9 3.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.152 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.703 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.2 m -125.45 135.43 52.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -100.83 109.25 21.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.3 mt-10 -107.16 126.81 52.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.944 0.402 . . . . 0.0 111.378 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.757 ' O ' HG22 ' A' ' 139' ' ' VAL . 14.4 t -118.82 116.36 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.26 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.505 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.9 m95 -112.53 150.18 31.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.058 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.464 ' HG3' HG11 ' A' ' 139' ' ' VAL . 5.6 mt-30 -128.58 118.31 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.303 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.6 ttpp -53.55 133.91 41.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.578 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.51 10.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.511 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.087 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' LEU . 91.4 m . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.52 0.2 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.79 152.64 28.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.648 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -115.45 116.26 27.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.458 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 114' ' ' LEU . 13.1 tp -115.25 122.03 44.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.686 ' CH2' HG12 ' A' ' 115' ' ' VAL . 2.8 p90 -168.35 165.2 12.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.569 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -126.88 141.65 51.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 4.9 pt20 -127.35 156.55 41.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.838 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.54 -170.52 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.54 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -50.01 -46.34 52.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.42 -21.42 59.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 90.2 47.94 3.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.16 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -87.27 174.72 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.378 -179.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 126' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 92' ' ' GLN . 86.5 mt -81.69 87.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.68 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.4 ttp -99.94 111.94 24.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.581 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.737 HG13 ' HB ' ' A' ' 60' ' ' VAL . 2.8 t -86.2 129.82 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.561 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 27.6 m -135.77 153.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.95 157.05 53.49 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.213 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.814 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.18 -52.78 57.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.397 . . . . 0.0 110.345 179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.449 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.7 tpt180 -56.82 -44.81 82.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.325 0.583 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 m -61.16 -36.65 80.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 9.5 t80 -66.02 -24.71 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -65.83 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.396 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.4 t -48.19 -31.65 6.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.222 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.561 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 3.5 m-30 -46.44 166.46 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.99 -70.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.795 2.33 . . . . 0.0 112.932 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -145.72 -167.11 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.97 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -132.3 113.81 14.61 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 6.4 Cg_exo -87.83 -160.9 1.72 Allowed 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.057 -0.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.727 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 12.2 mt -86.9 168.27 18.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 37.8 Cg_endo -66.87 93.9 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.443 2.095 . . . . 0.0 113.043 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 64.99 14.05 9.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.33 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.727 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 6.0 mtp180 -109.11 116.95 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.388 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.4 m -67.11 110.93 3.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.866 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.479 HD21 ' HB2' ' A' ' 57' ' ' ARG . 2.4 m120 -106.0 157.48 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.437 0.637 . . . . 0.0 112.641 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.737 ' HB ' HG13 ' A' ' 40' ' ' VAL . 8.2 t -136.14 135.76 49.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.33 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 43' ' ' ARG . 85.9 t -109.46 128.11 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.925 0.393 . . . . 0.0 111.636 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -107.61 119.74 40.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.936 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.9 t -150.47 170.95 17.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -95.06 -10.13 31.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.718 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.0 tt0 -68.87 132.27 46.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.8 0.334 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.22 56.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.71 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.01 14.64 18.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.936 ' CG ' HG21 ' A' ' 63' ' ' THR . 6.1 t80 -60.95 142.1 56.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.444 0.64 . . . . 0.0 111.978 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.834 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.2 mt-30 -135.79 172.99 12.21 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.316 1.055 . . . . 0.0 112.873 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.97 140.61 17.99 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.094 -1.867 . . . . 0.0 110.106 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.8 mp0 -73.77 100.2 3.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.78 0.324 . . . . 0.0 110.85 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 87.15 -38.17 3.16 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.395 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.514 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.62 171.34 10.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.674 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.726 HG21 ' CE2' ' A' ' 85' ' ' TYR . 22.4 t -99.46 140.37 18.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.507 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 69' ' ' GLN . 30.3 t -107.95 116.84 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 0.0 112.032 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 33.1 m -126.29 171.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -121.14 -22.54 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.736 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.461 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -155.2 -173.95 4.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.7 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.937 HG13 ' CD2' ' A' ' 106' ' ' PHE . 14.8 t -68.22 -10.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.14 -33.92 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.088 0.47 . . . . 0.0 110.075 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.19 -27.22 53.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.886 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 76' ' ' VAL . 72.4 t -73.47 -53.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.525 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.6 m-85 -55.01 -26.74 39.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.709 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.84 97.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 74' ' ' VAL . 38.9 t80 -67.19 -57.68 6.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.553 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -51.04 -25.66 5.17 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.232 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -66.58 -44.37 82.43 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -79.74 -0.3 33.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.546 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.411 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 62.9 m-70 -127.57 60.26 43.11 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.981 0.42 . . . . 0.0 110.269 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.3 -0.25 7.08 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.146 2.564 . . . . 0.0 112.812 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.5 -38.29 30.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.067 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.463 ' HG3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -114.17 167.68 10.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 111.243 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.54 166.31 11.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.501 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.625 HD11 ' CG1' ' A' ' 82' ' ' VAL . 13.6 tp -97.43 116.64 30.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.988 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 39' ' ' MET . 12.3 t -122.82 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.529 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 12.7 mm -80.59 140.53 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.418 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.73 -37.99 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.405 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.75 -168.42 41.52 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.681 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.42 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.54 -160.97 34.0 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 117.561 0.681 . . . . 0.0 112.528 -0.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.54 63.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.458 ' NE2' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -56.3 -29.06 60.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.599 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.458 HD13 ' NE2' ' A' ' 101' ' ' GLN . 27.7 mm -84.08 -26.31 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.547 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.2 m-85 -60.45 -58.46 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.734 ' CA ' HD13 ' A' ' 129' ' ' ILE . 3.8 t -66.51 -9.08 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.762 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.34 -39.35 39.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.71 0.29 . . . . 0.0 111.283 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.937 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.3 m-85 -103.23 -5.76 22.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 7.0 pttt -42.47 -31.14 0.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -90.35 -26.76 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.733 ' OD2' HG11 ' A' ' 79' ' ' VAL . 12.0 m-20 -89.1 -31.68 17.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 3' ' ' PHE . 70.8 t -48.99 129.32 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 6.3 t70 -105.86 9.24 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.2 m -166.85 140.91 3.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 110' ' ' VAL . 13.8 mt -121.62 144.24 48.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.305 0.574 . . . . 0.0 111.743 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.489 ' HB2' HD12 ' A' ' 4' ' ' LEU . 5.4 mt -135.38 117.53 15.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.139 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.686 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -136.33 146.51 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.479 . . . . 0.0 112.108 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.97 108.47 16.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.301 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 8.3 tpt180 -79.51 101.16 8.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.317 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.583 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 3.2 mt -82.49 124.89 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.3 6.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.29 175.31 3.27 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.664 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.6 p -105.72 159.37 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 110.947 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.583 ' CZ ' HD22 ' A' ' 118' ' ' LEU . 6.3 m-85 -147.31 155.17 41.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.84 170.1 10.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.652 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.587 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 157.57 163.85 13.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.262 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.45 -27.1 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.6 0.238 . . . . 0.0 111.348 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.489 HG22 HD11 ' A' ' 13' ' ' ILE . 90.4 m -109.17 146.67 33.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.742 0.306 . . . . 0.0 111.008 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 177.56 4.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.0 tpt -76.94 156.68 31.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.734 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.3 pp -82.84 157.79 66.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.26 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.22 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.72 2.28 . . . . 0.0 112.507 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.45 146.63 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.38 75.78 2.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.012 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.571 ' HH2' HG11 ' A' ' 115' ' ' VAL . 88.0 m95 -56.39 -23.45 38.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -27.81 63.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.554 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.5 t70 -78.7 -24.82 44.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.737 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.459 ' CD1' HD11 ' A' ' 113' ' ' LEU . 78.5 m-85 -104.05 173.58 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.654 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -128.72 139.79 52.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpp -83.7 108.0 16.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.574 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.3 m -95.79 -18.11 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.722 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 m -162.62 140.46 8.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.722 0.296 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.484 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 2.2 p -169.85 108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -142.66 118.12 10.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.753 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -67.11 145.28 55.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.04 103.74 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.284 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.86 102.15 14.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.32 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 174.23 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.6 p -52.53 -44.16 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.495 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 3.2 t30 -80.51 128.49 72.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.352 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.43 -30.35 86.85 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.393 2.062 . . . . 0.0 112.592 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.7 -22.98 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.4 mt -81.01 6.3 13.85 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 153' ' ' HIS . 99.6 m -70.2 162.38 28.5 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.163 0.506 . . . . 0.0 110.396 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -172.38 159.09 4.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.836 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.753 ' OG1' HG23 ' A' ' 143' ' ' THR . 6.8 m -119.0 150.25 40.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' SER . 48.9 m-85 -113.84 105.04 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.498 ' HB2' HG22 ' A' ' 115' ' ' VAL . 28.5 mt-10 -109.78 125.29 52.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.037 0.446 . . . . 0.0 112.183 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.685 ' O ' HG22 ' A' ' 139' ' ' VAL . 16.3 t -116.84 114.22 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.211 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.471 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.1 m95 -108.31 150.59 27.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.064 0.459 . . . . 0.0 111.985 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.489 ' CD ' HG11 ' A' ' 139' ' ' VAL . 31.3 mt-30 -129.33 125.33 36.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.32 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -48.07 123.28 6.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.661 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.654 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -107.67 -177.59 3.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.133 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.748 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.77 149.2 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.499 ' CE1' HG22 ' A' ' 110' ' ' VAL . 3.4 m-30 -113.64 108.35 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.845 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.48 117.15 33.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.605 0.717 . . . . 0.0 112.45 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.677 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.1 p90 -161.52 166.84 26.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.261 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.86 132.55 54.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.607 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.7 pt20 -118.5 143.87 46.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -91.93 -167.82 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.42 52.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.01 -27.68 48.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 106.73 29.53 4.64 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.259 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.66 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.9 tt -84.27 157.87 21.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.962 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.536 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.459 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 93' ' ' GLU . 6.7 mmtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.559 0.695 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.544 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 20.4 mt -64.41 110.7 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.692 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.8 ttp -100.79 115.26 29.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.584 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.806 HG21 HG11 ' A' ' 82' ' ' VAL . 2.7 t -88.99 124.3 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.167 0.508 . . . . 0.0 112.201 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 15.7 m -130.0 144.33 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.379 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.09 156.97 51.79 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.172 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.45 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -55.48 -51.01 68.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 110.514 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -58.43 -34.87 71.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -68.24 -47.49 67.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -54.13 -31.91 53.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -66.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.652 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 49' ' ' PHE . 2.4 m -57.6 -30.75 65.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.42 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -32.92 122.7 0.42 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.9 -179.23 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.28 -38.2 88.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.963 2.442 . . . . 0.0 113.311 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.57 116.28 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.429 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.51 135.09 14.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.709 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.42 -171.86 8.41 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.354 -1.519 . . . . 0.0 112.161 -0.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 57' ' ' ARG . 95.7 mt -97.84 147.2 32.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.571 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.67 -86.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.091 2.527 . . . . 0.0 113.451 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.84 25.65 8.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.624 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.142 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 80.3 m -74.7 122.0 22.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 111.873 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.416 HD21 HD12 ' A' ' 54' ' ' LEU . 2.6 m-80 -102.81 152.79 20.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.718 ' HB ' HG13 ' A' ' 40' ' ' VAL . 2.2 t -137.38 131.71 44.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.5 t -103.47 126.19 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.272 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -109.87 108.29 18.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.944 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.981 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.9 t -144.19 164.11 31.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 111.396 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -81.1 -9.83 59.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.289 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.664 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.9 tp60 -71.74 127.18 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.332 . . . . 0.0 110.392 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -27.91 55.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -105.13 16.93 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.641 0.258 . . . . 0.0 111.493 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.981 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.6 t80 -62.25 137.24 58.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.485 0.659 . . . . 0.0 112.454 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.832 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -127.41 171.99 11.06 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.251 1.024 . . . . 0.0 112.357 178.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.07 140.14 16.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -76.07 96.81 3.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.813 0.339 . . . . 0.0 110.941 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.95 -42.26 2.31 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.556 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 167.92 19.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.133 0.492 . . . . 0.0 112.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' HG13 ' A' ' 60' ' ' VAL . 21.9 t -94.81 140.89 15.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.127 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.875 HG11 ' O ' ' A' ' 68' ' ' TYR . 33.8 t -107.01 121.61 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.386 0.612 . . . . 0.0 111.955 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.718 HG21 HG22 ' A' ' 82' ' ' VAL . 18.0 m -132.74 178.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.131 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -127.79 -21.11 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.648 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -153.8 -177.11 6.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.457 . . . . 0.0 111.591 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 106' ' ' PHE . 24.2 t -70.08 -11.17 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.433 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.11 -37.24 17.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.107 0.48 . . . . 0.0 110.064 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -68.83 -30.63 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.665 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.806 HG11 HG21 ' A' ' 40' ' ' VAL . 23.3 t -72.35 -55.81 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.484 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 8.5 m-85 -52.49 -31.21 34.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.6 -43.81 97.87 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 87.5 t80 -61.04 -52.6 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.3 -22.33 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.35 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mtmt -70.99 -37.14 72.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.126 0.489 . . . . 0.0 109.874 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -8.7 59.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 92' ' ' GLN . 95.1 m-70 -120.01 62.45 8.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.93 -6.04 8.69 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.655 2.237 . . . . 0.0 112.226 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -99.55 -25.75 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.982 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 89' ' ' HIS . 10.3 mt-30 -94.11 151.6 19.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 29.2 mt-10 -99.09 174.76 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.58 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 1' ' ' THR . 17.2 tp -131.23 111.17 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 111.308 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 39' ' ' MET . 83.9 t -129.23 116.14 38.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 40' ' ' VAL . 6.3 mm -82.02 138.13 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.88 0.371 . . . . 0.0 111.082 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.76 -33.14 5.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.94 -171.89 44.41 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.462 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.62 -160.97 36.17 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 117.588 0.694 . . . . 0.0 112.632 -0.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.01 -55.75 15.9 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.8 0.333 . . . . 0.0 111.294 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -56.47 -31.92 64.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.025 0.441 . . . . 0.0 110.464 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.4 mm -77.11 -30.54 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.053 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.0 m-85 -58.02 -52.98 63.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.366 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.696 ' CA ' HD13 ' A' ' 129' ' ' ILE . 12.0 t -69.53 -10.22 57.19 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -73.36 -39.71 64.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.9 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.8 m-85 -102.35 -3.55 26.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.584 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 5.9 pttt -51.65 -31.23 24.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.7 -5.69 58.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.555 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.82 -20.65 8.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.657 0.265 . . . . 0.0 111.475 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 106' ' ' PHE . 73.4 t -45.58 134.15 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.12 0.486 . . . . 0.0 111.427 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 18.1 t70 -111.26 -0.32 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.748 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.6 m -166.74 137.44 3.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.565 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 6.1 mt -118.13 145.64 44.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.24 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 4' ' ' LEU . 9.4 mt -134.96 112.74 10.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.062 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.677 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -127.94 137.39 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.055 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.92 119.93 36.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.182 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 100.6 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 0.9 OUTLIER -81.13 135.31 35.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -55.94 -53.84 52.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 122' ' ' PHE . . . -58.04 156.32 19.52 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.234 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 p -97.04 154.13 17.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -142.68 156.48 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.824 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 156.92 16.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.252 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.66 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 178.56 175.41 45.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.911 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.22 22.08 4.45 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.463 HG22 HD11 ' A' ' 13' ' ' ILE . 1.3 m -133.0 126.96 33.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.75 0.31 . . . . 0.0 110.838 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -108.65 162.31 14.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.3 tpt -72.93 158.44 35.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.696 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.2 pp -88.75 164.97 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.178 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.22 96.79 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 112.655 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.1 149.49 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.997 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.02 71.35 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.479 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HH2' HG11 ' A' ' 115' ' ' VAL . 95.6 m95 -58.96 -20.11 49.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.86 -32.06 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.756 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -79.39 -24.52 42.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.57 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 95.5 m-85 -101.46 171.62 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 111.076 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -134.93 141.76 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.2 ttpm? -84.76 105.81 15.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.9 m -89.9 -17.96 7.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.985 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -161.85 141.47 10.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 111.17 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.607 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 99.2 p -172.01 108.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.412 ' C ' HG23 ' A' ' 154' ' ' THR . 1.7 ttt-85 -147.87 130.52 15.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.26 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.756 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.4 m -74.27 146.3 43.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.148 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' THR . 11.3 t -118.3 104.62 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.383 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -93.33 104.89 17.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.72 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.7 -174.51 4.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.498 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -54.58 -54.89 35.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.864 0.364 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.554 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.8 t30 -75.93 141.08 71.07 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.769 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.77 -36.57 18.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.819 1.679 . . . . 0.0 112.369 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.91 -23.4 44.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.878 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -77.69 9.61 3.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.566 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 144' ' ' VAL . 50.3 m -83.95 158.64 21.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -170.68 155.83 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.756 ' OG1' HG23 ' A' ' 143' ' ' THR . 39.6 m -117.69 129.44 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.404 ' OH ' ' CE1' ' A' ' 153' ' ' HIS . 57.2 m-85 -100.77 105.64 16.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.409 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.548 ' HB2' HG22 ' A' ' 115' ' ' VAL . 17.0 mt-10 -104.61 126.68 51.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.307 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.745 ' O ' HG22 ' A' ' 139' ' ' VAL . 6.2 t -118.07 112.56 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.552 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 30.2 m95 -104.63 148.27 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.067 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -128.33 119.22 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.747 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.452 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.4 tttt -51.54 135.13 28.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.26 -165.86 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.575 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 9.6 m . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.93 148.64 33.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.9 m-85 -113.87 112.24 23.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.278 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.807 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.84 127.83 55.34 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.664 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.5 p90 -168.63 163.8 12.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.216 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.22 131.73 53.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.862 0.363 . . . . 0.0 111.732 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.544 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 7.5 pt20 -130.61 161.54 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.415 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.11 -169.03 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HD3' ' HB3' ' A' ' 121' ' ' SER . 0.0 OUTLIER -55.34 -27.73 49.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.67 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 9.2 t70 -90.63 -33.98 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 105.17 57.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.859 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 67.1 mt -110.22 152.23 26.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.343 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.506 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 40.8 mt -76.82 88.96 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 111.579 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.492 ' HE2' HD12 ' A' ' 54' ' ' LEU . 27.5 ttp -103.11 126.74 50.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.641 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.597 HG21 HG11 ' A' ' 82' ' ' VAL . 39.3 t -79.87 156.51 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.759 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 31.2 m -163.7 140.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.984 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.76 147.75 48.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.32 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.614 ' HG2' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -49.93 -46.39 52.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.445 0.622 . . . . 0.0 110.613 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -58.97 -39.55 82.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 109.963 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -65.98 -48.67 70.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.984 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 4.5 t80 -57.31 -27.22 61.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.79 -66.23 0.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.658 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.12 -23.88 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.787 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -35.71 133.12 0.53 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.901 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 99.6 Cg_exo -46.8 -35.96 18.74 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.144 2.563 . . . . 0.0 113.534 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.84 148.55 31.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.197 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.95 111.84 6.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.252 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 12.9 Cg_exo -81.76 179.09 28.53 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 123.408 -1.497 . . . . 0.0 111.787 -0.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.787 HD11 ' CE1' ' A' ' 49' ' ' PHE . 77.8 mt -78.87 143.42 62.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.766 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.81 109.2 2.06 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.514 2.143 . . . . 0.0 112.609 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 73.19 0.12 3.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.968 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.776 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -109.89 106.88 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 -179.343 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.506 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 87.9 m -64.99 120.31 12.36 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.613 ' ND2' HD12 ' A' ' 54' ' ' LEU . 4.8 m120 -110.11 157.32 19.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.203 0.525 . . . . 0.0 112.362 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 76' ' ' VAL . 17.7 t -134.15 143.58 37.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.765 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.8 t -113.58 111.04 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.179 0.514 . . . . 0.0 111.891 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -91.58 118.35 30.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.304 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.895 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -155.37 148.17 24.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.936 179.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -69.02 -6.32 27.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.258 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.7 tt0 -73.29 131.6 42.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.329 . . . . 0.0 110.747 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -85.42 5.47 30.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.838 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -134.6 7.72 3.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.895 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.4 t80 -59.91 137.51 58.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.289 0.566 . . . . 0.0 111.594 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.956 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.3 mt-30 -133.15 171.94 13.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.454 1.121 . . . . 0.0 113.14 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.5 140.29 17.13 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.138 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.97 102.56 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.07 -41.05 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.274 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -72.49 170.51 14.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.017 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 60' ' ' VAL . 21.6 t -98.53 141.33 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.956 HG21 ' HA ' ' A' ' 69' ' ' GLN . 14.8 t -114.37 122.37 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 0.0 112.187 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.008 HG21 HG22 ' A' ' 82' ' ' VAL . 27.3 m -129.91 173.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.111 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' THR . 6.0 m170 -118.44 -24.22 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -157.1 -171.82 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 111.165 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.841 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.6 t -68.91 -11.29 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.54 -36.84 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 110.094 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.81 -29.67 63.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.89 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.008 HG22 HG21 ' A' ' 76' ' ' VAL . 21.5 t -72.3 -55.19 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 120.904 0.383 . . . . 0.0 110.039 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.552 ' O ' ' HG3' ' A' ' 87' ' ' LYS . 9.4 m-85 -53.61 -27.59 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.817 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.08 -48.64 79.28 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.846 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.424 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 83.1 t80 -58.98 -51.24 70.91 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.99 -22.84 16.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.095 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' PHE . 6.6 mtmp? -67.78 -44.5 77.29 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -79.63 -2.83 44.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.596 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.424 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 61.7 m-70 -128.68 64.43 69.04 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-O 120.995 0.426 . . . . 0.0 110.388 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.19 -0.01 6.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.184 2.589 . . . . 0.0 112.935 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.89 -31.83 18.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.169 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.74 162.94 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.364 . . . . 0.0 111.34 -179.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -104.17 174.71 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.223 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.676 HD21 ' CG1' ' A' ' 82' ' ' VAL . 6.2 tp -110.5 117.08 32.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 t -121.53 107.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.093 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.479 HD12 ' HB ' ' A' ' 40' ' ' VAL . 16.4 mm -76.76 132.08 33.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 111.593 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.405 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.13 -37.15 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.027 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.34 -172.66 45.0 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.827 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.9 -161.11 31.7 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 122.216 -0.579 . . . . 0.0 112.535 -0.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.3 -55.36 32.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.737 0.303 . . . . 0.0 111.045 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -55.14 -26.49 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.571 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.9 mm -80.62 -26.41 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' HB3' HG12 ' A' ' 129' ' ' ILE . 3.4 m-85 -62.71 -55.84 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.472 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.729 ' CA ' HD13 ' A' ' 129' ' ' ILE . 4.6 t -66.72 -10.11 43.53 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.772 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.38 -41.3 48.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.841 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.5 m-85 -96.69 -8.28 31.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.478 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.91 -29.24 19.23 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.856 0.36 . . . . 0.0 111.161 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.52 -3.74 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.551 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -128.8 -19.09 3.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 106' ' ' PHE . 77.7 t -44.45 131.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.459 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 9.9 t70 -109.22 4.36 22.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.285 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.709 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 21.7 m -167.74 135.72 2.38 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.6 0.238 . . . . 0.0 110.821 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 13.8 mt -116.52 142.44 46.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 4' ' ' LEU . 3.7 mt -135.53 115.69 13.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -138.1 147.39 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.92 105.91 13.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.022 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 18.3 ttt180 -86.39 104.71 16.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.79 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 6.8 mp -85.14 128.3 34.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.931 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -61.55 -54.0 48.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.463 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -63.13 168.52 19.85 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.46 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 95.3 p -105.28 141.97 35.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.683 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -137.11 175.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 162.55 29.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.48 ' CA ' HD13 ' A' ' 12' ' ' LEU . . . 164.08 133.15 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -106.05 -24.8 12.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.64 0.257 . . . . 0.0 111.237 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.36 144.73 37.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 111.198 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.56 -174.63 2.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.0 tpt -86.24 160.01 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.189 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.729 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.6 pp -86.87 166.24 27.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.193 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' A' ' 129' ' ' ILE . 20.3 Cg_exo -66.29 94.25 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.874 2.383 . . . . 0.0 112.908 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.42 149.01 23.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.068 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.7 77.74 3.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -59.32 -18.2 35.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.532 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.57 -30.93 61.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 111.032 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.78 -25.79 49.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.274 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.506 ' CD1' HD11 ' A' ' 113' ' ' LEU . 95.8 m-85 -97.18 174.23 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.004 0.43 . . . . 0.0 111.541 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.453 HG21 ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -136.88 142.74 42.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.0 OUTLIER -78.26 119.3 21.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.978 179.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 157' ' ' VAL . 29.2 m -102.16 -23.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.219 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.7 m -163.23 140.77 7.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 80.9 p -160.7 110.12 1.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.978 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -141.64 114.54 8.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.015 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.737 HG23 ' OG1' ' A' ' 154' ' ' THR . 7.4 m -73.07 143.99 47.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.481 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.48 105.3 18.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.951 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.437 ' HA ' HG23 ' A' ' 152' ' ' THR . 1.7 mt-10 -90.73 102.15 14.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.714 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.79 -177.73 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.595 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 36.3 p -59.51 -49.52 77.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.53 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 4.3 t30 -74.41 125.44 89.83 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.774 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.5 -28.21 86.91 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.089 1.859 . . . . 0.0 112.338 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.463 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -89.3 -20.07 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.027 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.8 mt -84.91 8.75 16.44 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 80.4 m -73.25 166.27 23.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.912 0.387 . . . . 0.0 110.004 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 3.6 p80 -173.74 160.33 3.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.737 ' OG1' HG23 ' A' ' 143' ' ' THR . 8.0 m -126.84 140.13 52.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.264 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -100.03 105.72 17.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.468 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.438 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.3 mt-10 -104.24 121.81 44.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.928 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.805 ' O ' HG22 ' A' ' 139' ' ' VAL . 9.6 t -114.51 112.96 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.8 m95 -112.63 150.8 30.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.274 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.526 ' CD ' HG11 ' A' ' 139' ' ' VAL . 26.6 mt-30 -128.51 118.89 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.36 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.3 tttt -57.35 133.08 54.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.865 0.364 . . . . 0.0 111.153 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.453 ' HE2' HG21 ' A' ' 137' ' ' THR . 0.0 OUTLIER 177.16 157.67 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.099 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.141 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.459 ' CG2' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.537 0.208 . . . . 0.0 110.539 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.23 143.08 37.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.296 0.57 . . . . 0.0 112.366 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.494 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.3 m-30 -112.36 112.98 24.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.543 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.816 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -113.15 123.16 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 111.648 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.646 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.6 p90 -166.29 173.88 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.518 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -128.68 137.65 51.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -130.25 157.0 43.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.592 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 20.7 p-10 -108.33 -171.67 1.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.71 -36.47 64.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.38 -28.03 34.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.702 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.6 -4.22 66.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.893 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 2.5 pp -80.59 157.46 26.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.927 0.363 . . . . 0.0 111.021 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.656 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.3 mt -81.34 88.67 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.118 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.472 ' HE3' ' CG1' ' A' ' 41' ' ' VAL . 4.1 ttp -99.07 123.13 43.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.766 HG21 HG11 ' A' ' 82' ' ' VAL . 4.4 t -89.22 128.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.472 ' CG1' ' HE3' ' A' ' 39' ' ' MET . 33.5 m -131.49 148.12 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.538 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.87 151.22 51.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.385 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.524 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -49.83 -51.12 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.8 tpt180 -62.18 -36.76 82.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.303 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -66.86 -36.25 81.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.942 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.476 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t80 -65.53 -22.34 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.592 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -65.22 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.2 t -48.37 -36.58 14.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -43.18 157.27 0.25 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.012 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.12 -67.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.673 2.249 . . . . 0.0 112.768 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.25 164.06 36.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 16.9 mtm180 -117.12 115.08 38.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 67.6 Cg_endo -88.74 -164.99 2.78 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.005 -1.248 . . . . 0.0 112.329 0.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.644 HD12 HD21 ' A' ' 59' ' ' ASN . 55.4 mt -107.51 144.63 29.63 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 37.3 Cg_endo -65.97 118.11 5.22 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.555 2.17 . . . . 0.0 112.638 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 7.1 mt-10 68.02 7.49 5.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.944 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 1.3 mtt180 -119.24 100.31 7.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.887 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 34.9 m -67.72 109.92 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.744 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.3 m-80 -104.39 139.51 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.305 0.574 . . . . 0.0 112.265 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' HG13 ' A' ' 40' ' ' VAL . 4.5 t -113.0 143.16 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.121 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 68' ' ' TYR . 84.9 t -114.77 125.06 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 111.9 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.937 HD12 HG23 ' A' ' 76' ' ' VAL . 1.9 tp -104.66 120.36 41.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.92 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -153.62 171.18 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -91.91 -8.03 47.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.6 tt0 -77.9 130.72 36.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.339 . . . . 0.0 110.786 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -80.79 0.05 36.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.004 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -126.79 10.03 7.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.578 0.228 . . . . 0.0 111.407 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.92 ' CD2' HG21 ' A' ' 63' ' ' THR . 4.4 t80 -59.34 141.62 54.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.95 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.7 mt-30 -132.52 174.54 10.17 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 122.343 1.068 . . . . 0.0 112.902 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.84 143.62 20.77 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.398 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -73.17 98.56 2.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.771 0.319 . . . . 0.0 110.835 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.18 -36.7 2.89 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.535 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -70.69 172.38 8.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 0.0 111.489 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.99 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.95 HG21 ' HA ' ' A' ' 69' ' ' GLN . 25.1 t -112.76 122.72 67.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.134 0.492 . . . . 0.0 111.365 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.937 HG23 HD12 ' A' ' 62' ' ' LEU . 30.8 m -133.61 168.61 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.334 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 65' ' ' GLN . 9.0 m80 -117.1 -22.52 8.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.358 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -150.06 -177.36 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 111.578 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.915 HG13 ' CD2' ' A' ' 106' ' ' PHE . 21.5 t -70.79 -8.57 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.99 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.76 -31.24 17.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 110.053 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.736 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.03 -27.26 54.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.681 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 76' ' ' VAL . 95.2 t -75.67 -52.59 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.659 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 8.2 m-85 -57.39 -25.02 58.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.689 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -66.3 -57.55 7.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.635 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -56.82 -23.4 43.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.04 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.14 -33.01 72.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 9.7 mt-30 -88.75 -4.13 58.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.26 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -126.02 63.97 50.69 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.33 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.06 -0.14 5.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.169 2.579 . . . . 0.0 112.94 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.79 -37.23 30.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -112.14 163.84 13.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -98.64 164.25 12.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.639 HD11 HG12 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -108.16 124.96 51.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.313 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' MET . 69.3 t -131.87 118.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.345 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 94' ' ' LEU . 3.0 mm -82.48 138.69 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 111.408 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -102.63 -52.98 2.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.775 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.11 -166.15 38.95 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.48 -161.01 36.77 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 117.813 0.806 . . . . 0.0 112.639 -0.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.78 -44.13 38.65 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.81 0.338 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.82 -34.33 74.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.717 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 62' ' ' LEU . 28.4 mm -80.97 -23.11 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -63.21 -52.06 63.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.55 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 14.5 t -68.48 -9.58 49.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.738 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.35 -39.99 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 110.68 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.915 ' CD2' HG13 ' A' ' 79' ' ' VAL . 4.2 m-85 -100.69 -4.8 27.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.368 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.3 pttt -48.18 -32.65 7.32 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.94 -2.16 58.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.789 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 m-20 -119.18 -26.89 5.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.585 0.231 . . . . 0.0 111.554 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.761 HG11 HD23 ' A' ' 113' ' ' LEU . 82.5 t -45.91 122.48 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 111.576 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 14.9 t70 -105.85 8.35 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.022 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.7 m -168.25 138.29 2.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.969 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.761 HD23 HG11 ' A' ' 110' ' ' VAL . 5.8 mt -121.46 146.2 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.319 0.581 . . . . 0.0 112.101 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 113' ' ' LEU . 14.3 mt -135.15 114.67 12.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.241 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -136.89 147.33 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.128 0.489 . . . . 0.0 112.133 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -107.93 119.01 38.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.915 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -79.46 99.01 7.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.383 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 6' ' ' ALA . 6.0 mt -85.94 108.96 18.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.177 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.33 78.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.034 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.5 171.49 54.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.554 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t -110.14 162.65 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 111.018 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 6.6 m-85 -138.42 170.05 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.253 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.42 169.95 8.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.89 -170.73 24.76 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.689 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.26 29.22 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.018 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -141.62 129.83 22.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 16.5 tttm -111.55 150.24 30.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.806 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -52.17 179.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.544 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.6 pt -97.27 162.67 21.91 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.188 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.2 Cg_endo -73.86 99.3 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.45 2.1 . . . . 0.0 112.102 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.427 ' CD1' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt -88.46 147.84 24.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 74.19 2.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.024 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.527 ' HH2' HG11 ' A' ' 115' ' ' VAL . 92.7 m95 -54.52 -24.17 19.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.94 -26.29 62.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.3 t0 -83.23 -19.51 36.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.737 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.699 ' CD1' HD11 ' A' ' 113' ' ' LEU . 89.9 m-85 -107.93 165.9 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.626 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.568 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -126.61 139.79 52.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 110.509 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 11.2 ttpt -79.6 117.25 20.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.464 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 157' ' ' VAL . 24.5 m -101.94 -21.84 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.927 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -163.09 140.61 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 8.6 p -155.94 111.02 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.501 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -141.42 117.1 10.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.789 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.787 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.2 m -72.62 133.48 44.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.161 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.64 109.77 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.583 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.779 ' HA ' HG23 ' A' ' 152' ' ' THR . 11.2 mt-10 -96.99 97.51 9.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -81.51 -161.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.191 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.2 p -74.38 -48.65 26.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.502 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.9 t30 -69.18 119.85 72.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.075 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.31 -20.57 56.29 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.083 1.856 . . . . 0.0 111.989 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -23.65 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.573 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.6 mt -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.779 HG23 ' HA ' ' A' ' 145' ' ' GLU . 1.7 m -85.86 82.21 8.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 5.3 p80 -97.12 -171.3 2.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.565 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.787 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 55.9 m -125.55 165.26 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.079 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.473 ' N ' HG22 ' A' ' 154' ' ' THR . 1.6 m-85 -118.79 105.85 11.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.96 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.488 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.4 mt-10 -109.69 125.27 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.778 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.752 ' O ' HG22 ' A' ' 139' ' ' VAL . 7.0 t -116.12 115.04 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.278 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.508 ' O ' HG23 ' A' ' 112' ' ' THR . 23.8 m95 -111.97 150.47 30.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.22 0.534 . . . . 0.0 111.655 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -127.28 121.12 30.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.784 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 2.3 tmmt? -54.94 130.42 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 0.0 111.62 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.568 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.59 -170.52 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.553 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.126 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 21.7 m . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.689 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.72 145.36 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.8 m-85 -112.17 111.53 22.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.314 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.849 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -111.16 119.07 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.544 0.688 . . . . 0.0 112.569 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.603 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.7 p90 -160.32 166.89 28.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.411 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.99 140.18 48.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.957 0.408 . . . . 0.0 111.769 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -138.99 141.34 38.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.675 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 5.7 p-10 -100.35 -163.38 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -51.63 -48.9 63.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.345 0.593 . . . . 0.0 109.978 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.55 -32.69 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.037 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.11 43.47 3.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.4 OUTLIER -82.51 165.15 20.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.753 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.452 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.519 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 62.8 mt -74.43 89.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.12 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 ttp -99.61 125.0 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.651 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.4 t -79.14 157.36 4.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.423 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 31.2 m -162.91 153.19 3.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.13 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 154.36 47.76 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.813 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.805 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.931 0.366 . . . . 0.0 110.813 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.4 tpm_? -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.575 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -71.4 -47.5 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 73' ' ' ALA . 9.7 t80 -58.21 -23.47 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.18 -65.82 0.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -56.45 -26.8 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.381 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -39.84 130.27 1.51 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.551 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.3 -27.96 5.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.383 . . . . 0.0 113.329 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -157.12 133.05 9.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.286 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -126.84 108.2 22.41 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 69.3 Cg_endo -80.49 -171.96 10.41 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.582 -1.424 . . . . 0.0 111.831 0.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.701 HD11 ' CE1' ' A' ' 49' ' ' PHE . 64.4 mt -91.55 158.19 40.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.44 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.78 -43.6 56.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.91 2.406 . . . . 0.0 113.533 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 4.6 mt-10 -140.58 46.05 1.8 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.835 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.6 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -146.53 111.37 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.339 . . . . 0.0 111.811 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.519 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.1 m -71.29 115.5 10.52 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.554 HD21 HD12 ' A' ' 54' ' ' LEU . 3.5 m-80 -101.07 159.42 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.475 0.655 . . . . 0.0 112.59 -178.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 74' ' ' VAL . 5.7 t -137.17 133.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.366 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 43' ' ' ARG . 86.8 t -104.7 126.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.691 HD13 HD12 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -105.24 118.8 37.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.052 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.811 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.97 161.85 42.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.15 -10.64 59.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.723 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -81.44 134.25 35.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 1.2 mp0 -82.88 -24.98 32.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -95.65 4.46 53.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.666 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.865 ' O ' HG11 ' A' ' 75' ' ' VAL . 6.0 t80 -59.3 140.68 55.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 111.403 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.966 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.1 mt-30 -132.79 172.92 11.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.314 1.054 . . . . 0.0 112.846 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . . . -155.38 143.83 20.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.728 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -88.2 98.05 11.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.52 62.01 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.036 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 46' ' ' TYR . . . -125.66 166.08 17.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.88 0.372 . . . . 0.0 111.182 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 60' ' ' VAL . 16.2 t -96.17 138.17 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.986 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.966 HG21 ' HA ' ' A' ' 69' ' ' GLN . 38.6 t -104.4 104.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.322 0.582 . . . . 0.0 112.541 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.831 HG21 ' CG2' ' A' ' 82' ' ' VAL . 26.5 m -117.41 166.29 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.398 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.407 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 6.8 m170 -116.35 -19.05 10.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.584 0.23 . . . . 0.0 111.062 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -157.99 -176.3 5.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.611 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.875 HG13 ' CD2' ' A' ' 106' ' ' PHE . 18.4 t -68.41 -8.36 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.952 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -35.93 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.219 0.533 . . . . 0.0 109.794 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.37 -32.57 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.701 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.831 ' CG2' HG21 ' A' ' 76' ' ' VAL . 97.6 t -70.7 -50.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -57.03 -25.54 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.202 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -67.65 -42.39 82.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.045 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' ' NE2' ' A' ' 89' ' ' HIS . 92.5 t80 -65.49 -56.65 11.24 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.78 -21.71 11.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.96 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.3 mmmt -69.13 -39.97 78.56 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.53 -5.6 58.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.387 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.452 ' NE2' ' CE1' ' A' ' 85' ' ' TYR . 98.1 m-70 -126.28 65.89 59.41 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.547 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.58 -0.42 5.94 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.104 2.536 . . . . 0.0 112.923 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.19 -30.91 16.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.69 158.34 16.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -98.86 164.49 12.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.683 HD11 ' CG1' ' A' ' 82' ' ' VAL . 8.8 tp -114.01 114.64 26.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.97 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.24 116.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.211 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.439 HD12 ' HB ' ' A' ' 40' ' ' VAL . 6.9 mm -77.98 134.9 27.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.087 0.47 . . . . 0.0 111.412 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.42 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -106.84 -46.92 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.87 -170.83 43.95 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.894 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -90.3 -160.81 36.89 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 122.002 -0.705 . . . . 0.0 112.647 -0.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.47 11.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -52.52 -28.68 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.691 HD12 HD13 ' A' ' 62' ' ' LEU . 48.5 mm -85.16 -27.36 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.3 m-85 -60.28 -52.97 63.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.551 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.536 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 12.6 t -67.66 -9.76 46.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.677 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.09 -41.71 58.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.799 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.875 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.3 m-85 -101.55 -3.62 28.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.7 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 20.9 pttp -48.07 -32.21 6.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.751 0.31 . . . . 0.0 111.669 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -87.35 -19.19 28.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.552 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.8 -22.79 15.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.486 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.914 HG11 HD23 ' A' ' 113' ' ' LEU . 98.2 t -44.76 126.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.968 0.413 . . . . 0.0 111.61 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -101.82 -7.96 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 35.2 m -160.1 141.95 12.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.308 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.914 HD23 HG11 ' A' ' 110' ' ' VAL . 15.5 mt -120.38 145.81 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 111.649 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.98 114.89 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.603 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -135.41 145.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.991 0.424 . . . . 0.0 111.956 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -109.94 99.12 8.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.692 179.209 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 99.82 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.796 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 1.6 mp -86.04 127.47 34.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.404 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -52.8 -47.52 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.665 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -82.24 160.44 40.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 13.7 t -91.39 166.28 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.584 ' CZ ' HD22 ' A' ' 118' ' ' LEU . 11.3 m-85 -138.55 167.55 21.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.31 167.66 13.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 161.83 166.26 20.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.7 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.29 -28.17 7.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.666 0.269 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.0 m -109.27 148.8 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.28 174.96 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.77 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.546 ' HE2' HG13 ' A' ' 129' ' ' ILE . 14.5 tpt -73.58 158.53 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.646 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -84.39 165.53 37.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.066 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.4 Cg_endo -74.97 96.11 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.323 2.015 . . . . 0.0 112.307 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.73 149.47 24.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.85 72.59 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.008 0.432 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.49 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.1 m95 -58.49 -21.04 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -32.31 65.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.93 0.395 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.5 t0 -80.43 -15.67 56.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 113' ' ' LEU . 68.9 m-85 -107.43 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.095 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.44 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -127.9 142.26 51.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.634 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.533 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.8 OUTLIER -83.62 109.88 17.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.1 m -93.65 -22.44 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.448 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.0 m -159.45 140.62 12.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.181 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.6 p -165.4 116.08 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.521 ' C ' HG23 ' A' ' 154' ' ' THR . 2.6 ttm-85 -147.3 122.78 10.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.832 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.8 m -78.41 145.01 35.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.22 0.533 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.528 HG21 ' HE2' ' A' ' 155' ' ' TYR . 8.1 t -120.35 103.41 13.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.138 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.42 103.76 15.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.717 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.71 -172.66 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.107 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.6 p -54.72 -58.86 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 110.465 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.509 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -69.84 118.76 66.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.896 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.88 -22.35 62.12 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.112 1.875 . . . . 0.0 112.361 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -95.27 -16.03 22.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.367 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.7 mt -88.4 9.05 24.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.785 0.326 . . . . 0.0 111.164 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.473 HG22 ' N ' ' A' ' 153' ' ' HIS . 61.2 m -68.94 167.91 14.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.936 0.398 . . . . 0.0 109.993 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.473 ' N ' HG22 ' A' ' 152' ' ' THR . 0.2 OUTLIER -167.99 153.9 7.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.832 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.4 m -122.69 128.96 51.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.826 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.528 ' HE2' HG21 ' A' ' 144' ' ' VAL . 67.2 m-85 -90.69 104.77 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.408 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.511 ' HB2' HG22 ' A' ' 115' ' ' VAL . 33.8 mt-10 -107.41 125.54 51.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.8 ' O ' HG22 ' A' ' 139' ' ' VAL . 30.6 t -116.66 114.02 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.093 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.533 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 22.7 m95 -108.77 148.91 29.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -129.14 121.0 26.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.33 130.07 6.44 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.44 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -127.2 -163.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.195 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.044 179.787 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 24.3 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.559 0.219 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.16 145.66 39.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.7 m-30 -109.83 114.05 27.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.824 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.15 120.75 42.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.475 -179.243 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.704 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -166.48 166.42 16.36 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.379 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.78 136.0 54.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.242 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -124.85 154.06 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.04 -179.48 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.07 -45.04 15.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 110.471 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -23.19 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.526 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 27.07 9.1 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.219 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -82.14 150.91 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.778 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.3 mttt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.555 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 61.3 mt -72.51 89.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 111.285 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 ttp -97.78 117.27 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.339 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.569 HG21 HG11 ' A' ' 82' ' ' VAL . 24.5 t -76.93 157.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.234 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 32.8 m -163.89 150.05 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.79 156.26 51.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.9 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.63 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.32 -50.18 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.962 0.381 . . . . 0.0 110.402 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.439 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.9 tpm_? -62.06 -29.64 70.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.323 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -74.1 -48.63 28.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.626 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -57.93 -28.32 64.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.708 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.91 -65.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.427 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.5 m -58.93 -26.59 64.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.395 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -35.74 137.83 0.44 Allowed Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 49' ' ' PHE . 58.5 Cg_exo -53.21 -32.34 59.72 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.928 2.419 . . . . 0.0 113.357 -179.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.18 137.99 18.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.383 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 5.8 ptm180 -141.43 114.84 6.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -89.25 168.2 34.51 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.657 -1.393 . . . . 0.0 111.919 -0.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 73.7 mt -78.07 149.92 77.13 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HG2' ' NH1' ' A' ' 57' ' ' ARG . 27.4 Cg_endo -63.6 -78.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.786 2.324 . . . . 0.0 113.098 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 37.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.294 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -148.33 133.19 18.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.128 0.49 . . . . 0.0 111.967 -179.246 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.1 m -92.11 119.63 31.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.153 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.09 157.43 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.608 . . . . 0.0 112.439 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG12 HG22 ' A' ' 76' ' ' VAL . 3.5 t -137.37 138.34 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.333 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.63 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.9 t -114.57 120.32 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.795 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -102.16 118.97 38.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.963 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.93 171.21 17.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.101 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -95.59 -12.47 25.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -62.94 133.03 54.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.885 0.374 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.28 1.69 20.86 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.45 16.63 2.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.963 ' CG ' HG21 ' A' ' 63' ' ' THR . 3.0 t80 -58.5 139.32 55.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.193 0.52 . . . . 0.0 111.955 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.919 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -130.36 173.56 10.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.23 1.014 . . . . 0.0 112.367 178.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.11 144.18 20.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -81.52 99.32 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.03 -46.79 2.45 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.2 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 172.84 6.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 0.0 111.657 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.4 t -97.98 139.73 19.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.919 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.8 t -105.96 115.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.116 0.484 . . . . 0.0 111.865 -179.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.826 HG21 HG22 ' A' ' 82' ' ' VAL . 25.5 m -125.33 170.16 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.973 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.461 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.9 m170 -120.9 -21.91 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.344 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 t70 -153.54 -175.31 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.102 0.477 . . . . 0.0 111.54 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.8 HG21 ' O ' ' A' ' 105' ' ' ALA . 33.7 t -69.61 -9.48 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.621 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.61 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 109.926 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.706 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.88 -29.96 58.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 76' ' ' VAL . 60.8 t -72.06 -52.45 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.501 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.2 m-85 -55.95 -26.79 49.6 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.986 178.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.92 -45.44 89.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.019 178.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.444 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 82.1 t80 -64.08 -54.49 33.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.579 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.77 -23.14 16.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.315 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 4.1 mmtp -67.28 -46.59 73.17 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -79.21 -2.83 42.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.448 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.444 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 54.7 m-70 -125.48 62.64 41.3 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.385 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.28 -0.53 5.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.064 2.51 . . . . 0.0 112.904 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -31.22 17.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.965 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 19.6 mt-30 -105.8 156.57 18.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -99.87 164.55 11.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.018 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 HG12 ' A' ' 82' ' ' VAL . 9.0 tp -104.72 111.81 24.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.87 103.43 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.438 ' CD1' HG21 ' A' ' 40' ' ' VAL . 13.1 mm -73.71 132.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.027 0.441 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -104.01 -45.18 4.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.685 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.1 -166.81 39.71 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.695 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.39 -160.99 26.34 Favored Glycine 0 C--N 1.34 0.801 0 O-C-N 122.196 -0.59 . . . . 0.0 112.552 -0.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.05 66.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.73 0.3 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -53.91 -27.45 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.583 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 mm -80.79 -29.0 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 129' ' ' ILE . 5.8 m-85 -59.64 -56.24 24.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.458 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.825 ' HA ' HD13 ' A' ' 129' ' ' ILE . 11.2 t -66.32 -10.16 40.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.8 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.35 -40.28 51.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.653 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.787 ' CD1' HG22 ' A' ' 79' ' ' VAL . 1.7 m-85 -99.59 -5.48 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.35 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.9 pttp -49.5 -31.67 10.6 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.756 0.313 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.25 0.48 53.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.288 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.05 -26.31 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.548 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 106' ' ' PHE . 92.7 t -43.95 127.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.845 0.355 . . . . 0.0 111.55 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 11.3 t70 -105.27 3.72 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.322 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 m -167.6 137.84 2.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.599 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.515 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 9.2 mt -118.78 145.24 45.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.3 0.571 . . . . 0.0 111.819 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.26 113.05 10.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.483 178.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.704 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.6 m -132.58 143.09 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.6 107.05 14.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.433 179.436 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.7 OUTLIER -79.62 100.18 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.19 126.57 30.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.19 -53.14 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.004 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.46 170.68 9.31 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.353 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.2 p -106.78 147.04 30.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.7 m-85 -141.63 139.76 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -110.72 149.04 31.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.009 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.14 -143.4 3.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.554 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.33 21.94 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.6 m -159.99 134.08 7.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -107.37 158.43 17.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.963 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.8 177.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.491 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.4 pp -103.36 154.58 37.66 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.0 102.39 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.74 2.293 . . . . 0.0 112.687 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.9 147.85 22.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.008 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.74 76.25 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.451 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.515 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.9 m95 -57.79 -20.97 39.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.304 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.81 -29.32 63.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.844 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -78.58 -26.93 45.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.1 m-85 -99.16 176.55 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.77 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 m -137.3 141.93 41.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.246 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -80.67 119.02 22.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 -179.652 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.1 m -103.52 -11.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.7 m -171.51 140.35 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.74 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.0 p -167.93 110.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -148.11 120.64 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.814 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.0 m -69.01 145.38 53.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.236 0.541 . . . . 0.0 111.594 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.63 105.21 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.261 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 152' ' ' THR . 18.4 mt-10 -87.61 101.97 14.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.814 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.04 -171.41 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.493 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.7 p -60.19 -57.19 13.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.0 110.685 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.525 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -71.86 124.5 90.98 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.002 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.2 -28.46 86.96 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.961 1.774 . . . . 0.0 112.362 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.9 -21.1 25.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.395 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.5 mt -85.32 7.23 23.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.504 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 153' ' ' HIS . 51.5 m -70.86 166.0 22.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.2 p80 -172.95 159.72 4.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.73 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.814 ' OG1' HG23 ' A' ' 143' ' ' THR . 28.8 m -119.93 147.05 45.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.347 179.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -110.29 104.68 13.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.653 0.264 . . . . 0.0 110.827 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.608 ' HB2' HG22 ' A' ' 115' ' ' VAL . 30.9 mt-10 -106.83 124.29 49.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 111.755 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.8 t -116.74 114.12 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.159 179.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.5 m95 -110.03 150.7 28.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.51 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.74 115.2 19.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -56.84 131.52 49.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.673 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.57 156.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 178.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.176 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 18.0 m . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.805 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.08 154.9 25.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.475 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 1.5 m-30 -119.08 113.46 20.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.552 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.866 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.94 117.37 33.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.3 p90 -162.25 165.41 26.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.827 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 8.9 pt20 -129.99 156.25 44.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.711 ' OD2' HD12 ' A' ' 12' ' ' LEU . 2.6 p30 -103.66 -171.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.506 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.3 -27.66 37.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.082 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -32.89 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.032 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 101.72 46.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.528 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD12 ' OD2' ' A' ' 8' ' ' ASP . 8.9 mt -95.91 163.99 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.827 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 58' ' ' THR . 12.0 mmtt . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 92' ' ' GLN . 62.0 mt -86.48 88.21 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.955 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.432 ' HE3' HG13 ' A' ' 41' ' ' VAL . 1.1 ttp -97.59 118.2 33.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.691 -179.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.882 HG21 HG11 ' A' ' 82' ' ' VAL . 3.3 t -89.93 125.11 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.669 HG11 ' CE2' ' A' ' 49' ' ' PHE . 25.5 m -133.89 145.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.309 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.63 156.0 49.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.041 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.758 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.94 -52.89 56.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.479 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -59.56 -35.7 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.105 0.479 . . . . 0.0 110.291 179.154 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.44 HG22 ' CE2' ' A' ' 49' ' ' PHE . 7.3 m -64.72 -50.43 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.162 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -49.15 -34.34 14.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -63.06 -66.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.677 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -49.22 -46.26 45.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.669 ' CE2' HG11 ' A' ' 41' ' ' VAL . 1.9 m-85 -26.13 138.02 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 O-C-N 123.474 0.484 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -35.64 -71.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.947 2.431 . . . . 0.0 112.806 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.37 134.53 46.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 0.0 110.619 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -112.77 125.2 30.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.49 -170.29 7.75 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.627 -1.406 . . . . 0.0 112.026 -0.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.783 HD13 ' HD2' ' A' ' 57' ' ' ARG . 35.9 mt -89.98 151.21 44.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.592 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.04 110.68 3.08 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.596 2.197 . . . . 0.0 113.08 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 68.21 8.25 6.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.783 ' HD2' HD13 ' A' ' 54' ' ' LEU . 6.0 mtt180 -109.45 113.88 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.795 0.331 . . . . 0.0 111.545 -178.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 63.5 m -64.11 109.32 1.79 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.676 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.85 152.57 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.609 HG12 HG22 ' A' ' 76' ' ' VAL . 14.1 t -133.79 130.62 56.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.305 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.758 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.2 t -102.6 130.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.418 . . . . 0.0 111.559 -178.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.833 HD22 HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.63 119.95 40.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.832 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.1 t -150.55 158.38 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.897 0.379 . . . . 0.0 111.36 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -75.41 -11.78 60.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.4 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.0 tt0 -88.03 132.74 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.786 0.327 . . . . 0.0 110.774 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 4.3 mp0 -82.8 -21.78 34.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.519 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -91.31 -0.59 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.582 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 63' ' ' THR . 7.2 t80 -59.28 140.83 55.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.108 0.48 . . . . 0.0 111.453 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.97 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -134.31 171.98 13.52 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.442 1.115 . . . . 0.0 113.213 179.563 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.41 139.54 16.5 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.877 -1.965 . . . . 0.0 110.049 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.06 102.01 6.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.9 0.381 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.18 -44.97 1.96 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.826 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 166.7 20.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 85' ' ' TYR . 22.6 t -97.15 140.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.267 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.97 HG21 ' HA ' ' A' ' 69' ' ' GLN . 22.8 t -106.76 118.44 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 112.185 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.863 HG21 HG22 ' A' ' 82' ' ' VAL . 30.8 m -127.54 168.14 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.69 178.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 1.6 m80 -119.86 -23.08 6.55 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.563 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -157.79 -177.33 6.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 111.467 -179.464 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.94 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.7 t -65.45 -11.4 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.615 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.83 -37.24 16.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.236 0.541 . . . . 0.0 109.751 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 84' ' ' ALA . . . -71.17 -34.41 70.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.694 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.882 HG11 HG21 ' A' ' 40' ' ' VAL . 29.2 t -68.38 -54.27 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.981 0.42 . . . . 0.0 109.988 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 5.8 m-85 -51.84 -27.83 13.87 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.933 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -63.05 -45.33 92.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.713 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 74' ' ' VAL . 76.1 t80 -62.76 -53.83 48.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.141 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.81 -22.88 5.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 179.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 8.3 mttt -70.23 -41.54 73.43 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.072 0.463 . . . . 0.0 109.754 178.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -4.54 56.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.625 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 90.1 m-70 -129.63 62.76 65.13 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.63 -0.35 5.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.174 2.582 . . . . 0.0 112.845 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.75 -30.16 17.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.773 0.32 . . . . 0.0 110.834 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HB2' HD11 ' A' ' 38' ' ' ILE . 1.2 mm100 -103.08 162.09 13.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.094 0.473 . . . . 0.0 111.624 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 7.5 mt-10 -97.69 174.44 6.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.591 HD11 ' CG2' ' A' ' 40' ' ' VAL . 1.1 tp -119.66 113.87 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 111.409 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' MET . 40.1 t -127.59 111.87 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.289 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.506 HD12 ' HB ' ' A' ' 40' ' ' VAL . 8.7 mm -82.62 141.51 14.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.67 -39.88 4.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.402 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.84 -165.48 38.29 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.556 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -80.04 -161.23 23.25 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 117.358 0.579 . . . . 0.0 112.48 -0.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.73 -50.88 69.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -57.03 -25.25 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.709 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.833 HD12 HD22 ' A' ' 62' ' ' LEU . 42.2 mm -79.29 -36.89 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.771 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.475 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.3 m-85 -50.81 -56.76 10.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.446 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.763 ' CA ' HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -67.22 -9.65 42.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.713 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.93 -42.25 24.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 110.977 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.94 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.4 m-85 -93.54 -11.53 31.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.244 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.6 OUTLIER -50.34 -28.71 8.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.235 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.12 -8.38 59.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.601 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.53 -23.58 4.39 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 106' ' ' PHE . 90.7 t -44.11 128.99 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.431 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 18.0 t70 -102.51 -12.73 17.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.341 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.805 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 77.9 m -151.61 140.07 20.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.016 -179.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.664 HD23 HG11 ' A' ' 110' ' ' VAL . 13.7 mt -119.18 146.05 45.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.279 0.562 . . . . 0.0 111.56 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 113' ' ' LEU . 19.6 mt -135.13 112.66 10.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.549 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.668 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -134.52 144.99 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 111.76 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -109.9 114.42 27.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.361 179.044 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -86.31 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.2 121.67 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.201 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -60.67 -61.72 2.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.224 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.65 -172.19 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.6 p -121.98 157.93 30.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.99 166.39 30.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.78 169.82 3.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . -163.89 135.95 4.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -38.46 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -117.57 137.31 52.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.3 163.34 12.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.014 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -173.16 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.763 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.6 pp -108.39 163.89 15.96 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.29 99.57 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.953 2.435 . . . . 0.0 112.736 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.4 146.02 25.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.074 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.48 80.77 2.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.44 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.4 m95 -60.82 -20.08 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.123 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.53 -30.34 65.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.913 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.46 -27.39 41.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.2 m-85 -97.83 176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.823 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 m -136.13 141.98 44.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.637 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 8.6 ttpt -83.56 116.79 22.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 157' ' ' VAL . 21.1 m -102.34 -18.95 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 157' ' ' VAL . 48.7 m -163.6 141.06 7.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.699 0.285 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.637 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 86.1 p -169.48 106.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -140.77 118.96 12.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.827 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.812 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.4 m -68.71 145.18 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.166 0.508 . . . . 0.0 111.527 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 153' ' ' HIS . 9.0 t -119.61 103.94 14.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.185 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.44 ' HA ' HG23 ' A' ' 152' ' ' THR . 7.3 mt-10 -86.83 103.68 15.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.503 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.2 -174.13 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.448 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.3 p -55.37 -56.62 18.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.722 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -72.73 121.75 85.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.57 -25.54 79.18 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.035 1.823 . . . . 0.0 112.292 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.14 -19.62 22.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -86.35 8.16 22.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.66 0.267 . . . . 0.0 111.367 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 153' ' ' HIS . 66.0 m -68.79 165.63 19.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.452 ' N ' HG22 ' A' ' 152' ' ' THR . 2.0 p80 -168.99 155.1 6.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.812 ' OG1' HG23 ' A' ' 143' ' ' THR . 21.8 m -118.26 132.21 56.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -94.94 104.42 16.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.843 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -100.8 151.37 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.23 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.84 ' O ' HG22 ' A' ' 139' ' ' VAL . 12.3 t -141.99 107.68 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.825 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 26.8 m95 -108.81 146.07 34.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -126.43 114.41 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.676 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.478 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -52.64 131.09 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.883 -179.436 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -97.45 176.31 5.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.741 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.132 179.985 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.537 HG23 ' HB3' ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.18 145.5 40.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.838 ' CE2' HG21 ' A' ' 110' ' ' VAL . 2.0 m-30 -109.3 112.3 24.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.425 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.992 HD12 HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -112.8 123.96 51.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.757 -179.504 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.622 ' CH2' HG12 ' A' ' 115' ' ' VAL . 7.8 p90 -165.52 164.95 19.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.319 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' ILE . . . -120.77 138.2 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.669 0.271 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -122.41 149.81 43.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 0.0 111.253 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -103.39 -162.96 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -42.04 72.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.53 -27.86 31.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.96 26.28 5.84 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.578 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -79.61 147.59 32.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 110.621 -179.929 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.768 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.1 mttp . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 121.941 0.877 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.575 HG12 HG21 ' A' ' 58' ' ' THR . 6.8 mt -62.76 110.23 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.583 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.685 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.0 ttp -99.17 114.27 26.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.495 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.75 HG21 HG11 ' A' ' 82' ' ' VAL . 11.3 t -87.53 125.55 41.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.57 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 32.3 m -132.2 149.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.158 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.14 158.02 53.61 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.086 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -55.83 -45.39 78.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -63.55 -32.4 73.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 110.477 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 m -72.2 -42.47 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.459 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 11.2 t80 -65.86 -24.41 66.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -66.8 -19.92 65.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.65 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.57 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -34.4 134.44 0.39 Allowed Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.658 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.14 -41.29 58.21 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.936 2.424 . . . . 0.0 113.252 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -151.15 131.29 13.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.341 . . . . 0.0 111.029 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -132.22 125.29 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.028 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 83.6 Cg_endo -90.12 -179.32 12.93 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.137 -0.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 65.5 mt -75.88 152.8 84.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.62 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.82 101.7 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.552 2.168 . . . . 0.0 112.959 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 68.46 21.04 8.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.149 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.523 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 3.8 mmt180 -116.63 139.84 50.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.575 HG21 HG12 ' A' ' 38' ' ' ILE . 55.7 m -86.8 115.47 24.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.0 0.429 . . . . 0.0 111.435 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -101.11 156.83 17.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.625 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 12.7 t -137.13 131.74 46.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.545 HG21 ' HB2' ' A' ' 70' ' ' ALA . 90.5 t -105.99 121.93 58.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.085 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -107.29 107.18 17.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.112 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.731 HG21 ' CD2' ' A' ' 68' ' ' TYR . 6.3 t -143.7 164.81 29.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.162 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -79.74 -8.45 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.312 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.5 tp60 -79.81 124.69 28.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.354 . . . . 0.0 110.489 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 3.3 mt-10 -77.27 -30.38 54.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.93 14.5 28.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.359 . . . . 0.0 111.181 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.783 ' O ' HG11 ' A' ' 75' ' ' VAL . 5.7 t80 -63.18 147.23 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.142 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.663 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.8 mm100 -124.89 174.76 7.74 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.475 1.131 . . . . 0.0 112.868 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.54 143.07 18.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.89 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -66.35 94.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.29 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.59 -20.17 2.31 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.775 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.693 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -76.76 170.85 15.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.12 0.485 . . . . 0.0 112.071 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.95 140.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.456 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 68' ' ' TYR . 24.5 t -103.47 106.98 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.457 . . . . 0.0 111.771 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.799 HG21 HG22 ' A' ' 82' ' ' VAL . 30.7 m -119.67 176.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.051 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 10.6 m170 -128.94 -21.12 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.82 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -155.69 -174.81 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.199 -179.719 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.825 HG21 ' O ' ' A' ' 105' ' ' ALA . 25.2 t -70.02 -11.06 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.67 -38.59 16.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.091 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -68.19 -34.45 76.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.672 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.799 HG22 HG21 ' A' ' 76' ' ' VAL . 20.8 t -69.29 -53.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.599 179.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -53.37 -31.03 42.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.062 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.55 -47.03 87.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 69.0 t80 -60.69 -52.75 63.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.81 -26.26 57.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.609 178.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -66.44 -39.55 88.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.002 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -84.84 -1.13 56.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.148 178.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 42.5 m-70 -124.83 60.34 26.28 Favored Pre-proline 0 N--CA 1.456 -0.142 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.098 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.14 -3.25 5.8 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.866 2.377 . . . . 0.0 112.508 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -100.66 -25.6 14.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.026 179.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -98.83 160.13 14.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.328 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -105.9 174.89 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.537 ' HB3' HG23 ' A' ' 1' ' ' THR . 10.0 tp -122.33 110.45 15.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.96 HG12 HD21 ' A' ' 4' ' ' LEU . 17.2 t -124.28 109.69 23.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 40' ' ' VAL . 3.7 mm -82.6 131.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.398 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.473 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.26 -47.31 5.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.718 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.76 -168.1 41.19 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.392 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -90.27 -160.78 36.85 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 117.8 0.8 . . . . 0.0 112.814 0.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.64 -57.99 3.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 111.69 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.98 -31.98 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 37.7 mm -80.97 -26.43 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.292 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -61.69 -51.93 66.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.631 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.771 ' HA ' HD13 ' A' ' 129' ' ' ILE . 13.9 t -68.81 -10.01 54.32 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.825 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -73.17 -47.07 46.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.803 ' CD2' HG13 ' A' ' 79' ' ' VAL . 8.0 m-85 -95.11 -2.61 49.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.726 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.575 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 37.4 pttt -54.38 -32.2 56.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -79.63 -8.46 59.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.793 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.05 -18.07 7.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.838 HG21 ' CE2' ' A' ' 3' ' ' PHE . 48.7 t -48.0 134.69 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 4.7 t70 -113.32 6.02 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.199 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 3.7 m -170.58 142.79 2.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.429 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 114' ' ' LEU . 8.3 mt -122.55 144.69 48.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.084 0.468 . . . . 0.0 111.578 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.992 HD12 HD12 ' A' ' 4' ' ' LEU . 22.1 mt -135.22 118.35 16.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.155 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 156' ' ' GLU . 1.2 m -131.54 140.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.819 0.342 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.22 121.99 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.26 101.4 10.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.661 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.578 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.8 mp -83.82 134.98 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.59 -51.99 61.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.63 170.95 9.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.0 p -105.76 170.72 7.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.1 m-85 -148.0 168.75 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.015 0.436 . . . . 0.0 111.279 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -114.1 146.89 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.315 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.449 ' O ' HD11 ' A' ' 12' ' ' LEU . . . 168.85 176.9 39.34 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.674 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.67 62.3 1.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.649 HG22 HD11 ' A' ' 13' ' ' ILE . 4.5 m -164.14 124.46 2.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.19 164.98 13.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.4 ' SD ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -76.75 -177.69 4.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.771 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -103.53 165.1 14.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.301 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.9 102.66 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.665 2.244 . . . . 0.0 112.071 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.4 HD12 ' SD ' ' A' ' 128' ' ' MET . 1.8 mt -90.26 148.24 23.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.73 78.96 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -61.23 -19.53 61.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.71 -32.92 66.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.652 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 4.5 t70 -81.72 -18.49 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 113' ' ' LEU . 62.7 m-85 -106.32 167.14 10.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.483 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.515 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -131.05 141.19 50.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.571 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.9 ttpm? -82.73 113.9 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.662 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 157' ' ' VAL . 35.3 m -97.41 -25.79 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.563 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -156.06 140.55 16.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.882 0.373 . . . . 0.0 111.184 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.571 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 53.4 p -166.15 105.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.753 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.589 ' C ' HG23 ' A' ' 154' ' ' THR . 7.2 ttt85 -146.07 129.83 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.755 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -77.54 146.72 36.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.767 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 152' ' ' THR . 6.1 t -117.32 104.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.363 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.77 104.7 16.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.57 -172.96 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.442 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 60.9 p -55.69 -58.48 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.589 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.658 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 10.2 t30 -76.6 136.01 67.99 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.841 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.21 -34.38 68.43 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.986 1.79 . . . . 0.0 112.686 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.74 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.487 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.3 mt -77.65 10.31 2.78 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 144' ' ' VAL . 57.4 m -85.44 159.91 19.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.08 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.578 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -173.46 160.55 3.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.755 ' OG1' HG23 ' A' ' 143' ' ' THR . 17.2 m -122.3 144.69 48.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.71 179.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.88 105.22 13.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.69 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.9 mt-10 -99.2 121.33 40.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.902 0.382 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.742 ' O ' HG22 ' A' ' 139' ' ' VAL . 18.1 t -116.2 111.62 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.499 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 32.1 m95 -106.13 148.62 27.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.959 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -129.68 123.86 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.225 179.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -51.45 128.82 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.542 -179.343 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.515 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.16 -173.82 2.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.758 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.125 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.542 0.21 . . . . 0.0 110.491 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.61 149.3 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.348 0.594 . . . . 0.0 112.438 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.486 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.5 m-30 -116.68 113.0 22.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.873 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.58 118.57 36.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 112.014 -179.486 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.792 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.4 p90 -164.09 174.51 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.12 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -128.42 135.17 49.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 111.673 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.6 pt20 -132.82 154.64 50.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 15.5 p-10 -107.55 -167.62 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -40.95 68.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -28.97 47.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.05 19.51 11.66 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.754 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 126' ' ' THR . 3.8 mt -70.97 175.73 4.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.168 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mttm . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.82 90.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ttp -102.69 121.59 42.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.932 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.734 HG13 ' HB ' ' A' ' 60' ' ' VAL . 9.7 t -89.55 131.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.731 HG11 ' HE2' ' A' ' 49' ' ' PHE . 21.6 m -132.28 142.06 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.184 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.94 156.83 43.5 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.095 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.64 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.3 -52.61 58.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.858 0.329 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -60.21 -34.25 73.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.075 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -67.65 -45.5 75.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 33.1 t80 -59.46 -27.27 65.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.5 -66.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.725 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -52.44 -30.37 29.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.925 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -37.05 122.34 0.83 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.935 -179.511 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 64.3 Cg_exo -42.91 -27.24 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.233 2.622 . . . . 0.0 113.729 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.62 148.92 28.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 111.236 -179.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.15 107.76 6.23 Favored Pre-proline 0 CA--C 1.533 0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.5 Cg_endo -88.43 178.78 18.39 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.158 -0.15 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 49' ' ' PHE . 10.6 mt -76.64 155.33 83.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.36 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.421 ' HD2' HD23 ' A' ' 54' ' ' LEU . 9.7 Cg_endo -52.98 -74.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.703 2.268 . . . . 0.0 112.385 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -113.38 50.64 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.104 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -142.47 101.49 3.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.987 -179.618 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.3 m -62.16 113.52 2.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.508 HD21 HD12 ' A' ' 54' ' ' LEU . 2.0 m-80 -107.74 148.34 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.431 0.634 . . . . 0.0 112.348 -178.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.751 HG12 HG22 ' A' ' 76' ' ' VAL . 21.8 t -122.86 139.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.389 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 43' ' ' ARG . 92.7 t -108.34 124.02 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.845 -178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.711 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -101.41 117.98 36.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.852 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.48 162.15 41.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.727 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -83.0 -8.57 59.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 8.8 tt0 -85.13 131.19 34.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 111.057 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -25.21 42.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.59 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -94.74 5.17 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.753 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.852 ' CG ' HG21 ' A' ' 63' ' ' THR . 5.9 t80 -58.98 148.05 32.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.023 0.439 . . . . 0.0 111.088 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.856 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -136.15 174.85 10.16 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.201 1.001 . . . . 0.0 112.848 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.87 145.0 21.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.793 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -74.65 95.91 2.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.311 . . . . 0.0 110.314 179.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.2 -34.95 3.18 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.305 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.558 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.76 169.64 14.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG11 ' CD1' ' A' ' 85' ' ' TYR . 5.1 t -96.69 140.65 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.331 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.856 HG21 ' HA ' ' A' ' 69' ' ' GLN . 20.1 t -107.63 118.54 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.186 0.517 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.896 HG21 HG22 ' A' ' 82' ' ' VAL . 35.6 m -128.44 171.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.839 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -122.38 -22.43 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.55 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 t70 -158.15 -175.65 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.051 0.453 . . . . 0.0 111.08 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.97 HG13 ' CD2' ' A' ' 106' ' ' PHE . 9.4 t -65.66 -11.34 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.72 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.49 16.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.15 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.68 -29.36 63.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.613 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.896 HG22 HG21 ' A' ' 76' ' ' VAL . 25.1 t -70.99 -52.63 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.443 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.6 m-85 -54.18 -26.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.586 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -65.34 -44.07 88.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.956 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.531 ' CD1' HG11 ' A' ' 74' ' ' VAL . 88.3 t80 -66.7 -56.6 9.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.57 -23.65 17.69 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.561 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.05 -39.75 78.98 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.723 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -83.73 -5.45 59.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.403 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -129.54 64.92 73.31 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.22 1.08 3.78 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.424 2.749 . . . . 0.0 113.001 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 -33.4 25.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.969 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.5 160.72 15.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 111.621 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -98.43 156.48 16.73 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.788 HD11 HG12 ' A' ' 82' ' ' VAL . 7.7 tp -96.29 115.08 26.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.349 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.55 114.55 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.2 mm -81.77 139.43 17.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.068 0.461 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.479 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -108.55 -46.1 3.74 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.51 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.87 -170.4 43.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.317 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.93 36.82 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 117.409 0.605 . . . . 0.0 112.605 0.018 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.38 -45.93 36.39 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -58.74 -34.34 71.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.711 ' CD1' HD22 ' A' ' 62' ' ' LEU . 28.7 mm -82.28 -29.51 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.1 m-85 -57.67 -57.13 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.661 -179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.741 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.2 t -67.47 -9.61 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.648 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.47 -44.45 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.0 111.302 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.97 ' CD2' HG13 ' A' ' 79' ' ' VAL . 16.2 m-85 -91.82 -7.95 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.524 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -52.21 -31.18 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 110.918 179.869 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 107' ' ' LYS . 1.5 t0 -75.35 -10.99 59.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.554 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -122.41 -19.77 6.31 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.857 HG11 HD23 ' A' ' 113' ' ' LEU . 75.8 t -45.18 120.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.44 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.421 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 19.4 t70 -100.3 -3.9 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.269 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 49.7 m -160.07 141.91 12.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.088 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.857 HD23 HG11 ' A' ' 110' ' ' VAL . 7.3 mt -123.29 147.62 46.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.248 0.547 . . . . 0.0 111.859 -179.161 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.76 113.58 11.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.387 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.792 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.3 m -129.65 140.94 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -110.57 106.76 16.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.507 179.502 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 35.8 mtp180 -80.06 98.64 7.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.2 mp -81.86 122.67 28.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.29 -66.81 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.51 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.65 162.9 5.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.604 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 p -95.1 168.16 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.899 0.381 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 3.4 m-85 -138.76 160.42 39.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.48 139.76 53.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.131 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.44 -146.41 5.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.634 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.86 -29.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.508 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.494 ' O ' HD23 ' A' ' 12' ' ' LEU . 5.6 m -108.9 137.98 45.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -178.71 3.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -73.75 159.17 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.741 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.16 156.23 48.96 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.269 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.36 100.83 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.725 2.283 . . . . 0.0 112.459 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.8 149.14 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 69.11 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.03 0.443 . . . . 0.0 110.709 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.547 ' HH2' HG11 ' A' ' 115' ' ' VAL . 89.9 m95 -55.22 -22.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -31.57 66.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 110.662 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -80.81 -20.06 43.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.937 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.581 ' CD1' HD11 ' A' ' 113' ' ' LEU . 94.1 m-85 -104.26 168.71 8.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.075 0.464 . . . . 0.0 111.29 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.634 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -130.54 142.56 50.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.929 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 6.1 ttpt -81.97 115.03 20.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.4 m -101.59 -17.43 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.603 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.3 m -165.93 140.64 4.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 110.969 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.2 p -165.71 112.87 0.93 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.404 ' C ' HG23 ' A' ' 154' ' ' THR . 7.7 ttt85 -147.85 121.03 8.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.84 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.81 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.6 m -73.54 144.45 46.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.176 0.512 . . . . 0.0 111.916 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 155' ' ' TYR . 6.5 t -117.3 105.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.968 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.438 ' HA ' HG23 ' A' ' 152' ' ' THR . 47.8 mt-10 -90.48 103.36 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.949 -178.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -169.7 2.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.352 179.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.6 p -60.23 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.931 0.396 . . . . 0.0 110.467 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.505 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -67.43 118.61 58.43 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.83 -25.48 61.65 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.887 1.725 . . . . 0.0 112.377 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.42 -20.27 25.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.147 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 mt -86.41 8.88 19.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.71 0.29 . . . . 0.0 111.106 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 153' ' ' HIS . 55.1 m -72.4 168.4 18.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.947 0.403 . . . . 0.0 110.001 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.49 ' N ' HG22 ' A' ' 152' ' ' THR . 1.5 p80 -173.52 160.18 3.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.038 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.81 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.6 m -122.04 145.41 48.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.772 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 144' ' ' VAL . 29.6 m-85 -106.41 104.64 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.767 0.318 . . . . 0.0 110.441 179.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.587 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.4 mt-10 -109.08 127.54 54.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.974 0.416 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.772 ' O ' HG22 ' A' ' 139' ' ' VAL . 25.0 t -117.35 114.02 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.557 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.475 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.3 m95 -108.4 148.14 30.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.123 -179.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.455 ' CD ' HG11 ' A' ' 139' ' ' VAL . 24.7 mt-30 -125.49 112.21 15.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -49.32 133.33 19.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.214 0.531 . . . . 0.0 112.259 -179.405 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.634 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 32.6 mtmt -108.48 -178.47 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.786 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.995 -179.875 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 25.4 m . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.3 151.14 30.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -116.1 111.8 20.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.346 178.933 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.746 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.31 122.81 48.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.42 0.628 . . . . 0.0 112.351 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.808 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.8 p90 -168.61 168.8 10.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.674 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.55 133.28 52.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -129.07 164.27 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.137 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.442 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -110.18 -171.62 1.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -54.96 -30.42 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.407 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -87.4 -32.22 19.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.903 -179.95 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.25 36.01 3.23 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.651 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.577 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -93.39 145.92 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.772 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 126' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.409 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 92' ' ' GLN . 7.0 mmtp . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.455 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 52.9 mt -79.06 88.29 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.237 0.471 . . . . 0.0 111.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.1 ttp -96.13 120.13 35.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.403 -179.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.4 t -81.23 153.42 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 40' ' ' VAL . 28.2 m -161.87 146.42 4.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.58 155.47 51.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.841 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.496 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.6 -51.33 56.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.938 0.369 . . . . 0.0 110.889 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 44' ' ' ARG . 5.4 tpp180 -60.14 -31.91 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -73.5 -43.4 60.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.612 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 52' ' ' ARG . 24.5 t80 -61.94 -29.24 70.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.8 -66.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.2 p -48.21 -37.08 15.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.357 -179.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' HG11 ' A' ' 41' ' ' VAL . 2.7 m-30 -37.68 149.42 0.19 Allowed Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.492 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.52 -73.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.503 2.135 . . . . 0.0 112.305 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.16 167.42 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.0 111.003 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 45.4 mtp180 -129.13 111.28 18.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.959 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 66.9 Cg_endo -89.5 -171.33 5.88 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.173 -0.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 74.7 mt -80.53 158.96 70.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.236 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 58.2 Cg_endo -72.2 107.16 2.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.531 2.154 . . . . 0.0 113.445 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 74.12 4.4 4.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.27 178.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.55 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 15.6 mtt180 -112.6 116.41 30.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 0.0 111.542 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 43.1 m -73.11 111.4 8.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.449 HD21 HD12 ' A' ' 54' ' ' LEU . 3.3 m-80 -98.92 156.94 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.247 0.546 . . . . 0.0 112.195 -178.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 76' ' ' VAL . 7.1 t -137.05 132.17 46.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.16 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 43' ' ' ARG . 88.6 t -104.61 128.39 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.717 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -107.65 125.33 51.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.504 -179.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.6 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -165.68 150.46 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 179.618 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 21.5 t-80 -74.43 -2.68 26.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.702 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.869 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 8.6 tp60 -70.95 133.61 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -88.57 -3.23 58.85 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 65' ' ' GLN . 4.9 m-20 -128.25 5.98 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.569 0.223 . . . . 0.0 111.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.869 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.0 t80 -59.93 141.8 54.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.236 0.541 . . . . 0.0 111.968 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.862 ' HA ' HG21 ' A' ' 75' ' ' VAL . 13.7 mm100 -127.11 178.45 6.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.08 0.943 . . . . 0.0 112.104 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.46 144.53 19.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.607 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -76.96 96.36 4.35 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.338 179.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.88 -40.15 3.09 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.961 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -68.61 168.46 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.732 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 60' ' ' VAL . 15.6 t -96.88 140.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.862 HG21 ' HA ' ' A' ' 69' ' ' GLN . 40.2 t -100.09 107.32 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 0.0 112.314 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.81 HG21 HG22 ' A' ' 82' ' ' VAL . 27.1 m -117.68 161.59 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.026 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 77' ' ' HIS . 1.3 m170 -111.67 -22.45 11.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.231 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.878 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -161.38 -168.86 2.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.174 0.512 . . . . 0.0 111.594 -179.153 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.858 HG13 ' CD2' ' A' ' 106' ' ' PHE . 3.1 t -70.3 -10.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.539 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.87 -37.35 16.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.212 0.53 . . . . 0.0 109.768 178.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.93 -32.95 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.757 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.811 HG12 HD11 ' A' ' 94' ' ' LEU . 24.3 t -70.0 -51.71 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.4 m-85 -56.33 -27.42 55.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.334 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -64.54 -44.83 89.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 179.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.27 -54.07 43.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.974 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -58.07 -22.84 52.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.899 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.21 -30.11 63.28 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.22 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.411 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 5.9 mt-30 -92.95 -13.0 29.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.33 178.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -125.16 65.03 47.42 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.433 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.8 0.17 5.3 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.258 2.638 . . . . 0.0 113.018 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.02 -41.42 35.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -100.51 165.89 11.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.092 0.472 . . . . 0.0 111.669 -179.436 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -98.4 170.38 8.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.034 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.974 HD12 ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -118.58 114.21 22.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.445 -179.465 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.46 113.29 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.308 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 5.7 mm -79.11 135.1 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.01 0.433 . . . . 0.0 111.183 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -110.27 -41.3 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.209 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.55 -169.7 41.88 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.738 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.3 -160.74 36.32 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 122.103 -0.645 . . . . 0.0 112.558 -0.151 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.49 60.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.669 0.271 . . . . 0.0 111.203 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 -60.19 -30.49 69.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.8 mm -76.88 -26.27 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.936 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 3.5 m-85 -62.58 -58.01 9.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.704 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.501 ' CA ' HD13 ' A' ' 129' ' ' ILE . 8.9 t -67.63 -10.27 50.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.688 -0.633 . . . . 0.0 111.751 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.56 -37.7 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.888 ' O ' HG23 ' A' ' 110' ' ' VAL . 2.8 m-85 -101.36 -3.17 29.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.503 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.49 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 20.2 pttp -49.84 -32.5 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.73 0.3 . . . . 0.0 111.486 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -92.5 1.59 57.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.651 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.662 ' CB ' HG11 ' A' ' 79' ' ' VAL . 2.5 m-20 -122.0 -26.87 4.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.705 0.288 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 106' ' ' PHE . 58.6 t -48.96 128.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 5.5 t70 -100.99 -7.38 23.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.734 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.3 m -156.21 140.29 16.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 HG11 ' A' ' 110' ' ' VAL . 11.5 mt -120.29 144.71 47.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.184 0.516 . . . . 0.0 111.674 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 113' ' ' LEU . 9.5 mt -135.61 117.02 14.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.805 179.149 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.808 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -134.94 144.83 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 111.663 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.57 109.85 18.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.435 179.319 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -93.45 103.64 15.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.548 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 1.2 mt -91.32 130.97 37.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.182 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -49.96 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.4 156.16 39.04 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.313 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 86.2 p -101.26 142.97 31.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -123.03 156.55 34.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -113.27 134.83 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.996 0.427 . . . . 0.0 111.409 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.577 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -158.34 -162.44 11.83 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.392 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 8.36 3.02 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.404 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.5 m -120.3 109.93 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.798 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -92.38 142.48 27.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -178.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.501 HD13 ' CA ' ' A' ' 104' ' ' THR . 2.3 pp -111.75 158.68 35.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 129' ' ' ILE . 31.2 Cg_exo -59.14 135.46 66.2 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.709 2.273 . . . . 0.0 112.281 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.419 HD11 ' CH2' ' A' ' 5' ' ' TRP . 3.8 mt -120.53 143.4 48.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.129 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 79.56 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -63.53 -15.03 56.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -33.46 62.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.996 0.426 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.6 t70 -83.18 -16.09 47.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.334 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.532 ' CD2' HD11 ' A' ' 113' ' ' LEU . 66.3 m-85 -106.9 164.47 12.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.813 0.34 . . . . 0.0 111.027 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.423 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -125.6 140.87 52.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -85.06 114.56 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.677 179.654 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.778 HG11 HE21 ' A' ' 159' ' ' GLN . 16.0 m -101.74 -18.96 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.52 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.69 139.98 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.398 . . . . 0.0 111.248 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -168.75 106.87 0.45 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.331 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -142.55 122.11 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.367 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.1 m -72.82 145.8 46.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.316 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 152' ' ' THR . 4.7 t -114.99 103.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 178.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 99.23 11.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.471 -179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.84 -177.66 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.7 p -54.33 -54.51 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -73.45 124.28 90.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.947 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 -29.53 89.33 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.124 1.882 . . . . 0.0 112.268 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.99 -18.52 28.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.801 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.5 mt -86.03 10.45 14.19 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 153' ' ' HIS . 55.1 m -74.69 166.15 24.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -172.15 158.94 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.218 179.7 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 143' ' ' THR . 33.4 m -123.06 133.76 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -98.77 107.86 20.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.551 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.3 mt-10 -97.17 149.69 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.081 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 139' ' ' VAL . 16.7 t -141.28 106.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.003 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.49 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 24.2 m95 -110.15 146.24 35.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.0 111.779 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.778 HE21 HG11 ' A' ' 139' ' ' VAL . 13.7 mt-30 -128.11 119.79 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.159 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 7.7 tttm -46.44 129.0 10.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.735 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 1.6 ptpt -109.28 -176.85 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.816 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.145 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.16 154.6 23.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 96' ' ' ILE . 0.8 OUTLIER -121.53 114.56 21.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.226 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.88 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.73 122.9 47.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.47 0.652 . . . . 0.0 112.466 -178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.778 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.7 p90 -164.12 165.15 22.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.189 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.39 136.06 53.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.361 . . . . 0.0 111.737 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -125.89 144.26 50.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.518 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.9 p30 -98.41 -169.29 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.489 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -49.46 -49.27 46.1 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.175 0.512 . . . . 0.0 110.59 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -29.24 63.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.288 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.02 31.09 6.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.758 HD23 ' N ' ' A' ' 13' ' ' ILE . 7.5 tt -83.43 167.9 17.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.592 0.235 . . . . 0.0 110.618 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.758 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -128.22 -64.59 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.348 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.64 ' H ' HD12 ' A' ' 13' ' ' ILE . . . -157.4 -163.59 12.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.642 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -105.64 168.64 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 0.0 110.917 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.93 -36.79 6.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -167.99 62.58 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.662 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.34 -43.14 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 110.659 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 62.92 51.19 1.45 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.55 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 42.8 Cg_endo -76.51 -67.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.103 1.869 . . . . 0.0 111.979 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.572 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 0.0 OUTLIER 175.82 164.43 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.395 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -123.15 145.61 48.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.843 0.354 . . . . 0.0 111.022 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.14 150.21 60.57 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.29 -39.89 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.574 2.183 . . . . 0.0 112.676 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -75.09 -43.14 54.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.294 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.89 -18.03 60.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.475 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 tp -84.62 -36.24 22.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.161 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -59.03 -39.59 82.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.243 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 33' ' ' GLN . 28.5 t80 -73.62 -41.4 62.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.198 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -51.41 -39.31 57.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.238 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.918 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.54 -57.48 2.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.683 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.497 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -46.17 -24.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 29' ' ' TYR . 5.8 mm-40 -52.63 -56.33 16.15 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.504 ' OG1' ' HB ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -121.81 3.62 10.02 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.918 HG13 ' O ' ' A' ' 31' ' ' ARG . 9.4 m -47.34 162.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.7 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 77.85 9.88 86.61 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.963 -0.91 . . . . 0.0 115.09 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' HA ' ' NE2' ' A' ' 92' ' ' GLN . 12.5 mmtp -152.12 -164.62 2.01 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.654 1.727 . . . . 0.0 109.081 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 68.0 mt -77.82 89.29 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.854 0.359 . . . . 0.0 111.813 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HG3' ' CG2' ' A' ' 34' ' ' THR . 9.6 ttp -99.4 120.81 40.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.667 HG21 HG11 ' A' ' 82' ' ' VAL . 40.3 t -79.82 158.36 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 111.646 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.5 m -161.67 149.93 4.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.89 149.35 44.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.846 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.824 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -48.22 -52.4 21.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.116 0.458 . . . . 0.0 110.119 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.459 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -56.34 -34.64 66.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.251 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.56 HG22 ' CE2' ' A' ' 49' ' ' PHE . 4.0 m -70.36 -54.8 11.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.131 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 35.7 t80 -50.39 -28.06 7.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.457 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -66.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -57.5 -30.41 65.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.591 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.718 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -36.42 133.69 0.61 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.705 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 47.7 Cg_exo -38.99 -29.12 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.394 2.729 . . . . 0.0 113.766 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -162.19 152.31 16.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 111.197 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.52 108.9 10.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 88.1 Cg_endo -82.22 -179.09 22.9 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.364 -0.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 49' ' ' PHE . 51.0 mt -82.23 145.82 53.24 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.774 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.402 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 56.1 Cg_endo -70.65 109.66 2.54 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.419 2.079 . . . . 0.0 112.236 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.468 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 2.9 mt-10 77.55 14.68 1.73 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.8 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -132.89 112.63 12.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.638 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 46.6 m -70.51 113.03 7.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.083 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.604 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -103.38 156.66 17.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.305 0.574 . . . . 0.0 112.079 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 76' ' ' VAL . 21.6 t -133.29 141.35 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.152 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.824 HG13 ' HA ' ' A' ' 43' ' ' ARG . 59.9 t -109.05 123.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.916 0.388 . . . . 0.0 111.351 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.506 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -105.62 120.12 40.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.829 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.8 t -153.6 155.77 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.5 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.861 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.2 tt0 -74.12 134.05 42.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.97 1.83 53.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.672 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -127.79 3.6 6.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.61 0.243 . . . . 0.0 111.503 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.886 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.0 t80 -57.1 137.82 55.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 111.419 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.934 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -130.39 173.39 10.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.218 1.008 . . . . 0.0 112.613 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.52 143.3 19.77 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.322 -1.763 . . . . 0.0 110.576 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.4 101.16 7.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.791 0.329 . . . . 0.0 110.336 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.46 -40.92 2.9 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.749 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.16 166.89 18.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.551 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.13 140.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.934 HG21 ' HA ' ' A' ' 69' ' ' GLN . 15.0 t -109.3 117.66 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.924 HG21 HG22 ' A' ' 82' ' ' VAL . 26.9 m -126.96 167.36 21.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.426 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -116.82 -22.33 8.6 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.685 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -155.64 -173.62 4.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 0.0 111.622 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.943 HG13 ' CD2' ' A' ' 106' ' ' PHE . 19.3 t -69.72 -9.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.728 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.64 -34.72 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.443 . . . . 0.0 110.107 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.24 -30.81 62.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.991 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.924 HG22 HG21 ' A' ' 76' ' ' VAL . 23.1 t -73.52 -49.39 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 109.998 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.438 ' CE2' HG12 ' A' ' 79' ' ' VAL . 5.7 m-85 -57.08 -28.02 62.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.909 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.29 -42.22 88.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.039 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.89 -56.23 12.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.16 -22.8 30.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.976 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.72 -41.73 71.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -83.82 -10.02 58.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.546 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -123.71 64.73 32.27 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.59 -0.8 6.45 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.044 2.496 . . . . 0.0 112.756 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.54 26.95 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -99.4 163.57 12.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.454 . . . . 0.0 111.457 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.98 159.76 14.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.571 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.527 HD11 ' CG1' ' A' ' 82' ' ' VAL . 51.4 tp -113.52 113.58 25.33 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.837 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.504 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 30.3 t -134.54 121.59 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.679 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.512 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 17.6 mm -81.0 132.02 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.06 0.457 . . . . 0.0 111.42 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -96.9 -50.55 4.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.067 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.09 -169.35 42.46 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.425 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.75 -160.78 36.47 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 117.635 0.717 . . . . 0.0 112.493 -0.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.57 -48.76 19.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.765 0.317 . . . . 0.0 111.301 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.8 -32.46 52.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.122 0.487 . . . . 0.0 110.403 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.506 ' CD1' HD22 ' A' ' 62' ' ' LEU . 45.8 mm -85.23 -27.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.205 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -60.67 -57.46 12.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.751 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' ' 129' ' ' ILE . 1.6 t -66.81 -9.97 42.84 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.93 -0.481 . . . . 0.0 112.263 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.747 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.34 -39.87 62.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.943 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.9 m-85 -101.36 -3.18 29.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.767 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 104' ' ' THR . 1.8 pttt -49.16 -32.52 10.33 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -0.73 57.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.2 m-20 -120.48 -26.9 5.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.342 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.801 HG11 HD23 ' A' ' 113' ' ' LEU . 62.7 t -50.11 126.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.207 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.59 -12.65 19.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.04 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 95.9 m -148.28 141.79 25.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.523 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.801 HD23 HG11 ' A' ' 110' ' ' VAL . 12.9 mt -123.62 146.78 47.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.262 0.554 . . . . 0.0 111.743 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.0 mt -135.55 116.97 14.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.778 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -131.71 141.95 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.427 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.41 99.25 7.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.608 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -75.53 100.06 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.384 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 mt -84.66 126.54 33.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.325 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.11 -43.51 82.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.208 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.85 167.55 48.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.514 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.2 p -101.2 150.79 22.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 111.0 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -130.37 149.32 52.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 167.38 15.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.983 0.421 . . . . 0.0 111.318 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.43 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . 146.69 164.67 11.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.89 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -1.29 12.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.503 0.192 . . . . 0.0 111.316 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.49 HG22 HD11 ' A' ' 13' ' ' ILE . 3.7 m -109.22 128.65 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.828 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -105.24 164.07 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.54 147.4 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.1 pt -71.14 164.39 57.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.27 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.61 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.0 Cg_endo -74.92 102.9 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.357 2.038 . . . . 0.0 112.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -88.1 144.35 26.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.54 70.49 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.302 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.443 ' HH2' HG11 ' A' ' 115' ' ' VAL . 85.2 m95 -55.04 -24.98 27.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.292 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.64 -30.3 65.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 0.0 110.474 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -80.32 -25.65 39.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.304 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 85.5 m-85 -100.26 176.58 5.33 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.772 0.32 . . . . 0.0 110.43 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -137.09 140.71 42.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.261 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.531 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.2 ttpm? -79.93 114.81 19.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.886 HG22 ' O ' ' A' ' 157' ' ' VAL . 17.1 m -97.64 -19.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -164.11 140.76 6.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.5 p -163.75 112.65 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.036 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.442 ' C ' HG23 ' A' ' 154' ' ' THR . 5.8 ttt-85 -148.1 125.34 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.662 HG23 ' OG1' ' A' ' 154' ' ' THR . 3.5 m -79.24 145.72 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 152' ' ' THR . 5.0 t -119.2 103.5 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -84.49 99.81 10.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 -179.92 7.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.4 p -53.41 -46.98 69.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 110.581 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.504 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -79.11 124.27 84.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.368 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.96 -29.44 89.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 112.599 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.37 -18.75 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.2 mt -83.94 7.06 19.5 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.579 0.228 . . . . 0.0 111.466 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 91.1 m -71.07 164.91 24.63 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -171.05 157.63 5.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.603 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.662 ' OG1' HG23 ' A' ' 143' ' ' THR . 45.1 m -123.2 126.56 47.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.588 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.22 105.44 17.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.75 ' HB2' HG22 ' A' ' 115' ' ' VAL . 75.3 mt-10 -106.37 124.61 49.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.196 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.886 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.8 t -116.55 113.68 43.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.259 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.531 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 20.2 m95 -108.62 150.23 27.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.937 0.399 . . . . 0.0 111.481 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.593 ' OE1' HG11 ' A' ' 139' ' ' VAL . 29.1 mt-30 -127.51 119.0 25.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -57.08 130.8 47.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -104.37 -176.06 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.137 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 52.2 m . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.68 151.11 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 96' ' ' ILE . 1.4 m-30 -118.03 107.8 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.212 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -106.36 124.78 50.11 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.332 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.58 ' CZ2' HG12 ' A' ' 115' ' ' VAL . 6.0 p90 -168.38 174.24 7.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.4 137.79 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.5 pt20 -119.26 156.57 29.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 111.332 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 121' ' ' SER . 45.3 t0 -102.58 169.06 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.23 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.11 -30.04 6.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.929 0.395 . . . . 0.0 110.568 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -89.02 -27.51 20.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.0 22.15 6.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.714 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.2 tt -77.27 166.46 23.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.645 0.259 . . . . 0.0 110.633 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG22 ' HD1' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -131.59 -51.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.466 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.48 -167.13 39.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.585 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -92.9 -172.78 3.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 110.795 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.98 20.07 7.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.33 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.78 96.61 2.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.581 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -149.28 -36.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.651 0.262 . . . . 0.0 111.316 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 mt 65.72 69.34 0.62 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.44 -167.97 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.555 2.17 . . . . 0.0 112.277 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -66.18 93.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.6 144.75 26.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.011 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mt -105.05 158.11 32.78 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.782 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.52 1.52 8.35 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.664 2.243 . . . . 0.0 113.019 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -85.57 -37.54 19.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.698 0.285 . . . . 0.0 111.268 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.17 -57.43 2.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.277 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -40.49 -35.19 0.42 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.195 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.94 -32.31 72.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.366 . . . . 0.0 111.438 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -81.3 -40.77 23.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -68.64 -40.88 80.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.902 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.851 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -63.39 -61.88 2.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.749 0.309 . . . . 0.0 111.772 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.58 -23.12 5.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -91.01 -6.46 53.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.653 HG23 ' HG ' ' A' ' 4' ' ' LEU . 37.4 p -146.0 24.99 1.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.851 HG13 ' O ' ' A' ' 31' ' ' ARG . 20.6 m -108.3 150.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.73 29.01 57.73 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 116.827 1.491 . . . . 0.0 116.827 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 5.5 mttp -145.74 -166.47 2.46 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.419 2.109 . . . . 0.0 108.732 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 54.2 mt -86.88 88.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 O-C-N 122.012 -0.43 . . . . 0.0 110.768 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 5.6 ttp -100.13 119.12 37.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.58 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 82' ' ' VAL . 2.7 t -87.53 128.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG11 ' CE2' ' A' ' 49' ' ' PHE . 19.1 m -132.43 154.94 40.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.378 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 162.13 53.79 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.843 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.694 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -58.5 -50.01 75.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.984 0.392 . . . . 0.0 110.654 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 3.0 tpt180 -61.03 -35.96 78.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 110.297 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 -50.41 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.387 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.45 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.3 t80 -52.59 -25.09 9.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -69.63 -65.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -28.07 61.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.33 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.62 ' CE2' HG11 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -37.69 136.86 0.72 Allowed Pre-proline 0 N--CA 1.467 0.404 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.779 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.17 -30.47 25.64 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.802 2.335 . . . . 0.0 113.074 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -159.34 151.96 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -140.98 110.93 6.61 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.173 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HG3' ' O ' ' A' ' 71' ' ' GLN . 10.9 Cg_exo -81.35 178.54 31.02 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.585 -1.423 . . . . 0.0 111.996 -0.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.566 HD13 ' HE ' ' A' ' 57' ' ' ARG . 31.8 mt -83.16 156.0 66.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 38.5 Cg_endo -67.15 107.42 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.404 2.069 . . . . 0.0 112.875 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.6 mm-40 70.74 4.75 5.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.566 ' HE ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -108.51 122.92 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.938 0.399 . . . . 0.0 111.411 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 92.4 m -75.13 117.02 16.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.158 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.414 HD21 HD12 ' A' ' 54' ' ' LEU . 3.3 m-80 -105.58 156.04 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.445 . . . . 0.0 112.015 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 24.6 t -136.97 137.42 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.337 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.694 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.6 t -107.76 126.59 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 0.0 111.323 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.637 ' HG ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -107.65 117.2 33.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.969 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.813 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.3 t -148.43 161.36 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.852 0.358 . . . . 0.0 110.959 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -79.08 -11.42 59.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.452 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tp60 -82.35 134.03 35.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.535 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 52.8 mt-10 -84.01 -29.63 26.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.636 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.85 2.24 54.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.159 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.875 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.2 t80 -58.83 139.5 56.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.469 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.926 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.3 mt-30 -128.7 174.37 9.49 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.219 1.009 . . . . 0.0 112.447 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.13 144.32 21.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.847 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 13.6 mt-30 -73.52 96.85 2.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.362 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.36 -37.01 3.15 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.645 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.12 171.51 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.45 . . . . 0.0 112.024 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 60' ' ' VAL . 13.8 t -97.78 140.35 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.467 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.926 HG21 ' HA ' ' A' ' 69' ' ' GLN . 38.9 t -106.95 104.77 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.24 0.543 . . . . 0.0 112.281 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.867 HG21 HG22 ' A' ' 82' ' ' VAL . 23.6 m -117.44 166.93 11.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.366 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.406 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 3.8 m80 -121.91 -19.89 6.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.307 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.8 t70 -155.65 -178.87 7.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.209 0.528 . . . . 0.0 111.602 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.718 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.8 t -66.29 -8.97 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.767 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.73 -35.02 16.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.487 . . . . 0.0 109.869 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.91 -32.93 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.903 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.867 HG22 HG21 ' A' ' 76' ' ' VAL . 39.9 t -70.73 -49.99 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.561 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.2 m-85 -55.79 -26.24 45.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.897 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -65.61 -43.76 88.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.026 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.07 -57.14 8.39 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.96 14.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.467 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.03 -36.72 80.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 -2.59 57.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.222 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -128.56 68.28 77.77 Favored Pre-proline 0 N--CA 1.456 -0.161 0 CA-C-O 121.082 0.467 . . . . 0.0 110.298 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.97 0.55 3.04 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.41 2.74 . . . . 0.0 113.087 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.92 -19.69 17.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.229 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 5.0 mm100 -109.83 154.99 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 43.9 mm-40 -98.16 174.92 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.365 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.49 109.07 18.84 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.574 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' MET . 39.2 t -124.24 108.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.298 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 40' ' ' VAL . 18.5 mm -85.55 142.36 13.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.384 0.612 . . . . 0.0 111.961 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -111.45 -44.66 3.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.371 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.91 -165.75 38.56 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.622 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -82.53 -161.19 29.28 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.401 0.6 . . . . 0.0 112.651 -0.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.71 -48.07 69.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.855 0.359 . . . . 0.0 111.078 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -58.09 -29.19 65.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.608 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -79.95 -29.28 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.358 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.428 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 3.5 m-85 -58.44 -55.91 28.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.733 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.703 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.4 t -65.17 -9.83 26.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.613 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.47 -43.41 27.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.843 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.718 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.6 m-85 -93.56 -6.79 45.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.338 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 10.9 pttp -49.8 -32.98 15.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.399 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -78.87 -6.04 55.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.764 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.09 -24.7 4.31 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 106' ' ' PHE . 76.6 t -44.43 124.58 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.94 0.4 . . . . 0.0 111.447 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 6.3 t70 -103.07 -1.22 29.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.687 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 86.3 m -161.46 142.51 11.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.585 0.231 . . . . 0.0 111.065 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.533 HD11 ' CG ' ' A' ' 136' ' ' PHE . 7.0 mt -123.58 144.95 49.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.213 0.53 . . . . 0.0 111.415 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 113' ' ' LEU . 12.9 mt -135.33 118.94 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.761 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.602 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.9 m -134.78 144.8 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.424 . . . . 0.0 111.688 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.84 119.31 35.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 7.1 mtm180 -102.05 104.7 15.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.418 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 153' ' ' HIS . 0.8 OUTLIER -87.8 136.46 32.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.308 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.44 -48.23 68.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.27 -138.77 0.01 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.406 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.7 p -144.23 168.2 20.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 0.0 111.335 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 118' ' ' LEU . 80.0 m-85 -131.2 137.74 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.743 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 166.53 10.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.734 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.24 -159.12 29.18 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.594 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.13 22.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.5 m -146.08 137.82 24.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.863 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -109.34 165.82 11.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -177.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.703 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pt -104.06 156.73 35.3 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.88 99.9 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.671 2.247 . . . . 0.0 112.194 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.73 148.08 23.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.955 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.37 70.6 6.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.413 ' HH2' HG11 ' A' ' 115' ' ' VAL . 94.4 m95 -53.41 -27.64 25.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.094 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.09 -29.11 67.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.421 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.57 -20.67 42.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.533 ' CG ' HD11 ' A' ' 113' ' ' LEU . 43.5 m-85 -100.02 175.86 5.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.5 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 2.5 m -134.32 139.95 46.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.422 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.654 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 7.7 ttpt -83.94 111.56 19.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 157' ' ' VAL . 4.4 m -98.8 -17.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.487 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -163.89 140.21 6.62 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.954 0.407 . . . . 0.0 111.443 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.654 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 81.0 p -168.04 105.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.464 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -142.79 121.25 12.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.649 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.684 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.2 m -71.16 145.59 49.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.21 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.77 103.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.579 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.4 mt-10 -86.61 100.27 12.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.358 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -83.24 -176.9 6.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -56.68 -54.15 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.942 0.401 . . . . 0.0 110.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.539 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.6 t30 -73.63 127.84 87.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.847 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.63 -31.6 92.34 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.037 1.825 . . . . 0.0 112.563 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.62 -21.48 28.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.8 mt -82.08 8.79 9.84 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 145' ' ' GLU . 95.5 m -75.28 164.1 26.79 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.9 p80 -175.58 162.19 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.994 0.426 . . . . 0.0 111.581 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.684 ' OG1' HG23 ' A' ' 143' ' ' THR . 7.7 m -122.12 144.85 48.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.911 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -111.65 110.06 20.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.71 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HB2' HG22 ' A' ' 115' ' ' VAL . 7.0 mm-40 -98.68 151.26 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 139' ' ' VAL . 10.7 t -141.77 106.06 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.009 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 25.1 m95 -108.5 146.18 33.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.106 0.479 . . . . 0.0 111.949 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -124.81 112.74 17.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.233 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.2 tttt -51.17 131.74 27.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.227 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -92.39 168.59 11.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.295 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.159 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 11.8 m . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.789 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.28 152.47 27.16 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.3 m-30 -118.11 112.03 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.093 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -115.21 126.34 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.673 0.749 . . . . 0.0 112.881 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.719 ' CH2' HG12 ' A' ' 115' ' ' VAL . 9.0 p90 -164.6 164.73 21.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.055 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.04 134.93 54.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.84 0.352 . . . . 0.0 111.472 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 2.7 pt20 -115.61 140.34 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.796 ' OD2' HD12 ' A' ' 12' ' ' LEU . 4.5 p30 -97.82 -167.42 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.423 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -51.36 -34.66 35.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.784 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.63 -28.42 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 94.83 45.86 3.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.871 HD13 ' HA3' ' A' ' 124' ' ' GLY . 1.4 mt -91.11 174.31 7.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.615 HG22 ' CD1' ' A' ' 5' ' ' TRP . 1.1 pp -139.72 -58.07 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.653 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 126' ' ' THR . . . -79.94 152.32 34.78 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.425 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 125' ' ' ASP . 0.0 OUTLIER -166.99 149.46 6.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 111.115 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.67 107.02 15.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.821 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.61 137.39 2.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.591 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.42 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 10.2 t60 -106.48 111.35 23.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.619 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.56 109.24 27.79 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.937 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 18' ' ' HIS . 69.7 Cg_endo -92.5 58.28 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.948 2.432 . . . . 0.0 112.511 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -90.82 178.48 6.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.157 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.9 -7.43 14.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.67 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.4 mt -94.4 112.48 57.79 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.592 0.234 . . . . 0.0 110.916 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -81.31 54.13 5.03 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.735 2.29 . . . . 0.0 112.416 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.75 -68.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.15 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -95.29 -21.85 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.536 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.87 -25.05 66.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.739 0.304 . . . . 0.0 111.338 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -84.53 -68.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.241 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.514 ' CE2' ' CE1' ' A' ' 155' ' ' TYR . 12.4 t80 -42.98 -26.27 0.13 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.082 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -69.09 0.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.687 0.28 . . . . 0.0 110.994 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.8 ' O ' HG13 ' A' ' 35' ' ' VAL . 13.8 ttm105 -92.59 -40.62 10.68 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . . . -59.59 -13.03 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' NE2' ' CE1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -81.16 -50.53 9.49 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.583 ' HB ' ' HG ' ' A' ' 4' ' ' LEU . 5.4 t -83.18 -24.43 32.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 31' ' ' ARG . 35.5 m -60.89 142.97 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 0.0 110.977 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.549 ' H ' ' CG ' ' A' ' 57' ' ' ARG . . . 119.82 -10.18 11.28 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.82 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -151.65 -164.51 2.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.503 1.151 . . . . 0.0 109.555 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.63 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 74.3 mt -74.55 94.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.92 0.391 . . . . 0.0 112.016 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.433 ' HG3' ' OG1' ' A' ' 34' ' ' THR . 8.6 ttp -103.48 126.81 50.85 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.014 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.1 t -78.9 158.22 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.689 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 40' ' ' VAL . 27.3 m -165.04 142.98 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.576 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.99 158.5 51.2 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.81 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.593 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.84 -48.51 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.058 0.429 . . . . 0.0 110.77 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.427 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -62.66 -27.01 68.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 0.0 110.467 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.2 m -75.73 -44.62 40.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.589 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.462 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 15.8 t80 -61.33 -31.59 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -66.63 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.71 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 49' ' ' PHE . 3.9 t -54.7 -33.05 60.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.223 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -26.38 114.31 0.23 Allowed Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.883 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.88 -37.0 21.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.043 2.495 . . . . 0.0 113.307 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' CE ' HD23 ' A' ' 54' ' ' LEU . 2.6 tmmm? -147.13 118.93 8.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.777 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.86 140.16 21.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.18 -167.1 5.06 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.23 -1.571 . . . . 0.0 112.004 -0.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.63 HD12 HD21 ' A' ' 59' ' ' ASN . 81.9 mt -111.61 137.47 21.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.06 -66.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.65 2.233 . . . . 0.0 113.302 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.82 19.8 1.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.488 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.612 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -142.27 121.43 12.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.119 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.63 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 39.9 m -80.59 128.11 33.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.289 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.63 HD21 HD12 ' A' ' 54' ' ' LEU . 2.8 m-80 -115.02 147.36 40.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 111.843 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.824 HG12 HG22 ' A' ' 76' ' ' VAL . 3.3 t -131.12 132.65 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.464 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 43' ' ' ARG . 78.7 t -97.73 128.89 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.289 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.669 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.07 115.38 30.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.824 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -147.4 156.75 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -74.15 -12.4 60.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.888 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.4 tt0 -80.39 133.5 35.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.413 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 3.1 mm-40 -84.67 -11.13 56.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.962 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.37 4.41 20.66 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.861 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.4 t80 -58.26 140.45 53.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.082 0.468 . . . . 0.0 111.54 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.848 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -126.48 173.85 9.09 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.145 0.974 . . . . 0.0 112.391 179.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.49 143.68 20.09 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.648 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.73 96.75 5.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.742 0.306 . . . . 0.0 110.696 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.11 2.65 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.959 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.462 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.16 167.75 17.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.071 0.462 . . . . 0.0 111.718 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HB ' HG13 ' A' ' 60' ' ' VAL . 32.3 t -97.07 140.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.421 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 68' ' ' TYR . 21.3 t -104.23 117.66 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.368 0.604 . . . . 0.0 112.477 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.824 HG22 HG12 ' A' ' 60' ' ' VAL . 28.1 m -127.31 167.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.962 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.413 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 4.7 m80 -119.13 -22.18 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.539 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.662 ' HA ' HD21 ' A' ' 62' ' ' LEU . 8.1 m-20 -159.33 -175.02 4.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.667 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.83 HG22 ' CD1' ' A' ' 106' ' ' PHE . 11.8 t -66.64 -11.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.786 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.69 -36.82 17.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.171 0.51 . . . . 0.0 109.752 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.65 -31.74 65.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.707 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 HG21 ' A' ' 76' ' ' VAL . 31.6 t -69.68 -53.82 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.986 0.422 . . . . 0.0 109.938 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 5.6 m-85 -53.61 -27.6 27.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.971 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -62.62 -46.49 88.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.895 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.43 -54.49 31.87 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.85 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.78 -24.2 34.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -71.39 -33.63 69.68 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -83.16 -8.72 59.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.376 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -124.82 66.01 47.32 Favored Pre-proline 0 C--N 1.333 -0.129 0 CA-C-O 121.019 0.437 . . . . 0.0 110.277 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.3 -0.46 2.89 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.099 2.533 . . . . 0.0 112.831 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.09 -30.28 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.009 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.93 161.81 14.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -98.76 174.77 6.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.85 HD13 ' HB2' ' A' ' 86' ' ' ALA . 8.5 tp -122.27 118.8 29.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.383 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 2' ' ' ALA . 53.5 t -132.87 121.34 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.452 ' CD1' HG21 ' A' ' 40' ' ' VAL . 8.7 mm -83.25 133.39 29.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.11 0.481 . . . . 0.0 111.832 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.402 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -101.22 -50.04 3.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.911 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.21 -171.13 43.94 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.717 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.408 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.45 -160.98 36.79 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.674 0.737 . . . . 0.0 112.69 -0.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.02 10.18 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.733 0.301 . . . . 0.0 111.508 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -52.62 -30.52 31.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.553 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.669 ' CD1' HD22 ' A' ' 62' ' ' LEU . 28.2 mm -82.89 -21.62 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . 2.7 m-85 -66.29 -51.75 54.25 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.518 ' OG1' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -70.75 -9.59 57.65 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 111.916 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.763 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.47 -37.87 35.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.83 ' CD1' HG22 ' A' ' 79' ' ' VAL . 6.3 m-85 -95.87 -11.12 27.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.682 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.518 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 9.4 pttp -51.4 -29.14 14.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.97 -12.45 60.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.411 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.89 -20.73 5.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 106' ' ' PHE . 81.0 t -44.53 128.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.063 0.458 . . . . 0.0 111.317 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 6.2 t0 -110.47 -3.87 15.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.582 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.789 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.9 m -155.7 134.47 11.92 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.598 0.237 . . . . 0.0 111.08 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.683 HD11 ' CD2' ' A' ' 136' ' ' PHE . 11.7 mt -117.01 144.08 44.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 4' ' ' LEU . 4.2 mt -135.91 115.51 12.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.502 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.719 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -131.4 141.34 46.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 111.39 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.44 112.78 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -96.26 100.44 12.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.366 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.0 OUTLIER -86.66 131.21 34.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.554 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -61.54 -46.47 89.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.67 -173.3 0.08 OUTLIER Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 p -124.54 136.58 54.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -138.15 157.49 46.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 3.8 mt-10 -70.91 170.37 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.871 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . -161.26 125.87 1.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.701 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -108.56 14.05 24.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.509 0.195 . . . . 0.0 111.42 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 14' ' ' GLY . 1.8 m -162.85 137.27 6.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.946 0.403 . . . . 0.0 110.939 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.33 160.78 14.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.202 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.554 ' SD ' HG21 ' A' ' 13' ' ' ILE . 15.9 tpt -81.51 159.34 24.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.425 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pp -91.81 165.07 21.48 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.415 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.63 128.37 23.23 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.628 2.218 . . . . 0.0 112.043 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.68 HD13 ' CZ2' ' A' ' 133' ' ' TRP . 2.5 mt -112.36 139.67 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.19 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 63.05 7.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.68 ' CZ2' HD13 ' A' ' 131' ' ' LEU . 89.8 m95 -53.9 -24.37 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -31.14 65.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 110.826 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.03 -16.39 47.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.397 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 113' ' ' LEU . 77.9 m-85 -103.45 168.28 9.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 110.69 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.676 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -132.59 140.93 48.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.978 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 5.6 ttpt -79.93 119.41 22.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 157' ' ' VAL . 32.8 m -105.41 -19.37 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.0 m -167.07 140.45 3.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 5.2 p -169.27 108.68 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.654 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -147.84 125.39 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.779 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.643 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.1 m -71.2 146.11 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.728 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 152' ' ' THR . 10.5 t -118.78 103.47 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.592 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.5 mt-10 -88.29 102.02 14.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.576 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.76 -174.4 4.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.654 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.9 p -58.0 -51.21 70.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.9 t30 -76.5 134.02 70.25 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.871 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.56 -35.29 60.48 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.985 1.79 . . . . 0.0 112.393 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.9 33.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.5 mt -78.45 8.91 4.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 144' ' ' VAL . 93.6 m -78.71 161.11 27.11 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.482 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -172.11 157.81 4.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.008 0.432 . . . . 0.0 111.594 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.643 ' OG1' HG23 ' A' ' 143' ' ' THR . 7.5 m -119.06 131.48 55.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.574 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.514 ' CE1' ' CE2' ' A' ' 29' ' ' TYR . 45.1 m-85 -99.79 105.21 16.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.755 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.59 ' HB2' HG22 ' A' ' 115' ' ' VAL . 4.3 mt-10 -102.81 122.11 43.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.477 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.721 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.8 t -116.79 114.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 138' ' ' LYS . 30.5 m95 -112.15 150.56 30.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 111.556 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -126.8 115.02 18.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.829 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 3.0 ttpt -51.73 138.22 23.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.287 0.565 . . . . 0.0 112.434 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.676 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -125.87 -164.03 1.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.339 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.063 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.446 HG23 HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.723 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.93 146.35 39.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.57 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.5 m-85 -110.2 115.79 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.531 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.542 HD21 ' HB3' ' A' ' 30' ' ' PHE . 12.1 tp -113.73 120.96 42.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.702 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.1 p90 -166.17 164.65 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.274 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.32 55.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 111.48 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 pt20 -123.29 153.05 40.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.157 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -103.18 -174.07 2.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.717 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -24.92 19.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.053 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -91.99 -31.17 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.744 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.98 22.74 7.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.669 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -87.22 153.09 21.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.409 HG23 ' HD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -112.02 -75.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.931 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.85 -154.55 6.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HB3' HD12 ' A' ' 19' ' ' LEU . 18.9 tttm -163.58 102.81 0.93 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.68 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -87.93 58.16 4.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.42 -101.62 0.26 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.442 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -139.25 85.98 2.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.656 HD13 ' H ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.83 156.74 40.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.963 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.8 -41.9 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.578 2.186 . . . . 0.0 112.642 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.11 176.69 9.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -130.9 -167.58 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.787 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -136.42 129.44 17.68 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.834 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.06 -24.75 9.42 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.504 2.136 . . . . 0.0 112.638 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.27 -28.66 59.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.219 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.23 -44.9 92.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 0.0 110.979 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.95 -69.21 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.537 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -17.58 64.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.89 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -62.21 -74.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.742 0.306 . . . . 0.0 111.424 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' HB3' HD21 ' A' ' 4' ' ' LEU . 3.7 p90 -91.91 30.38 1.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.826 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.72 ' O ' HG13 ' A' ' 35' ' ' VAL . 28.0 ttp85 -73.29 -61.35 1.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.832 0.349 . . . . 0.0 110.958 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -85.29 -11.41 54.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.818 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -84.26 -8.04 59.16 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.7 p -145.19 11.25 1.33 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.742 HG12 ' CD ' ' A' ' 57' ' ' ARG . 6.9 m -94.32 150.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.628 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 54.15 35.33 54.52 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 116.136 1.215 . . . . 0.0 116.136 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.9 mmtt -149.46 -176.2 5.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 120.262 2.031 . . . . 0.0 107.721 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 71.8 mt -86.6 85.27 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.051 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 ttp -102.12 123.07 45.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.39 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 41' ' ' VAL . 43.3 t -76.01 156.51 5.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.522 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 40' ' ' VAL . 34.9 m -164.18 137.46 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.74 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.21 161.37 34.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.933 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.642 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.99 -47.2 81.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.861 0.33 . . . . 0.0 110.767 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.419 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.8 tpp180 -66.36 -30.48 70.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.388 . . . . 0.0 110.336 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.711 HG22 ' CE2' ' A' ' 49' ' ' PHE . 7.0 m -68.2 -43.73 77.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.204 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.452 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 13.7 t80 -59.05 -31.14 68.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.42 -66.1 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.1 t -50.07 -41.61 48.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.9 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.711 ' CE2' HG22 ' A' ' 45' ' ' THR . 6.9 m-85 -42.44 152.92 0.32 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-O 120.781 0.324 . . . . 0.0 111.448 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -41.73 -72.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.063 2.509 . . . . 0.0 113.542 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.66 177.15 8.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.45 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 2.4 ptp180 -122.1 105.76 36.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 86.9 Cg_endo -87.89 -179.96 17.07 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 123.803 -1.332 . . . . 0.0 112.457 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 49' ' ' PHE . 34.2 mt -61.18 158.53 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 12.9 Cg_endo -56.72 87.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.412 2.075 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 42.8 mt-10 69.62 47.55 0.64 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.351 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.742 ' CD ' HG12 ' A' ' 35' ' ' VAL . 17.0 mtt180 -140.79 126.05 18.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.671 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 92.0 m -76.5 105.84 7.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.479 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 1.8 m-80 -104.6 145.86 29.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.224 -178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 76' ' ' VAL . 12.1 t -117.63 141.78 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.097 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.642 HG13 ' HA ' ' A' ' 43' ' ' ARG . 58.8 t -108.32 124.42 64.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.784 0.326 . . . . 0.0 111.116 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.28 121.05 44.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.484 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.536 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.5 t -157.17 160.13 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -75.52 -5.51 45.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.19 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.4 tp60 -78.71 129.85 35.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.63 -28.06 31.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.139 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.56 7.55 46.0 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.68 ' O ' HG11 ' A' ' 75' ' ' VAL . 7.7 t80 -60.57 142.49 55.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.348 0.594 . . . . 0.0 111.897 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.939 ' HA ' HG21 ' A' ' 75' ' ' VAL . 14.9 mm100 -134.77 175.72 9.29 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.39 1.09 . . . . 0.0 112.888 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 142.64 19.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -78.11 100.94 6.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.35 -43.0 2.8 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.807 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -70.08 170.18 11.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.446 . . . . 0.0 111.709 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.5 t -99.48 140.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.483 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.939 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.5 t -111.36 119.97 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.357 0.599 . . . . 0.0 112.121 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.973 HG21 HG22 ' A' ' 82' ' ' VAL . 34.1 m -126.61 168.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.409 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -119.14 -25.46 6.17 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.794 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 t70 -149.07 -176.13 5.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.641 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.912 HG13 ' CD2' ' A' ' 106' ' ' PHE . 21.7 t -69.63 -10.73 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.688 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.72 -30.99 18.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 110.364 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.26 -26.59 52.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.133 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.973 HG22 HG21 ' A' ' 76' ' ' VAL . 16.7 t -78.41 -50.81 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 109.806 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.592 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.2 m-85 -57.33 -28.78 63.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.913 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.77 -38.29 79.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.7 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -68.12 -59.23 3.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.51 -22.84 14.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.202 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.89 -37.38 75.99 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.035 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 7.5 mt-30 -83.81 -4.49 58.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.233 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -124.76 65.04 43.77 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.563 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.8 -0.99 6.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.925 2.417 . . . . 0.0 112.829 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.7 -31.67 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 20.6 mt-30 -102.28 157.44 16.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -99.14 158.99 15.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.446 HD23 HG23 ' A' ' 1' ' ' THR . 29.9 tp -111.51 115.89 29.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.28 110.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.33 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.471 HD12 HG21 ' A' ' 40' ' ' VAL . 4.9 mm -77.2 129.03 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.774 0.321 . . . . 0.0 111.079 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.19 -37.14 6.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.59 -169.11 42.17 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.785 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.34 -161.01 30.6 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 122.266 -0.549 . . . . 0.0 112.545 -0.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -55.12 -51.18 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.801 0.334 . . . . 0.0 111.054 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -55.53 -27.64 50.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.591 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 62' ' ' LEU . 49.0 mm -79.34 -32.94 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.0 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 3' ' ' PHE . 6.2 m-85 -54.08 -58.16 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.65 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.568 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 6.1 t -65.78 -9.92 32.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.811 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.74 -41.56 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.912 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.0 m-85 -101.56 -2.57 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.462 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 39.0 pttt -49.8 -34.36 19.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.731 0.3 . . . . 0.0 111.767 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 4.07 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.64 -25.0 3.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.856 HG11 HD23 ' A' ' 113' ' ' LEU . 62.9 t -44.04 129.35 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 120.97 0.414 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 24.5 t70 -103.41 2.77 34.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.124 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 97.8 m -166.97 138.63 3.32 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.538 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.856 HD23 HG11 ' A' ' 110' ' ' VAL . 21.2 mt -120.17 144.81 47.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 113' ' ' LEU . 19.9 mt -135.31 115.23 13.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.684 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 156' ' ' GLU . 2.2 m -132.16 143.05 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.848 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.35 105.67 13.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.235 179.31 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -81.98 101.67 10.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.748 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -84.91 125.73 32.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.974 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 -56.93 12.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.312 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.16 168.26 15.85 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.87 163.19 12.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.748 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 4.5 m-85 -136.39 147.99 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -98.75 132.67 43.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.692 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.14 -179.7 47.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.527 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.26 -0.18 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.532 0.206 . . . . 0.0 111.395 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.7 m -118.13 122.45 43.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.032 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.407 ' O ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.74 175.98 5.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.4 tpt -76.61 153.3 35.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.855 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.519 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.8 pp -81.23 164.14 51.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.249 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.27 101.6 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.839 2.359 . . . . 0.0 112.686 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.415 ' CD1' ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -91.25 145.42 24.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.67 75.7 4.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.247 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.553 ' HH2' HG11 ' A' ' 115' ' ' VAL . 93.7 m95 -55.29 -21.25 13.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.304 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -28.36 61.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 3.3 t0 -80.74 -17.27 51.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.177 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.648 ' CD1' HD11 ' A' ' 113' ' ' LEU . 91.5 m-85 -109.1 166.35 10.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.94 0.4 . . . . 0.0 111.559 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.748 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -125.24 140.31 52.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.739 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.545 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpm? -81.19 121.35 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.615 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.1 m -110.21 -15.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.612 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.407 ' OG ' HG23 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -167.33 139.87 3.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.81 0.338 . . . . 0.0 110.928 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.2 p -163.09 109.79 1.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -143.65 119.27 10.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.332 . . . . 0.0 111.283 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.742 HG23 ' OG1' ' A' ' 154' ' ' THR . 5.0 m -74.09 144.61 44.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.244 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 t -116.53 106.22 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.126 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.69 105.49 17.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.588 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -83.86 -177.18 6.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.559 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 p -59.64 -42.01 91.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.498 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.4 t30 -81.78 126.35 75.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.23 -29.18 88.44 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.295 1.997 . . . . 0.0 112.274 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.54 -24.08 23.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.037 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 17.7 mt -81.32 6.28 14.78 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.571 ' O ' HD23 ' A' ' 118' ' ' LEU . 52.1 m -71.38 164.5 25.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.071 0.463 . . . . 0.0 110.124 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.1 p80 -174.37 160.95 3.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.13 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.742 ' OG1' HG23 ' A' ' 143' ' ' THR . 26.9 m -122.69 150.16 43.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.629 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -111.05 105.21 13.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.54 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.713 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.1 mt-10 -105.05 121.63 44.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 111.631 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 139' ' ' VAL . 4.1 t -112.93 111.91 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.696 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.2 m95 -110.89 150.33 29.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 111.487 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -128.39 120.91 27.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.496 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.5 tmmt? -45.5 125.93 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.643 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.748 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -109.79 -176.27 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.105 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.508 HG22 HG12 ' A' ' 96' ' ' ILE . 2.9 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.743 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.51 144.92 42.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 1.8 m-30 -107.66 112.9 25.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.44 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.846 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.33 124.92 53.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.36 0.6 . . . . 0.0 112.43 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.76 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.9 p90 -170.91 174.05 4.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.617 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -121.76 139.77 53.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.183 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -120.48 154.76 34.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 111.422 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 122' ' ' PHE . 1.1 p30 -108.62 -177.7 3.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.882 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HG2' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -47.88 -49.63 29.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.32 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.23 -19.55 64.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.55 25.89 21.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.347 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -90.4 161.98 15.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.857 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.679 HG22 ' CD1' ' A' ' 5' ' ' TRP . 11.4 pt -111.91 -44.69 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.202 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 13' ' ' ILE . . . -155.67 162.73 31.35 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.386 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.9 150.69 19.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.421 . . . . 0.0 111.213 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.32 123.92 42.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.24 -81.74 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.533 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -87.32 171.71 10.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.934 0.397 . . . . 0.0 110.974 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -97.17 147.62 33.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.785 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 31.2 Cg_exo -58.98 168.44 4.46 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.466 2.11 . . . . 0.0 112.182 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -172.73 2.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.257 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.23 75.8 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.794 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.61 136.34 48.63 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.517 ' HA ' HD23 ' A' ' 27' ' ' LEU . 80.0 Cg_endo -77.71 -40.03 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.55 2.167 . . . . 0.0 112.694 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -76.93 -14.91 59.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.614 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.21 -25.1 17.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.591 0.234 . . . . 0.0 111.547 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 24' ' ' PRO . 1.7 pp -84.03 -30.7 25.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.711 0.291 . . . . 0.0 111.202 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -48.83 -32.28 8.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.527 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.402 ' CZ ' ' OE1' ' A' ' 33' ' ' GLN . 45.4 t80 -105.27 -59.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.442 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -50.9 -40.42 56.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.613 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.802 ' O ' HG22 ' A' ' 35' ' ' VAL . 55.0 ttt-85 -69.94 -60.92 2.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.243 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -55.85 -22.38 24.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.521 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.402 ' OE1' ' CZ ' ' A' ' 29' ' ' TYR . 3.2 mm-40 -84.31 -7.16 59.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.828 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.597 ' CG2' HD11 ' A' ' 4' ' ' LEU . 4.2 p -138.73 1.25 2.09 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 31' ' ' ARG . 29.3 m -107.99 147.03 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 82.78 7.5 87.23 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -147.23 -165.07 2.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.963 1.882 . . . . 0.0 109.465 179.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.509 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 58.6 mt -82.18 88.42 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.418 ' SD ' ' HB ' ' A' ' 34' ' ' THR . 1.6 ttp -97.91 116.89 31.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.801 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 82' ' ' VAL . 5.8 t -86.3 125.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.09 0.471 . . . . 0.0 111.688 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 49' ' ' PHE . 24.5 m -132.13 155.13 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.502 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.13 147.0 32.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.756 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.7 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -45.09 -49.29 11.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.72 0.26 . . . . 0.0 111.459 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.442 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 3.8 ttt180 -62.14 -36.88 83.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.984 0.421 . . . . 0.0 110.146 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -63.34 -49.38 74.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.475 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.83 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 2.9 t80 -50.3 -43.76 53.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.875 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -52.38 -63.98 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.766 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -35.08 67.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.37 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -34.98 138.52 0.35 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-O 120.905 0.384 . . . . 0.0 111.973 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.19 -29.99 18.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.253 2.635 . . . . 0.0 113.877 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 149.33 31.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.912 0.387 . . . . 0.0 111.501 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.4 mtm180 -138.65 106.37 7.63 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.965 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 95.1 Cg_endo -86.0 -166.91 4.37 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.273 -0.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.616 HD12 HD21 ' A' ' 59' ' ' ASN . 75.4 mt -100.58 142.05 23.86 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.92 121.17 6.77 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 112.798 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 69.98 3.09 4.18 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.771 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HD2' HD13 ' A' ' 54' ' ' LEU . 3.4 mtt-85 -114.42 108.8 17.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.85 0.357 . . . . 0.0 111.322 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.0 m -68.24 113.19 5.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.616 HD21 HD12 ' A' ' 54' ' ' LEU . 2.5 m-80 -104.73 150.37 24.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.397 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 76' ' ' VAL . 6.6 t -134.83 133.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.7 HG13 ' HA ' ' A' ' 43' ' ' ARG . 79.2 t -103.01 124.04 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.753 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -105.72 111.23 23.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.907 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.954 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -142.83 170.81 15.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 111.285 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -86.91 -14.19 42.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.683 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.6 tt0 -79.17 133.58 36.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.455 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 23.4 mt-10 -80.89 -25.61 37.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.79 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.89 6.78 48.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.954 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.2 t80 -60.08 136.24 57.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.216 0.532 . . . . 0.0 111.6 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.95 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -132.04 173.71 10.93 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.254 1.026 . . . . 0.0 112.703 179.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.07 141.41 18.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.096 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.26 101.56 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.807 0.337 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -41.39 2.92 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.638 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.83 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -69.44 167.74 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.52 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.78 140.77 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.178 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.95 HG21 ' HA ' ' A' ' 69' ' ' GLN . 19.2 t -110.03 119.87 59.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.228 0.537 . . . . 0.0 112.066 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.821 HG21 HG22 ' A' ' 82' ' ' VAL . 27.6 m -130.19 167.11 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.664 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.455 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 17.3 m80 -118.28 -22.51 7.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.642 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.65 -176.72 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.206 0.527 . . . . 0.0 111.507 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.873 HG13 ' CD2' ' A' ' 106' ' ' PHE . 35.6 t -71.89 -9.36 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.661 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.13 -33.78 19.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.487 . . . . 0.0 109.785 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.542 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.85 -32.3 63.59 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.124 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.821 HG22 HG21 ' A' ' 76' ' ' VAL . 43.4 t -72.19 -52.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.3 m-85 -54.13 -28.09 37.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.27 -40.19 93.6 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.471 ' CE2' ' CD2' ' A' ' 89' ' ' HIS . 65.1 t80 -66.99 -57.42 6.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -53.33 -23.3 8.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.097 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 3.5 mmtp -69.4 -40.11 77.56 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -85.06 -4.95 59.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.529 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CE2' ' A' ' 85' ' ' TYR . 93.4 m-70 -127.38 60.59 44.26 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.02 -0.03 5.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.236 2.624 . . . . 0.0 112.916 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.75 -35.7 19.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.03 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.401 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 12.1 mt-30 -99.5 163.92 12.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.473 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.3 160.69 14.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.926 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.795 HD11 HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -115.3 117.06 29.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.53 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.451 HG12 HD12 ' A' ' 4' ' ' LEU . 59.3 t -131.94 117.83 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.174 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 1' ' ' THR . 5.4 mm -81.92 133.13 29.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.262 0.553 . . . . 0.0 111.484 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.53 -48.66 4.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.056 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.404 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.43 -164.13 36.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.165 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.404 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -86.15 -161.02 34.83 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 117.674 0.737 . . . . 0.0 112.704 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -50.77 -48.97 59.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.323 . . . . 0.0 111.41 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -58.5 -29.85 66.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.877 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.2 mm -79.43 -29.93 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.268 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.9 m-85 -57.16 -54.14 50.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.862 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -70.12 -8.49 50.0 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.024 -0.423 . . . . 0.0 111.839 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.814 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.34 -38.98 40.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.873 ' CD2' HG13 ' A' ' 79' ' ' VAL . 29.3 m-85 -99.63 -10.03 22.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.308 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 18.5 pttp -52.17 -31.73 32.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.758 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.74 -5.1 52.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.656 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -128.2 -21.66 3.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 106' ' ' PHE . 76.9 t -44.81 123.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 111.302 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.433 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 3.9 t70 -103.13 7.69 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.267 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.2 m -168.39 135.84 2.09 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.821 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.63 HD23 HG11 ' A' ' 110' ' ' VAL . 17.0 mt -117.92 143.7 46.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.491 . . . . 0.0 111.531 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 4' ' ' LEU . 6.5 mt -135.28 115.08 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.664 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.76 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -134.69 144.69 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.024 0.44 . . . . 0.0 111.744 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.79 105.56 13.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.577 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 6.5 mmt85 -80.7 100.33 8.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.489 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.5 mp -82.21 127.94 33.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.431 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -63.08 -52.11 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.884 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -50.43 144.49 11.09 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.443 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.467 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 35.3 p -91.5 132.61 36.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.981 0.42 . . . . 0.0 111.374 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 8' ' ' ASP . 2.1 m-85 -134.23 163.57 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.399 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -116.56 150.86 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.112 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.8 -173.72 23.95 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.788 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -33.98 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.954 0.407 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 60.7 m -108.71 139.44 43.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.98 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -115.89 172.39 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.087 0.47 . . . . 0.0 111.681 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -70.22 143.6 52.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.488 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.1 pt -68.45 154.33 94.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.314 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.96 97.73 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.512 2.142 . . . . 0.0 111.975 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.62 146.69 26.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 72.45 4.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.325 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.475 ' HH2' HG11 ' A' ' 115' ' ' VAL . 89.8 m95 -55.7 -22.37 23.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.423 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.02 -28.81 62.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -80.64 -23.46 39.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 71.8 m-85 -102.09 174.08 6.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -137.79 142.85 40.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 1.6 ttpt -79.96 120.54 24.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.787 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.6 m -103.01 -21.75 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.433 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.4 m -162.74 140.69 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.824 0.345 . . . . 0.0 110.858 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 16.1 p -160.62 109.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -139.43 115.2 10.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.27 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 8.4 m -74.42 144.14 44.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.603 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.432 HG11 ' HE2' ' A' ' 155' ' ' TYR . 2.5 p -121.77 105.26 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.997 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.53 ' HA ' HG23 ' A' ' 152' ' ' THR . 19.6 mt-10 -88.7 107.14 18.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.787 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.27 -175.77 5.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.486 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.7 p -57.45 -50.45 72.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.749 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.494 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -74.41 124.66 90.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.102 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.97 -27.21 84.44 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.154 1.903 . . . . 0.0 112.301 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -19.89 22.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.674 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.3 mt -84.85 7.77 19.72 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 74.5 m -72.88 168.22 19.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -175.46 162.48 2.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.257 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 24.5 m -125.23 137.91 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.797 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.432 ' HE2' HG11 ' A' ' 144' ' ' VAL . 94.4 m-85 -98.4 106.3 18.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.493 ' HB2' HG22 ' A' ' 115' ' ' VAL . 62.7 mt-10 -108.69 126.61 53.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.032 0.444 . . . . 0.0 111.857 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.7 t -118.72 115.9 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.251 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 19.3 m95 -111.97 151.16 29.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 0.0 111.377 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -127.02 117.13 21.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.828 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.1 OUTLIER -55.46 131.47 46.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.93 0.395 . . . . 0.0 111.613 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.493 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 1.8 ptmt 177.5 156.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.991 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 85.2 m . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.83 148.93 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.597 ' C ' HD13 ' A' ' 4' ' ' LEU . 2.6 m-30 -114.18 112.28 22.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.491 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.078 HD11 HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -112.82 121.52 44.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 0.0 111.807 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.86 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.0 p90 -166.85 172.73 10.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.448 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.88 134.37 50.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -119.98 155.81 32.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.952 0.406 . . . . 0.0 111.182 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.7 -172.83 2.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.687 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -43.13 63.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.06 -23.12 52.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.71 22.61 17.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.358 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.37 159.75 20.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.46 -37.38 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.22 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 165.93 174.31 35.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.547 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HG2' ' HA2' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -68.25 -179.76 1.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 110.908 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.67 -29.37 59.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.08 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.89 66.63 0.4 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.491 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.03 -30.12 6.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 111.109 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.64 120.26 9.42 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.868 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.57 -178.98 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.421 2.081 . . . . 0.0 112.153 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.7 121.96 44.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.71 43.33 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.24 142.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.598 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.78 -39.08 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.731 2.287 . . . . 0.0 112.965 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.09 -32.52 74.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.623 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.81 -23.64 29.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.647 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -14.75 30.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.768 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -63.92 -70.67 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.441 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 78.7 t80 -62.43 -34.77 77.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -81.49 9.35 7.56 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.859 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.19 -62.37 1.42 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.59 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.5 -40.4 50.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . 60.1 mm-40 -56.91 -20.16 21.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.944 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.83 HG22 HD23 ' A' ' 4' ' ' LEU . 68.7 p -119.44 -25.27 6.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 31' ' ' ARG . 1.5 m -107.98 161.75 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 111.87 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . 89.77 1.06 77.61 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.748 -0.739 . . . . 0.0 114.272 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 1.8 mtpm? -150.6 -164.82 2.11 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.396 1.098 . . . . 0.0 109.835 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.6 mt -78.62 86.75 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 34' ' ' THR . 9.4 ttp -99.99 120.31 39.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.934 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.498 HG21 HG11 ' A' ' 82' ' ' VAL . 80.3 t -77.57 156.76 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.974 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 60' ' ' VAL . 33.6 m -162.49 141.22 2.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.43 153.45 52.92 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.506 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.765 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.33 -51.05 57.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.223 0.512 . . . . 0.0 110.815 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.489 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.9 tpt85 -57.88 -34.48 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.061 0.458 . . . . 0.0 110.19 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.577 HG22 ' CE2' ' A' ' 49' ' ' PHE . 2.8 m -69.75 -55.9 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.398 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -46.63 -28.69 1.55 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.041 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -65.44 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.237 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -50.18 -35.4 26.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.654 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 45' ' ' THR . 5.4 m-85 -40.93 157.95 0.18 Allowed Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.132 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HD2' HD21 ' A' ' 54' ' ' LEU . 68.5 Cg_exo -52.23 -71.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.611 2.207 . . . . 0.0 113.257 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -124.15 173.6 8.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.7 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 1.9 mtp180 -133.99 104.43 11.63 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.913 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 89.9 Cg_endo -85.19 -167.06 4.76 Favored 'Cis proline' 0 C--N 1.349 0.588 0 C-N-CA 123.912 -1.287 . . . . 0.0 112.144 -0.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 HD21 ' A' ' 59' ' ' ASN . 95.4 mt -93.87 151.36 39.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.629 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.35 110.15 2.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.666 2.244 . . . . 0.0 112.972 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.18 4.27 5.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.002 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.574 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 5.7 mtt180 -112.59 101.07 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.965 0.412 . . . . 0.0 111.038 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 24.0 m -66.05 107.81 2.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.195 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.706 HD21 HD12 ' A' ' 54' ' ' LEU . 2.3 m-80 -103.38 156.1 17.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.243 0.544 . . . . 0.0 112.14 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.642 HG12 HG22 ' A' ' 76' ' ' VAL . 8.3 t -132.43 136.91 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.883 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.765 HG13 ' HA ' ' A' ' 43' ' ' ARG . 66.4 t -105.93 127.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 111.586 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.535 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -109.92 116.12 31.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.202 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.847 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.6 t -147.19 167.14 24.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.903 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -85.14 -12.01 53.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -72.93 134.83 44.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -85.2 -7.9 58.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.883 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -118.7 7.46 11.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.606 0.241 . . . . 0.0 111.522 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.925 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.9 t80 -58.14 139.57 54.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.193 0.52 . . . . 0.0 111.817 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.888 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -126.27 173.84 8.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.043 0.925 . . . . 0.0 111.99 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.27 142.97 19.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.495 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -77.93 97.99 5.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.745 0.307 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.56 -42.41 2.99 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.234 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.89 171.72 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 111.599 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 60' ' ' VAL . 12.4 t -97.46 139.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.476 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.925 HG11 ' O ' ' A' ' 68' ' ' TYR . 41.9 t -103.69 107.95 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.281 0.562 . . . . 0.0 112.193 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 82' ' ' VAL . 28.7 m -118.23 167.79 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.973 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 63' ' ' THR . 13.1 m170 -120.38 -21.21 6.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 m-20 -160.59 -173.32 3.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.839 HG13 ' CD2' ' A' ' 106' ' ' PHE . 12.8 t -66.94 -10.18 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.765 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.0 -38.33 16.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 110.019 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.32 -30.73 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG22 HG21 ' A' ' 76' ' ' VAL . 21.5 t -71.01 -53.59 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.969 0.414 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' CE2' HG12 ' A' ' 79' ' ' VAL . 6.7 m-85 -54.09 -27.08 30.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.934 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.36 -44.99 85.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.95 -55.33 19.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.16 -22.61 17.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.875 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.4 mmpt? -70.09 -38.04 75.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.05 -6.2 59.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.622 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -126.48 67.4 65.52 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-O 120.998 0.427 . . . . 0.0 110.558 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.8 -0.23 4.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.162 2.575 . . . . 0.0 113.079 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.33 -30.3 22.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 111.039 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.405 ' NE2' HG13 ' A' ' 38' ' ' ILE . 12.3 mt-30 -112.27 156.83 21.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 111.529 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.66 174.96 6.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.699 HD11 HG12 ' A' ' 82' ' ' VAL . 7.8 tp -104.68 110.73 23.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.078 HG13 HD11 ' A' ' 4' ' ' LEU . 80.8 t -119.52 102.46 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.694 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.505 ' O ' HD22 ' A' ' 4' ' ' LEU . 11.1 mm -78.36 128.45 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 111.634 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -95.77 -47.64 6.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.0 -168.29 41.36 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.41 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -94.31 -160.82 34.64 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 117.824 0.812 . . . . 0.0 112.557 -0.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.14 -51.57 13.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -55.84 -33.09 64.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.536 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.535 ' CD1' HD22 ' A' ' 62' ' ' LEU . 39.3 mm -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.2 m-85 -60.51 -57.5 12.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.694 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.837 ' HA ' HD13 ' A' ' 129' ' ' ILE . 3.9 t -67.13 -9.98 45.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.609 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.76 -46.04 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.839 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.3 m-85 -94.53 -6.44 43.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 14.7 pttp -52.26 -30.2 26.67 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.912 0.386 . . . . 0.0 111.056 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.83 -7.21 58.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.269 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.43 -20.06 6.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.728 HG11 HD23 ' A' ' 113' ' ' LEU . 74.0 t -44.75 127.34 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.958 0.409 . . . . 0.0 111.358 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.423 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 12.7 t70 -105.04 2.78 29.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 52.1 m -167.47 139.29 3.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.728 HD23 HG11 ' A' ' 110' ' ' VAL . 11.6 mt -119.72 146.62 45.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.33 0.586 . . . . 0.0 112.164 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.061 HD12 HD12 ' A' ' 4' ' ' LEU . 27.1 mt -135.6 112.39 10.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.198 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.86 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -130.59 141.79 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 111.596 -179.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -117.43 102.8 9.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.665 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.4 ttp85 -80.42 102.77 9.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.736 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 152' ' ' THR . 0.5 OUTLIER -80.93 123.46 28.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.17 -46.26 82.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.372 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 150' ' ' ALA . . . -57.71 -163.25 0.05 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.609 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.3 p -143.41 137.83 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.057 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.567 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -128.81 162.04 28.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -111.87 143.08 43.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' HA2' ' HG2' ' A' ' 15' ' ' LYS . . . -163.8 -166.67 23.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.597 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.46 -23.48 3.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -109.1 134.01 52.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.802 0.334 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -112.88 -174.0 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -164.8 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.837 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.1 pt -118.31 166.27 14.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.224 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.2 Cg_endo -75.7 103.52 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.43 2.087 . . . . 0.0 112.221 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.83 145.93 26.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.6 74.6 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.236 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -57.5 -20.53 31.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.48 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.93 -30.87 64.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.76 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.04 -21.96 39.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 78.5 m-85 -103.44 176.6 5.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 111.326 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -138.93 141.9 38.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.441 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 3.0 ttpt -78.15 124.33 27.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.8 m -109.18 -18.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.511 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.3 m -168.05 140.28 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.867 0.365 . . . . 0.0 111.368 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 6.4 p -155.48 111.13 3.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -144.08 115.42 8.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.8 m -76.97 143.1 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.124 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 105.73 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.212 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.651 ' HA ' HG23 ' A' ' 152' ' ' THR . 23.2 mt-10 -86.13 97.2 10.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.652 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -78.98 178.18 8.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.1 p -57.41 -52.05 66.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.699 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.501 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.32 125.68 91.3 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.806 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -28.83 87.77 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.085 1.857 . . . . 0.0 112.633 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HA ' ' CA ' ' A' ' 120' ' ' GLY . . . -90.02 -20.86 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.664 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.7 mt -83.24 7.19 17.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.597 0.237 . . . . 0.0 111.477 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.835 ' O ' HD23 ' A' ' 118' ' ' LEU . 62.6 m -72.43 167.0 21.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.5 p80 -175.37 162.14 2.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.641 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 19.4 m -125.79 139.11 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.588 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.9 105.17 17.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.37 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.721 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.2 mm-40 -103.56 121.55 43.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.284 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.785 ' O ' HG22 ' A' ' 139' ' ' VAL . 13.7 t -115.13 114.02 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.709 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.442 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.6 m95 -112.35 150.63 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.462 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.409 ' HG3' HG11 ' A' ' 139' ' ' VAL . 7.9 mt-30 -127.5 117.62 22.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.3 OUTLIER -54.91 132.8 47.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.299 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -114.67 -168.32 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.403 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.089 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 m . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.33 150.14 29.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.506 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 2.3 m-30 -117.95 115.83 25.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.259 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -114.89 124.49 51.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.469 0.652 . . . . 0.0 112.602 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.61 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.3 p90 -171.85 173.22 4.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.513 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.41 140.45 52.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.387 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -128.58 157.87 40.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.6 179.76 4.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.688 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.0 OUTLIER -50.94 -36.09 36.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.119 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -30.95 51.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.752 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.54 46.9 2.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.312 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.89 HD11 ' HA3' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -107.34 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.58 ' N ' ' HG ' ' A' ' 12' ' ' LEU . 4.6 pt -110.68 -41.62 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.596 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.83 -155.65 27.06 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.281 -0.962 . . . . 0.0 113.03 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CG ' ' HA2' ' A' ' 124' ' ' GLY . 7.6 mtpp -107.6 -166.67 1.17 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.72 0.295 . . . . 0.0 110.973 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.84 88.69 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.806 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.71 -76.33 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.666 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -164.85 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.042 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp 68.08 73.5 0.34 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 15.3 Cg_exo -68.03 -14.43 40.99 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.732 2.288 . . . . 0.0 112.174 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.431 ' CE3' ' HB2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -146.08 144.17 29.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.618 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 -47.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.083 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.504 HD22 HD21 ' A' ' 151' ' ' LEU . 1.2 mt -125.95 146.21 54.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.119 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.16 -46.41 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.642 2.228 . . . . 0.0 112.471 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.67 -28.43 69.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.951 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 23' ' ' LEU . 3.8 t0 -68.82 -13.87 62.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.517 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.7 tp -93.53 -34.75 13.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 110.63 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -58.95 -26.51 64.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -62.29 -68.9 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.18 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.484 ' HB2' ' CD2' ' A' ' 4' ' ' LEU . 1.7 p90 -91.19 31.25 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.689 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.502 ' O ' HG13 ' A' ' 35' ' ' VAL . 3.7 tmt_? -73.85 -53.98 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -95.75 -34.23 11.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.74 -8.61 55.27 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.463 HG21 ' CD2' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -117.7 -16.48 10.04 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.673 -179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.532 HG12 ' HD3' ' A' ' 57' ' ' ARG . 3.4 m -107.56 158.9 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.076 0.465 . . . . 0.0 111.978 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 73.09 15.78 78.57 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 115.904 1.122 . . . . 0.0 115.904 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -148.4 -170.13 3.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.068 1.934 . . . . 0.0 109.617 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 80.8 mt -82.05 86.7 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.476 ' HE3' HG11 ' A' ' 41' ' ' VAL . 17.2 ttp -99.34 117.59 34.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.686 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.857 HG21 HG11 ' A' ' 82' ' ' VAL . 3.6 t -85.08 127.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG11 ' HE3' ' A' ' 39' ' ' MET . 19.8 m -134.58 149.66 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.32 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.71 51.78 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.116 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.701 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -58.59 -52.56 65.16 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.854 0.327 . . . . 0.0 110.321 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.503 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 1.1 tpp180 -58.89 -37.27 76.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 m -69.96 -42.1 73.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.226 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CG ' HG22 ' A' ' 61' ' ' VAL . 53.1 t80 -64.1 -41.65 97.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.18 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -57.8 -66.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.785 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' PHE . 88.6 p -61.23 -30.63 70.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.78 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -30.41 133.32 0.22 Allowed Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.775 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_exo -38.39 -35.08 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.129 2.553 . . . . 0.0 113.252 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.786 ' HB3' HD23 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -152.35 139.76 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -140.3 108.12 6.75 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 91.6 Cg_endo -75.55 -170.51 8.46 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.519 -1.45 . . . . 0.0 112.195 -0.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.786 HD23 ' HB3' ' A' ' 51' ' ' LYS . 28.0 mt -99.21 155.95 35.98 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 104.63 1.45 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.576 2.184 . . . . 0.0 112.704 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.521 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 27.1 mt-10 69.8 6.89 5.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.783 ' HD2' HD13 ' A' ' 54' ' ' LEU . 1.8 mtt180 -109.3 113.0 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.885 0.374 . . . . 0.0 111.552 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.7 m -67.33 107.98 2.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.996 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.734 HD21 HD12 ' A' ' 54' ' ' LEU . 1.6 m-80 -108.23 141.83 39.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.929 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 76' ' ' VAL . 16.1 t -117.15 143.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.095 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 43' ' ' ARG . 94.2 t -110.87 124.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 0.0 111.589 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -103.58 121.08 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.94 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.742 HG21 ' CD2' ' A' ' 68' ' ' TYR . 7.0 t -158.58 162.52 37.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.816 0.341 . . . . 0.0 111.208 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -86.08 -3.65 58.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.335 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tp60 -77.96 131.56 37.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.857 0.36 . . . . 0.0 110.38 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.49 -30.27 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.275 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -98.99 10.85 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.742 ' CD2' HG21 ' A' ' 63' ' ' THR . 5.9 t80 -61.84 141.98 57.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.22 0.533 . . . . 0.0 111.917 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.903 ' HA ' HG21 ' A' ' 75' ' ' VAL . 12.5 mm-40 -134.31 177.58 7.65 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.388 1.09 . . . . 0.0 112.899 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.54 144.69 19.62 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 112.996 -1.911 . . . . 0.0 110.641 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.03 96.92 2.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.688 0.28 . . . . 0.0 110.46 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.53 -34.66 3.28 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.41 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.33 169.46 13.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 112.021 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.93 140.4 18.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.572 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.903 HG21 ' HA ' ' A' ' 69' ' ' GLN . 43.3 t -106.08 109.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.401 0.62 . . . . 0.0 112.461 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.891 HG21 HG22 ' A' ' 82' ' ' VAL . 34.6 m -117.81 163.89 14.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.891 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -116.69 -24.46 7.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.727 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -150.93 -174.03 4.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.143 0.497 . . . . 0.0 111.495 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.793 HG21 ' O ' ' A' ' 105' ' ' ALA . 45.5 t -70.25 -10.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.476 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.94 -31.43 18.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.023 0.44 . . . . 0.0 110.304 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.24 -28.79 60.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.891 HG22 HG21 ' A' ' 76' ' ' VAL . 22.6 t -76.5 -52.9 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -54.55 -28.06 43.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.65 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -68.15 -39.63 82.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 88.9 t80 -66.12 -56.81 9.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -55.02 -22.23 14.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.923 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -67.72 -41.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -82.69 -4.88 58.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.564 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 98.1 m-70 -125.95 64.42 51.77 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 110.301 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.6 0.13 3.86 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.371 2.714 . . . . 0.0 113.011 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.7 -30.13 21.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.725 0.298 . . . . 0.0 110.808 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.81 157.6 23.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.427 . . . . 0.0 111.592 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -98.45 169.41 9.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.273 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 86' ' ' ALA . 5.5 tp -105.34 115.82 30.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.306 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -123.86 106.35 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.433 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.1 mm -78.42 139.49 18.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.981 0.419 . . . . 0.0 111.265 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.463 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.2 -39.48 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.194 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.49 -168.04 41.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -81.73 -161.29 27.68 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 117.347 0.574 . . . . 0.0 112.549 -0.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -55.65 -42.13 74.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 110.978 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.72 -28.12 69.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.633 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.7 mm -80.39 -35.45 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.16 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.9 m-85 -51.76 -55.98 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.526 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.778 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.1 t -66.18 -9.66 33.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.793 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.02 -41.58 28.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.695 0.283 . . . . 0.0 111.226 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.784 ' CD2' HG13 ' A' ' 79' ' ' VAL . 4.0 m-85 -95.33 -7.46 38.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.23 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.566 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.5 OUTLIER -50.85 -32.46 20.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.846 0.355 . . . . 0.0 111.36 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -4.64 47.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.71 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.0 -20.6 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.561 ' HA ' ' HB ' ' A' ' 1' ' ' THR . 90.7 t -44.74 140.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.154 0.502 . . . . 0.0 111.692 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -126.94 7.35 6.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.604 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 53.7 m -168.41 138.33 2.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.873 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.573 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 11.6 mt -122.8 142.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.313 0.577 . . . . 0.0 112.049 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.8 mt -130.52 114.35 15.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.2 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.61 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.5 m -138.37 148.53 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.29 112.71 24.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 9.0 mmt180 -89.22 104.7 17.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.627 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 14.6 mt -85.96 114.6 22.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.03 -26.89 28.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.652 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 150' ' ' ALA . . . -92.22 -173.44 41.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.848 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 32.3 t -116.82 165.74 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.372 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.627 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 10.2 m-85 -152.03 168.26 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.04 170.3 16.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.89 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . 148.97 153.99 6.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.819 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -120.07 5.11 10.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.628 0.251 . . . . 0.0 111.459 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.508 HG22 HD11 ' A' ' 13' ' ' ILE . 12.5 m -131.25 138.71 49.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.7 mttt -114.32 163.09 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.415 ' HG3' ' NE1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.93 -179.12 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.022 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.778 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.5 pt -101.27 159.72 28.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.21 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.59 105.14 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.794 2.329 . . . . 0.0 112.421 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mt -96.09 150.77 20.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.038 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.31 72.8 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.574 ' HH2' HG11 ' A' ' 115' ' ' VAL . 81.0 m95 -56.9 -23.09 42.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.32 -30.26 66.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 0.0 110.457 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.63 -19.42 45.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.99 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.402 ' CD1' HD11 ' A' ' 113' ' ' LEU . 52.0 m-85 -107.87 167.76 9.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.576 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -129.98 141.24 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 111.01 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -79.92 109.11 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.498 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.767 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.2 m -90.54 -22.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.7 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.2 m -159.58 140.72 12.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.66 0.267 . . . . 0.0 111.003 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -157.11 113.03 2.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.211 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.757 ' C ' HG23 ' A' ' 154' ' ' THR . 1.4 ttp180 -136.28 130.11 32.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 3.8 m -89.84 132.03 35.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.15 0.5 . . . . 0.0 112.194 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 t -105.15 113.0 41.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.626 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.683 ' HA ' HG23 ' A' ' 152' ' ' THR . 17.1 mt-10 -96.88 97.47 9.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.36 -176.04 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.267 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.4 p -63.49 -24.03 67.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 111.041 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.529 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -90.69 120.66 68.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.91 -18.79 59.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.529 2.153 . . . . 0.0 112.36 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 120' ' ' GLY . . . -95.81 -25.87 15.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 110.816 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.2 mt -85.1 2.45 43.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.741 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 145' ' ' GLU . 16.6 m -83.47 82.46 8.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 111.083 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.584 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.5 OUTLIER -98.04 -171.74 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.757 HG23 ' C ' ' A' ' 142' ' ' ARG . 21.6 m -134.11 137.84 44.84 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' SER . 10.9 m-85 -86.06 106.76 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.561 ' HB2' HG22 ' A' ' 115' ' ' VAL . 11.3 mt-10 -105.46 121.47 44.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.767 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.5 t -114.61 111.8 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.895 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 16.3 m95 -107.93 151.34 25.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.114 0.483 . . . . 0.0 112.022 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.421 ' HB2' ' CG1' ' A' ' 139' ' ' VAL . 3.3 mt-30 -132.39 131.61 41.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.364 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -49.44 123.74 8.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 111.465 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.429 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -110.1 -175.55 2.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.959 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.191 179.694 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 13.8 m . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.5 154.62 24.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.587 . . . . 0.0 112.557 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.501 ' HB2' HD23 ' A' ' 113' ' ' LEU . 1.3 m-85 -121.22 117.47 27.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.778 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.833 HD21 ' HA ' ' A' ' 30' ' ' PHE . 9.5 tp -115.41 124.56 51.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.707 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.3 p90 -168.52 163.3 12.42 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.51 136.29 53.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -118.21 153.17 34.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.069 0.462 . . . . 0.0 111.391 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -102.89 -178.17 3.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.235 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -48.82 -49.08 40.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.28 0.562 . . . . 0.0 109.843 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' HB3' HD23 ' A' ' 12' ' ' LEU . 7.6 t70 -69.79 -25.65 63.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.58 32.64 5.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 1.5 pp -100.93 166.04 11.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -121.49 -52.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.298 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' H ' HD12 ' A' ' 13' ' ' ILE . . . -167.61 -141.38 3.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.804 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.63 -158.73 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.585 0.231 . . . . 0.0 110.789 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -160.8 36.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -162.93 -68.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.566 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.775 ' O ' HD23 ' A' ' 19' ' ' LEU . 2.8 m80 -94.15 147.45 23.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.748 0.308 . . . . 0.0 111.013 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -150.55 88.74 4.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.709 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.3 -64.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.588 2.192 . . . . 0.0 112.447 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.95 137.51 33.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.037 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.47 138.23 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.982 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.498 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -86.93 124.18 69.27 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.051 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.498 ' HD2' HD23 ' A' ' 23' ' ' LEU . 7.6 Cg_exo -72.28 -30.15 13.25 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.565 2.176 . . . . 0.0 112.472 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.63 -34.82 59.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.35 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 30' ' ' PHE . 6.7 m-20 -78.94 -43.02 25.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.085 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.549 ' O ' ' HG2' ' A' ' 31' ' ' ARG . 4.9 tp -55.54 -14.53 2.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.179 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -84.6 -57.35 3.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.515 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 44.9 t80 -78.04 -35.98 49.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.737 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.833 ' HA ' HD21 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -62.9 -14.47 46.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.887 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -92.74 -60.37 1.83 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.656 ' H ' ' HG3' ' A' ' 31' ' ' ARG . . . -54.72 -20.57 8.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.644 ' HB2' HD22 ' A' ' 4' ' ' LEU . 9.8 mm-40 -92.8 -5.79 50.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.843 HG22 HG12 ' A' ' 95' ' ' VAL . 21.0 p -141.49 -35.49 0.46 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.887 HG22 ' O ' ' A' ' 31' ' ' ARG . 4.8 m -70.28 143.73 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.772 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.51 -7.48 26.35 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.367 -0.92 . . . . 0.0 114.016 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -154.69 -164.03 1.72 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.602 1.201 . . . . 0.0 109.788 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.551 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 54.0 mt -72.28 89.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.15 126.95 51.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.144 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.62 HG21 HG11 ' A' ' 82' ' ' VAL . 21.4 t -79.77 158.73 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.108 0.48 . . . . 0.0 112.189 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.502 ' N ' HG12 ' A' ' 40' ' ' VAL . 31.1 m -160.24 150.86 5.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.852 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.7 155.87 43.68 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.907 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -54.87 -49.09 72.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.922 0.361 . . . . 0.0 110.776 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 15.2 tpt85 -62.88 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -69.88 -43.27 72.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.664 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.537 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -63.9 -29.26 70.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.023 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -66.15 -66.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.901 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 17.0 t -53.27 -30.73 40.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.415 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -31.13 123.37 0.34 Allowed Pre-proline 0 N--CA 1.468 0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.606 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.61 -27.46 5.33 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.789 2.326 . . . . 0.0 113.251 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -171.31 117.57 0.44 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.727 0.298 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -122.05 141.2 33.72 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.96 -174.41 12.2 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.261 -1.558 . . . . 0.0 111.702 -0.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.762 HD12 HD21 ' A' ' 59' ' ' ASN . 17.0 mt -95.1 154.91 39.48 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.52 -83.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.702 2.268 . . . . 0.0 113.137 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -96.42 33.57 1.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HD2' HD13 ' A' ' 54' ' ' LEU . 4.0 mtt180 -132.09 100.96 5.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.326 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.551 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 51.6 m -68.23 121.85 17.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.785 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.762 HD21 HD12 ' A' ' 54' ' ' LEU . 2.1 m-80 -105.83 151.09 24.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.252 0.548 . . . . 0.0 112.191 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.696 HG12 HG22 ' A' ' 76' ' ' VAL . 11.3 t -128.0 140.93 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.174 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.1 t -111.31 118.33 57.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 111.604 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.883 HD12 HG23 ' A' ' 76' ' ' VAL . 3.4 tp -104.21 112.16 25.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.537 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.9 t -149.99 162.24 40.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -76.9 -6.39 52.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.594 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.777 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.6 tp60 -74.01 125.29 27.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.706 0.288 . . . . 0.0 110.441 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.1 -8.13 59.7 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' H ' ' HG3' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -127.52 11.8 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.777 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 6.3 t80 -58.37 148.26 28.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.119 0.485 . . . . 0.0 111.45 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.893 ' HA ' HG21 ' A' ' 75' ' ' VAL . 25.9 mm100 -132.32 174.46 10.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.437 1.113 . . . . 0.0 112.728 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.2 141.96 16.78 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.375 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -82.15 96.65 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 110.147 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.33 -45.77 1.36 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.544 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -72.72 163.36 28.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.986 0.422 . . . . 0.0 111.759 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 t -96.17 140.62 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 69' ' ' GLN . 18.7 t -102.55 119.23 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.699 . . . . 0.0 112.26 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.883 HG23 HD12 ' A' ' 62' ' ' LEU . 30.0 m -128.32 167.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.729 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -115.43 -23.59 8.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.713 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.728 ' CA ' HD11 ' A' ' 62' ' ' LEU . 1.4 t70 -153.02 179.84 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.134 0.493 . . . . 0.0 111.581 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.964 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.6 t -65.53 -10.15 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.751 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.5 -33.0 19.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.679 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.59 -27.23 58.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.807 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.839 HG22 HG21 ' A' ' 76' ' ' VAL . 16.5 t -74.01 -55.22 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.653 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 13.0 m-85 -55.57 -28.23 53.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.801 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.82 -46.37 90.81 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.46 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 89' ' ' HIS . 73.8 t80 -63.4 -54.05 42.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.394 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.66 -23.81 44.18 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.328 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -71.75 -33.41 68.64 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.406 ' HG2' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -89.02 -9.36 51.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.246 179.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 94.5 m-70 -125.0 66.23 49.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.61 0.24 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.393 2.729 . . . . 0.0 113.014 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -37.17 27.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.409 ' NE2' HG13 ' A' ' 38' ' ' ILE . 9.1 mt-30 -107.75 161.79 14.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.34 174.67 6.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.253 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.464 HD11 ' CG1' ' A' ' 82' ' ' VAL . 13.2 tp -116.1 114.84 25.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.504 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.843 HG12 HG22 ' A' ' 34' ' ' THR . 23.1 t -127.58 112.65 28.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.817 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 96' ' ' ILE . 3.4 mm -81.4 131.38 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.844 0.354 . . . . 0.0 111.416 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.463 ' HB1' ' HE1' ' A' ' 30' ' ' PHE . . . -105.78 -41.88 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.876 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.57 -168.49 41.56 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.806 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.421 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.76 -160.74 33.93 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 122.027 -0.69 . . . . 0.0 112.588 -0.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.434 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . . . -50.52 -58.35 5.99 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.81 -28.13 5.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.67 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 62' ' ' LEU . 37.2 mm -81.23 -28.66 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.386 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.3 m-85 -59.39 -58.67 7.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.007 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.629 ' CA ' HD13 ' A' ' 129' ' ' ILE . 13.6 t -66.79 -9.9 41.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.771 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.25 -41.62 57.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.011 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.964 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.2 m-85 -98.21 -3.97 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.644 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.508 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 38.7 pttt -51.61 -33.99 35.53 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.88 0.372 . . . . 0.0 111.114 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.17 -3.85 47.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.586 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.34 -21.93 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 106' ' ' PHE . 94.7 t -45.87 134.88 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.036 0.446 . . . . 0.0 111.505 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -116.66 6.01 13.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.598 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 46.2 m -168.03 141.66 3.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.311 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.708 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 13.8 mt -123.54 146.0 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.22 0.533 . . . . 0.0 111.814 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.491 HD13 ' OE1' ' A' ' 33' ' ' GLN . 13.2 mt -135.57 117.44 15.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.884 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.707 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.4 m -135.13 144.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.408 . . . . 0.0 111.49 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -112.92 113.19 25.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.802 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.37 100.7 12.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.464 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 2.2 mp -91.54 131.61 36.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.416 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.48 -52.63 64.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.047 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.24 -172.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.564 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -123.27 164.03 19.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.347 . . . . 0.0 111.038 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -147.29 165.15 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 166.57 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.54 153.12 6.5 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.762 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.98 6.1 12.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.653 0.264 . . . . 0.0 111.107 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.8 m -133.94 145.23 49.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.368 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 1.2 pttp -122.21 173.77 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 18.5 tpt -69.32 153.15 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.629 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.7 pp -78.9 163.36 60.84 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.56 101.42 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.336 . . . . 0.0 112.653 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.41 149.03 21.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.636 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.49 77.31 3.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.708 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.4 m95 -61.16 -17.83 54.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.352 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.26 -34.45 63.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 110.464 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.11 -17.79 56.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.211 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -105.39 169.23 8.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 110.826 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.721 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -129.31 141.33 51.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 0.7 OUTLIER -82.88 119.06 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.312 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 157' ' ' VAL . 10.0 m -101.45 -21.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.896 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.2 m -160.74 143.36 12.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.264 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.87 111.7 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.688 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.463 ' C ' HG23 ' A' ' 154' ' ' THR . 9.2 ttp-105 -146.66 120.41 9.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.416 . . . . 0.0 111.398 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.649 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -74.57 145.97 42.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.214 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.525 HG21 ' HE2' ' A' ' 155' ' ' TYR . 14.4 t -116.45 102.57 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.426 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -85.31 99.66 11.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.63 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.47 -176.51 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.507 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.0 p -54.36 -56.53 17.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.515 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 34.2 t-20 -74.54 124.16 89.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.796 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.8 -27.52 84.13 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.262 1.975 . . . . 0.0 112.887 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.16 -19.44 26.95 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 15.5 mt -84.32 8.0 17.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.639 0.257 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 144' ' ' VAL . 97.0 m -73.33 165.17 25.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p-80 -172.73 159.33 4.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.223 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.649 ' OG1' HG23 ' A' ' 143' ' ' THR . 19.1 m -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.548 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.525 ' HE2' HG21 ' A' ' 144' ' ' VAL . 98.5 m-85 -118.69 105.76 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.661 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HB2' HG22 ' A' ' 115' ' ' VAL . 12.8 mt-10 -106.63 124.88 50.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.856 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 139' ' ' VAL . 10.5 t -116.3 112.84 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 22.0 m95 -106.75 149.83 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.435 . . . . 0.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.713 HE21 HG11 ' A' ' 139' ' ' VAL . 14.5 mt-30 -132.29 129.7 39.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.614 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -46.52 123.55 5.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.523 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.721 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -105.42 178.49 4.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.066 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.647 HG23 HD23 ' A' ' 94' ' ' LEU . 4.7 m . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.43 154.47 22.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -122.76 116.35 23.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.505 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 30' ' ' PHE . 4.8 tp -114.95 122.5 46.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.673 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.0 p90 -167.22 168.33 13.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.615 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HB2' ' HZ ' ' A' ' 30' ' ' PHE . . . -119.85 141.26 49.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 111.29 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.39 153.77 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.89 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.77 -177.06 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -36.2 14.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.15 -21.32 29.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.46 25.04 29.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.596 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.5 tt -101.58 148.87 24.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.318 . . . . 0.0 111.003 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 126' ' ' THR . 1.1 pt -112.29 173.32 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.28 153.66 51.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.768 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -79.36 109.89 14.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.795 0.331 . . . . 0.0 110.874 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.25 101.53 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.002 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.01 -83.09 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.502 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 19' ' ' LEU . 7.3 m170 -120.04 133.68 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.72 0.295 . . . . 0.0 110.853 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 18' ' ' HIS . 3.6 mp -142.33 140.58 19.29 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.61 -65.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.407 2.071 . . . . 0.0 112.239 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -160.99 -171.53 3.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.684 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.485 ' CD2' HD11 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -131.65 170.6 14.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.976 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.442 HD11 HD22 ' A' ' 151' ' ' LEU . 4.4 mm? -88.84 145.27 34.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.95 -41.35 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.601 2.201 . . . . 0.0 112.486 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -78.24 -22.38 48.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.01 -20.5 24.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.399 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.485 HD11 ' CD2' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -71.15 -28.34 64.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.762 0.315 . . . . 0.0 111.29 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -66.36 -23.86 66.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.483 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.423 ' CD1' ' CD1' ' A' ' 155' ' ' TYR . 34.0 t80 -73.28 -45.36 56.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.406 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.747 ' HZ ' ' HB2' ' A' ' 6' ' ' ALA . 14.4 m-85 -86.03 4.33 38.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.796 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.777 ' O ' HG13 ' A' ' 35' ' ' VAL . 4.5 ttt-85 -92.24 -62.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 0.0 111.775 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.57 -15.98 63.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.579 ' O ' HG11 ' A' ' 95' ' ' VAL . 6.7 mm-40 -93.27 -9.4 39.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.461 HG23 HD22 ' A' ' 4' ' ' LEU . 54.7 p -144.79 22.22 1.61 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 31' ' ' ARG . 23.3 m -108.51 148.35 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.028 0.442 . . . . 0.0 111.968 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 54.33 34.22 53.83 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 116.868 1.507 . . . . 0.0 116.868 176.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -151.17 -165.17 2.19 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.692 2.246 . . . . 0.0 108.631 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.63 87.72 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.644 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.1 ttp -99.0 124.21 43.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.603 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.593 HG21 HG11 ' A' ' 82' ' ' VAL . 20.9 t -77.54 157.39 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.989 0.423 . . . . 0.0 111.838 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 60' ' ' VAL . 32.6 m -161.18 147.8 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.956 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.39 155.55 53.06 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.062 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.7 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.31 -52.19 62.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.972 0.386 . . . . 0.0 110.126 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -57.77 -30.68 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.46 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.47 HG22 ' CE2' ' A' ' 49' ' ' PHE . 21.5 m -71.29 -49.26 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.798 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 13.1 t80 -55.03 -35.7 64.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.487 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -66.83 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.938 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 49' ' ' PHE . 99.7 p -52.8 -37.19 59.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.815 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.971 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.49 127.35 0.25 Allowed Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.908 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.5 -27.68 19.57 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.071 2.514 . . . . 0.0 113.814 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 2.7 ttmm -151.75 147.95 27.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.966 0.412 . . . . 0.0 111.525 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -135.09 109.69 10.67 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.612 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 4.0 Cg_exo -86.53 168.04 46.0 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.792 -1.337 . . . . 0.0 112.048 -0.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.971 HD11 ' CE1' ' A' ' 49' ' ' PHE . 7.7 mt -59.45 164.86 4.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.645 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 10.9 Cg_endo -54.23 91.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 113.05 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 14.9 mm-40 64.82 23.36 12.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.262 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 23.1 mtt180 -109.57 132.19 54.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.917 0.389 . . . . 0.0 111.444 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.8 m -84.05 108.14 16.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.772 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.51 158.17 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 112.089 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.775 HG12 HG22 ' A' ' 76' ' ' VAL . 10.7 t -130.8 143.33 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.042 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.7 HG13 ' HA ' ' A' ' 43' ' ' ARG . 99.5 t -108.84 122.08 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.716 0.293 . . . . 0.0 111.419 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -104.25 122.94 46.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.272 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.586 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -156.29 165.71 35.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.217 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -84.36 -9.0 58.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.3 tt0 -76.0 133.55 40.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -88.1 6.81 34.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.938 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.98 3.15 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.887 ' O ' HG11 ' A' ' 75' ' ' VAL . 4.4 t80 -57.27 139.19 53.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.059 0.456 . . . . 0.0 111.299 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.877 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -126.67 176.37 7.28 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.92 0.866 . . . . 0.0 112.253 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.65 146.19 23.16 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.118 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -94.34 96.23 9.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.508 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.59 13.38 53.82 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.057 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.694 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -136.55 172.87 12.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.925 0.393 . . . . 0.0 111.627 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 14.0 t -100.24 140.17 19.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.654 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 68' ' ' TYR . 21.6 t -106.41 116.0 49.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.09 0.472 . . . . 0.0 111.992 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.928 HG21 HG22 ' A' ' 82' ' ' VAL . 27.4 m -124.83 162.2 27.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.656 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 63' ' ' THR . 3.5 m170 -111.19 -23.19 11.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.365 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -155.71 -171.39 3.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.222 0.534 . . . . 0.0 111.64 -179.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.894 HG13 ' CD2' ' A' ' 106' ' ' PHE . 6.0 t -69.87 -9.22 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.63 -33.07 16.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.149 0.499 . . . . 0.0 109.948 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -76.43 -28.14 56.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.694 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 76' ' ' VAL . 22.0 t -74.74 -51.08 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.545 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 6.3 m-85 -57.23 -25.51 59.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.667 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.93 -42.28 81.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.176 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 68.2 t80 -65.06 -56.07 15.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.72 -22.55 36.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.954 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.9 -31.88 68.66 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.457 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 15.3 mt-30 -87.1 -7.42 58.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.443 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.19 67.92 56.2 Favored Pre-proline 0 N--CA 1.456 -0.132 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.65 -0.32 2.99 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.133 2.555 . . . . 0.0 112.928 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.94 -24.54 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.304 . . . . 0.0 111.17 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -101.75 155.17 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 0.0 111.533 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.14 167.59 10.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.994 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.68 HD11 ' CG1' ' A' ' 82' ' ' VAL . 9.7 tp -120.04 113.02 19.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.081 0.467 . . . . 0.0 111.499 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 33' ' ' GLN . 9.0 t -127.49 109.72 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.188 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 40' ' ' VAL . 3.7 mm -77.59 130.68 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -105.5 -42.89 5.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.492 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.7 -169.02 41.34 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.896 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.417 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -87.06 -160.92 35.75 Favored Glycine 0 C--N 1.342 0.871 0 O-C-N 122.118 -0.637 . . . . 0.0 112.7 -0.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.76 -53.5 39.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 111.404 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -27.62 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.841 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.1 mm -81.42 -22.7 10.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.1 m-85 -64.65 -55.24 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.726 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.617 ' CA ' HD13 ' A' ' 129' ' ' ILE . 10.6 t -66.54 -9.75 38.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.01 -41.73 41.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.624 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.894 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.6 m-85 -95.66 -5.37 42.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.57 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 2.0 pttt -51.52 -33.57 32.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.79 0.328 . . . . 0.0 111.336 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -84.73 -0.29 53.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.739 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -124.42 -24.58 4.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.872 HG11 HD23 ' A' ' 113' ' ' LEU . 58.5 t -48.21 122.14 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.634 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.95 3.47 44.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 93.9 m -165.43 142.21 5.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.284 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.872 HD23 HG11 ' A' ' 110' ' ' VAL . 8.1 mt -125.76 146.09 49.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.902 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.4 mt -134.75 119.31 18.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.697 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.673 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -135.29 145.26 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 106.47 15.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.309 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.4 OUTLIER -93.1 104.58 16.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.835 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 1.2 mp -91.48 128.13 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.52 -49.09 37.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.217 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.46 172.6 3.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.298 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.2 t -112.71 147.96 35.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 1.5 m-85 -122.02 153.0 39.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -111.13 141.0 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.052 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.596 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -169.62 -167.77 30.62 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.55 -16.68 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.606 0.241 . . . . 0.0 111.537 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 13' ' ' ILE . 40.7 m -109.14 131.96 54.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.697 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.57 173.44 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.755 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.455 ' HE2' ' CE2' ' A' ' 5' ' ' TRP . 17.1 tpt -78.35 147.14 34.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.662 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -64.08 166.96 8.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.662 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 70.1 Cg_endo -77.13 98.04 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.265 1.977 . . . . 0.0 112.674 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.71 145.08 25.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.012 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.52 78.58 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.81 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.469 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.1 m95 -60.16 -20.11 56.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.51 -32.88 66.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -24.13 51.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.013 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.621 ' CD1' HD11 ' A' ' 113' ' ' LEU . 77.3 m-85 -97.49 173.6 7.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.867 0.365 . . . . 0.0 110.76 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.13 143.36 44.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.522 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.8 ttpm? -84.0 108.64 17.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.816 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 157' ' ' VAL . 28.2 m -91.37 -26.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.318 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.0 m -154.86 140.7 18.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.943 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 35.4 p -164.6 111.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.445 ' C ' HG23 ' A' ' 154' ' ' THR . 0.3 OUTLIER -143.07 122.57 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.68 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.731 HG23 ' OG1' ' A' ' 154' ' ' THR . 4.0 m -78.43 144.28 35.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.18 0.514 . . . . 0.0 111.54 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.492 HG21 ' HE2' ' A' ' 155' ' ' TYR . 3.3 t -116.27 105.12 17.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.48 ' HA ' HG23 ' A' ' 152' ' ' THR . 6.2 mt-10 -86.12 98.97 11.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.847 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -81.33 -175.3 5.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.0 p -57.72 -57.66 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.487 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -68.56 120.17 73.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.91 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.5 -25.96 76.27 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.964 1.776 . . . . 0.0 112.324 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.47 -18.4 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.431 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.1 mt -87.15 8.86 21.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.599 0.237 . . . . 0.0 111.359 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.491 HG22 ' N ' ' A' ' 153' ' ' HIS . 79.7 m -71.48 169.29 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.491 ' N ' HG22 ' A' ' 152' ' ' THR . 11.0 p80 -174.34 160.79 3.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.731 ' OG1' HG23 ' A' ' 143' ' ' THR . 10.4 m -127.69 133.95 49.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.627 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.492 ' HE2' HG21 ' A' ' 144' ' ' VAL . 67.9 m-85 -94.33 106.45 18.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.446 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.627 ' HB2' HG22 ' A' ' 115' ' ' VAL . 13.9 mt-10 -103.3 121.75 43.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.973 0.415 . . . . 0.0 111.971 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 139' ' ' VAL . 17.9 t -113.43 111.26 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.094 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.522 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 21.5 m95 -107.61 148.34 29.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.979 0.418 . . . . 0.0 111.721 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -126.92 117.28 22.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 12.8 tmtt? -49.77 132.45 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -99.96 171.91 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.626 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 2.7 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.02 148.87 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.518 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -111.81 114.45 27.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.244 178.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.27 121.26 43.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.66 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.1 p90 -167.58 176.21 6.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.499 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . . . -124.6 150.33 46.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 111.823 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.98 147.6 37.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.617 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -103.69 -167.91 1.43 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.421 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -52.6 -48.59 66.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.842 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.68 -26.49 60.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.65 20.89 12.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.636 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.656 HD11 ' HA3' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -74.58 149.37 40.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.766 0.317 . . . . 0.0 110.645 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.16 -17.55 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.499 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' HD21 ' A' ' 12' ' ' LEU . . . 164.77 -157.51 29.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.424 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HG2' ' HA2' ' A' ' 124' ' ' GLY . 0.2 OUTLIER -129.6 109.35 10.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.397 . . . . 0.0 111.026 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -99.78 154.31 18.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.82 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.25 -15.1 8.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.768 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -142.35 -72.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.683 0.278 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.85 128.16 1.47 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.978 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.25 112.91 2.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.619 2.212 . . . . 0.0 112.459 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -91.09 165.48 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.768 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -89.64 145.04 25.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.274 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -105.31 121.0 47.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.498 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 23' ' ' LEU . 69.5 Cg_exo -51.28 -24.8 16.35 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.413 2.075 . . . . 0.0 112.746 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -95.18 -23.13 17.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.46 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -49.23 13.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.824 0.345 . . . . 0.0 111.322 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -52.26 -33.11 40.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.352 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -40.84 -32.58 0.23 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.082 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -105.7 -36.85 6.93 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 34' ' ' THR . 2.5 m-85 -91.99 30.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.659 ' HG3' ' N ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -92.5 -45.11 8.29 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.174 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.659 ' N ' ' HG3' ' A' ' 31' ' ' ARG . . . -98.08 -40.05 8.61 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.714 HE22 HD13 ' A' ' 114' ' ' LEU . 1.1 mt-30 -68.93 -7.63 36.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -120.95 -5.22 9.58 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.909 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 32' ' ' ALA . 20.6 m -108.0 155.51 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.059 0.457 . . . . 0.0 112.092 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.99 28.64 58.39 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 116.346 1.299 . . . . 0.0 116.346 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.0 mtmt -147.65 -178.41 6.24 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.11 1.955 . . . . 0.0 108.28 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 79.0 mt -80.19 87.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.54 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.8 ttp -100.73 122.45 43.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.412 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.784 HG13 ' HB ' ' A' ' 60' ' ' VAL . 3.1 t -91.12 129.18 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.92 147.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.115 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.79 151.76 52.44 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.932 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.799 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -48.07 -55.91 9.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.906 0.384 . . . . 0.0 110.385 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -34.35 68.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.57 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.5 m -73.68 -31.37 63.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.811 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CG ' HG22 ' A' ' 61' ' ' VAL . 51.8 t80 -75.82 -33.04 60.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.815 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.0 mt-10 -64.21 -67.23 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.575 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -58.73 -30.04 67.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.738 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.766 ' CE2' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -34.31 149.44 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.905 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.55 -32.73 5.93 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.187 2.591 . . . . 0.0 113.932 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.38 152.9 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 9.1 mtp180 -124.72 101.72 32.93 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.2 Cg_endo -86.25 -168.11 5.08 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.965 -1.265 . . . . 0.0 112.213 0.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 49' ' ' PHE . 88.0 mt -95.76 159.8 31.65 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 18.9 Cg_endo -60.26 95.85 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.728 2.285 . . . . 0.0 113.638 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.534 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 10.6 mt-10 66.35 18.49 10.89 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.441 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HG3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -109.77 107.57 17.61 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.946 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.4 m -62.13 106.67 0.76 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.982 0.42 . . . . 0.0 110.164 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.524 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -105.54 156.88 17.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.201 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.784 ' HB ' HG13 ' A' ' 40' ' ' VAL . 5.2 t -130.2 144.08 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.84 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.799 HG13 ' HA ' ' A' ' 43' ' ' ARG . 89.6 t -116.09 106.86 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -89.0 118.14 28.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.015 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.864 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -148.95 169.84 19.67 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.926 0.393 . . . . 0.0 111.352 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -88.24 -9.25 53.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.5 tp60 -78.1 128.76 34.31 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.45 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 7.5 mt-10 -79.76 -16.15 56.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.787 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.29 9.12 25.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.865 ' O ' HG11 ' A' ' 75' ' ' VAL . 3.5 t80 -58.77 140.37 55.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.007 0.432 . . . . 0.0 111.612 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.913 ' HA ' HG21 ' A' ' 75' ' ' VAL . 18.6 mm100 -124.96 178.34 5.57 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.107 0.956 . . . . 0.0 112.004 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.97 145.33 20.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.784 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.45 95.88 4.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.368 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.93 -39.35 2.96 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.051 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -69.29 172.33 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.688 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.42 HG21 ' CE1' ' A' ' 85' ' ' TYR . 9.4 t -97.38 140.21 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.98 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.913 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.9 t -105.55 118.29 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.173 0.511 . . . . 0.0 111.391 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.7 HG21 HG22 ' A' ' 82' ' ' VAL . 30.5 m -127.72 165.09 27.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.845 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 5.1 m170 -116.18 -23.19 8.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 110.813 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -154.19 -167.57 2.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.0 111.305 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.936 HG13 ' CD2' ' A' ' 106' ' ' PHE . 4.0 t -74.42 -8.83 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.7 -32.9 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.092 0.472 . . . . 0.0 109.922 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.667 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.89 -27.54 57.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.7 HG22 HG21 ' A' ' 76' ' ' VAL . 68.7 t -73.09 -54.05 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.467 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.9 m-85 -55.98 -24.82 40.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.941 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.74 86.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.831 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 74' ' ' VAL . 81.9 t80 -66.69 -57.26 7.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.81 -23.15 11.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.028 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.91 -38.06 76.14 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -83.89 -4.78 58.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.563 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -127.26 66.42 68.37 Favored Pre-proline 0 N--CA 1.455 -0.182 0 CA-C-O 121.015 0.436 . . . . 0.0 110.248 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.61 -0.01 5.41 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.231 2.621 . . . . 0.0 113.058 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -27.88 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.707 0.289 . . . . 0.0 111.087 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -105.08 159.23 16.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.658 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 42.1 mt-10 -98.09 159.23 15.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.135 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.623 HD21 HG12 ' A' ' 82' ' ' VAL . 20.1 tp -108.54 116.39 31.88 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.525 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 39' ' ' MET . 38.5 t -130.43 114.61 29.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.36 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.0 mm -82.51 131.1 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.632 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.429 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.86 -45.34 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.636 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.3 -166.3 39.05 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.406 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.42 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -92.74 -160.7 35.9 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 117.821 0.81 . . . . 0.0 112.741 -0.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.98 -48.56 16.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.466 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -60.19 -30.94 69.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.67 -26.61 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.501 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.467 ' HB3' HG12 ' A' ' 129' ' ' ILE . 4.2 m-85 -60.39 -56.38 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.811 ' CA ' HD13 ' A' ' 129' ' ' ILE . 14.9 t -65.93 -10.1 35.79 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.539 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.54 -43.28 49.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.936 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.1 m-85 -95.4 -3.61 46.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.555 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 16.5 pttp -48.91 -33.07 10.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.783 0.325 . . . . 0.0 111.397 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -89.05 3.85 50.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' HB2' HG11 ' A' ' 79' ' ' VAL . 1.4 m-20 -127.53 -27.9 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.661 0.267 . . . . 0.0 111.517 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.66 HG11 HD23 ' A' ' 113' ' ' LEU . 92.7 t -52.04 123.09 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 0.0 111.196 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.65 8.01 43.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.426 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 76.3 m -167.56 142.97 3.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.815 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.66 HD23 HG11 ' A' ' 110' ' ' VAL . 16.2 mt -123.49 145.35 48.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.321 0.581 . . . . 0.0 111.723 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.714 HD13 HE22 ' A' ' 33' ' ' GLN . 9.5 mt -135.64 120.0 17.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.46 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.66 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.9 m -136.35 145.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.043 0.449 . . . . 0.0 111.864 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -111.81 108.5 17.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.038 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 1.9 ttm180 -80.57 99.24 8.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.98 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.59 125.93 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.21 74.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.71 163.75 6.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.497 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 59.5 p -105.87 159.47 15.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.802 0.334 . . . . 0.0 111.034 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -147.4 145.43 29.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.779 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -100.72 147.11 26.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.764 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 12' ' ' LEU . . . -179.43 174.19 46.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.733 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.9 42.83 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.204 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 m -162.38 124.81 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -112.67 172.74 6.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.964 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.1 tpt -72.62 157.59 37.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.811 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -79.2 163.76 58.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.289 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.58 93.76 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.749 2.3 . . . . 0.0 111.961 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 mt -83.49 142.67 30.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.809 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.87 70.48 8.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -56.57 -21.75 28.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -73.31 -33.27 65.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.509 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 -10.49 58.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.102 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 45.1 m-85 -108.73 169.43 8.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.425 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -132.44 141.2 48.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.585 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 158' ' ' TRP . 3.3 ttpp -85.11 128.99 34.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.175 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 157' ' ' VAL . 5.7 m -115.92 -17.86 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.1 m -164.51 143.32 7.11 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.975 0.417 . . . . 0.0 111.493 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.72 111.76 2.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.161 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.552 ' C ' HG23 ' A' ' 154' ' ' THR . 10.2 ttt180 -139.73 118.34 12.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.747 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.4 m -81.48 145.06 30.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.392 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' A' ' 155' ' ' TYR . 5.4 t -121.12 103.36 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.549 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.5 mt-10 -84.34 102.22 12.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.33 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.44 -176.46 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.3 p -53.86 -55.84 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.504 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -72.46 121.77 85.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.946 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.06 -27.02 83.86 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.134 1.889 . . . . 0.0 112.413 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.65 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.669 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.6 mt -86.96 9.26 20.0 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.592 0.234 . . . . 0.0 111.551 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 145' ' ' GLU . 95.9 m -70.72 165.92 21.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 11.8 p-80 -170.61 156.51 5.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.133 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.747 ' OG1' HG23 ' A' ' 143' ' ' THR . 16.3 m -120.05 153.58 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.589 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.452 ' HE1' HG21 ' A' ' 144' ' ' VAL . 96.1 m-85 -116.3 105.04 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.8 mt-10 -101.26 153.96 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.957 0.408 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.903 ' O ' HG22 ' A' ' 139' ' ' VAL . 26.7 t -142.31 107.09 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.512 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 28.8 m95 -107.54 145.5 33.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.977 0.417 . . . . 0.0 111.897 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -125.83 114.75 18.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.504 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 1.9 ttmt -46.44 134.0 9.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.08 0.467 . . . . 0.0 112.06 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.425 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -124.19 -166.08 1.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.399 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.076 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -110.79 154.41 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.29 0.567 . . . . 0.0 112.446 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -119.07 112.59 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.603 179.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 30' ' ' PHE . 8.4 tp -113.52 121.78 45.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.81 ' CH2' HG12 ' A' ' 115' ' ' VAL . 2.8 p90 -167.31 164.5 15.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.927 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.76 135.34 54.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.699 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 11.7 pt20 -128.06 155.48 44.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -96.62 -172.49 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -38.56 59.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.023 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -32.65 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.84 37.01 2.64 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 9.3 mt -98.35 151.32 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.739 0.304 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.35 -31.77 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.285 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.88 -171.84 44.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.498 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -99.18 -92.4 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.469 0.176 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.03 -53.56 2.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.814 0.34 . . . . 0.0 111.032 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -169.59 43.3 0.21 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.481 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -124.57 126.3 45.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.856 0.36 . . . . 0.0 110.868 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -157.71 94.73 2.07 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -80.69 -160.43 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.079 2.519 . . . . 0.0 112.133 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.47 125.18 39.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.266 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.523 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.4 t-80 -96.32 -70.06 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.359 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -140.13 165.4 30.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.137 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.672 ' HA ' HD21 ' A' ' 27' ' ' LEU . 88.8 Cg_endo -81.9 5.06 6.56 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.602 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -95.22 -18.4 20.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.75 -16.07 60.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.412 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -76.98 -14.68 59.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.627 0.251 . . . . 0.0 111.262 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -90.37 -32.59 16.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' A' ' 155' ' ' TYR . 18.0 t80 -106.26 -45.81 4.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.505 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.8 t80 -73.97 -33.54 63.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.632 ' O ' HG22 ' A' ' 35' ' ' VAL . 18.6 mtt85 -92.03 -61.74 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.98 -27.77 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.554 ' O ' HG11 ' A' ' 95' ' ' VAL . 1.4 mt-30 -86.83 -8.68 57.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.614 HG22 ' HG3' ' A' ' 39' ' ' MET . 1.4 p -132.75 -35.64 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 31' ' ' ARG . 7.6 m -79.96 155.07 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.836 0.351 . . . . 0.0 111.53 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.97 13.73 67.02 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.766 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 58' ' ' THR . 7.0 mtmt -151.57 -165.88 2.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.191 1.496 . . . . 0.0 109.23 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.66 87.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.614 ' HG3' HG22 ' A' ' 34' ' ' THR . 2.2 ttp -102.04 125.76 48.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 112.155 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 41' ' ' VAL . 20.8 t -82.19 158.81 3.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.646 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 60' ' ' VAL . 34.5 m -165.1 141.06 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.455 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.01 154.13 53.03 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.477 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.16 -51.92 60.47 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.336 0.568 . . . . 0.0 110.687 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.424 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.9 tpt180 -57.64 -32.78 67.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.013 0.435 . . . . 0.0 110.112 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.409 HG22 ' CE2' ' A' ' 49' ' ' PHE . 8.7 m -70.74 -46.79 62.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.986 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 11.5 t80 -55.16 -40.7 70.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.112 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -66.15 0.55 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.941 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -52.26 -40.03 61.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.552 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.409 ' CE2' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER -33.52 127.95 0.41 Allowed Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.674 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -43.88 -26.52 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.144 2.562 . . . . 0.0 113.771 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.745 ' HB3' HD23 ' A' ' 54' ' ' LEU . 5.0 ttpt -151.59 138.02 18.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.59 107.95 6.03 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 71.6 Cg_endo -77.48 166.51 81.57 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.593 -1.42 . . . . 0.0 112.244 -0.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 51' ' ' LYS . 75.8 mt -76.23 158.95 81.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.47 112.04 3.46 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.492 2.128 . . . . 0.0 112.802 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 69.15 8.48 6.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.022 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.545 ' HD3' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -114.06 110.71 20.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.427 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 25.0 m -68.73 107.19 2.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.551 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -101.11 154.58 18.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.983 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 HG22 ' A' ' 76' ' ' VAL . 8.8 t -125.72 141.37 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.633 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 68' ' ' TYR . 98.8 t -110.72 124.67 67.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 111.72 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.913 HD13 HD12 ' A' ' 102' ' ' ILE . 2.1 mt -105.33 118.69 37.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.102 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.997 HG21 ' CD2' ' A' ' 68' ' ' TYR . 1.3 t -155.51 158.67 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.284 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -75.15 -4.32 38.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.62 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -85.83 126.03 33.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.398 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 6.2 mt-10 -78.31 -29.57 47.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.547 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -92.31 6.51 46.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.418 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.997 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.1 t80 -59.81 139.31 57.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.935 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -137.16 169.89 17.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.758 1.266 . . . . 0.0 113.752 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.75 134.09 11.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.267 -2.242 . . . . 0.0 109.566 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -78.97 106.51 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.108 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 -56.51 0.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -71.1 169.31 15.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 12.8 t -94.11 140.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.335 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.935 HG21 ' HA ' ' A' ' 69' ' ' GLN . 17.2 t -112.01 123.16 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 111.419 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 27.1 m -130.32 175.88 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.18 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.458 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.5 m80 -123.16 -25.32 4.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.012 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.47 -171.33 3.9 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.969 HG13 ' CD2' ' A' ' 106' ' ' PHE . 18.7 t -71.38 -10.81 14.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.732 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.86 -32.72 18.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 110.15 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.09 -27.62 59.96 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.903 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.055 HG12 HD11 ' A' ' 94' ' ' LEU . 57.4 t -74.5 -52.48 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 9.6 m-85 -54.74 -27.93 44.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.933 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -64.13 -45.82 86.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.14 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.48 ' CD1' HG11 ' A' ' 74' ' ' VAL . 56.1 t80 -62.64 -54.42 39.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -53.05 -23.28 7.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 83' ' ' PHE . 12.3 mttt -68.61 -44.11 74.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.54 -2.32 41.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.7 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -129.01 61.63 57.92 Favored Pre-proline 0 N--CA 1.456 -0.136 0 CA-C-O 120.951 0.405 . . . . 0.0 110.491 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.01 -0.75 8.97 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.011 2.474 . . . . 0.0 112.954 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.22 -38.69 26.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.92 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -107.73 168.83 8.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.23 164.67 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.321 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.055 HD11 HG12 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -110.78 122.91 49.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.796 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG11 ' O ' ' A' ' 33' ' ' GLN . 41.4 t -132.47 118.82 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.27 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 40' ' ' VAL . 8.0 mm -83.52 130.73 35.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.907 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -98.38 -48.73 4.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.82 -168.01 39.21 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.572 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.427 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -93.84 -160.86 35.1 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 117.717 0.758 . . . . 0.0 112.622 -0.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.48 -56.38 7.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.838 0.351 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -52.53 -29.81 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.913 HD12 HD13 ' A' ' 62' ' ' LEU . 46.5 mm -83.43 -28.52 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.982 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 m-85 -59.62 -55.44 34.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.699 ' HA ' HD13 ' A' ' 129' ' ' ILE . 12.4 t -67.76 -10.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.961 -0.462 . . . . 0.0 112.065 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.774 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.51 -39.07 58.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.949 0.404 . . . . 0.0 110.707 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.969 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.3 m-85 -100.0 -5.34 28.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.564 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.506 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 11.9 pttt -51.23 -31.33 20.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 111.617 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.64 2.77 52.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 41.4 m-20 -126.83 -24.86 3.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.587 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 106' ' ' PHE . 77.8 t -49.07 125.75 3.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.937 0.399 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -102.96 4.38 37.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.92 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 92.1 m -166.76 139.59 3.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.638 HD23 HG11 ' A' ' 110' ' ' VAL . 16.2 mt -118.25 144.98 45.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.213 0.53 . . . . 0.0 111.933 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -135.34 113.82 11.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.598 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.81 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -133.98 143.88 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.782 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -113.32 107.49 15.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -92.21 103.9 16.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 1.3 mp -86.33 129.07 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.03 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -57.91 -49.74 75.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.161 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.41 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -59.43 177.65 2.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.473 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 p -111.85 156.87 21.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 0.0 110.966 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -148.9 154.25 39.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.765 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.77 134.41 35.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 138.21 6.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.457 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.26 6.88 19.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.622 0.249 . . . . 0.0 111.339 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.4 m -128.0 124.18 36.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -94.88 136.46 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.448 ' HE3' ' CZ2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -61.26 174.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.84 163.26 33.15 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.159 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 65.2 Cg_endo -74.85 101.04 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.41 2.073 . . . . 0.0 112.198 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.72 147.22 25.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.57 84.21 2.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.406 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 88.7 m95 -64.86 -16.35 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.083 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.85 -32.65 63.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.905 0.384 . . . . 0.0 110.73 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -79.56 -28.01 41.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.927 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 72.3 m-85 -97.6 169.71 9.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.653 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -134.66 143.74 47.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.521 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 2.3 ttpm? -81.13 119.97 24.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 157' ' ' VAL . 25.6 m -103.12 -21.36 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.235 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.0 m -162.56 140.33 8.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.473 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 18.2 p -165.19 113.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.741 ' C ' HG23 ' A' ' 154' ' ' THR . 5.8 ttt180 -147.96 130.95 16.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.002 0.429 . . . . 0.0 111.236 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.704 HG23 ' OG1' ' A' ' 154' ' ' THR . 5.1 m -84.8 146.12 27.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.073 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 153' ' ' HIS . 5.0 t -117.16 102.69 13.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.899 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.562 ' HA ' HG23 ' A' ' 152' ' ' THR . 35.4 mt-10 -81.04 97.82 7.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.096 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.96 -178.19 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.299 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -60.97 2.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 110.574 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.494 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.37 117.06 40.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.666 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 148' ' ' ASN . 11.6 Cg_endo -55.75 -26.73 58.12 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.979 1.786 . . . . 0.0 112.402 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.41 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -91.53 -17.16 26.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 12.7 mt -88.34 11.25 17.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.622 0.248 . . . . 0.0 111.387 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.562 HG23 ' HA ' ' A' ' 145' ' ' GLU . 87.7 m -71.59 168.43 17.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.486 ' N ' HG22 ' A' ' 152' ' ' THR . 0.4 OUTLIER -171.45 157.65 4.94 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.544 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 142' ' ' ARG . 17.6 m -126.71 147.59 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 84.8 m-85 -108.33 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.441 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.583 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.4 mt-10 -104.37 124.57 49.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.808 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.684 ' O ' HG22 ' A' ' 139' ' ' VAL . 12.3 t -118.42 115.72 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.272 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.521 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 18.5 m95 -112.61 151.21 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.508 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.402 HE21 HG11 ' A' ' 139' ' ' VAL . 8.3 mt-30 -125.95 110.95 14.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.863 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 4.5 tttt -49.09 138.85 11.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.653 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 39.5 mtmt -115.59 -175.11 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.409 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.103 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.77 HG23 HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.25 147.12 38.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.708 ' HB2' HD23 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -110.28 115.59 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.574 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.794 HD21 ' HA ' ' A' ' 30' ' ' PHE . 9.1 tp -116.06 123.93 49.17 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.664 ' CH2' HG12 ' A' ' 115' ' ' VAL . 3.8 p90 -167.99 162.77 13.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.668 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -114.77 131.57 56.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.114 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -122.44 154.33 37.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.717 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 2.2 p-10 -102.97 -176.8 3.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -47.92 -42.15 26.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.34 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 -25.99 54.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.455 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.63 25.47 9.22 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.59 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -95.65 162.48 13.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.665 0.269 . . . . 0.0 110.736 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 pt -111.92 -42.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.343 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.1 -173.07 33.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.646 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.38 96.32 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.97 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.92 95.34 1.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.69 34.73 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.541 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -146.43 176.71 9.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.767 0.318 . . . . 0.0 110.786 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -95.61 -51.81 0.24 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.334 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 81.3 Cg_endo -93.16 168.04 2.37 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.819 2.346 . . . . 0.0 112.651 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -127.9 129.54 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.588 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -94.46 38.13 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.11 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mp -122.35 89.85 49.22 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 27' ' ' LEU . 74.4 Cg_endo -75.37 -11.17 20.83 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.624 2.216 . . . . 0.0 112.945 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -22.8 17.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.522 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -72.67 -49.24 32.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 111.476 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -56.66 -18.9 13.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.576 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -41.49 75.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.688 0.28 . . . . 0.0 111.55 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.413 ' CZ ' ' OE1' ' A' ' 33' ' ' GLN . 55.3 t80 -105.22 -15.36 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.794 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.5 t80 -81.77 -57.36 3.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.739 0.304 . . . . 0.0 111.766 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.864 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -53.91 -62.43 1.66 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.26 -28.89 20.54 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.466 ' CB ' HD22 ' A' ' 4' ' ' LEU . 0.8 OUTLIER -92.34 -3.35 55.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.494 HG23 ' CD2' ' A' ' 4' ' ' LEU . 34.4 p -140.57 4.52 1.96 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 31' ' ' ARG . 34.4 m -109.0 158.84 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.038 0.447 . . . . 0.0 112.05 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 72.2 11.21 75.12 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-O 119.177 -0.79 . . . . 0.0 114.592 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 6.5 mttt -149.2 -163.9 1.9 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.145 1.472 . . . . 0.0 108.559 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.463 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 60.4 mt -84.74 88.41 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.558 ' HE3' HG11 ' A' ' 41' ' ' VAL . 18.2 ttp -95.31 118.24 31.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.223 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.605 HG21 HG11 ' A' ' 82' ' ' VAL . 3.5 t -88.11 126.61 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.558 HG11 ' HE3' ' A' ' 39' ' ' MET . 15.9 m -133.01 148.49 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.323 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.59 157.6 52.74 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.61 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.639 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -50.94 -53.13 35.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.097 0.449 . . . . 0.0 110.606 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.477 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 14.9 tpt180 -59.95 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.592 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -64.6 -38.33 90.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.508 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.53 ' HD1' HG21 ' A' ' 41' ' ' VAL . 2.0 t80 -60.56 -39.82 89.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.634 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -66.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.062 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.2 t -54.24 -34.92 61.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.576 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.807 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -35.12 124.54 0.58 Allowed Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.839 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -43.43 -29.67 2.13 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.154 2.57 . . . . 0.0 113.652 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.589 ' HB3' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -142.11 132.81 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.171 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -141.21 107.96 6.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.804 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -90.14 176.8 18.7 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.162 0.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.863 HD13 ' HD2' ' A' ' 57' ' ' ARG . 55.0 mt -87.38 140.03 32.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.52 -84.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.962 2.442 . . . . 0.0 113.917 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.3 mt-10 -85.19 11.66 9.46 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.863 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -112.27 113.42 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.959 0.409 . . . . 0.0 111.412 -178.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 81.4 m -70.15 114.05 7.92 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.512 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.765 HD21 HD12 ' A' ' 54' ' ' LEU . 2.4 m-80 -104.69 154.68 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.72 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 74' ' ' VAL . 10.8 t -135.8 132.35 50.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.788 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.639 HG13 ' HA ' ' A' ' 43' ' ' ARG . 58.1 t -105.03 125.32 60.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.827 0.346 . . . . 0.0 111.648 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.27 115.26 29.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.884 HG21 ' CD2' ' A' ' 68' ' ' TYR . 3.6 t -149.02 166.37 28.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 111.194 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -82.69 -10.19 59.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.351 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.8 tp60 -79.65 132.06 36.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.307 . . . . 0.0 110.484 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 2.4 mt-10 -82.95 -31.07 27.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.809 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.91 6.25 45.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.263 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.884 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.0 t80 -60.43 136.76 58.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 111.67 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.852 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -129.76 171.88 12.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 122.408 1.099 . . . . 0.0 112.78 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.6 139.99 16.75 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.108 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 3.4 mt-30 -71.73 100.67 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.3 -36.96 3.33 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.694 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.91 170.17 14.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.483 HG21 ' CE1' ' A' ' 85' ' ' TYR . 25.2 t -98.82 140.24 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.466 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.852 HG21 ' HA ' ' A' ' 69' ' ' GLN . 24.4 t -107.15 106.76 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.739 HG21 HG22 ' A' ' 82' ' ' VAL . 29.1 m -117.73 167.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 6.6 m170 -119.61 -20.66 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -155.73 -175.2 5.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 111.77 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.963 HG13 ' CD2' ' A' ' 106' ' ' PHE . 7.5 t -68.33 -9.81 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.004 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.17 -34.1 16.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.3 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.686 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.1 -29.38 60.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.718 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 76' ' ' VAL . 95.8 t -73.02 -55.84 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.519 ' CE2' HG12 ' A' ' 79' ' ' VAL . 8.1 m-85 -53.43 -26.12 18.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.987 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.76 87.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.483 ' CE1' HG21 ' A' ' 74' ' ' VAL . 59.7 t80 -67.67 -58.21 5.06 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.62 -23.02 15.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.211 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -70.95 -36.3 72.54 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.37 -7.18 59.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.663 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -124.96 66.63 50.71 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.031 0.443 . . . . 0.0 110.578 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.21 -0.41 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.234 2.623 . . . . 0.0 113.04 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.91 -31.74 15.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 160.1 14.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 111.411 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -98.59 166.22 11.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.082 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.77 HD23 HG23 ' A' ' 1' ' ' THR . 7.4 tp -121.88 117.91 27.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.44 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.76 112.06 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.314 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.493 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 11.9 mm -77.76 118.99 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.496 ' HB1' ' CZ ' ' A' ' 30' ' ' PHE . . . -91.43 -40.61 11.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.083 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.8 -166.36 39.29 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.501 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.455 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.4 -160.97 36.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 117.708 0.754 . . . . 0.0 112.524 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.27 -49.38 53.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 111.094 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.92 -30.37 61.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.304 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.528 HD12 HD22 ' A' ' 62' ' ' LEU . 42.2 mm -81.67 -26.75 9.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 6.0 m-85 -61.35 -58.61 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.731 ' HA ' HD13 ' A' ' 129' ' ' ILE . 4.6 t -67.14 -9.99 45.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.697 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.07 -38.84 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.089 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.963 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.1 m-85 -100.21 -3.85 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.404 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.466 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 4.2 pttp -47.71 -33.56 7.12 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 4.35 52.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.678 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -125.0 -28.82 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 106' ' ' PHE . 92.1 t -45.16 131.13 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.273 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.7 t70 -104.3 1.83 30.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 40.3 m -167.5 143.34 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.365 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.763 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 33.7 mt -119.93 145.01 47.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.443 0.639 . . . . 0.0 111.925 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -135.47 115.05 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.333 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' CH2' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -135.16 145.36 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 0.0 111.833 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.68 105.4 12.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.626 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -75.01 100.14 4.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.14 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.668 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.2 mt -84.32 120.76 26.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.89 -52.81 47.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.023 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.24 162.61 36.05 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.009 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 3.6 t -102.72 156.89 17.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.956 0.408 . . . . 0.0 111.079 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.9 m-85 -136.03 138.65 42.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -112.29 144.13 42.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.174 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.81 -125.39 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.318 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.13 31.92 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 0.0 110.818 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 2.9 m -156.78 123.01 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.727 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HG2' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -99.2 167.5 10.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.092 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.418 ' HE2' HD12 ' A' ' 131' ' ' LEU . 17.3 tpt -79.79 155.89 27.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.736 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.731 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.5 pp -81.28 162.72 57.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.81 103.59 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.052 2.502 . . . . 0.0 112.744 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.418 HD12 ' HE2' ' A' ' 128' ' ' MET . 2.0 mt -91.68 145.07 24.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.94 78.76 2.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.971 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.763 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 80.2 m95 -60.44 -19.94 58.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.8 -29.47 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.554 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -78.6 -28.17 45.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.832 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 92.5 m-85 -97.58 177.13 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.693 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 158' ' ' TRP . 1.9 m -134.89 141.03 46.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.715 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 9.0 ttpt -84.0 117.84 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.494 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.2 m -105.68 -16.1 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.976 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 m -164.53 140.77 6.07 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.6 p -163.46 113.54 1.33 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.409 ' C ' HG23 ' A' ' 154' ' ' THR . 19.1 ttt-85 -148.17 120.27 8.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.196 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.787 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.5 m -73.65 144.71 45.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.309 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.468 HG21 ' HE2' ' A' ' 155' ' ' TYR . 3.8 t -122.34 108.93 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.378 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.566 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.7 OUTLIER -88.23 101.0 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.45 -179.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -80.8 -176.14 5.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.75 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.431 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.8 t30 -77.08 130.89 74.0 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.138 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.73 -30.3 78.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.218 1.945 . . . . 0.0 112.656 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -89.89 -23.94 21.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.775 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.431 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 18.8 mt -80.06 4.06 18.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.491 0.186 . . . . 0.0 111.452 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 145' ' ' GLU . 98.9 m -69.19 163.41 24.97 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.3 p80 -176.35 163.59 2.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.182 0.515 . . . . 0.0 112.265 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.787 ' OG1' HG23 ' A' ' 143' ' ' THR . 87.8 m -120.8 147.17 45.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.024 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.468 ' HE2' HG21 ' A' ' 144' ' ' VAL . 96.9 m-85 -108.81 105.4 14.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.732 0.301 . . . . 0.0 110.905 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.433 ' HB2' HG22 ' A' ' 115' ' ' VAL . 30.4 mt-10 -108.78 125.7 52.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.809 ' O ' HG22 ' A' ' 139' ' ' VAL . 15.5 t -116.5 114.79 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.597 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.5 m95 -110.5 150.57 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.646 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -126.85 116.21 20.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.881 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 8.6 ttpt -51.8 130.1 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.384 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HG3' ' OG1' ' A' ' 137' ' ' THR . 3.8 mmpt? -96.08 172.9 7.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.097 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.44 HG23 HD23 ' A' ' 94' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -104.99 154.65 19.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 112.308 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.506 ' CD1' ' HB ' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -123.9 114.01 19.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.825 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.632 HD13 ' HB3' ' A' ' 33' ' ' GLN . 13.2 tp -112.86 121.57 45.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.646 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -165.18 163.89 20.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.525 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 118' ' ' LEU . . . -113.86 135.97 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.966 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -126.29 149.71 48.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.893 0.377 . . . . 0.0 110.969 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 1.5 p-10 -110.78 -168.24 1.28 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.021 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.428 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.78 -35.41 70.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.088 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 -28.95 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.012 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.12 12.81 22.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.879 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 126' ' ' THR . 2.8 mm? -59.93 144.96 47.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.768 0.284 . . . . 0.0 110.586 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.14 -81.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.44 133.17 6.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.586 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -166.5 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.667 0.27 . . . . 0.0 110.79 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.92 30.62 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.752 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.24 -76.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.397 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -78.41 165.39 23.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.293 . . . . 0.0 110.772 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 21' ' ' TRP . 0.6 OUTLIER -146.52 92.91 5.04 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.146 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.02 89.0 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.608 2.205 . . . . 0.0 112.388 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.515 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -145.03 75.98 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.858 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -113.43 -26.12 8.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.203 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.4 143.56 85.6 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.755 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HA ' HD13 ' A' ' 27' ' ' LEU . 90.2 Cg_endo -80.8 -27.63 3.05 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.688 2.259 . . . . 0.0 112.928 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -60.95 -18.67 58.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.543 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.98 -21.58 31.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.327 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' NH2' ' A' ' 31' ' ' ARG . 7.8 mp -83.68 -14.69 51.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.445 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.545 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -76.3 -32.84 58.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.752 0.31 . . . . 0.0 110.994 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.466 ' CE2' HD11 ' A' ' 4' ' ' LEU . 35.0 t80 -105.41 -63.11 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.365 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -43.81 -36.36 2.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.043 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.755 ' O ' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -92.09 -60.67 1.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -48.91 -36.77 17.99 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.632 ' HB3' HD13 ' A' ' 4' ' ' LEU . 20.3 mm-40 -76.33 -4.54 42.72 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 4' ' ' LEU . 1.1 p -140.54 -0.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 31' ' ' ARG . 34.2 m -108.17 142.88 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.518 0.199 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.569 ' H ' ' HG3' ' A' ' 57' ' ' ARG . . . 112.61 -9.09 26.05 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.231 -0.985 . . . . 0.0 114.048 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.479 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -148.43 -163.8 1.86 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.789 1.295 . . . . 0.0 109.223 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 51.6 mt -74.64 91.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.765 0.317 . . . . 0.0 111.522 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.1 ttp -101.92 120.45 40.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 HG11 ' A' ' 82' ' ' VAL . 15.3 t -80.3 159.19 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.869 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' HG12 ' A' ' 40' ' ' VAL . 28.7 m -161.72 157.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.64 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.34 155.51 43.89 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.906 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -56.8 -52.68 64.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.982 0.391 . . . . 0.0 110.389 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -59.06 -32.64 69.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.332 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -71.59 -38.14 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.539 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.448 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 6.7 t80 -66.5 -25.94 66.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -72.65 -66.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 111.109 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.4 t -57.08 -31.44 65.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.43 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -26.24 135.16 0.1 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.88 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.64 -33.91 88.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.701 2.267 . . . . 0.0 112.929 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -160.08 122.41 3.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.25 135.62 15.22 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.252 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.77 160.41 71.42 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.14 -1.608 . . . . 0.0 111.838 -0.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.803 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 51.1 mt -75.15 156.36 85.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.023 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.05 -82.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.953 2.435 . . . . 0.0 113.653 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' HB2' ' NH1' ' A' ' 57' ' ' ARG . 5.3 mt-10 -93.18 27.6 2.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.411 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.803 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -125.2 111.68 15.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.403 . . . . 0.0 111.637 -178.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 53.4 m -72.35 119.53 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -102.73 151.44 22.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 112.083 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.623 HG12 HG22 ' A' ' 76' ' ' VAL . 17.1 t -132.07 142.76 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.392 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 43' ' ' ARG . 50.0 t -115.45 121.03 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.727 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.913 HD12 HG23 ' A' ' 76' ' ' VAL . 1.1 tp -104.78 117.14 33.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.722 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.25 167.44 26.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.822 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -89.13 -10.05 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.5 tt0 -73.79 137.06 43.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -88.46 5.96 39.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.118 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.55 5.85 4.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.607 0.241 . . . . 0.0 111.618 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.901 ' O ' HG11 ' A' ' 75' ' ' VAL . 3.5 t80 -60.17 141.71 55.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.333 0.587 . . . . 0.0 112.014 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.85 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -131.93 173.8 10.82 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.249 1.024 . . . . 0.0 112.641 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.3 143.4 20.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.699 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.96 98.85 2.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.636 0.255 . . . . 0.0 110.799 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.57 -36.13 3.14 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.662 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -69.75 170.49 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 111.892 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.33 139.75 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.172 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.901 HG11 ' O ' ' A' ' 68' ' ' TYR . 20.1 t -104.59 107.85 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 111.835 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.913 HG23 HD12 ' A' ' 62' ' ' LEU . 30.3 m -117.96 168.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.754 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.3 m170 -119.01 -22.37 7.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.552 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.711 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -155.44 -169.48 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 111.523 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.977 HG13 ' CD2' ' A' ' 106' ' ' PHE . 4.8 t -73.44 -10.36 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.62 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.1 -34.82 19.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.231 0.539 . . . . 0.0 109.836 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.46 -30.38 61.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.762 HG22 HG21 ' A' ' 76' ' ' VAL . 17.5 t -72.16 -53.06 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.006 0.431 . . . . 0.0 109.876 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.67 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 4.3 m-85 -54.54 -28.34 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.823 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.6 96.43 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.72 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.57 -55.93 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.75 -23.9 13.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.333 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 14.4 mmmt -69.35 -39.71 77.96 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -81.3 -4.61 56.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -126.86 65.58 63.21 Favored Pre-proline 0 N--CA 1.456 -0.151 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.549 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.7 -0.5 6.95 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.19 2.593 . . . . 0.0 112.775 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -91.71 -32.25 15.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -104.18 161.53 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.127 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -99.03 162.76 12.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.454 HD11 ' CG1' ' A' ' 82' ' ' VAL . 46.3 tp -109.29 115.84 30.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 2' ' ' ALA . 44.7 t -131.05 115.5 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 40' ' ' VAL . 7.0 mm -82.36 141.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.403 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.08 -44.66 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.433 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 176.01 -168.63 40.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.691 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.433 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.76 36.67 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 121.94 -0.741 . . . . 0.0 112.479 -0.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.47 -52.95 15.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.288 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -56.07 -29.27 60.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.535 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 62' ' ' LEU . 40.2 mm -81.47 -28.51 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CB ' HG12 ' A' ' 129' ' ' ILE . 6.0 m-85 -60.2 -58.36 8.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.873 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.63 ' HA ' HD13 ' A' ' 129' ' ' ILE . 11.7 t -65.63 -10.12 33.08 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 121.73 -0.606 . . . . 0.0 112.228 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.698 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.58 -43.77 54.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.842 0.354 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.977 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.9 m-85 -96.19 -1.37 48.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.559 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 6.9 pttt -50.91 -34.59 29.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.915 0.388 . . . . 0.0 110.956 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.66 2.66 40.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.69 -27.62 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.619 0.247 . . . . 0.0 111.572 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 106' ' ' PHE . 68.0 t -45.46 123.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.912 0.387 . . . . 0.0 111.284 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 13.8 t70 -107.02 7.54 29.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.24 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.5 m -168.39 140.0 2.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.365 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.821 HD23 HG11 ' A' ' 110' ' ' VAL . 7.1 mt -125.51 147.34 49.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.323 0.583 . . . . 0.0 112.079 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt -135.4 117.03 14.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.317 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -131.76 141.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.94 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.25 109.6 18.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.198 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 14.0 mtt180 -84.07 99.59 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.385 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.449 ' CD1' ' HB1' ' A' ' 6' ' ' ALA . 1.3 mp -82.63 120.62 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.305 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.504 ' HB2' ' HB ' ' A' ' 152' ' ' THR . . . -48.99 -47.55 44.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.83 152.1 49.97 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.378 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 173.04 8.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.817 0.341 . . . . 0.0 111.093 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 3.2 m-85 -145.52 178.37 8.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.777 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -121.85 170.05 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.186 0.517 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 148.96 176.88 22.65 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.771 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.12 17.56 9.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.163 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.531 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.8 m -133.65 131.74 39.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.637 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -113.14 170.41 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.413 ' HE3' ' HB3' ' A' ' 103' ' ' PHE . 16.4 tpt -74.13 145.83 43.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.678 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 2.0 pp -66.42 166.66 16.21 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.187 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.678 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.1 Cg_endo -75.1 106.71 2.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.243 1.962 . . . . 0.0 112.319 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.92 147.51 23.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.86 69.51 5.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.448 ' HH2' HG11 ' A' ' 115' ' ' VAL . 88.7 m95 -53.39 -24.92 13.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.36 -29.8 64.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.328 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 7.5 t0 -79.6 -18.57 51.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.033 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.465 ' CG ' HD11 ' A' ' 113' ' ' LEU . 85.0 m-85 -106.83 168.49 9.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.438 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -131.22 141.61 50.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.599 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.0 ttpt -81.88 109.43 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.547 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 157' ' ' VAL . 35.4 m -92.27 -26.42 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.384 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.1 m -154.93 140.3 17.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 51.9 p -169.58 115.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.969 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.409 ' HB2' ' NH1' ' A' ' 142' ' ' ARG . 8.9 ttm105 -147.91 119.02 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.076 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.783 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.5 m -71.08 145.91 49.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.032 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 t -119.67 104.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.657 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.668 ' HA ' HG23 ' A' ' 152' ' ' THR . 3.6 mt-10 -85.07 100.2 11.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.22 173.78 11.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.1 p -53.54 -44.25 69.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.631 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.493 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 9.9 t30 -82.68 132.17 52.61 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.34 -33.29 89.43 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.395 2.063 . . . . 0.0 112.613 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.55 -28.52 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.0 mt -76.74 5.05 8.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.668 HG23 ' HA ' ' A' ' 145' ' ' GLU . 31.9 m -71.56 158.4 36.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -174.12 160.59 3.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.951 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.783 ' OG1' HG23 ' A' ' 143' ' ' THR . 22.2 m -122.58 138.6 54.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.946 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' SER . 88.6 m-85 -102.6 106.35 17.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HB2' HG22 ' A' ' 115' ' ' VAL . 32.7 mt-10 -108.16 125.72 51.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 139' ' ' VAL . 25.1 t -116.6 112.35 39.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.75 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.511 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 17.4 m95 -107.22 151.16 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.23 0.538 . . . . 0.0 112.003 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -130.35 127.18 38.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.831 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 10.9 tttp -54.13 130.54 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.972 0.415 . . . . 0.0 111.359 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -116.79 -168.56 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.836 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.15 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.702 HG23 HD23 ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -114.32 146.67 40.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.503 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 3.6 m-30 -110.2 111.07 22.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.551 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.767 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -108.63 118.99 38.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.775 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.6 p90 -167.96 172.99 8.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -132.32 135.67 46.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -117.58 161.51 19.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.047 0.451 . . . . 0.0 111.444 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.6 -167.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -39.5 71.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.759 0.314 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.56 -27.49 37.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.25 22.98 10.85 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.683 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.1 tp -70.33 152.91 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.691 HG21 ' HG3' ' A' ' 128' ' ' MET . 1.5 pp -126.26 -41.42 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.679 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.01 -166.14 11.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.904 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.48 ' HG2' ' HA2' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -140.18 121.61 15.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.61 0.243 . . . . 0.0 110.689 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.4 -30.17 42.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.672 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.91 -121.32 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.394 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -164.23 119.42 1.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.998 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -120.17 137.69 26.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.745 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -87.46 39.94 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.809 2.339 . . . . 0.0 112.86 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.492 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -115.81 110.29 18.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.71 109.12 21.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.02 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.542 HD22 ' OD2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -113.41 122.14 36.06 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.799 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.75 -30.11 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.687 2.258 . . . . 0.0 112.981 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' HB3' HD21 ' A' ' 23' ' ' LEU . 5.1 t70 -53.63 -38.58 64.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.325 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.542 ' OD2' HD22 ' A' ' 23' ' ' LEU . 72.3 m-20 -74.44 -61.89 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.054 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.25 -33.56 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.583 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -53.97 -66.89 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.809 0.338 . . . . 0.0 111.188 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -70.09 -9.73 56.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.405 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -85.66 -24.95 26.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.448 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 35' ' ' VAL . 10.1 ptm180 -92.02 -46.82 7.6 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 31' ' ' ARG . . . -54.73 -23.94 20.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.572 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.658 ' NE2' HD13 ' A' ' 114' ' ' LEU . 2.8 mt-30 -92.51 -3.93 54.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.7 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.758 HG23 ' HG ' ' A' ' 4' ' ' LEU . 25.4 p -145.8 26.67 1.24 Allowed 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 31' ' ' ARG . 11.8 m -108.15 145.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.44 29.93 57.91 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 58' ' ' THR . 17.7 mttm -147.07 -167.33 2.75 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.498 2.149 . . . . 0.0 108.417 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 93' ' ' GLU . 75.4 mt -88.93 88.55 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.302 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.2 OUTLIER -102.06 126.29 48.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.368 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.884 HG21 HG11 ' A' ' 82' ' ' VAL . 2.0 t -90.79 129.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.531 HG11 ' CE2' ' A' ' 49' ' ' PHE . 21.7 m -133.54 138.03 51.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.242 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.43 153.74 39.31 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.005 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.696 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -50.74 -53.53 30.84 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.936 0.398 . . . . 0.0 110.075 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -54.5 -42.41 70.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -65.06 -40.76 95.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 28.8 t80 -60.48 -29.57 69.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.913 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.51 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.6 t -58.49 -31.08 67.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.305 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.74 ' HE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -29.8 135.79 0.18 Allowed Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.996 -179.369 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 75.9 Cg_exo -48.83 -35.11 30.06 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.276 . . . . 0.0 112.85 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.07 142.78 24.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.35 112.04 6.55 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.173 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -81.72 178.81 29.52 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.984 -0.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.74 HD11 ' HE1' ' A' ' 49' ' ' PHE . 64.1 mt -84.21 140.69 39.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.603 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.62 110.98 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.495 2.13 . . . . 0.0 112.835 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.0 OUTLIER 74.37 -0.17 3.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.35 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.683 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -109.57 116.23 31.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.66 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 33.3 m -70.08 111.5 5.79 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.456 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.648 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -107.14 154.86 20.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.947 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.687 HG12 HG22 ' A' ' 76' ' ' VAL . 18.8 t -128.02 143.42 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.389 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' A' ' 43' ' ' ARG . 90.0 t -111.69 126.98 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.889 0.376 . . . . 0.0 111.069 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -105.64 123.39 47.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.361 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.873 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -157.2 158.33 36.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -79.67 -6.57 57.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.3 tt0 -78.78 131.29 36.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.817 0.341 . . . . 0.0 110.974 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 4.21 29.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.91 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.4 7.29 4.92 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.424 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.873 ' CG ' HG21 ' A' ' 63' ' ' THR . 6.0 t80 -59.23 144.98 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.051 0.453 . . . . 0.0 111.2 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.971 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -133.94 174.27 10.65 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.368 1.08 . . . . 0.0 113.014 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.91 144.47 21.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.709 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -81.0 96.66 7.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.89 0.376 . . . . 0.0 110.643 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -44.7 2.06 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.78 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.06 168.04 17.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 111.74 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 28.3 t -96.26 141.07 16.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.971 HG21 ' HA ' ' A' ' 69' ' ' GLN . 28.4 t -108.1 120.83 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.333 0.587 . . . . 0.0 111.912 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.919 HG21 HG22 ' A' ' 82' ' ' VAL . 27.7 m -127.59 169.55 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.633 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' THR . 7.9 m170 -117.52 -25.58 6.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.835 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.5 -174.62 5.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.015 0.436 . . . . 0.0 111.16 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.2 t -67.92 -11.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.533 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -34.21 19.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.441 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -74.86 -26.15 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.023 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.919 HG22 HG21 ' A' ' 76' ' ' VAL . 43.1 t -75.98 -54.71 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 14.5 m-85 -53.34 -27.89 25.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.885 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.53 87.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.969 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.43 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 86.1 t80 -65.3 -56.32 13.37 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.892 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -57.95 -24.86 59.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.034 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -68.8 -43.5 75.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -79.1 -10.7 59.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.286 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -122.88 65.6 26.92 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.367 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.15 -0.4 4.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.159 2.572 . . . . 0.0 113.166 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.92 -37.85 26.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.803 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.1 164.1 11.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.433 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 5.7 mm-40 -99.13 171.26 8.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 86' ' ' ALA . 8.1 tp -115.91 116.67 28.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 39' ' ' MET . 49.1 t -128.58 114.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.527 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 7.6 mm -83.34 140.2 16.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.077 0.465 . . . . 0.0 111.234 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 34' ' ' THR . . . -114.84 -36.34 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.57 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -170.93 43.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.555 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.45 -161.23 32.81 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 117.376 0.588 . . . . 0.0 112.512 -0.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.04 -53.53 54.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -55.34 -27.3 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.602 ' CD1' HD22 ' A' ' 62' ' ' LEU . 32.5 mm -83.16 -27.47 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.854 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.466 ' HB3' HG12 ' A' ' 129' ' ' ILE . 1.9 m-85 -60.61 -56.52 20.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.38 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.816 ' CA ' HD13 ' A' ' 129' ' ' ILE . 1.8 t -67.71 -10.07 49.25 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.24 -47.21 20.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.343 . . . . 0.0 110.732 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.9 ' CD2' HG13 ' A' ' 79' ' ' VAL . 9.3 m-85 -86.18 -9.38 56.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.321 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 3.2 pttp -52.42 -29.76 25.95 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -75.88 -7.43 54.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 22.5 m-20 -129.58 -19.89 3.32 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 113' ' ' LEU . 53.5 t -43.81 127.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.112 0.482 . . . . 0.0 110.935 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 10.5 t0 -108.55 6.58 26.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.48 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.756 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 18.7 m -169.68 137.92 1.8 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.72 0.295 . . . . 0.0 110.6 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.604 HD23 HG11 ' A' ' 110' ' ' VAL . 6.1 mt -122.7 145.67 48.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.168 0.509 . . . . 0.0 111.605 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.658 HD13 ' NE2' ' A' ' 33' ' ' GLN . 5.6 mt -134.84 117.41 15.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.578 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.775 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -133.96 144.0 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.009 0.433 . . . . 0.0 111.837 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -116.36 104.71 11.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.4 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 2.9 ttt-85 -75.8 100.75 4.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.452 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.706 HD22 ' HZ ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -92.4 108.29 19.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.087 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.45 -39.73 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.408 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.6 -167.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.701 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.81 146.8 41.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 111.007 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.706 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 1.3 m-85 -134.47 162.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -99.73 134.05 43.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.002 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.604 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.01 -174.36 33.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.86 21.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.251 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -139.11 127.69 23.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.691 ' HG3' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -74.02 -173.6 1.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.201 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.816 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.3 pp -112.11 160.15 31.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.88 102.48 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.831 2.354 . . . . 0.0 112.746 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mt -84.34 146.44 27.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.29 76.35 5.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.44 ' HH2' HG11 ' A' ' 115' ' ' VAL . 84.4 m95 -60.04 -19.12 51.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.365 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.13 -33.22 65.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -81.77 -17.19 48.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.521 ' CD2' HD11 ' A' ' 113' ' ' LEU . 79.6 m-85 -106.68 167.75 9.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.906 0.384 . . . . 0.0 111.163 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.542 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -127.68 141.02 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.516 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 12.1 ttpp -81.81 115.99 21.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 157' ' ' VAL . 27.1 m -101.04 -18.76 6.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.783 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.4 m -164.25 140.54 6.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.535 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.657 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 93.0 p -164.95 113.33 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.512 ' C ' HG23 ' A' ' 154' ' ' THR . 0.2 OUTLIER -146.48 126.02 13.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.681 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.9 m -80.5 145.04 32.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.061 0.458 . . . . 0.0 111.294 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 152' ' ' THR . 3.5 t -122.79 109.05 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.792 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.91 104.5 16.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.63 -177.2 5.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.3 p -58.02 -42.34 85.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.481 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 3.4 t30 -80.99 134.5 52.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.342 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.96 -32.31 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.202 1.934 . . . . 0.0 112.429 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.11 -25.61 22.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.5 mt -76.18 5.11 7.33 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 153' ' ' HIS . 72.0 m -72.89 162.27 29.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -175.97 162.67 2.61 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 0.0 112.033 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.681 ' OG1' HG23 ' A' ' 143' ' ' THR . 38.5 m -122.5 129.82 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.33 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -93.66 107.89 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.496 ' HB2' HG22 ' A' ' 115' ' ' VAL . 4.6 mt-10 -101.28 152.29 20.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.818 ' O ' HG22 ' A' ' 139' ' ' VAL . 19.0 t -142.41 110.22 2.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.759 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.468 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 29.8 m95 -109.8 145.74 36.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.397 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.15 129.51 39.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.373 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -49.08 122.19 5.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 111.447 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.542 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.9 OUTLIER -97.8 176.14 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.063 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 87.6 m . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.758 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -107.95 154.79 21.11 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.8 m-30 -120.68 107.92 13.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.831 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.791 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.44 115.38 30.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.475 0.655 . . . . 0.0 112.231 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.667 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.7 p90 -158.37 166.19 32.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.856 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.36 133.28 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.1 pt20 -131.63 157.03 44.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.015 0.435 . . . . 0.0 111.123 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -108.18 -162.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.361 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -57.28 -49.96 74.41 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.4 -33.37 72.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.23 33.15 3.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.776 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 1.4 mm? -73.84 127.14 32.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.681 HG21 ' HG3' ' A' ' 128' ' ' MET . 0.7 OUTLIER -112.45 -63.65 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.58 -168.63 11.76 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.66 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -149.06 166.1 29.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.812 0.339 . . . . 0.0 110.734 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.53 98.71 10.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.66 117.93 3.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.713 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 116.44 31.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.75 0.31 . . . . 0.0 110.719 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.568 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -160.0 -55.64 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.564 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 93.4 Cg_endo -93.72 60.81 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.648 2.232 . . . . 0.0 112.635 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -174.58 110.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.519 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -129.57 142.14 50.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.74 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 22' ' ' HIS . 0.8 OUTLIER -156.17 145.16 14.93 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.791 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.461 ' HD2' ' HG ' ' A' ' 23' ' ' LEU . 87.4 Cg_endo -85.12 -41.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.665 2.243 . . . . 0.0 112.92 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -37.69 70.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.382 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -71.63 -22.83 61.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.421 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tt -90.54 -38.67 13.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 111.214 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.69 -27.66 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.638 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -105.28 -29.43 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.516 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -76.41 -23.73 54.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.639 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.813 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -91.91 -61.47 1.62 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -50.04 -32.39 15.32 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -81.85 -6.36 59.02 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.692 ' CG2' HD11 ' A' ' 4' ' ' LEU . 21.1 p -142.4 13.94 1.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 31' ' ' ARG . 33.2 m -108.25 154.69 9.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 57.48 26.28 56.55 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 115.799 1.08 . . . . 0.0 115.799 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 58' ' ' THR . 16.0 mtmm -151.38 -169.0 3.25 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.957 1.878 . . . . 0.0 108.41 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 92' ' ' GLN . 80.7 mt -84.52 87.46 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.759 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.439 ' HE1' ' OD1' ' A' ' 59' ' ' ASN . 0.4 OUTLIER -100.31 122.63 43.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.922 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.642 HG21 HG11 ' A' ' 82' ' ' VAL . 21.6 t -82.84 158.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.612 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 40' ' ' VAL . 35.1 m -164.32 144.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.36 152.9 52.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.753 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.593 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.27 -52.26 53.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.861 0.33 . . . . 0.0 110.81 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.81 -32.18 70.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.036 0.446 . . . . 0.0 110.086 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.419 HG22 ' CE1' ' A' ' 49' ' ' PHE . 10.5 m -70.15 -37.38 75.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.443 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -66.96 -26.28 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.034 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.73 -66.42 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -47.27 -37.97 11.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.469 ' CE2' HG11 ' A' ' 41' ' ' VAL . 2.8 m-30 -36.21 148.26 0.17 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -43.77 -69.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 0.0 112.713 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -139.09 167.57 21.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -122.53 117.38 29.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 95.6 Cg_endo -83.65 -171.0 8.34 Favored 'Cis proline' 0 C--N 1.349 0.594 0 C-N-CA 123.716 -1.369 . . . . 0.0 112.348 -0.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.648 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 19.0 mt -79.98 162.87 60.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 24.4 Cg_endo -61.56 92.47 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.744 2.296 . . . . 0.0 113.101 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 9.9 mt-10 60.29 33.8 20.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.624 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.648 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 10.7 mtp180 -124.02 114.3 19.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.203 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 41.4 m -65.14 107.21 1.48 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.124 0.488 . . . . 0.0 110.192 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.483 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.3 154.45 18.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.424 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 11.8 t -130.91 132.61 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.731 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.0 t -104.22 127.59 58.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 111.717 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -109.32 113.3 26.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.995 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.801 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.2 t -148.6 167.37 25.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 111.279 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -84.11 -7.31 59.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.282 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.1 tp60 -80.46 128.8 34.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.467 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -79.35 -28.01 42.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.8 9.62 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.801 ' CD2' HG21 ' A' ' 63' ' ' THR . 4.2 t80 -59.86 141.08 56.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.064 0.459 . . . . 0.0 111.489 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.825 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.2 mt-30 -129.93 174.0 10.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 122.255 1.026 . . . . 0.0 112.54 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -155.47 143.72 20.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.58 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -74.31 96.24 2.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.445 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.94 -35.52 3.65 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.172 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.96 166.32 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.094 0.473 . . . . 0.0 111.95 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 15.3 t -96.67 140.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.412 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.825 HG21 ' HA ' ' A' ' 69' ' ' GLN . 23.2 t -106.8 120.56 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.313 0.578 . . . . 0.0 112.18 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.929 HG21 HG22 ' A' ' 82' ' ' VAL . 24.9 m -132.77 172.04 17.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.965 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.414 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 11.2 m80 -122.21 -20.2 6.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -156.06 -175.68 5.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.101 0.476 . . . . 0.0 111.74 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.862 HG13 ' CD2' ' A' ' 106' ' ' PHE . 14.4 t -69.19 -10.24 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.614 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.48 -36.22 17.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.138 0.494 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.62 -33.71 66.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.929 HG22 HG21 ' A' ' 76' ' ' VAL . 27.2 t -70.29 -49.98 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.652 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 2.9 m-85 -54.34 -28.7 44.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.178 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.33 -39.79 85.86 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.088 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 50.8 t80 -66.37 -57.62 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.98 -23.06 43.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.893 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.652 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -72.08 -32.0 66.62 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 109.958 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 10.0 mt-30 -84.64 -9.02 58.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -121.21 65.17 14.54 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.027 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.36 -1.53 3.16 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.808 2.339 . . . . 0.0 112.647 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.03 -29.06 15.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.402 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -104.32 159.81 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -100.68 170.01 8.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.201 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -112.95 113.15 25.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.2 t -124.09 107.18 18.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.721 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.2 mm -76.46 134.69 28.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.137 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.434 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -110.96 -38.52 5.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.14 -167.35 40.31 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.514 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.09 -161.08 23.07 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 122.063 -0.669 . . . . 0.0 112.571 -0.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . -54.5 -51.63 64.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.826 0.346 . . . . 0.0 111.26 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -31.71 68.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.591 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 33.4 mm -72.67 -27.66 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.786 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 129' ' ' ILE . 2.4 m-85 -60.85 -54.35 46.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.572 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.553 ' CA ' HD13 ' A' ' 129' ' ' ILE . 7.7 t -69.26 -10.38 57.54 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.872 -0.517 . . . . 0.0 111.989 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.694 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.12 -39.91 54.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.862 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.4 m-85 -96.17 -8.24 33.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.552 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.84 -28.83 17.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.16 -1.46 49.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.469 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -132.01 -20.1 2.51 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.868 HG11 HD23 ' A' ' 113' ' ' LEU . 71.0 t -44.04 128.76 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.887 0.375 . . . . 0.0 111.222 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.436 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 14.9 t70 -106.16 1.59 26.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.301 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.758 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 72.7 m -166.99 135.09 2.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.674 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.868 HD23 HG11 ' A' ' 110' ' ' VAL . 9.6 mt -118.99 144.38 46.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 111.672 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mt -134.95 115.97 14.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.044 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.667 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -132.77 142.74 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 111.672 -179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.8 114.4 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.5 102.29 14.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.706 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -83.47 133.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.36 -57.43 10.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.339 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.14 168.2 38.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.747 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -99.33 172.51 7.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.804 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.604 ' HZ ' HD22 ' A' ' 118' ' ' LEU . 3.0 m-85 -148.97 178.49 8.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.11 0.481 . . . . 0.0 111.442 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.55 171.48 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.435 ' HA3' ' CD1' ' A' ' 12' ' ' LEU . . . 161.41 -179.69 36.66 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.61 5.75 4.02 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.3 m -134.24 137.22 44.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 111.108 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 165.4 11.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.681 ' HG3' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -71.39 -173.72 0.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.063 0.459 . . . . 0.0 111.086 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.553 HD13 ' CA ' ' A' ' 104' ' ' THR . 2.2 pp -118.47 164.03 22.48 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.083 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.529 ' O ' HD12 ' A' ' 129' ' ' ILE . 24.8 Cg_exo -63.11 136.65 57.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.636 2.224 . . . . 0.0 112.006 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -128.3 148.27 50.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.095 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.07 77.47 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -60.32 -19.0 53.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.324 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -29.31 62.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.57 -26.73 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.577 ' CD1' HD11 ' A' ' 113' ' ' LEU . 95.4 m-85 -97.71 173.95 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -136.18 140.5 43.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.505 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -79.72 111.67 16.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.833 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.4 m -93.88 -25.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.3 m -160.28 140.46 11.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 111.158 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 17.2 p -162.99 111.53 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -147.76 122.41 9.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 111.434 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.703 HG23 ' OG1' ' A' ' 154' ' ' THR . 4.8 m -76.38 144.93 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.35 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 t -115.62 105.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -93.61 104.94 17.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.406 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -86.69 -177.09 6.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.469 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 p -54.42 -51.49 64.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.808 0.337 . . . . 0.0 110.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -76.58 127.0 85.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.044 179.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.21 -31.5 93.15 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.137 1.891 . . . . 0.0 112.413 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.26 -22.41 33.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.869 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.9 mt -81.75 10.46 6.16 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.511 ' O ' HD23 ' A' ' 118' ' ' LEU . 46.0 m -79.55 164.97 23.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.959 0.409 . . . . 0.0 110.32 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.706 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 7.9 p80 -174.08 160.9 3.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.152 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.703 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.2 m -125.45 135.43 52.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -100.83 109.25 21.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.657 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 115' ' ' VAL . 2.3 mt-10 -107.16 126.81 52.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.944 0.402 . . . . 0.0 111.378 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.757 ' O ' HG22 ' A' ' 139' ' ' VAL . 14.4 t -118.82 116.36 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.26 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.505 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.9 m95 -112.53 150.18 31.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.058 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.464 ' HG3' HG11 ' A' ' 139' ' ' VAL . 5.6 mt-30 -128.58 118.31 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.303 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 111' ' ' ASP . 2.6 ttpp -53.55 133.91 41.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.578 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.51 10.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.511 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.087 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 94' ' ' LEU . 91.4 m . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.52 0.2 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.79 152.64 28.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.648 ' CD1' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -115.45 116.26 27.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.458 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' A' ' 30' ' ' PHE . 13.1 tp -115.25 122.03 44.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.686 ' CH2' HG12 ' A' ' 115' ' ' VAL . 2.8 p90 -168.35 165.2 12.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.569 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -126.88 141.65 51.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 4.9 pt20 -127.35 156.55 41.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.838 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.54 -170.52 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.54 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -50.01 -46.34 52.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.42 -21.42 59.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 90.2 47.94 3.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.16 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -87.27 174.72 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.891 0.377 . . . . 0.0 111.378 -179.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 126' ' ' THR . 1.0 OUTLIER -146.71 -42.45 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.406 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.66 162.86 34.84 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.58 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HD3' HD21 ' A' ' 19' ' ' LEU . 9.4 tttm -118.45 110.97 18.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.365 . . . . 0.0 111.131 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -92.02 134.19 35.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.3 -141.84 13.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.72 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -92.98 120.95 33.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.688 0.28 . . . . 0.0 110.806 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.605 HD21 ' HD3' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -151.18 128.21 5.46 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.317 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 7.2 Cg_exo -72.52 -56.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.554 2.17 . . . . 0.0 111.857 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -117.25 -176.04 2.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -143.69 -173.02 3.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.12 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.88 120.33 77.33 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.32 -21.38 1.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.685 2.257 . . . . 0.0 112.93 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -74.24 -44.28 53.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 29' ' ' TYR . 7.3 t0 -71.81 -33.23 68.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . 14.3 mt -55.07 -42.54 72.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.42 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -68.19 -14.73 63.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.937 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CZ ' HD11 ' A' ' 4' ' ' LEU . 19.3 t80 -71.39 -66.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.636 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.5 p90 -72.46 -41.86 65.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' O ' HG13 ' A' ' 35' ' ' VAL . 6.3 mtp180 -55.37 -27.7 49.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.47 -22.41 16.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.76 -48.72 6.43 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 30' ' ' PHE . 14.4 t -94.45 32.95 1.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -92.24 160.11 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.27 0.557 . . . . 0.0 111.862 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.66 27.12 54.59 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -147.23 -166.82 2.61 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 120.076 1.938 . . . . 0.0 109.009 178.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 92' ' ' GLN . 86.5 mt -81.69 87.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.68 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.4 ttp -99.94 111.94 24.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.581 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.737 HG13 ' HB ' ' A' ' 60' ' ' VAL . 2.8 t -86.2 129.82 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.561 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 27.6 m -135.77 153.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.95 157.05 53.49 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.213 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.814 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.18 -52.78 57.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.397 . . . . 0.0 110.345 179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.449 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 4.7 tpt180 -56.82 -44.81 82.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.325 0.583 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 m -61.16 -36.65 80.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.244 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 9.5 t80 -66.02 -24.71 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -65.83 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.396 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.4 t -48.19 -31.65 6.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.222 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.561 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 3.5 m-30 -46.44 166.46 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.99 -70.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.795 2.33 . . . . 0.0 112.932 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -145.72 -167.11 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.97 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -132.3 113.81 14.61 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 6.4 Cg_exo -87.83 -160.9 1.72 Allowed 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.057 -0.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.727 ' HB3' ' HD3' ' A' ' 57' ' ' ARG . 12.2 mt -86.9 168.27 18.79 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 37.8 Cg_endo -66.87 93.9 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.443 2.095 . . . . 0.0 113.043 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 7.0 mt-10 64.99 14.05 9.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.33 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.727 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 6.0 mtp180 -109.11 116.95 32.92 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.388 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.4 m -67.11 110.93 3.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.866 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.479 HD21 ' HB2' ' A' ' 57' ' ' ARG . 2.4 m120 -106.0 157.48 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.437 0.637 . . . . 0.0 112.641 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.737 ' HB ' HG13 ' A' ' 40' ' ' VAL . 8.2 t -136.14 135.76 49.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.33 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 43' ' ' ARG . 85.9 t -109.46 128.11 65.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.925 0.393 . . . . 0.0 111.636 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -107.61 119.74 40.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.936 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.9 t -150.47 170.95 17.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -95.06 -10.13 31.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.718 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 2.0 tt0 -68.87 132.27 46.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.8 0.334 . . . . 0.0 110.813 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.45 -19.22 56.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.71 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -114.01 14.64 18.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.936 ' CG ' HG21 ' A' ' 63' ' ' THR . 6.1 t80 -60.95 142.1 56.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.444 0.64 . . . . 0.0 111.978 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.834 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.2 mt-30 -135.79 172.99 12.21 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.316 1.055 . . . . 0.0 112.873 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.97 140.61 17.99 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.094 -1.867 . . . . 0.0 110.106 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.8 mp0 -73.77 100.2 3.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.78 0.324 . . . . 0.0 110.85 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . 87.15 -38.17 3.16 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.395 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.514 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -70.62 171.34 10.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.674 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.726 HG21 ' CE2' ' A' ' 85' ' ' TYR . 22.4 t -99.46 140.37 18.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.507 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.834 HG21 ' HA ' ' A' ' 69' ' ' GLN . 30.3 t -107.95 116.84 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 0.0 112.032 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 33.1 m -126.29 171.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.782 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -121.14 -22.54 6.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.736 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -155.2 -173.95 4.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.7 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.937 HG13 ' CD2' ' A' ' 106' ' ' PHE . 14.8 t -68.22 -10.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.14 -33.92 18.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.088 0.47 . . . . 0.0 110.075 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.19 -27.22 53.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.886 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 76' ' ' VAL . 72.4 t -73.47 -53.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.525 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.6 m-85 -55.01 -26.74 39.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.709 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.84 97.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 74' ' ' VAL . 38.9 t80 -67.19 -57.68 6.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.553 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -51.04 -25.66 5.17 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.232 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -66.58 -44.37 82.43 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -79.74 -0.3 33.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.546 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.411 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 62.9 m-70 -127.57 60.26 43.11 Favored Pre-proline 0 N--CA 1.455 -0.193 0 CA-C-O 120.981 0.42 . . . . 0.0 110.269 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.3 -0.25 7.08 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.146 2.564 . . . . 0.0 112.812 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.5 -38.29 30.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.067 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.463 ' HG3' HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -114.17 167.68 10.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 111.243 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -98.54 166.31 11.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.501 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.625 HD11 ' CG1' ' A' ' 82' ' ' VAL . 13.6 tp -97.43 116.64 30.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.988 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 39' ' ' MET . 12.3 t -122.82 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.529 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 12.7 mm -80.59 140.53 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.418 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -114.73 -37.99 4.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.405 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.75 -168.42 41.52 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.681 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.42 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -85.54 -160.97 34.0 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 117.561 0.681 . . . . 0.0 112.528 -0.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.54 63.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.458 ' NE2' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -56.3 -29.06 60.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.599 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.458 HD13 ' NE2' ' A' ' 101' ' ' GLN . 27.7 mm -84.08 -26.31 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.547 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.2 m-85 -60.45 -58.46 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.734 ' CA ' HD13 ' A' ' 129' ' ' ILE . 3.8 t -66.51 -9.08 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.762 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -78.34 -39.35 39.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.71 0.29 . . . . 0.0 111.283 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.937 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.3 m-85 -103.23 -5.76 22.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 7.0 pttt -42.47 -31.14 0.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -90.35 -26.76 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.733 ' OD2' HG11 ' A' ' 79' ' ' VAL . 12.0 m-20 -89.1 -31.68 17.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 3' ' ' PHE . 70.8 t -48.99 129.32 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 6.3 t70 -105.86 9.24 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.2 m -166.85 140.91 3.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.667 0.27 . . . . 0.0 110.764 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 110' ' ' VAL . 13.8 mt -121.62 144.24 48.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.305 0.574 . . . . 0.0 111.743 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.489 ' HB2' HD12 ' A' ' 4' ' ' LEU . 5.4 mt -135.38 117.53 15.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.139 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.686 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -136.33 146.51 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.105 0.479 . . . . 0.0 112.108 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.97 108.47 16.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.301 179.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 8.3 tpt180 -79.51 101.16 8.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.317 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.583 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 3.2 mt -82.49 124.89 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.258 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.67 -58.3 6.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.29 175.31 3.27 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.664 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.6 p -105.72 159.37 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 110.947 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.583 ' CZ ' HD22 ' A' ' 118' ' ' LEU . 6.3 m-85 -147.31 155.17 41.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -68.84 170.1 10.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.652 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.587 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 157.57 163.85 13.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.262 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.45 -27.1 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.6 0.238 . . . . 0.0 111.348 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.489 HG22 HD11 ' A' ' 13' ' ' ILE . 90.4 m -109.17 146.67 33.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.742 0.306 . . . . 0.0 111.008 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 177.56 4.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 17.0 tpt -76.94 156.68 31.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.734 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.3 pp -82.84 157.79 66.08 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.26 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.22 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.72 2.28 . . . . 0.0 112.507 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -96.45 146.63 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.38 75.78 2.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.012 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.571 ' HH2' HG11 ' A' ' 115' ' ' VAL . 88.0 m95 -56.39 -23.45 38.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -27.81 63.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.554 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.5 t70 -78.7 -24.82 44.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.737 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.459 ' CD1' HD11 ' A' ' 113' ' ' LEU . 78.5 m-85 -104.05 173.58 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.654 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -128.72 139.79 52.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.2 ttpp -83.7 108.0 16.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.574 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.3 m -95.79 -18.11 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.722 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 m -162.62 140.46 8.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.722 0.296 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.484 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 2.2 p -169.85 108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -142.66 118.12 10.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.753 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -67.11 145.28 55.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.04 103.74 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.284 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.86 102.15 14.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.32 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 174.23 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.6 p -52.53 -44.16 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.495 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 3.2 t30 -80.51 128.49 72.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.352 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.43 -30.35 86.85 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.393 2.062 . . . . 0.0 112.592 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.7 -22.98 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.4 mt -81.01 6.3 13.85 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 153' ' ' HIS . 99.6 m -70.2 162.38 28.5 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.163 0.506 . . . . 0.0 110.396 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -172.38 159.09 4.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.836 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.753 ' OG1' HG23 ' A' ' 143' ' ' THR . 6.8 m -119.0 150.25 40.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' SER . 48.9 m-85 -113.84 105.04 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.498 ' HB2' HG22 ' A' ' 115' ' ' VAL . 28.5 mt-10 -109.78 125.29 52.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.037 0.446 . . . . 0.0 112.183 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.685 ' O ' HG22 ' A' ' 139' ' ' VAL . 16.3 t -116.84 114.22 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.211 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.471 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.1 m95 -108.31 150.59 27.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.064 0.459 . . . . 0.0 111.985 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.489 ' CD ' HG11 ' A' ' 139' ' ' VAL . 31.3 mt-30 -129.33 125.33 36.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.32 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -48.07 123.28 6.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.038 0.447 . . . . 0.0 111.661 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.654 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -107.67 -177.59 3.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.133 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.748 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.77 149.2 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.499 ' CE1' HG22 ' A' ' 110' ' ' VAL . 3.4 m-30 -113.64 108.35 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.845 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -107.48 117.15 33.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.605 0.717 . . . . 0.0 112.45 -178.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.677 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.1 p90 -161.52 166.84 26.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.261 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.86 132.55 54.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 111.607 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.7 pt20 -118.5 143.87 46.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -91.93 -167.82 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.42 52.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.231 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.01 -27.68 48.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.044 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 106.73 29.53 4.64 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.259 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.66 HD21 ' HA3' ' A' ' 124' ' ' GLY . 1.9 tt -84.27 157.87 21.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.962 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.536 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -111.93 -58.53 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.459 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.0 -162.23 24.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.96 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.673 ' HG3' ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -126.24 -164.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.716 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.11 86.41 6.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.654 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.35 114.98 3.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.311 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -100.71 133.9 44.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 0.0 111.134 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.632 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -101.38 -51.38 0.17 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.219 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 19' ' ' LEU . 77.2 Cg_endo -93.62 107.95 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.764 2.309 . . . . 0.0 112.448 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -126.53 111.76 14.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.87 119.67 9.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.774 HD22 ' OD1' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -161.75 101.97 1.18 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.16 -48.39 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.554 2.169 . . . . 0.0 113.068 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.86 -14.75 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.488 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.774 ' OD1' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -57.28 -31.28 65.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 mp -62.92 -49.87 73.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.717 0.294 . . . . 0.0 111.287 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -52.86 -25.43 11.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.989 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -73.88 -62.75 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.455 ' CA ' ' HB2' ' A' ' 33' ' ' GLN . 27.5 p90 -92.49 27.68 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.491 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -53.81 25.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.849 0.357 . . . . 0.0 110.809 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.0 -19.55 51.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.559 ' HA ' ' CG ' ' A' ' 37' ' ' LYS . 1.5 mt-30 -67.36 -7.52 25.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.76 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 57' ' ' ARG . 18.3 p -88.9 -18.71 26.99 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 37' ' ' LYS . 3.5 m -107.8 117.67 53.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.068 0.461 . . . . 0.0 112.222 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 92' ' ' GLN . . . 57.42 -10.35 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.72 -0.673 . . . . 0.0 114.7 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 33' ' ' GLN . 6.7 mmtt -69.46 95.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.559 0.695 . . . . 0.0 110.944 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.544 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 20.4 mt -64.41 110.7 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.692 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.8 ttp -100.79 115.26 29.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.584 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.806 HG21 HG11 ' A' ' 82' ' ' VAL . 2.7 t -88.99 124.3 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.167 0.508 . . . . 0.0 112.201 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 15.7 m -130.0 144.33 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.379 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.09 156.97 51.79 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.172 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.45 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -55.48 -51.01 68.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 110.514 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -58.43 -34.87 71.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -68.24 -47.49 67.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -54.13 -31.91 53.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.15 -66.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.652 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 49' ' ' PHE . 2.4 m -57.6 -30.75 65.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.42 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -32.92 122.7 0.42 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.9 -179.23 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.28 -38.2 88.49 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.963 2.442 . . . . 0.0 113.311 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -143.57 116.28 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.429 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.51 135.09 14.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.709 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -85.42 -171.86 8.41 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.354 -1.519 . . . . 0.0 112.161 -0.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 57' ' ' ARG . 95.7 mt -97.84 147.2 32.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.571 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.67 -86.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.091 2.527 . . . . 0.0 113.451 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -101.84 25.65 8.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.624 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -115.07 122.48 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.142 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 80.3 m -74.7 122.0 22.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.925 0.393 . . . . 0.0 111.873 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.416 HD21 HD12 ' A' ' 54' ' ' LEU . 2.6 m-80 -102.81 152.79 20.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.718 ' HB ' HG13 ' A' ' 40' ' ' VAL . 2.2 t -137.38 131.71 44.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 0.0 111.366 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.5 t -103.47 126.19 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.272 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -109.87 108.29 18.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.944 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.981 HG21 ' CD2' ' A' ' 68' ' ' TYR . 2.9 t -144.19 164.11 31.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 111.396 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -81.1 -9.83 59.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.289 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.664 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 6.9 tp60 -71.74 127.18 31.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.332 . . . . 0.0 110.392 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -27.91 55.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -105.13 16.93 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.641 0.258 . . . . 0.0 111.493 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.981 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.6 t80 -62.25 137.24 58.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.485 0.659 . . . . 0.0 112.454 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.832 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -127.41 171.99 11.06 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.251 1.024 . . . . 0.0 112.357 178.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.07 140.14 16.42 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -76.07 96.81 3.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.813 0.339 . . . . 0.0 110.941 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.95 -42.26 2.31 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.556 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 167.92 19.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.133 0.492 . . . . 0.0 112.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' HG13 ' A' ' 60' ' ' VAL . 21.9 t -94.81 140.89 15.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.127 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.875 HG11 ' O ' ' A' ' 68' ' ' TYR . 33.8 t -107.01 121.61 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.386 0.612 . . . . 0.0 111.955 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.718 HG21 HG22 ' A' ' 82' ' ' VAL . 18.0 m -132.74 178.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.131 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -127.79 -21.11 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.648 ' HA ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -153.8 -177.11 6.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.457 . . . . 0.0 111.591 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 106' ' ' PHE . 24.2 t -70.08 -11.17 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.433 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.11 -37.24 17.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.107 0.48 . . . . 0.0 110.064 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -68.83 -30.63 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.665 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.806 HG11 HG21 ' A' ' 40' ' ' VAL . 23.3 t -72.35 -55.81 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.484 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 8.5 m-85 -52.49 -31.21 34.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.205 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.6 -43.81 97.87 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 87.5 t80 -61.04 -52.6 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.3 -22.33 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.35 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mtmt -70.99 -37.14 72.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.126 0.489 . . . . 0.0 109.874 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -8.7 59.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 92' ' ' GLN . 95.1 m-70 -120.01 62.45 8.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.93 -6.04 8.69 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.655 2.237 . . . . 0.0 112.226 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -99.55 -25.75 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.982 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.643 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 10.3 mt-30 -94.11 151.6 19.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 29.2 mt-10 -99.09 174.76 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.58 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 1' ' ' THR . 17.2 tp -131.23 111.17 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 111.308 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 39' ' ' MET . 83.9 t -129.23 116.14 38.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 40' ' ' VAL . 6.3 mm -82.02 138.13 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.88 0.371 . . . . 0.0 111.082 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -113.76 -33.14 5.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.774 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.94 -171.89 44.41 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.462 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.62 -160.97 36.17 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 117.588 0.694 . . . . 0.0 112.632 -0.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.01 -55.75 15.9 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.8 0.333 . . . . 0.0 111.294 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -56.47 -31.92 64.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.025 0.441 . . . . 0.0 110.464 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.4 mm -77.11 -30.54 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.053 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' HB3' HG12 ' A' ' 129' ' ' ILE . 2.0 m-85 -58.02 -52.98 63.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.366 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.696 ' CA ' HD13 ' A' ' 129' ' ' ILE . 12.0 t -69.53 -10.22 57.19 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -73.36 -39.71 64.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 0.0 110.671 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.9 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.8 m-85 -102.35 -3.55 26.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.584 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 5.9 pttt -51.65 -31.23 24.67 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.683 0.277 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.7 -5.69 58.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.555 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.82 -20.65 8.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.657 0.265 . . . . 0.0 111.475 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 106' ' ' PHE . 73.4 t -45.58 134.15 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.12 0.486 . . . . 0.0 111.427 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 18.1 t70 -111.26 -0.32 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.724 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.748 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 51.6 m -166.74 137.44 3.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.565 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 6.1 mt -118.13 145.64 44.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.24 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 4' ' ' LEU . 9.4 mt -134.96 112.74 10.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.062 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.677 HG12 ' CH2' ' A' ' 5' ' ' TRP . 2.1 m -127.94 137.39 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.055 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.92 119.93 36.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.182 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 100.6 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.68 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 153' ' ' HIS . 0.9 OUTLIER -81.13 135.31 35.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -55.94 -53.84 52.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 122' ' ' PHE . . . -58.04 156.32 19.52 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.234 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 p -97.04 154.13 17.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -142.68 156.48 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.824 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 156.92 16.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.252 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.673 ' HA2' ' HG3' ' A' ' 15' ' ' LYS . . . 178.56 175.41 45.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.911 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.22 22.08 4.45 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.463 HG22 HD11 ' A' ' 13' ' ' ILE . 1.3 m -133.0 126.96 33.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.75 0.31 . . . . 0.0 110.838 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -108.65 162.31 14.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.034 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.3 tpt -72.93 158.44 35.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.917 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.696 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.2 pp -88.75 164.97 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.178 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.22 96.79 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 112.655 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.1 149.49 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.997 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.02 71.35 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.479 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HH2' HG11 ' A' ' 115' ' ' VAL . 95.6 m95 -58.96 -20.11 49.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -72.86 -32.06 65.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.829 0.347 . . . . 0.0 110.756 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -79.39 -24.52 42.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.57 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 95.5 m-85 -101.46 171.62 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 111.076 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 m -134.93 141.76 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.415 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.607 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.2 ttpm? -84.76 105.81 15.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.9 m -89.9 -17.96 7.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.985 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -161.85 141.47 10.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 111.17 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.607 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 99.2 p -172.01 108.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.198 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.412 ' C ' HG23 ' A' ' 154' ' ' THR . 1.7 ttt-85 -147.87 130.52 15.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.26 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.756 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.4 m -74.27 146.3 43.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.148 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 152' ' ' THR . 11.3 t -118.3 104.62 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.383 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -93.33 104.89 17.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.72 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.7 -174.51 4.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.498 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.2 p -54.58 -54.89 35.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.864 0.364 . . . . 0.0 110.79 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.554 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 2.8 t30 -75.93 141.08 71.07 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.769 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.77 -36.57 18.31 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.819 1.679 . . . . 0.0 112.369 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.91 -23.4 44.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.878 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -77.69 9.61 3.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.566 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 144' ' ' VAL . 50.3 m -83.95 158.64 21.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -170.68 155.83 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.756 ' OG1' HG23 ' A' ' 143' ' ' THR . 39.6 m -117.69 129.44 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.404 ' OH ' ' CE1' ' A' ' 153' ' ' HIS . 57.2 m-85 -100.77 105.64 16.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.409 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.548 ' HB2' HG22 ' A' ' 115' ' ' VAL . 17.0 mt-10 -104.61 126.68 51.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.307 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.745 ' O ' HG22 ' A' ' 139' ' ' VAL . 6.2 t -118.07 112.56 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.517 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.552 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 30.2 m95 -104.63 148.27 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.067 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -128.33 119.22 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.747 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.452 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.4 tttt -51.54 135.13 28.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.26 -165.86 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.575 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 9.6 m . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -111.93 148.64 33.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.525 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 1.9 m-85 -113.87 112.24 23.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.278 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.807 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -115.84 127.83 55.34 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -178.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.664 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.5 p90 -168.63 163.8 12.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.216 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.22 131.73 53.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.862 0.363 . . . . 0.0 111.732 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.544 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 7.5 pt20 -130.61 161.54 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.415 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.11 -169.03 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HD3' ' HB3' ' A' ' 121' ' ' SER . 0.0 OUTLIER -55.34 -27.73 49.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.67 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 9.2 t70 -90.63 -33.98 15.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 105.17 57.3 0.68 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.859 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 67.1 mt -110.22 152.23 26.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 pt -112.4 -39.37 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.343 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.33 151.31 10.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.627 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.74 -73.99 0.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.815 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.75 150.23 3.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.73 173.07 12.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.561 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -87.33 -19.5 28.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.655 0.264 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.451 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 2.1 tp 65.75 63.26 1.01 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 14.8 Cg_exo -68.46 -66.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.635 2.224 . . . . 0.0 112.15 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -77.59 144.73 37.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -126.31 171.84 10.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -130.07 129.48 22.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.732 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 31.5 Cg_exo -58.84 -12.08 13.89 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.542 2.161 . . . . 0.0 112.98 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -76.2 -44.54 37.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.36 -23.64 17.09 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.585 HD12 ' HG2' ' A' ' 31' ' ' ARG . 3.5 mm? -78.52 -35.38 46.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 1.9 t-80 -52.75 -35.42 56.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.482 ' HB2' ' CE1' ' A' ' 155' ' ' TYR . 31.6 t80 -105.35 -7.42 18.85 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.455 ' HA ' HD23 ' A' ' 4' ' ' LEU . 53.3 t80 -92.32 -75.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.805 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -62.35 -54.86 34.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.515 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.76 -25.77 3.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.848 0.356 . . . . 0.0 111.953 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.679 ' OE1' HD13 ' A' ' 114' ' ' LEU . 1.8 mm-40 -92.92 -3.39 54.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.599 ' HB ' ' HG ' ' A' ' 4' ' ' LEU . 12.9 t -135.6 -35.56 0.8 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 31' ' ' ARG . 13.0 m -74.42 161.58 4.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.525 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . 83.56 2.86 89.98 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.483 -0.865 . . . . 0.0 114.918 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -149.53 -164.23 1.97 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.29 1.545 . . . . 0.0 109.298 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.506 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 40.8 mt -76.82 88.96 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 111.579 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.492 ' HE2' HD12 ' A' ' 54' ' ' LEU . 27.5 ttp -103.11 126.74 50.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.641 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.597 HG21 HG11 ' A' ' 82' ' ' VAL . 39.3 t -79.87 156.51 4.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.759 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 31.2 m -163.7 140.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.984 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.76 147.75 48.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.32 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.614 ' HG2' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -49.93 -46.39 52.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.445 0.622 . . . . 0.0 110.613 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -58.97 -39.55 82.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 109.963 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -65.98 -48.67 70.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.984 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 4.5 t80 -57.31 -27.22 61.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -67.79 -66.23 0.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.658 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.12 -23.88 65.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.272 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.787 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -35.71 133.12 0.53 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.901 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 99.6 Cg_exo -46.8 -35.96 18.74 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.144 2.563 . . . . 0.0 113.534 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.84 148.55 31.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.197 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.95 111.84 6.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.252 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 12.9 Cg_exo -81.76 179.09 28.53 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 123.408 -1.497 . . . . 0.0 111.787 -0.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.787 HD11 ' CE1' ' A' ' 49' ' ' PHE . 77.8 mt -78.87 143.42 62.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.766 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.81 109.2 2.06 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.514 2.143 . . . . 0.0 112.609 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 mt-10 73.19 0.12 3.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.968 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.776 ' HD2' HD13 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -109.89 106.88 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 -179.343 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.506 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 87.9 m -64.99 120.31 12.36 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.613 ' ND2' HD12 ' A' ' 54' ' ' LEU . 4.8 m120 -110.11 157.32 19.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.203 0.525 . . . . 0.0 112.362 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 76' ' ' VAL . 17.7 t -134.15 143.58 37.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.765 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 43' ' ' ARG . 57.8 t -113.58 111.04 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.179 0.514 . . . . 0.0 111.891 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -91.58 118.35 30.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.304 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.895 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -155.37 148.17 24.34 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.936 179.472 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -69.02 -6.32 27.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.258 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.7 tt0 -73.29 131.6 42.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.329 . . . . 0.0 110.747 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -85.42 5.47 30.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.838 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -134.6 7.72 3.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.895 ' CD2' HG21 ' A' ' 63' ' ' THR . 3.4 t80 -59.91 137.51 58.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.289 0.566 . . . . 0.0 111.594 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.956 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.3 mt-30 -133.15 171.94 13.33 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.454 1.121 . . . . 0.0 113.14 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.5 140.29 17.13 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 112.955 -1.929 . . . . 0.0 110.138 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.97 102.56 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.07 -41.05 2.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.274 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB2' ' OH ' ' A' ' 46' ' ' TYR . . . -72.49 170.51 14.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.017 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 60' ' ' VAL . 21.6 t -98.53 141.33 16.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.956 HG21 ' HA ' ' A' ' 69' ' ' GLN . 14.8 t -114.37 122.37 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 0.0 112.187 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.008 HG21 HG22 ' A' ' 82' ' ' VAL . 27.3 m -129.91 173.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.111 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' THR . 6.0 m170 -118.44 -24.22 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -157.1 -171.82 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.421 . . . . 0.0 111.165 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.841 HG13 ' CD2' ' A' ' 106' ' ' PHE . 15.6 t -68.91 -11.29 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.59 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.54 -36.84 17.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.102 0.477 . . . . 0.0 110.094 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.81 -29.67 63.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.89 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.008 HG22 HG21 ' A' ' 76' ' ' VAL . 21.5 t -72.3 -55.19 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 120.904 0.383 . . . . 0.0 110.039 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.552 ' O ' ' HG3' ' A' ' 87' ' ' LYS . 9.4 m-85 -53.61 -27.59 27.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.817 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -62.08 -48.64 79.28 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.846 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 83.1 t80 -58.98 -51.24 70.91 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.99 -22.84 16.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.095 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' PHE . 6.6 mtmp? -67.78 -44.5 77.29 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -79.63 -2.83 44.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.596 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.424 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 61.7 m-70 -128.68 64.43 69.04 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-O 120.995 0.426 . . . . 0.0 110.388 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.19 -0.01 6.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.184 2.589 . . . . 0.0 112.935 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.89 -31.83 18.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.169 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.74 162.94 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.364 . . . . 0.0 111.34 -179.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -104.17 174.71 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.223 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.676 HD21 ' CG1' ' A' ' 82' ' ' VAL . 6.2 tp -110.5 117.08 32.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.586 HG11 ' O ' ' A' ' 33' ' ' GLN . 11.3 t -121.53 107.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.093 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.479 HD12 ' HB ' ' A' ' 40' ' ' VAL . 16.4 mm -76.76 132.08 33.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.173 0.511 . . . . 0.0 111.593 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.13 -37.15 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.027 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.34 -172.66 45.0 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.827 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.9 -161.11 31.7 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 122.216 -0.579 . . . . 0.0 112.535 -0.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.3 -55.36 32.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.737 0.303 . . . . 0.0 111.045 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -55.14 -26.49 38.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.571 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.9 mm -80.62 -26.41 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' HB3' HG12 ' A' ' 129' ' ' ILE . 3.4 m-85 -62.71 -55.84 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.472 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.729 ' CA ' HD13 ' A' ' 129' ' ' ILE . 4.6 t -66.72 -10.11 43.53 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.772 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.38 -41.3 48.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.841 ' CD2' HG13 ' A' ' 79' ' ' VAL . 2.5 m-85 -96.69 -8.28 31.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.478 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -51.91 -29.24 19.23 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.856 0.36 . . . . 0.0 111.161 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.52 -3.74 48.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.551 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -128.8 -19.09 3.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 106' ' ' PHE . 77.7 t -44.45 131.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.506 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.459 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 9.9 t70 -109.22 4.36 22.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.285 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.709 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 21.7 m -167.74 135.72 2.38 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.6 0.238 . . . . 0.0 110.821 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 158' ' ' TRP . 13.8 mt -116.52 142.44 46.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.106 0.479 . . . . 0.0 111.465 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.679 HD13 ' OE1' ' A' ' 33' ' ' GLN . 3.7 mt -135.53 115.69 13.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -138.1 147.39 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.985 0.422 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -115.92 105.91 13.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.022 178.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 18.3 ttt180 -86.39 104.71 16.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.79 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 6.8 mp -85.14 128.3 34.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.931 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -61.55 -54.0 48.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.463 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -63.13 168.52 19.85 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.46 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 95.3 p -105.28 141.97 35.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.683 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -137.11 175.98 9.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.048 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.62 162.55 29.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.48 ' CA ' HD13 ' A' ' 12' ' ' LEU . . . 164.08 133.15 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -106.05 -24.8 12.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.64 0.257 . . . . 0.0 111.237 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.36 144.73 37.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 111.198 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.56 -174.63 2.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.0 tpt -86.24 160.01 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.189 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.729 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.6 pp -86.87 166.24 27.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.193 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' A' ' 129' ' ' ILE . 20.3 Cg_exo -66.29 94.25 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.874 2.383 . . . . 0.0 112.908 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.42 149.01 23.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.068 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.7 77.74 3.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -59.32 -18.2 35.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.532 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.57 -30.93 61.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 111.032 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.78 -25.79 49.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.274 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.506 ' CD1' HD11 ' A' ' 113' ' ' LEU . 95.8 m-85 -97.18 174.23 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.004 0.43 . . . . 0.0 111.541 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.453 HG21 ' HE2' ' A' ' 161' ' ' LYS . 1.2 m -136.88 142.74 42.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 1.0 OUTLIER -78.26 119.3 21.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.978 179.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 157' ' ' VAL . 29.2 m -102.16 -23.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.219 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.7 m -163.23 140.77 7.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 80.9 p -160.7 110.12 1.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.978 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -141.64 114.54 8.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.015 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.737 HG23 ' OG1' ' A' ' 154' ' ' THR . 7.4 m -73.07 143.99 47.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.481 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 t -113.48 105.3 18.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.951 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.437 ' HA ' HG23 ' A' ' 152' ' ' THR . 1.7 mt-10 -90.73 102.15 14.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.714 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.79 -177.73 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.595 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 36.3 p -59.51 -49.52 77.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.53 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 4.3 t30 -74.41 125.44 89.83 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.774 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.5 -28.21 86.91 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.089 1.859 . . . . 0.0 112.338 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.463 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -89.3 -20.07 24.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.027 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.8 mt -84.91 8.75 16.44 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 80.4 m -73.25 166.27 23.46 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.912 0.387 . . . . 0.0 110.004 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.606 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 3.6 p80 -173.74 160.33 3.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.737 ' OG1' HG23 ' A' ' 143' ' ' THR . 8.0 m -126.84 140.13 52.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.264 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.482 ' CE1' ' HB2' ' A' ' 29' ' ' TYR . 51.0 m-85 -100.03 105.72 17.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.468 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.438 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.3 mt-10 -104.24 121.81 44.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.928 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.805 ' O ' HG22 ' A' ' 139' ' ' VAL . 9.6 t -114.51 112.96 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 18.8 m95 -112.63 150.8 30.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.274 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.526 ' CD ' HG11 ' A' ' 139' ' ' VAL . 26.6 mt-30 -128.51 118.89 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.36 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 5.3 tttt -57.35 133.08 54.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.865 0.364 . . . . 0.0 111.153 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.453 ' HE2' HG21 ' A' ' 137' ' ' THR . 0.0 OUTLIER 177.16 157.67 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.099 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.141 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.459 ' CG2' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.537 0.208 . . . . 0.0 110.539 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -108.23 143.08 37.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.296 0.57 . . . . 0.0 112.366 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.494 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.3 m-30 -112.36 112.98 24.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.543 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.816 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -113.15 123.16 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 111.648 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.646 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.6 p90 -166.29 173.88 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.518 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -128.68 137.65 51.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -130.25 157.0 43.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.592 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 20.7 p-10 -108.33 -171.67 1.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.71 -36.47 64.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.38 -28.03 34.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.702 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.6 -4.22 66.24 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.893 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 2.5 pp -80.59 157.46 26.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.927 0.363 . . . . 0.0 111.021 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.656 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -120.96 -35.91 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.377 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.1 -156.87 27.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.81 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.501 ' H ' HD21 ' A' ' 19' ' ' LEU . 14.0 mttm -103.84 -139.46 0.36 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.671 -0.122 . . . . 0.0 110.671 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -149.95 107.75 3.69 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.902 0.382 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.64 -95.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.367 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.1 -71.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.641 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.501 HD21 ' H ' ' A' ' 15' ' ' LYS . 86.2 mt 58.24 80.69 0.27 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.339 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.41 109.8 2.36 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.256 . . . . 0.0 112.01 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.04 121.64 42.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 111.243 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -120.57 27.33 8.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.716 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.22 147.2 33.34 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.04 -24.72 23.54 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.599 2.2 . . . . 0.0 112.348 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -48.59 -27.37 2.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.552 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -90.31 -54.49 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.192 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 27' ' ' LEU . 4.7 tp -63.16 -14.45 49.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.914 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -91.44 -29.12 17.22 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -105.17 -39.53 6.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 111.599 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 5' ' ' TRP . 17.7 m-85 -92.2 30.37 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.369 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.831 ' O ' HG22 ' A' ' 35' ' ' VAL . 4.2 ttm-85 -91.86 -61.52 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.35 -28.16 15.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.704 0.288 . . . . 0.0 111.636 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -69.14 -17.61 63.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.753 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.688 ' CG2' HD21 ' A' ' 4' ' ' LEU . 34.9 p -116.52 -31.07 5.67 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.831 HG22 ' O ' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -107.63 151.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.183 0.516 . . . . 0.0 112.36 -178.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 103.27 -7.5 51.64 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.935 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -145.45 -164.53 1.97 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.387 1.094 . . . . 0.0 109.563 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 75.3 mt -81.34 88.67 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.118 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.472 ' HE3' ' CG1' ' A' ' 41' ' ' VAL . 4.1 ttp -99.07 123.13 43.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.281 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.766 HG21 HG11 ' A' ' 82' ' ' VAL . 4.4 t -89.22 128.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.472 ' CG1' ' HE3' ' A' ' 39' ' ' MET . 33.5 m -131.49 148.12 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.538 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.87 151.22 51.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.385 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.524 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -49.83 -51.12 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 10.8 tpt180 -62.18 -36.76 82.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.303 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -66.86 -36.25 81.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.942 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.476 ' OH ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t80 -65.53 -22.34 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.592 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -65.22 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.2 t -48.37 -36.58 14.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -43.18 157.27 0.25 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.012 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.12 -67.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.673 2.249 . . . . 0.0 112.768 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.25 164.06 36.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 16.9 mtm180 -117.12 115.08 38.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 67.6 Cg_endo -88.74 -164.99 2.78 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 124.005 -1.248 . . . . 0.0 112.329 0.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.644 HD12 HD21 ' A' ' 59' ' ' ASN . 55.4 mt -107.51 144.63 29.63 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 37.3 Cg_endo -65.97 118.11 5.22 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.555 2.17 . . . . 0.0 112.638 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 7.1 mt-10 68.02 7.49 5.85 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.944 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 1.3 mtt180 -119.24 100.31 7.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.887 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 34.9 m -67.72 109.92 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.744 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.3 m-80 -104.39 139.51 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.305 0.574 . . . . 0.0 112.265 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.654 ' HB ' HG13 ' A' ' 40' ' ' VAL . 4.5 t -113.0 143.16 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.121 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 68' ' ' TYR . 84.9 t -114.77 125.06 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 111.9 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.937 HD12 HG23 ' A' ' 76' ' ' VAL . 1.9 tp -104.66 120.36 41.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.92 HG21 ' CD2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -153.62 171.18 19.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -91.91 -8.03 47.52 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 1.6 tt0 -77.9 130.72 36.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.339 . . . . 0.0 110.786 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -80.79 0.05 36.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.004 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -126.79 10.03 7.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.578 0.228 . . . . 0.0 111.407 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.92 ' CD2' HG21 ' A' ' 63' ' ' THR . 4.4 t80 -59.34 141.62 54.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.95 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.7 mt-30 -132.52 174.54 10.17 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 122.343 1.068 . . . . 0.0 112.902 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.84 143.62 20.77 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.398 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -73.17 98.56 2.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.771 0.319 . . . . 0.0 110.835 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.18 -36.7 2.89 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.535 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -70.69 172.38 8.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 0.0 111.489 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.1 t -97.99 140.02 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.95 HG21 ' HA ' ' A' ' 69' ' ' GLN . 25.1 t -112.76 122.72 67.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.134 0.492 . . . . 0.0 111.365 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.937 HG23 HD12 ' A' ' 62' ' ' LEU . 30.8 m -133.61 168.61 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.334 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 65' ' ' GLN . 9.0 m80 -117.1 -22.52 8.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.358 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -150.06 -177.36 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 111.578 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.915 HG13 ' CD2' ' A' ' 106' ' ' PHE . 21.5 t -70.79 -8.57 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.99 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.76 -31.24 17.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 110.053 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.736 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -77.03 -27.26 54.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.681 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 76' ' ' VAL . 95.2 t -75.67 -52.59 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.659 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 8.2 m-85 -57.39 -25.02 58.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.689 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -67.16 -41.36 86.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -66.3 -57.55 7.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.635 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -56.82 -23.4 43.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.04 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.14 -33.01 72.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 9.7 mt-30 -88.75 -4.13 58.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.26 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -126.02 63.97 50.69 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.33 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.06 -0.14 5.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.169 2.579 . . . . 0.0 112.94 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.79 -37.23 30.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -112.14 163.84 13.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.344 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -98.64 164.25 12.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.639 HD11 HG12 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -108.16 124.96 51.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.313 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' MET . 69.3 t -131.87 118.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.345 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 94' ' ' LEU . 3.0 mm -82.48 138.69 18.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 111.408 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.459 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -102.63 -52.98 2.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.775 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 172.11 -166.15 38.95 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.341 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.48 -161.01 36.77 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 117.813 0.806 . . . . 0.0 112.639 -0.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.78 -44.13 38.65 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.81 0.338 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.82 -34.33 74.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.717 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 62' ' ' LEU . 28.4 mm -80.97 -23.11 10.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -63.21 -52.06 63.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.55 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.53 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 14.5 t -68.48 -9.58 49.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.738 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.35 -39.99 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.821 0.343 . . . . 0.0 110.68 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.915 ' CD2' HG13 ' A' ' 79' ' ' VAL . 4.2 m-85 -100.69 -4.8 27.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.368 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.3 pttt -48.18 -32.65 7.32 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.94 -2.16 58.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.789 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 m-20 -119.18 -26.89 5.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.585 0.231 . . . . 0.0 111.554 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.761 HG11 HD23 ' A' ' 113' ' ' LEU . 82.5 t -45.91 122.48 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 111.576 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 14.9 t70 -105.85 8.35 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.022 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 84.7 m -168.25 138.29 2.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.969 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.761 HD23 HG11 ' A' ' 110' ' ' VAL . 5.8 mt -121.46 146.2 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.319 0.581 . . . . 0.0 112.101 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 113' ' ' LEU . 14.3 mt -135.15 114.67 12.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.241 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -136.89 147.33 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.128 0.489 . . . . 0.0 112.133 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -107.93 119.01 38.24 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.915 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -79.46 99.01 7.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.383 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 6' ' ' ALA . 6.0 mt -85.94 108.96 18.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.177 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.33 78.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.034 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.5 171.49 54.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.554 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 t -110.14 162.65 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.739 0.304 . . . . 0.0 111.018 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 6.6 m-85 -138.42 170.05 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.253 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.42 169.95 8.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.89 -170.73 24.76 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.689 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.26 29.22 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.018 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -141.62 129.83 22.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 16.5 tttm -111.55 150.24 30.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.806 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -52.17 179.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.544 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.6 pt -97.27 162.67 21.91 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.188 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.2 Cg_endo -73.86 99.3 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.45 2.1 . . . . 0.0 112.102 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.427 ' CD1' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt -88.46 147.84 24.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 74.19 2.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.024 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.527 ' HH2' HG11 ' A' ' 115' ' ' VAL . 92.7 m95 -54.52 -24.17 19.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.94 -26.29 62.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.37 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.3 t0 -83.23 -19.51 36.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.737 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.699 ' CD1' HD11 ' A' ' 113' ' ' LEU . 89.9 m-85 -107.93 165.9 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.626 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.568 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -126.61 139.79 52.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 110.509 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 11.2 ttpt -79.6 117.25 20.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.464 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 157' ' ' VAL . 24.5 m -101.94 -21.84 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.927 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -163.09 140.61 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 155' ' ' TYR . 8.6 p -155.94 111.02 2.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.501 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -141.42 117.1 10.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.789 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.787 ' HA ' ' HA ' ' A' ' 154' ' ' THR . 10.2 m -72.62 133.48 44.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.161 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.64 109.77 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.583 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.779 ' HA ' HG23 ' A' ' 152' ' ' THR . 11.2 mt-10 -96.99 97.51 9.31 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -81.51 -161.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.191 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.2 p -74.38 -48.65 26.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.287 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.502 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.9 t30 -69.18 119.85 72.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.075 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.31 -20.57 56.29 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.083 1.856 . . . . 0.0 111.989 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.59 -23.65 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.573 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 19.6 mt -89.35 2.29 54.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.779 HG23 ' HA ' ' A' ' 145' ' ' GLU . 1.7 m -85.86 82.21 8.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 5.3 p80 -97.12 -171.3 2.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.565 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.787 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 55.9 m -125.55 165.26 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.079 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.473 ' N ' HG22 ' A' ' 154' ' ' THR . 1.6 m-85 -118.79 105.85 11.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.96 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.488 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.4 mt-10 -109.69 125.27 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.778 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.752 ' O ' HG22 ' A' ' 139' ' ' VAL . 7.0 t -116.12 115.04 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.278 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.508 ' O ' HG23 ' A' ' 112' ' ' THR . 23.8 m95 -111.97 150.47 30.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.22 0.534 . . . . 0.0 111.655 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -127.28 121.12 30.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.784 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 2.3 tmmt? -54.94 130.42 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 0.0 111.62 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.568 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.59 -170.52 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.553 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.126 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 21.7 m . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.689 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.72 145.36 36.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.8 m-85 -112.17 111.53 22.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.314 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.849 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -111.16 119.07 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.544 0.688 . . . . 0.0 112.569 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.603 ' CH2' HG12 ' A' ' 115' ' ' VAL . 6.7 p90 -160.32 166.89 28.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.411 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.99 140.18 48.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.957 0.408 . . . . 0.0 111.769 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -138.99 141.34 38.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.675 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 5.7 p-10 -100.35 -163.38 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HD2' ' HB2' ' A' ' 121' ' ' SER . 0.1 OUTLIER -51.63 -48.9 63.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.345 0.593 . . . . 0.0 109.978 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.55 -32.69 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.037 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.11 43.47 3.27 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -82.51 165.15 20.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.753 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.83 -37.92 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.452 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 12' ' ' LEU . . . 168.36 -153.31 22.26 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.43 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -120.37 157.24 29.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.939 0.399 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -6.08 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.734 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.63 -51.42 1.41 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.615 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.82 179.92 4.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 0.0 111.039 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.413 ' HG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -77.63 145.46 71.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.972 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD2' ' HG ' ' A' ' 19' ' ' LEU . 93.5 Cg_endo -86.92 -170.89 0.68 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.836 2.357 . . . . 0.0 112.342 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -93.52 177.48 6.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.906 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -113.26 117.22 31.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.603 HD22 ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -120.33 132.98 23.94 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.646 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.09 -45.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.716 2.278 . . . . 0.0 113.24 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -64.07 -29.89 70.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.607 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.603 ' HB2' HD22 ' A' ' 23' ' ' LEU . 1.3 t0 -88.02 -18.02 29.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.603 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.425 HD22 ' CD ' ' A' ' 31' ' ' ARG . 7.1 mt -73.83 -34.45 64.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.752 0.311 . . . . 0.0 111.231 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -59.98 -24.65 64.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.469 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -103.9 -21.88 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.633 0.254 . . . . 0.0 111.512 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -86.99 -28.43 22.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.684 0.278 . . . . 0.0 111.307 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.903 ' O ' HG22 ' A' ' 35' ' ' VAL . 9.8 mtp-105 -91.98 -61.14 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.735 0.302 . . . . 0.0 111.655 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.87 -21.83 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.626 HE22 HD22 ' A' ' 114' ' ' LEU . 2.8 mm100 -91.71 -7.69 49.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.498 ' OG1' ' HB2' ' A' ' 97' ' ' ALA . 3.6 t -129.21 -27.9 2.41 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 31' ' ' ARG . 23.1 m -93.68 150.37 3.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' C ' ' HG2' ' A' ' 37' ' ' LYS . . . 106.2 -6.81 39.95 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.419 -0.896 . . . . 0.0 114.416 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 34.6 mmtm -149.09 -165.14 2.2 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.681 1.241 . . . . 0.0 109.729 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.519 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 62.8 mt -74.43 89.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 111.12 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 ttp -99.61 125.0 45.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.651 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.4 t -79.14 157.36 4.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.423 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 31.2 m -162.91 153.19 3.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.13 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 154.36 47.76 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.813 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.805 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.76 -48.26 69.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.931 0.366 . . . . 0.0 110.813 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.4 tpm_? -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.575 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.5 m -71.4 -47.5 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.598 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 73' ' ' ALA . 9.7 t80 -58.21 -23.47 55.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -72.18 -65.82 0.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -56.45 -26.8 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.381 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -39.84 130.27 1.51 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.551 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -46.3 -27.96 5.3 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.383 . . . . 0.0 113.329 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -157.12 133.05 9.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.286 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -126.84 108.2 22.41 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 69.3 Cg_endo -80.49 -171.96 10.41 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.582 -1.424 . . . . 0.0 111.831 0.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.701 HD11 ' CE1' ' A' ' 49' ' ' PHE . 64.4 mt -91.55 158.19 40.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.44 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.78 -43.6 56.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.91 2.406 . . . . 0.0 113.533 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 4.6 mt-10 -140.58 46.05 1.8 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.835 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.6 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -146.53 111.37 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.339 . . . . 0.0 111.811 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.519 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 55.1 m -71.29 115.5 10.52 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.554 HD21 HD12 ' A' ' 54' ' ' LEU . 3.5 m-80 -101.07 159.42 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.475 0.655 . . . . 0.0 112.59 -178.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 74' ' ' VAL . 5.7 t -137.17 133.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.366 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 43' ' ' ARG . 86.8 t -104.7 126.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.691 HD13 HD12 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -105.24 118.8 37.46 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.052 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.811 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.97 161.85 42.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.15 -10.64 59.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.723 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -81.44 134.25 35.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 110.749 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 1.2 mp0 -82.88 -24.98 32.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -95.65 4.46 53.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.666 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.865 ' O ' HG11 ' A' ' 75' ' ' VAL . 6.0 t80 -59.3 140.68 55.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 111.403 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.966 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.1 mt-30 -132.79 172.92 11.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.314 1.054 . . . . 0.0 112.846 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . . . -155.38 143.83 20.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.23 -1.804 . . . . 0.0 110.728 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -88.2 98.05 11.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.52 62.01 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.036 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 46' ' ' TYR . . . -125.66 166.08 17.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.88 0.372 . . . . 0.0 111.182 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 60' ' ' VAL . 16.2 t -96.17 138.17 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.986 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.966 HG21 ' HA ' ' A' ' 69' ' ' GLN . 38.6 t -104.4 104.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.322 0.582 . . . . 0.0 112.541 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.831 HG21 ' CG2' ' A' ' 82' ' ' VAL . 26.5 m -117.41 166.29 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.398 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.407 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 6.8 m170 -116.35 -19.05 10.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.584 0.23 . . . . 0.0 111.062 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -157.99 -176.3 5.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.611 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.875 HG13 ' CD2' ' A' ' 106' ' ' PHE . 18.4 t -68.41 -8.36 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.952 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.69 -35.93 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.219 0.533 . . . . 0.0 109.794 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -73.37 -32.57 64.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.701 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.831 ' CG2' HG21 ' A' ' 76' ' ' VAL . 97.6 t -70.7 -50.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -57.03 -25.54 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.202 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -67.65 -42.39 82.32 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.045 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' ' NE2' ' A' ' 89' ' ' HIS . 92.5 t80 -65.49 -56.65 11.24 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.78 -21.71 11.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.96 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 2.3 mmmt -69.13 -39.97 78.56 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.53 -5.6 58.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.387 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.452 ' NE2' ' CE1' ' A' ' 85' ' ' TYR . 98.1 m-70 -126.28 65.89 59.41 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.547 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.58 -0.42 5.94 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.104 2.536 . . . . 0.0 112.923 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.19 -30.91 16.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.69 158.34 16.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -98.86 164.49 12.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.683 HD11 ' CG1' ' A' ' 82' ' ' VAL . 8.8 tp -114.01 114.64 26.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.97 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 33' ' ' GLN . 59.9 t -130.24 116.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.211 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.439 HD12 ' HB ' ' A' ' 40' ' ' VAL . 6.9 mm -77.98 134.9 27.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.087 0.47 . . . . 0.0 111.412 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.498 ' HB2' ' OG1' ' A' ' 34' ' ' THR . . . -106.84 -46.92 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.986 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 41' ' ' VAL . . . 172.87 -170.83 43.95 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.894 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -90.3 -160.81 36.89 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 122.002 -0.705 . . . . 0.0 112.647 -0.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.47 11.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -52.52 -28.68 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.691 HD12 HD13 ' A' ' 62' ' ' LEU . 48.5 mm -85.16 -27.36 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.148 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.3 m-85 -60.28 -52.97 63.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.551 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.536 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 12.6 t -67.66 -9.76 46.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.677 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -75.09 -41.71 58.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.955 0.407 . . . . 0.0 110.799 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.875 ' CD2' HG13 ' A' ' 79' ' ' VAL . 3.3 m-85 -101.55 -3.62 28.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.7 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 20.9 pttp -48.07 -32.21 6.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.751 0.31 . . . . 0.0 111.669 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -87.35 -19.19 28.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.552 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.8 -22.79 15.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.486 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.914 HG11 HD23 ' A' ' 113' ' ' LEU . 98.2 t -44.76 126.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.968 0.413 . . . . 0.0 111.61 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -101.82 -7.96 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 35.2 m -160.1 141.95 12.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.308 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.914 HD23 HG11 ' A' ' 110' ' ' VAL . 15.5 mt -120.38 145.81 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 111.649 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.626 HD22 HE22 ' A' ' 33' ' ' GLN . 4.0 mt -134.98 114.89 12.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.603 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.2 m -135.41 145.24 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.991 0.424 . . . . 0.0 111.956 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -109.94 99.12 8.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.692 179.209 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 99.82 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.796 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 1.6 mp -86.04 127.47 34.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.404 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -52.8 -47.52 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.665 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -82.24 160.44 40.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 9' ' ' ARG . 13.7 t -91.39 166.28 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 0.0 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.584 ' CZ ' HD22 ' A' ' 118' ' ' LEU . 11.3 m-85 -138.55 167.55 21.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.684 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.31 167.66 13.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . 161.83 166.26 20.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.7 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.29 -28.17 7.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.666 0.269 . . . . 0.0 111.066 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.0 m -109.27 148.8 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.28 174.96 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.77 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.546 ' HE2' HG13 ' A' ' 129' ' ' ILE . 14.5 tpt -73.58 158.53 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.646 ' HB ' ' HD2' ' A' ' 130' ' ' PRO . 1.1 pt -84.39 165.53 37.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.066 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' A' ' 129' ' ' ILE . 60.4 Cg_endo -74.97 96.11 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.323 2.015 . . . . 0.0 112.307 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.73 149.47 24.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.85 72.59 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.008 0.432 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.49 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.1 m95 -58.49 -21.04 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -32.31 65.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.93 0.395 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.5 t0 -80.43 -15.67 56.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 113' ' ' LEU . 68.9 m-85 -107.43 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.095 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.44 ' OG1' ' CE ' ' A' ' 161' ' ' LYS . 1.1 m -127.9 142.26 51.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.634 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.533 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.8 OUTLIER -83.62 109.88 17.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.1 m -93.65 -22.44 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.448 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.0 m -159.45 140.62 12.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.181 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 20.6 p -165.4 116.08 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.521 ' C ' HG23 ' A' ' 154' ' ' THR . 2.6 ttm-85 -147.3 122.78 10.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.832 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.8 m -78.41 145.01 35.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.22 0.533 . . . . 0.0 111.307 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.528 HG21 ' HE2' ' A' ' 155' ' ' TYR . 8.1 t -120.35 103.41 13.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.138 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -86.42 103.76 15.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.717 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.71 -172.66 4.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.107 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.6 p -54.72 -58.86 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 110.465 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.509 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -69.84 118.76 66.25 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.896 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.88 -22.35 62.12 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.112 1.875 . . . . 0.0 112.361 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -95.27 -16.03 22.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.367 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 13.7 mt -88.4 9.05 24.8 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.785 0.326 . . . . 0.0 111.164 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.473 HG22 ' N ' ' A' ' 153' ' ' HIS . 61.2 m -68.94 167.91 14.78 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.936 0.398 . . . . 0.0 109.993 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.473 ' N ' HG22 ' A' ' 152' ' ' THR . 0.2 OUTLIER -167.99 153.9 7.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.832 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.4 m -122.69 128.96 51.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.826 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.528 ' HE2' HG21 ' A' ' 144' ' ' VAL . 67.2 m-85 -90.69 104.77 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.408 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.511 ' HB2' HG22 ' A' ' 115' ' ' VAL . 33.8 mt-10 -107.41 125.54 51.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.8 ' O ' HG22 ' A' ' 139' ' ' VAL . 30.6 t -116.66 114.02 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.093 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.533 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 22.7 m95 -108.77 148.91 29.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -129.14 121.0 26.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.33 130.07 6.44 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.44 ' CE ' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -127.2 -163.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.195 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.044 179.787 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 24.3 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.559 0.219 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.713 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.16 145.66 39.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 110' ' ' VAL . 1.7 m-30 -109.83 114.05 27.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.507 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.824 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.15 120.75 42.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.475 -179.243 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.704 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.5 p90 -166.48 166.42 16.36 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.379 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.78 136.0 54.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.242 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -124.85 154.06 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.04 -179.48 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.07 -45.04 15.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 110.471 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -23.19 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.526 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.01 27.07 9.1 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.219 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -82.14 150.91 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 110.778 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -124.36 178.44 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.607 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.48 150.85 52.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.77 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 125' ' ' ASP . 1.1 mmtm -58.93 -60.67 3.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.33 8.21 3.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.359 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.13 30.17 4.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.647 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.0 134.46 43.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.328 . . . . 0.0 110.893 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -97.97 125.92 42.32 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.779 179.967 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.29 -30.08 5.72 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.524 2.149 . . . . 0.0 112.67 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.526 ' CZ2' HD11 ' A' ' 151' ' ' LEU . 3.7 m95 -98.67 166.4 11.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.178 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.74 27.8 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.52 HD12 ' CZ3' ' A' ' 21' ' ' TRP . 0.4 OUTLIER -76.68 127.29 84.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.721 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -44.8 -36.49 10.79 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.511 2.141 . . . . 0.0 112.778 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.95 -29.14 66.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.49 -60.05 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.222 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -17.65 58.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.325 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.692 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 74.0 t60 -67.02 -25.75 66.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.638 0.256 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -105.29 -23.14 12.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.681 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CG ' HD11 ' A' ' 19' ' ' LEU . 1.1 t80 -85.24 -39.58 17.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.579 0.228 . . . . 0.0 111.551 -179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 35' ' ' VAL . 17.8 mtt180 -91.38 -52.13 4.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.456 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 28' ' ' HIS . . . -51.15 -40.22 58.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.83 0.348 . . . . 0.0 111.594 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.62 HE22 HD13 ' A' ' 114' ' ' LEU . 2.5 mm100 -73.41 -6.65 47.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.653 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.702 HG23 HD21 ' A' ' 4' ' ' LEU . 0.7 OUTLIER -119.57 -19.93 7.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.701 0.286 . . . . 0.0 111.579 -179.802 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 31' ' ' ARG . 35.6 m -107.87 138.74 32.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.513 ' H ' ' HG3' ' A' ' 57' ' ' ARG . . . 121.11 -12.22 9.82 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-O 119.159 -0.801 . . . . 0.0 114.923 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -152.43 -164.97 2.08 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.396 1.598 . . . . 0.0 109.552 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.555 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 61.3 mt -72.51 89.77 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.849 0.357 . . . . 0.0 111.285 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.401 ' SD ' ' HB ' ' A' ' 34' ' ' THR . 1.9 ttp -97.78 117.27 31.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.339 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.569 HG21 HG11 ' A' ' 82' ' ' VAL . 24.5 t -76.93 157.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.234 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 32.8 m -163.89 150.05 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.79 156.26 51.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.9 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.63 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.32 -50.18 67.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.962 0.381 . . . . 0.0 110.402 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.439 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 2.9 tpm_? -62.06 -29.64 70.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.323 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -74.1 -48.63 28.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.626 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -57.93 -28.32 64.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.708 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.91 -65.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.427 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.5 m -58.93 -26.59 64.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.395 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CD2' ' HD2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -35.74 137.83 0.44 Allowed Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 49' ' ' PHE . 58.5 Cg_exo -53.21 -32.34 59.72 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.928 2.419 . . . . 0.0 113.357 -179.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.18 137.99 18.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.383 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 5.8 ptm180 -141.43 114.84 6.83 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -89.25 168.2 34.51 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.657 -1.393 . . . . 0.0 111.919 -0.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 73.7 mt -78.07 149.92 77.13 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HG2' ' NH1' ' A' ' 57' ' ' ARG . 27.4 Cg_endo -63.6 -78.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.786 2.324 . . . . 0.0 113.098 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 37.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.294 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -148.33 133.19 18.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.128 0.49 . . . . 0.0 111.967 -179.246 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 22.1 m -92.11 119.63 31.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.153 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.09 157.43 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.608 . . . . 0.0 112.439 -178.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG12 HG22 ' A' ' 76' ' ' VAL . 3.5 t -137.37 138.34 45.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.333 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.63 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.9 t -114.57 120.32 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.795 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -102.16 118.97 38.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.072 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.963 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -150.93 171.21 17.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.101 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -95.59 -12.47 25.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 4.1 tt0 -62.94 133.03 54.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.885 0.374 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.28 1.69 20.86 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.45 16.63 2.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.66 0.267 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.963 ' CG ' HG21 ' A' ' 63' ' ' THR . 3.0 t80 -58.5 139.32 55.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.193 0.52 . . . . 0.0 111.955 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.919 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -130.36 173.56 10.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.23 1.014 . . . . 0.0 112.367 178.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.11 144.18 20.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -81.52 99.32 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.03 -46.79 2.45 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.2 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 172.84 6.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 0.0 111.657 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.4 t -97.98 139.73 19.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.919 HG21 ' HA ' ' A' ' 69' ' ' GLN . 21.8 t -105.96 115.29 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.116 0.484 . . . . 0.0 111.865 -179.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.826 HG21 HG22 ' A' ' 82' ' ' VAL . 25.5 m -125.33 170.16 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.973 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.461 ' HA ' ' O ' ' A' ' 63' ' ' THR . 20.9 m170 -120.9 -21.91 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.344 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 t70 -153.54 -175.31 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.102 0.477 . . . . 0.0 111.54 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.8 HG21 ' O ' ' A' ' 105' ' ' ALA . 33.7 t -69.61 -9.48 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.621 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.61 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 109.926 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.706 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -75.88 -29.96 58.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.025 179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 76' ' ' VAL . 60.8 t -72.06 -52.45 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.501 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 6.2 m-85 -55.95 -26.79 49.6 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.986 178.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.92 -45.44 89.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.019 178.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 82.1 t80 -64.08 -54.49 33.22 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.579 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.77 -23.14 16.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.315 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 4.1 mmtp -67.28 -46.59 73.17 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -79.21 -2.83 42.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.448 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.444 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 54.7 m-70 -125.48 62.64 41.3 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.385 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.28 -0.53 5.85 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.064 2.51 . . . . 0.0 112.904 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -31.22 17.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.965 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . 19.6 mt-30 -105.8 156.57 18.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -99.87 164.55 11.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.018 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.626 HD21 HG12 ' A' ' 82' ' ' VAL . 9.0 tp -104.72 111.81 24.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 t -121.87 103.43 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.438 ' CD1' HG21 ' A' ' 40' ' ' VAL . 13.1 mm -73.71 132.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.027 0.441 . . . . 0.0 111.447 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 34' ' ' THR . . . -104.01 -45.18 4.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.685 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.1 -166.81 39.71 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.695 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.39 -160.99 26.34 Favored Glycine 0 C--N 1.34 0.801 0 O-C-N 122.196 -0.59 . . . . 0.0 112.552 -0.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.05 66.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.73 0.3 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -53.91 -27.45 30.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.583 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 mm -80.79 -29.0 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 129' ' ' ILE . 5.8 m-85 -59.64 -56.24 24.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.458 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.825 ' HA ' HD13 ' A' ' 129' ' ' ILE . 11.2 t -66.32 -10.16 40.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.8 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -76.35 -40.28 51.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.927 0.394 . . . . 0.0 110.653 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.787 ' CD1' HG22 ' A' ' 79' ' ' VAL . 1.7 m-85 -99.59 -5.48 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.35 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 6.9 pttp -49.5 -31.67 10.6 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.756 0.313 . . . . 0.0 111.586 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.25 0.48 53.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.288 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.05 -26.31 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.548 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 106' ' ' PHE . 92.7 t -43.95 127.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.845 0.355 . . . . 0.0 111.55 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 11.3 t70 -105.27 3.72 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.322 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 m -167.6 137.84 2.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.599 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.515 HD13 ' CZ3' ' A' ' 133' ' ' TRP . 9.2 mt -118.78 145.24 45.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.3 0.571 . . . . 0.0 111.819 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.62 HD13 HE22 ' A' ' 33' ' ' GLN . 5.8 mt -135.26 113.05 10.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.483 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.704 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.6 m -132.58 143.09 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 111.837 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.6 107.05 14.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.433 179.436 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.7 OUTLIER -79.62 100.18 7.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.771 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.19 126.57 30.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.19 -53.14 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.004 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.46 170.68 9.31 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.353 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.2 p -106.78 147.04 30.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.7 m-85 -141.63 139.76 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.809 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -110.72 149.04 31.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.009 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.14 -143.4 3.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.554 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 5.7 t70 -142.33 21.94 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.6 m -159.99 134.08 7.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -107.37 158.43 17.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.963 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.8 177.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.491 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.4 pp -103.36 154.58 37.66 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.384 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.0 102.39 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.74 2.293 . . . . 0.0 112.687 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.9 147.85 22.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.008 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.74 76.25 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.451 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.515 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 86.9 m95 -57.79 -20.97 39.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.304 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.81 -29.32 63.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.844 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -78.58 -26.93 45.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.1 m-85 -99.16 176.55 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.77 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 m -137.3 141.93 41.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.246 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -80.67 119.02 22.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 -179.652 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 157' ' ' VAL . 33.1 m -103.52 -11.91 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.7 m -171.51 140.35 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.74 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.0 p -167.93 110.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.18 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -148.11 120.64 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.814 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.0 m -69.01 145.38 53.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.236 0.541 . . . . 0.0 111.594 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.63 105.21 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.261 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 152' ' ' THR . 18.4 mt-10 -87.61 101.97 14.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.814 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.04 -171.41 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.493 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.7 p -60.19 -57.19 13.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.0 110.685 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.525 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -71.86 124.5 90.98 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.002 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.2 -28.46 86.96 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.961 1.774 . . . . 0.0 112.362 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.9 -21.1 25.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.395 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.526 HD11 ' CZ2' ' A' ' 21' ' ' TRP . 17.5 mt -85.32 7.23 23.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.504 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 153' ' ' HIS . 51.5 m -70.86 166.0 22.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.2 p80 -172.95 159.72 4.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.73 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.814 ' OG1' HG23 ' A' ' 143' ' ' THR . 28.8 m -119.93 147.05 45.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.347 179.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -110.29 104.68 13.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.653 0.264 . . . . 0.0 110.827 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.608 ' HB2' HG22 ' A' ' 115' ' ' VAL . 30.9 mt-10 -106.83 124.29 49.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 111.755 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 139' ' ' VAL . 21.8 t -116.74 114.12 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.159 179.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 19.5 m95 -110.03 150.7 28.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.51 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.74 115.2 19.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -56.84 131.52 49.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.673 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.57 156.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 178.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.176 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 18.0 m . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.805 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.08 154.9 25.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.475 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE . 1.5 m-30 -119.08 113.46 20.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.552 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.866 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.94 117.37 33.19 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CH2' HG12 ' A' ' 115' ' ' VAL . 5.3 p90 -162.25 165.41 26.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.827 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB2' ' OG1' ' A' ' 116' ' ' THR . . . -123.49 135.8 54.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.361 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 8.9 pt20 -129.99 156.25 44.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.711 ' OD2' HD12 ' A' ' 12' ' ' LEU . 2.6 p30 -103.66 -171.39 1.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.506 ' HG3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.3 -27.66 37.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.082 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -32.89 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.032 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . 101.72 46.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.528 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD12 ' OD2' ' A' ' 8' ' ' ASP . 8.9 mt -95.91 163.99 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pp -141.04 -44.55 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.62 148.82 18.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.679 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.7 144.72 44.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -78.07 156.12 30.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.58 140.71 2.64 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.492 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -94.88 100.82 12.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mp -81.47 123.36 81.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.837 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.6 7.32 5.08 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.57 2.18 . . . . 0.0 112.867 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.4 102.8 12.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.756 0.313 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.02 138.9 39.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.17 158.29 33.39 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.38 -14.72 43.92 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.665 2.243 . . . . 0.0 112.647 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -72.75 -36.99 67.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.214 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.18 -29.03 14.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 tp -72.48 -29.34 63.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.435 -179.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -79.91 -43.16 22.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.33 . . . . 0.0 111.34 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.527 ' HE2' ' HG1' ' A' ' 116' ' ' THR . 31.1 t80 -64.92 -29.85 70.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.609 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.13 -27.76 26.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.653 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.854 ' O ' HG13 ' A' ' 35' ' ' VAL . 11.8 mtp180 -91.98 -59.28 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -47.17 -33.27 5.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 111.941 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.483 ' HB3' ' HG ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -79.52 -5.25 54.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.26 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.0 p -145.15 25.79 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 31' ' ' ARG . 26.2 m -108.46 144.99 16.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 56' ' ' GLU . . . 56.35 30.37 58.28 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 177.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 58' ' ' THR . 12.0 mmtt -146.99 -168.63 3.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.389 2.095 . . . . 0.0 107.786 178.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 92' ' ' GLN . 62.0 mt -86.48 88.21 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.955 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.432 ' HE3' HG13 ' A' ' 41' ' ' VAL . 1.1 ttp -97.59 118.2 33.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.691 -179.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.882 HG21 HG11 ' A' ' 82' ' ' VAL . 3.3 t -89.93 125.11 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.669 HG11 ' CE2' ' A' ' 49' ' ' PHE . 25.5 m -133.89 145.29 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.309 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.63 156.0 49.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.041 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.758 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.94 -52.89 56.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.479 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -59.56 -35.7 74.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.105 0.479 . . . . 0.0 110.291 179.154 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.44 HG22 ' CE2' ' A' ' 49' ' ' PHE . 7.3 m -64.72 -50.43 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.162 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -49.15 -34.34 14.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -63.06 -66.62 0.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.677 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -49.22 -46.26 45.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.669 ' CE2' HG11 ' A' ' 41' ' ' VAL . 1.9 m-85 -26.13 138.02 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 O-C-N 123.474 0.484 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -35.64 -71.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.947 2.431 . . . . 0.0 112.806 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.37 134.53 46.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.793 0.33 . . . . 0.0 110.619 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -112.77 125.2 30.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.49 -170.29 7.75 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.627 -1.406 . . . . 0.0 112.026 -0.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.783 HD13 ' HD2' ' A' ' 57' ' ' ARG . 35.9 mt -89.98 151.21 44.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.592 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.04 110.68 3.08 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.596 2.197 . . . . 0.0 113.08 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.625 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.1 mt-10 68.21 8.25 6.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 179.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.783 ' HD2' HD13 ' A' ' 54' ' ' LEU . 6.0 mtt180 -109.45 113.88 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.795 0.331 . . . . 0.0 111.545 -178.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 37' ' ' LYS . 63.5 m -64.11 109.32 1.79 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.676 HD21 HD12 ' A' ' 54' ' ' LEU . 1.9 m-80 -101.85 152.57 20.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.609 HG12 HG22 ' A' ' 76' ' ' VAL . 14.1 t -133.79 130.62 56.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.305 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.758 HG13 ' HA ' ' A' ' 43' ' ' ARG . 96.2 t -102.6 130.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.979 0.418 . . . . 0.0 111.559 -178.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.833 HD22 HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -107.63 119.95 40.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.907 179.992 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.832 HG21 ' CG ' ' A' ' 68' ' ' TYR . 1.1 t -150.55 158.38 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.897 0.379 . . . . 0.0 111.36 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -75.41 -11.78 60.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.4 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.0 tt0 -88.03 132.74 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.786 0.327 . . . . 0.0 110.774 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 4.3 mp0 -82.8 -21.78 34.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.519 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -91.31 -0.59 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.582 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 63' ' ' THR . 7.2 t80 -59.28 140.83 55.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.108 0.48 . . . . 0.0 111.453 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.97 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -134.31 171.98 13.52 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.442 1.115 . . . . 0.0 113.213 179.563 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.41 139.54 16.5 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.877 -1.965 . . . . 0.0 110.049 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.06 102.01 6.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.9 0.381 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.18 -44.97 1.96 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.826 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 166.7 20.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 111.758 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 85' ' ' TYR . 22.6 t -97.15 140.59 17.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.267 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.97 HG21 ' HA ' ' A' ' 69' ' ' GLN . 22.8 t -106.76 118.44 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 112.185 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.863 HG21 HG22 ' A' ' 82' ' ' VAL . 30.8 m -127.54 168.14 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.69 178.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' NE2' ' HA ' ' A' ' 66' ' ' GLU . 1.6 m80 -119.86 -23.08 6.55 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.563 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -157.79 -177.33 6.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.46 . . . . 0.0 111.467 -179.464 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.94 HG13 ' CD2' ' A' ' 106' ' ' PHE . 11.7 t -65.45 -11.4 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.615 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.83 -37.24 16.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.236 0.541 . . . . 0.0 109.751 178.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 84' ' ' ALA . . . -71.17 -34.41 70.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.694 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.882 HG11 HG21 ' A' ' 40' ' ' VAL . 29.2 t -68.38 -54.27 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.981 0.42 . . . . 0.0 109.988 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.469 ' O ' ' CG ' ' A' ' 87' ' ' LYS . 5.8 m-85 -51.84 -27.83 13.87 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.933 179.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -63.05 -45.33 92.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.713 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 74' ' ' VAL . 76.1 t80 -62.76 -53.83 48.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.141 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.81 -22.88 5.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.028 179.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 8.3 mttt -70.23 -41.54 73.43 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.072 0.463 . . . . 0.0 109.754 178.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.41 -4.54 56.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.625 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.471 ' CD2' ' CZ ' ' A' ' 85' ' ' TYR . 90.1 m-70 -129.63 62.76 65.13 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 110.515 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.63 -0.35 5.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.174 2.582 . . . . 0.0 112.845 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.75 -30.16 17.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.773 0.32 . . . . 0.0 110.834 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.424 ' HB2' HD11 ' A' ' 38' ' ' ILE . 1.2 mm100 -103.08 162.09 13.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.094 0.473 . . . . 0.0 111.624 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 7.5 mt-10 -97.69 174.44 6.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.591 HD11 ' CG2' ' A' ' 40' ' ' VAL . 1.1 tp -119.66 113.87 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 111.409 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' MET . 40.1 t -127.59 111.87 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.289 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.506 HD12 ' HB ' ' A' ' 40' ' ' VAL . 8.7 mm -82.62 141.51 14.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -111.67 -39.88 4.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.402 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.84 -165.48 38.29 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.556 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -80.04 -161.23 23.25 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 117.358 0.579 . . . . 0.0 112.48 -0.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.73 -50.88 69.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -57.03 -25.25 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.709 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.833 HD12 HD22 ' A' ' 62' ' ' LEU . 42.2 mm -79.29 -36.89 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.771 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.475 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 5.3 m-85 -50.81 -56.76 10.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.446 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.763 ' CA ' HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -67.22 -9.65 42.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.713 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -79.93 -42.25 24.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 110.977 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.94 ' CD2' HG13 ' A' ' 79' ' ' VAL . 5.4 m-85 -93.54 -11.53 31.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.244 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.6 OUTLIER -50.34 -28.71 8.43 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.235 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.12 -8.38 59.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.601 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -124.53 -23.58 4.39 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 106' ' ' PHE . 90.7 t -44.11 128.99 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.431 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 18.0 t70 -102.51 -12.73 17.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.341 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.805 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 77.9 m -151.61 140.07 20.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.016 -179.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.664 HD23 HG11 ' A' ' 110' ' ' VAL . 13.7 mt -119.18 146.05 45.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.279 0.562 . . . . 0.0 111.56 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 113' ' ' LEU . 19.6 mt -135.13 112.66 10.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.549 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.668 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.1 m -134.52 144.99 33.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.989 0.423 . . . . 0.0 111.76 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.527 ' HG1' ' HE2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -109.9 114.42 27.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.361 179.044 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -86.31 99.62 11.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.2 121.67 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.201 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 152' ' ' THR . . . -60.67 -61.72 2.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.224 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -56.65 -172.19 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.691 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.6 p -121.98 157.93 30.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.99 166.39 30.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.78 169.82 3.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 12' ' ' LEU . . . -163.89 135.95 4.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.953 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -38.46 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 110.483 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 m -117.57 137.31 52.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.3 163.34 12.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.014 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -173.16 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.763 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.6 pp -108.39 163.89 15.96 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.29 99.57 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.953 2.435 . . . . 0.0 112.736 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.4 146.02 25.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.074 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.48 80.77 2.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.44 ' HH2' HG11 ' A' ' 115' ' ' VAL . 91.4 m95 -60.82 -20.08 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.123 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.53 -30.34 65.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.913 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.46 -27.39 41.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 160' ' ' LYS . 77.2 m-85 -97.83 176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.823 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 m -136.13 141.98 44.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.637 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 8.6 ttpt -83.56 116.79 22.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 157' ' ' VAL . 21.1 m -102.34 -18.95 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.554 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 157' ' ' VAL . 48.7 m -163.6 141.06 7.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.699 0.285 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.637 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 86.1 p -169.48 106.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.069 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 ttp-105 -140.77 118.96 12.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.827 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.812 HG23 ' OG1' ' A' ' 154' ' ' THR . 1.4 m -68.71 145.18 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.166 0.508 . . . . 0.0 111.527 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HB ' ' CE1' ' A' ' 153' ' ' HIS . 9.0 t -119.61 103.94 14.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.185 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.44 ' HA ' HG23 ' A' ' 152' ' ' THR . 7.3 mt-10 -86.83 103.68 15.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.503 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.2 -174.13 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.448 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.3 p -55.37 -56.62 18.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.722 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.7 t30 -72.73 121.75 85.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.052 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.57 -25.54 79.18 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.035 1.823 . . . . 0.0 112.292 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.14 -19.62 22.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 16.2 mt -86.35 8.16 22.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.66 0.267 . . . . 0.0 111.367 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 153' ' ' HIS . 66.0 m -68.79 165.63 19.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.452 ' N ' HG22 ' A' ' 152' ' ' THR . 2.0 p80 -168.99 155.1 6.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.812 ' OG1' HG23 ' A' ' 143' ' ' THR . 21.8 m -118.26 132.21 56.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.494 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -94.94 104.42 16.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.843 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -100.8 151.37 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.23 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.84 ' O ' HG22 ' A' ' 139' ' ' VAL . 12.3 t -141.99 107.68 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.825 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 113' ' ' LEU . 26.8 m95 -108.81 146.07 34.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -126.43 114.41 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.676 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.478 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -52.64 131.09 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.883 -179.436 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -97.45 176.31 5.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.741 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.132 179.985 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.537 HG23 ' HB3' ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -113.18 145.5 40.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.838 ' CE2' HG21 ' A' ' 110' ' ' VAL . 2.0 m-30 -109.3 112.3 24.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.425 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.992 HD12 HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -112.8 123.96 51.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.757 -179.504 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.622 ' CH2' HG12 ' A' ' 115' ' ' VAL . 7.8 p90 -165.52 164.95 19.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.319 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' ILE . . . -120.77 138.2 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.669 0.271 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.2 pt20 -122.41 149.81 43.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 0.0 111.253 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -103.39 -162.96 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -42.04 72.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.53 -27.86 31.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.96 26.28 5.84 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.578 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -79.61 147.59 32.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 110.621 -179.929 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.768 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -112.48 -31.05 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.771 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.92 142.83 3.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.862 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' HA2' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -77.26 -170.09 1.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.757 0.313 . . . . 0.0 110.63 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.07 36.66 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.744 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.7 -135.63 3.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.539 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -64.63 -176.35 0.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.753 0.311 . . . . 0.0 110.908 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.588 HD21 ' HG3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -89.5 106.4 13.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.939 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.493 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 38.6 Cg_endo -68.25 -52.92 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.447 2.098 . . . . 0.0 112.661 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 20' ' ' PRO . 13.6 p-90 -107.28 132.98 52.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.924 0.393 . . . . 0.0 111.147 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.543 ' NE2' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -159.8 106.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.603 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.1 mt -129.12 162.47 52.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.207 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.99 -41.68 16.49 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.712 2.275 . . . . 0.0 111.899 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -73.26 -20.83 60.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.995 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -77.08 -40.83 44.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.134 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.543 HD21 ' NE2' ' A' ' 22' ' ' HIS . 86.0 mt -71.74 -30.52 65.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.989 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 31' ' ' ARG . 0.2 OUTLIER -66.3 -14.77 62.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.354 -179.876 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -50.14 -62.29 1.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.865 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.47 ' O ' HG22 ' A' ' 34' ' ' THR . 0.5 OUTLIER -92.11 -0.87 57.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.187 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.61 ' HB2' ' HA ' ' A' ' 28' ' ' HIS . 2.8 tpt180 -35.35 -60.78 0.47 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.17 -20.68 19.04 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 37' ' ' LYS . 2.7 mt-30 -79.93 -14.7 58.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.617 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 57' ' ' ARG . 15.3 t -84.41 -13.91 50.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.642 ' C ' ' H ' ' A' ' 37' ' ' LYS . 22.8 m -56.18 121.32 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.758 0.313 . . . . 0.0 110.662 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 92' ' ' GLN . . . 58.87 -24.44 0.02 OUTLIER Glycine 0 CA--C 1.532 1.123 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.418 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 35' ' ' VAL . 11.1 mttp -63.14 108.06 1.17 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.941 0.877 . . . . 0.0 110.171 -176.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.575 HG12 HG21 ' A' ' 58' ' ' THR . 6.8 mt -62.76 110.23 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.583 -177.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.685 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 9.0 ttp -99.17 114.27 26.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.495 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.75 HG21 HG11 ' A' ' 82' ' ' VAL . 11.3 t -87.53 125.55 41.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.57 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 32.3 m -132.2 149.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.158 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.14 158.02 53.61 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.086 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -55.83 -45.39 78.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 110.937 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -63.55 -32.4 73.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.974 0.416 . . . . 0.0 110.477 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 m -72.2 -42.47 65.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.459 ' HA ' ' CD2' ' A' ' 49' ' ' PHE . 11.2 t80 -65.86 -24.41 66.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -65.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -66.8 -19.92 65.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.65 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.57 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -34.4 134.44 0.39 Allowed Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.658 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.588 ' HG3' HD21 ' A' ' 19' ' ' LEU . 71.3 Cg_exo -51.14 -41.29 58.21 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.936 2.424 . . . . 0.0 113.252 -179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -151.15 131.29 13.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.341 . . . . 0.0 111.029 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -132.22 125.29 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.028 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 83.6 Cg_endo -90.12 -179.32 12.93 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.137 -0.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 65.5 mt -75.88 152.8 84.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.62 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.82 101.7 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.552 2.168 . . . . 0.0 112.959 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 68.46 21.04 8.34 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.149 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.691 ' HD2' HG23 ' A' ' 34' ' ' THR . 3.8 mmt180 -116.63 139.84 50.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.575 HG21 HG12 ' A' ' 38' ' ' ILE . 55.7 m -86.8 115.47 24.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.0 0.429 . . . . 0.0 111.435 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -101.11 156.83 17.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.625 ' HB ' ' HA ' ' A' ' 40' ' ' VAL . 12.7 t -137.13 131.74 46.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.242 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.545 HG21 ' HB2' ' A' ' 70' ' ' ALA . 90.5 t -105.99 121.93 58.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.085 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 ' CG2' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -107.29 107.18 17.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.112 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.731 HG21 ' CD2' ' A' ' 68' ' ' TYR . 6.3 t -143.7 164.81 29.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.162 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -79.74 -8.45 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.312 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 7.5 tp60 -79.81 124.69 28.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.354 . . . . 0.0 110.489 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 3.3 mt-10 -77.27 -30.38 54.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -98.93 14.5 28.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.359 . . . . 0.0 111.181 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.783 ' O ' HG11 ' A' ' 75' ' ' VAL . 5.7 t80 -63.18 147.23 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.142 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.663 ' HA ' HG21 ' A' ' 75' ' ' VAL . 1.8 mm100 -124.89 174.76 7.74 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.475 1.131 . . . . 0.0 112.868 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.54 143.07 18.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.89 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -66.35 94.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.29 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.59 -20.17 2.31 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.775 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.693 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -76.76 170.85 15.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.12 0.485 . . . . 0.0 112.071 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -92.95 140.45 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.456 179.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 68' ' ' TYR . 24.5 t -103.47 106.98 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.457 . . . . 0.0 111.771 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.799 HG21 HG22 ' A' ' 82' ' ' VAL . 30.7 m -119.67 176.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.051 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CE1' ' HA ' ' A' ' 66' ' ' GLU . 10.6 m170 -128.94 -21.12 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.82 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -155.69 -174.81 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.199 -179.719 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.825 HG21 ' O ' ' A' ' 105' ' ' ALA . 25.2 t -70.02 -11.06 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.67 -38.59 16.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.091 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -68.19 -34.45 76.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.672 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.799 HG22 HG21 ' A' ' 76' ' ' VAL . 20.8 t -69.29 -53.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.599 179.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -53.37 -31.03 42.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.062 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.55 -47.03 87.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 89' ' ' HIS . 69.0 t80 -60.69 -52.75 63.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.81 -26.26 57.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.609 178.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -66.44 -39.55 88.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.002 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -84.84 -1.13 56.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.148 178.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 42.5 m-70 -124.83 60.34 26.28 Favored Pre-proline 0 N--CA 1.456 -0.142 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.098 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.14 -3.25 5.8 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.866 2.377 . . . . 0.0 112.508 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -100.66 -25.6 14.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.026 179.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 4.9 mt-30 -98.83 160.13 14.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.328 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -105.9 174.89 5.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.537 ' HB3' HG23 ' A' ' 1' ' ' THR . 10.0 tp -122.33 110.45 15.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.077 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.96 HG12 HD21 ' A' ' 4' ' ' LEU . 17.2 t -124.28 109.69 23.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.122 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 40' ' ' VAL . 3.7 mm -82.6 131.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.072 0.463 . . . . 0.0 111.398 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.473 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -99.26 -47.31 5.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.718 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.76 -168.1 41.19 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.392 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -90.27 -160.78 36.85 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 117.8 0.8 . . . . 0.0 112.814 0.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -45.64 -57.99 3.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.8 0.333 . . . . 0.0 111.69 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.98 -31.98 43.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 37.7 mm -80.97 -26.43 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.292 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.8 m-85 -61.69 -51.93 66.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.631 -179.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.771 ' HA ' HD13 ' A' ' 129' ' ' ILE . 13.9 t -68.81 -10.01 54.32 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.825 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -73.17 -47.07 46.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.803 ' CD2' HG13 ' A' ' 79' ' ' VAL . 8.0 m-85 -95.11 -2.61 49.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.726 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.575 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 37.4 pttt -54.38 -32.2 56.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -79.63 -8.46 59.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.793 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.05 -18.07 7.6 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.838 HG21 ' CE2' ' A' ' 3' ' ' PHE . 48.7 t -48.0 134.69 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 4.7 t70 -113.32 6.02 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.199 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 3.7 m -170.58 142.79 2.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.429 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 114' ' ' LEU . 8.3 mt -122.55 144.69 48.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.084 0.468 . . . . 0.0 111.578 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.992 HD12 HD12 ' A' ' 4' ' ' LEU . 22.1 mt -135.22 118.35 16.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.155 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 156' ' ' GLU . 1.2 m -131.54 140.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.819 0.342 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -116.22 121.99 43.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.26 101.4 10.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.661 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.578 ' HG ' ' HB3' ' A' ' 153' ' ' HIS . 1.8 mp -83.82 134.98 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.59 -51.99 61.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.63 170.95 9.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.543 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.0 p -105.76 170.72 7.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 2.1 m-85 -148.0 168.75 21.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.015 0.436 . . . . 0.0 111.279 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -114.1 146.89 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.315 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.449 ' O ' HD11 ' A' ' 12' ' ' LEU . . . 168.85 176.9 39.34 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.674 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.67 62.3 1.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.649 HG22 HD11 ' A' ' 13' ' ' ILE . 4.5 m -164.14 124.46 2.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.19 164.98 13.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.4 ' SD ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -76.75 -177.69 4.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.771 HD13 ' HA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -103.53 165.1 14.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.301 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.9 102.66 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.665 2.244 . . . . 0.0 112.071 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.4 HD12 ' SD ' ' A' ' 128' ' ' MET . 1.8 mt -90.26 148.24 23.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.73 78.96 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -61.23 -19.53 61.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.71 -32.92 66.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.652 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 4.5 t70 -81.72 -18.49 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 113' ' ' LEU . 62.7 m-85 -106.32 167.14 10.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.483 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.515 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.2 m -131.05 141.19 50.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.571 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 2.9 ttpm? -82.73 113.9 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.662 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 157' ' ' VAL . 35.3 m -97.41 -25.79 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.563 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -156.06 140.55 16.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.882 0.373 . . . . 0.0 111.184 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.571 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 53.4 p -166.15 105.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.753 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.589 ' C ' HG23 ' A' ' 154' ' ' THR . 7.2 ttt85 -146.07 129.83 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.438 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.755 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.3 m -77.54 146.72 36.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.767 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 152' ' ' THR . 6.1 t -117.32 104.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.363 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.77 104.7 16.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.716 -179.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -87.57 -172.96 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.442 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 60.9 p -55.69 -58.48 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 110.589 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.658 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 10.2 t30 -76.6 136.01 67.99 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.841 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.21 -34.38 68.43 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.986 1.79 . . . . 0.0 112.686 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.74 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.487 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 22.3 mt -77.65 10.31 2.78 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 144' ' ' VAL . 57.4 m -85.44 159.91 19.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.08 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.578 ' HB3' ' HG ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -173.46 160.55 3.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.755 ' OG1' HG23 ' A' ' 143' ' ' THR . 17.2 m -122.3 144.69 48.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.71 179.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.88 105.22 13.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.69 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.9 mt-10 -99.2 121.33 40.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.902 0.382 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.742 ' O ' HG22 ' A' ' 139' ' ' VAL . 18.1 t -116.2 111.62 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.499 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 32.1 m95 -106.13 148.62 27.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.959 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -129.68 123.86 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.225 179.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -51.45 128.82 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.542 -179.343 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.515 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 0.0 OUTLIER -111.16 -173.82 2.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.758 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.125 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 94' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.542 0.21 . . . . 0.0 110.491 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -109.61 149.3 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.348 0.594 . . . . 0.0 112.438 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.486 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.5 m-30 -116.68 113.0 22.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.426 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.873 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -110.58 118.57 36.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 112.014 -179.486 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.792 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.4 p90 -164.09 174.51 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.12 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 118' ' ' LEU . . . -128.42 135.17 49.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 111.673 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 6.6 pt20 -132.82 154.64 50.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 122' ' ' PHE . 15.5 p-10 -107.55 -167.62 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -40.95 68.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -28.97 47.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.05 19.51 11.66 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.754 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 126' ' ' THR . 3.8 mt -70.97 175.73 4.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.61 -60.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.168 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.06 132.27 1.59 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.547 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -91.17 111.06 22.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.736 0.303 . . . . 0.0 110.794 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.58 124.48 15.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.116 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.29 -115.34 0.64 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.468 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -104.22 96.99 7.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 110.792 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.08 98.48 26.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 -167.41 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.49 2.127 . . . . 0.0 112.285 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -98.81 107.84 20.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -79.71 -70.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.173 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HG ' ' HD2' ' A' ' 24' ' ' PRO . 1.2 tp -150.52 150.92 29.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 -179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HG ' ' A' ' 23' ' ' LEU . 27.7 Cg_exo -61.99 -17.08 53.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.542 2.161 . . . . 0.0 112.377 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -55.0 -23.36 18.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -92.3 -30.56 15.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.274 -179.753 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.458 HD23 ' HD3' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -84.94 -15.63 43.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.757 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -59.54 -40.78 88.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' CD1' ' HG3' ' A' ' 33' ' ' GLN . 56.2 t80 -105.42 -9.63 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.618 ' O ' HG22 ' A' ' 34' ' ' THR . 0.3 OUTLIER -92.82 -26.38 17.71 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.895 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -92.1 -61.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.832 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.8 -21.49 56.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.43 ' HG3' ' CD1' ' A' ' 29' ' ' TYR . 8.3 mm100 -90.19 -5.13 56.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 30' ' ' PHE . 13.9 t -132.87 -35.15 1.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 31' ' ' ARG . 16.7 m -79.15 154.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 112.051 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.527 ' C ' ' HG2' ' A' ' 37' ' ' LYS . . . 96.15 -1.17 62.6 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.587 -0.815 . . . . 0.0 114.662 178.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.527 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 3.6 mttm -148.82 -164.22 1.97 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.344 1.572 . . . . 0.0 109.744 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.82 90.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ttp -102.69 121.59 42.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.932 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.734 HG13 ' HB ' ' A' ' 60' ' ' VAL . 9.7 t -89.55 131.7 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.731 HG11 ' HE2' ' A' ' 49' ' ' PHE . 21.6 m -132.28 142.06 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.184 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.94 156.83 43.5 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.095 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.64 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.3 -52.61 58.54 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.858 0.329 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -60.21 -34.25 73.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.075 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -67.65 -45.5 75.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 52' ' ' ARG . 33.1 t80 -59.46 -27.27 65.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.5 -66.39 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.725 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -52.44 -30.37 29.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.081 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.925 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -37.05 122.34 0.83 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.935 -179.511 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 49' ' ' PHE . 64.3 Cg_exo -42.91 -27.24 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.233 2.622 . . . . 0.0 113.729 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.62 148.92 28.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 111.236 -179.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -141.15 107.76 6.23 Favored Pre-proline 0 CA--C 1.533 0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.213 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 97.5 Cg_endo -88.43 178.78 18.39 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.158 -0.15 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 49' ' ' PHE . 10.6 mt -76.64 155.33 83.43 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.36 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.421 ' HD2' HD23 ' A' ' 54' ' ' LEU . 9.7 Cg_endo -52.98 -74.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.703 2.268 . . . . 0.0 112.385 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -113.38 50.64 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.104 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HB2' ' CB ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -142.47 101.49 3.9 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.987 -179.618 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.3 m -62.16 113.52 2.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.508 HD21 HD12 ' A' ' 54' ' ' LEU . 2.0 m-80 -107.74 148.34 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.431 0.634 . . . . 0.0 112.348 -178.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.751 HG12 HG22 ' A' ' 76' ' ' VAL . 21.8 t -122.86 139.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.389 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 43' ' ' ARG . 92.7 t -108.34 124.02 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.845 -178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.711 HD22 ' CD1' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -101.41 117.98 36.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.852 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -151.48 162.15 41.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.727 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -83.0 -8.57 59.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 8.8 tt0 -85.13 131.19 34.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 111.057 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -25.21 42.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.59 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -94.74 5.17 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.753 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.852 ' CG ' HG21 ' A' ' 63' ' ' THR . 5.9 t80 -58.98 148.05 32.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.023 0.439 . . . . 0.0 111.088 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.856 ' HA ' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -136.15 174.85 10.16 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.201 1.001 . . . . 0.0 112.848 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -154.87 145.0 21.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.793 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -74.65 95.91 2.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.754 0.311 . . . . 0.0 110.314 179.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.2 -34.95 3.18 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.305 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.558 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -70.76 169.64 14.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG11 ' CD1' ' A' ' 85' ' ' TYR . 5.1 t -96.69 140.65 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.331 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.856 HG21 ' HA ' ' A' ' 69' ' ' GLN . 20.1 t -107.63 118.54 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.186 0.517 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.896 HG21 HG22 ' A' ' 82' ' ' VAL . 35.6 m -128.44 171.75 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.839 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -122.38 -22.43 5.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.55 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.6 t70 -158.15 -175.65 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.051 0.453 . . . . 0.0 111.08 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.97 HG13 ' CD2' ' A' ' 106' ' ' PHE . 9.4 t -65.66 -11.34 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.72 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.08 -37.49 16.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.15 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.68 -29.36 63.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.613 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.896 HG22 HG21 ' A' ' 76' ' ' VAL . 25.1 t -70.99 -52.63 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.443 ' O ' ' HG2' ' A' ' 87' ' ' LYS . 7.6 m-85 -54.18 -26.56 28.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.586 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' ALA . . . -65.34 -44.07 88.89 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.956 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.531 ' CD1' HG11 ' A' ' 74' ' ' VAL . 88.3 t80 -66.7 -56.6 9.82 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -54.57 -23.65 17.69 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.561 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -69.05 -39.75 78.98 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.723 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -83.73 -5.45 59.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.403 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -129.54 64.92 73.31 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.22 1.08 3.78 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.424 2.749 . . . . 0.0 113.001 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 -33.4 25.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.969 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.5 160.72 15.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.028 0.442 . . . . 0.0 111.621 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -98.43 156.48 16.73 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.788 HD11 HG12 ' A' ' 82' ' ' VAL . 7.7 tp -96.29 115.08 26.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.349 -179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.55 114.55 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' CE1' ' A' ' 3' ' ' PHE . 9.2 mm -81.77 139.43 17.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.068 0.461 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.479 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . . . -108.55 -46.1 3.74 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.51 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 171.87 -170.4 43.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.317 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -91.33 -160.93 36.82 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 117.409 0.605 . . . . 0.0 112.605 0.018 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.38 -45.93 36.39 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -58.74 -34.34 71.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.711 ' CD1' HD22 ' A' ' 62' ' ' LEU . 28.7 mm -82.28 -29.51 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' A' ' 97' ' ' ALA . 2.1 m-85 -57.67 -57.13 14.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.661 -179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.741 ' CA ' HD13 ' A' ' 129' ' ' ILE . 6.2 t -67.47 -9.61 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.648 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -77.47 -44.45 28.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.0 111.302 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.97 ' CD2' HG13 ' A' ' 79' ' ' VAL . 16.2 m-85 -91.82 -7.95 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.524 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -52.21 -31.18 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.11 0.481 . . . . 0.0 110.918 179.869 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 107' ' ' LYS . 1.5 t0 -75.35 -10.99 59.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.554 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -122.41 -19.77 6.31 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.857 HG11 HD23 ' A' ' 113' ' ' LEU . 75.8 t -45.18 120.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.025 0.44 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.421 ' HA ' ' CB ' ' A' ' 160' ' ' LYS . 19.4 t70 -100.3 -3.9 30.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.269 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 49.7 m -160.07 141.91 12.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.088 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.857 HD23 HG11 ' A' ' 110' ' ' VAL . 7.3 mt -123.29 147.62 46.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.248 0.547 . . . . 0.0 111.859 -179.161 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.76 113.58 11.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.387 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.792 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.3 m -129.65 140.94 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -110.57 106.76 16.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.507 179.502 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 35.8 mtp180 -80.06 98.64 7.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 6' ' ' ALA . 1.2 mp -81.86 122.67 28.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.29 -66.81 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.51 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.65 162.9 5.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.604 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 p -95.1 168.16 10.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.899 0.381 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 3.4 m-85 -138.76 160.42 39.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -123.48 139.76 53.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.131 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.44 -146.41 5.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.634 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.86 -29.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.508 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.494 ' O ' HD23 ' A' ' 12' ' ' LEU . 5.6 m -108.9 137.98 45.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -178.71 3.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.6 tpt -73.75 159.17 33.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.741 HD13 ' CA ' ' A' ' 104' ' ' THR . 1.0 OUTLIER -89.16 156.23 48.96 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.269 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.36 100.83 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.725 2.283 . . . . 0.0 112.459 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.8 149.14 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 69.11 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.03 0.443 . . . . 0.0 110.709 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.547 ' HH2' HG11 ' A' ' 115' ' ' VAL . 89.9 m95 -55.22 -22.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -31.57 66.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 110.662 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -80.81 -20.06 43.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.937 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.581 ' CD1' HD11 ' A' ' 113' ' ' LEU . 94.1 m-85 -104.26 168.71 8.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.075 0.464 . . . . 0.0 111.29 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.634 ' OG1' ' HE2' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -130.54 142.56 50.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.929 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 6.1 ttpt -81.97 115.03 20.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 157' ' ' VAL . 34.4 m -101.59 -17.43 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.603 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.3 m -165.93 140.64 4.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 110.969 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 83.2 p -165.71 112.87 0.93 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.404 ' C ' HG23 ' A' ' 154' ' ' THR . 7.7 ttt85 -147.85 121.03 8.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.84 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.81 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.6 m -73.54 144.45 46.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.176 0.512 . . . . 0.0 111.916 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 155' ' ' TYR . 6.5 t -117.3 105.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.968 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.438 ' HA ' HG23 ' A' ' 152' ' ' THR . 47.8 mt-10 -90.48 103.36 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.949 -178.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.47 -169.7 2.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.352 179.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.6 p -60.23 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.931 0.396 . . . . 0.0 110.467 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.505 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.1 t30 -67.43 118.61 58.43 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.83 -25.48 61.65 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.887 1.725 . . . . 0.0 112.377 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.42 -20.27 25.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.147 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 mt -86.41 8.88 19.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.71 0.29 . . . . 0.0 111.106 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 153' ' ' HIS . 55.1 m -72.4 168.4 18.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.947 0.403 . . . . 0.0 110.001 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.49 ' N ' HG22 ' A' ' 152' ' ' THR . 1.5 p80 -173.52 160.18 3.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.038 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.81 ' OG1' HG23 ' A' ' 143' ' ' THR . 18.6 m -122.04 145.41 48.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.772 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 144' ' ' VAL . 29.6 m-85 -106.41 104.64 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.767 0.318 . . . . 0.0 110.441 179.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.587 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.4 mt-10 -109.08 127.54 54.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.974 0.416 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.772 ' O ' HG22 ' A' ' 139' ' ' VAL . 25.0 t -117.35 114.02 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.557 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.475 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 28.3 m95 -108.4 148.14 30.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.123 -179.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.455 ' CD ' HG11 ' A' ' 139' ' ' VAL . 24.7 mt-30 -125.49 112.21 15.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -49.32 133.33 19.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.214 0.531 . . . . 0.0 112.259 -179.405 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.634 ' HE2' ' OG1' ' A' ' 137' ' ' THR . 32.6 mtmt -108.48 -178.47 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.786 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.995 -179.875 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 110' ' ' VAL . 25.4 m . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 112' ' ' THR . . . -112.3 151.14 30.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -116.1 111.8 20.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.346 178.933 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.746 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -112.31 122.81 48.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.42 0.628 . . . . 0.0 112.351 -179.042 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.808 ' CH2' HG12 ' A' ' 115' ' ' VAL . 4.8 p90 -168.61 168.8 10.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.674 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.55 133.28 52.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -129.07 164.27 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.137 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' HB3' ' HD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -110.18 -171.62 1.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.101 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -54.96 -30.42 58.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.407 ' N ' ' HG2' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -87.4 -32.22 19.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.903 -179.95 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.25 36.01 3.23 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.651 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.577 HD21 ' HA3' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -93.39 145.92 24.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.772 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 126' ' ' THR . 0.6 OUTLIER -112.33 -54.67 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.409 -179.769 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.19 -158.83 8.39 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.429 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 13.21 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.527 0.203 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.43 28.71 4.63 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.746 0.307 . . . . 0.0 111.089 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.12 -132.76 5.03 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.571 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -81.89 -173.56 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.954 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.21 135.61 59.65 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.973 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.69 162.84 7.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.548 2.165 . . . . 0.0 112.154 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -76.37 145.63 39.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -88.34 143.38 27.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.1 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 10.9 mt -156.25 123.81 2.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.58 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 23' ' ' LEU . 22.8 Cg_exo -64.59 -34.6 51.54 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.627 2.218 . . . . 0.0 113.147 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.24 -25.17 36.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' PHE . 4.4 t0 -95.2 -28.51 15.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' HG ' ' HG2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -67.1 -25.38 66.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.461 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -60.65 -38.2 84.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.659 0.266 . . . . 0.0 111.589 -179.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.529 ' OH ' HD22 ' A' ' 114' ' ' LEU . 46.8 t80 -105.48 -4.76 20.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -86.86 -49.52 7.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.269 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.828 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -91.84 -51.72 5.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.622 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.406 ' H ' ' HG3' ' A' ' 31' ' ' ARG . . . -49.68 -34.76 19.5 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.439 ' HG3' ' CD1' ' A' ' 29' ' ' TYR . 12.4 mm100 -78.76 -7.03 57.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.647 HG21 HD11 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -135.09 -36.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.762 -0.375 . . . . 0.0 112.001 -179.773 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 31' ' ' ARG . 6.2 m -74.54 161.94 4.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.437 -179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 37' ' ' LYS . . . 72.78 9.04 74.31 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 119.186 -0.786 . . . . 0.0 114.287 178.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 36' ' ' GLY . 7.0 mmtp -150.64 -164.97 2.14 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.885 1.342 . . . . 0.0 108.46 179.294 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.455 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 52.9 mt -79.06 88.29 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 118.237 0.471 . . . . 0.0 111.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 34' ' ' THR . 24.1 ttp -96.13 120.13 35.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.403 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 41' ' ' VAL . 21.4 t -81.23 153.42 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 40' ' ' VAL . 28.2 m -161.87 146.42 4.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.58 155.47 51.22 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.841 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.496 ' HA ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.6 -51.33 56.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.938 0.369 . . . . 0.0 110.889 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 44' ' ' ARG . 5.4 tpp180 -60.14 -31.91 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -73.5 -43.4 60.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.612 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 52' ' ' ARG . 24.5 t80 -61.94 -29.24 70.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.8 -66.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.2 p -48.21 -37.08 15.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.357 -179.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' HG11 ' A' ' 41' ' ' VAL . 2.7 m-30 -37.68 149.42 0.19 Allowed Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.492 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.52 -73.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.503 2.135 . . . . 0.0 112.305 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.16 167.42 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.0 111.003 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 45.4 mtp180 -129.13 111.28 18.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.959 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 66.9 Cg_endo -89.5 -171.33 5.88 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.076 -1.218 . . . . 0.0 112.173 -0.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 57' ' ' ARG . 74.7 mt -80.53 158.96 70.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.236 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 58.2 Cg_endo -72.2 107.16 2.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.531 2.154 . . . . 0.0 113.445 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.7 OUTLIER 74.12 4.4 4.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.27 178.899 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.55 ' HD2' ' HB3' ' A' ' 54' ' ' LEU . 15.6 mtt180 -112.6 116.41 30.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 0.0 111.542 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 43.1 m -73.11 111.4 8.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.449 HD21 HD12 ' A' ' 54' ' ' LEU . 3.3 m-80 -98.92 156.94 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.247 0.546 . . . . 0.0 112.195 -178.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 76' ' ' VAL . 7.1 t -137.05 132.17 46.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.16 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 43' ' ' ARG . 88.6 t -104.61 128.39 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.717 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -107.65 125.33 51.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.504 -179.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.6 HG21 ' CG ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -165.68 150.46 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.077 179.618 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 21.5 t-80 -74.43 -2.68 26.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.702 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.869 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 8.6 tp60 -70.95 133.61 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -88.57 -3.23 58.85 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 65' ' ' GLN . 4.9 m-20 -128.25 5.98 5.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.569 0.223 . . . . 0.0 111.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.869 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . 4.0 t80 -59.93 141.8 54.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.236 0.541 . . . . 0.0 111.968 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.862 ' HA ' HG21 ' A' ' 75' ' ' VAL . 13.7 mm100 -127.11 178.45 6.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.08 0.943 . . . . 0.0 112.104 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -156.46 144.53 19.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.607 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -76.96 96.36 4.35 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.338 179.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.88 -40.15 3.09 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.961 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -68.61 168.46 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.732 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 60' ' ' VAL . 15.6 t -96.88 140.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.862 HG21 ' HA ' ' A' ' 69' ' ' GLN . 40.2 t -100.09 107.32 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 0.0 112.314 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.81 HG21 HG22 ' A' ' 82' ' ' VAL . 27.1 m -117.68 161.59 16.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.026 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.48 ' CD2' ' N ' ' A' ' 77' ' ' HIS . 1.3 m170 -111.67 -22.45 11.18 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.231 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.878 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -161.38 -168.86 2.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.174 0.512 . . . . 0.0 111.594 -179.153 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.858 HG13 ' CD2' ' A' ' 106' ' ' PHE . 3.1 t -70.3 -10.19 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.539 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.87 -37.35 16.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.212 0.53 . . . . 0.0 109.768 178.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -72.93 -32.95 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.757 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.811 HG12 HD11 ' A' ' 94' ' ' LEU . 24.3 t -70.0 -51.71 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.102 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 3.4 m-85 -56.33 -27.42 55.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.334 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' CG ' ' A' ' 87' ' ' LYS . . . -64.54 -44.83 89.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.897 179.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.27 -54.07 43.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.974 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -58.07 -22.84 52.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.899 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.21 -30.11 63.28 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.22 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.411 ' N ' ' HG3' ' A' ' 87' ' ' LYS . 5.9 mt-30 -92.95 -13.0 29.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.33 178.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -125.16 65.03 47.42 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.433 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.8 0.17 5.3 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.258 2.638 . . . . 0.0 113.018 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.02 -41.42 35.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -100.51 165.89 11.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.092 0.472 . . . . 0.0 111.669 -179.436 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -98.4 170.38 8.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.034 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.974 HD12 ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -118.58 114.21 22.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.445 -179.465 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 33' ' ' GLN . 21.8 t -128.46 113.29 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.308 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' A' ' 3' ' ' PHE . 5.7 mm -79.11 135.1 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.01 0.433 . . . . 0.0 111.183 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . . . -110.27 -41.3 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.209 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' HA3' ' HA2' ' A' ' 99' ' ' GLY . . . 177.55 -169.7 41.88 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.738 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 98' ' ' GLY . . . -88.3 -160.74 36.32 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 122.103 -0.645 . . . . 0.0 112.558 -0.151 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.49 60.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.669 0.271 . . . . 0.0 111.203 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 -60.19 -30.49 69.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 110.573 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.8 mm -76.88 -26.27 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.936 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 3.5 m-85 -62.58 -58.01 9.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.704 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.501 ' CA ' HD13 ' A' ' 129' ' ' ILE . 8.9 t -67.63 -10.27 50.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.688 -0.633 . . . . 0.0 111.751 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -74.56 -37.7 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.888 ' O ' HG23 ' A' ' 110' ' ' VAL . 2.8 m-85 -101.36 -3.17 29.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.503 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.49 ' HD3' ' OG1' ' A' ' 104' ' ' THR . 20.2 pttp -49.84 -32.5 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.73 0.3 . . . . 0.0 111.486 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -92.5 1.59 57.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.651 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.662 ' CB ' HG11 ' A' ' 79' ' ' VAL . 2.5 m-20 -122.0 -26.87 4.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.705 0.288 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 106' ' ' PHE . 58.6 t -48.96 128.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 160' ' ' LYS . 5.5 t70 -100.99 -7.38 23.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.734 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.3 m -156.21 140.29 16.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 HG11 ' A' ' 110' ' ' VAL . 11.5 mt -120.29 144.71 47.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.184 0.516 . . . . 0.0 111.674 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.529 HD22 ' OH ' ' A' ' 29' ' ' TYR . 9.5 mt -135.61 117.02 14.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.805 179.149 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.808 HG12 ' CH2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -134.94 144.83 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 111.663 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -114.57 109.85 18.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.435 179.319 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -93.45 103.64 15.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.548 -179.79 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 122' ' ' PHE . 1.2 mt -91.32 130.97 37.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.182 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -49.96 70.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.117 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.4 156.16 39.04 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.313 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 86.2 p -101.26 142.97 31.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.856 0.36 . . . . 0.0 111.046 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -123.03 156.55 34.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 179.885 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -113.27 134.83 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.996 0.427 . . . . 0.0 111.409 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.577 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -158.34 -162.44 11.83 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.392 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 8.36 3.02 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.404 ' O ' HG13 ' A' ' 13' ' ' ILE . 6.5 m -120.3 109.93 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.798 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -92.38 142.48 27.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -178.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.907 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.501 HD13 ' CA ' ' A' ' 104' ' ' THR . 2.3 pp -111.75 158.68 35.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.163 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.437 ' O ' HD12 ' A' ' 129' ' ' ILE . 31.2 Cg_exo -59.14 135.46 66.2 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.709 2.273 . . . . 0.0 112.281 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.419 HD11 ' CH2' ' A' ' 5' ' ' TRP . 3.8 mt -120.53 143.4 48.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.129 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 79.56 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -63.53 -15.03 56.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -33.46 62.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.996 0.426 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.6 t70 -83.18 -16.09 47.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.334 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.532 ' CD2' HD11 ' A' ' 113' ' ' LEU . 66.3 m-85 -106.9 164.47 12.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.813 0.34 . . . . 0.0 111.027 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.423 ' OG1' ' HE3' ' A' ' 161' ' ' LYS . 1.1 m -125.6 140.87 52.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 158' ' ' TRP . 0.5 OUTLIER -85.06 114.56 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.677 179.654 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.778 HG11 HE21 ' A' ' 159' ' ' GLN . 16.0 m -101.74 -18.96 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.52 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.69 139.98 9.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.937 0.398 . . . . 0.0 111.248 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 138' ' ' LYS . 0.3 OUTLIER -168.75 106.87 0.45 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.331 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -142.55 122.11 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.367 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 154' ' ' THR . 2.1 m -72.82 145.8 46.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.316 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 152' ' ' THR . 4.7 t -114.99 103.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 178.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 99.23 11.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.471 -179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.84 -177.66 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.7 p -54.33 -54.51 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 1.2 t30 -73.45 124.28 90.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.947 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.13 -29.53 89.33 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.124 1.882 . . . . 0.0 112.268 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.99 -18.52 28.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.801 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 148' ' ' ASN . 14.5 mt -86.03 10.45 14.19 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 153' ' ' HIS . 55.1 m -74.69 166.15 24.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -172.15 158.94 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.218 179.7 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 143' ' ' THR . 33.4 m -123.06 133.76 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -98.77 107.86 20.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.551 ' HB2' HG22 ' A' ' 115' ' ' VAL . 3.3 mt-10 -97.17 149.69 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.002 0.43 . . . . 0.0 111.081 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 139' ' ' VAL . 16.7 t -141.28 106.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.003 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.49 ' CZ2' ' HD3' ' A' ' 138' ' ' LYS . 24.2 m95 -110.15 146.24 35.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.0 111.779 -178.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.778 HE21 HG11 ' A' ' 139' ' ' VAL . 13.7 mt-30 -128.11 119.79 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.159 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 111' ' ' ASP . 7.7 tttm -46.44 129.0 10.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.735 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HE3' ' OG1' ' A' ' 137' ' ' THR . 1.6 ptpt -109.28 -176.85 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.816 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.145 179.973 . . . . . . . . 0 0 . 1 stop_ save_